Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.5987425544352613,-2.085444071196949,0.0,0.13817020731449198,0.116,17/35,7.03%,KSR1;PDE7B;RAPGEF3;IRAG1;PDE4D;APOE;ADGRG6;RAPGEF2;RIMS2;CAP2;GUCY1B1;NUDT4;ADCY1;AHR;AKAP6;HTR2C;PDE2A
prerank,B cell receptor signaling pathway (GO:0050853),-0.6243710832081522,-2.0563695758162996,0.005813953488372093,0.10695397529158823,0.175,11/32,11.76%,BCL2;TEC;PRKCB;RFTN1;BMX;NFATC2;CD38;VAV3;SYK;PIK3CD;SH2B2
prerank,vasculature development (GO:0001944),-0.7397321441324588,-2.0404367789274995,0.0,0.08563141243441354,0.205,14/16,21.09%,CDH5;ERRFI1;PDGFRB;PDGFRA;NOTCH4;FLT4;BMPR2;SOX18;ACVRL1;APLNR;ACVR2B;STRA6;STK11;FOXF1
prerank,collagen fibril organization (GO:0030199),0.7262321835004011,2.0060612081732487,0.0,0.005966747117189595,0.006,30/88,4.96%,COL12A1;PLOD2;COL6A3;COL6A2;COL6A1;ADAMTS3;ADAMTS2;COL8A2;COL8A1;BMP1;COL11A1;DDR2;COL3A1;COL1A2;COL1A1;COL5A3;COL14A1;P4HB;SERPINH1;COL5A2;COL15A1;COL27A1;COL16A1;LOXL1;CYP1B1;TLL1;TGFB2;PLOD1;P3H1;PLOD3
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6100347249025494,-2.0059873854742745,0.0,0.11002442434302138,0.331,14/30,9.27%,TJP1;GJB6;OCLN;PECAM1;CDH5;LAMA2;CLDN5;ESAM;JAM2;LSR;F11R;SLC1A1;CLDN1;MFSD2A
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.7146098330572714,-1.9621522948155834,0.0,0.15065670012365345,0.485,5/15,11.88%,PLTP;APOE;ABCG1;ABCA5;SCARB1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6496496551875766,-1.9152542759581825,0.0038314176245210726,0.22448394176033507,0.677,6/19,6.31%,TJP1;ROCK2;OCLN;CLDN5;PRKCH;F11R
prerank,cellular response to zinc ion (GO:0071294),-0.6570240467776118,-1.8745239551435204,0.0,0.2903767531498212,0.814,12/15,18.02%,GLRA2;MT1B;MT1G;MT1E;MT1F;MT1A;MT1H;MT1M;MT1X;GLRA1;ATP13A2;MT3
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5164509165598322,-1.8728019662470714,0.0,0.25881326796038634,0.823,18/46,14.80%,ATP1A2;GRM7;GRM5;NRXN1;SHANK3;GRM3;GRM8;GRM1;CACNG7;OPHN1;CACNG8;CDH2;HOMER1;CACNG3;CACNG4;DGKZ;RELN;TPRG1L
prerank,melanocyte differentiation (GO:0030318),-0.7333184269402337,-1.8719123978157826,0.006430868167202572,0.23210320422129885,0.826,4/11,4.51%,LRMDA;KIT;ENPP1;MITF
prerank,positive regulation of blood coagulation (GO:0030194),0.8280916116651436,1.8432187203735781,0.0,0.32916554929829267,0.417,3/17,1.07%,THBS1;ST3GAL4;F3
prerank,bicarbonate transport (GO:0015701),0.777752865590275,1.841511889069407,0.0,0.23005124996275436,0.434,7/25,7.30%,SLC4A10;SLC26A7;SLC4A4;SLC26A6;SLC4A8;SLC4A11;SLC4A2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6610609263618069,1.837716282586311,0.0,0.18472054616966121,0.457,11/79,2.20%,BMPER;THBS1;SLIT2;HTRA3;FGF2;SKIL;NEDD4;CRIM1;SMAD9;EMILIN1;SMAD6
prerank,response to ketone (GO:1901654),0.764666770168922,1.8325122541907024,0.0024875621890547263,0.1660744614284437,0.495,5/24,4.20%,THBS1;SLIT3;SLIT2;TGFB3;TGFB2
prerank,response to glucocorticoid (GO:0051384),0.7523615510814674,1.8221798715489343,0.0,0.16988654986442595,0.565,3/26,1.23%,SLIT3;SLIT2;ADAM9
prerank,muscle tissue morphogenesis (GO:0060415),-0.6439433934684752,-1.8211122489037288,0.007575757575757576,0.3446067318725144,0.946,8/16,15.96%,TGFBR3;MYLK;NOTCH1;TBX1;PROX1;HEY2;EFEMP2;BMP2
prerank,negative regulation of leukocyte activation (GO:0002695),-0.6584455740992399,-1.818899921439838,0.0,0.3191406135277491,0.948,12/15,25.05%,IL31RA;NR1H3;LRFN5;CD200;ZC3H12A;CD300A;CD84;HAVCR2;GPER1;MILR1;CD300LF;GRN
prerank,carboxylic acid transmembrane transport (GO:1905039),0.7029438098287745,1.8073665650462833,0.0,0.20102255168626848,0.671,10/40,7.05%,SLC38A2;SLC38A1;SLC23A1;SLC23A2;SLC5A6;SLC16A1;SLC38A6;ABCC1;SLC7A10;SLC38A3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.701518329581426,1.8031605776604016,0.0,0.19093590775006705,0.698,11/39,6.39%,SLIT2;LRP6;SIX1;PKD1;VEGFA;FGF2;GLI2;LRP5;PKHD1;SEMA3E;TGFBR2
prerank,negative regulation of heart contraction (GO:0045822),-0.7130200949790948,-1.8018712243661859,0.010067114093959731,0.3419286179776532,0.966,2/11,1.29%,ATP1A2;PDE4D
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.693177323611205,-1.791580080806155,0.007220216606498195,0.3444414000005141,0.975,7/12,21.69%,IL34;LYN;BST2;CSF1;PTK2;MAPK3;CSF1R
prerank,external encapsulating structure organization (GO:0045229),0.6099924504222665,1.7878827101561663,0.0,0.23038273591370936,0.785,36/205,3.24%,THBS1;COL6A3;COL6A2;SMOC2;COL6A1;ADAMTSL3;SH3PXD2A;ADAMTS3;ADAMTS17;ADAMTS2;SMOC1;COL8A2;COL8A1;MFAP5;ELN;COL11A1;ITGA11;DDR2;FGF2;COL3A1;COL1A2;COL1A1;COL5A3;COL14A1;TGFBI;ADAMTSL1;COL5A2;BGN;VIT;COL15A1;COL27A1;COL16A1;LOXL1;DMP1;COMP;SPARC
prerank,extracellular matrix organization (GO:0030198),0.6047366074284777,1.7868019586271935,0.0,0.2121178600160901,0.792,58/276,6.99%,COL12A1;PLOD2;THBS1;COL6A3;COL6A2;SMOC2;COL6A1;ADAMTSL3;SH3PXD2A;ADAMTS3;ADAMTS17;ADAMTS2;SMOC1;COL8A2;COL8A1;BMP1;MFAP5;ELN;COL11A1;ITGA11;GAS6;DDR2;FGF2;COL3A1;COL1A2;GSN;COL1A1;COL5A3;COL14A1;P4HB;HTRA1;TGFBI;SERPINH1;TIMP2;ADAMTSL1;COL5A2;BGN;VIT;COL15A1;COL27A1;COL16A1;LOXL1;DMP1;COMP;SPARC;CYP1B1;TLL1;TGFB2;ADAMTS10;PLOD1;P3H1;PLOD3;MMP28;ADAM10;P4HA1;MMP14;LOX;QSOX1
prerank,extracellular structure organization (GO:0043062),0.6082893899909663,1.782849037375243,0.0,0.20901695962033853,0.819,36/204,3.24%,THBS1;COL6A3;COL6A2;SMOC2;COL6A1;ADAMTSL3;SH3PXD2A;ADAMTS3;ADAMTS17;ADAMTS2;SMOC1;COL8A2;COL8A1;MFAP5;ELN;COL11A1;ITGA11;DDR2;FGF2;COL3A1;COL1A2;COL1A1;COL5A3;COL14A1;TGFBI;ADAMTSL1;COL5A2;BGN;VIT;COL15A1;COL27A1;COL16A1;LOXL1;DMP1;COMP;SPARC
prerank,positive regulation of coagulation (GO:0050820),0.8788447909229238,1.7758256193074173,0.0,0.20156895709993053,0.851,2/10,0.30%,THBS1;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.8788447909229238,1.7758256193074173,0.0,0.20156895709993053,0.851,2/10,0.30%,THBS1;ST3GAL4
prerank,positive regulation of macrophage activation (GO:0043032),0.7896642998220498,1.7721220531302306,0.001310615989515072,0.19953086490697108,0.874,3/17,1.29%,THBS1;LBP;IL33
prerank,protein hydroxylation (GO:0018126),0.8087455254100261,1.76869008145522,0.001358695652173913,0.19875897619260452,0.89,6/15,7.69%,PLOD2;P3H3;PLOD1;P3H1;PLOD3;P3H2
prerank,establishment of endothelial barrier (GO:0061028),-0.5394000347028246,-1.7673571533732062,0.0,0.396380351354061,0.989,11/29,11.59%,TJP1;RAPGEF3;PDE4D;PECAM1;PPP1R16B;RAPGEF2;F11R;PDE2A;ROBO4;SOX18;RAP2B
prerank,Golgi to endosome transport (GO:0006895),0.7843781609216752,1.764185069013326,0.0013404825737265416,0.20305586283185842,0.914,6/16,7.32%,VPS13A;VPS13C;DOP1B;AP2A1;GBF1;MON2
prerank,negative regulation of interleukin-12 production (GO:0032695),0.8188443199219113,1.7635630222710377,0.0,0.19298332097655368,0.915,3/14,7.14%,THBS1;CMKLR1;IRAK3
prerank,regulation of cellular pH (GO:0030641),0.7106954924901516,1.7590197128609963,0.0012121212121212121,0.1978418650616291,0.931,9/29,7.30%,SLC4A10;SLC4A4;SLC26A6;SLC4A8;TM9SF4;SLC9A8;SLC9A4;SLC9A1;SLC4A2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.6847234406911263,-1.7522718583480668,0.020134228187919462,0.4184680896097675,0.993,3/12,2.53%,ROCK2;APOE;PICALM
prerank,type I interferon signaling pathway (GO:0060337),-0.4940390712980907,-1.7520138159008634,0.0,0.37007941802273736,0.993,23/41,21.25%,IFNAR2;STAT1;SAMHD1;IFITM1;BST2;SP100;IFIT3;IP6K2;IFIT2;RNASEL;IFIT1;EGR1;RSAD2;IFITM3;OAS2;PSMB8;IRF9;IFI27;MYD88;IRF8;ISG15;IRF7;ADAR
prerank,cellular response to type I interferon (GO:0071357),-0.4940390712980907,-1.7520138159008634,0.0,0.37007941802273736,0.993,23/41,21.25%,IFNAR2;STAT1;SAMHD1;IFITM1;BST2;SP100;IFIT3;IP6K2;IFIT2;RNASEL;IFIT1;EGR1;RSAD2;IFITM3;OAS2;PSMB8;IRF9;IFI27;MYD88;IRF8;ISG15;IRF7;ADAR
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.6588176491208014,1.744821542100544,0.001141552511415525,0.2416532582461786,0.964,11/51,8.27%,BMPER;HTRA3;CHRDL1;FSTL1;SKIL;CRIM1;SMAD9;SMAD6;SMAD4;SKI;NOG
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.7807896639433283,1.7438993911616827,0.002688172043010753,0.23300147492625367,0.965,5/16,6.30%,ESR1;DDX5;DDX17;RBFOX2;SAFB
prerank,positive regulation of leukocyte activation (GO:0002696),0.760886904471328,1.735811809089147,0.001314060446780552,0.25439178979001986,0.973,3/18,1.29%,THBS1;LBP;IL33
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.7687679006614194,1.7343105820728217,0.00130718954248366,0.2488404763646115,0.974,3/18,1.72%,IRS1;KCNB1;CCN3
prerank,Rap protein signal transduction (GO:0032486),-0.7022682079574908,-1.7327668867940413,0.00967741935483871,0.4072893806558461,0.998,4/10,11.64%,RAPGEF3;RAPGEF2;RAP2B;PLK2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.757587746944736,1.7323449233797452,0.0038510911424903724,0.24671202210640455,0.976,5/20,8.27%,THBS1;SMOC2;FGF2;SULF1;NOG
prerank,cAMP-mediated signaling (GO:0019933),-0.5543607149868908,-1.7314740169938536,0.005154639175257732,0.3898931620047925,0.998,12/24,7.03%,KSR1;PDE7B;RAPGEF3;PDE4D;ADGRG6;RAPGEF2;RIMS2;CAP2;ADCY1;AHR;AKAP6;PDE2A
prerank,cardiac muscle cell contraction (GO:0086003),0.7629879890705594,1.7289713259263468,0.0013192612137203166,0.2523436801644766,0.978,5/19,3.61%,KCNJ2;CACNA1G;CACNA1C;GSN;CAMK2D
prerank,mesonephros development (GO:0001823),-0.6788209403488408,-1.7287865998544116,0.007220216606498195,0.37899576124856577,0.998,4/11,2.44%,OSR1;ZBTB16;BMP7;FGF1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6786962821993132,1.72553301807048,0.004728132387706856,0.2565701260391526,0.98,11/35,11.56%,ESR1;PMEPA1;NEDD4;DDX5;DDX17;ZMIZ1;RBFOX2;PLPP1;SAFB;UBR5;RNF14
prerank,negative regulation of insulin secretion (GO:0046676),0.7631858534772075,1.7221578815195175,0.003875968992248062,0.2611216831349574,0.985,3/17,1.72%,IRS1;KCNB1;CCN3
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.8019178503885354,1.7197101179181131,0.004201680672268907,0.2604742939059556,0.988,2/13,0.94%,CACNA1G;KCNB1
prerank,motor neuron axon guidance (GO:0008045),0.7923221855364933,1.7183665994373727,0.005449591280653951,0.2563925442797124,0.989,4/15,2.65%,SLIT2;SLIT1;NTN1;TMEFF1
prerank,embryonic digestive tract development (GO:0048566),0.7593118619441671,1.71449552328574,0.002574002574002574,0.2640799974107878,0.99,6/18,4.20%,PKDCC;ID2;PCSK5;RARB;GLI2;TGFB2
prerank,regulation of intracellular pH (GO:0051453),0.6769147609380869,1.7058375112025819,0.004767580452920143,0.29130985369923423,0.996,13/34,15.01%,SLC4A10;SLC4A4;SLC26A6;SLC4A8;TM9SF4;SLC9A8;SLC9A4;SLC9A1;SLC4A2;TMEM165;CHP1;SLC4A3;SLC4A5
prerank,regulation of fibrinolysis (GO:0051917),0.8004726722776937,1.7054737286140809,0.004189944134078212,0.2832921709242006,0.996,2/13,3.76%,THBS1;FAP
prerank,digestive tract development (GO:0048565),0.6716586143747757,1.7030611361827324,0.0035545023696682463,0.28407310103244837,0.997,12/33,9.71%,PKD1;PKDCC;PCSK5;RARB;GLI2;COBL;CLMP;TGFB2;AGR2;EPHB3;CCDC39;FGFR2
prerank,ion homeostasis (GO:0050801),0.6973926217706422,1.7023435736507253,0.004895960832313341,0.27796603741897385,0.998,12/30,15.01%,SLC4A10;SLC4A4;FHL1;HCN4;SLC4A8;CAMK2D;SLC4A11;SLC4A2;AP3D1;SLC4A3;WNK1;SLC4A5
prerank,carbohydrate transport (GO:0008643),0.8213916598275793,1.6967316772492633,0.001366120218579235,0.2948860021348309,0.999,3/11,2.98%,SLC23A1;SLC23A2;SLC26A6
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6565331669316248,-1.6957441779189146,0.025362318840579712,0.4648562389296735,1.0,2/12,0.54%,IGF1R;INSR
prerank,lipoprotein catabolic process (GO:0042159),-0.667895485952937,-1.6951258879421125,0.02356902356902357,0.4465642491622251,1.0,4/11,15.58%,APOE;NOTUM;ABHD17C;LYPLA1
prerank,response to prostaglandin E (GO:0034695),-0.6836204348307262,-1.6942897923476663,0.017421602787456445,0.4299073664622566,1.0,3/10,12.39%,TGFBR3;GNG2;SFRP1
prerank,regulation of cell junction assembly (GO:1901888),-0.543314427848886,-1.690926724774483,0.005,0.4237219690977753,1.0,7/27,6.31%,TJP1;ROCK2;OCLN;CLDN5;RAPGEF2;PRKCH;F11R
prerank,regulation of acrosome reaction (GO:0060046),-0.7003336778631801,-1.6903797748444058,0.021739130434782608,0.4080831485958091,1.0,1/10,0.15%,PLCB1
prerank,transition metal ion transport (GO:0000041),-0.49147621106068945,-1.688711530702502,0.006211180124223602,0.3978987052805939,1.0,6/35,6.30%,CP;SLC30A10;TRPC3;TFRC;SLC39A8;TRPC6
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6971444472037703,-1.6874213664178286,0.014760147601476014,0.38710402115105397,1.0,2/10,2.11%,LYN;KIT
prerank,regulation of muscle cell differentiation (GO:0051147),0.6789194163829855,1.687050197732662,0.0012121212121212121,0.32959174552094905,1.0,11/31,13.64%,BOC;CDON;ID2;HDAC9;FGFR2;ABL1;MAPK12;SRF;MEF2A;PTBP1;RBM4
prerank,regulation of mononuclear cell migration (GO:0071675),0.7154055177174359,1.681511223773415,0.0037926675094816687,0.3474801480885552,1.0,3/23,0.51%,THBS1;SLIT2;CMKLR1
prerank,regulation of fibroblast migration (GO:0010762),0.7316534103731325,1.6725958127270548,0.006345177664974619,0.38474768010166244,1.0,4/20,2.21%,THBS1;DDR2;FGF2;PRKCE
prerank,B cell homeostasis (GO:0001782),-0.6942068526121996,-1.67230696897942,0.021148036253776436,0.41644792908307054,1.0,3/10,3.05%,LYN;DOCK11;DOCK10
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.7273982252103318,1.6705600682809947,0.007761966364812419,0.38564028736362227,1.0,8/18,16.21%,ESR1;EGFR;DDX5;NCOR2;BMP4;TERT;IL6;ZC3H10
prerank,regulation of BMP signaling pathway (GO:0030510),0.6043668911832609,1.6703958890380675,0.0,0.3767720316392883,1.0,18/73,11.76%,BMPER;HTRA3;FSTL1;ZNF423;FOXD1;SKIL;SFRP4;CRIM1;SMAD9;SMAD6;HES5;SMAD4;SULF1;SKI;NOG;BMP4;BMPR1A;SMAD7
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6727074065324539,-1.6691444393049957,0.0273972602739726,0.4128165810875128,1.0,4/10,8.23%,SLC1A3;SLC25A13;SLC1A1;SLC1A2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.8167330406974445,1.669052625100051,0.005555555555555556,0.3737918454456065,1.0,2/11,1.72%,SLIT2;CCN3
prerank,skeletal system development (GO:0001501),0.5774596396858279,1.6682252583637769,0.0,0.3688953532737258,1.0,34/148,9.71%,MYOC;GNAS;EXT1;PKD1;XYLT1;CMKLR1;CDH11;PKDCC;GDF10;BMP1;ALPL;PCSK5;COL1A2;COL1A1;NPR3;PAPSS2;GLI2;COMP;DEAF1;TLL1;HES5;TGFB2;P3H1;KIAA1217;SLC10A7;SULF1;MMP14;FGFR1;SOX9;NOG;HAPLN4;SH3PXD2B;EVC;FGFR2
prerank,endoderm formation (GO:0001706),0.6713226703107048,1.668147918327858,0.001182033096926714,0.36053832679938874,1.0,4/35,0.88%,COL12A1;COL6A1;COL8A1;COL11A1
prerank,cell differentiation in spinal cord (GO:0021515),-0.671924536459322,-1.6645874961608136,0.03669724770642202,0.41273658471375896,1.0,3/10,3.71%,SOX13;MDGA2;SOX6
prerank,transepithelial transport (GO:0070633),0.7522348345130812,1.66278480245951,0.009873060648801129,0.3786109188198095,1.0,5/15,3.96%,SLC23A1;SLC23A2;SLC12A2;SLC26A6;ABCC1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.7209790085334229,1.6626433842400319,0.005305039787798408,0.37075196859991705,1.0,4/20,1.33%,THBS1;PDCD4;GSN;SFRP4
prerank,endodermal cell differentiation (GO:0035987),0.680823993584259,1.6620565624307266,0.004819277108433735,0.36525331982559117,1.0,4/31,0.88%,COL12A1;COL6A1;COL8A1;COL11A1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5966266602004493,-1.6616199348516947,0.030508474576271188,0.40724719407987064,1.0,6/15,7.99%,GRM7;GRM5;GRM3;GRM8;GRM1;HOMER1
prerank,positive regulation of wound healing (GO:0090303),0.6489046349328875,1.6539325095685826,0.007471980074719801,0.39858303115806004,1.0,5/36,2.21%,THBS1;SMOC2;ST3GAL4;PRKCE;PLPP3
prerank,peptide cross-linking (GO:0018149),0.6886395282815667,1.652760600071415,0.005025125628140704,0.39568843205164056,1.0,4/25,2.73%,THBS1;COL3A1;TGM5;TGM6
prerank,negative regulation of coagulation (GO:0050819),-0.6092877200868948,-1.649299996247634,0.02364864864864865,0.43133412403778676,1.0,6/14,13.04%,VTN;APOE;TFPI;EDN1;SERPINE1;CD34
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.5906608877257463,1.646869702099432,0.0,0.41889465264741815,1.0,43/80,24.01%,ARFGAP1;ARFGAP3;KDELR3;PLPP3;SCYL1;ARCN1;COPA;COPB1;COPG1;TMEM115;COPE;ARFGAP2;GBF1;KLC2;KDELR1;ARF4;COPZ2;ERGIC1;NSF;SCFD1;KDELR2;ATP9A;TMED9;RER1;ZW10;PICK1;LMAN2;ERGIC2;SEC22B;RINT1;COPB2;KLC1;NAPA;GOLPH3;BNIP1;TMED2;RAB1A;UVRAG;RAB1B;COPZ1;USE1;ARF5;TMED7
prerank,organic cation transport (GO:0015695),0.7018823020417468,1.6452293433873837,0.006493506493506494,0.41919442756990166,1.0,1/20,0.01%,SLC47A1
prerank,amino acid transmembrane transport (GO:0003333),0.6213642879806948,1.6437620435124547,0.005780346820809248,0.41840819701439164,1.0,8/45,7.05%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SFXN3;LRRC8D;SLC7A10;SLC38A3
prerank,response to zinc ion (GO:0010043),-0.5119240931783945,-1.6437160575894174,0.005235602094240838,0.43420491636428454,1.0,14/25,18.02%,PAM;GLRA2;CRIP1;MT1B;MT1G;MT1E;MT1F;MT1A;MT1H;MT1M;MT1X;GLRA1;ATP13A2;MT3
prerank,nucleotide biosynthetic process (GO:0009165),0.7178832849065595,1.6417379653202608,0.01683937823834197,0.4220401130864431,1.0,2/18,0.29%,PRPS2;ME1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.6779423480249824,-1.6414670695685938,0.024305555555555556,0.4282072329082023,1.0,3/10,7.81%,TGFA;ADRA2A;HBEGF
prerank,atrioventricular valve morphogenesis (GO:0003181),0.7132351978950979,1.6404576114849316,0.00651890482398957,0.4209999071724735,1.0,10/19,12.13%,SLIT3;SMAD6;TGFB2;ACVR1;SMAD4;TGFBR2;HEYL;MDM4;BMPR1A;HEY1
prerank,androgen receptor signaling pathway (GO:0030521),0.784240966714266,1.6403850971113876,0.011095700416088766,0.41365694008038306,1.0,6/11,11.56%,PMEPA1;DDX5;DDX17;ZMIZ1;PLPP1;RNF14
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.5476277642577084,-1.6400200668424256,0.009523809523809525,0.4205930353025054,1.0,5/22,8.98%,SORBS1;APOE;PPARA;PPARD;ZBTB20
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.728643823156053,1.6388466219337814,0.017105263157894738,0.4147625881893335,1.0,8/18,15.53%,NUP93;ENY2;NXF1;ZC3H11A;PABPN1;SARNP;DDX19A;THOC2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5753954400693234,1.6385149549923277,0.0,0.4090114743574116,1.0,32/104,17.11%,BMPER;HTRA3;HTRA4;PMEPA1;SKIL;CRIM1;CCN3;SMAD9;EMILIN1;SMAD6;LDLRAD4;SPRED2;ACVR1;BCL9L;SMAD4;TGFBR2;SKI;NOG;BMPR1A;PDPK1;SMAD7;CIDEA;TGFB1I1;TGFBR1;LRP2;NBL1;STUB1;CD109;IL17RD;RPS27A;UBC;SLC2A10
prerank,spliceosomal complex assembly (GO:0000245),0.6114467576299847,1.63651467417177,0.008036739380022962,0.4120251982530743,1.0,20/46,17.74%,SRSF6;KHDC4;LUC7L2;SRSF1;NOL3;SRSF5;CELF4;CELF3;LUC7L;LUC7L3;SF3B1;SF3A1;RBM5;CRNKL1;ZRSR2;SRPK1;YTHDC1;NCBP1;SMN1;SRSF10
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7535456326818901,1.6362286599000224,0.010854816824966078,0.40626220283882136,1.0,3/15,1.12%,THBS1;SMOC2;FGF2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7239652905717011,1.6354490045700647,0.018396846254927726,0.4032526593367302,1.0,4/17,6.57%,SLIT2;FSTL1;SFRP4;SULF1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7162397412502299,1.6341273269305046,0.015424164524421594,0.4035307704311754,1.0,4/19,1.98%,SLC26A2;PAPSS2;SULT1C2;SULT1C4
prerank,axon extension (GO:0048675),0.6930345264955494,1.6325673210473766,0.01272264631043257,0.4052912979351033,1.0,5/23,1.37%,SLIT3;SLIT2;SLIT1;MAP1B;ULK2
prerank,regulation of interleukin-1 production (GO:0032652),0.7540465398484391,1.6323611579928519,0.012,0.39969054391294345,1.0,5/15,13.07%,FOXP1;GAS6;HMGB1;ANXA1;F2R
prerank,myoblast differentiation (GO:0045445),0.7597578903137573,1.6323101212527333,0.013568521031207599,0.39348451687875036,1.0,7/14,11.43%,TCF7L2;DDX5;DDX17;SDC1;MBNL1;JAG1;MAPK12
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.7500927914440204,1.631159980265958,0.005398110661268556,0.39331597333072255,1.0,7/15,12.84%,SIX1;VEGFA;SIX4;SOX9;NOG;BMP4;SMO
prerank,embryonic skeletal system development (GO:0048706),0.6612097863431425,1.6307958603995247,0.004767580452920143,0.38875532845043353,1.0,12/35,8.27%,SIX1;XYLT1;WNT9A;PCSK5;HOXA3;COL1A1;DEAF1;HOXB3;KIAA1217;SULF1;HOXA9;NOG
prerank,heart trabecula morphogenesis (GO:0061384),-0.5651578170424093,-1.6298639494333784,0.01702127659574468,0.4386477630977977,1.0,9/18,7.37%,TGFBR3;ENG;TEK;ADGRG6;BMP7;RBP4;NOTCH1;S1PR1;RBPJ
prerank,response to hexose (GO:0009746),0.6868112728810405,1.6298312459953763,0.013871374527112233,0.3876090723435856,1.0,2/25,1.27%,THBS1;TCF7L2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.6481285872698647,1.6295551927831757,0.010575793184488837,0.38309228650137744,1.0,5/33,1.12%,BMPER;THBS1;RHOJ;VEGFA;FGF2
prerank,regulation of cilium movement (GO:0003352),0.8020348845853292,1.6292109879743262,0.009859154929577466,0.3789478125596208,1.0,5/10,11.53%,CFAP298;CFAP206;ODAD2;CCDC39;CFAP43
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.7268937331108001,1.6288749358613654,0.011968085106382979,0.3746619960668633,1.0,6/17,15.34%,CACNA1G;KCNB1;SLC4A8;RAB3D;NLGN1;STX1A
prerank,O-glycan processing (GO:0016266),0.6036780432359717,1.628850125081648,0.0067039106145251395,0.369347411527096,1.0,10/54,9.01%,ST3GAL4;GXYLT2;GALNT10;GALNT15;GALNT13;MUC1;B3GNT7;MUC13;ST3GAL2;B4GALT5
prerank,endothelial cell development (GO:0001885),-0.5062947141967299,-1.6261366067476108,0.02,0.43799540793146463,1.0,9/25,7.31%,COL22A1;RAPGEF3;PDE4D;PECAM1;COL18A1;PPP1R16B;RAPGEF2;PDE2A;ROBO4
prerank,negative regulation of cellular protein localization (GO:1903828),-0.4716443245088039,-1.6253432503852245,0.006024096385542169,0.42883938418349726,1.0,6/34,2.53%,ROCK2;MFHAS1;NEDD4L;ACTN2;RIPOR2;PICALM
prerank,response to estradiol (GO:0032355),0.6597726060320113,1.6238614756160663,0.006002400960384154,0.38734133369089124,1.0,8/31,9.84%,ESR1;EGFR;CYP19A1;STAT3;NRIP1;SOCS2;ANXA1;FOXA1
prerank,negative regulation of hemostasis (GO:1900047),-0.6329396237456523,-1.6233160107786138,0.035256410256410256,0.42332832178348906,1.0,6/12,13.04%,VTN;APOE;TFPI;EDN1;SERPINE1;CD34
prerank,neutral amino acid transport (GO:0015804),0.6635939892982363,1.622534554183818,0.017220172201722016,0.3883147818708083,1.0,8/28,9.01%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC7A10;SLC38A3;SLC43A1;SLC6A7
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.7439291702211555,1.6212739194401347,0.015047879616963064,0.388653465580088,1.0,2/14,1.28%,THBS1;PDCD4
prerank,organic anion transport (GO:0015711),0.590142638416918,1.6208700878111055,0.004338394793926247,0.3850186615824875,1.0,10/76,5.65%,SLC4A10;SLC26A7;SLC4A4;SLC23A1;SLCO3A1;SLCO2A1;SLC26A6;SLC4A8;LRRC8D;SLC4A11
prerank,monosaccharide transmembrane transport (GO:0015749),0.7209790682528047,1.6202285331800643,0.013003901170351105,0.3824631147639997,1.0,3/16,2.03%,SLC23A1;SLC23A2;SLC5A2
prerank,negative regulation of protein catabolic process (GO:0042177),0.6277907501035123,1.6175450100424311,0.006936416184971098,0.39009266708381757,1.0,15/40,16.82%,EGFR;TIMP2;PTPN3;TIMP3;RILP;SNRNP70;RIC1;IRAK3;MDM4;CST3;CDK5RAP3;RGP1;NELL1;SIRT2;AZIN1
prerank,negative regulation of macroautophagy (GO:0016242),0.667283501283194,1.6172074645418437,0.01597051597051597,0.3864253856685156,1.0,19/26,24.52%,TMEM39A;LZTS1;NRBP2;QSOX1;CLEC16A;SCFD1;SMG1;PHF23;USP36;SEC22B;AKT1;CHMP4A;CHMP4B;LRRK2;RUBCN;TSC2;MTM1;SMCR8;PINK1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.6409244289159686,-1.6147563258055921,0.030405405405405407,0.43707842247150963,1.0,5/12,20.76%,GCNT2;BMP7;CD44;THY1;AGER
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.4983250889641293,-1.6130917677402594,0.03048780487804878,0.4311110172215495,1.0,6/29,6.41%,TGFBR3;ENG;NOTCH1;TPM1;PROX1;S1PR1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.5525485439093696,1.6122835647283351,0.0,0.40477017619012795,1.0,92/173,24.31%,GAS6;ARFGAP1;ARFGAP3;SEC31A;KDELR3;SEC24D;STX5;ATL2;SEC13;ARCN1;SEC23A;LMAN2L;RAB2A;COPA;COPB1;DYNC1H1;GOPC;COPG1;NRBP2;GOLGB1;TMEM115;ATL3;CNIH4;CNIH2;COPE;ARFGAP2;PROZ;ANK2;GBF1;KDELR1;ARF4;COPZ2;ERGIC1;BET1;DCTN2;NSF;SCFD1;KDELR2;HYOU1;SPAST;TRAPPC12;TRAPPC6A;BCAP31;TMED9;USO1;NRBP1;ZW10;DYNC1LI2;SEC24C;TRIP11;SEC24B;PREB;LMAN2;ERGIC2;SEC16A;SEC22B;BCAP29;MIA3;COPB2;CNIH1;COG6;DCTN5;SEC16B;SPTBN1;YIF1A;SEC24A;IER3IP1;NAPA;TMED2;COG2;TRAPPC3;ACTR10;CTSZ;TRAPPC11;COG8;DYNC1I2;TRAPPC6B;DCTN1;MIA2;CAPZA1;COG5;RAB1A;LMAN1;KLHL12;ACTR1A;VAMP4;RAB1B;COPZ1;USE1;PGAP1;TMED7;BET1L
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7205890822809076,1.6095967991073532,0.01859229747675963,0.41240677136694837,1.0,3/16,1.12%,THBS1;VEGFA;FGF2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.48306194911680256,-1.607573196837331,0.024509803921568627,0.4378070449051433,1.0,13/30,17.41%,BCL2L1;NOS3;FAS;DDX3X;RFFL;ARHGEF2;FAIM;SERPINE1;FAIM2;GPX1;TNFAIP3;ICAM1;BRCA1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.7446938537223201,1.6074075576064273,0.013458950201884253,0.41728206790657785,1.0,2/14,0.51%,THBS1;CMKLR1
prerank,cellular response to estradiol stimulus (GO:0071392),0.7069059055021635,1.606227712863211,0.016774193548387096,0.4178338976043622,1.0,2/18,0.31%,ESR1;EGFR
prerank,regulation of protein acetylation (GO:1901983),-0.6123491942565351,-1.606097117621446,0.028169014084507043,0.4321954564025056,1.0,5/12,14.05%,RAPGEF3;DDX3X;FAM161A;TERF2IP;SIRT1
prerank,anterior/posterior pattern specification (GO:0009952),0.6017664203930235,1.6044648952550424,0.0033370411568409346,0.421343198178662,1.0,17/53,13.92%,HOXA5;PCSK5;HOXA3;HOXB6;LRP5;HOXC6;HOXB3;HES5;BHLHE40;SKI;HEYL;HOXA9;HOXA6;HEY1;TGFBR1;HOXB4;HOXA4
prerank,retinoic acid metabolic process (GO:0042573),-0.5848752095293666,-1.602928808408013,0.03435114503816794,0.4317004844359691,1.0,6/14,20.85%,ALDH1A2;CYP26B1;ADH1A;ALDH1A3;CYP2S1;BCO2
prerank,apoptotic cell clearance (GO:0043277),0.6605973781561203,1.6027183952211652,0.009696969696969697,0.4244030800122965,1.0,8/30,9.72%,THBS1;RHOBTB1;GAS6;LRP1;HMGB1;RARA;ANXA1;ITGAV
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.714481709311805,1.60236317369461,0.020942408376963352,0.4210510586190296,1.0,9/16,15.34%,SRSF6;DDX5;DDX17;SRSF1;CELF4;SFPQ;HNRNPM;RBM17;SCNM1
prerank,amino sugar biosynthetic process (GO:0046349),0.7675771001513557,1.602212796157034,0.02051983584131327,0.41665416278248135,1.0,6/12,8.39%,UAP1L1;PGM3;GFPT1;GNPDA1;GFPT2;NANP
prerank,detection of mechanical stimulus (GO:0050982),0.7073630233158342,1.6021038012786346,0.016709511568123392,0.4124309203434659,1.0,5/19,10.81%,PIEZO2;PKD1;LHFPL5;JUP;CSRP3
prerank,cell-cell junction organization (GO:0045216),-0.40603391912123554,-1.598147227363517,0.0,0.43511674668864947,1.0,25/79,9.52%,TJP1;SDK1;TLN2;CADM1;CDH8;CDH13;OCLN;CDH5;CLDN5;CADM2;LIMS2;PKP4;SMAD3;CDH4;ARVCF;GJC1;CXADR;CDH1;CDH6;CDH2;CLDN1;NECTIN2;CDH7;CDH19;CDH20
prerank,atrioventricular valve development (GO:0003171),0.7270361867940128,1.5974916875501444,0.024691358024691357,0.4300567675104617,1.0,7/14,11.28%,SLIT3;TGFB2;ACVR1;TGFBR2;HEYL;MDM4;BMPR1A
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6605580976347583,-1.5969537496555946,0.046296296296296294,0.42850563972138495,1.0,5/10,10.96%,LRCH1;RIPOR2;APOD;CD200;PADI2
prerank,cellular component maintenance (GO:0043954),-0.599134716964359,-1.5957354544182663,0.023809523809523808,0.4228944721902969,1.0,4/12,9.00%,IGF1R;INSR;ITGA3;CLDN1
prerank,neuron remodeling (GO:0016322),-0.6576136974369514,-1.5944182755939702,0.046296296296296294,0.4174531356177659,1.0,8/10,16.32%,APP;EPHA8;ANKS1A;ADGRB3;CX3CL1;C1QA;SCARF1;C3
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5940091041118895,1.5942168529508538,0.006659267480577136,0.44139068952160193,1.0,19/56,14.52%,BMPER;GDF10;PMEPA1;EMILIN1;INHBC;SMAD6;TGFB3;LDLRAD4;TGFB2;ACVR1;SMAD4;NOG;BMP4;BMPR1A;SMAD7;TGFBR1;INHBA;DAB2;BMP5
prerank,dopaminergic neuron differentiation (GO:0071542),0.6978706556266456,1.5940589327117345,0.02328589909443726,0.43724503685284055,1.0,4/19,13.61%,LRP6;VEGFA;FOXA1;MANF
prerank,mesonephric tubule development (GO:0072164),0.7197417213779573,1.5934739382209426,0.02086230876216968,0.4354049342987396,1.0,3/15,0.46%,SLIT2;SIX1;PKD1
prerank,response to alcohol (GO:0097305),0.6463505118873091,1.5899316590334691,0.018315018315018316,0.4472187459650586,1.0,7/27,12.61%,SLIT3;SLIT2;GRIN3A;TGFBR2;CHRNB2;SOD1;TGFBR1
prerank,bone development (GO:0060348),0.6217594463648828,1.5881267757528834,0.008215962441314555,0.4517352116909639,1.0,12/39,11.15%,MYOC;GNAS;LRP6;SFRP4;LRP5;P3H1;SLC10A7;SULF1;SKI;SH3PXD2B;FGFR2;IFITM5
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.64238202674904,1.586886070306697,0.017094017094017096,0.45267289089432217,1.0,15/29,20.54%,GOLGA5;COPA;COPB1;TRAPPC10;COPG1;COPE;COPZ2;NSF;COPB2;COG6;NAPA;COG2;TRAPPC3;COG8;COG5
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.6774712665522499,1.584514729971878,0.012610340479192938,0.4589476456447624,1.0,6/23,12.78%,SLC12A7;SLC12A2;SLC9A1;SLC12A4;SLC26A4;SCNN1A
prerank,cGMP-mediated signaling (GO:0019934),-0.5998008875414075,-1.5839171632939115,0.042801556420233464,0.4382387180144151,1.0,6/13,8.10%,IRAG1;APOE;GUCY1B1;HTR2C;PDE2A;KCNC2
prerank,negative regulation of protein processing (GO:0010955),0.7406311388681346,1.5838602194385354,0.019858156028368795,0.4575352470287511,1.0,2/12,3.37%,THBS1;GAS1
prerank,positive regulation of chemotaxis (GO:0050921),0.6153700294913143,1.5835458364904502,0.013636363636363636,0.45431021909829555,1.0,6/43,1.89%,THBS1;SMOC2;VEGFA;F3;FGF2;NTRK3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.7224343340323472,1.5832772386366167,0.033967391304347824,0.4510384309540836,1.0,3/15,2.87%,PIEZO2;COL11A1;LHFPL5
prerank,regulation of sensory perception of pain (GO:0051930),0.7772313481826179,1.583072271717834,0.020028612303290415,0.4474547730751544,1.0,7/11,16.95%,MGLL;TMEM100;CCN3;SCN11A;VIP;F2R;ACP3
prerank,actomyosin structure organization (GO:0031032),-0.39652734513298094,-1.5829075171812672,0.013513513513513514,0.4320940601780164,1.0,19/75,8.20%,TJP1;SORBS1;FRMD5;ROCK2;PHACTR1;FAM171A1;ACTN2;EPB41L3;EPB41;TPM1;PGM5;MYH10;TMOD3;TMOD1;F11R;MYH9;TNFAIP1;FRMD3;LMOD1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.686189421535987,1.5827416797581428,0.01509433962264151,0.4444414799977379,1.0,2/21,0.51%,THBS1;CMKLR1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.4758695480610197,-1.58169690209553,0.011049723756906077,0.4268124864436623,1.0,15/32,16.32%,SORBS1;APOE;PPARA;PRKAA2;PRKAG2;ADIPOR1;ZBTB20;MID1IP1;ASXL3;CEACAM1;GPER1;CREBL2;AVIL;STAR;C3
prerank,positive regulation of macrophage migration (GO:1905523),0.6985523502748309,1.5793276501385385,0.014138817480719794,0.4571090813380972,1.0,2/19,0.51%,THBS1;CMKLR1
prerank,mRNA splice site selection (GO:0006376),0.6341669368256626,1.57876285738813,0.014598540145985401,0.45564069902565474,1.0,12/30,9.69%,SRSF6;KHDC4;LUC7L2;SRSF1;NOL3;SRSF5;CELF4;CELF3;LUC7L;LUC7L3;PSIP1;SF3A1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5906546670198987,1.5767111624504757,0.012235817575083427,0.46140875149461846,1.0,5/51,0.97%,THBS1;PGF;CMKLR1;VEGFA;GAS6
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5948715460586151,-1.5761780359034785,0.025735294117647058,0.4328349044235032,1.0,5/15,11.88%,ATP1A2;ADRA2A;PACSIN3;NOS1;SLC30A1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.7359995098509543,1.5759944584848433,0.024193548387096774,0.4608044701745899,1.0,6/14,15.28%,ME1;AK5;AK3;NMNAT3;AK1;NMNAT2
prerank,response to glucose (GO:0009749),0.606449569576756,1.5758164932792047,0.008064516129032258,0.4571319996077278,1.0,7/46,5.38%,THBS1;SLC39A14;KCNB1;GAS6;TCF7L2;UNC13B;ADCY8
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.5972248383248572,-1.5753304357627642,0.034482758620689655,0.42702415015309025,1.0,12/14,40.32%,CSF1;TYROBP;POU4F1;CCR1;ATP6AP1;TRAF6;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,sulfate transport (GO:0008272),0.7194081308253564,1.5748699749026638,0.028985507246376812,0.4568003898756111,1.0,3/14,2.98%,SLC26A7;SLC26A2;SLC26A6
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6496366121015482,1.5733431414800996,0.018796992481203006,0.4596668326756822,1.0,5/25,6.70%,THBS1;EGFR;GLMN;ILK;FZD7
prerank,acidic amino acid transport (GO:0015800),-0.5554988795773891,-1.571987177671618,0.03862660944206009,0.42834659606413145,1.0,6/17,8.23%,SLC6A13;SLC1A3;SLC6A1;SLC25A13;SLC1A1;SLC1A2
prerank,regulation of mast cell activation (GO:0033003),-0.6171941226089093,-1.5692968743170415,0.056962025316455694,0.42755537821653433,1.0,5/10,22.28%,LYN;NECTIN2;CD84;MILR1;CD300LF
prerank,RNA 3'-end processing (GO:0031123),0.5675947505845964,1.5683878108939264,0.0054525627044711015,0.4796570438059,1.0,31/69,22.02%,SRSF6;SRSF1;SRSF5;SRSF2;CASC3;TENT4B;SRSF11;SYMPK;ZC3H11A;SRRM1;U2AF1;CHTOP;PABPN1;SUPV3L1;U2AF2;CLP1;CPSF4;SARNP;THOC2;SRSF3;PCF11;RPRD1A;TUT7;NCBP1;SRSF7;CPSF7;NCBP2;CSTF2;CSTF2T;TENT2;SRSF4
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7281529726769163,1.568059085705054,0.0260989010989011,0.4770702434150454,1.0,4/15,1.89%,PGF;VEGFA;F3;NTRK3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.6501752963928223,1.567851155053276,0.019801980198019802,0.4737302556869911,1.0,9/27,15.26%,EGFR;DDX5;STAT3;PUM1;BMP4;AGO2;EIF4G1;LIMD1;IL6
prerank,regulation of dendrite extension (GO:1903859),-0.5251010443261008,-1.5671432048298048,0.03056768558951965,0.4261527412634932,1.0,5/18,14.65%,NEDD4L;RIMS2;RIMS1;SYT3;SYT2
prerank,regulation of cardiac conduction (GO:1903779),-0.4194924318039042,-1.5670735548772567,0.018691588785046728,0.4188200241209259,1.0,16/54,13.07%,ATP1A2;ITPR1;ATP1B3;SLC8A1;RYR2;ITPR3;ABCC9;ATP2B1;SLC8A3;ATP1B2;ATP2A3;NPR1;ITPR2;NOS1;ACE2;FXYD1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.7513490704051277,1.565968347800268,0.023842917251051893,0.4787265362892545,1.0,5/11,11.28%,ZFPM2;TGFB2;JAG1;BMP4;BMPR1A
prerank,carboxylic acid transport (GO:0046942),0.5729194617547996,1.5650054416631825,0.00772626931567329,0.47924732034748124,1.0,8/55,3.80%,SLC38A2;SLC38A1;SLC23A1;SLC23A2;SLC16A9;SLC16A1;SLC38A6;SLC1A5
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6326751530400014,1.5649792537803258,0.014475271411338963,0.4750641631172605,1.0,9/32,9.70%,THBS1;RHOJ;VEGFA;FGF2;HDAC9;MEOX2;FOXC2;RHOA;ANXA1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7472851699599503,1.5640899409346847,0.027816411682892908,0.47535085366943763,1.0,6/12,12.84%,SIX1;VEGFA;SIX4;SOX9;NOG;SMO
prerank,engulfment of apoptotic cell (GO:0043652),0.7336478722770271,1.5639122356899204,0.02606310013717421,0.4719890580960359,1.0,2/15,0.83%,THBS1;RHOBTB1
prerank,supramolecular fiber organization (GO:0097435),0.5259761971730248,1.5634842432045875,0.0,0.4698813354786806,1.0,66/334,10.65%,COL12A1;PLOD2;COL6A3;COL6A2;COL6A1;ADAMTS3;ADAMTS2;COL8A2;COL8A1;BMP1;RHOBTB1;COL11A1;MAP7D3;DDR2;FGF13;COL3A1;COL1A2;LTBP2;LTBP3;GSN;COL1A1;COL5A3;COL14A1;P4HB;TGFBI;SERPINH1;EMILIN1;COL5A2;STMND1;COL15A1;RND3;COL27A1;COL16A1;LOXL1;PPP1R9B;CYP1B1;TLL1;ARHGAP17;TGFB2;CORO6;SNCAIP;PLOD1;P3H1;DYNC1H1;PLOD3;CLIP4;TUBGCP3;FAT1;TLE6;MYO1E;CDC42EP2;ADAM10;GGA2;P4HA1;LOX;P3H2;IAPP;ELMO3;CST3;DLG1;RHOA;BACE1;SPAST;RIPK3;CKAP5;COL25A1
prerank,mRNA export from nucleus (GO:0006406),0.5484379409005097,1.5633451774853202,0.0010438413361169101,0.4664785601299646,1.0,49/102,27.02%,SRSF6;NUP93;SRSF1;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;ENY2;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;CHTOP;PABPN1;NUP37;RANBP2;U2AF2;CPSF4;NUP88;YTHDC1;SARNP;DDX19A;THOC2;SRSF3;FYTTD1;NCBP1;SRSF7;POM121;NUP210;NCBP2;GLE1;NUP62;UPF1;SRSF4;NDC1;NUP35;UPF3B;DDX39B;NUP85;NUP160;TPR;EIF4E
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6490238323655964,1.562752879210382,0.01982651796778191,0.4653034001904921,1.0,2/24,0.24%,BOC;CDON
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7280402203017861,1.5623566191546712,0.030013642564802184,0.4633153637578416,1.0,3/14,6.57%,THBS1;FGF2;SULF1
prerank,cellular response to fatty acid (GO:0071398),0.7388112707459156,1.5621918950436726,0.02538787023977433,0.4600463158660249,1.0,2/12,0.49%,IRS1;PID1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.5491984537905762,1.5616447309787433,0.0010482180293501049,0.45906347253301966,1.0,46/96,27.02%,SRSF6;NUP93;SRSF1;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;CHTOP;NUP37;RANBP2;U2AF2;CPSF4;NUP88;YTHDC1;SARNP;THOC2;SRSF3;FYTTD1;NCBP1;SRSF7;POM121;NUP210;NCBP2;GLE1;NUP62;UPF1;SRSF4;NDC1;NUP35;UPF3B;DDX39B;NUP85;NUP160;TPR;EIF4E
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6292874825240617,1.5610460773748334,0.03198031980319803,0.4579892769881708,1.0,2/27,0.11%,SLC47A1;SLC38A1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.7352500715110065,1.5609831038753723,0.0323943661971831,0.4545412066987434,1.0,2/12,5.19%,PRPS2;ADA
prerank,response to acidic pH (GO:0010447),0.7156471142318284,1.5570629111697096,0.019363762102351315,0.46971015830728585,1.0,6/13,15.52%,SLC9A1;IMPACT;RAB11FIP5;CHP1;RAB11B;PKD2L1
prerank,RNA export from nucleus (GO:0006405),0.5465635708633517,1.5569881086550301,0.0010351966873706005,0.4662228624833848,1.0,48/100,27.34%,SRSF6;NUP93;SRSF1;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;CHTOP;NUP37;RANBP2;U2AF2;CPSF4;NUP88;YTHDC1;SARNP;THOC2;SRSF3;FYTTD1;NCBP1;SRSF7;POM121;NUP210;NCBP2;GLE1;NUP62;HNRNPA1;UPF1;SRSF4;NDC1;NUP35;UPF3B;DDX39B;NUP85;NUP160;TPR;EIF4E;XPO5
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6553499270570526,1.5563439749841734,0.0273972602739726,0.4656147904970343,1.0,9/23,12.84%,SIX1;VEGFA;FGF2;SIX4;LBX2;SOX9;NOG;BMP4;SMO
prerank,positive regulation of dendrite extension (GO:1903861),-0.5330897259411816,-1.5558766890907707,0.030434782608695653,0.44131528923730906,1.0,5/17,14.65%,NEDD4L;RIMS2;RIMS1;SYT3;SYT2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5841677561813367,1.5549115004350809,0.01564245810055866,0.46904201305086257,1.0,16/49,15.82%,PMEPA1;SMAD6;ANKRD27;LDLRAD4;DACT1;PRRT2;HMGB1;TMC8;PEX5;RAF1;IAPP;IMPACT;LCMT1;HSPA5;TFIP11;HDAC6
prerank,organic acid transport (GO:0015849),0.5466781275368087,1.5538420280864185,0.007337526205450734,0.47039434945039665,1.0,15/94,7.48%,SLC38A2;SLC38A1;SLC26A7;SLC23A1;SLC23A2;SLC5A6;SLC16A1;SLC26A6;SLC1A5;RXRA;LRRC8D;SLC25A32;SLC7A10;SLC38A3;SLC43A1
prerank,bone morphogenesis (GO:0060349),0.7140434261546993,1.5535255480393726,0.04032258064516129,0.46821738040991057,1.0,6/14,11.15%,LRP6;SFRP4;LRP5;SKI;FGFR2;IFITM5
prerank,membrane repolarization during action potential (GO:0086011),0.7480037313115945,1.5532353232911573,0.02197802197802198,0.4660744265106821,1.0,4/13,6.99%,KCNJ2;ATP1B1;KCNE5;KCNIP2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.7555978537848405,1.5504824015200036,0.036011080332409975,0.47565150371797826,1.0,5/11,7.90%,UAP1L1;PGM3;GFPT1;GNPDA1;GFPT2
prerank,cell junction organization (GO:0034330),-0.3860261830195217,-1.5491786208838754,0.0,0.4519805086728297,1.0,22/71,10.23%,TJP1;SDK1;OCLN;GRM5;PPFIA2;SLC6A1;PPFIBP1;APP;LIMS2;SMAD3;PPFIBP2;CXADR;PAK3;OPHN1;RAB8B;SLC8A3;CDC42;CLDN1;FLNC;ELFN1;RAB39B;APBB2
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.7222451766182039,1.548986762800691,0.029166666666666667,0.47921393994402844,1.0,12/14,26.67%,SEC31A;SEC24D;SEC13;SEC23A;SEC24C;SEC24B;MIA3;SEC24A;SEC23B;RAB1A;TBC1D20;SAR1A
prerank,sprouting angiogenesis (GO:0002040),0.587813293413047,1.548186596584675,0.015590200445434299,0.47904780767207306,1.0,9/51,4.72%,BMPER;THBS1;SLIT2;PGF;VEGFA;FGF2;RSPO3;SEMA3E;RAMP2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.677674362959206,1.5474688296350987,0.0445945945945946,0.4751938340084591,1.0,5/17,8.51%,IRS1;STAT5A;STAT3;BRWD1;SOCS2
prerank,cellular response to interleukin-7 (GO:0098761),0.677674362959206,1.5474688296350987,0.0445945945945946,0.4751938340084591,1.0,5/17,8.51%,IRS1;STAT5A;STAT3;BRWD1;SOCS2
prerank,peptidyl-lysine modification (GO:0018205),0.5457049867042567,1.5474451985254483,0.005268703898840885,0.4717366672937271,1.0,48/99,26.60%,PLOD2;NUP93;LOXL1;P3H3;HDAC9;HDAC4;TOPORS;EEF1AKMT3;PLOD1;TRIM28;RAE1;PLOD3;SEH1L;SIRT5;LOX;TRPM4;NUP37;EEF1AKMT2;SENP5;VIPAS39;RANBP2;PIAS4;GCSH;NUP88;STX1A;SIRT2;HDAC6;LIPT1;SUMO1;USPL1;POM121;NUP210;SAE1;NUP62;SENP1;LOXL2;SUMO2;NDC1;SENP7;NUP35;SENP6;KAT2B;SENP3;P3H4;NUP85;NUP160;TPR;ESCO1
prerank,response to progesterone (GO:0032570),0.6810219529623475,1.546522236198606,0.0266497461928934,0.47264740158053825,1.0,4/18,9.66%,THBS1;TGFB3;TGFB2;CATSPER3
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.7339137627284796,1.5458653306895926,0.029891304347826088,0.4723894166811268,1.0,5/13,7.90%,UAP1L1;PGM3;GFPT1;GNPDA1;GFPT2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.5578214452650369,-1.5450477190542333,0.03529411764705882,0.4554670006795371,1.0,7/15,10.23%,PPARA;LPGAT1;NR1H3;PPARGC1A;PPARD;SLC45A3;MID1IP1
prerank,skeletal system morphogenesis (GO:0048705),0.6095042980289976,1.5445817738573895,0.016260162601626018,0.47478466598678476,1.0,15/42,14.52%,LRP6;SIX1;HOXA3;SFRP4;LRP5;HOXB3;FGFR1;SKI;HOXA9;FGFR2;IFITM5;TGFBR1;HOXB4;HOXA4;FUZ
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6400454099096244,1.5445496936495153,0.025252525252525252,0.4681750175081174,1.0,12/23,19.01%,THBS1;SMAD4;GIPC1;TGFB1I1;DAB2;CREBBP;SLC2A10;FLCN;CDKN1C;MEN1;CITED2;HIPK2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6400454099096244,1.5445496936495153,0.025252525252525252,0.4681750175081174,1.0,12/23,19.01%,THBS1;SMAD4;GIPC1;TGFB1I1;DAB2;CREBBP;SLC2A10;FLCN;CDKN1C;MEN1;CITED2;HIPK2
prerank,protein trimerization (GO:0070206),0.7065209354226434,1.544304912786747,0.03333333333333333,0.46259922389653135,1.0,4/14,11.93%,SCARA5;SLC1A5;DISP1;CLYBL
prerank,protein homotrimerization (GO:0070207),0.7065209354226434,1.544304912786747,0.03333333333333333,0.46259922389653135,1.0,4/14,11.93%,SCARA5;SLC1A5;DISP1;CLYBL
prerank,positive regulation of response to wounding (GO:1903036),-0.47778105586158626,-1.5439349272609064,0.004524886877828055,0.4510875559987998,1.0,7/24,9.00%,PTN;MYLK;VTN;OCLN;ADRA2A;HBEGF;CLDN1
prerank,regulation of interleukin-12 production (GO:0032655),0.5901507462320155,1.5435126699462547,0.013651877133105802,0.46296915307883774,1.0,5/47,7.14%,THBS1;FOXP1;CMKLR1;HMGB1;IRAK3
prerank,response to hydrogen peroxide (GO:0042542),0.5860858898668905,1.543427483118923,0.019340159271899887,0.46005150208690027,1.0,18/45,17.54%,PRKCD;ADAM9;CYP1B1;MAP3K5;FXN;NFE2L2;IMPACT;ANXA1;RIPK3;ABL1;SOD1;STK25;PRDX3;RHOB;CAT;IL6;HDAC6;HMOX1
prerank,positive regulation of protein acetylation (GO:1901985),-0.5927674420426567,-1.5434174280847779,0.060897435897435896,0.4453306669920012,1.0,6/12,12.75%,RAPGEF3;PRKAA2;DDX3X;PRKAA1;FAM161A;TERF2IP
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.6725248603565528,1.5426282241215243,0.02442159383033419,0.4605099514068909,1.0,2/19,0.51%,THBS1;CMKLR1
prerank,"phagocytosis, engulfment (GO:0006911)",0.6183466050432057,1.5413010350409289,0.018028846153846152,0.4631841762143868,1.0,3/36,1.30%,THBS1;RHOBTB1;GSN
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.49293600419264083,-1.5381333821076626,0.02843601895734597,0.45213580714516466,1.0,8/23,13.95%,EFNB2;AKAP6;PIEZO1;PROX1;NIBAN2;EDN1;MYOCD;IGF1
prerank,endoderm development (GO:0007492),-0.5919312321481964,-1.5378982712044895,0.045454545454545456,0.44590276510995136,1.0,9/13,33.62%,SOX17;SOX7;LHX1;DUSP4;TBX20;DUSP5;DUSP2;GATA4;LAMC1
prerank,ureteric bud development (GO:0001657),0.6766516430477578,1.5368621079077516,0.03595206391478029,0.48014604769969055,1.0,3/17,1.31%,SLIT2;SIX1;GPC3
prerank,purine nucleotide metabolic process (GO:0006163),0.6456627362753784,1.5366803300198832,0.0325,0.4779756811994486,1.0,3/24,4.54%,PRPS2;FHIT;XDH
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.6697944104365359,1.536263696722695,0.018726591760299626,0.4765670487462523,1.0,6/19,8.42%,UAP1L1;PGM3;GFPT1;GNPDA1;GFPT2;PMM2
prerank,mRNA transport (GO:0051028),0.5382408343113274,1.53593580111038,0.0020898641588296763,0.47499712033922403,1.0,47/101,27.02%,SRSF6;NUP93;SRSF1;ARC;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;CHTOP;NUP37;RANBP2;U2AF2;CPSF4;NUP88;YTHDC1;SARNP;THOC2;SRSF3;FYTTD1;NCBP1;SRSF7;POM121;NUP210;NCBP2;GLE1;NUP62;UPF1;SRSF4;NDC1;NUP35;UPF3B;DDX39B;NUP85;NUP160;TPR;EIF4E
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.6902717370713178,1.5352844412899498,0.03783783783783784,0.4746945114865469,1.0,3/16,1.16%,SIX1;FGF2;FOXD1
prerank,lipid phosphorylation (GO:0046834),-0.6270777587306486,-1.5345206946098102,0.05128205128205128,0.44830130740181207,1.0,7/10,14.57%,DGKB;DGKD;DGKG;DGKH;DGKE;DGKZ;DGKA
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5457002710188914,-1.5340606552133729,0.040160642570281124,0.44273394150715445,1.0,3/17,3.56%,ATP1A2;BMP7;TFPI
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.5348940525700906,1.5336656934546085,0.001026694045174538,0.4789730511467603,1.0,45/136,19.92%,ESR1;PKD1;CMKLR1;ID2;GAS6;TCF7L2;SFRP4;PTGIS;GLIS2;CYP1B1;HDAC4;PKHD1;ANXA4;TAX1BP1;BHLHE40;IRAK3;HEYL;DAP;CDK5RAP3;WWP2;ITCH;CHUK;IRAK1;COMMD7;SMAD7;RNF2;CHP1;TRAF3;USP7;MAP3K10;ID1;ARRB1;OTULIN;SUMO1;MDFI;UFL1;RWDD3;MEN1;ACOD1;SUFU;LRRC14;ERBIN;ZNF431;NFKBIA;EIF2AK4
prerank,sensory perception of chemical stimulus (GO:0007606),0.695320414674973,1.5327715318687627,0.03146374829001368,0.4800876134422944,1.0,1/15,0.25%,GNAS
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.7230366439558991,1.5292367359807575,0.04945054945054945,0.4932250961228924,1.0,6/13,16.91%,TMEM30B;TM9SF4;EDEM2;BCAP31;SEC16A;SEC16B
prerank,negative regulation of leukocyte migration (GO:0002686),0.7589985761118523,1.528612203293518,0.04927536231884058,0.4927603236130992,1.0,2/10,1.76%,SLIT2;EMILIN1
prerank,response to organic cyclic compound (GO:0014070),0.5782817183146831,1.528429253716284,0.012181616832779624,0.4904281178902931,1.0,10/52,9.84%,ESR1;ALPL;IGFBP5;CYP19A1;CYP1B1;STAT3;CHRNB2;SOCS2;ANXA1;FOXA1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.6915467608605188,1.5271200707258676,0.034993270524899055,0.49342321272631007,1.0,6/17,14.43%,PLA2G4F;PLA2G4A;LPCAT1;LPCAT4;PLA2G5;PLA2G12A
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7156047910638462,1.5256790236633628,0.042134831460674156,0.49703256851247385,1.0,2/13,5.57%,SLC4A10;RAB3GAP1
prerank,actin filament depolymerization (GO:0030042),0.7409942371805616,1.5246947220740497,0.037037037037037035,0.4986513788042857,1.0,2/11,1.30%,MICAL2;GSN
prerank,regulation of blood coagulation (GO:0030193),0.6257631044184914,1.5243855868454435,0.03602484472049689,0.4970225295196075,1.0,4/27,3.76%,THBS1;ST3GAL4;EPHB2;FAP
prerank,regulation of RNA splicing (GO:0043484),0.555988405730605,1.520724777089502,0.007700770077007701,0.5106665381693036,1.0,31/69,20.91%,SLC38A2;CLK1;HNRNPH1;AHNAK;AHNAK2;CLK3;MBNL1;RBM39;FASTK;SNRNP70;FUS;HNRNPL;HNRNPH2;MBNL2;METTL16;KHDRBS1;CLK4;PTBP1;U2AF2;SRPK1;HNRNPK;YTHDC1;SRSF3;SRSF10;RBM22;CLK2;BRDT;LARP7;TRA2B;HNRNPH3;AFF2
prerank,negative regulation of vascular permeability (GO:0043116),0.7284715679707935,1.5198554813468712,0.0420899854862119,0.51146635097193,1.0,5/12,8.41%,SLIT2;VEGFA;PDE3A;RAMP2;DDAH1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5721766397964868,1.5196850791138765,0.02288329519450801,0.5092299455827807,1.0,8/47,12.20%,THBS1;PID1;PRKCD;XDH;TGFBR2;AKR1C1;SOD1;DHRS4
prerank,peroxisomal membrane transport (GO:0015919),0.6235984217843971,1.5183293588539486,0.03209876543209877,0.5128169007519136,1.0,14/27,22.68%,ABCD3;PEX7;PXMP2;PEX5;PEX16;PEX13;PEX1;PEX10;ALDH3A2;PEX6;PEX2;ABCD1;ACBD5;PEX14
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.7274112832819737,1.5180189636107169,0.037089871611982884,0.5113029305574632,1.0,4/11,15.26%,EGFR;DDX5;BMP4;IL6
prerank,negative chemotaxis (GO:0050919),0.6021909467982036,1.5175430490491877,0.030193236714975844,0.5105004185052455,1.0,8/33,9.72%,SLIT3;SLIT2;SLIT1;NTN1;SEMA3E;SEMA4B;RHOA;ITGAV
prerank,spinal cord development (GO:0021510),0.730828883408473,1.5168935869024922,0.04467805519053877,0.5104683954374752,1.0,3/12,2.48%,PKD1;VIT;GLI2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.7218728871467179,1.5163245785128754,0.04871060171919771,0.5100437366083066,1.0,6/12,8.71%,NFIB;GLI2;EPHB2;EPHB6;CHRNB2;TSKU
prerank,positive regulation of potassium ion transport (GO:0043268),0.5931915794661644,1.514975741432562,0.016489988221436984,0.5132704787018946,1.0,8/38,8.78%,KCNJ2;KCNJ15;FHL1;DRD1;KCNN1;KCNE5;ANK2;DLG1
prerank,thymus development (GO:0048538),0.7089495710821296,1.5145132162545922,0.046008119079837616,0.5123340939372253,1.0,5/13,12.61%,SIX1;EPHB3;RIPK3;SOD1;TGFBR1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.655470826397634,1.5144298647707755,0.04392764857881137,0.5097356963702617,1.0,2/20,1.56%,PLOD2;GCLC
prerank,chordate embryonic development (GO:0043009),0.5651951930555213,1.5127907714450117,0.022099447513812154,0.5145243513121173,1.0,19/55,9.71%,PKD1;XYLT1;VEGFA;PCSK5;COL1A1;TGFB3;DEAF1;MBNL1;HES5;SIX4;DACT1;KIAA1217;DVL1;ADAM10;SULF1;FGFR1;NOG;FUT8;FGFR2
prerank,hemidesmosome assembly (GO:0031581),-0.6170505154339175,-1.512373793911996,0.06115107913669065,0.4954879872253026,1.0,4/11,11.05%,ITGA6;DST;ITGB4;LAMC2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.5925035981053759,1.5120387202662031,0.027315914489311165,0.515400909174062,1.0,9/38,8.87%,KCNJ2;CACNA1G;CACNA1C;HCN4;CAMK2D;KCNE5;ANK2;JUP;TRPM4
prerank,actin filament-based transport (GO:0099515),-0.4996130993977499,-1.5111846213324527,0.03056768558951965,0.49157287264611194,1.0,7/21,14.70%,MYO1B;SYNE2;MYO6;ACTN4;MYO1D;SUN2;MYO5C
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.584849762470653,1.5096915478624968,0.021372328458942633,0.5239758188566311,1.0,8/46,6.18%,THBS1;FOXP1;ID2;IGFBP5;ELN;TCF7L2;HES5;PRKDC
prerank,protein localization to nucleus (GO:0034504),0.5318259976882612,1.5050595798675064,0.008359456635318705,0.5437626956165253,1.0,53/102,30.29%,SIX1;COL1A1;NUP93;PRICKLE1;SEC13;TOPORS;IPO5;LMNA;SIX4;STAT3;MORC3;RRS1;IPO4;DVL1;HIKESHI;E2F3;BMP4;WRN;INTS13;CNEP1R1;IPO13;TNPO2;YWHAE;ARL2;NUP88;POM121;AKT1;IPO9;TNPO1;APPL2;APPL1;CALR;NUP62;PPP1R10;TBRG1;PAF1;TSC2;IPO8;HNRNPU;NUTF2;NUP85;TPR;XPA;RPAIN;NOP53;TAF3;TOR1AIP1;TOR1AIP2;RPF2;NUP50;ZBTB7A;PIKFYVE;FAM53C
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6460432187854199,1.5046317465104737,0.04066073697585769,0.5429512571990448,1.0,2/20,0.46%,EGFR;PKD1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6284760022796111,-1.5039032273715656,0.05740181268882175,0.5056154435565311,1.0,3/10,9.13%,ATP1A2;ADRA2A;SESTD1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5984991681793698,1.503149454821418,0.0364963503649635,0.5472625871547331,1.0,13/33,20.37%,ESR1;DDX5;CARM1;AXIN1;RNF14;RUNX1;UBA5;HDAC6;DNAAF4;UFL1;SAFB2;CBFB;CALR
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6983484995680338,1.5029061598502402,0.03867403314917127,0.5452494420733509,1.0,3/14,9.03%,THBS1;MEOX2;RHOA
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.6851260530348642,1.5019679977415772,0.035668789808917196,0.5469629927594529,1.0,5/17,9.70%,TMEM100;FGF2;SFRP4;SOX9;BMP4
prerank,neural tube closure (GO:0001843),0.6034317624422106,1.5014951137307406,0.028169014084507043,0.5464184785512713,1.0,11/34,16.73%,LRP6;PRICKLE1;DEAF1;COBL;TGFB2;DVL1;SKI;LMO4;LRP2;FUZ;MTHFD1
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.6001772050005487,-1.501321840595999,0.066006600660066,0.5058930341885103,1.0,3/11,2.53%,NEDD4L;ACTN2;PICALM
prerank,protein O-linked glycosylation (GO:0006493),0.524278620555144,1.500429443212879,0.012486992715920915,0.548393782962367,1.0,18/96,9.92%,PLOD2;ST3GAL4;GXYLT2;GALNT10;GALNT15;GALNT13;MUC1;PGM3;PLOD1;POGLUT3;PLOD3;B3GNT7;POGLUT1;MUC13;ST3GAL2;B4GALT5;OGT;GALNT18
prerank,potassium ion export across plasma membrane (GO:0097623),0.7065156780277619,1.500408626888088,0.05652173913043478,0.545468373659837,1.0,3/13,6.99%,KCNK5;KCNE5;KCNIP2
prerank,regulation of T cell migration (GO:2000404),-0.5251291117505772,-1.499950182510524,0.05905511811023622,0.5028905427619579,1.0,5/18,3.54%,LRCH1;RIPOR2;APOD;APP;CXCL12
prerank,positive regulation of protein maturation (GO:1903319),-0.5771780256600738,-1.4996449548916877,0.07534246575342465,0.4967730694464559,1.0,9/11,39.75%,CCBE1;NKD2;SOX4;BAG2;NLRC4;RHBDD1;TFR2;ADAM8;ANGPTL8
prerank,response to fatty acid (GO:0070542),0.661292683585849,1.4990926641685944,0.04933333333333333,0.5488259896445737,1.0,2/17,0.49%,IRS1;PID1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.6163372575184631,1.4988148425030725,0.04433497536945813,0.5472506998511641,1.0,15/27,23.44%,MORF4L2;MRGBP;TRRAP;ATAT1;SGF29;MORF4L1;KAT6B;TAF6;KAT2A;CREBBP;BRD8;KAT7;KAT8;TAF6L;KAT2B
prerank,cation transport (GO:0006812),0.5089181515936945,1.4987056178227003,0.0020304568527918783,0.544768335529205,1.0,22/167,9.66%,SLC47A1;PIEZO2;SLC4A4;KCNJ2;SLC23A1;KCNJ15;KCNK5;SLC5A6;ATP1B1;FGF13;SLC12A2;SLC5A2;HCN4;SLC9B2;KCNN1;SLC4A11;SCN11A;KCNIP2;TRPM7;TRPM4;KCNK6;CATSPER3
prerank,regulation of endothelial cell migration (GO:0010594),0.5419177644489546,1.4975371117822796,0.01694915254237288,0.5467206748180199,1.0,12/85,5.88%,BMPER;THBS1;SLIT2;SMOC2;FOXP1;RHOJ;VEGFA;FGF2;SPARC;PRKCA;BCAS3;FOXC2
prerank,positive regulation of cell cycle (GO:0045787),0.5525421310462933,1.4974081671559396,0.019889502762430938,0.54441220896759,1.0,12/62,9.84%,SMOC2;EGFR;LRP6;PKD1;TGFB2;PRKCA;USP2;RARA;PKN2;FGFR2;CDC25B;FOXA1
prerank,cell junction assembly (GO:0034329),-0.3465902962006097,-1.4971887139576459,0.0,0.49713234002610407,1.0,34/100,12.85%,TJP1;SDK1;TLN2;ADGRL3;CDH8;GPM6A;CDH5;ITGA6;NRXN1;SHANK3;CLDN5;DNM3;SPOCK2;LIMS2;PKP4;PLXND1;ARVCF;GJC1;CDH1;OPHN1;CDH6;CDH2;DNER;CDC42;FLNC;CDH7;CDH19;CDH20;SLITRK1;FN1;CTNND1;SDK2;FBLIM1;PKP2
prerank,primary neural tube formation (GO:0014020),0.6095623983158943,1.4967988319446959,0.03588516746411483,0.5445959643761451,1.0,10/30,16.73%,LRP6;PRICKLE1;DEAF1;COBL;TGFB2;SKI;LMO4;LRP2;FUZ;MTHFD1
prerank,peptidyl-threonine modification (GO:0018210),0.5466802848599432,1.4967369540853688,0.013100436681222707,0.5419160537782267,1.0,34/66,24.66%,PRKCD;CIT;GALNT13;ACVR1B;CAMK2D;CSNK2A2;CSNK2A1;PRKCA;DYRK4;ACVR1;PRKDC;TGFBR2;STK39;CDK10;MAPK8;MAP3K12;PDPK1;TGFBR1;MAP3K10;WNK1;CDC42BPB;GALNT1;GALNT3;CAD;AKT1;HIPK2;CDK5;LRRK2;HIPK4;GALNT2;TAF1;TBK1;ROCK1;LMTK2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5522568278701244,1.4965872781580574,0.015384615384615385,0.5397748851534496,1.0,30/59,24.66%,PRKCD;CIT;ACVR1B;CAMK2D;CSNK2A2;CSNK2A1;PRKCA;DYRK4;ACVR1;PRKDC;TGFBR2;STK39;CDK10;MAPK8;MAP3K12;PDPK1;TGFBR1;MAP3K10;WNK1;CDC42BPB;CAD;AKT1;HIPK2;CDK5;LRRK2;HIPK4;TAF1;TBK1;ROCK1;LMTK2
prerank,cardiac myofibril assembly (GO:0055003),-0.5336383329048964,-1.4963715345190094,0.04680851063829787,0.49254428657494376,1.0,4/15,6.33%,NEBL;PDGFRB;PROX1;PDGFRA
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6910520452734813,1.4961702863830872,0.0481283422459893,0.5390641981058842,1.0,3/15,1.12%,BMPER;VEGFA;FGF2
prerank,positive regulation of embryonic development (GO:0040019),-0.501755252163349,-1.4954474188594373,0.04897959183673469,0.4886926710261009,1.0,5/19,7.94%,PLCB1;WNT4;OSR1;TENM4;NIBAN2
prerank,circulatory system development (GO:0072359),0.5225605769182522,1.4932731952475677,0.006211180124223602,0.5502267614288648,1.0,39/118,16.86%,MICAL2;PKD1;CACNA1C;ID2;ZFPM2;PCSK5;PLCE1;COL3A1;NTRK3;ECE1;GLI2;PDLIM7;NXN;HDAC9;TGFB2;RAMP2;ACVR1;FOXC2;TGFBR2;SOX9;FOXL1;SH3PXD2B;ALPK3;TAB2;POU6F1;ZDHHC16;WDR11;SRF;HEY1;KAT2A;TGFBR1;MEF2A;TCF25;AKAP13;CRB2;DNAAF4;MTHFD1;KDM6B;NF1
prerank,xenobiotic transport (GO:0042908),0.6747834960385036,1.4930723869058895,0.044897959183673466,0.5482933012834837,1.0,2/17,3.96%,SLC47A1;ABCC1
prerank,histone modification (GO:0016570),0.5199401061746708,1.4896132592197417,0.005208333333333333,0.5621623868563206,1.0,38/109,19.39%,PRMT8;PRKCD;EYA2;PRDM5;HDAC9;HDAC4;BAZ2A;UBE2B;MORF4L2;MIDEAS;MRGBP;TRRAP;SGF29;EHMT1;RPS6KA4;HUWE1;NSD1;RCOR3;ENY2;CARM1;MORF4L1;MIER2;MAP3K12;KAT6B;TAF6;KDM4A;KAT2A;HDAC1;USP36;SIRT2;HDAC6;CREBBP;SIN3B;MTA3;UFL1;CDK2;BRD8;NTMT1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6082443571674291,1.4893367772505712,0.037383177570093455,0.5605051518745525,1.0,12/31,14.52%,SIX1;HOXA3;TWIST1;HOXB3;TGFBR2;HOXA9;NOG;FGFR2;TGFBR1;HOXB4;HOXA4;FUZ
prerank,nucleotide metabolic process (GO:0009117),0.6410139299526485,1.4885233595472385,0.0421455938697318,0.5614811032952627,1.0,7/23,15.28%,ME1;AK5;FHIT;REXO2;NMNAT3;AK1;NMNAT2
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7236265569286532,1.4882596706961209,0.043909348441926344,0.5599406563376222,1.0,3/11,7.69%,P4HB;P4HA1;P3H2
prerank,tube closure (GO:0060606),0.6052843980902671,1.487420172150743,0.035629453681710214,0.5611266294860923,1.0,10/31,16.73%,LRP6;PRICKLE1;DEAF1;COBL;TGFB2;SKI;LMO4;LRP2;FUZ;MTHFD1
prerank,muscle cell differentiation (GO:0042692),-0.4421286102871971,-1.487322763152575,0.03763440860215054,0.5045905943339863,1.0,10/32,10.68%,NEBL;WNT5B;MRTFB;SGCZ;TBX18;TBX1;TMEM204;GATA6;CHRNB1;MYOCD
prerank,aortic valve morphogenesis (GO:0003180),0.5975351995620667,1.4872514016858553,0.04631828978622328,0.5592770694339481,1.0,11/30,9.70%,SLIT3;SLIT2;ELN;EMILIN1;SMAD6;TWIST1;JAG1;HEYL;SOX9;NFATC1;BMP4
prerank,ventricular septum morphogenesis (GO:0060412),0.6060617318139662,1.486744257802965,0.039951573849878935,0.5589852588229428,1.0,14/27,12.61%,SLIT3;SLIT2;ZFPM2;TGFB2;ACVR1;SMAD4;TGFBR2;HEYL;NOG;BMP4;BMPR1A;SMAD7;HEY1;TGFBR1
prerank,aortic valve development (GO:0003176),0.5869390711590374,1.4862899953579058,0.03608847497089639,0.5581842205238222,1.0,12/34,9.70%,SLIT3;SLIT2;ELN;EMILIN1;SMAD6;TWIST1;TNFRSF1B;JAG1;HEYL;SOX9;NFATC1;BMP4
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6584088410471995,1.4857956315581353,0.04504504504504504,0.557658320536408,1.0,2/17,0.46%,EGFR;PKD1
prerank,positive regulation of locomotion (GO:0040017),0.6116737027465415,1.4845646652010767,0.043583535108958835,0.5607511525488832,1.0,3/27,2.99%,THBS1;NTN1;TWIST1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5323110978099044,-1.4826931099915623,0.06439393939393939,0.5114889608147153,1.0,8/17,7.37%,MAML2;MAML3;STAT1;NOTCH1;PLXND1;NOTCH3;NOTCH4;RBPJ
prerank,establishment of protein localization to extracellular region (GO:0035592),0.5808575581605512,1.4819564701934924,0.028605482717520857,0.5700937840852397,1.0,17/39,20.71%,LTBP2;NECAB3;ARFGAP3;COPG1;RAB8A;MON1A;RAB3D;ABCA1;PREB;TMEM167A;MIA3;RAB3B;TANGO6;GOLPH3;STEAP3;MIA2;RCN3
prerank,peptidyl-lysine dimethylation (GO:0018027),0.6481551437670042,1.4810233745216916,0.047865459249676584,0.5718132653973362,1.0,14/18,26.51%,EHMT1;ASH1L;EEF1AKMT2;KMT2D;SETD4;KMT2B;SUV39H2;SETD1A;SUV39H1;SETD2;KMT2A;SMYD2;EHMT2;SETD7
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.6198583393169057,1.481023120509965,0.046632124352331605,0.5690287834093144,1.0,15/23,27.67%,SEC13;VCP;FAF2;SYVN1;TMED9;TECPR2;PREB;SEC16A;NPLOC4;LMAN1;DERL1;HERPUD1;SELENOS;SEC61B;SURF4
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5076809953395678,-1.481011941102918,0.06463878326996197,0.5096945425379037,1.0,6/16,12.05%,APOE;NOS3;GUCY1B1;KCNC2;NOS1;DDAH2
prerank,peptidyl-serine modification (GO:0018209),0.5096363670486319,1.4808585880389007,0.0010193679918450561,0.5669954550227769,1.0,76/166,24.66%,PKD1;PRKCD;GAS6;ULK2;GALNT13;MARK1;PRKCE;CSNK1D;CAMK2D;CSNK2A2;CSNK2A1;MORC3;POGLUT3;PRKCA;DYRK4;PRKDC;POGLUT1;TGFBR2;TLK1;STK39;RPS6KA4;AKT2;DGKQ;PKN2;PAK2;MAPK8;SMG1;CSNK1G1;CHUK;MAP3K12;ATM;MAPK12;PDPK1;UHMK1;CSNK1E;TGFBR1;MAP3K10;DMPK;WNK1;NDNF;LATS2;CAMK4;GALNT1;TLK2;GALNT3;PARP1;MKNK2;VRK2;MAST2;AKT1;HIPK2;CDK2;IKBKE;NTMT1;CDK5;SGK3;MAPK9;PRKACA;VRK3;LRRK2;CSNK1G3;MAST4;CAMK1;STK38;EIF2AK3;PRKCI;TOP1;HIPK4;GALNT2;RPS6KA2;RPS6KB1;TAF1;TBK1;ROCK1;PINK1;LMTK2
prerank,cell-cell junction maintenance (GO:0045217),-0.5884381425277708,-1.4803153181159632,0.08098591549295775,0.5050435247764501,1.0,1/11,0.05%,TJP1
prerank,potassium ion import across plasma membrane (GO:1990573),0.5726592435306946,1.478679737644015,0.027058823529411764,0.5748590928307487,1.0,6/41,2.89%,KCNJ2;KCNJ15;SLC12A7;ATP1B1;SLC12A2;HCN4
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.46774688649951174,-1.4776918772789442,0.05687203791469194,0.5060611778270411,1.0,14/26,22.13%,LYN;ROCK2;EPHA4;PICALM;GRIN2B;AIM2;PSME3;PSME1;GRIN1;PYCARD;PRELID1;AGER;APH1B;MBP
prerank,import into cell (GO:0098657),0.5736131212761988,1.4763213515449605,0.029832935560859187,0.583206501278957,1.0,7/41,5.42%,SLC47A1;SLC38A1;SLC5A6;SLC39A14;SLC12A7;LRRC8D;LRSAM1
prerank,serine family amino acid metabolic process (GO:0009069),0.6737123199745711,1.475707528652495,0.05352480417754569,0.5833661059081308,1.0,9/16,20.14%,GCLC;SRR;GLYAT;MTHFD1;SHMT2;SHMT1;DAO;SARS1;SEPHS2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6928521277004482,1.4755529144081034,0.06963788300835655,0.5812322019180427,1.0,2/12,6.48%,FOXP1;HMGB1
prerank,action potential (GO:0001508),0.5648991542926545,1.474523373916175,0.04312354312354312,0.5835770890975773,1.0,6/44,6.62%,KCNJ2;CACNA1G;KCNB1;DMD;KCNE5;SCN11A
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5614361580477556,1.4744492345383624,0.037252619324796274,0.5811714890599095,1.0,18/46,18.32%,PRKCD;GAS6;TCF7L2;NEDD4;IPO5;TRIM28;BAG3;MAVS;JUP;ZIC1;ANP32B;UBR5;XPO4;KHDRBS1;YWHAE;CPSF6;RBM22;NCBP2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5908381185158894,1.4744406216283468,0.0341047503045067,0.5784896725785421,1.0,7/33,9.43%,THBS1;FGF2;MEOX2;HMGB1;JUP;RHOA;ANGPT4
prerank,chloride transport (GO:0006821),0.5352020410795387,1.474391232538559,0.021482277121374866,0.575986270779919,1.0,9/74,5.17%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;SLC26A6;CLIC3;SLC4A8;CLIC4;GABRA3
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.5368292019212673,-1.473676504106214,0.06130268199233716,0.5110591865607629,1.0,5/14,14.05%,RAPGEF2;PRKAR2B;PRKAR1B;PKIG;SIRT1
prerank,myotube cell development (GO:0014904),0.7238278833710606,1.4735553339731144,0.044444444444444446,0.5772850962807744,1.0,3/10,8.09%,SIX1;SKI;SELENON
prerank,eye development (GO:0001654),0.5513366776300711,1.473270306518781,0.03678929765886288,0.5758877802111577,1.0,19/54,17.09%,SMOC1;CACNA1C;CHRDL1;PBX3;COL5A2;HES5;TGFB2;RAB3GAP1;PBX1;MEIS3;SKI;TSKU;SH3PXD2B;CPAMD8;ZDHHC16;BLOC1S3;SIPA1L3;NIPBL;MAB21L2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.5999584552321955,1.4730694633602135,0.05256723716381418,0.5741642187545698,1.0,6/30,7.38%,KCNJ2;CACNA1G;CACNA1C;KCNE5;ANK2;SNTA1
prerank,miRNA metabolic process (GO:0010586),0.6364853137129892,1.4721314447617708,0.05491698595146871,0.5759553192065167,1.0,8/20,16.62%,DDX17;TENT4B;PRKRA;DIS3L2;DGCR8;AGO2;SND1;TUT7
prerank,regulation of cellular metabolic process (GO:0031323),0.5551594975488217,1.4719926379390047,0.03416856492027335,0.5740019808543266,1.0,13/45,15.73%,PID1;COQ7;NCOR2;CYP1B1;LAMTOR1;PM20D2;RSPO1;ARF4;FOXM1;ARF1;ACACA;STUB1;EIF6
prerank,embryonic eye morphogenesis (GO:0048048),0.7216618378359553,1.4716707363483092,0.05805515239477504,0.5729568919281309,1.0,2/11,0.73%,LRP6;MFAP5
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.48994764287244946,-1.4714101854203865,0.05,0.5113171375650838,1.0,9/22,19.07%,SLC7A5;RFTN1;SPHK1;PRKCQ;ZBTB7B;NR1H4;NOD2;MYD88;TGFB1
prerank,fatty acid transport (GO:0015908),-0.5351945966777278,-1.471328074010767,0.05737704918032787,0.5054033125383104,1.0,5/17,9.27%,APOE;ACSL1;PPARD;SLC27A4;MFSD2A
prerank,regulation of smooth muscle cell migration (GO:0014910),0.6330575451550624,1.4708431561627422,0.047865459249676584,0.5742161635576524,1.0,3/20,1.02%,SLIT2;IGFBP5;LRP1
prerank,ventricular septum development (GO:0003281),0.5711307735114655,1.4704306586327047,0.03859649122807018,0.5734841337717445,1.0,15/37,12.61%,SLIT3;SLIT2;ZFPM2;TGFB2;ACVR1;SMAD4;TGFBR2;MATR3;HEYL;MDM4;NOG;BMPR1A;SMAD7;HEY1;TGFBR1
prerank,negative regulation of secretion by cell (GO:1903531),-0.4160720094491869,-1.4701211539834258,0.03424657534246575,0.5027494792072811,1.0,13/38,17.93%,GRM7;APOE;STXBP6;IL1RAPL1;NOTCH1;RHBDF1;TNFRSF1A;SLC30A1;RSAD2;RHBDF2;SNCA;SERGEF;SYT11
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.7182853893785253,1.4695865423000818,0.06437768240343347,0.5747832605991661,1.0,1/11,0.08%,THBS1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.540129846320496,1.4695051725159018,0.015350877192982455,0.5725591087869848,1.0,9/61,6.48%,SMOC2;EGFR;FGF2;EYA2;GNL3;PARP3;TRIM28;ERCC8;HMGB1
prerank,mRNA 3'-end processing (GO:0031124),0.5288839722694665,1.4688174831542133,0.011752136752136752,0.573161308264553,1.0,33/78,22.02%,SRSF6;CPSF4L;SRSF1;PABPC1;SRSF5;SRSF2;CASC3;TENT4B;SRSF11;SYMPK;ZC3H11A;SRRM1;U2AF1;CHTOP;PABPN1;U2AF2;CLP1;CPSF4;SARNP;THOC2;SRSF3;PCF11;RPRD1A;NCBP1;SRSF7;CPSF7;CPSF6;NCBP2;CSTF2;CSTF2T;TENT2;PAF1;SRSF4
prerank,nuclear export (GO:0051168),0.5316129428335742,1.4687261046157576,0.01814300960512273,0.5710124188078609,1.0,41/80,27.34%,PKD1;SRSF6;XPO1;SRSF1;SRSF5;STRADA;RAE1;SRSF2;CASC3;XPO6;SRSF11;NXF1;ZC3H11A;SRRM1;U2AF1;CHTOP;XPO4;CHP1;WASHC4;U2AF2;SARNP;THOC2;SRSF3;NCBP1;SRSF7;POM121;NCBP2;CALR;NUP62;RITA1;CCHCR1;HNRNPA1;SRSF4;DESI1;UPF3B;DDX39B;NUTF2;TPR;XPO7;EIF4E;XPO5
prerank,osteoclast differentiation (GO:0030316),0.6250915907269983,1.4662976508246577,0.0648854961832061,0.5797514047338614,1.0,5/22,9.20%,FOXP1;GAB2;ANXA2;GLO1;SBNO2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6544467243681136,1.465516839580248,0.047106325706594884,0.5808811508188546,1.0,8/17,16.86%,SPRED2;CALM2;DGKQ;SMAD7;PPEF2;EIF4G1;SIRT2;CALM3
prerank,response to cholesterol (GO:0070723),0.6504129881512513,1.4646198175392333,0.06016042780748663,0.5825438564647129,1.0,7/17,13.95%,LRP6;GRAMD1A;OSBPL7;TGFBR2;TGFBR1;SMO;GRAMD1C
prerank,iron ion transmembrane transport (GO:0034755),0.7281939963411583,1.4637596881216501,0.045588235294117645,0.5841186003940909,1.0,2/10,0.72%,SCARA5;SLC39A14
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6873031430026488,1.4637441496093058,0.051075268817204304,0.5816459136048838,1.0,3/15,1.12%,SMOC2;VEGFA;FGF2
prerank,microtubule polymerization (GO:0046785),0.6028029374304389,1.4637282494835877,0.05263157894736842,0.5792288347311997,1.0,10/29,18.76%,MAP7D3;FGF13;TUBG2;CSNK1D;TUBGCP3;CKAP5;AKAP9;NDEL1;CCDC57;SLAIN2
prerank,chromatin assembly or disassembly (GO:0006333),0.701406680914908,1.4636351925661943,0.0764872521246459,0.5772166286665508,1.0,7/11,26.20%,CHAF1B;M1AP;CDAN1;SUV39H2;NOC2L;TP53;CHAF1A
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6889855811792053,1.4635122343763356,0.04679144385026738,0.5752003718449147,1.0,4/14,6.04%,EHHADH;ACOXL;ACOX3;ECI2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5419218547046886,1.4626035466914127,0.03240223463687151,0.577030995323219,1.0,14/55,16.42%,THBS1;PID1;COQ7;CYP1B1;XDH;TGFBR2;SIRT5;ARF4;AKR1C1;FOXM1;DHRS4;SIRT2;EIF6;AATF
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.5877209195097467,-1.4622488431167444,0.10139860139860139,0.5185326194153622,1.0,5/11,15.33%,ADIPOR1;SH2B3;CAV1;PTPRT;SOCS3
prerank,Golgi organization (GO:0007030),0.5173244852229353,1.461984727758043,0.00932642487046632,0.5775145428334644,1.0,61/112,30.17%,STX5;ATL2;CSNK1D;LMAN2L;RAB2A;FBXW8;GOLGA8B;GOLGA5;RAB30;RAB43;BCAS3;GOLGB1;ATL3;GBF1;ATP8B2;HUWE1;TJAP1;ARHGAP21;BET1;PLEKHM2;TRAPPC12;TMED9;ZW10;TRIP11;STK25;PI4K2A;LMAN2;SEC16A;SEC22B;STX16;SEC16B;GOLPH3;TMED2;NPLOC4;COG2;BLZF1;SEC23IP;TRAPPC11;OPTN;LRRK2;RAB1A;LMAN1;ATP8B1;VAMP4;GORASP2;DYNC2H1;TMED7;VPS51;TBC1D20;CUL7;VTI1B;GOLGA2;GCC2;CSNK1A1;SURF4;ARL1;UBXN2A;TMED3;PRMT5;STX17;VTI1A
prerank,protein localization to cilium (GO:0061512),0.5882467886818492,1.4619458122787483,0.05166051660516605,0.5753127499934938,1.0,9/32,11.96%,ZNF423;EHD1;MAPK15;CSNK1D;BBS9;TMEM107;IFT20;TCTN1;INVS
prerank,nucleosome assembly (GO:0006334),0.5848463597285138,1.4615560535675465,0.052318668252080855,0.5748175309276299,1.0,16/31,27.86%,CHAF1B;IPO4;NAA60;SOX9;ANP32B;SPTY2D1;CABIN1;KAT6B;BRD2;NAP1L3;NAP1L2;UBN1;H3-3A;DAXX;CHAF1A;HIRA
prerank,protein targeting to peroxisome (GO:0006625),0.598428482376142,1.4612921258258391,0.046798029556650245,0.5736523882884086,1.0,15/29,22.68%,ABCD3;PEX7;PXMP2;PEX5;PEX16;PEX13;PEX1;PEX10;ALDH3A2;HACL1;PEX6;PEX2;ABCD1;ACBD5;PEX14
prerank,muscle contraction (GO:0006936),-0.3412924020855573,-1.4606172837284535,0.0,0.517549179646221,1.0,29/126,11.61%,SORBS1;ITGA1;ROCK2;MYLK;SLC8A1;SNTB1;ACTN2;TPM1;UTRN;GJC1;TMOD3;MYOF;SMTN;BDKRB2;MYL6;MYL9;TMOD1;DYSF;LMOD1;KCNJ12;DES;MYH11;TPM3;CHRNB1;VIM;ADRA1A;NOS1;ACTA2;TPM2
prerank,response to UV (GO:0009411),0.5155746548231197,1.459592751585212,0.011615628299894404,0.5789692183635767,1.0,40/95,26.93%,EGFR;PRKCD;NEDD4;SCARA3;UBE2B;ATF4;CCAR2;ERCC8;ERCC5;ERCC4;MAPK8;WRN;SDE2;ERCC3;ERCC2;CAT;N4BP1;CREBBP;PARP1;CDC25A;REV1;MEN1;AKT1;USP1;EIF2AK4;NOC2L;CIRBP;EIF2S1;MAP2K7;USP47;TRIAP1;PRIMPOL;SDF4;TAF1;TP53;UVSSA;POLD1;XPA;YY1;ZRANB3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5303295697503364,1.4586485523592774,0.03162486368593239,0.5809449468429382,1.0,22/65,17.11%,HTRA3;HTRA4;PMEPA1;SKIL;EMILIN1;SMAD6;LDLRAD4;SPRED2;BCL9L;TGFBR2;SKI;PDPK1;SMAD7;CIDEA;TGFB1I1;TGFBR1;STUB1;CD109;IL17RD;RPS27A;UBC;SLC2A10
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5785882557033907,1.4585887731091371,0.04600484261501211,0.5788155636670959,1.0,6/36,9.43%,THBS1;SLIT2;FGF2;HMGB1;JUP;ANGPT4
prerank,COPII-coated vesicle budding (GO:0090114),0.532030343751514,1.4582774708030137,0.0227765726681128,0.5779232471846915,1.0,40/68,26.67%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;NSF;SCFD1;TRAPPC6A;USO1;SEC24C;SEC24B;PREB;SEC16A;SEC22B;MIA3;CNIH1;SEC16B;SEC24A;NAPA;TMED2;SEC23B;TRAPPC3;SEC23IP;CTSZ;TRAPPC6B;RAB1A;LMAN1;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;GOLGA2;SAR1A
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5124700121078755,1.4578659425222351,0.018046709129511677,0.5772868592350313,1.0,33/95,17.75%,THBS1;HTRA3;HTRA4;PMEPA1;SKIL;EMILIN1;SMAD6;DKK3;LDLRAD4;SPRED2;BCL9L;SMAD4;TGFBR2;SKI;GIPC1;PDPK1;SMAD7;CIDEA;TGFB1I1;TGFBR1;DAB2;STUB1;CD109;LATS2;IL17RD;CREBBP;RPS27A;UBC;SLC2A10;FLCN;CDKN1C;MEN1;CITED2
prerank,response to estrogen (GO:0043627),0.5848258134515487,1.4566179751982846,0.04739336492890995,0.5803899570018407,1.0,9/31,17.75%,ESR1;BCAS3;RARA;SRA1;SFR1;SERPINB9;KMT2D;CYP27B1;CITED2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.5726875288950906,1.455014696769864,0.04180790960451977,0.585319296642953,1.0,6/43,4.11%,THBS1;FOXP1;ID2;IGFBP5;FGF2;HES5
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.6703608287468212,1.45465252873655,0.07133058984910837,0.5846848514524341,1.0,3/14,1.02%,SLIT2;IGFBP5;LRP1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.4451453077271881,-1.4538671225950406,0.05235602094240838,0.5313053276240443,1.0,6/28,6.04%,ARHGAP28;ARHGAP18;ESAM;CXCL12;PLEKHG2;PAK3
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.5857681050961943,1.4537482845301004,0.06174334140435835,0.5865817664945199,1.0,4/31,5.57%,CACNA1G;KCNB1;SYT8;RAB3GAP1
prerank,muscle organ development (GO:0007517),0.546313803402321,1.4516673086834868,0.03937007874015748,0.5938191399727811,1.0,14/54,13.48%,COL6A3;FHL1;ITGA11;SGCD;MKX;MRAS;DMD;MEF2B;EVC;CTF1;POU6F1;MAPK12;MEF2D;MEF2A
prerank,regulation of chromosome segregation (GO:0051983),0.6539585100555866,1.450712002247972,0.07723035952063914,0.5960899705014748,1.0,6/16,8.66%,CSNK2A2;CSNK2A1;HORMAD1;PUM1;RMI2;CDC6
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6836264590752819,1.4506100962584842,0.07387140902872777,0.5942063960124461,1.0,6/12,16.21%,ESR1;NCOR2;STAT3;TERT;IL6;ZC3H10
prerank,adherens junction organization (GO:0034332),-0.3868869546645163,-1.4500158184199063,0.037037037037037035,0.5365493412491126,1.0,15/48,9.52%,TJP1;CADM1;CDH8;CDH13;CDH5;CADM2;CDH4;PIP5K1C;CDH1;CDH6;CDH2;NECTIN2;CDH7;CDH19;CDH20
prerank,ceramide transport (GO:0035627),-0.5601591496623725,-1.448771778407002,0.0851063829787234,0.5337751429637503,1.0,3/12,9.49%,PLTP;CERT1;GLTP
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6626835311978744,1.44722087772502,0.07960893854748603,0.6074440588636754,1.0,6/14,20.89%,GAS6;CARD16;PTPN2;TRAIP;CCDC3;GPS2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6611342960661897,1.4469256423680161,0.07713125845737483,0.606497439680657,1.0,7/15,6.20%,GPC3;SFRP4;RSPO3;TIAM1;CSNK1D;DACT1;LBX2
prerank,protein deacetylation (GO:0006476),0.5600196369263578,1.446653672753709,0.047180667433831994,0.6053194476997696,1.0,15/41,17.05%,PRDM5;HDAC9;HDAC4;BAZ2A;MORF4L2;MIDEAS;SIRT5;RCOR3;MORF4L1;MIER2;HDAC1;SIRT2;HDAC6;SIN3B;MTA3
prerank,mitotic nuclear membrane organization (GO:0101024),0.5422170273165291,1.4455355039633169,0.044642857142857144,0.6059356004737642,1.0,25/51,27.36%,NUP93;SEC13;LMNA;SEH1L;SPAST;RCC1;NUP37;CHMP3;REEP3;SIRT2;SUMO1;POM121;CC2D1B;IST1;CHMP4A;CHMP4B;NDC1;NUP35;CHMP2A;PPP2CA;NUP85;BANF1;NUP160;PPP2R1A;AHCTF1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.5422170273165291,1.4455355039633169,0.044642857142857144,0.6059356004737642,1.0,25/51,27.36%,NUP93;SEC13;LMNA;SEH1L;SPAST;RCC1;NUP37;CHMP3;REEP3;SIRT2;SUMO1;POM121;CC2D1B;IST1;CHMP4A;CHMP4B;NDC1;NUP35;CHMP2A;PPP2CA;NUP85;BANF1;NUP160;PPP2R1A;AHCTF1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5547476830999645,-1.4443171658688434,0.08080808080808081,0.5407856821920454,1.0,5/12,15.08%,CDH5;MAP2;EML2;SNCA;TUBB4A
prerank,regulation of autophagosome maturation (GO:1901096),0.6747879787676216,1.4438927929943715,0.06342780026990553,0.6112046309310522,1.0,8/13,24.23%,TMEM39A;CLEC16A;TBC1D25;PHF23;CLN3;RUBCN;UVRAG;SMCR8
prerank,cellular response to hexose stimulus (GO:0071331),0.6131627486192134,1.4436004545709615,0.07161125319693094,0.6101924004398793,1.0,6/23,5.38%,SLC39A14;KCNB1;GAS6;UNC13B;SLC26A6;ADCY8
prerank,negative regulation of actin filament polymerization (GO:0030837),0.619732157447144,1.4434938018472128,0.0697084917617237,0.6083663107999391,1.0,4/22,6.31%,SLIT2;PRKCD;GSN;PFN2
prerank,calcium ion import into cytosol (GO:1902656),-0.5127235980759464,-1.4434450118292919,0.07326007326007326,0.5371711250750876,1.0,5/15,7.35%,SLC8A1;SLC24A2;CACNA2D1;TRPV2;SLC8A3
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5739965815980146,-1.443180268674799,0.10299003322259136,0.5320776711302352,1.0,4/11,11.59%,TJP1;RAPGEF2;F11R;RAP2B
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.5678470458586766,-1.4422257458026995,0.07903780068728522,0.5290306679263197,1.0,7/11,21.60%,MECOM;WNT5A;ETV6;CD34;YJEFN3;WNT2B;WNT10B
prerank,regulation of exit from mitosis (GO:0007096),0.5731545700416105,1.4417540378213716,0.03778040141676505,0.6144334340683898,1.0,15/38,18.89%,ANAPC5;PPP1R9B;CDC16;CDC14A;UBE2C;ANAPC4;ZW10;ANAPC2;SIRT2;ANAPC1;RPS27A;UBC;ANAPC10;CDC20;CDC27
prerank,positive regulation of lipid catabolic process (GO:0050996),0.6261841618688688,1.441739560360058,0.0625,0.61216310701358,1.0,4/19,8.56%,IRS1;PRKCD;TWIST1;AKT2
prerank,myelination in peripheral nervous system (GO:0022011),0.6887892565751544,1.4414523501023089,0.0667574931880109,0.6112803369778307,1.0,7/13,16.86%,MYOC;LGI4;SKI;SOD1;NCMAP;SIRT2;NF1
prerank,fatty acid beta-oxidation (GO:0006635),0.5454112053428497,1.4407627146152568,0.04067796610169491,0.6122457285938561,1.0,30/51,32.95%,ABCD3;EHHADH;ACOXL;ECHDC2;ACOX3;ECI2;ETFDH;ETFA;ETFB;AUH;ACAT1;BDH2;CRAT;SLC27A2;PEX2;ABCD1;ECHDC1;MCAT;HADHA;GCDH;ACOT8;MTLN;ACAT2;SCP2;ECI1;CPT2;ABCD4;MECR;DECR2;CROT
prerank,histone methylation (GO:0016571),0.5970729326587606,1.4407275892290905,0.055,0.6101187271616677,1.0,15/26,30.14%,PRMT8;EHMT1;NSD1;CARM1;CREBBP;SUV39H2;NTMT1;SUV39H1;FBL;PRMT1;SMYD2;TRMT112;EHMT2;PRMT5;NSD3
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6853482606526106,1.440513815802249,0.06767955801104972,0.6087958395104831,1.0,6/13,15.73%,XPO1;LTV1;RRS1;ABCE1;NUP88;EIF6
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.6113132463360804,1.4404128170180006,0.07944514501891552,0.6070193165267688,1.0,4/20,5.27%,PID1;PKDCC;RHOQ;PPFIA1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.7068515546816353,1.4399059506271286,0.07906295754026355,0.607125830577158,1.0,8/10,26.97%,ATF4;NFE2L2;HSPA5;QRICH1;EIF2S1;EIF2AK3;HERPUD1;CCL2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5365818774084112,1.4396880870943454,0.03662597114317425,0.6058548935398097,1.0,8/53,6.12%,EGFR;PRKCD;EYA2;DDX5;SPRED2;TRIM28;CCAR2;ERCC8
prerank,nucleosome organization (GO:0034728),0.53775015320139,1.4388402827787996,0.041666666666666664,0.6077505322661094,1.0,26/55,26.20%,CHAF1B;NAA60;SOX9;SMARCC2;ANP32B;SPTY2D1;KAT6B;ACTR6;ZNHIT1;BRD2;NFE2;VPS72;HMGA1;NAP1L3;NAP1L2;BRDT;BPTF;PAF1;SETD2;SMARCA4;SRCAP;ANP32E;H3-3A;DAXX;ARID1A;CHAF1A
prerank,vesicle coating (GO:0006901),0.5325022574816499,1.4386086542915446,0.028761061946902654,0.6021003567691491,1.0,37/61,26.50%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;NSF;SCFD1;TRAPPC6A;USO1;SEC24C;SEC24B;PREB;SEC16A;SEC22B;CNIH1;SEC16B;SEC24A;NAPA;TMED2;TRAPPC3;SEC23IP;CTSZ;TRAPPC6B;RAB1A;LMAN1;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;GOLGA2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.5325022574816499,1.4386086542915446,0.028761061946902654,0.6021003567691491,1.0,37/61,26.50%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;NSF;SCFD1;TRAPPC6A;USO1;SEC24C;SEC24B;PREB;SEC16A;SEC22B;CNIH1;SEC16B;SEC24A;NAPA;TMED2;TRAPPC3;SEC23IP;CTSZ;TRAPPC6B;RAB1A;LMAN1;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;GOLGA2
prerank,COPII vesicle coating (GO:0048208),0.5325022574816499,1.4386086542915446,0.028761061946902654,0.6021003567691491,1.0,37/61,26.50%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;NSF;SCFD1;TRAPPC6A;USO1;SEC24C;SEC24B;PREB;SEC16A;SEC22B;CNIH1;SEC16B;SEC24A;NAPA;TMED2;TRAPPC3;SEC23IP;CTSZ;TRAPPC6B;RAB1A;LMAN1;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;GOLGA2
prerank,positive regulation of protein sumoylation (GO:0033235),0.6949783821599342,1.4378619120779914,0.09104258443465492,0.6034537815511267,1.0,6/10,21.22%,GNL3;HDAC4;PIAS4;RWDD3;SAE1;MUL1
prerank,potassium ion homeostasis (GO:0055075),0.6109787294681557,1.4373390754198048,0.0693196405648267,0.6035923637903484,1.0,4/23,1.20%,KCNJ2;SLC12A7;ATP1B1;SLC12A2
prerank,glucan catabolic process (GO:0009251),0.658178852491376,1.4370672583854847,0.06438356164383562,0.6026667723087675,1.0,5/15,7.74%,PYGB;STBD1;PHKA1;GAA;PHKB
prerank,tRNA transport (GO:0051031),0.5668870963333714,1.4370006345322748,0.06532066508313539,0.600807476781409,1.0,18/35,26.42%,NUP93;SEC13;RAE1;SEH1L;SSB;NUP37;RANBP2;NUP88;XPOT;POM121;NUP210;NUP62;NDC1;NUP35;YBX1;NUP85;NUP160;TPR
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.5688272843625904,-1.4364128481328367,0.08080808080808081,0.5396259767307752,1.0,6/11,19.07%,EFNB2;FRS2;SOX6;MYOCD;BMP2;TGFB1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.46291755500586923,-1.4358017607669826,0.05238095238095238,0.5357125581842583,1.0,11/22,24.95%,PPM1E;DUSP16;DUSP10;PPP2CB;PPM1G;DUSP6;PPP5C;DUSP4;PPP1CA;PPM1D;PPM1A
prerank,early endosome to Golgi transport (GO:0034498),0.7084727387090414,1.435575062513232,0.06573426573426573,0.6050647767086539,1.0,5/11,11.72%,STX5;SNX2;TRAPPC10;SNX1;TMED9
prerank,embryonic limb morphogenesis (GO:0030326),0.5677296112133587,1.4351236219241217,0.061371841155234655,0.6048664688522714,1.0,9/34,8.27%,LRP6;CACNA1C;AFF3;ECE1;TWIST1;MBNL1;TGFB2;SKI;NOG
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.6546734087990901,1.4350339106807792,0.05585106382978723,0.6031761135957538,1.0,14/16,32.28%,CELF4;THRAP3;CELF3;DAZAP1;NCBP1;RBMXL1;TRA2B;CIRBP;TRA2A;RBM3;SF3B4;PRDX6;SNW1;NCL
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4388925043347392,-1.4343125183528194,0.06698564593301436,0.5345673121107979,1.0,10/26,14.89%,NRXN1;SHANK3;APP;RIMS2;RIMS1;SLC8A3;CUX2;RELN;GRIN1;PRKCZ
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5081761887330764,1.4342091878635217,0.015873015873015872,0.6047546817734871,1.0,29/86,17.75%,THBS1;GDF10;ZNF423;FOXD1;NUP93;INHBC;ACVR1B;TGFB3;HES5;TGFB2;ACVR1;SMAD4;SULF1;GIPC1;BMP4;SH2B1;BMPR1A;TGFB1I1;TGFBR1;INHBA;DAB2;BMP5;CRB2;CREBBP;SLC2A10;FLCN;CDKN1C;MEN1;CITED2
prerank,positive regulation of calcium ion transport (GO:0051928),-0.42019935718851376,-1.433915753267474,0.023529411764705882,0.530185305623413,1.0,9/36,6.58%,MYLK;CACNA1D;CACNB2;TRPC3;CXCL12;PDGFRB;ATP2B1;TRPC6;ORAI1
prerank,ureteric bud morphogenesis (GO:0060675),0.6490482651621589,1.4335620236429025,0.07133058984910837,0.6054514215947782,1.0,2/16,1.12%,SIX1;FGF2
prerank,limb morphogenesis (GO:0035108),0.632797029346416,1.4324423354131013,0.05721716514954486,0.6083825133909864,1.0,5/20,7.28%,LRP6;PCSK5;MBNL1;TGFB2;SKI
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.6450454783651959,1.4324066320176507,0.08979591836734693,0.6063662833027104,1.0,5/15,11.76%,ACVR1B;DACT1;ACVR1;SKI;SMAD7
prerank,water transport (GO:0006833),-0.5516981605876076,-1.431854741951801,0.07942238267148015,0.530373076965923,1.0,9/12,44.86%,AQP11;CFTR;AQP1;AQP4;AQP9;PDPN;AQP6;AQP7;SLC5A1
prerank,histone deacetylation (GO:0016575),0.5507796581720962,1.43181691589394,0.047619047619047616,0.6067523515096118,1.0,17/43,17.33%,PRDM5;HDAC9;HDAC4;BAZ2A;MORF4L2;MIDEAS;RCOR3;MORF4L1;MIER2;SFPQ;HDAC1;PER1;SIRT2;HDAC6;SIN3B;MTA3;SMARCAD1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.510886216680763,1.431688113072081,0.028481012658227847,0.605174709366605,1.0,21/92,12.40%,THBS1;SMOC2;FOXP1;VEGFA;FGF2;ADAM9;PRKCE;SPARC;TGFB2;PRKCA;BCAS3;FOXC2;DOCK5;GFUS;SOX9;ANGPT4;BMP4;ABL1;IQSEC1;PIK3CB;NRP1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6661753118317635,1.430167591811264,0.07464788732394366,0.6102076836187857,1.0,2/14,0.78%,PGF;VEGFA
prerank,regulation of response to stress (GO:0080134),0.712269671107584,1.4298109123085645,0.07735583684950774,0.6098348194722035,1.0,2/10,5.38%,SLC38A2;ADCY8
prerank,regulation of T cell mediated immunity (GO:0002709),0.7108938306144218,1.4296154387205764,0.08789625360230548,0.6086047529746829,1.0,4/10,10.46%,TNFRSF1B;HMGB1;TRPM4;RIPK3
prerank,chromatin assembly (GO:0031497),0.5509704046484235,1.4286426413070041,0.06666666666666667,0.6110066043043658,1.0,18/38,26.20%,CHAF1B;M1AP;NAA60;EZH1;SOX9;CDAN1;ANP32B;SPTY2D1;KAT6B;BRD2;NAP1L3;NAP1L2;NOC2L;PAF1;TP53;H3-3A;DAXX;CHAF1A
prerank,cellular polysaccharide catabolic process (GO:0044247),0.6470445906198513,1.4286104569954856,0.06998654104979811,0.6090471390746033,1.0,5/16,7.74%,PYGB;STBD1;PHKA1;GAA;PHKB
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.6723010149579428,1.4280130907573876,0.08274894810659186,0.6096675940440196,1.0,6/12,17.87%,SEH1L;CENPC;MAD1L1;MIS12;RMDN1;CDT1
prerank,positive regulation of axonogenesis (GO:0050772),0.5480967467810955,1.4279965278635764,0.058486238532110095,0.6076580219089917,1.0,5/43,2.40%,SLIT2;PLXNA4;NTN1;TIAM1;TIAM2
prerank,tRNA export from nucleus (GO:0006409),0.57281523203046,1.4276716898135209,0.07151515151515152,0.6049415654346122,1.0,17/32,26.42%,NUP93;SEC13;RAE1;SEH1L;SSB;NUP37;RANBP2;NUP88;XPOT;POM121;NUP210;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.57281523203046,1.4276716898135209,0.07151515151515152,0.6049415654346122,1.0,17/32,26.42%,NUP93;SEC13;RAE1;SEH1L;SSB;NUP37;RANBP2;NUP88;XPOT;POM121;NUP210;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5468294857279353,1.4273575532674225,0.058959537572254334,0.6041988809650427,1.0,5/44,4.18%,THBS1;VEGFA;GAS6;CSNK2A1;CARD16
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.6596609806652559,1.427321311193686,0.07840440165061899,0.6023290109296746,1.0,10/14,25.06%,SRSF6;PCBP4;PTBP1;U2AF2;SRSF7;SRSF10;SAP18;SFSWAP;SRSF4;C1QBP
prerank,regulation of vasculature development (GO:1901342),0.587372967582191,1.4272883278436732,0.07626076260762607,0.6004750809546555,1.0,3/26,1.91%,BMPER;FGF2;PROK2
prerank,positive regulation of organelle organization (GO:0010638),0.5753011082362287,1.4268886539102499,0.06190476190476191,0.6002420789830958,1.0,12/32,12.95%,SORBS3;ANXA2;C2CD5;RAB3GAP1;ATL3;AKT2;ANXA1;SYNJ1;PLA2G5;KATNBL1;TMED9;LIG4
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6075404804681094,1.426053951520424,0.06298200514138817,0.6017733869311399,1.0,7/23,14.43%,PLA2G4F;PLA2G4A;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6698917146426874,1.4256410195532698,0.09078014184397164,0.6014116459581061,1.0,5/12,14.45%,FOXP1;NCOR2;HEYL;HDAC1;DAB2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.70301357694708,1.4246378353505138,0.06647807637906648,0.6038671859571221,1.0,3/11,6.99%,KCNJ2;ATP1B1;KCNIP2
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6999579006249048,1.4244505843781718,0.09261939218523878,0.6026315801157563,1.0,5/10,16.03%,GALNT13;POGLUT3;POGLUT1;GALNT1;GALNT3
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.5572929193826064,1.4241476779713613,0.0624263839811543,0.6019391024648187,1.0,7/39,9.03%,THBS1;MYOC;EFNA5;SEMA3E;JAG1;FZD7;RHOA
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5769357750527896,1.4239044543502288,0.0631704410011919,0.6010745334692994,1.0,5/32,6.53%,THBS1;MYOC;SEMA3E;BCAS3;JAG1
prerank,histone deubiquitination (GO:0016578),0.6336513857136574,1.4238348517399544,0.07936507936507936,0.5994461516367798,1.0,12/18,27.85%,TRRAP;ENY2;KAT2A;USP7;USP36;BRCC3;USP49;ATXN7;TAF10;USP21;USP16;USP22
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.533881888616314,1.4221597478765744,0.04927211646136618,0.6049586106305697,1.0,8/50,9.53%,THBS1;VEGFA;GAS6;NOL3;CSNK2A1;CARD16;RAF1;PAK2
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5400237233258148,1.422155455803001,0.04914285714285714,0.6030010185158495,1.0,19/49,23.44%,THBS1;RAB7B;KMT2C;AGO1;PITHD1;WDR5;HDAC1;KMT2D;RUNX1;SCIN;EIF6;NFE2;KMT2B;SETD1A;CBFB;DPY30;KMT2A;PRMT1;KAT2B
prerank,oligosaccharide biosynthetic process (GO:0009312),0.623151461581076,1.4214817313321466,0.08408796895213454,0.6040265965597824,1.0,6/20,11.14%,ST3GAL4;ST6GALNAC5;B4GALT1;ST3GAL2;FUT8;FUT4
prerank,stress fiber assembly (GO:0043149),-0.5111144116357872,-1.4210265527229804,0.09236947791164658,0.5498253116401349,1.0,3/15,0.88%,SORBS1;PHACTR1;FAM171A1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.5111144116357872,-1.4210265527229804,0.09236947791164658,0.5498253116401349,1.0,3/15,0.88%,SORBS1;PHACTR1;FAM171A1
prerank,heart development (GO:0007507),0.49317702915218253,1.4208615556056385,0.008171603677221655,0.6047237055377789,1.0,46/150,16.94%,MICAL2;PKD1;CACNA1C;ID2;ZFPM2;VEGFA;PCSK5;PLCE1;SGCD;COL3A1;GPC3;NTRK3;ECE1;GLI2;PDLIM7;HDAC9;TGFB2;RAMP2;ACVR1;FOXC2;TGFBR2;SOX9;FOXL1;CRELD1;SH3PXD2B;ALPK3;BMP4;TAB2;POU6F1;CSRP3;FLRT2;ZDHHC16;WDR11;SRF;KAT2A;TGFBR1;MEF2D;MEF2A;TCF25;BMP5;AKAP13;DNAAF4;MTHFD1;KDM6B;NF1;NIPBL
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5859111046126712,1.419609620735746,0.07021791767554479,0.6083740271686318,1.0,12/29,19.65%,ESR1;CARM1;FOXA1;AXIN1;KMT2D;RUNX1;UBA5;DNAAF4;UFL1;VPS11;CNOT9;CBFB
prerank,monoacylglycerol metabolic process (GO:0046462),0.6603394765203414,1.4195401128825562,0.09449929478138223,0.6067120210441782,1.0,2/13,1.79%,MGLL;PLA2G4A
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.47093078565758784,-1.419370458443025,0.075,0.5490125039885989,1.0,6/22,6.42%,LYN;ROCK2;EPHA4;PICALM;ABCG1;GSAP
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5667069788699801,1.4191404029109036,0.061893203883495146,0.6064471725423052,1.0,7/34,12.40%,MYOC;P4HB;ILK;S100A10;DOCK5;ABL1;NRP1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.5083164112425574,1.418586952754621,0.03404255319148936,0.6070323238606198,1.0,42/80,30.17%,SGSM2;STX5;RAB7B;SNX2;ERC1;TRAPPC10;RIC1;GBF1;VPS52;TBC1D23;TRIM27;SNX1;RGP1;VPS26A;TMED9;SNX32;TMEM87B;VPS53;CLTC;TBC1D10A;TBC1D17;SPAG9;STX16;GGA1;PHETA2;EVI5;HEATR5A;DCTN1;LMAN1;VPS51;BET1L;SNX3;RNF126;VTI1B;GCC2;SURF4;CLN5;SNX5;ARL1;ARFRP1;PIKFYVE;VTI1A
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6768973865846925,1.417785452311125,0.07407407407407407,0.6085638670681791,1.0,6/12,11.91%,KDELR3;GPAA1;KDELR1;KDELR2;RER1;HSPA5
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.399873595026649,-1.4166506474037648,0.05755395683453238,0.5513061510878817,1.0,12/39,14.70%,MYO1B;PPFIA2;DYNC1I1;MYO6;ACTN4;BICDL1;TRAK2;MYO1D;KIF1A;TRAK1;KIF5B;MYO5C
prerank,smooth muscle contraction (GO:0006939),-0.5262386355976898,-1.4165162895074563,0.08843537414965986,0.5463312598603439,1.0,9/14,12.54%,ROCK2;MYLK;SLC8A1;SMTN;BDKRB2;MYH11;ADRA1A;ACTA2;PIK3C2A
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.6568485630763002,1.416487119278471,0.09686221009549795,0.6124502859753597,1.0,8/13,21.00%,CPSF4L;CPSF4;NCBP1;CPSF7;CPSF6;NCBP2;CSTF2;CSTF2T
prerank,regulation of autophagosome assembly (GO:2000785),0.5717292501979452,1.416305377161839,0.05369928400954654,0.6112831716968046,1.0,21/33,27.19%,NPRL3;TMEM39A;LRSAM1;RAB3GAP1;IFT20;SCFD1;PIP4K2B;PHF23;SEC22B;IFT88;RAB3GAP2;CHMP4A;CHMP4B;LRRK2;RAB1B;MTM1;NPRL2;SMCR8;PINK1;RAB5A;PIP4K2C
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5882200866900271,1.4162898165081383,0.0741687979539642,0.6094363979822229,1.0,4/27,1.86%,IRS1;PID1;PRKCD;GRB10
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.5808585375365866,1.4154559994435525,0.0865265760197775,0.6113007474983597,1.0,10/25,25.11%,LDB1;TCEA2;CCAR2;HMGN1;CCNT2;SETD5;ZMYND11;KAT7;EAF1;DDX39B
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.44492346729796967,-1.4151697303613264,0.057291666666666664,0.5448374065208132,1.0,5/25,7.59%,WNT5A;KIT;B2M;SLC7A5;LACC1
prerank,lymphocyte chemotaxis (GO:0048247),0.5639474328125552,1.4151500005647273,0.06039488966318235,0.6107467579504088,1.0,5/34,7.22%,GAS6;SLC12A2;CCL13;CCL15;CXCL16
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.6175106025318466,1.4151294459800057,0.07402597402597402,0.6089127586707785,1.0,8/18,19.63%,RDX;DNAJC13;RAB21;EZR;CHMP3;DAB2;VPS11;PTPN23
prerank,carboxylic acid metabolic process (GO:0019752),0.5655037717954666,1.4142934550417854,0.07380952380952381,0.6107396296379838,1.0,4/33,1.79%,SLC23A1;SLC23A2;PTGIS;PLA2G4A
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.6125804373142588,1.4136298341775986,0.08205128205128205,0.6119992454640396,1.0,6/19,12.40%,MYOC;VEGFA;COL16A1;S100A10;ABL1;NRP1
prerank,smooth muscle cell differentiation (GO:0051145),-0.5608842137533622,-1.4133577820285275,0.11071428571428571,0.5450193278153442,1.0,8/12,14.97%,MRTFB;TBX18;TMEM204;GATA6;EDNRB;MYOCD;HEY2;APLNR
prerank,glycogen metabolic process (GO:0005977),0.5783029127998377,1.4128994409951252,0.06134969325153374,0.6133095593320531,1.0,6/27,7.74%,PYGB;PPP1R3C;STBD1;PHKA1;GAA;PHKB
prerank,protein import into peroxisome membrane (GO:0045046),0.5943494884743882,1.4125174134073093,0.07388535031847134,0.6129942561747708,1.0,10/22,22.68%,ABCD3;PXMP2;PEX5;PEX16;PEX13;ALDH3A2;PEX2;ABCD1;ACBD5;PEX14
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6217492584070641,1.4125085031246865,0.07702523240371846,0.6111478983160399,1.0,6/16,15.26%,ST3GAL4;NFAT5;RHOA;IRAK1;FUT4;IL6
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4870509189151097,1.4121979724439508,0.006103763987792472,0.6106154245643359,1.0,36/150,12.81%,SLIT2;RASSF2;LRP6;PID1;PRKCD;PMEPA1;EMILIN1;UBASH3B;NTRK3;SMAD6;PLPP3;EPHB2;TWIST1;LDLRAD4;SPRED2;WWTR1;XDH;CALM2;DVL1;DMD;PRKDC;TRIM27;NOG;IMPACT;AKT1S1;CDK5RAP3;DGKQ;PAK2;PAQR3;NIBAN1;PDPK1;SMAD7;DEPTOR;CHP1;PPEF2;EIF4G1
prerank,antibacterial humoral response (GO:0019731),0.6420812672947822,1.4119169449709779,0.09018567639257294,0.6100497136666658,1.0,5/16,18.51%,RNASE7;RNASE3;RNASE6;DEFB1;DMBT1
prerank,intestinal lipid absorption (GO:0098856),0.6851501487487032,1.4118808287897056,0.08513708513708514,0.6083292726531448,1.0,3/11,8.81%,LIMA1;CEL;AKR1C1
prerank,histone H3-K4 methylation (GO:0051568),0.5847342285087535,1.411623483526096,0.08104738154613467,0.60758049874977,1.0,12/26,22.61%,KMT2C;OGT;WDR5;KMT2D;SETD4;KMT2B;MEN1;WDR82;SETD1A;DPY30;TET2;KMT2A
prerank,mitochondrion transport along microtubule (GO:0047497),0.6694524926147902,1.4109965266196585,0.0787292817679558,0.6082676794764486,1.0,4/13,9.94%,SYBU;RHOT2;RHOT1;SPAST
prerank,ncRNA export from nucleus (GO:0097064),0.5595139193240319,1.4109820414273135,0.066746126340882,0.6064931052632574,1.0,18/36,26.42%,NUP93;SEC13;RAE1;SEH1L;SSB;NUP37;RANBP2;NUP88;XPOT;POM121;NUP210;NCBP2;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,regulation of cholesterol esterification (GO:0010872),-0.5755036149543776,-1.4095316000352773,0.10736196319018405,0.5508462842272374,1.0,4/10,8.10%,APOE;ABCG1;STARD4;AGTR1
prerank,integrated stress response signaling (GO:0140467),0.6560833233915124,1.4094230747092853,0.08486562942008487,0.611582593446998,1.0,10/14,26.97%,ATF4;NFE2L2;IMPACT;HSPA5;QRICH1;EIF2AK4;EIF2S1;EIF2AK3;HERPUD1;CCL2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.5142219098382446,-1.408883543706069,0.07407407407407407,0.5475155878630336,1.0,5/14,7.35%,SLC8A1;SLC24A2;CACNA2D1;TRPV2;SLC8A3
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5483069541612822,1.4083997737376388,0.058823529411764705,0.6143151397576176,1.0,16/40,15.98%,TCF7L2;COL1A1;TIAM1;TGFB3;TWIST1;WWTR1;TGFB2;BCL9L;SMAD4;TGFBR2;JAG1;TGFB1I1;TGFBR1;DAB2;IL6;CRB2
prerank,protein import (GO:0017038),0.5002790055979472,1.4079337650758776,0.03632478632478633,0.614509449858663,1.0,44/84,31.45%,ABCD3;NUP93;PRICKLE1;PXMP2;SEC13;IPO5;STAT3;IPO4;HIKESHI;E2F3;PEX5;PEX16;PEX13;IPO13;TNPO2;ALDH3A2;NUP88;POM121;AKT1;IPO9;TNPO1;APPL2;APPL1;CLU;NUP62;PPP1R10;LAMP2;PEX2;ABCD1;ACBD5;PEX14;TSC2;IPO8;NUTF2;NUP85;TPR;RPAIN;FIS1;NUP50;FAM53C;ATAD1;HSP90AA1;NUP188;RANBP6
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5706901849182353,1.4075423235058468,0.06090133982947625,0.6144116838708041,1.0,8/29,14.43%,PLA2G4F;PLA2G4A;LPCAT1;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A
prerank,vitamin transport (GO:0051180),0.5786421492355556,1.4073880053663934,0.08200734394124846,0.6133082031865218,1.0,3/29,5.92%,SLC23A1;SLC5A6;SLC25A32
prerank,catecholamine metabolic process (GO:0006584),0.6564828283466726,1.4070306826774037,0.09266943291839558,0.6131142508830857,1.0,3/14,4.35%,DRD1;LRTOMT;SNCAIP
prerank,regulation of protein metabolic process (GO:0051246),-0.3786786325030024,-1.4067464375307832,0.038461538461538464,0.5489091048058986,1.0,10/44,11.43%,ROCK2;NEDD4L;APOE;APP;FAF1;GSAP;KLF2;ACE;MTPN;SPOP
prerank,visual system development (GO:0150063),0.5553820190548898,1.4063703231303517,0.07100591715976332,0.6141130303400555,1.0,14/37,20.04%,SMOC1;CHRDL1;PBX3;TGFB2;PBX1;MEIS3;SH3PXD2B;CPAMD8;ZDHHC16;BLOC1S3;SIPA1L3;MAB21L2;HIPK2;ATF6
prerank,cellular senescence (GO:0090398),0.5789823593862413,1.4049430260309492,0.0773955773955774,0.6188813369289523,1.0,3/27,0.88%,ID2;PRKCD;ECRG4
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5803726224678571,1.4046077702776476,0.07653701380175659,0.6184767377050043,1.0,12/24,20.37%,SEC31A;SEC24D;SEC13;SEC23A;FCER1G;PDIA3;BCAP31;SEC24C;SEC24B;IDE;SEC24A;CALR
prerank,embryonic appendage morphogenesis (GO:0035113),0.6832095344011703,1.4040435291373807,0.09180790960451977,0.6190748019472749,1.0,4/12,7.28%,LRP6;MBNL1;TGFB2;SKI
prerank,protein import into peroxisome matrix (GO:0016558),0.6648400945448593,1.4038951380556017,0.11142061281337047,0.6178723659510805,1.0,9/12,22.68%,PEX7;PEX5;PEX16;PEX13;PEX1;PEX10;PEX6;PEX2;PEX14
prerank,cellular response to organic substance (GO:0071310),0.48961941784877633,1.4037754708094694,0.01867219917012448,0.6166131567747967,1.0,25/116,13.71%,SLIT3;SLIT2;PID1;IGFBP5;GHR;DPYSL3;ACVR1B;SHC1;CYP1B1;NFAT5;STAT3;RAMP2;ACVR1;TGFBR2;SOCS2;RHOA;PTPN18;MAPK8;RAMP1;URI1;BMPR1A;TGFBR1;PTPN2;LRP2;CASP1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.4834362475788284,1.4037511672324088,0.00819672131147541,0.6149623290946094,1.0,67/153,24.66%,PKD1;PRKCD;GAS6;ULK2;MARK1;PRKCE;CSNK1D;CAMK2D;CSNK2A2;CSNK2A1;MORC3;PRKCA;DYRK4;PRKDC;TGFBR2;TLK1;STK39;RPS6KA4;AKT2;DGKQ;PKN2;PAK2;MAPK8;SMG1;CSNK1G1;CHUK;MAP3K12;ATM;MAPK12;PDPK1;UHMK1;CSNK1E;TGFBR1;MAP3K10;DMPK;WNK1;LATS2;CAMK4;TLK2;MKNK2;VRK2;MAST2;AKT1;HIPK2;CDK2;IKBKE;CDK5;SGK3;MAPK9;PRKACA;VRK3;LRRK2;CSNK1G3;MAST4;CAMK1;STK38;EIF2AK3;PRKCI;TOP1;HIPK4;RPS6KA2;RPS6KB1;TAF1;TBK1;ROCK1;PINK1;LMTK2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5022682498037025,-1.4035358107240088,0.09363295880149813,0.553169096385413,1.0,7/16,12.94%,PDGFD;PLAT;PDGFRB;PDGFRA;PDGFC;PIK3C2A;PTPN1
prerank,global genome nucleotide-excision repair (GO:0070911),0.5813690245060116,1.4035012772781148,0.08955223880597014,0.614220407227333,1.0,18/26,34.40%,CHD1L;ERCC4;CUL4A;USP45;ERCC3;ERCC2;PARP1;RPS27A;UBC;GTF2H4;RNF111;XPA;DDB1;RBX1;ERCC1;RAD23B;CUL4B;CETN2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5392694892616018,1.401527644868798,0.052868391451068614,0.621202755985865,1.0,12/48,9.70%,THBS1;RHOJ;VEGFA;FGF2;HDAC9;STAT5A;PRKCA;FOXC2;HMGB1;FGFR1;ANGPT4;ANXA1
prerank,chemical homeostasis (GO:0048878),0.520943531667467,1.4012048512393347,0.052805280528052806,0.620888470793472,1.0,15/61,15.91%,SLC4A10;SLC4A4;ACOXL;SLC4A8;TLCD2;ACOX3;TENT4B;SLC4A11;SLC4A2;NR1D2;SLC4A3;WNK1;PNPLA3;SLC4A5;THADA
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5900720515527318,1.3999221012225558,0.08513341804320203,0.6245938301743917,1.0,7/22,17.99%,ESR1;MED13;SRF;PSMC5;PSMC4;MED14;MED12
prerank,sodium ion homeostasis (GO:0055078),-0.4559511177113283,-1.3998720750634375,0.09016393442622951,0.5584681605003662,1.0,4/21,1.29%,ATP1A2;ATP1B3;NEDD4L;SLC8A1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5160633617436506,1.399864786672575,0.04008667388949079,0.6230321189940329,1.0,10/69,8.13%,THBS1;LBP;IL33;EPHB2;TWIST1;SPN;STAT3;MAVS;HMGB1;FZD5
prerank,positive regulation of catabolic process (GO:0009896),0.5108135237891663,1.3992964229130327,0.0391304347826087,0.6237609023228492,1.0,15/65,11.35%,WWP1;GPC3;NEDD4;STX5;CSNK2A1;ACTN3;RILP;VCP;DACT1;HUWE1;WWP2;NSF;ITCH;VIP;AXIN1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.48122786394564154,-1.3988329610862202,0.09565217391304348,0.5563321740758883,1.0,5/18,8.73%,OCLN;SLC2A1;PRKCB;PRKAG2;BRAF
prerank,dermatan sulfate metabolic process (GO:0030205),0.6406057091635828,1.3986937035063114,0.08089260808926081,0.6246611922619789,1.0,3/13,4.29%,DSE;BGN;CSPG4
prerank,endomembrane system organization (GO:0010256),0.47966036603285894,1.3983576998819223,0.01314459049544995,0.6242991687795088,1.0,69/178,24.23%,NUP93;SEC31A;MAPK15;ATL2;SEC61A1;CSNK1D;LMAN2L;RAB2A;FBXW8;GOLGA8B;GOLGA5;RAB30;RAB43;TLCD2;DOP1B;DNAJC13;BCAS3;SMPD4;GOLGB1;LAMTOR1;ATL3;USP50;GBF1;ATP8B2;HUWE1;TJAP1;ARHGAP21;LAPTM4B;PLEKHM2;TRAPPC12;AP3D1;TMED9;ZW10;TRIP11;WASHC4;PI4K2A;DMPK;REEP3;LMAN2;SEC16A;SQSTM1;MIA3;SEC16B;SPTBN1;TLCD1;VPS11;TMEM170A;GOLPH3;BNIP1;TMED2;NPLOC4;COG2;BLZF1;PHETA2;SEC23IP;TRAPPC11;REEP5;OPTN;ARFGEF2;ATL1;LRRK2;RAB1A;LMAN1;ATP8B1;EIF2AK3;GORASP2;DYNC2H1;TMED7;VPS51
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5757859341416597,1.3980662848090244,0.0792838874680307,0.6237391779865896,1.0,4/28,1.86%,IRS1;PID1;PRKCD;GRB10
prerank,cellular component disassembly (GO:0022411),0.5185708956442922,1.3972104005205466,0.05909090909090909,0.6258089557643329,1.0,10/53,10.36%,BMP1;GSN;HTRA1;TIMP2;TLL1;ADAM10;MMP14;CAPN2;SH3PXD2B;SCUBE3
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5132145259621519,1.3971631148222092,0.03779697624190065,0.6242338000470868,1.0,10/73,8.13%,THBS1;LBP;IL33;EPHB2;TWIST1;SPN;STAT3;MAVS;HMGB1;FZD5
prerank,regulation of phospholipase activity (GO:0010517),0.688808009052531,1.3967620089588177,0.08563134978229318,0.6242429829266113,1.0,5/10,11.57%,LRP1;FGFR1;FGFR2;PLA2G5;PDPK1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.5922787004927901,1.3960598457017455,0.0941320293398533,0.6254304215652472,1.0,17/23,34.50%,GPS1;CUL4A;PARP1;RPS27A;UBC;COPS4;COPS7A;COPS3;XPA;DDB1;RBX1;COPS5;RAD23B;CUL4B;COPS2;CETN2;COPS7B
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.6412117918210309,1.3950275287263625,0.10738255033557047,0.6282723599768886,1.0,2/13,1.76%,NEDD4;EMILIN1
prerank,histone lysine demethylation (GO:0070076),0.5722653084291418,1.3946652861177395,0.08782936010037641,0.62821481509701,1.0,9/25,16.74%,JMJD1C;RIOX2;KDM2A;PHF8;KDM5B;KDM4A;HR;KDM5C;KDM6B
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5551797071898759,1.3943825455754157,0.0703030303030303,0.6277294205575916,1.0,12/33,15.82%,PRKCD;CYP1B1;MAP3K5;FXN;NFE2L2;IMPACT;ANXA1;RIPK3;ABL1;RHOB;IL6;HDAC6
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.6418197047638785,1.3940462731082655,0.10358565737051793,0.6273899611911035,1.0,4/15,11.76%,TGFB3;TGFB2;IRAK3;SMAD7
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6519660855267373,1.393935953291103,0.08615819209039548,0.62614582731436,1.0,5/13,16.48%,BGN;ARSB;CSPG4;HEXA;VCAN
prerank,glycogen catabolic process (GO:0005980),0.6372325922123712,1.3932996318511015,0.09959072305593451,0.627234428933032,1.0,5/15,7.74%,PYGB;STBD1;PHKA1;GAA;PHKB
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.5852650173461535,1.3931913461980052,0.08236808236808237,0.6259374536476306,1.0,9/25,12.31%,CACNA1C;FGF13;HCN4;CAMK2D;ANK2;JUP;DLG1;TRPM4;AKAP9
prerank,regulation of tumor necrosis factor production (GO:0032680),0.49266665955156314,1.392593842341334,0.022610483042137718,0.6267236861278563,1.0,15/112,8.13%,THBS1;FOXP1;GAS6;LBP;IL33;EPHB2;TWIST1;SPN;STAT3;MAVS;HMGB1;IRAK3;TRIM27;RARA;FZD5
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6459212679509244,1.392040206957553,0.1008174386920981,0.6273561818680055,1.0,7/13,25.75%,PKD1;GOPC;MDFI;SUFU;NFKBIA;YWHAB;GET4
prerank,positive regulation of cytokinesis (GO:0032467),0.5590772373738138,1.3915506158019744,0.07932692307692307,0.6278443266549413,1.0,11/32,15.12%,CIT;PRKCE;CDC14A;GIPC1;CDC6;RHOA;PKN2;CDC25B;SPAST;OPN1MW;CSPP1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6774785235915838,1.3904994285575936,0.1005586592178771,0.6305808603056342,1.0,6/11,19.63%,RDX;RAB21;EZR;DAB2;VPS11;PTPN23
prerank,extracellular matrix assembly (GO:0085029),0.6006761442071263,1.390412807521577,0.08066581306017925,0.6292492701676816,1.0,6/23,6.99%,GAS6;LTBP3;EMILIN1;NTN4;RAMP2;QSOX1
prerank,neutrophil activation (GO:0042119),0.6439543429464045,1.3898450234215374,0.12517193947730398,0.6301019341948545,1.0,2/12,8.57%,PRKCD;FCER1G
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.39995917012659576,-1.3893535220961093,0.07894736842105263,0.578569466646986,1.0,11/35,9.40%,TJP1;TEK;RAPGEF3;ESAM;F11R;PDGFRA;BAIAP2;ARHGDIA;IQGAP2;CDC42;ABI3
prerank,actin filament bundle organization (GO:0061572),-0.3998670251568226,-1.3891390233477354,0.03821656050955414,0.5739747104376709,1.0,12/33,13.26%,MYO1B;PAWR;SHROOM2;EPS8;PLS3;NEDD9;BAIAP2;SHROOM1;AIF1L;LCP1;RFLNA;RFLNB
prerank,extracellular matrix disassembly (GO:0022617),0.5180250348414687,1.3890770819579439,0.06091954022988506,0.6316683701263764,1.0,10/53,10.36%,BMP1;GSN;HTRA1;TIMP2;TLL1;ADAM10;MMP14;CAPN2;SH3PXD2B;SCUBE3
prerank,protein alkylation (GO:0008213),0.5928286591482983,1.3890614694269265,0.08497536945812807,0.630023802349309,1.0,10/22,23.22%,PRMT8;FAM98A;GSPT1;FAM98B;LCMT1;EEF1AKMT2;ETF1;PCMT1;SNRPB;PRMT1
prerank,ion transport (GO:0006811),0.4849233128317165,1.3889563158675517,0.03128258602711158,0.6288706179688172,1.0,15/111,7.65%,PIEZO2;SLC26A7;SLC26A2;SLC12A7;SLC12A2;SLC24A3;HCN4;SLC26A6;KCNN1;SLC9A8;SLC9A4;CHRNB2;SLC9A1;SLC4A2;SLC12A4
prerank,protein localization to Golgi apparatus (GO:0034067),0.5720674609316585,1.388641323420737,0.08690330477356181,0.6284282295770157,1.0,6/27,10.28%,VPS13A;VPS13C;CSNK1D;IFT20;GBF1;PAQR3
prerank,positive regulation of integrin activation (GO:0033625),-0.5493093825296114,-1.3886028127717158,0.11551155115511551,0.5705109807671674,1.0,3/11,11.13%,RASIP1;PIEZO1;PLEK
prerank,intracellular protein transport (GO:0006886),0.4708160739522825,1.388273210690265,0.003006012024048096,0.6284204582700159,1.0,116/304,23.74%,PKD1;SGSM2;XPO1;LTBP2;NUP93;ARFGAP3;CTTN;SEC31A;KIF13A;PRICKLE1;EHD1;TBC1D8B;TBC1D2B;STX5;SEC13;ARCN1;IPO5;STRADA;RAB43;STAT3;C2CD5;COPA;BAG3;RAB24;STX11;AP2A1;IPO4;RAB21;RIC1;TLK1;GGA2;XPO6;HIKESHI;E2F3;GIPC1;ARF4;COPZ2;AKT2;SNX1;NSF;SCFD1;STX2;VPS26A;ARFIP2;RAB38;XPO4;ARF1;SNX9;AP3D1;TMED9;WDR11;USO1;EVI5L;IPO13;CHP1;TECPR2;TBC1D9B;NLGN1;TBC1D25;TNPO2;ERP29;PICK1;VIPAS39;PREB;CLTC;SEC16A;RAB23;HPS4;TBCK;NUP88;TBC1D10A;SIL1;STX4;COPB2;STX1A;SCFD2;TBC1D17;HDAC6;STX16;GGA1;BCS1L;SNX13;NAPA;TMED2;POM121;RAB5B;VPS45;AKT1;IPO9;TNPO1;SNX15;SEC23IP;RAB3GAP2;COX18;EVI5;APPL2;APPL1;CALR;TBC1D22B;VPS26C;NUP62;IFT27;PPP1R10;CCHCR1;LAMP2;RAB1A;LMAN1;RAB18;DESI1;CAMSAP3;TSC2;RAB1B;COPZ1;IPO8;RABGAP1;ARF5
prerank,ERBB2 signaling pathway (GO:0038128),0.5653617062043151,1.3877485382584098,0.08072289156626505,0.6290527783008013,1.0,4/31,4.91%,MYOC;EGFR;SHC1;PRKCA
prerank,positive regulation of mRNA processing (GO:0050685),0.6051558039898656,1.3873645709810711,0.0830188679245283,0.6290618563276482,1.0,16/21,32.28%,CELF4;THRAP3;CELF3;DAZAP1;NCBP1;NCBP2;RBMXL1;TRA2B;CIRBP;TRA2A;PAF1;RBM3;SF3B4;PRDX6;SNW1;NCL
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5737988070978987,1.3869614412752456,0.09898477157360407,0.6290814096861294,1.0,8/27,8.87%,CACNA1C;FGF13;HCN4;CAMK2D;ANK2;JUP;DLG1;TRPM4
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.4646442894096998,-1.3863218847459764,0.08771929824561403,0.572305003630171,1.0,10/20,23.25%,WNT4;ASXL3;CEACAM1;GPER1;BMP2;BRCA1;ERLIN2;TRIB3;SIK1;APOC1
prerank,negative regulation of locomotion (GO:0040013),-0.5398252735767922,-1.385983749690786,0.12091503267973856,0.5683771765640011,1.0,5/12,12.01%,FRMD5;FBLN1;SPOCK3;DUSP3;SPINT2
prerank,protein O-linked mannosylation (GO:0035269),-0.4738383102293449,-1.385946319786647,0.09803921568627451,0.5636592154675081,1.0,3/18,2.16%,TMTC2;TMTC4;CRPPA
prerank,skin development (GO:0043588),0.5116207291652238,1.3854254950874343,0.04112554112554113,0.6339445780569372,1.0,10/65,6.78%,PKD1;COL3A1;ADAM9;COL1A2;COL1A1;COL5A3;COL5A2;CLIC4;JAG1;BCR
prerank,positive regulation of immune system process (GO:0002684),0.6176901777900157,1.3849587296728891,0.11385459533607682,0.6343384943990441,1.0,5/16,14.89%,VEGFA;TGFB2;ANXA1;PIK3CB;MIA3
prerank,endothelial cell proliferation (GO:0001935),0.6231328720807695,1.3848958035096561,0.11381074168797954,0.6329685081601324,1.0,5/17,9.70%,BMPER;PROK2;DLG1;ANGPT4;BMP4
prerank,cardiac muscle cell action potential (GO:0086001),0.5677700915466275,1.384739938534464,0.08312342569269521,0.6320013951309414,1.0,8/30,6.99%,KCNJ2;CACNA1G;CACNA1C;ATP1B1;HCN4;DMD;ANK2;KCNIP2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5848853071281792,1.3847249280008442,0.11153846153846154,0.6304083838453857,1.0,5/22,5.50%,ADAM9;TIMP2;PTPN3;TIMP3;TNFRSF1B
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5757818232191425,1.3842605824521483,0.09045848822800495,0.6308410722732487,1.0,7/25,13.08%,SLIT2;PRKCD;LIMK2;PFN2;CDK10;EVI5L;ARHGAP44
prerank,regulation of plasminogen activation (GO:0010755),0.6568595308230036,1.3840784856199975,0.10027855153203342,0.630072997530761,1.0,1/12,0.08%,THBS1
prerank,cell-substrate junction assembly (GO:0007044),-0.40805459560807433,-1.3840108072223989,0.07386363636363637,0.5640779198048129,1.0,9/33,6.89%,SORBS1;ACTN2;ITGA6;DST;PEAK1;THSD1;ITGB4;WHAMM;PTPRK
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.49867730909292957,1.3834846685355573,0.05200433369447454,0.6309628971173517,1.0,36/69,29.11%,UBXN8;VCP;DNAJB14;EDEM2;FAF2;SYVN1;HSPA5;RNF103-CHMP3;UBQLN1;FBXO17;STUB1;USP19;RNF121;YOD1;TRIM13;UBE4A;DNAJC18;NPLOC4;UBXN4;UBE2G2;ECPAS;DERL1;SGTB;HERPUD1;AMFR;TMEM67;SELENOS;DNAJB12;JKAMP;SEC61B;TMUB2;SEL1L2;FAM8A1;STT3B;UBE4B;TMUB1
prerank,regulation of calcium ion transport (GO:0051924),-0.3706011754753452,-1.3833710550031435,0.042735042735042736,0.56116971781193,1.0,15/54,11.56%,MYLK;BCL2;EPB41;CACNA1D;CACNB2;CACNA2D1;ATP2B1;TRPC6;ORAI1;ADRA2A;PLPP4;HOMER1;PACSIN3;CD84;NOS1
prerank,regulation of actin nucleation (GO:0051125),0.6526819597139847,1.3833690744214566,0.10245901639344263,0.6297821922779047,1.0,5/12,14.92%,GSN;ARFIP2;ARF1;PICK1;SCIN
prerank,ubiquinone metabolic process (GO:0006743),0.6260940823926429,1.3829805488337492,0.11007957559681697,0.6298685871118814,1.0,8/15,20.19%,COQ7;UBIAD1;COQ10B;FDXR;COQ8B;COQ2;COQ9;COQ6
prerank,negative regulation of cellular component movement (GO:0051271),-0.49231528910426253,-1.3829060331253504,0.08243727598566308,0.5579517667962615,1.0,5/15,7.71%,TGFBR3;FRMD5;FBLN1;SPOCK3;SP100
prerank,protein localization to cell-cell junction (GO:0150105),-0.4882037874804656,-1.3826825843608075,0.096,0.5540341952310514,1.0,5/15,6.31%,TJP1;CDH5;CGNL1;LSR;F11R
prerank,DNA duplex unwinding (GO:0032508),0.5231838683364352,1.3825516369581945,0.06382978723404255,0.6300184489295438,1.0,33/50,35.18%,CHD1L;MCMDC2;MCM2;ANXA1;WRN;CUL4A;ERCC3;RAD50;ERCC2;SUPV3L1;PARP1;RPS27A;UBC;MCM4;HMGA1;RAD51;TWNK;RECQL5;GTF2H4;MCM7;XPA;RTEL1;DDB1;RBX1;DDX11;SSBP1;BLM;RAD23B;PURA;CUL4B;CETN2;DHX9;MRE11
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5600641437352897,1.3824637399988589,0.07142857142857142,0.6287829509068448,1.0,11/31,8.87%,GDF10;TWIST2;CRIM1;SMAD6;LRP5;TWIST1;NBR1;SKI;SOX9;NOG;TRPM4
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.42911716279259815,-1.3822905456383825,0.06666666666666667,0.5505751387882691,1.0,9/26,13.58%,TGFA;ERRFI1;CBLB;APP;ADRA2A;HBEGF;SNX6;SOCS5;GPRC5A
prerank,negative regulation of transmembrane transport (GO:0034763),0.6754381615787419,1.3816318391250906,0.09882005899705015,0.6307660494678126,1.0,1/10,0.08%,THBS1
prerank,nuclear membrane reassembly (GO:0031468),0.51580405599997,1.381243734651381,0.06548279689234185,0.6307729464137493,1.0,26/54,28.52%,NUP93;SEC13;LMNA;SEH1L;SPAST;RCC1;NUP37;CHMP3;REEP3;SIRT2;SUMO1;POM121;CC2D1B;IST1;CHMP4A;CHMP4B;NDC1;NUP35;CHMP2A;PPP2CA;NUP85;BANF1;NUP160;PPP2R1A;AHCTF1;UBXN2A
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6010637320182597,1.3810047836859682,0.09247842170160296,0.6301800970364775,1.0,4/21,8.76%,SLIT2;EPHB2;TGFB2;LZTR1
prerank,negative regulation of bone mineralization (GO:0030502),-0.5231184171375562,-1.380679317735386,0.11721611721611722,0.5500513932139222,1.0,5/13,13.26%,ENPP1;SRGN;BCOR;RFLNA;RFLNB
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.36398484481612214,-1.3800276540944254,0.01834862385321101,0.547324051208559,1.0,23/59,13.93%,ROBO1;SDK1;CADM1;CDH13;PECAM1;BSG;ROBO2;CDH4;TENM3;CNTN6;CDH1;DSCAML1;CNTN4;CDH2;ROBO4;NECTIN2;NEXN;PLXNB2;CD84;CEACAM1;SDK2;PTPRT;IGSF21
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.636861861172976,1.37962830885957,0.09959072305593451,0.6346786505275568,1.0,3/15,6.99%,KCNJ2;ATP1B1;KCNIP2
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.3869374356243401,-1.379001238715325,0.05714285714285714,0.5454345694965855,1.0,13/40,9.14%,PTN;WNT4;SLC8A1;ADGRV1;BMP6;OSR1;WNT6;BMP7;KL;ATP2B1;FBN2;ANO6;BMPR2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.64282020158885,1.3788690105942454,0.10384068278805121,0.636314557018601,1.0,3/12,4.29%,DSE;BGN;CSPG4
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3956680394576032,-1.3782279039672416,0.06666666666666667,0.5432257956710149,1.0,12/41,10.39%,ITPR1;SLC8A1;SLC24A2;RYR2;CACNA2D1;ITPR3;GRIN2B;HTR2C;TRPV2;SLC8A3;GRIN2A;ITPR2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.5015644680926473,1.3774154891190908,0.04333694474539545,0.640877861027365,1.0,26/76,19.73%,CMKLR1;PTGIS;CYP1B1;PKHD1;ANXA4;TAX1BP1;IRAK3;DAP;CDK5RAP3;ITCH;CHUK;NFKBIB;IRAK1;COMMD7;CHP1;TRAF3;USP7;G3BP2;ARRB1;OTULIN;UFL1;RWDD3;ACOD1;LRRC14;ERBIN;NFKBIA
prerank,energy reserve metabolic process (GO:0006112),0.5993201150592551,1.3766187675902024,0.11818181818181818,0.6427930077620231,1.0,6/19,7.90%,PID1;PPP1R3C;GFPT1;PHKA1;PHKB;GFPT2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5801608988673235,1.3765823669479573,0.10608020698576973,0.6413378627741371,1.0,13/24,25.83%,FLVCR1;FXN;RSAD1;SUCLA2;NFE2L1;HMBS;ABCB6;FECH;UROS;SLC25A38;ABCG2;ABCB10;COX15
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5266427283340208,1.3759293052210568,0.08695652173913043,0.642546884104872,1.0,9/47,12.40%,MYOC;EFNA5;P4HB;ILK;S100A10;DOCK5;ABL1;RCC2;NRP1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.4213802041161409,-1.3758887047421025,0.057971014492753624,0.544678320312894,1.0,14/26,26.77%,PPARA;SLC30A10;SLC25A33;SLC5A3;TRAP1;ADGRB1;GRIN1;SNCA;ABCD2;ABCB7;SLC18A2;CD36;TLR6;ALOX5
prerank,ether lipid biosynthetic process (GO:0008611),0.6741852091648161,1.3740680262382154,0.11988716502115655,0.6492815321355144,1.0,4/10,17.93%,PLA2G4A;PEX7;FAR1;AGPS
prerank,protein import into nucleus (GO:0006606),0.5010024313869402,1.3737412734303776,0.06174200661521499,0.6491528230019392,1.0,32/66,27.61%,NUP93;PRICKLE1;SEC13;IPO5;STAT3;IPO4;HIKESHI;E2F3;RGPD1;KPNA2;IPO13;TNPO2;RANBP2;NUP88;KPNA3;POM121;AKT1;IPO9;TNPO1;KPNA4;APPL2;APPL1;NUP62;PPP1R10;TSC2;NUP35;IPO8;NUTF2;NUP85;TPR;RPAIN;KPNA6
prerank,negative regulation of mRNA processing (GO:0050686),0.6270988609229388,1.373649948025721,0.10733695652173914,0.6478967124687637,1.0,10/15,25.06%,SRSF6;PCBP4;PTBP1;U2AF2;SRSF7;SRSF10;SAP18;SFSWAP;SRSF4;C1QBP
prerank,establishment of protein localization to organelle (GO:0072594),0.4991654970575794,1.373173645380615,0.049891540130151846,0.6483322320461916,1.0,32/72,27.28%,NUP93;TSPAN10;PRICKLE1;SEC13;IPO5;STAT3;LRSAM1;IPO4;HIKESHI;E2F3;IPO13;TNPO2;NUP88;POM121;AKT1;IPO9;TNPO1;NEURL1B;APPL2;APPL1;NUP62;LAMP1;PPP1R10;LAMP2;TSC2;IPO8;PINK1;NUTF2;NUP85;TPR;RPAIN;RALA
prerank,polyol metabolic process (GO:0019751),-0.36575337265397545,-1.373081605227511,0.028985507246376812,0.5480031920311752,1.0,11/46,8.82%,PLCB1;INPP4B;ITPKB;INPP5D;ISYNA1;NUDT4;PLCB4;PLCH1;SLC5A3;IP6K2;PLCD1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5706444713425807,-1.372660758635389,0.15,0.5448103241958964,1.0,3/10,2.42%,ENG;ERRFI1;ENPP1
prerank,cellular response to hormone stimulus (GO:0032870),0.492586475042933,1.372550399105111,0.06181015452538632,0.649378516391462,1.0,14/69,10.49%,SLIT3;SLIT2;GHR;RDX;STAT3;RAMP2;BCAS3;RARA;SRA1;SOCS2;AKR1C1;SFR1;RAMP1;URI1
prerank,mitotic chromosome condensation (GO:0007076),0.5636104543900515,1.3724257725397455,0.09305210918114144,0.6483349555866764,1.0,6/26,10.77%,SMC4;CSNK2A2;CSNK2A1;KMT5A;MCPH1;PHF8
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4379653121409567,-1.3721502848767646,0.05853658536585366,0.5419893682019519,1.0,5/23,5.34%,TGFBR3;ENG;NREP;SMAD3;ITGA3
prerank,regulation of focal adhesion assembly (GO:0051893),0.5134473485440145,1.371845593882252,0.08555555555555555,0.6491311387557954,1.0,13/54,12.40%,THBS1;MYOC;VEGFA;EFNA5;LDB1;COL16A1;BCAS3;S100A10;SLC9A1;RHOA;ABL1;RCC2;NRP1
prerank,regulation of interleukin-17 production (GO:0032660),-0.4340649985034035,-1.371540230117185,0.062146892655367235,0.5393755500350909,1.0,24/31,42.06%,SLC7A5;RFTN1;SPHK1;PRKCQ;ZBTB7B;NR1H4;NOD2;MYD88;TGFB1;LY9;NCKAP1L;SLAMF6;IL18;IL15;IL12A;CARD9;IL23A;FOXP3;TLR4;IL23R;CCL1;IL12B;IL2;OSM
prerank,ERAD pathway (GO:0036503),0.48561440072247974,1.3706895771257364,0.04021164021164021,0.6524889641341772,1.0,43/83,29.91%,UBXN8;VCP;DNAJB14;FAF2;SYVN1;UGGT2;UGGT1;HSPA5;RNF103-CHMP3;UBQLN1;USP13;FBXO17;STUB1;USP19;RNF121;YOD1;TRIM13;UBE4A;DNAJC18;NPLOC4;UBXN4;ERLEC1;UBE2G2;RCN3;ECPAS;DERL1;SGTB;HERPUD1;AMFR;TMEM67;SELENOS;DNAJB12;GET4;JKAMP;SEC61B;TMUB2;SEL1L2;CCDC47;FAM8A1;STT3B;UBE4B;TMUB1;PRKN
prerank,positive regulation of ossification (GO:0045778),-0.38343389840696274,-1.3705874128046283,0.036231884057971016,0.5380031523530109,1.0,14/39,9.14%,PTN;WNT4;SLC8A1;ADGRV1;BMP6;WNT5A;OSR1;ZBTB16;BMP7;KL;ATP2B1;FBN2;ANO6;BMPR2
prerank,nucleotide-sugar metabolic process (GO:0009225),0.6603456284107487,1.3698442730750156,0.11204481792717087,0.6543435175983328,1.0,5/12,9.51%,GFPT1;GMDS;GFUS;GFPT2;FUT8
prerank,protein methylation (GO:0006479),0.5342568972375471,1.3696585180279597,0.08525345622119816,0.6536286988717912,1.0,21/40,31.19%,PRMT8;EEF1AKMT3;FAM98A;EHMT1;NSD1;GSPT1;CARM1;FAM98B;LCMT1;EEF1AKMT2;ETF1;PCMT1;NTMT1;SNRPB;PRMT1;TRMT112;EHMT2;PRMT5;PRMT3;NSD3;EEF2KMT
prerank,RNA transport (GO:0050658),0.5020663370720041,1.3696322275651043,0.05308775731310943,0.6521218007835751,1.0,36/71,27.34%,SRSF6;SRSF1;ARC;SRSF5;SIDT2;RAE1;SRSF2;CASC3;TGFBR2;HNRNPA2B1;SRSF11;NXF1;ZC3H11A;SRRM1;U2AF1;CKAP5;CHTOP;U2AF2;SARNP;THOC2;SRSF3;NCBP1;SRSF7;POM121;NCBP2;RTRAF;NUP62;ATXN2;HNRNPA1;SRSF4;YBX1;UPF3B;DDX39B;TPR;EIF4E;XPO5
prerank,cellular response to copper ion (GO:0071280),-0.4810264512612592,-1.369442027121888,0.09811320754716982,0.536705259757278,1.0,10/16,18.02%,MT1B;MT1G;MT1E;MT1F;MT1A;MT1H;MT1M;MT1X;SNCA;MT3
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.48361349343491866,-1.369309643596926,0.08,0.532959686345529,1.0,4/18,1.91%,ROCK2;TEK;CDH5;RIPOR2
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.5261687402510318,1.3691034415556251,0.08036739380022963,0.6527079354577577,1.0,18/42,25.81%,VARS1;VARS2;WARS2;HARS2;PPA2;YARS1;DARS2;YARS2;NARS2;EPRS1;PPA1;SARS2;SARS1;DARS1;CARS2;TARS2;QARS1;CARS1
prerank,response to light stimulus (GO:0009416),0.5075006899870091,1.3680706224898913,0.07119021134593993,0.6557146124011834,1.0,26/55,27.18%,UBE2B;CCAR2;ERCC8;ERCC5;ERCC4;MAPK8;ERCC3;OPN1MW;OPN1MW3;ERCC2;FECH;REV1;MEN1;USP1;CIRBP;MAP2K7;DRD2;CRY2;OPN3;PRIMPOL;UVSSA;POLD1;COPS3;ZRANB3;RRH;GPR52
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.4437160924690905,-1.367952486185358,0.0966183574879227,0.5328100960140016,1.0,10/23,16.81%,DYNC1I1;CCDC88A;TUBA1B;KIF1A;CCDC88C;TUBA1A;KIF1C;KIF5B;HOOK2;MAP6D1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6110058710080231,1.367942886099491,0.12398921832884097,0.6546735163241838,1.0,10/15,26.42%,GAS6;TCF7L2;BAG3;ANP32B;XPO4;YWHAE;RBM22;CAMK1;TP53;TPR
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4873282850265622,-1.367698910173774,0.116,0.5295546284367568,1.0,6/17,10.26%,PPARA;PRKAA2;PRKAG2;PPARD;ADIPOR1;CAV1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.6337458536821816,1.3672678783765149,0.12096774193548387,0.6561428109058608,1.0,10/13,24.52%,TMEM39A;SCFD1;PHF23;SEC22B;CHMP4A;CHMP4B;LRRK2;MTM1;SMCR8;PINK1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.3365819578898218,-1.3669877878219059,0.0410958904109589,0.5275419945667937,1.0,44/87,23.31%,RPS14;RPS15;RPS25;RPL8;RPS8;RPL4;RPS20;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;RPL11;RPL18A;RPS12;RPL12;RPS11;UBA52;RPL18;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;SRP68;RPS3;RPS18;RPS19;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37
prerank,tRNA methylation (GO:0030488),0.5449113408381281,1.3665533104955507,0.08374384236453201,0.6575187583264137,1.0,19/34,33.88%,TRMT61B;TARBP1;TRMT1;DALRD3;TYW3;THADA;THUMPD3;TRMT44;ALKBH8;TRMT61A;METTL1;NSUN6;MTO1;TRMT112;TRMT1L;METTL6;PRORP;METTL2A;METTL2B
prerank,eye photoreceptor cell development (GO:0042462),0.6295225693360561,1.3663146041969287,0.11096075778078485,0.6570019674278523,1.0,5/15,19.48%,VEGFA;TOPORS;RPGRIP1L;CRB2;MYO7A
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4782740971096182,1.3658475428782637,0.04756871035940803,0.657470189040508,1.0,18/95,9.68%,ST3GAL4;EXT1;XYLT1;GPC6;GPC3;DSE;BGN;CHST11;SDC1;CHPF2;CSPG4;B3GNT7;SLC10A7;B4GALT1;ST3GAL2;B4GALT5;ABCC5;HS6ST2
prerank,intracellular protein transmembrane transport (GO:0065002),0.5279037645116004,1.3651828765905722,0.07719298245614035,0.6587212686632595,1.0,18/42,22.68%,PEX7;SEC61A1;C2CD5;TOMM40;PEX5;AKT2;PEX16;PEX1;AIFM1;HSPA5;HSPD1;PEX10;TOMM70;GRPEL1;PEX6;ZFAND2B;PEX2;PEX14
prerank,regulation of Wnt signaling pathway (GO:0030111),0.48187141653788085,1.3647346444831925,0.04512820512820513,0.6590953358964005,1.0,26/108,11.35%,ESR1;TRABD2B;CTNND2;LRP1;GPC3;SFRP4;RSPO3;TIAM1;GRB10;ATP6V1C2;MDFIC;NXN;CSNK2A1;TCF7L1;DACT1;SULF1;FZD7;SKI;RSPO1;DACT3;TSKU;NFATC1;FOXL1;FGFR2;TERT;AXIN1
prerank,regulation of myotube differentiation (GO:0010830),0.5712037841258517,1.3647104577726121,0.09913258983890955,0.6576207715588247,1.0,8/24,13.87%,CCN3;HDAC9;HDAC4;MMP14;TMEM119;FBXO22;HDAC1;DMPK
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5831883143758371,1.364680614312959,0.09571788413098237,0.6561886442674916,1.0,4/22,4.63%,NTRK3;NTRK1;EHD1;KIDINS220
prerank,regulation of protein sumoylation (GO:0033233),0.6044405005936115,1.364472121042858,0.10477453580901856,0.6554561256570232,1.0,7/17,21.22%,ZMIZ1;GNL3;HDAC4;PIAS4;RWDD3;SAE1;MUL1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.492171207363998,-1.3641628589072539,0.1044776119402985,0.5306388616713511,1.0,4/15,1.29%,ATP1A2;ATP1B3;NEDD4L;SLC8A1
prerank,quinone biosynthetic process (GO:1901663),0.6340951534863497,1.3640733279390074,0.10848400556328233,0.6556533503828426,1.0,8/14,20.19%,COQ7;UBIAD1;COQ10B;FDXR;COQ8B;COQ2;COQ9;COQ6
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.6233291568732168,1.3640181321276816,0.1261744966442953,0.6543603034435185,1.0,7/15,16.94%,SIX1;TWIST1;TGFBR2;FGFR2;TGFBR1;MTHFD1;NIPBL
prerank,regulation of macrophage activation (GO:0043030),0.5484507786798841,1.364011727328663,0.09166666666666666,0.6528510508520919,1.0,4/30,4.66%,THBS1;LBP;IL33;SHPK
prerank,camera-type eye morphogenesis (GO:0048593),0.6710095189298956,1.3639686723567932,0.11589895988112928,0.6514982860723232,1.0,3/10,7.28%,LRP6;VEGFA;SKI
prerank,gastrulation (GO:0007369),0.6334268021836582,1.3636610198326091,0.10490463215258855,0.6511975519845822,1.0,2/15,2.62%,GPC3;LRP5
prerank,negative regulation of B cell proliferation (GO:0030889),-0.5343593954513431,-1.3635338708711429,0.1423841059602649,0.5284117643334506,1.0,4/11,15.02%,LYN;TNFRSF21;CD300A;TYROBP
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5783388156307934,1.363302222139615,0.1034047919293821,0.6511189556636584,1.0,8/24,16.49%,PLA2G4F;PLA2G4A;LPCAT1;LPCAT4;PGS1;PLA2G5;PLA2G12A;PLA2G15
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5405758769125878,1.3632597009957321,0.1161928306551298,0.649798232963961,1.0,8/30,15.82%,FOXP1;DDX5;NCOR2;HEYL;RNF14;HDAC1;DAB2;HDAC6
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6851698092043007,1.3631674966703111,0.11509715994020926,0.6486547924189414,1.0,1/10,0.08%,MYOC
prerank,icosanoid biosynthetic process (GO:0046456),0.6790859778011398,1.3626802452404798,0.1289855072463768,0.6491479379135171,1.0,3/10,10.33%,PLA2G4A;PLA2G5;FADS1
prerank,ncRNA metabolic process (GO:0034660),0.5394591868602344,1.3622595298909987,0.10308056872037914,0.6494477355081459,1.0,12/37,23.20%,DDX17;TENT4B;PRKRA;MAEL;DTD1;DGCR8;AGO2;TDRD12;TUT7;TDRKH;ZCCHC8;NIFK
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6631873020026205,1.3621591130465223,0.13925925925925925,0.648416376770216,1.0,3/10,8.56%,IRS1;PRKCE;AKT2
prerank,negative regulation of macrophage activation (GO:0043031),-0.47721977006699556,-1.3620444886085188,0.10276679841897234,0.5283365546358908,1.0,7/16,17.93%,IL31RA;NR1H3;LRFN5;CD200;ZC3H12A;CX3CL1;SYT11
prerank,sulfur compound biosynthetic process (GO:0044272),0.4749960085023708,1.3617749400864045,0.036016949152542374,0.6485996181792641,1.0,26/104,16.64%,SLC26A2;ST3GAL4;DSE;GCLC;GSTT1;BGN;PAPSS2;CHST11;CHPF2;CSPG4;GSTM5;MPST;B3GNT7;SLC10A7;B4GALT1;LIAS;ST3GAL2;B4GALT5;METTL16;MAT2B;GSTO2;SLC35B3;GSTZ1;B4GAT1;VCAN;AKR1A1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5893152099761139,1.3613955680185892,0.11851851851851852,0.6487500115589833,1.0,5/21,12.74%,IGFBP5;FGF2;P2RY6;BMPR1A;MEF2D
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4436910104357348,-1.3603776359516841,0.11618257261410789,0.5288576288163518,1.0,8/22,15.97%,APOD;ADRA2A;PRKAA1;ASXL3;CEACAM1;BSCL2;GPER1;PPP2R5A
prerank,regulation of ion transmembrane transport (GO:0034765),0.5377845621389444,1.3603693088578996,0.09642857142857143,0.6515637672905068,1.0,8/33,13.93%,KCNJ2;KCNJ15;NEDD4;KCNE5;WWP2;AKAP9;YWHAE;WNK1
prerank,DNA packaging (GO:0006323),0.605705021191195,1.3597425884252115,0.1334231805929919,0.6527170768047826,1.0,8/16,26.20%,CHAF1B;M1AP;CDAN1;AIFM1;NOC2L;TP53;BANF1;CHAF1A
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4681343806940488,1.359397171203931,0.018274111675126905,0.6527140010441016,1.0,12/150,2.35%,THBS1;MYOC;ESR1;EGFR;IRS1;TNFAIP8L3;GAS6;F3;FGF2;TCF7L2;FGF17;GAB2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5775521680146639,1.3586540241797824,0.11082802547770701,0.6544008380619142,1.0,4/22,5.85%,RASSF2;VEGFA;CALM2;TOM1L1
prerank,brain morphogenesis (GO:0048854),-0.5357918397521307,-1.3585174515722689,0.12367491166077739,0.530084918985097,1.0,2/12,4.18%,SHANK3;CTNNA2
prerank,triglyceride metabolic process (GO:0006641),-0.3675023111820902,-1.3584089179347125,0.04316546762589928,0.5267716787540331,1.0,19/48,26.80%,APOE;PLAAT3;LPGAT1;GK;MOGAT3;CAV1;LPIN2;LPL;SIRT1;GK5;DGAT2;FABP5;DGAT1;FABP7;FABP3;APOC1;LIPH;LIPC;LPIN1
prerank,carbohydrate biosynthetic process (GO:0016051),0.590068770844232,1.358375170402697,0.11125319693094629,0.6541543756145526,1.0,6/21,11.14%,ST3GAL4;ST6GALNAC5;B4GALT1;ST3GAL2;FUT8;FUT4
prerank,positive regulation of glucose metabolic process (GO:0010907),0.6172312231398991,1.3580051837434142,0.13668061366806136,0.6541818866934753,1.0,7/14,18.70%,IRS1;ACTN3;AKT2;NNMT;PTPN2;ARPP19;AKT1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5655010578052847,1.357824239085788,0.11346633416458853,0.653401557520506,1.0,7/24,12.40%,MYOC;VEGFA;COL16A1;S100A10;ABL1;IQSEC1;NRP1
prerank,cellular response to reactive oxygen species (GO:0034614),0.5021939744742228,1.3573593959372774,0.06361607142857142,0.6538369572389429,1.0,16/59,15.82%,EGFR;PRKCD;CYP1B1;MAP3K5;FXN;NFE2L2;IMPACT;MAPK8;ANXA1;CHUK;RIPK3;ABL1;PRDX3;RHOB;IL6;HDAC6
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6347116591396823,1.3572173476536973,0.12324929971988796,0.6529892472923446,1.0,4/12,14.58%,P4HB;SOAT1;LPCAT3;ACSL3
prerank,protein secretion (GO:0009306),0.5036798368638805,1.3560623471893332,0.06465997770345597,0.6563578260480916,1.0,21/56,20.71%,PCSK5;LTBP2;NECAB3;ARFGAP3;COPG1;RAB8A;NAGPA;MON1A;ANXA1;VIP;RAB3D;ABCA1;PREB;TMEM167A;MIA3;RAB3B;TANGO6;GOLPH3;STEAP3;MIA2;RCN3
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.6744470266489658,1.3556566476387382,0.13224368499257058,0.6566543445487054,1.0,1/10,0.33%,LRP6
prerank,regulation of lipid kinase activity (GO:0043550),-0.5366373808991367,-1.3556433685493163,0.1551155115511551,0.5299296546893625,1.0,3/11,4.76%,PIK3R1;WDR91;RB1
prerank,negative regulation of lipid storage (GO:0010888),-0.446625107077077,-1.3551170064285207,0.1016260162601626,0.5275454980576151,1.0,6/19,6.83%,OSBPL8;PPARA;ABCG1;NR1H3;ABHD5;PPARD
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.5192660170064631,-1.354984334359072,0.10714285714285714,0.5242476298227786,1.0,7/13,15.66%,NOS3;ALDH4A1;GLUL;GLS;PRODH;NOS1;GAD1
prerank,membrane lipid catabolic process (GO:0046466),0.6761952015571842,1.3529862938457446,0.10979228486646884,0.6664447178122418,1.0,2/10,3.46%,PDXDC1;CYP1B1
prerank,lamellipodium assembly (GO:0030032),-0.41851597490402653,-1.3529216019337973,0.058823529411764705,0.5259031715441086,1.0,11/26,8.76%,ABLIM1;CDH13;KIT;CCDC88A;PARVB;PTPRO;S1PR1;WHAMM;SPATA13;SPEF1;ARHGEF6
prerank,ubiquinone biosynthetic process (GO:0006744),0.6166714782432541,1.3524822582059737,0.12092391304347826,0.6671435934088035,1.0,8/15,20.19%,COQ7;UBIAD1;COQ10B;FDXR;COQ8B;COQ2;COQ9;COQ6
prerank,cellular response to light stimulus (GO:0071482),0.4963496593421541,1.3524147152543822,0.07025246981339188,0.6659390333952291,1.0,28/66,28.72%,PRKCD;NEDD4;ATF4;PDE6A;ERCC4;SDE2;OPN1MW;OPN1MW3;N4BP1;CREBBP;PARP1;CDC25A;SAG;EIF2AK4;NOC2L;EIF2S1;GNB1;USP47;TRIAP1;OPN3;TAF1;TP53;POLD1;YY1;RRH;GPR52;PDE6G;ATR
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5068137668731807,1.351817504692665,0.08239277652370203,0.6668524974424679,1.0,17/52,20.76%,ARFGAP1;SEC31A;KDELR3;SHC1;LMNA;GFPT1;ERN2;SYVN1;HYOU1;ATP6V0D1;HSPA5;ADD1;PREB;SSR1;YIF1A;DCTN1;FKBP14
prerank,regulation of cell differentiation (GO:0045595),0.4663676152531854,1.3514780286255623,0.017258883248730966,0.6670033884753387,1.0,30/148,13.69%,SIX1;SMOC1;ID2;ZFHX3;DDX5;TIAM1;DDX17;PHLDB1;HES5;ATF4;TCFL5;MBOAT2;FGFR1;RAF1;PA2G4;CDK5RAP3;EDN3;FGFR2;ANP32B;RUNX2;FADS1;SMAD7;SRF;NR1D2;HEY1;TGFBR1;PDCD2;NLGN1;PTBP1;RUNX1
prerank,muscle cell migration (GO:0014812),0.6787552091883944,1.3512307242772303,0.1377840909090909,0.6665529769066655,1.0,2/10,1.72%,SIX1;CCN3
prerank,metal ion export (GO:0070839),0.544721770449506,1.3510581123190062,0.1150990099009901,0.6658367308238374,1.0,6/31,6.99%,SLC4A4;KCNK5;ATP1B1;KCNE5;SLC9A1;KCNIP2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.40827155255073067,-1.3509536416809709,0.08196721311475409,0.5274326096931425,1.0,10/29,11.88%,SORBS1;APOE;PPARA;LPGAT1;NR1H3;SLC45A3;ZBTB20;MFSD2A;MID1IP1;SCARB1
prerank,metanephros development (GO:0001656),0.5630251400106165,1.3501827452601733,0.12484394506866417,0.6681267274908848,1.0,4/26,4.17%,SIX1;PKD1;FOXD1;SIX4
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5111205802400582,-1.3498877467958998,0.11152416356877323,0.5266472679493959,1.0,5/12,19.82%,DOCK11;DOCK10;LFNG;MFNG;DLL1
prerank,cytosolic transport (GO:0016482),0.4721532884891681,1.3498735083056246,0.04573804573804574,0.6679828038235118,1.0,36/108,21.00%,VPS13A;ANKRD27;VPS13C;STX5;SNX2;DOP1B;ERC1;AP2A1;RILP;RIC1;GBF1;VPS52;MON2;TBC1D23;TRIM27;EEA1;SNX1;RGP1;VPS26A;SNX32;TMEM87B;VPS53;CLTC;TBC1D10A;TBC1D17;SPAG9;STX16;GGA1;CLN3;PHETA2;EVI5;PTPN23;HEATR5A;DCTN1;CORO7;LAMP1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6165693586065816,1.3498156771654415,0.12244897959183673,0.6667490970879419,1.0,6/15,15.26%,LRP1;DDR2;FAP;CST3;DDR1;IL6
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5479029699501645,-1.349638270429797,0.1245674740484429,0.5237367295331247,1.0,2/11,1.06%,LYN;MFHAS1
prerank,amino acid transport (GO:0006865),0.5069508564418935,1.3494253271770873,0.08484162895927602,0.6670353248798669,1.0,7/49,7.48%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC7A10;SLC38A3;SLC43A1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.548672129393502,1.3492421611161012,0.10669975186104218,0.666388812771218,1.0,8/28,10.64%,PRKCD;IPO5;TRIM28;BAG3;MAVS;JUP;ZIC1;UBR5
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6555481190404121,1.3492295387966504,0.13662790697674418,0.664971650489899,1.0,1/11,0.33%,LRP6
prerank,regulation of cell projection organization (GO:0031344),-0.5061446522443205,-1.3491584132574932,0.11824324324324324,0.5214205400190943,1.0,5/13,12.67%,NTNG1;MACF1;MFSD2A;SEMA4D;ERMN
prerank,negative regulation of double-strand break repair (GO:2000780),0.5394001259495708,1.348784610937474,0.12106537530266344,0.6653939112168239,1.0,18/30,32.75%,HELB;TWIST1;RMI2;OTUB1;OGG1;UBR5;OTUB2;TFIP11;MAD2L2;CGAS;FBH1;SHLD3;SHLD1;HSF1;TRIP12;PARPBP;ERCC6;POLQ
prerank,positive regulation of endothelial cell migration (GO:0010595),0.4864397868331825,1.3479325097096118,0.059574468085106386,0.6675443946694403,1.0,20/84,12.40%,THBS1;SMOC2;FOXP1;VEGFA;FGF2;PLPP3;SPARC;STAT5A;PRKCA;BCAS3;FOXC2;HMGB1;FGFR1;GFUS;ANGPT4;BMP4;ABL1;PDPK1;PIK3CB;NRP1
prerank,actin filament bundle assembly (GO:0051017),-0.3901857826673826,-1.3477523412396077,0.07407407407407407,0.5214443969123573,1.0,10/33,11.92%,MYO1B;PAWR;SHROOM2;EPS8;PLS3;NEDD9;BAIAP2;SHROOM1;AIF1L;LCP1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.6133722711365154,1.3473973723557588,0.13154362416107382,0.6683294897796105,1.0,8/14,21.00%,CPSF4L;CPSF4;NCBP1;CPSF7;CPSF6;NCBP2;CSTF2;CSTF2T
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.5870440803500262,1.3471949163895507,0.12,0.6677279735561622,1.0,7/20,16.67%,ZC3H7A;PUM1;PRKRA;AGO1;TERT;AGO2;TSN
prerank,regulation of protein polymerization (GO:0032271),-0.39337520411337634,-1.3463002347825475,0.08379888268156424,0.5218157923880058,1.0,7/35,6.68%,ARHGAP28;ARHGAP18;MAP2;ESAM;PLEKHG2;PAK3;CAMSAP1
prerank,regulation of osteoblast differentiation (GO:0045667),0.4829392421155429,1.3461832957306843,0.059012875536480686,0.6706053661038213,1.0,26/82,15.26%,SMOC1;GDF10;DDR2;TWIST2;CRIM1;DDX5;SMAD6;LRP5;TWIST1;WWTR1;ATF4;ACVR1;NBR1;SKI;SOX9;NOG;TRPM4;BMP4;FGFR2;TMEM119;RUNX2;BMPR1A;NELL1;LIMD1;HGF;IL6
prerank,respiratory tube development (GO:0030323),0.554355658012952,1.345775766083962,0.11005917159763313,0.6708056634476846,1.0,7/28,9.71%,VEGFA;PCSK5;FGF2;GLI2;CCDC39;BMP4;FGFR2
prerank,regulation of metal ion transport (GO:0010959),-0.4755169639463852,-1.345655296229442,0.15018315018315018,0.5200423546008505,1.0,5/16,6.58%,BCL2;EPB41;SLC30A10;CACNA2D1;ORAI1
prerank,cell projection assembly (GO:0030031),0.5780030106172418,1.3452276561716043,0.1229404309252218,0.6718053622939869,1.0,6/22,14.92%,RHOJ;GSN;RHOQ;CYFIP1;PARVA;SCIN
prerank,regulation of membrane depolarization (GO:0003254),0.5884850330754368,1.3448585407017217,0.13474240422721268,0.6719191833056456,1.0,4/18,3.61%,FHL1;PTPN3;HCN4;CAMK2D
prerank,vesicle transport along actin filament (GO:0030050),-0.4538476240495078,-1.3448424275883823,0.11983471074380166,0.5187540180186914,1.0,4/19,8.28%,MYO1B;MYO6;ACTN4;MYO1D
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.6286153627250086,1.3447614842653122,0.13962765957446807,0.6708489430650197,1.0,7/13,21.88%,RHOQ;AK3;RAB23;EFL1;ENTPD7;LRRK2;MFN1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.5384128455830944,-1.3446835187575525,0.15359477124183007,0.5157698327550556,1.0,6/10,22.00%,RIF1;JARID2;SIRT1;BRCA1;KDM1A;DNMT3B
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5812836384982563,1.3446722460141172,0.11558441558441558,0.6697811463694439,1.0,4/20,7.85%,ADAM9;HM13;ADAM10;MBTPS1
prerank,protein polymerization (GO:0051258),0.4975107091444636,1.344648900853605,0.10045146726862303,0.6684618734891753,1.0,16/56,20.58%,PSTPIP1;MAP7D3;FGF13;GSN;COBL;CKAP5;UBE2C;TTC17;CHMP3;SPIRE2;MICALL2;WASHC3;TRIM6;CORO7;CHMP4A;CHMP4B
prerank,regulation of macroautophagy (GO:0016241),0.47353003303227464,1.3444279165305917,0.04952581664910432,0.6679610821781501,1.0,55/105,28.61%,NEDD4;ATP6V1C2;EXOC4;SESN3;LZTS1;NRBP2;LAMTOR1;ATP6V0A1;QSOX1;CLEC16A;MAPK8;SMG1;VPS26A;ATP6V0D1;SESN2;SNX32;TBC1D25;PAFAH1B2;ATP6V1B2;UBQLN1;USP36;ATP6V1E1;HDAC6;TRIM13;PRKAG1;CLN3;RB1CC1;AKT1;ATP6V1C1;CDK5;PRKAB1;RHEB;UCHL1;PRKACA;IL4;RUFY4;CAPNS1;LRRK2;TSC2;RPTOR;ATP6V0E1;SMCR8;TBK1;PINK1;ATP6V0B;LAMTOR2;EXOC7;ATG13;GPSM1;ERN1;CAPN1;LAMTOR3;SNX5;ULK1;LARP1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6733824101239693,1.344387218669038,0.11127596439169139,0.666701821158942,1.0,4/10,8.07%,RARB;RXRA;RXRB;RARA
prerank,in utero embryonic development (GO:0001701),0.5722433739410713,1.3439794329627666,0.09541984732824428,0.6669406227138833,1.0,9/25,12.95%,PKD1;VEGFA;TGFB3;MBNL1;ADAM10;FUT8;FGFR2;TGFBR1;LIG4
prerank,response to UV-A (GO:0070141),0.6277513294941125,1.3439137083547894,0.1335149863760218,0.6657517682708116,1.0,1/14,0.31%,EGFR
prerank,sodium ion transport (GO:0006814),0.4795084370479425,1.3434838155597937,0.061027837259100645,0.6661339289494855,1.0,14/85,7.04%,SLC4A4;SLC23A1;SLC5A6;ATP1B1;FGF13;SLC12A2;SLC24A3;SLC5A2;HCN4;SLC9B2;SLC4A8;SLC4A11;SCN11A;SLC6A2
prerank,regulation of vacuole organization (GO:0044088),0.5874359945294051,1.3433540620338005,0.11772315653298836,0.6652943927638097,1.0,12/20,26.20%,NPRL3;ANXA2;IFT20;LAPTM4B;IFT88;ENO2;RAB1B;MTM1;NPRL2;ENO4;SCARB2;RAB5A
prerank,histone lysine methylation (GO:0034968),0.5379954651412441,1.342946860474955,0.09892729439809297,0.6655674994504516,1.0,15/33,26.40%,PRDM5;WDR5;KMT2D;SETDB1;KMT2B;MEN1;WDR82;SUV39H2;DPY30;SUV39H1;KMT2A;SETDB2;SMYD2;TRMT112;EHMT2
prerank,relaxation of cardiac muscle (GO:0055119),0.6355417901623903,1.3426344894640205,0.13287671232876713,0.6653776022527642,1.0,4/13,3.61%,KCNJ2;ATP1B1;GSN;CAMK2D
prerank,negative regulation of protein modification process (GO:0031400),0.48502217882277315,1.3419544129954646,0.0574468085106383,0.6668701490116865,1.0,18/79,11.15%,SLIT2;LRP6;PID1;NTRK3;PLPP3;EPHB2;WWTR1;XDH;P3H1;DMD;PRKDC;PPP1R8;SNTA1;BEX4;IMPACT;CDK5RAP3;PAQR3;NIBAN1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5886301006054426,1.3415597854016021,0.12907608695652173,0.6671548402535681,1.0,9/17,26.61%,HM13;VCP;FAF2;SYVN1;NPLOC4;DERL1;HERPUD1;SELENOS;SEC61B
prerank,odontogenesis (GO:0042476),0.5334970571778136,1.3414055697149416,0.11150234741784038,0.666375663057079,1.0,9/35,13.03%,LRP6;COL1A2;GLI2;TGFB3;TGFB2;BMP4;FGFR2;HDAC1;INHBA
prerank,regulation of B cell differentiation (GO:0045577),0.6144379763383438,1.3413893818061022,0.13026315789473683,0.6650488470798388,1.0,5/17,13.03%,ID2;MMP14;IKZF3;CD27;INHBA
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.48024600559770736,1.340452343844565,0.05609492988133765,0.6674871111673728,1.0,43/84,25.06%,SRSF6;DDX5;DDX17;RBFOX2;MBNL1;RBM39;CELF4;THRAP3;CELF3;HNRNPL;MBNL2;RBM25;PCBP4;DAZAP1;RBM5;METTL16;KHDRBS1;PTBP1;RBM4;U2AF2;SRPK1;HNRNPK;YTHDC1;SRSF3;ZC3H10;NCBP1;SRSF7;SRSF10;LARP7;RBMXL1;TRA2B;CIRBP;TRA2A;SAP18;SFSWAP;HNRNPA1;FXR2;SRSF4;HNRNPU;SF1;RBM24;RBM3;C1QBP
prerank,relaxation of muscle (GO:0090075),0.6356104625889027,1.3397831717967368,0.13121546961325967,0.6689496072403993,1.0,4/13,3.61%,KCNJ2;ATP1B1;GSN;CAMK2D
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5790460856337845,1.3393308590583286,0.13065976714100905,0.6694054632632317,1.0,5/21,9.68%,EXT1;XYLT1;HS3ST4;SULF1;HS6ST2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.6163404275185252,1.3392517602215628,0.12371134020618557,0.668392311070941,1.0,8/16,27.05%,HNRNPA2B1;SMG6;ERCC4;ATM;TNKS2;PARP1;SLX4;RTEL1
prerank,embryonic organ morphogenesis (GO:0048562),0.5241278355534954,1.3387363253667126,0.09523809523809523,0.6691537405271483,1.0,13/42,17.63%,SIX1;ID2;MFAP5;HOXA3;HOXB3;ACVR1;HOXA9;FGFR2;HOXB4;HOXA4;FUZ;NIPBL;DYNC2I1
prerank,protein modification process (GO:0036211),0.4849406864268271,1.3377209764796922,0.07181136120042872,0.6721332769520242,1.0,31/76,24.13%,PLOD2;ST8SIA2;TGM5;GGCX;PRKDC;LOX;NAGPA;AKT2;WWP2;RIPK3;ABL1;LCMT1;FBXO22;ATG3;UBE2L6;PARP1;LIPT1;GNMT;NTAQ1;ARAF;FBXW2;CSNK1G3;LOXL2;CDKL3;STK38;UBA3;MAN2B1;B4GALT7;FBXO11;PHEX;PHKA2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6260146710813692,1.3375281063014506,0.14246196403872752,0.6716535799751502,1.0,4/14,11.90%,CARD14;TNFSF15;IRAK1;TNFRSF10B
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.6517953726410727,1.3374539850236191,0.1272984441301273,0.6705933727741566,1.0,4/10,16.31%,ESR1;HMGB1;PSMC5;PSMC4
prerank,negative regulation of cell growth (GO:0030308),0.4661399620194082,1.3368975547819768,0.03715170278637771,0.6715588058003752,1.0,28/121,17.28%,SLIT3;SLIT2;FHL1;FGF13;OSGIN2;ULK2;CCN3;ACVR1B;PPP1R9B;PRDM11;PTPRS;TGFB2;CCAR2;SMAD4;DACT3;NDRG3;SERTAD2;DCBLD2;SESN2;INHBA;CGRRF1;RBBP7;SERTAD3;CYP27B1;MINAR1;APBB1;DIP2B;FLCN
prerank,B cell proliferation (GO:0042100),-0.4673417102138828,-1.3361875592562178,0.1183206106870229,0.5335606019376845,1.0,5/17,15.04%,BCL2;CD180;CD40;CTPS1;CR2
prerank,protein K11-linked ubiquitination (GO:0070979),0.5532260842334923,1.3359667277007972,0.1136079900124844,0.6738401943385216,1.0,16/27,31.32%,ANAPC5;CDC16;UBE2B;UBE2C;ANAPC4;ANAPC2;ANAPC1;ANAPC10;CDC27;RNF4;UBE2W;PRKN;UBE2H;ANAPC11;UBE2S;UBE2A
prerank,regulation of cell morphogenesis (GO:0022604),0.54389480703199,1.3356326305172466,0.12375,0.6738531131560085,1.0,10/30,19.43%,EFNA5;FMNL2;ARC;SPARC;BCL9L;MYO9A;PHIP;SH3D19;ZMYM3;ZRANB1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.4844028707927017,1.335587776512921,0.06746463547334058,0.6726480707617177,1.0,13/75,8.87%,KCNJ2;KCNJ15;SLC39A14;SLC12A7;ATP1B1;SLC12A2;SLC5A2;HCN4;TRPV3;SLC9A4;SLC9A1;SLC12A4;TRPM4
prerank,blood vessel morphogenesis (GO:0048514),-0.3531016976530808,-1.335434605107292,0.07766990291262135,0.5319844479935608,1.0,18/54,11.48%,FLT1;TGFBR3;EFNB2;ENG;LAMA1;CCBE1;KDR;RASIP1;TBX1;PROX1;SOX17;SLC1A1;CDH2;RBPJ;FLT4;CAV1;SYK;SOX18
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5586201214756081,1.3352164898035401,0.1188118811881188,0.6727939310870391,1.0,3/24,6.48%,SLIT2;CCN3;HMGB1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.49942658781709137,1.3343436968735485,0.10158013544018059,0.67510054513159,1.0,5/48,7.14%,SLIT3;SLIT2;GAS6;CARD16;IRAK3
prerank,sulfation (GO:0051923),0.6526886297758288,1.3342492623634297,0.1379800853485064,0.6741383763383015,1.0,2/11,1.98%,SULT1C2;SULT1C4
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.44018950432127674,-1.3342211362685648,0.13278008298755187,0.5315803429045131,1.0,11/20,21.23%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;SEMA4D;SEMA3G;SEMA4A;SEMA4G;SEMA5B;SEMA6D;SEMA3B
prerank,positive regulation of RNA metabolic process (GO:0051254),0.5044786424792645,1.3341674254532208,0.10538373424971363,0.673136139803695,1.0,3/45,1.55%,SLC38A2;EGFR;DDX5
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3820261621149209,-1.3336585010508433,0.08333333333333333,0.5297164290607907,1.0,9/40,10.25%,TCF4;ZEB1;BRINP3;BRINP1;PROX1;GPRC5B;BRINP2;ARHGEF2;MMD
prerank,peptidyl-arginine modification (GO:0018195),0.5981318465362211,1.333640812431589,0.146374829001368,0.6739195741980072,1.0,1/15,0.46%,PRMT8
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5934871112917814,1.3335713398940485,0.14267015706806283,0.6728462054170019,1.0,6/18,9.70%,RHOJ;VEGFA;FGF2;HDAC9;FOXC2;ANXA1
prerank,cytoplasmic translational initiation (GO:0002183),0.5966520081025378,1.3335244012670708,0.12027027027027028,0.67169970865456,1.0,13/17,32.21%,EIF4A2;EIF4A1;EIF4G1;DHX29;RBM4;EIF2S2;EIF3D;EIF3A;EIF4B;EIF4H;EIF3M;EIF3I;EIF2D
prerank,electron transport chain (GO:0022900),0.6076873190566742,1.3330869775038765,0.16085790884718498,0.6721108771315026,1.0,5/15,10.20%,ETFRF1;ENOX2;ETFDH;ETFA;ETFB
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5051019697312333,1.333032677099498,0.10067873303167421,0.6709802861564856,1.0,8/48,6.89%,MYOC;P4HB;CUX1;FBXW8;ILK;S100A10;PRKDC;DOCK5
prerank,response to iron ion (GO:0010039),-0.5016032554015768,-1.3329179306949512,0.12,0.5282888768555889,1.0,3/12,2.11%,BCL2;BMP6;B2M
prerank,inorganic anion transport (GO:0015698),0.5059541295801572,1.3327670182560616,0.07666290868094701,0.6707006547069231,1.0,6/53,5.65%,SLC4A10;SLC26A7;SLC26A6;CLIC3;CLIC4;SLC4A11
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6449830968106687,1.3323962615849627,0.1285310734463277,0.6709439749284664,1.0,2/12,2.70%,ESR1;NCOR2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.642323959031152,1.3322816268533708,0.1370056497175141,0.6700601983315614,1.0,4/11,12.82%,ZMIZ1;ELOF1;SERTAD2;ZMIZ2
prerank,protein transport (GO:0015031),0.44751314021146965,1.3316338383634483,0.004,0.6714041983783305,1.0,133/332,25.72%,SGSM2;LRP1;LTBP2;NECAB3;ARFGAP3;CTTN;SEC31A;ATP6V1C2;KIF13A;EHD1;TBC1D8B;TBC1D2B;STX5;SEC13;ARCN1;LMAN2L;RAB34;RAB43;TCIRG1;COPA;RAMP2;RAB24;STX11;AP2A1;RILP;COPG1;LRSAM1;DNM2;SLC10A7;RAB21;ATP6V0A1;RIC1;TLK1;GGA2;RAB8A;HIKESHI;ARF4;GOLGA4;COPZ2;MON1A;SNX1;NSF;SCFD1;STX2;VPS26A;RAMP1;ARFIP2;RAB38;ATP6V0D1;ARF1;RAB3D;SNX9;AP3D1;TMED9;WDR11;USO1;EVI5L;TBC1D9B;LRP2;TBC1D25;ATP6V1B2;RAB11B;ERP29;ABCA1;PICK1;TOM1;VIPAS39;CHMP3;PREB;CLTC;RAB23;ATP6V1E1;TMEM167A;TBCK;MIA3;TBC1D10A;SIL1;STX4;COPB2;STX1A;RAB3B;SCFD2;TBC1D17;HDAC6;STX16;SCAMP2;GGA1;TANGO6;SPTBN1;SNX13;NAPA;GOLPH3;TMED2;BLZF1;RAB5B;VPS45;SNX15;SEC23IP;RAB3GAP2;ATP6V1C1;NEURL1B;EVI5;STEAP3;SCAMP3;MIA2;CLU;TBC1D22B;RCN3;VPS26C;OPTN;IFT27;LAMP2;RAB1A;RAB18;ZG16;NDC1;VAMP4;RAB1B;SNX4;COPZ1;RABGAP1;ARF5;ATP6V0E1;SCAMP1;TMED7;CHMP2A;LMTK2;AP3B1;ATP6V0B;STX1B;VAMP2;FAM91A1;STX19
prerank,protein homooligomerization (GO:0051260),0.46717832973860246,1.3316037530873475,0.044605809128630707,0.670192161845618,1.0,33/114,21.39%,SCARA5;KCNJ2;PRMT8;MPP2;EHD1;TRMT61B;ARC;ATL2;SLC1A5;ADCY8;ATL3;CRYZ;DISP1;FUS;C9;TRPM4;SPAST;CBR4;CLYBL;LETM1;ACACA;MICU1;G3BP2;PKD2L1;SHMT2;GNMT;ACOT13;SHMT1;TK1;APPL2;IKZF4;PDCD6IP;ATL1
prerank,histone H4 deacetylation (GO:0070933),0.6537120661141306,1.3312549587000846,0.14032496307237813,0.6703114827886634,1.0,5/10,17.33%,HDAC9;HDAC4;HDAC1;SIRT2;SMARCAD1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4863975298764625,1.33053213812627,0.09502762430939227,0.6718303764698872,1.0,22/63,21.31%,THBS1;TCF7L2;NOL3;ACVR1;FGFR1;TMC8;PAK2;BMP4;ITGAV;LTBR;MADD;PHIP;TNFRSF10B;DEPTOR;TGFBR1;STX4;BIRC6;BID;ZMYND11;BCL2L12;IL4;SH3RF1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5472221145627933,1.32989550160322,0.1093167701863354,0.6731389847070536,1.0,15/26,29.96%,FOXP1;NCOR2;HEYL;HDAC1;DAB2;PER1;VPS11;CNOT9;CALR;CRY2;SMARCA4;NCOR1;KANK2;VPS18;ZBTB7A
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.4971514656630039,1.329198650651002,0.0859375,0.6746716726515711,1.0,10/54,8.96%,KCNJ2;KCNJ15;FHL1;NEDD4;KCNN1;KCNE5;STK39;KCNIP2;DLG1;WWP2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.5661057445576066,1.3291316959457196,0.14612452350698857,0.6723483109390104,1.0,14/21,33.39%,CHD1L;ERCC5;ERCC4;CUL4A;ERCC3;ERCC2;PARP1;GTF2H4;XPA;DDB1;RBX1;ERCC1;RPA3;CUL4B
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.5661057445576066,1.3291316959457196,0.14612452350698857,0.6723483109390104,1.0,14/21,33.39%,CHD1L;ERCC5;ERCC4;CUL4A;ERCC3;ERCC2;PARP1;GTF2H4;XPA;DDB1;RBX1;ERCC1;RPA3;CUL4B
prerank,regulation of gene silencing by RNA (GO:0060966),0.5003068965093695,1.328844734213319,0.11711711711711711,0.6710374176352257,1.0,30/50,30.87%,NUP93;SEC13;RAE1;SEH1L;PUM1;AGO1;NUP37;AGO2;EIF4G1;RANBP2;NUP88;POLR2F;POM121;NUP210;NUP62;POLR2B;NDC1;NUP35;IPO8;H3-3A;NUP85;POLR2H;NUP160;TPR;TNRC6A;POLR2I;PUM2;NUP50;POLR2L;NUP188
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.5003068965093695,1.328844734213319,0.11711711711711711,0.6710374176352257,1.0,30/50,30.87%,NUP93;SEC13;RAE1;SEH1L;PUM1;AGO1;NUP37;AGO2;EIF4G1;RANBP2;NUP88;POLR2F;POM121;NUP210;NUP62;POLR2B;NDC1;NUP35;IPO8;H3-3A;NUP85;POLR2H;NUP160;TPR;TNRC6A;POLR2I;PUM2;NUP50;POLR2L;NUP188
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.35830828411864885,-1.327176632454771,0.06666666666666667,0.5394576813883185,1.0,19/47,23.25%,ROCK2;WNT4;RAPGEF2;PROX1;C1QTNF3;ZC3H12A;CAV1;PLEK;CEACAM1;CD34;SIRPA;BRCA1;C1QTNF12;GLA;ERLIN2;TRIB3;SIK1;EP300;APOC1
prerank,import into nucleus (GO:0051170),0.48083476963181593,1.3264214658798106,0.0915032679738562,0.6796628927711929,1.0,32/73,27.23%,NUP93;PRICKLE1;SEC13;IPO5;STAT3;IPO4;HIKESHI;E2F3;IPO13;SNUPN;TNPO2;GEMIN7;NUP88;SMN1;POM121;AKT1;IPO9;TNPO1;APPL2;APPL1;NUP62;PPP1R10;SNRPB;GEMIN2;HNRNPA1;TSC2;IPO8;NUTF2;NUP85;DDX20;TPR;RPAIN
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.6320885570265593,1.3260715306124407,0.16260162601626016,0.6797157820387908,1.0,8/12,25.72%,STX11;PRRT2;STX2;SNAP23;STX4;STX1A;STX1B;STX19
prerank,endoplasmic reticulum organization (GO:0007029),0.4844553324208932,1.3256862457752574,0.08,0.6799734905967962,1.0,30/72,22.45%,SEC31A;MAPK15;STX5;ATL2;SEC61A1;LMAN2L;DOP1B;TLE6;SMPD4;ATL3;TRAM2;LPCAT3;ALDH3A2;REEP3;LMAN2;SEC16A;MIA3;STX1A;SEC16B;HMOX1;TMEM170A;BNIP1;TMEM33;REEP5;SHTN1;ATL1;LRRK2;LMAN1;RAB18;EIF2AK3
prerank,regulation of protein import into nucleus (GO:0042306),0.5174596397920693,1.3249471594403661,0.13237063778580024,0.6816281862188942,1.0,14/36,18.53%,PRKCD;MDFIC;IPO5;TRIM28;BAG3;MAVS;JUP;ZIC1;BMP4;UBR5;CHP1;RAB23;RBM22;SUFU
prerank,cellular potassium ion homeostasis (GO:0030007),0.61959412888762,1.324068162129906,0.14285714285714285,0.6839025992776439,1.0,3/13,1.20%,KCNJ2;ATP1B1;SLC12A2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5406768899707864,1.3238779704990635,0.12252475247524752,0.6833906744521128,1.0,6/29,8.51%,PKD1;GHR;STAT5A;STAT3;SOCS6;SOCS2
prerank,receptor signaling pathway via STAT (GO:0097696),0.553367222072497,1.323674838769454,0.13653603034134007,0.6828616927836035,1.0,6/25,8.51%,PKD1;GHR;STAT5A;STAT3;SOCS6;SOCS2
prerank,photoreceptor cell development (GO:0042461),0.6150939242195714,1.3235636411123668,0.14147018030513175,0.6819551660631171,1.0,2/14,3.66%,VEGFA;TOPORS
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4772110374075302,1.322594049396236,0.0939524838012959,0.6846719193621849,1.0,23/63,24.64%,PLAGL1;MUC1;CRADD;PRKDC;MDM4;CARM1;PCBP4;ATM;CHEK2;SDE2;TFDP1;CNOT8;CNOT10;RBL2;E2F1;CNOT9;CDK2;TNKS1BP1;SFN;TRIAP1;PRMT1;TP53;RPS27L
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.4439624859315807,1.3224555344698201,0.009009009009009009,0.683962020861395,1.0,106/264,25.90%,SRSF6;DDX5;DDX17;HNRNPH1;SRSF1;PABPC1;SRSF5;CELF4;SRSF2;CASC3;SNRNP70;SNRNP48;PRPF40B;FUS;HNRNPA2B1;SRSF11;CHERP;SYMPK;HNRNPL;RAVER2;HNRNPH2;SF3B2;SF3B1;PPIL3;SF3A1;PNN;RBM10;SNRNP25;GTF2F1;SRRM1;U2AF1;RBM6;RBM5;PABPN1;SFPQ;CRNKL1;SNUPN;XAB2;CWF19L1;HNRNPM;PCBP2;LSM2;ZRSR2;PTBP1;RALY;GEMIN7;RBM4;HNRNPC;U2AF2;SRPK1;RBM17;CLP1;CPSF4;HNRNPK;YTHDC1;POLR2F;TFIP11;SCNM1;SRSF3;ISY1;PCF11;IK;NCBP1;WDR83;SNRPA;SRSF7;SMN1;SRSF10;CWC25;CPSF7;AQR;U2SURP;RBM22;NCBP2;SYNCRIP;CSTF2;TRA2B;MTREX;HNRNPH3;TRA2A;ZCCHC8;SNRPB2;CSTF2T;DHX8;HNRNPA3;SNRPB;GEMIN2;HNRNPA1;SRSF4;POLR2B;DHX16;WDR77;RBM19;SF3B6;HNRNPU;YBX1;USP49;SF1;CDK13;SUGP1;UPF3B;SNRNP35;DDX39B;METTL14;POLR2H;DDX20
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5605764330302163,1.3208354314007116,0.15139949109414758,0.6891611790521968,1.0,14/22,34.40%,CHD1L;CUL4A;ERCC3;ERCC2;PARP1;RPS27A;UBC;GTF2H4;XPA;DDB1;RBX1;RAD23B;CUL4B;CETN2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6349210229002302,1.3207533230348225,0.16115107913669063,0.6881667176254365,1.0,1/11,0.08%,THBS1
prerank,phagolysosome assembly (GO:0001845),0.6284299135042747,1.3206200595418802,0.15730337078651685,0.6873790432893433,1.0,4/12,18.37%,RAB7B;RAB34;PLA2G5;CLN3
prerank,mRNA catabolic process (GO:0006402),0.49906128814226497,1.3202127703602904,0.11361079865016872,0.6877295243299585,1.0,13/44,16.63%,DDX5;THRAP3;ZC3H12D;AGO1;DIS3L2;METTL16;LSM2;SUPV3L1;XRN1;EXOSC4;MRTO4;TUT7;CNOT10
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.47264479003658283,-1.3200916622824113,0.12757201646090535,0.5545645403324667,1.0,6/14,14.05%,WNT5A;KIT;SEMA7A;GPRC5B;CD74;SIRT1
prerank,positive regulation of RNA splicing (GO:0033120),0.5371849257802948,1.3199174662508548,0.14041514041514042,0.6876647960531267,1.0,12/29,20.68%,SLC38A2;CELF4;THRAP3;CELF3;DAZAP1;U2AF2;NCBP1;RBM22;RBMXL1;TRA2B;CIRBP;TRA2A
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.4307310925607667,-1.3197838599058822,0.125,0.551988105996364,1.0,8/22,23.88%,GCNT2;BMP7;CD44;THY1;AGER;MAPK7;MBP;MYADM
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6443249132648387,1.3196517736035271,0.15718562874251496,0.6874171215112063,1.0,2/10,1.86%,PID1;GRB10
prerank,positive regulation of DNA replication (GO:0045740),0.6025566816734076,1.3196113375369054,0.15111695137976347,0.6863121200213796,1.0,3/16,9.06%,EGFR;GLI2;BRPF3
prerank,regulation of RNA metabolic process (GO:0051252),0.4887389428506653,1.319560881914092,0.08830022075055188,0.6852429158845088,1.0,24/59,20.91%,CLK1;HNRNPH1;AHNAK;AHNAK2;CLK3;MBNL1;FASTK;TNFRSF1B;SNRNP70;FUS;HNRNPL;HNRNPH2;MBNL2;PCBP4;PCBP2;CLK4;PTBP1;USP36;RC3H2;CLK2;BRDT;TRA2B;HNRNPH3;AFF2
prerank,membrane depolarization during action potential (GO:0086010),0.5396271895545219,1.3192084054585362,0.14593908629441624,0.6852929886074374,1.0,4/26,2.89%,KCNJ2;CACNA1G;CACNA1C;HCN4
prerank,RNA splicing (GO:0008380),0.4708730266909226,1.3182276088324847,0.0646186440677966,0.6881073188962669,1.0,40/95,25.11%,NOL3;PPP1R9B;MBNL1;SRSF2;SNRNP48;CCAR2;FUS;YJU2;SRSF11;CELF3;LUC7L3;CDK12;SF3B2;SF3B1;SNRNP25;SRRM1;U2AF1;SFPQ;ZRSR2;PTBP1;HNRNPC;SRPK1;SCNM1;NCBP1;WDR83;SRSF7;SRSF10;NCBP2;SYNCRIP;TRA2B;HNRNPH3;DHX8;SNRPB;GEMIN2;SRSF4;DHX16;PPIG;PPP2CA;SNRNP35;DDX39B
prerank,cellular response to sterol (GO:0036315),0.6254848037421848,1.3180636243280908,0.13687150837988826,0.6875148254183702,1.0,6/13,13.95%,LRP6;GRAMD1A;OSBPL7;RORA;SMO;GRAMD1C
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5047105387970756,1.3180093301283804,0.12703962703962704,0.6864698195894531,1.0,5/41,6.98%,KCNJ2;KCNJ15;KCNN1;KCNE5;ANK2
prerank,histone H2A acetylation (GO:0043968),0.5842479219098914,1.3174083865985595,0.16404199475065617,0.6876611477375758,1.0,5/16,8.86%,MORF4L2;NAA40;TRRAP;ING3;MORF4L1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4747668430868244,-1.317161254721054,0.15702479338842976,0.5551185797169845,1.0,7/16,11.22%,TRIM14;FUCA2;NECTIN2;TRIM21;CAV1;EXOC2;TRIM68
prerank,secondary palate development (GO:0062009),-0.4982076709515462,-1.317113126082093,0.12867647058823528,0.5518793064132163,1.0,4/14,2.06%,TGFBR3;LEF1;CHD7;WNT5A
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5030883515729384,1.317064521485124,0.10238907849829351,0.6879291108396319,1.0,18/50,19.33%,GPC3;GLIS2;GAS1;RAB34;ARMC9;VCP;TEDC1;ZIC1;EVC;RORA;FGFR2;WDR11;PDCL;SMO;FUZ;CREBBP;SUFU;UCHL5
prerank,fluid transport (GO:0042044),0.6336678839473657,1.317027839283832,0.15247252747252749,0.6867935484926307,1.0,2/12,5.65%,SLC26A6;SLC4A11
prerank,aminoglycan biosynthetic process (GO:0006023),0.4950934708269349,1.3168714888793709,0.1143827859569649,0.6861557357528524,1.0,12/49,16.70%,EXT1;XYLT1;GPC6;GPC3;SDC1;B3GNT7;HS6ST2;HEXA;B3GNT9;B4GAT1;B3GNT6;XYLT2
prerank,negative regulation of proteolysis (GO:0045861),0.5207457793460603,1.3167014079231294,0.12773722627737227,0.6856521340460127,1.0,15/34,24.84%,TIMP2;PTPN3;TIMP3;GAS1;CST3;SERPINE2;CAMK2N1;HDAC6;EFNA1;CLN3;AKT1;CDK5;LRRK2;ROCK1;DNAJC1
prerank,camera-type eye development (GO:0043010),0.5495046651716493,1.3166646837798468,0.12826899128268993,0.6845507842282796,1.0,7/25,8.71%,CACNA1C;VEGFA;CYP1B1;HES5;RAB3GAP1;SKI;TSKU
prerank,synaptic vesicle membrane organization (GO:0048499),0.5918252067588534,1.3164315530681263,0.1646746347941567,0.6842326201037737,1.0,7/17,15.34%,STX11;PRRT2;STX2;AP3D1;SNAP23;STX4;STX1A
prerank,T cell differentiation (GO:0030217),-0.3732923814451571,-1.3161517953296062,0.07792207792207792,0.550879008856528,1.0,7/40,7.55%,LEPR;CHD7;SOX13;KIT;TCF7;JAG2;RHOH
prerank,negative regulation of signal transduction (GO:0009968),0.447955031719032,1.3155725345195628,0.016145307769929364,0.6864910122653486,1.0,36/249,9.40%,THBS1;EGFR;IRS1;PID1;TRABD2B;IGFBP5;NTN1;PRKCD;LRP1;FGF2;GPC3;SFRP4;NEDD4;EMILIN1;UBASH3B;GRB10;NXN;GLIS2;DKK3;LRPAP1;CSNK2A2;CSNK2A1;CARD16;XDH;VCP;DACT1;ACVR1;SULF1;MMP14;IRAK3;NOG;DACT3;TSKU;NFATC1;WWP2;PTPN18
prerank,positive regulation of angiogenesis (GO:0045766),0.46732517509763444,1.3148187470178025,0.05785123966942149,0.688283005591009,1.0,19/108,10.01%,BMPER;THBS1;SMOC2;PGF;VEGFA;F3;FGF2;PTGIS;TWIST1;CYP1B1;RAMP2;PRKCA;FOXC2;ANGPTL4;JUP;PAK4;STIM1;ANGPT4;AGGF1
prerank,regulation of peptide hormone secretion (GO:0090276),-0.3305344730288695,-1.3135952412606595,0.0449438202247191,0.5540515654416435,1.0,12/67,8.10%,ITPR1;RAPGEF4;CHD7;RAPGEF3;SLC2A1;DPP4;CACNA1D;CACNA1E;ITPR3;ADRA2A;HTR2C;KCNC2
prerank,gland development (GO:0048732),0.4822072293099006,1.3131202054102542,0.10690423162583519,0.6939428520721719,1.0,16/59,12.61%,SIX1;IGSF3;GLI2;TGFB3;DKK3;COBL;PRKCSH;EPHB3;SOX9;CDK5RAP3;ANXA1;FGFR2;RIPK3;SOD1;EZR;TGFBR1
prerank,regulation of spindle organization (GO:0090224),0.57329032030983,1.3120820302786282,0.1453104359313078,0.6968541134542876,1.0,8/18,23.15%,PARP3;RAE1;DYNC1H1;CLTC;DCTN1;NUP62;RNF4;SENP6
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.615431416149434,1.3120696801000815,0.1592797783933518,0.6956268842893942,1.0,8/13,32.56%,TMEM30B;TM9SF4;SEC16A;SEC16B;SAR1A;GCC2;INSIG1;SAR1B
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.5174724849369584,1.3120425890225926,0.11664779161947905,0.6944907412139155,1.0,18/38,29.91%,ABLIM3;CSNK2A2;HUWE1;FZD5;SREBF1;USP36;HPS4;MICALL2;VPS11;NPEPPS;SAE1;LRRK2;LMAN1;PINK1;ATG13;HTRA2;SREBF2;PRKN
prerank,positive regulation of intracellular protein transport (GO:0090316),0.454156228871845,1.3118199100452612,0.04897959183673469,0.694210849679299,1.0,44/144,19.03%,PRKCD;KCNB1;GAS6;TMEM30B;TCF7L2;ABLIM3;IPO5;CSNK2A2;C2CD5;TM9SF4;TRIM28;BAG3;MAVS;BCAS3;MIEF2;JUP;HUWE1;FZD5;AKT2;ZIC1;PPP3CC;MAPK8;ANP32B;UBR5;XPO4;TENM1;CHP1;YWHAE;SEC16A;USP36;HPS4;YWHAQ;PCM1;TFDP1;MICALL2;ERBB2;SEC16B;VPS11;E2F1;BID;KIF20B;RBM22;NPEPPS;SAE1
prerank,reverse cholesterol transport (GO:0043691),-0.5069509607167846,-1.3113200947985706,0.16549295774647887,0.5566354707384132,1.0,4/13,11.88%,APOE;ABCG1;ABCA5;SCARB1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.45201200333603797,1.3113018336357467,0.058151609553478714,0.695170996560041,1.0,34/128,16.53%,TMEM100;GDF10;COL3A1;ADAM9;COL1A2;LTBP2;PDCD4;DDX5;SMAD9;SMAD6;ZMIZ1;ACVR1B;TGFB3;TGFB2;ACVR1;SMAD4;TGFBR2;SKI;CBL;RHOA;BMP4;RUNX2;BMPR1A;SMAD7;RGMA;TGFB1I1;TGFBR1;ZMIZ2;INHBA;BMP5;ID1;STUB1;RPS27A;UBC
prerank,regulation of protein kinase activity (GO:0045859),0.46293059556929766,1.310304269962162,0.0700836820083682,0.6979640136388323,1.0,29/106,20.31%,RASSF2;LRP6;PLCE1;GAS6;DDR2;UBASH3B;CAMKK1;WWTR1;DVL1;TRIM27;AKT1S1;PAK2;TAB2;SNX9;PDPK1;SOD1;DEPTOR;CHP1;MAPRE3;CAMK2N1;IQGAP1;GSKIP;NF1;PRKAG1;AKT1;XRCC6;DUSP19;MAP2K3;RTRAF
prerank,cellular response to amyloid-beta (GO:1904646),-0.36786606926670806,-1.3101198693639342,0.09411764705882353,0.5564917983747466,1.0,13/35,14.19%,IGF1R;GRM5;EPHA4;APP;CACNA2D1;VCAM1;CASP4;GRIN2A;SNX6;ITGA4;IGF1;CACNB1;GRIN1
prerank,carnitine shuttle (GO:0006853),-0.5142168839708844,-1.309880559680022,0.16558441558441558,0.5538958412607767,1.0,5/11,14.38%,PRKAA2;PRKAG2;CPT1A;MID1IP1;ACACB
prerank,natural killer cell mediated immunity (GO:0002228),0.6049486690614614,1.3092927869293598,0.1644021739130435,0.7007523412390669,1.0,3/15,8.96%,KLRK1;RAET1E;PLEKHM2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4643651676717327,1.3091483586419563,0.0675818373812038,0.7001269459090812,1.0,40/100,25.09%,RNF144A;XPO1;PRICKLE1;FHIT;CSNK1D;GLMN;COP1;VCP;DVL1;CCAR2;GIPC1;OGT;FBXO22;RNF14;SMAD7;CSNK1E;USP7;DAB2;DDA1;STUB1;SIRT2;TLK2;N4BP1;SUMO1;UFL1;ARAF;HECTD1;RYBP;UCHL5;CLU;USP5;LRRK2;DESI1;SUMO2;DET1;TAF1;HERPUD1;CAMLG;RCHY1;BBS7
prerank,regulation of mRNA metabolic process (GO:1903311),0.6332125931582199,1.3089354523108503,0.16216216216216217,0.6997912426885593,1.0,5/11,19.23%,SAFB;SLTM;SRPK1;NCBP1;SAFB2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4484555269064215,-1.3077298574329248,0.13807531380753138,0.5562451683699997,1.0,4/18,4.57%,RIPOR2;CAMK1D;DNM1L;DAPK2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4824863477324712,1.307524581969639,0.1074561403508772,0.704281110819554,1.0,11/64,9.03%,THBS1;MYOC;EFNA5;LDB1;PKHD1;CD3E;SEMA3E;JAG1;SLC9A1;JUP;RHOA
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5887562235535224,1.3073822877847638,0.15476190476190477,0.703558472466684,1.0,3/17,1.12%,SLIT2;VEGFA;FGF2
prerank,positive regulation of protein catabolic process (GO:0045732),0.46863199221153934,1.3071749570169153,0.08886509635974305,0.7031456314089058,1.0,19/84,12.28%,WWP1;ADAM9;GPC3;NEDD4;RDX;STX5;CSNK2A1;RILP;VCP;TNFRSF1B;DACT1;HUWE1;WWP2;NSF;ITCH;VIP;AXIN1;SNX9;EZR
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.6260022634079945,1.3071013465505859,0.16852367688022285,0.7021865126427145,1.0,2/12,1.72%,SLIT2;CCN3
prerank,regulation of lipase activity (GO:0060191),0.6056211481450626,1.3070093350645318,0.16598079561042525,0.7013440549799319,1.0,3/13,9.03%,PCSK5;LMF1;RHOA
prerank,vascular transport (GO:0010232),0.4655743402287284,1.3065054796643876,0.0962566844919786,0.702050150668095,1.0,13/81,3.96%,SLC38A2;SLC38A1;SLC4A4;SLC5A6;SLCO3A1;LRP1;SLC12A2;SLC2A13;SLC24A3;SLC16A1;SLC4A8;SLC1A5;ABCC1
prerank,phagosome-lysosome fusion (GO:0090385),0.640680031513091,1.306342671472352,0.1806543385490754,0.7014930379233242,1.0,4/10,18.37%,RAB7B;RAB34;PLA2G5;CLN3
prerank,acute inflammatory response (GO:0002526),0.5439929487928012,1.3058292656696464,0.15974842767295597,0.7022738149764541,1.0,2/23,1.07%,LBP;F3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.4397112030361322,1.305638279997385,0.014,0.7018553210898187,1.0,94/241,25.11%,SRSF6;DDX5;HNRNPH1;SRSF1;PABPC1;SRSF5;SRSF2;CASC3;SNRNP70;SNRNP48;PRPF40B;FUS;HNRNPA2B1;SRSF11;CHERP;SYMPK;HNRNPL;RAVER2;HNRNPH2;SF3B2;SF3B1;PPIL3;SF3A1;PNN;RBM10;SNRNP25;GTF2F1;SRRM1;U2AF1;RBM6;RBM5;PABPN1;SFPQ;CRNKL1;XAB2;CWF19L1;HNRNPM;PCBP2;LSM2;ZRSR2;PTBP1;RALY;GEMIN7;RBM4;HNRNPC;U2AF2;RBM17;CLP1;CPSF4;HNRNPK;YTHDC1;POLR2F;TFIP11;SRSF3;ISY1;PCF11;IK;NCBP1;WDR83;SNRPA;SRSF7;SRSF10;CWC25;CPSF7;AQR;U2SURP;RBM22;NCBP2;SYNCRIP;CSTF2;TRA2B;MTREX;HNRNPH3;TRA2A;ZCCHC8;SNRPB2;CSTF2T;DHX8;HNRNPA3;SNRPB;HNRNPA1;SRSF4;POLR2B;DHX16;RBM19;SF3B6;HNRNPU;YBX1;USP49;SF1;SUGP1;UPF3B;SNRNP35;DDX39B
prerank,glutamate receptor signaling pathway (GO:0007215),-0.3644847979740513,-1.3052228834431203,0.08536585365853659,0.5594251682148731,1.0,14/37,10.81%,PLCB1;GRM7;GRM5;GRM3;APP;GRM8;GRID2;GRM1;GRIK2;GRIN2B;GRIA4;HOMER1;GRIN2A;GRIA3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5079665734917861,-1.3051556861708626,0.15789473684210525,0.556398307802998,1.0,5/11,14.05%,LYN;RAPGEF2;PIK3CD;LGALS9;SIRT1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4808226965943501,1.3050182458379778,0.11026200873362445,0.7032185057012983,1.0,22/65,19.01%,VEGFA;P4HB;PTGIS;TWIST1;LMNA;CARD16;MDM4;NDRG1;ANGPT4;RORA;HYOU1;TERT;PICK1;UBQLN1;NDNF;STUB1;SIRT2;PGK1;HMOX1;SUV39H2;NPEPPS;HIPK2
prerank,regulation of heart contraction (GO:0008016),-0.31901872046446816,-1.304903021104973,0.06451612903225806,0.5537511000701817,1.0,21/90,11.99%,ATP1A2;ITPR1;ATP1B3;CELF2;SLC8A1;PDE4D;TPM1;RYR2;ITPR3;ABCC9;ATP2B1;SLC8A3;ATP1B2;KCNJ12;ATP2A3;DES;NPR1;TBX2;ITPR2;NOS1;ACE2
prerank,positive regulation of protein import (GO:1904591),0.5252472968309494,1.3047929357496113,0.12942612942612944,0.7028330875122909,1.0,8/30,10.64%,PRKCD;IPO5;TRIM28;BAG3;MAVS;JUP;ZIC1;UBR5
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.3553432980129334,-1.3045450938716647,0.03614457831325301,0.5515759328190051,1.0,10/57,8.56%,ADCY5;LPAR1;GRM7;GRM8;ADCY1;ADRA2A;PDE2A;HTR4;ADCY4;OPRM1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.45534085761886045,-1.3043034291149207,0.13991769547325103,0.5491593537921998,1.0,4/17,4.57%,RIPOR2;CAMK1D;DNM1L;DAPK2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.574022663949516,1.3042066491002515,0.14954486345903772,0.7040010074774528,1.0,8/19,19.94%,PLCE1;NFAT5;NFATC1;EDN3;PPP3CC;NFATC3;NMUR1;NFATC4
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5984089243502588,1.3041432664408936,0.16120218579234974,0.70298749017892,1.0,6/13,20.79%,UPP2;DCTPP1;OGG1;TDG;SMUG1;NT5C
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.5512680794338377,1.3031795446006749,0.16983523447401774,0.7056575393912468,1.0,8/22,17.53%,EDEM3;EDEM2;SYVN1;UGGT2;UGGT1;RPS27A;UBC;TRIM13
prerank,sensory organ development (GO:0007423),0.4975370214254454,1.3031236482719952,0.11405529953917051,0.7046707482648754,1.0,17/51,20.04%,SMOC1;CHRDL1;PBX3;ECE1;SIX4;TGFB2;PBX1;MEIS3;SH3PXD2B;CPAMD8;ZDHHC16;BLOC1S3;SIPA1L3;MAB21L2;HIPK2;MYO7A;ATF6
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4621002654098207,1.3030244043278243,0.10242872228088701,0.7038349213614469,1.0,29/86,24.30%,VEGFA;MUC1;PSMD7;GCN1;ATF4;BAG3;PSMA8;NFE2L2;IMPACT;PSMA4;PSMD12;PSMA6;LIMD1;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;RPS27A;UBC;HIGD1A;HMOX1;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;TP53
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5699479819589177,1.3028876211263554,0.15465268676277852,0.7031527346792833,1.0,7/20,12.60%,VEGFA;SMAD9;ATF4;SMAD4;NFE2L2;RUNX2;SESN2
prerank,phagosome maturation (GO:0090382),0.5133961618262075,1.3027740629347933,0.1349112426035503,0.7023760692729526,1.0,9/35,14.53%,ATP6V1C2;RAB34;RAB43;TCIRG1;ATP6V0A1;RAB38;ATP6V0D1;ATP6V1B2;ATP6V1E1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5736680839999182,1.3020980980868118,0.15934065934065933,0.703841357279779,1.0,6/17,8.87%,KCNJ2;CACNA1G;CACNA1C;HCN4;ANK2;TRPM4
prerank,regulation of protein localization to membrane (GO:1905475),0.5397341520344761,1.3018514791693225,0.1339712918660287,0.7036246035762913,1.0,12/28,25.98%,GPC6;GSN;GPC3;MMP14;SPTBN1;CLN3;CDK5;APPL1;CRIPT;GPC1;GPC4;VTI1B
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5832816083489835,1.30170706563082,0.15508021390374332,0.7029440607501973,1.0,2/16,4.91%,SLC39A14;PRKCA
prerank,regulation of nervous system process (GO:0031644),-0.438401586036419,-1.3017063809442178,0.1222707423580786,0.5528993256324144,1.0,5/18,7.35%,ROCK2;APP;NOS3;HTR2C;SLC8A3
prerank,proteolysis (GO:0006508),0.43822066751717703,1.301429166007188,0.018072289156626505,0.7028120476008962,1.0,71/252,24.75%,ADAMTS3;CAPN5;HTRA3;TRABD2B;BMP1;PCSK5;F3;HTRA4;HTRA1;ECE1;PRSS38;CPZ;FAP;HM13;CPQ;ADAM10;SPG7;MMP14;PM20D2;BACE2;TASP1;CLPP;MBTPS1;CAPN10;XPNPEP1;DDI2;CAPN2;OGT;BACE1;SDE2;FBXO3;LONP1;PSMA6;MMP16;CASP1;NLN;LNPEP;CPXM2;PSEN2;HGF;LAP3;IDE;CAPN15;PSMC4;DPP8;PCSK7;NAPSA;CLN3;SUFU;FBXW2;NPEPPS;CTSZ;LVRN;CPB2;RNPEPL1;CTSB;SENP1;CTSK;DESI2;DESI1;UBA3;CTSO;CAPN6;MMP2;SENP6;AFG3L2;SPPL2A;PHEX;METAP2;ADAMTS9;VASH1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.5442485252797017,1.300741717862858,0.1557478368355995,0.7043676388542119,1.0,7/24,17.18%,PID1;RHOQ;GDI1;PPFIA1;CLTC;DAB2;LZTFL1
prerank,response to lipid (GO:0033993),0.46099223358631336,1.3006045865687494,0.06694560669456066,0.7036944660225395,1.0,24/105,16.58%,ESR1;FOXP1;ALPL;LBP;SMAD6;CYP19A1;RXRA;STAT3;RXRB;IRAK3;LIAS;RARA;SOX9;SOCS2;ANXA1;FOXA1;IRAK1;TAB2;F2R;SRR;PRDX3;CYP27B1;FOXO3;OTUD5
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5551744856157632,1.3002730419054882,0.16354556803995007,0.703906999471957,1.0,11/21,17.11%,NUP93;CCN3;TGFB3;WWTR1;SMAD4;BMP4;SH2B1;BMPR1A;TGFBR1;DAB2;SLC2A10
prerank,histone H3 deacetylation (GO:0070932),0.591425168055451,1.2999102004752343,0.17053206002728513,0.7041955630011004,1.0,12/15,33.14%,HDAC9;HDAC4;SFPQ;HDAC1;PER1;SIRT2;SMARCAD1;HDAC2;PER2;ELK4;HDAC3;SIRT7
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5336945904149384,-1.2994498814370907,0.15699658703071673,0.5553567513363119,1.0,1/10,0.70%,ROCK2
prerank,positive regulation of cell division (GO:0051781),0.5126543809169837,1.2992801289581175,0.13647058823529412,0.705416293955435,1.0,13/38,15.40%,CIT;PRKCE;CDC14A;GIPC1;CDC6;RHOA;PKN2;FGFR2;CDC25B;SPAST;OPN1MW;CSPP1;SIRT2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.6081567451612818,1.2990962474754448,0.16939890710382513,0.7049499227965305,1.0,4/13,12.82%,ZMIZ1;ELOF1;SERTAD2;ZMIZ2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.49662461836277766,1.2989714317747012,0.12471395881006865,0.7042458625336392,1.0,14/43,17.46%,FGF2;NFIB;DDX5;GNL3;KLF5;TGFB2;STAT3;SOX9;BMP4;TERT;SRF;NFATC3;FOXO3;NR3C1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5358451348709651,1.2983322103804942,0.15355329949238578,0.7057313307350996,1.0,3/25,2.00%,MAP7D3;FGF13;STMND1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.47871061411027516,1.298135144374629,0.12263099219620958,0.705322614654157,1.0,19/54,24.30%,PLAGL1;MUC1;CRADD;MDM4;CARM1;PCBP4;ATM;CHEK2;TFDP1;CNOT8;CNOT10;RBL2;E2F1;CNOT9;TNKS1BP1;SFN;TRIAP1;PRMT1;TP53
prerank,autophagy of nucleus (GO:0044804),0.595161074793528,1.298037289283445,0.17254901960784313,0.7045016324581208,1.0,8/16,28.39%,ULK2;WIPI2;ATG3;RB1CC1;ATG9A;ATG13;ATG2B;ULK1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5233417833769451,1.2980045459328062,0.1455621301775148,0.7034457746809629,1.0,2/33,0.58%,PKD1;ID2
prerank,transport across blood-brain barrier (GO:0150104),0.4629707729817512,1.2978762493395382,0.09051724137931035,0.7027805040809848,1.0,13/83,3.96%,SLC38A2;SLC38A1;SLC4A4;SLC5A6;SLCO3A1;LRP1;SLC12A2;SLC2A13;SLC24A3;SLC16A1;SLC4A8;SLC1A5;ABCC1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.49697823427032994,1.297385106057951,0.1341743119266055,0.7035906896941189,1.0,7/44,6.99%,KCNJ2;KCNJ15;ATP1B1;KCNN1;KCNE5;ANK2;KCNIP2
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.5026251002578946,1.2968677105559419,0.12295081967213115,0.7044786385546582,1.0,19/41,26.42%,NUP93;SEC13;RAE1;SEH1L;OGT;NUP37;RANBP2;NUP88;EIF6;PRKAG1;POM121;NUP210;NUP62;NDC1;NUP35;SCARB2;NUP85;NUP160;TPR
prerank,glycosaminoglycan metabolic process (GO:0030203),0.48629612161680924,1.2964272283189076,0.11836283185840708,0.7050153700227446,1.0,5/54,3.14%,EXT1;XYLT1;GPC6;GPC3;SDC1
prerank,neuron differentiation (GO:0030182),0.445297158939034,1.2960016997486394,0.03567787971457696,0.7054299595944573,1.0,32/165,16.23%,LRP6;ID2;WNT9A;VEGFA;PBX3;VSX1;LDB1;GLI2;LHX9;TGFB2;NRBP2;FZD7;PBX1;FZD5;MYEF2;FOXA1;RUNX2;CTF1;NEUROD2;SRF;ERCC3;TENM1;TGFBR1;INHBA;MANF;ERCC2;RUNX1;WNK1;ACSL3;EN2;THOC2;ERBB2
prerank,fatty acid oxidation (GO:0019395),0.48729520726552655,1.2957766300321372,0.11843575418994413,0.7051206742845693,1.0,18/57,22.46%,ABCD3;EHHADH;ECHDC2;ECI2;ADIPOR2;PEX13;AUH;ACAT1;ALDH3A2;BDH2;HACL1;PHYH;SLC27A2;PEX2;ABCD1;ECHDC1;MCAT;HADHA
prerank,cellular response to alkaloid (GO:0071312),-0.46016962589623134,-1.2954978253763743,0.1278538812785388,0.5624437200381729,1.0,3/17,3.25%,SLC8A1;TGM2;RYR2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.44500038824187804,-1.2954037072961293,0.10080645161290322,0.559619026285792,1.0,8/18,14.89%,NRXN1;SHANK3;RIMS2;RIMS1;CUX2;RELN;GRIN1;PRKCZ
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.45545613844816235,-1.2953227792250486,0.13709677419354838,0.5567353965951167,1.0,9/17,19.82%,OSR1;AJAP1;APOLD1;CAV1;CEACAM1;PRKX;MAFF;DSPP;DLL1
prerank,organic substance transport (GO:0071702),0.45149373740481474,1.2943956897609654,0.07304526748971193,0.7096081439646611,1.0,24/121,14.89%,SLC47A1;SLC23A1;ABCD3;SLCO2A1;LMAN2L;FLVCR1;RAMP2;RILP;HIKESHI;DISP1;SLC6A2;ATP8A1;RAMP1;RAB38;PCTP;LRP2;SLC22A18;ABCA1;PICK1;TOM1;CHMP3;ABCB6;SLC50A1;MIA3
prerank,embryonic organ development (GO:0048568),0.47655352678475565,1.2942980477347532,0.10733844468784227,0.7087624177370234,1.0,15/61,12.13%,PKDCC;PCSK5;PBX3;RARB;GLI2;COBL;TGFB2;ATF4;TGFBR2;PBX1;TBC1D23;FGFR2;BMPR1A;ERCC3;HEY1
prerank,cellular response to amino acid starvation (GO:0034198),0.46686270588676637,1.2942726423992628,0.10321864594894561,0.7076621848069837,1.0,31/71,25.64%,NPRL3;ATP6V1C2;SEC13;MAP3K5;GCN1;SESN3;TCIRG1;ATF4;LAMTOR1;SEH1L;DAP;IMPACT;CASTOR2;MAPK8;ATP6V0D1;SESN2;ATP6V1B2;ATP6V1E1;FLCN;ATF2;KPTN;ATP6V1C1;RHEB;EIF2AK4;EIF2S1;EIF2AK3;RPTOR;NPRL2;ATP6V0E1;ATP6V0B;LAMTOR2
prerank,regulation of chromatin organization (GO:1902275),0.6084508268055817,1.2942383945103297,0.17541436464088397,0.7066335739399899,1.0,10/14,28.54%,TLK1;SETD5;TLK2;MLLT3;SSRP1;SETD1A;HNRNPU;PARG;IGF2;CDK9
prerank,ribonucleoprotein complex assembly (GO:0022618),0.4487172031840417,1.2941023269076606,0.06818181818181818,0.7060518381583568,1.0,37/132,18.09%,SRSF6;RPSA;KHDC4;LUC7L2;SRSF1;NOL3;SRSF5;CELF4;RRS1;PRKDC;RRP7A;CELF3;LUC7L;LUC7L3;NLE1;SF3B1;RBM5;CRNKL1;SNUPN;XAB2;DHX29;ZRSR2;GEMIN7;SRPK1;CLP1;EIF2S2;YTHDC1;EIF6;ISY1;PPAN;EIF3A;NCBP1;BOP1;SMN1;SRSF10;CPSF7;CPSF6
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6417515536669117,1.2939910394639134,0.189873417721519,0.7053117984894071,1.0,7/10,26.51%,KMT5A;EHMT1;EEF1AKMT2;SETD4;SETD2;SMYD2;SETD7
prerank,positive regulation of cell adhesion (GO:0045785),0.46784313690929524,1.2935772584329879,0.10930735930735931,0.7057170977447912,1.0,19/74,17.75%,ZFHX3;VEGFA;ADAM9;P4HB;VIT;TGFB2;PRKCA;AGR2;FOXC2;TFE3;ITGAV;ATM;SMAD7;ARL2;NDNF;STX4;ERBB2;FLCN;CITED2
prerank,cation transmembrane transport (GO:0098655),-0.36342790144652165,-1.2931869868587922,0.0821917808219178,0.5589503618383989,1.0,7/44,8.07%,ATP1A2;TRPM3;SLC7A5;ABCC9;SLC6A9;SLC38A5;SLC7A1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5301173064275188,1.2931787301677917,0.16352201257861634,0.7061062368690716,1.0,7/24,12.60%,VEGFA;MUC1;GCN1;ATF4;NFE2L2;HSPA5;SESN2
prerank,chromatin organization (GO:0006325),0.4503116152349067,1.2930728534129734,0.061601642710472276,0.7053188212114564,1.0,51/132,26.75%,ESR1;HDAC4;BAZ2A;CHD1L;TCF7L1;PHF1;SAFB;EZH1;TADA2A;BRWD1;EHMT1;SOX9;HMGN1;SMARCC2;CDAN1;FOXA1;SETD5;KDM5B;PBRM1;KDM4A;KAT2A;HDAC1;BAZ2B;SETDB1;HMGN2;SUPV3L1;KDM5C;HMG20A;KDM6B;GATAD1;SMARCAD1;SUV39H2;HCFC1;BRDT;MPND;BPTF;SUV39H1;LOXL2;FAM50A;SETD2;TOP1;TAF6L;KAT2B;SETDB2;SMARCA4;HDAC2;DAXX;CHD1;ARID1A;SETD7;MYSM1
prerank,regulation of protein catabolic process (GO:0042176),0.45660978336697633,1.2924051562013799,0.0893970893970894,0.7067969702574977,1.0,18/99,11.36%,EGFR;WWP1;GPC3;NEDD4;STX5;CSNK2A1;RILP;VCP;DACT1;IRAK3;MDM4;HUWE1;WWP2;NSF;ITCH;VIP;AXIN1;CHEK2
prerank,histone mRNA catabolic process (GO:0071044),0.6013992677286386,1.2920798155100381,0.16976127320954906,0.7069317447337159,1.0,8/15,21.97%,TENT4B;SSB;ATM;XRN1;EXOSC4;TUT7;TENT2;UPF1
prerank,lung development (GO:0030324),0.5200085457281446,1.2918682348245125,0.15123094958968347,0.7066718910989259,1.0,7/33,9.71%,PKD1;VEGFA;FGF2;GLI2;CCDC39;BMP4;FGFR2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.5188635858207891,1.2916742494302438,0.14303030303030304,0.7062626607560999,1.0,14/31,24.85%,PEX7;TOMM40;PEX5;PEX16;PEX1;AIFM1;HSPD1;PEX10;TOMM70;GRPEL1;PEX6;PEX2;PEX14;TIMM17B
prerank,sulfur compound transport (GO:0072348),0.5335887223721288,1.291100791017083,0.14652014652014653,0.7073692825542528,1.0,4/27,5.40%,SLC26A7;SLC5A6;SLC26A6;LRRC8D
prerank,negative regulation of phosphorylation (GO:0042326),0.45986103011741186,1.2909439832627838,0.08447729672650475,0.7068837536028272,1.0,19/85,13.03%,SLIT2;LRP6;PID1;NTRK3;PLPP3;EPHB2;HDAC4;WWTR1;XDH;ACTN3;PRKDC;IMPACT;CDK5RAP3;BMP4;PAQR3;NIBAN1;GIT1;CHP1;INHBA
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6133242835529605,1.290365375380579,0.16666666666666666,0.7079451208539791,1.0,5/13,15.61%,GLI2;BMP4;SOD1;CLPTM1;CAMK4
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.420494534179502,-1.2902329378464978,0.13679245283018868,0.5636943965076736,1.0,7/23,9.59%,UACA;BMP7;DDX3X;C1QTNF3;TMSB4X;ADIPOR1;ZC3H12A
prerank,protein localization to cell junction (GO:1902414),-0.41027673643782125,-1.2896022596818615,0.13761467889908258,0.5623402960035576,1.0,4/22,4.79%,TJP1;CGNL1;HEG1;BSN
prerank,cellular response to pH (GO:0071467),0.5758310166641263,1.2892021860283163,0.17245989304812834,0.7112531280846112,1.0,7/17,20.27%,SLC9A1;IMPACT;RAB11FIP5;CHP1;RAB11B;PKD2L1;HVCN1
prerank,calcium ion transmembrane transport (GO:0070588),0.45752864801251464,1.2887642191239048,0.10311493018259936,0.7118633802788195,1.0,17/86,13.04%,CACNA1G;PKD1;CACNA1C;SLC35G1;GAS6;SLC24A3;TRPV3;MCU;SPG7;TRPC4AP;TRPM7;TRPM4;ITGAV;TMEM165;TRPM6;MICU2;LETM1
prerank,regulation of protein binding (GO:0043393),0.45394081754380217,1.2886734637599673,0.07484407484407485,0.7110810239236744,1.0,43/114,25.50%,PRMT8;PKD1;PRKCD;LRP1;TCF7L2;TIAM1;HDAC4;LRPAP1;CARD16;DACT1;DVL1;TMC8;SYMPK;EFHB;MAPK8;BMP4;GTF2F1;NVL;TERT;CSNK1E;ADD1;USP33;DAB2;MITD1;TFIP11;IDE;STYX;MEN1;AKT1;HIPK2;SNAPIN;CRK;CTSZ;PRKACA;LRRK2;CAMK1;PEX14;DERL1;TAF1;AMFR;ROCK1;PPP2CA;STK3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.46099229400357483,1.2883255256064652,0.09005235602094241,0.7112197896967608,1.0,26/93,21.03%,RASSF2;EGFR;VEGFA;GAS6;NTRK3;DOCK7;DMD;PFN2;RAF1;NSD1;PAQR3;AXIN1;SMAD7;TENM1;AKAP9;EIF4G1;IL6;HDAC6;ARAF;TRIM6;CNOT9;AKT1;MLXIPL;TNKS1BP1;MAD2L2;ATP2B4
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5276540415402879,1.2880919334235235,0.16523867809057527,0.710964835457456,1.0,5/27,11.27%,SMOC2;FGF2;TOM1L1;SMG6;ATM
prerank,pulmonary valve development (GO:0003177),0.5687311057556615,1.2879183457079322,0.16623711340206185,0.7105079527699598,1.0,9/18,12.13%,SLIT2;SMAD6;TGFB2;TNFRSF1B;JAG1;HEYL;NFATC1;BMP4;HEY1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5189610346788823,1.2877517937889391,0.14532019704433496,0.7101007429434667,1.0,6/30,4.29%,DSE;BGN;CHST11;ARSB;CHPF2;CSPG4
prerank,cartilage development (GO:0051216),0.49260311084010117,1.2875323054917114,0.13641488162344984,0.7097958964466244,1.0,12/49,13.69%,PKD1;SLC39A14;FGF2;NFIB;CCN3;HES5;SULF1;SOX9;BMP4;RUNX2;TRIP11;RUNX1
prerank,actin polymerization or depolymerization (GO:0008154),0.48846285878707585,1.2866503102214633,0.12316384180790961,0.7121871566476329,1.0,12/50,16.87%,PSTPIP1;MICAL2;GSN;VILL;COBL;ABI1;TTC17;SCIN;SPIRE2;MICALL2;WASHC3;WDR1
prerank,regulation of interleukin-4 production (GO:0032673),-0.43763457661029403,-1.2863995880797636,0.1415525114155251,0.5676423901376215,1.0,7/21,14.89%,LEF1;SLC7A5;SYK;PRKCQ;HAVCR2;LGALS9;PRKCZ
prerank,regulation of mRNA processing (GO:0050684),0.5160814167112274,1.2863506783327434,0.14927184466019416,0.7122204818581052,1.0,15/32,19.47%,RBM39;SAFB;SLTM;PABPN1;METTL16;KHDRBS1;SRPK1;CPSF4;HNRNPK;YTHDC1;SRSF3;NCBP1;SRSF10;SAFB2;LARP7
prerank,response to interleukin-6 (GO:0070741),0.6362121688945988,1.2863108889151973,0.19383259911894274,0.7112720121569679,1.0,3/10,9.20%,PID1;PTGIS;SBNO2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.44458184835076825,1.2860047597162936,0.07605344295991778,0.7113146655458602,1.0,10/122,4.20%,THBS1;SMOC2;EGFR;IRS1;FGF2;IL33;LDB1;GLI2;SAMD4A;TGFB2
prerank,response to amino acid starvation (GO:1990928),0.4612559051065618,1.2840799579856657,0.11147902869757174,0.7177344417627605,1.0,31/72,25.64%,NPRL3;ATP6V1C2;SEC13;MAP3K5;GCN1;SESN3;TCIRG1;ATF4;LAMTOR1;SEH1L;DAP;IMPACT;CASTOR2;MAPK8;ATP6V0D1;SESN2;ATP6V1B2;ATP6V1E1;FLCN;ATF2;KPTN;ATP6V1C1;RHEB;EIF2AK4;EIF2S1;EIF2AK3;RPTOR;NPRL2;ATP6V0E1;ATP6V0B;LAMTOR2
prerank,smooth muscle tissue development (GO:0048745),-0.5429876199168582,-1.2835515520290444,0.1793103448275862,0.571825982166904,1.0,4/10,5.87%,ENG;MYLK;PTCH1;PROX1
prerank,response to purine-containing compound (GO:0014074),-0.45032493779696275,-1.2834149529919912,0.1469387755102041,0.5691327743527037,1.0,4/17,3.96%,STAT1;RYR2;TRPC3;ABCC9
prerank,negative regulation of organelle assembly (GO:1902116),0.5113825522982105,1.2831525656979577,0.16370106761565836,0.7202861405482345,1.0,18/35,25.59%,TMEM39A;LIMK2;SMAD4;CDK10;SCFD1;EVI5L;KAT2A;PHF23;SEC22B;CHMP4A;CHMP4B;LRRK2;CDK5RAP2;MTM1;KAT2B;SMCR8;PINK1;CCP110
prerank,positive regulation of bone mineralization (GO:0030501),-0.37676224830547345,-1.2831222957226542,0.10738255033557047,0.5668254728599845,1.0,12/35,9.14%,PTN;WNT4;SLC8A1;ADGRV1;BMP6;OSR1;BMP7;KL;ATP2B1;FBN2;ANO6;BMPR2
prerank,epithelial tube morphogenesis (GO:0060562),0.5228938858578301,1.2830745827127283,0.1440677966101695,0.7194466399752846,1.0,5/32,5.63%,SLIT2;PKD1;GLI2;PKHD1;ACVR1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5698565974486707,1.2829306556967095,0.18659658344283836,0.7188837639400601,1.0,4/17,8.51%,PCSK5;HDAC9;ANGPTL4;LMF1
prerank,cortical cytoskeleton organization (GO:0030865),0.49544796975212196,1.2821345555007713,0.14602803738317757,0.7208855014685311,1.0,10/41,14.75%,RHOBTB1;FMNL2;RHOQ;RND3;LLGL1;DLG1;RHOA;EZR;NLGN1;RHOB
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.5733829915425389,1.2819843473864174,0.1889655172413793,0.7203647480564884,1.0,8/15,26.61%,VCP;FAF2;SYVN1;NPLOC4;DERL1;HERPUD1;SELENOS;SEC61B
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5683844231308077,1.2808919336659719,0.18848167539267016,0.7235397960928444,1.0,4/17,14.43%,PLA2G4F;PLA2G4A;PLA2G5;PLA2G12A
prerank,protein depolymerization (GO:0051261),0.5277784633784157,1.280644455280309,0.1751207729468599,0.7233327661628043,1.0,3/27,2.00%,MICAL2;GSN;STMND1
prerank,visual perception (GO:0007601),0.45754550515721104,1.2806220972143199,0.09957173447537473,0.7222921768962536,1.0,7/84,6.91%,SLC4A10;COL11A1;COL1A1;PDE6C;PITPNA;CRYZ;CHRNB2
prerank,regulation of trophoblast cell migration (GO:1901163),0.5858871860791958,1.2805220971520166,0.1713091922005571,0.7215293657098044,1.0,7/14,25.38%,VEGFA;ACVR1B;AGO2;CALR;SMURF2;C1QBP;ARHGDIB
prerank,estrogen metabolic process (GO:0008210),0.5777841561730237,1.2804619366871777,0.19505494505494506,0.7206311424466953,1.0,2/15,3.46%,CYP19A1;CYP1B1
prerank,neural crest cell migration (GO:0001755),-0.37070718190430046,-1.2801047728439632,0.12658227848101267,0.5713782479553793,1.0,16/36,21.23%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;TBX1;ERBB4;CORO1C;SEMA4D;SEMA3G;FN1;SEMA4A;HTR2B;SEMA4G;SEMA5B;SEMA6D;SEMA3B
prerank,positive regulation of lipid transport (GO:0032370),0.6096184741471451,1.279902633381589,0.1902097902097902,0.7217199686518437,1.0,2/12,2.66%,LRP1;CYP19A1
prerank,regulation of neuron projection development (GO:0010975),-0.2799002450162084,-1.2796564584536378,0.0,0.5695120342676564,1.0,37/163,10.48%,EFNB2;LYN;PTN;LPAR1;CSMD3;APOE;ITGA6;SHANK3;PPFIA2;IL1RAPL1;PTK7;WNT5A;EPHA4;LRRC4C;RAPGEF2;CCDC88A;CHN1;CAMK1D;CTNNA2;SERPINI1;PTPRO;NTNG1;PTPN9;ROR2;TENM3;PAK3;CDH2;DCC;PRAG1;ATP1B2;PAK1;MFSD2A;ABI3;PDLIM5;PLXNB2;KIF1A;BAG5
prerank,negative regulation of myotube differentiation (GO:0010832),0.6076269706595515,1.2794429925894097,0.18118948824343015,0.7224119643525458,1.0,4/12,12.69%,CCN3;HDAC4;TMEM119;HDAC1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5622037149266724,1.2786565431168235,0.18798955613577023,0.7242957636957137,1.0,3/19,10.69%,LBP;PRKCE;IRAK1
prerank,dendritic spine morphogenesis (GO:0060997),0.5877387311700775,1.2781131207912735,0.18207282913165265,0.7252912606894908,1.0,6/15,11.52%,CTNND2;EPHB2;ARC;EPHB3;DLG4;SHANK1
prerank,presynaptic endocytosis (GO:0140238),0.5355371964657187,1.2778594246895019,0.18135376756066413,0.7252021738401716,1.0,10/24,20.59%,STON2;SYT8;CEL;FCHO2;STON1;SYNJ1;NLGN1;STX1A;CDK5;SYNJ2
prerank,renal system development (GO:0072001),0.4866093761208602,1.2777839769759254,0.13816534541336353,0.7243609280439869,1.0,9/52,9.70%,SIX1;PKD1;VEGFA;PCSK5;GLI2;TGFB2;SULF1;PYGO1;BMP4
prerank,tRNA processing (GO:0008033),0.46733544755294887,1.2774459430665794,0.132821075740944,0.7245492897992691,1.0,24/61,23.80%,TSEN54;SSB;ANKRD16;ELP5;FAM98B;TRMT1;PUS3;TRUB1;CTU2;CLP1;CPSF4;RTCB;RPP40;ELAC2;ADAT1;TRMT6;SARS1;CSTF2;RTRAF;TRMT61A;METTL1;NSUN6;TSEN34;RPP21
prerank,mRNA processing (GO:0006397),0.4282742406895647,1.2770865460958944,0.019,0.7248035690726892,1.0,111/287,25.90%,SRSF6;DDX5;HNRNPH1;SRSF1;PABPC1;SRSF5;SRSF2;CASC3;SNRNP70;SNRNP48;PRPF40B;FUS;HNRNPA2B1;SRSF11;CHERP;SYMPK;HNRNPL;RAVER2;HNRNPH2;SF3B2;SF3B1;PPIL3;SF3A1;PNN;TBRG4;ZC3H11A;RBM10;SNRNP25;GTF2F1;SRRM1;U2AF1;RBM6;CHTOP;RBM5;PABPN1;SFPQ;CRNKL1;ERCC3;XAB2;CWF19L1;HNRNPM;PCBP2;LSM2;ZRSR2;PTBP1;RALY;GEMIN7;RBM4;ERCC2;HNRNPC;U2AF2;RBM17;CLP1;CPSF4;HNRNPK;YTHDC1;POLR2F;SARNP;TFIP11;THOC2;SRSF3;ISY1;PCF11;RPRD1A;IK;NCBP1;WDR83;SNRPA;SRSF7;SRSF10;CWC25;CPSF7;AQR;CPSF6;U2SURP;RBM22;NCBP2;SYNCRIP;CSTF2;TRA2B;RAMAC;MTREX;HNRNPH3;TRA2A;PRKACA;ZCCHC8;SNRPB2;CSTF2T;DHX8;HNRNPA3;SNRPB;GEMIN2;HNRNPA1;SRSF4;POLR2B;DHX16;RBM19;PRMT9;SF3B6;HNRNPU;YBX1;USP49;SF1;SUGP1;UPF3B;SNRNP35;DDX39B;GTF2H4;METTL14;POLR2H;RNMT
prerank,cellular response to purine-containing compound (GO:0071415),-0.5095401440711343,-1.276641781059152,0.1540983606557377,0.5740140533965711,1.0,2/10,3.25%,SLC8A1;RYR2
prerank,protein targeting to lysosome (GO:0006622),0.549491588402768,1.2759885213338829,0.18882978723404256,0.727970943702956,1.0,11/20,34.66%,NEDD4;NAGPA;ZFYVE16;CLU;LAMP2;SCARB2;GCC2;GGA3;GNPTAB;M6PR;SNX16
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5533719101355724,1.2757046796729121,0.18904823989569752,0.7280711172921505,1.0,4/21,11.35%,LRP6;DVL1;FZD5;AXIN1
prerank,heme biosynthetic process (GO:0006783),0.5484076805219164,1.2754692197715052,0.2002652519893899,0.7278292320724989,1.0,11/22,25.83%,FLVCR1;FXN;NFE2L1;HMBS;ABCB6;FECH;UROS;SLC25A38;ABCG2;ABCB10;COX15
prerank,protein modification by small protein removal (GO:0070646),0.4332323497130226,1.2754004464869928,0.029,0.7269686718230712,1.0,106/252,26.82%,ESR1;IL33;PSMD7;USP24;VCP;USP2;PSMA8;SMAD4;OTUB1;USP50;TRRAP;MDM4;GPS1;MBD6;FOXK1;OGT;RHOA;INO80E;RHOT1;PSMA4;USP40;UCHL3;INO80B;WDR48;USP48;USP45;SMAD7;PSMD12;OTUB2;KAT2A;USP34;TRAF3;TGFBR1;USP11;PSMA6;STAM2;SENP5;USP7;USP33;USP36;PSMD1;USP13;PSMC5;USP19;USP35;PSMD11;PSMC4;PSMD14;RPS27A;UBC;OTUD5;CDC25A;POLB;YOD1;USPL1;SENP8;CDC20;USP32;USP10;HCFC1;USP46;ACTR8;USP1;UCHL5;ZRANB1;NFKBIA;TAF9B;OTUD6B;PSMA3;UCHL1;BRCC3;USP5;SMURF2;PSMB1;SENP1;PSMD4;COPS4;USP47;DESI2;DESI1;BIRC3;SENP7;SENP6;PSMA5;CYLD;KAT2B;PSMA7;USP4;USP49;COPS7A;ASXL2;USP14;TP53;SNX3;SENP3;CCP110;SUDS3;PSMC1;COPS3;RIPK1;YY1;ATXN7;TAF10;MYSM1;USP21;USP16
prerank,sodium ion import across plasma membrane (GO:0098719),0.5762811140615807,1.2750657448939544,0.19333333333333333,0.7271082947910218,1.0,6/17,8.87%,SLC12A2;SLC5A2;HCN4;SLC9A4;SLC9A1;TRPM4
prerank,protein sumoylation (GO:0016925),0.4780163629359833,1.274728349006424,0.15454545454545454,0.7272995854339515,1.0,22/49,26.42%,NUP93;TOPORS;TRIM28;RAE1;SEH1L;TRPM4;NUP37;RANBP2;PIAS4;NUP88;STX1A;SUMO1;POM121;NUP210;SAE1;NUP62;SUMO2;NDC1;NUP35;NUP85;NUP160;TPR
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5892140062107476,1.2747149766097945,0.1908713692946058,0.72622656104957,1.0,8/14,23.30%,TSEN54;FAM98B;CLP1;CPSF4;RTCB;CSTF2;RTRAF;TSEN34
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5255015370422889,1.2743203998775854,0.16370558375634517,0.7267669078260001,1.0,5/29,7.83%,SLC4A10;EPHB2;ARC;RAB3GAP1;DLG4
prerank,regulation of cell cycle (GO:0051726),0.4312856780077528,1.2742637010715334,0.01903807615230461,0.7258703442755916,1.0,71/271,21.17%,THBS1;PLAGL1;LRP6;PKD1;ID2;TCF7L2;PDCD4;TTC28;GADD45G;PPP1R9B;PRDM11;FAP;CSNK2A2;CSNK2A1;TGFB2;STAT3;EIF4G2;CDC14A;NEK7;ADAM10;PUM1;GBF1;CDK10;RARA;SOX9;SRA1;AKT2;CDK5RAP3;BMP4;FGFR2;TBRG4;CDC123;MADD;FOXM1;ABL1;INTS13;ATM;MAPK12;FBXL12;TAF6;MED25;UHMK1;TGFBR1;INHBA;SND1;RHOB;CAMK2N1;ING4;SIRT2;IQGAP1;APBB1;CDC25A;BOP1;E4F1;MEN1;CITED2;DAPK3;KIF20B;HCFC1;UHRF2;BIRC5;HIPK2;MLXIPL;CKS1B;GMNC;CDK5;DLGAP5;CALR;PRKACA;WDR12;TBRG1
prerank,protein maturation (GO:0051604),0.4511601335319909,1.2739836414552834,0.11770943796394485,0.7259009308688124,1.0,26/95,18.37%,ADAMTS3;PCSK5;F3;ECE1;CPZ;NAA60;ADAM10;NAA40;MMP14;TASP1;LMF1;DDI2;OGT;BACE1;NAA16;SDE2;HSPD1;MMP16;GCSH;CPXM2;MMS19;PSEN2;STUB1;LIPT1;PCSK7;CLN3
prerank,gas transport (GO:0015669),0.6300697995507926,1.2738266637668227,0.2057142857142857,0.7254433184651582,1.0,1/10,1.37%,CYGB
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6194040075659139,1.2737440775347268,0.18687589158345222,0.7246819338422392,1.0,2/10,1.49%,XYLT1;DSE
prerank,purine-containing compound biosynthetic process (GO:0072522),0.5333458081644433,1.2730247816167126,0.17042606516290726,0.7262892557400031,1.0,7/25,18.44%,PRPS2;ADA;AMPD3;DGUOK;MTHFD1;SHMT2;SHMT1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5695679957768938,1.2717711828616107,0.17777777777777778,0.73017424551954,1.0,4/17,5.88%,ADAM9;TGFB2;CD3E;FOXC2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4957206310781764,1.2717294771134273,0.1801909307875895,0.7292353389722058,1.0,9/39,6.91%,FGF13;FXYD5;NEDD4;PRKCE;PTPN3;CAMK2D;DMD;STK39;SLMAP
prerank,regulation of organelle assembly (GO:1902115),0.4688044843351181,1.2711943167953592,0.10810810810810811,0.7302338721524402,1.0,32/73,26.20%,GSN;NPRL3;RDX;MAPK15;TBC1D2B;DYNLT2B;ATXN2L;ALMS1;IFT20;TBC1D24;TRAPPC12;ATG3;SDCCAG8;EZR;TBC1D9B;TBC1D10A;TBC1D17;IFT88;VPS11;EVI5;TBC1D22B;PDCD6IP;RNF4;ATXN2;RAB1B;SENP6;CYLD;RABGAP1;NPRL2;SPICE1;TBC1D20;RAB5A
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5193934795693577,-1.2710599711522388,0.18421052631578946,0.5858565274717258,1.0,2/10,4.87%,LYN;FAS
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.33405387325265845,-1.2708225838024443,0.08433734939759036,0.5834011468292656,1.0,11/62,7.84%,ROBO1;AUTS2;LYN;LPAR1;MAP4K4;ARHGEF3;NOTCH1;NET1;F11R;RASGEF1A;PRAG1
prerank,regulation of protein kinase B signaling (GO:0051896),0.4315234316666488,1.2705596301372346,0.050454086781029264,0.7317040070861471,1.0,17/193,4.54%,THBS1;MYOC;ESR1;EGFR;IRS1;TNFAIP8L3;GAS6;F3;FGF2;TCF7L2;NTRK3;NTRK1;FGF17;GAB2;PKHD1;PHLPP2;XDH
prerank,endocrine system development (GO:0035270),0.5405355642333136,1.26986623899039,0.20077220077220076,0.7332795204667402,1.0,3/21,3.09%,SIX1;GLI2;DKK3
prerank,regulation of receptor recycling (GO:0001919),0.5676565322374271,1.269729268925594,0.19440745672436752,0.7326991204454242,1.0,6/16,20.95%,ECE1;ANXA2;LAMTOR1;NSF;TRAT1;OPTN
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5032627117766674,1.2697275081576878,0.17964071856287425,0.731595493503354,1.0,8/32,11.12%,PEMT;CSNK2A2;CSNK2A1;LPCAT1;STARD7;GPAT4;LPCAT3;PCTP
prerank,positive regulation of vacuole organization (GO:0044090),0.6319133429043035,1.2696380941478622,0.2050520059435364,0.73087709849858,1.0,4/10,10.06%,ANXA2;LRSAM1;RAB3GAP1;PIP4K2B
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4907443957061157,1.2693523020954465,0.1519721577726218,0.7309160538783268,1.0,5/40,3.19%,ESR1;EGFR;FGF2;NTRK3;EDNRA
prerank,epithelial to mesenchymal transition (GO:0001837),-0.34410787374785134,-1.2692127156132518,0.07258064516129033,0.5847184720100156,1.0,12/47,7.46%,TGFBR3;LEF1;ENG;ROCK2;WNT4;WNT5A;BMP7;TBX3;NOTCH1;NOTCH4;RBPJ;AKNA
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.631284832318364,1.2687977597665794,0.19855072463768117,0.7320822431441901,1.0,3/10,4.67%,PDE11A;UBE2B;PDE3A
prerank,cellular response to misfolded protein (GO:0071218),0.5517002973019507,1.2677751357135094,0.1809775429326288,0.7350146829240247,1.0,10/20,25.97%,VCP;DNAJB14;UGGT2;UGGT1;STUB1;DNAJC18;DERL1;DNAJB12;UBE2W;RNF126
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3651352417518215,-1.2671400788607885,0.10869565217391304,0.5870562818184856,1.0,11/39,8.54%,ROBO1;TSPAN5;MAML2;ROBO2;NOS3;MAML3;NOTCH1;JAG2;NOTCH4;RBPJ;EPN2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.4698917358992596,-1.2667173650923982,0.2116788321167883,0.5852712301033828,1.0,3/13,9.99%,GRM3;ADGRV1;EDNRB
prerank,protein localization to centrosome (GO:0071539),0.5649954101622107,1.2659510097599727,0.18275418275418276,0.7411792632220139,1.0,5/17,15.08%,CSNK1D;GOLGB1;DCTN2;NUDCD3;PCM1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.43784410521924966,-1.2659337476048862,0.16872427983539096,0.5844036336832965,1.0,2/18,1.08%,ATP1A2;NEDD4L
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.462400430157294,1.265501270642846,0.1308108108108108,0.7417659638035446,1.0,22/74,17.25%,COL1A1;TIAM1;PHLDB1;TGFB3;TWIST1;LDLRAD4;SPRED2;WWTR1;TGFB2;BCL9L;SMAD4;TGFBR2;FOXA1;SMAD7;TGFB1I1;TGFBR1;DAB2;BMP5;IL6;IL17RD;CRB2;EFNA1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5954812613153109,1.2651218844772705,0.19505494505494506,0.7421282732222503,1.0,4/12,6.89%,IGFBP5;DOCK4;DOCK7;DOCK5
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.549757179976275,1.2647898661964245,0.1877444589308996,0.7423709384575481,1.0,2/19,0.50%,EXT1;XYLT1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.4662888875833946,1.2647261575387307,0.15300546448087432,0.7415163141103406,1.0,32/62,29.94%,NUP93;SEC13;STAT3;RAE1;SEH1L;PUM1;AGO1;NUP37;AGO2;EIF4G1;LIMD1;RANBP2;NUP88;POLR2F;POM121;NUP210;NUP62;POLR2B;NDC1;NUP35;IPO8;H3-3A;NUP85;POLR2H;NUP160;TPR;TNRC6A;FXR1;POLR2I;PUM2;NUP50;POLR2L
prerank,regulation of MAPK cascade (GO:0043408),-0.28497854134285006,-1.2645558814986273,0.0625,0.5848613982945127,1.0,28/157,6.71%,FLT1;IGF1R;TGFBR3;KSR1;INSR;LYN;ROCK2;LPAR1;TEK;PHLPP1;MAP4K4;PELI2;KIT;TNIK;LBH;JCAD;EPHA7;KDR;DAG1;CAV2;FAS;ROR2;TBX1;EPHA8;PAK3;ADRA2A;DUSP3;PAK5
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.537685576177154,1.2645187325866951,0.20024570024570024,0.7412301691187673,1.0,10/24,25.69%,TENT4B;ERCC4;TEN1;HNRNPC;TNKS2;XRN1;PARP1;HNRNPA1;HNRNPU;SLX4
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4552323165848459,1.264164721046074,0.12363238512035012,0.7414907922214715,1.0,16/70,16.49%,PLA2G4F;PLA2G4A;PEMT;CSNK2A2;CSNK2A1;LPCAT1;MBOAT2;LPCAT4;STARD7;GPAT4;PLA2G5;LPCAT3;PCTP;PLA2G12A;CHKB;PLA2G15
prerank,protein processing (GO:0016485),0.44143847413533704,1.2633750432364506,0.10740354535974973,0.7435229879920147,1.0,20/102,15.15%,ADAMTS3;PCSK5;F3;ECE1;PRSS12;CPZ;HM13;FXN;ADAM10;SPG7;MMP14;DDI2;OGT;BACE1;SDE2;MMP16;SPCS2;CASP1;CPXM2;PSEN2
prerank,negative regulation of DNA replication (GO:0008156),0.5907796668046442,1.2630803569502378,0.2099125364431487,0.743522007264349,1.0,9/13,30.54%,CDC6;CDAN1;GMNC;PDS5A;GTPBP4;S100A11;WAPL;ATR;RAD17
prerank,negative regulation of telomere maintenance (GO:0032205),0.5718564230607711,1.2625949324040608,0.20603674540682415,0.7443450927359634,1.0,8/15,27.05%,SMG6;ERCC4;ATM;RAD50;TNKS2;PARP1;SLX4;RTEL1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.52523981691142,1.2624044065512519,0.17472118959107807,0.7439835481185626,1.0,9/26,13.56%,FHL1;ATP1B1;NEDD4;STK39;ANK2;DLG1;WWP2;AKAP9;YWHAE
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.55323400663786,1.2623883262776636,0.19556714471968709,0.7429493561917611,1.0,7/18,17.53%,EDEM2;SYVN1;UGGT2;UGGT1;RPS27A;UBC;TRIM13
prerank,DNA modification (GO:0006304),0.5424110837640075,1.2621767294439687,0.18639798488664988,0.7426918357179288,1.0,7/22,16.22%,PARP3;MPG;OGG1;TDG;SMUG1;EXOSC4;PARP1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5467192552558354,1.262056927680015,0.19790301441677588,0.7420539357159762,1.0,7/20,6.98%,CACNA1C;ATP1B1;CAMK2D;CALM2;DMD;SLC9A1;ANK2
prerank,cellular response to heat (GO:0034605),0.5024577412514096,1.2619620368379545,0.18399044205495818,0.7413304174278534,1.0,9/35,17.54%,THBS1;BAG3;VCP;HIKESHI;RBBP7;YWHAE;STUB1;SUMO1;HMOX1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5904003460101789,1.2616671153385925,0.18050065876152832,0.7413632332603167,1.0,6/14,19.73%,PKD1;NFKBIB;G3BP2;MDFI;SUFU;NFKBIA
prerank,cellular response to peptide (GO:1901653),-0.3340049843478576,-1.2615671654361396,0.10309278350515463,0.5897974408747089,1.0,22/56,18.23%,IGF1R;GRM5;EPHA4;APP;CACNA2D1;VCAM1;CASP4;ARHGEF2;VIM;GRIN2A;SNX6;CAV1;ITGA4;IGF1;CACNB1;GRIN1;GPER1;ICAM1;NOD2;PTPN22;CACNA1A;XBP1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5360863933708392,1.261512729695212,0.19289340101522842,0.7409147169568688,1.0,7/22,16.86%,ATP1B1;CALM2;SLC9A1;ANK2;P2RY6;STAC3;CALM3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5927566270494758,1.2607077303126626,0.2122905027932961,0.7430153547620119,1.0,4/13,11.05%,BLOC1S2;RHOT2;RHOT1;VDAC2
prerank,negative regulation of cell junction assembly (GO:1901889),0.5340433103006479,1.2603558542437636,0.17045454545454544,0.7434239287792656,1.0,3/25,5.22%,THBS1;SLIT1;BCAS3
prerank,glycerolipid catabolic process (GO:0046503),0.5645478231061167,1.259702206834677,0.18170103092783504,0.7449632872112295,1.0,7/19,16.32%,MGLL;PLA2G4F;PLA2G4A;SMPD4;ABHD6;ENPP6;GDPD3
prerank,regulation of amyloid-beta formation (GO:1902003),-0.36908706158151705,-1.2594007031704417,0.09941520467836257,0.5923624369823767,1.0,6/34,6.42%,ROCK2;APOE;EPHA4;PICALM;ABCG1;GSAP
prerank,BMP signaling pathway (GO:0030509),0.4658022107660482,1.2593123493956173,0.13140311804008908,0.7454140960697736,1.0,15/62,12.49%,TMEM100;PDCD4;DDX5;SMAD9;SMAD6;TGFB3;TGFB2;ACVR1;SMAD4;NOG;BMP4;RUNX2;BMPR1A;SMAD7;RGMA
prerank,regulation of cell killing (GO:0031341),0.5786350755894515,1.2588890292173638,0.18542199488491048,0.7459862798191401,1.0,4/16,9.65%,CFH;TGFB2;FZD7;MAPK8
prerank,regulation of filopodium assembly (GO:0051489),0.4858920640438651,1.2587798310479716,0.1692126909518214,0.745288510991666,1.0,12/38,13.08%,PRKCD;ARAP1;RHOQ;DPYSL3;TGFB3;BCAS3;GAP43;TENM1;NRP1;MIEN1;NLGN1;ARHGAP44
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.42240708180465536,-1.2587134285260249,0.1829787234042553,0.591309713033754,1.0,4/19,4.57%,RIPOR2;CAMK1D;DNM1L;DAPK2
prerank,regulation of angiogenesis (GO:0045765),0.4308887646095726,1.2584943809587499,0.07243460764587525,0.7452993881025591,1.0,29/192,10.01%,BMPER;THBS1;SMOC2;PGF;RHOJ;HOXA5;VEGFA;F3;FGF2;PTGIS;EMILIN1;PROK2;ISM1;TWIST1;SPARC;CYP1B1;TGFB2;SERPINF1;SEMA3E;RAMP2;PRKCA;THBS2;SULF1;ANGPTL4;JUP;PAK4;STIM1;ANGPT4;AGGF1
prerank,negative regulation of RNA splicing (GO:0033119),0.553219382029478,1.2583364723413948,0.18617021276595744,0.7448259385506816,1.0,10/19,25.06%,SRSF6;PCBP4;PTBP1;U2AF2;SRSF7;SRSF10;SAP18;SFSWAP;SRSF4;C1QBP
prerank,pulmonary valve morphogenesis (GO:0003184),0.565925216476147,1.2581664560655241,0.21438263229308005,0.7444083855320112,1.0,8/17,12.13%,SLIT2;SMAD6;TGFB2;JAG1;HEYL;NFATC1;BMP4;HEY1
prerank,potassium ion transmembrane transport (GO:0071805),0.43457455740866546,1.2578185517803753,0.09420289855072464,0.7446411560196595,1.0,17/135,7.65%,KCNJ2;KCNJ15;KCNK5;SLC12A7;KCNB1;ATP1B1;SLC12A2;SLC24A3;HCN4;KCNN1;SLC9A8;SLC9A4;KCNE5;SLC9A1;KCNIP2;KCND1;SLC12A4
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5236922369181546,1.2574146280059346,0.1980319803198032,0.7451308140936967,1.0,6/26,9.84%,SMOC2;PRKCA;USP2;PKN2;CDC25B;FOXA1
prerank,protein glycosylation (GO:0006486),0.437303008287494,1.2573748222915193,0.10164271047227925,0.7442116786314986,1.0,23/125,11.18%,PLOD2;ST3GAL4;ST8SIA2;GALNT10;PGM3;GFPT1;PLOD1;PLOD3;B3GNT7;POGLUT1;B4GALT1;GFPT2;PMM2;ST3GAL2;B4GALT5;OGT;MGAT4B;FUT8;DOLPP1;GALNT18;NPC1;FUT4;TMEM165
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.5543789113115634,1.2573466613578734,0.2,0.7432480972034177,1.0,5/19,11.94%,GAS6;ZMIZ1;PRKDC;MMP14;CD27
prerank,cellular defense response (GO:0006968),0.48525560921381605,1.2573328475825984,0.16981132075471697,0.7422345619390908,1.0,4/40,4.23%,LSP1;LBP;SPN;TCIRG1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4666313606218007,1.2571278340557228,0.1605351170568562,0.7419765277830528,1.0,16/52,18.70%,EGFR;LRP1;PRKCE;EPHB2;PLS1;AGR2;DLG1;PDPK1;SQSTM1;ACSL3;STAC3;STX4;CNST;SPTBN1;CLN3;AKT1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.3682807352149823,-1.2567157341371067,0.1566265060240964,0.5934588127193657,1.0,10/37,6.79%,ALCAM;CADM1;IL1RAPL1;GRID2;VCAM1;PTPRD;TENM4;TENM3;CXADR;TENM2
prerank,regulation of cellular response to stress (GO:0080135),0.4393117585038635,1.256546993424138,0.1087866108786611,0.7431711393326438,1.0,54/115,31.20%,SLC38A2;NUP93;SEC13;CAMK2D;ATF4;RAE1;BAG3;ADCY8;CCAR2;SEH1L;HIKESHI;AKT1S1;SMG1;ABL1;ATM;NUP37;DNAJC7;CHORDC1;EIF4G1;YWHAE;MANF;RANBP2;NUP88;USP19;CREBBP;POM121;NUP210;CLN3;ARMT1;NUP62;NEK4;ABCD1;DNAJC2;NDC1;RPTOR;NUP35;FKBP4;AMFR;PINK1;VASH1;NUP85;NUP160;TPR;HSPB8;NEK6;HSF1;BAG1;ATR;DNAJB1;NUP50;PRKN;HSP90AA1;NUP188;HSPH1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4532200878046347,1.2562326519515012,0.11205976520811099,0.7433650474675938,1.0,22/78,19.98%,EGFR;PID1;LRP1;RHOQ;PRKCE;EPHB2;PLS1;PPFIA1;AGR2;MMP14;DLG1;PDPK1;CLTC;SQSTM1;DAB2;STAC3;STX4;SPTBN1;CLN3;AKT1;CDK5;APPL1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6180299698083639,1.2560275512536323,0.19562043795620437,0.742114526348341,1.0,1/10,0.75%,PRKCD
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6180299698083639,1.2560275512536323,0.19562043795620437,0.742114526348341,1.0,1/10,0.75%,PRKCD
prerank,nitrogen compound transport (GO:0071705),0.43194890632014543,1.2560173523359535,0.08700102354145343,0.7410942883683984,1.0,27/141,14.89%,SLC38A2;SLC38A1;SLC23A1;TMEM30B;SLC12A2;LMAN2L;SLC1A5;FLVCR1;ABCC1;RAMP2;RILP;LRRC8D;SLC7A10;HIKESHI;SLC6A2;SLC38A3;SLC43A1;RAMP1;RAB38;SLC25A47;LRP2;SLC1A4;PICK1;TOM1;CHMP3;ABCB6;MIA3
prerank,negative regulation of secretion (GO:0051048),-0.5042062132728549,-1.255947018094538,0.19407894736842105,0.5924762571598761,1.0,5/10,23.36%,NR1H3;CD74;ERBB3;PTGER3;NRG1
prerank,regulation of bone mineralization (GO:0030500),-0.33492996599099817,-1.2559281355933336,0.07476635514018691,0.5896160846766711,1.0,16/55,6.41%,PTN;WNT4;SLC8A1;ADGRV1;BMP6;OSR1;BMP7;ENPP1;KL;ANKH;SRGN;BCOR;ATP2B1;NOTUM;FBN2;S1PR1
prerank,microglial cell activation (GO:0001774),-0.4173330314537114,-1.2556143438301564,0.17269076305220885,0.5875885558524165,1.0,10/21,25.05%,APP;CX3CR1;CX3CL1;C1QA;SNCA;TYROBP;ITGAM;AGER;TREM2;GRN
prerank,cell-cell junction assembly (GO:0007043),-0.32476427360705307,-1.2553997973264952,0.0975609756097561,0.5853185654713499,1.0,18/63,9.52%,TJP1;TLN2;GJB6;CDH8;CDH5;CLDN5;EPB41L3;PKP4;GJB2;ARVCF;GJC1;GJD3;PIP5K1C;CDH6;CDH2;CDH7;CDH19;CDH20
prerank,response to molecule of bacterial origin (GO:0002237),0.4584539749087926,1.2551292102267118,0.13759479956663057,0.7435060610498382,1.0,18/69,18.91%,FOXP1;LBP;SMAD6;IRAK3;LIAS;FZD5;IRAK1;TAB2;F2R;SRR;PRDX3;CYP27B1;IL6;SIRT2;OTUD5;TRIM6;ACOD1;ERBIN
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5885544345718496,1.2547513889572133,0.2061711079943899,0.7438939141977573,1.0,4/12,9.01%,EPHB2;EPHB6;CHRNB2;B4GALT5
prerank,cellular response to retinoic acid (GO:0071300),-0.35256985876787056,-1.2547255911156299,0.15315315315315314,0.5842464232723007,1.0,9/42,6.52%,LYN;WNT5B;PTK7;WNT5A;WNT6;BRINP3;TBX1;BRINP1;BRINP2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3019684282010289,-1.2545064038182892,0.0,0.5819455876811968,1.0,33/138,9.38%,FLT1;IGF1R;PTPRG;MTSS1;INSR;LYN;PTN;TEK;KIT;EPHA4;EPHA7;TIE1;FRS2;IL31RA;KDR;NEDD9;PTPRD;PDGFRB;MPZL1;ROR2;EPHA8;BDKRB2;ERBB4;EPHA6;PDGFRA;MERTK;CSF1;FGFR4;FLT4;LIFR;BMPR2;ANGPTL1;NPR1
prerank,regulation of leukocyte activation (GO:0002694),-0.47355809342656197,-1.2539618747422936,0.17279411764705882,0.580573178339479,1.0,5/14,15.50%,LYN;MFHAS1;CD200;CD74;GPER1
prerank,protein mannosylation (GO:0035268),-0.4136072783965304,-1.2537919781330158,0.14479638009049775,0.5782970084690554,1.0,3/22,2.16%,TMTC2;TMTC4;CRPPA
prerank,gliogenesis (GO:0042063),0.5712684400407942,1.2536119185369672,0.20804438280166435,0.7472738898415758,1.0,4/15,9.70%,NFIB;TGFB2;CD9;ANXA1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.43995852462986523,1.253105063653033,0.10466321243523316,0.7482143569589197,1.0,20/118,9.71%,BMPER;PID1;EFNA5;FGF2;NEDD4;FMNL2;SRCIN1;PROK2;PHLDB1;ARC;SPARC;SIPA1L1;LZTS1;EPHB3;BCL9L;POGLUT1;CHRNB2;TANC2;PAK2;FGFR2
prerank,zinc ion transport (GO:0006829),0.541444167640765,1.253051388691829,0.2139240506329114,0.7473904799331987,1.0,8/21,17.32%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13;SLC39A3;SLC30A6;SLC30A9
prerank,cellular response to estrogen stimulus (GO:0071391),0.5724416804309558,1.2526726823890009,0.19515477792732167,0.7478435105133348,1.0,5/14,12.63%,BCAS3;RARA;SRA1;SFR1;SERPINB9
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5010682390438645,1.25234260554566,0.17883211678832117,0.7481078443094424,1.0,6/32,13.60%,CCL13;RNASE7;RNASE3;RNASE6;DEFB1;HMGN2
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.44031296413775356,-1.2521789963924155,0.18614718614718614,0.5796727799601106,1.0,4/15,11.93%,OSBPL8;PPARA;ABHD5;LPL
prerank,protein localization to organelle (GO:0033365),0.4359502728991092,1.2521332064833786,0.09259259259259259,0.7478462724591044,1.0,24/133,13.56%,SIX1;ZNF423;COL1A1;CNTLN;TSPAN10;EHD1;STX5;CSNK1D;TOPORS;LMNA;SIX4;DVL1;BBS9;SSB;IFT20;ANK2;GBF1;TRAM2;BMP4;PAQR3;CSRP3;CNEP1R1;ALDH3A2;YWHAE
prerank,non-motile cilium assembly (GO:1905515),0.5044946819226532,1.252022817881972,0.18002466091245375,0.7472381411954945,1.0,9/30,16.02%,GORAB;CSNK1D;TMEM107;TMEM216;RPGRIP1L;TMEM80;FUZ;PCM1;IFT88
prerank,lysosome organization (GO:0007040),0.49925227280914564,1.251900241297645,0.18765133171912832,0.7466526053525012,1.0,15/36,22.33%,ARSB;GAA;LAMTOR1;MBTPS1;NAGPA;TMEM106B;TMEM165;ABCA1;HPS4;ACP3;CLN3;SNAPIN;MYO7A;LRRK2;ZKSCAN3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5123666613450808,1.2518677455051828,0.17786069651741293,0.7457293399369023,1.0,5/27,4.29%,XYLT1;BGN;CHST11;CHPF2;CSPG4
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5634091998069495,1.2515187079049654,0.18532818532818532,0.7459975583940458,1.0,5/18,10.59%,PRKDC;TBX21;IKZF3;CRTAM;ABL1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3872094367278809,-1.2514790321018463,0.14871794871794872,0.5788012690757937,1.0,8/27,11.93%,PPARA;PRKCH;ABCG1;NR1H3;AGTR1;CSF1;ABCA5;LPL
prerank,protein deubiquitination (GO:0016579),0.42489775604740027,1.2513643549715026,0.05205205205205205,0.7455590606949514,1.0,113/242,30.65%,ESR1;IL33;PSMD7;USP24;VCP;USP2;PSMA8;SMAD4;OTUB1;USP50;TRRAP;MDM4;MBD6;FOXK1;ENY2;OGT;RHOA;INO80E;RHOT1;PSMA4;USP40;UCHL3;INO80B;WDR48;USP48;USP45;SMAD7;PSMD12;OTUB2;KAT2A;USP34;TRAF3;TGFBR1;USP11;PSMA6;STAM2;USP7;USP33;USP36;PSMD1;USP13;PSMC5;USP19;USP35;PSMD11;PSMC4;PSMD14;RPS27A;UBC;OTUD5;OTULIN;CDC25A;POLB;SHMT2;YOD1;SENP8;CDC20;USP32;USP10;HCFC1;USP46;ACTR8;USP1;UCHL5;ZRANB1;NFKBIA;TAF9B;OTUD6B;PSMA3;UCHL1;BRCC3;USP5;SMURF2;PSMB1;PSMD4;USP47;DESI2;BIRC3;PSMA5;CYLD;KAT2B;PSMA7;USP4;USP49;ASXL2;USP14;TP53;SNX3;CCP110;SUDS3;PSMC1;RIPK1;YY1;ATXN7;TAF10;MYSM1;USP21;USP16;PSMA1;USP22;USP37;USP30;TADA3;NLRP3;FOXO4;ADRM1;PRKN;OTUD3;PSMD2;USP26;SPATA2;KEAP1;COPS5
prerank,regulation of axonogenesis (GO:0050770),0.4715699611473815,1.251268345146084,0.1702857142857143,0.7449264939682028,1.0,9/51,9.53%,SLIT2;PLXNA4;TIAM1;TIAM2;GDI1;SIPA1L1;EPHB3;RHOA;PAK2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6210781224839755,1.2511545864385882,0.2056338028169014,0.7443330308513023,1.0,8/10,33.82%,DGKQ;OGT;USP7;GNMT;SELENOS;ZNF692;SIRT7;SDHAF3
prerank,neurogenesis (GO:0022008),0.48140662281861385,1.2509752812793156,0.16550925925925927,0.7439870683233515,1.0,10/43,15.84%,SIX1;CIT;SIX4;TGFB2;WDR62;DAGLA;ANXA1;DCHS1;THOC2;CXCR4
prerank,cellular protein localization (GO:0034613),0.42237907096757277,1.2506143818705704,0.035035035035035036,0.7443951500571486,1.0,102/285,25.74%,EGFR;SGSM2;CNTLN;ARFGAP3;CTTN;SEC31A;KIF13A;EHD1;TBC1D8B;TBC1D2B;STX5;SEC13;ARCN1;RAB43;PTPRU;TM9SF4;COPA;RAB24;STX11;AP2A1;RIC3;PACS2;DMD;RAB21;LAMTOR1;RIC1;TLK1;GGA2;ANK2;WIPI2;ARF4;COPZ2;SNX1;SH3PXD2B;NSF;SCFD1;STX2;VPS26A;ARFIP2;RAB38;CSRP3;ARF1;SNX9;AP3D1;TMED9;WDR11;USO1;EVI5L;TBC1D9B;TBC1D25;ERP29;PICK1;VIPAS39;CLTC;RAB23;TBCK;TBC1D10A;SIL1;STX4;ID1;COPB2;STX1A;SCFD2;TBC1D17;HDAC6;STX16;GGA1;NIPBL;SNX13;NAPA;TMED2;RAB5B;VPS45;SNX15;SEC23IP;RAB3GAP2;MYO7A;COX18;EVI5;TBC1D22B;TM9SF1;VPS26C;IFT27;FBLN5;LRRK2;RAB1A;RAB18;UNC50;RAB1B;COPZ1;RABGAP1;ARF5;USP4;TMED7;ATG9A;AP3B1;STX1B;PRRT1;LAMTOR2;FAM91A1;STX19;ATG13
prerank,negative regulation of cyclase activity (GO:0031280),-0.4622250839546471,-1.2505887238495605,0.2134387351778656,0.5782392089010501,1.0,3/14,9.99%,GRM3;ADGRV1;EDNRB
prerank,regulation of astrocyte differentiation (GO:0048710),0.5997001944561559,1.2500897288038961,0.20451339915373765,0.7453599343767388,1.0,6/12,15.26%,ID2;HES5;NOG;SERPINE2;CLCF1;IL6
prerank,canonical Wnt signaling pathway (GO:0060070),0.4585650361590482,1.2500606467013122,0.15577342047930284,0.7444376691429899,1.0,11/68,8.13%,LRP6;WNT9A;TCF7L2;SFRP4;PLPP3;LRP5;TCF7L1;DVL1;BCL9L;FZD7;FZD5
prerank,regulation of phosphatase activity (GO:0010921),0.5144564236822805,1.2500304749326054,0.2,0.7435385550118108,1.0,11/24,21.95%,PPP6R1;CDK5RAP3;TIPRL;PPP6R3;ZCCHC9;RIPK3;URI1;CHP1;PPP6R2;PPP1R35;PPP1R36
prerank,activation of protein kinase B activity (GO:0032148),-0.3775006660025175,-1.2498755245245536,0.15,0.5774015144115994,1.0,8/29,6.59%,INSR;OSBPL8;WNT5A;FGF1;CCDC88A;RICTOR;PPIA;ADRA2A
prerank,aminoglycan catabolic process (GO:0006026),0.515737917655527,1.2496297048887548,0.1733490566037736,0.7441315504757678,1.0,3/28,3.14%,GPC6;GPC3;SDC1
prerank,monocarboxylic acid transport (GO:0015718),0.46567378494963807,1.249606520389905,0.17042889390519186,0.7432243766808236,1.0,7/51,3.81%,SLC5A6;SLCO3A1;SLC16A9;SLCO2A1;SLC16A1;SLC26A6;RXRA
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5201437041518834,1.24927014513114,0.19254658385093168,0.7434865108584844,1.0,8/25,15.82%,VCP;CLPP;UGGT2;UGGT1;LONP1;NGLY1;STUB1;HDAC6
prerank,hepaticobiliary system development (GO:0061008),-0.4262338238772654,-1.2490740490691188,0.13901345291479822,0.5766663432986385,1.0,5/20,5.87%,TGFBR3;WNT4;ARID5B;LSR;PROX1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.559413433236426,1.24886644453826,0.20557029177718833,0.7440197615806022,1.0,9/16,21.66%,ANK2;GBF1;BCAP31;HSPA5;SEC16A;BCAP29;MIA3;SEC16B;LRRK2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.47543251434032324,1.2485912273173896,0.17435320584926883,0.744049545922338,1.0,12/48,15.19%,SLC26A2;AK5;PAPSS2;ADCY2;ADCY8;ADCY9;PANK4;DCAKD;ACAT1;AMPD3;GUCY2D;SLC35B3
prerank,arachidonic acid metabolic process (GO:0019369),0.4902276841515534,1.2485500746205964,0.18536009445100354,0.743166527072152,1.0,6/35,7.99%,MGLL;PTGIS;PLA2G4A;CYP1B1;PTGES2;DAGLA
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5177653088357423,1.2484158138679697,0.18610421836228289,0.7426328280443748,1.0,12/26,22.61%,KMT5C;OGT;SETD5;KMT2D;SETD4;WDR82;SUV39H2;SETD1A;TET2;SUV39H1;SETD2;KMT2A
prerank,regulation of histone modification (GO:0031056),0.5893692480711755,1.2480823134292223,0.20880681818181818,0.7428763186778565,1.0,9/13,31.49%,SETD5;NNMT;FLCN;AKAP8;MTHFR;PARG;IGF2;CDK9;UBE2N
prerank,acylglycerol catabolic process (GO:0046464),0.5051672780995466,1.2479861621368493,0.1964956195244055,0.7422128723031788,1.0,4/30,14.82%,MGLL;DAGLA;ABHD6;PNPLA3
prerank,regulation of cell growth (GO:0001558),0.4258477697549672,1.2478368219432725,0.054490413723511606,0.7417503962243057,1.0,48/204,17.72%,SLIT3;SLIT2;EGFR;FHL1;PLCE1;OSGIN2;CCN3;ACVR1B;PPP1R9B;PRDM11;CAMK2D;CSNK2A1;TGFB2;EIF4G2;FXN;DCUN1D5;LAMTOR1;CCAR2;SMAD4;ADAM10;MMP14;CXCL16;TMC8;PAK4;DACT3;SOCS2;NDRG3;SERTAD2;DCBLD2;ITCH;URI1;SESN2;TGFBR1;EIF4G1;INHBA;CGRRF1;RBBP7;SUPV3L1;SERTAD3;CYP27B1;EXOSC4;KLHL22;ERBB2;MINAR1;APBB1;NCBP1;FLCN;HDGFL2
prerank,histone acetylation (GO:0016573),0.4516398959648056,1.2477464976132873,0.16143011917659805,0.7410605209277775,1.0,30/69,23.44%,MORF4L2;TADA1;NAA60;MRGBP;NAA40;TRRAP;TADA2A;ING3;SGF29;KAT14;MORF4L1;BRPF3;ING5;KAT6B;TAF6;WDR5;KAT2A;PER1;ING4;CREBBP;APBB1;ATF2;BRD8;KAT7;YEATS2;KAT8;TAF6L;MEAF6;ZZZ3;KAT2B
prerank,histone H4 acetylation (GO:0043967),0.47235466461078807,1.2474952697336543,0.17545871559633028,0.740990002953739,1.0,23/47,23.26%,KANSL2;MORF4L2;NAA60;NAA40;TRRAP;ING3;MORF4L1;OGT;ING5;WDR5;PER1;ING4;APBB1;HCFC1;ATF2;BRD8;KANSL1;KAT7;MSL1;KAT8;KMT2A;MEAF6;ZZZ3
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.4315480180045942,1.2473516552980013,0.07388663967611336,0.740528369998177,1.0,68/185,25.78%,PKD1;ID2;ANAPC5;PSMD7;PPP1R9B;CSNK1D;CDC16;DYNC1H1;SFI1;PSMA8;ODF2;CDC14A;ALMS1;CDC6;DCTN2;PSMA4;CKAP5;UBE2C;PSMD12;ANAPC4;ERCC3;SDCCAG8;AKAP9;ZW10;CUL1;CEP164;CSNK1E;PSMA6;YWHAE;ERCC2;PSMD1;CEP41;CEP63;PCM1;ANAPC2;SIRT2;PSMC5;HAUS5;ANAPC1;PSMD11;PSMC4;PSMD14;RPS27A;UBC;ANAPC10;E2F1;CDC20;CDC27;CDK2;DYNC1I2;APPL2;APPL1;PSMA3;DCTN1;PRKACA;PSMB1;PSMD4;ACTR1A;CDK5RAP2;NEDD1;PSMA5;PSMA7;PLK4;CNTRL;RIOK2;TUBB4B;CCP110;PSMC1
prerank,actin filament polymerization (GO:0030041),0.5064327344070355,1.247213898978435,0.20024721878862795,0.7400612505611066,1.0,7/29,15.63%,PSTPIP1;GSN;COBL;TTC17;SPIRE2;MICALL2;WASHC3
prerank,regulation of protein phosphorylation (GO:0001932),0.42227022144475557,1.2469322719225873,0.044044044044044044,0.7401619267870001,1.0,45/256,12.60%,BMPER;SLIT2;PGF;EGFR;LRP6;PID1;SLCO3A1;VEGFA;EFNA5;PLCE1;GAS6;FGF2;CARD14;NTRK3;NTRK1;FGF17;PLPP3;EPHB2;CSNK1D;WWTR1;LIMK2;ATF4;XDH;MAVS;BRD4;ILK;PRKDC;RSPO1;NSD1;SOX9;AKT2;IMPACT;CDK5RAP3;BMP4;TMEM119;PAQR3;MUSK;ABL1;NIBAN1;AXIN1;ROPN1L;SOD1;PHIP;CHP1;SESN2
prerank,myofibril assembly (GO:0030239),-0.3422465580170818,-1.2465985750829542,0.1297709923664122,0.580116777233677,1.0,8/42,8.20%,ACTN2;TPM1;PGM5;PDGFRB;TMOD3;TMOD1;PDGFRA;LMOD1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5685148129240453,1.246549591918068,0.2267037552155772,0.7405942648199285,1.0,5/14,13.93%,ATP1B1;DMD;SLC9A1;CHP1;WNK1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.4790586365476233,1.2460777563567673,0.1788154897494305,0.7413837628672282,1.0,10/44,15.31%,GSN;CTTN;PRKCE;CDC42EP2;PFN2;SNX9;TENM1;CDC42EP5;SCIN;SPIRE2
prerank,positive regulation of heart rate (GO:0010460),-0.4333327355408554,-1.2453709870397942,0.19921875,0.5804932760174327,1.0,7/17,18.42%,PDE4D;TPM1;RYR2;EDN1;ADRA1A;SCN3B;KCNQ1
prerank,protein stabilization (GO:0050821),0.42702747028416227,1.2452226765764454,0.07621951219512195,0.7435757040866409,1.0,51/168,21.48%,RASSF2;PRKCD;ATP1B1;PLPP3;UBE2B;MORC3;P3H1;BAG3;HYPK;USP2;DVL1;RAB21;PER3;PFN2;PRKRA;ANK2;COA8;MDM4;SYVN1;TELO2;CHEK2;NAA16;SMAD7;NCLN;CHP1;PARVA;HSPD1;USP7;IFT46;USP33;SEC16A;USP36;HPS4;USP13;USP19;CREB1;HIP1;SUMO1;EFNA1;PEX6;HCFC1;CCT4;CCT6A;TAF9B;CALR;CLU;LAMP1;CCT8;TBRG1;MUL1;LAMP2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5259504762946965,1.2450529935324286,0.17884130982367757,0.743234778134253,1.0,8/27,15.24%,ID2;PPP1CC;USP2;PER3;BHLHE40;FBXL12;RBM4;PER1
prerank,GTP metabolic process (GO:0046039),0.5713974733541382,1.2448444346013614,0.20767195767195767,0.743017739244188,1.0,7/15,21.88%,RHOQ;AK3;RAB23;EFL1;ENTPD7;LRRK2;MFN1
prerank,regulation of multicellular organismal development (GO:2000026),-0.3914859660118172,-1.244832018099326,0.15934065934065933,0.5791838986197294,1.0,7/25,13.72%,INSR;PTN;SOX17;SPAAR;DUSP6;OAS2;RACGAP1
prerank,heart morphogenesis (GO:0003007),-0.3327490267399142,-1.2445254952423703,0.12931034482758622,0.5772258128873032,1.0,10/50,5.92%,TGFBR3;ENG;INSR;CHD7;NOS3;TBX3;NOTCH1;RYR2;TBX1;SOX17
prerank,cellular response to mechanical stimulus (GO:0071260),0.47645584403769387,1.2439309786383463,0.19020501138952164,0.7455176880163517,1.0,8/46,13.71%,PIEZO2;CRADD;SLC9A1;SOX9;MAPK8;LTBR;TNFRSF10B;CASP1
prerank,cardiac conduction system development (GO:0003161),0.531105077978044,1.2431908463840569,0.2052896725440806,0.747303083145867,1.0,6/24,12.13%,CACNA1G;HCN4;SMAD4;BMP4;BMPR1A;HEY1
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.39437934918766215,-1.2430557628877765,0.15454545454545454,0.5785874536828804,1.0,9/25,13.58%,ERRFI1;PPARA;CBLB;SLC6A9;CNRIP1;SNX6;SOCS5;ACE2;GPRC5A
prerank,ear morphogenesis (GO:0042471),0.5415873258664472,1.242778986549486,0.22151088348271447,0.7478229864722739,1.0,6/20,9.71%,SIX1;EPHB2;TWIST1;NOG;ZIC1;FGFR2
prerank,regulation of cytoplasmic transport (GO:1903649),0.5990440949511986,1.2427366813622005,0.21301775147928995,0.7469628194777265,1.0,5/11,21.66%,DNAJC13;ATP9A;USP7;CHMP3;LRRK2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.48419604148022555,-1.242568990316587,0.18604651162790697,0.5770876720181587,1.0,4/11,13.17%,ENPP3;SLC19A3;ERH;SLC19A2
prerank,negative regulation of endocytosis (GO:0045806),-0.4063487658786953,-1.2425000618461917,0.1358695652173913,0.5746742401017163,1.0,7/24,13.30%,MCTP1;PICALM;NR1H3;PACSIN3;CD300A;CAV1;PRKD1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5081090823689701,1.242428049708795,0.21046228710462286,0.7471206506025793,1.0,6/27,11.27%,DDX5;TWIST1;SPRED2;KMT5A;YJU2;ATM
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5773598666406407,1.2424194760847214,0.22375690607734808,0.7461483567235779,1.0,2/13,11.86%,PRKCD;SOD1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.49281713921852416,1.2423340817745876,0.19976359338061467,0.7455229385163514,1.0,9/36,13.20%,EGFR;CYGB;NPR3;DNM2;DDAH1;TERT;NOSIP;PIK3CB;S100A1
prerank,Golgi ribbon formation (GO:0090161),0.5795677075829466,1.2423062404877085,0.22934472934472935,0.7446452795227744,1.0,9/13,30.17%,TRIP11;STX16;GOLPH3;OPTN;VAMP4;GOLGA2;GCC2;PRMT5;VTI1A
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.6156377052340205,1.2420635112451592,0.21508379888268156,0.7445781962582019,1.0,2/11,2.25%,GSN;PRR7
prerank,lipoxygenase pathway (GO:0019372),-0.4533220707964486,-1.2412039112828648,0.19083969465648856,0.5755584161635121,1.0,4/14,12.79%,PON2;HPGD;ALOX12;GPX1
prerank,digestive tract morphogenesis (GO:0048546),0.5752415384248246,1.2409989715466627,0.2154255319148936,0.7475909448941185,1.0,4/14,9.71%,ID2;AGR2;EPHB3;FGFR2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.45156097393517713,-1.2409713716539934,0.18076923076923077,0.5736645055161325,1.0,4/15,8.06%,ALDH4A1;GGT5;GGACT;PRODH
prerank,cellular glucose homeostasis (GO:0001678),0.47682444622860676,1.2407308816636178,0.19653179190751446,0.7476347309465754,1.0,7/41,8.58%,SLC39A14;KCNB1;GAS6;UNC13B;ADCY8;LRRC8D;FOXK1
prerank,negative regulation of anoikis (GO:2000811),-0.4554774591787366,-1.240598167068689,0.20754716981132076,0.5720092607498805,1.0,5/14,15.88%,BCL2;NOTCH1;TLE1;CAV1;PTK2
prerank,cellular response to hypoxia (GO:0071456),0.4307348836435044,1.2399227199216907,0.1130524152106886,0.7496252234145547,1.0,45/126,24.52%,VEGFA;P4HB;PTGIS;TWIST1;PSMD7;LMNA;CARD16;PSMA8;MDM4;NDRG1;ANGPT4;RORA;PSMA4;HYOU1;TERT;PSMD12;PSMA6;LIMD1;UBQLN1;NDNF;PSMD1;STUB1;SIRT2;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;RPS27A;UBC;HIGD1A;PGK1;HMOX1;SUV39H2;NPEPPS;HIPK2;PSMA3;SUV39H1;PSMB1;PSMD4;PSMA5;PSMA7;TP53;BAD;PINK1
prerank,positive regulation of vasculature development (GO:1904018),0.4455534509392087,1.2399189486520816,0.13445378151260504,0.7486507297168267,1.0,17/94,10.01%,THBS1;SMOC2;PGF;VEGFA;F3;FGF2;PTGIS;TWIST1;CYP1B1;RAMP2;PRKCA;ANGPTL4;JUP;PAK4;STIM1;ANGPT4;AGGF1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.4128446066965303,1.2395317778773416,0.023,0.7491783657199166,1.0,131/417,22.38%,FOXP2;WWP1;FOXP1;ID2;ZFPM2;GAS6;ZNF423;FOXD1;TCF7L2;PDCD4;TWIST2;GCLC;LDB1;PHC2;PRICKLE1;MDFIC;PRDM5;NCOR2;GLIS2;TWIST1;DKK3;DEAF1;SHC1;PRDM11;TLE2;LHX9;HDAC9;RBFOX2;HDAC4;EIF4A2;SIX4;KMT5A;TRIM28;MIDEAS;CCAR2;SMAD4;ERN2;BHLHE40;HEYL;TBX21;EHMT1;MAEL;BTAF1;RARA;MBTD1;PA2G4;SOX9;DAP;RCOR3;FOXK1;SMARCC2;WWP2;EID2B;SBNO2;SPINDOC;ILF3;BMP4;PHC3;TSC22D4;SCMH1;RUNX2;FOXM1;ID4;COMMD7;KAT6B;SFPQ;KDM4A;NR1D2;HEY1;KHDRBS1;HDAC1;NPAS1;NACC1;MAP3K10;LIMD1;PIAS4;HEXIM1;ZNF148;RING1;VDR;YWHAQ;MBD1;L3MBTL2;ID1;PER1;ING4;SIRT2;HDAC6;FOXN3;NKX6-2;KDM5C;SUMO1;DPF3;NIPBL;L3MBTL3;MTA3;CBX5;CALCA;NR3C1;CDKN1C;MEN1;THAP7;CITED2;HMGA1;E2F1;SUV39H2;BIRC5;ZMYND11;CHD8;CBFA2T2;KLF10;MLXIPL;XRCC6;CDK5;SCML2;CALR;IKZF4;KAT7;SUV39H1;IL4;MPHOSPH8;SMURF2;YEATS2;SAMD11;SAP18;CRY2;USP47;ATP8B1;LOXL2;ZKSCAN3;KAT8
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.504158896829834,1.2392706103752253,0.20347394540942929,0.7491503878313491,1.0,8/26,17.97%,ST3GAL4;TKT;ST3GAL2;B4GALT5;GAL3ST4;B3GNT6;RRM2B;GOLPH3
prerank,epithelial cell differentiation (GO:0030855),0.4386642979843718,1.2391982884307402,0.14984059511158343,0.7484211290830993,1.0,22/88,18.88%,SIX1;VEGFA;FSTL1;ANXA7;ANXA4;JAG1;FZD7;AKT2;AKR1C1;ANXA1;BMP4;FGFR2;EHF;HDAC1;DHRS9;BDH2;DAB2;KDM6B;PGK1;DMBT1;AKT1;CNN3
prerank,icosanoid metabolic process (GO:0006690),0.4801002567521464,1.2387055534849731,0.18561484918793503,0.7492514659696872,1.0,7/40,10.33%,MGLL;PTGIS;PLA2G4A;CYP1B1;ABCC1;DAGLA;FADS1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5546066738453971,1.2382425113081192,0.2226775956284153,0.7499869640356367,1.0,3/15,4.29%,DSE;BGN;CSPG4
prerank,photoperiodism (GO:0009648),0.5178833362336086,1.238110842562715,0.17861635220125785,0.7495058097883462,1.0,8/28,15.24%,ID2;PPP1CC;USP2;PER3;BHLHE40;FBXL12;RBM4;PER1
prerank,endocardial cushion morphogenesis (GO:0003203),0.5460142388804714,1.238087036899342,0.21428571428571427,0.7486028800257591,1.0,10/18,12.13%,TGFB2;ACVR1;TGFBR2;HEYL;MDM4;SOX9;NOG;BMP4;BMPR1A;HEY1
prerank,regulation of anoikis (GO:2000209),-0.4183171066838223,-1.2380262230945707,0.17338709677419356,0.5759323795637545,1.0,8/19,21.48%,BCL2;NOTCH1;TLE1;CAV1;BRMS1;PTK2;SIK1;MCL1
prerank,regulation of transmembrane transport (GO:0034762),0.4958302829607002,1.2376302118591898,0.19474313022700118,0.749340241445048,1.0,3/31,1.35%,KCNJ2;KCNJ15;NEDD4
prerank,iron ion transport (GO:0006826),0.4697566063983297,1.2368098550236544,0.19310344827586207,0.7514193641631314,1.0,12/47,15.46%,SCARA5;SLC39A14;ATP6V1C2;TCIRG1;DNM2;ATP6V0A1;ATP6V0D1;ATP6V1B2;RAB11B;CLTC;ATP6V1E1;IREB2
prerank,peroxisome organization (GO:0007031),0.5176818056355077,1.2361296888355753,0.2073170731707317,0.7530185262298658,1.0,14/25,25.85%,ABCD3;PEX7;PEX11A;PEX16;PEX1;PEX10;TMEM135;SEC16B;PEX6;PEX2;ABCD1;PEX14;ACOT8;LONP2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5464990190865548,1.2361148598186467,0.22162883845126835,0.752092417770999,1.0,7/17,12.13%,ACVR1;JAG1;HEYL;NOG;BMP4;BMPR1A;HEY1
prerank,mitochondrial gene expression (GO:0140053),0.47127694323139263,1.2360935081445652,0.17073170731707318,0.7512100997779445,1.0,15/42,23.88%,MRPS2;MRPS28;NOA1;MRPS18B;MRPS14;MRPS17;FOXO3;TFB2M;PTCD3;TWNK;MRPL12;MRPL47;MRPS24;MRPS21;MRPS18A
prerank,positive regulation of axon extension (GO:0045773),0.5278341217643776,1.236045252609694,0.20078226857887874,0.7504166042681731,1.0,4/22,12.40%,NTN1;VEGFA;GOLGA4;NRP1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.4158275080066582,1.2356596714741723,0.039,0.7509614295451559,1.0,86/327,19.79%,BNC2;ESR1;SIX1;ZFHX3;ZNF423;VSX1;NFIA;LDB1;ZMIZ1;PRRX2;DMTF1;ACVR1B;JMJD1C;APBB3;WWTR1;SBNO1;BAZ2A;STAT3;TCF7L1;MLF2;ATF4;ERC1;CHD3;TCFL5;DNM2;PHF1;DVL1;CCAR2;NFX1;NFXL1;BHLHE40;FZD7;TRRAP;FUS;TBX21;RPS6KA4;NSD1;ESRRB;CARM1;SBNO2;RORA;OGG1;CRABP2;FADS1;ABL1;SPTY2D1;CHEK2;KAT6B;RNF14;SFPQ;NR1D2;TGFBR1;KMT2D;RALY;LIMD1;SERTAD3;USP13;FOXN3;NKX6-2;ZFPL1;CREBBP;APBB1;HMG20A;PRDM2;NFYA;NFKB2;MAGED1;NR3C1;THAP7;SRSF10;HMGA1;DAPK3;E2F1;RYBP;HCFC1;SUFU;BRDT;ATF2;GON4L;ACTR8;GPBP1L1;MLXIPL;TEAD2;ZNF431;WWC2;TCF3
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5277857209387672,1.2353678420909564,0.2247191011235955,0.7511428710045107,1.0,4/21,11.76%,RASSF2;DMD;PAQR3;SMAD7
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.6038589587892138,1.2352449521541424,0.2305433186490455,0.7506304241513001,1.0,7/11,16.00%,RSPO3;PLEKHA4;CSNK1D;LBX2;CSNK1E;DAB2;MLLT3
prerank,regulation of ATP metabolic process (GO:1903578),0.4646648920593807,1.2351298206305452,0.15188470066518847,0.7501051683282253,1.0,28/54,31.56%,NUP93;SEC13;RAE1;SEH1L;OGT;NUP37;RANBP2;NUP88;EIF6;SHMT2;PRKAG1;POM121;NUP210;NUP62;ABCD1;NDC1;COX7A2L;NUP35;PINK1;NUP85;NUP160;TPR;SPHK2;FIS1;NUP50;ZBTB7A;NUP188;ATP7A
prerank,chromosome organization (GO:0051276),0.43741313701705414,1.2345364663868779,0.158004158004158,0.7514008050819355,1.0,35/99,26.55%,TCF7L2;LDB1;TCF7L1;RAE1;PHF1;SAFB;EZH1;BRWD1;EHMT1;GPS1;HMGN1;CDAN1;CUL4A;CENPT;ABL1;HDAC1;LIG4;HMGN2;PARP1;RPS27A;UBC;HMG20A;GATAD1;CDT1;MTHFR;SUV39H1;COPS4;FAM50A;COPS7A;SMARCA4;HDAC2;H3-3A;COPS3;SETD7;XPA
prerank,regulation of cellular response to heat (GO:1900034),0.44402116293981403,1.2343445047530568,0.16775599128540306,0.751175785429332,1.0,37/77,31.20%,NUP93;SEC13;CAMK2D;RAE1;BAG3;CCAR2;SEH1L;HIKESHI;AKT1S1;ATM;NUP37;DNAJC7;CHORDC1;YWHAE;RANBP2;NUP88;CREBBP;POM121;NUP210;NUP62;DNAJC2;NDC1;RPTOR;NUP35;FKBP4;NUP85;NUP160;TPR;HSPB8;HSF1;BAG1;ATR;DNAJB1;NUP50;HSP90AA1;NUP188;HSPH1
prerank,tRNA aminoacylation (GO:0043039),0.4823569492962765,1.2339560434711534,0.18522860492379836,0.7516258356966322,1.0,12/37,20.24%,VARS1;WARS2;HARS2;PPA2;YARS1;DARS2;YARS2;EPRS1;PPA1;SARS2;SARS1;DARS1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.49000095039557245,1.2336888569040603,0.1896348645465253,0.7516478023863081,1.0,14/36,20.21%,EHMT1;RBBP8;PHC3;RNF2;RBBP7;RING1;L3MBTL2;TFDP1;CBX5;PCGF2;E2F1;RYBP;RAD51;MAX
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.41952251396744644,-1.2336560798356802,0.18269230769230768,0.5843504463016241,1.0,8/21,18.02%,EPHA7;GRIN2B;AIM2;SOX2;GRIN1;DELE1;PYCARD;MT3
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4817646889312796,1.2332512990919633,0.2073310423825888,0.7522952381575303,1.0,6/39,8.17%,THBS1;GAS6;PDCD4;RAMP2;NFE2L2;PAK4
prerank,sphingoid metabolic process (GO:0046519),0.5901880404442752,1.2328508525366355,0.23521505376344087,0.7528594172952581,1.0,3/12,6.19%,PLPP3;KDSR;PLPP1
prerank,synaptic vesicle recycling (GO:0036465),0.4961618305566546,1.2326000744231111,0.2096177558569667,0.7528338808295297,1.0,11/31,20.59%,STON2;SYT8;CEL;FCHO2;TBC1D24;STON1;SYNJ1;NLGN1;STX1A;CDK5;SYNJ2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4411451613334575,1.2325961283703761,0.14494264859228362,0.7518851661946856,1.0,30/86,22.72%,PLCE1;ARHGEF28;ARFGAP1;NTRK1;RDX;EPHB2;SHC1;ARHGAP17;TGFB2;EPS8L1;BCR;RAF1;LZTR1;OGT;MADD;FOXM1;SHOC2;ARHGAP44;STK19;SQSTM1;AKAP13;LRRC59;FLCN;ERBIN;RASGRF1;MAPKAP1;NUP62;DENND4B;DENND1A;SYNGAP1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.562616003534489,1.2325865190452783,0.22982216142270862,0.7509604658801078,1.0,9/15,26.76%,TSEN54;FAM98B;CLP1;CPSF4;RTCB;CSTF2;RTRAF;TSEN34;ERN1
prerank,inorganic cation transmembrane transport (GO:0098662),0.4126240437189943,1.2323568492268884,0.05911823647294589,0.7508537321471898,1.0,39/268,11.81%,SCARA5;SLC4A4;KCNJ2;CACNA1G;KCNK5;PKD1;CACNA1C;SLC39A14;KCNB1;ATP1B1;GAS6;SLC12A2;SLC24A3;HCN4;SLC4A8;SLC39A11;TRPV3;KCNN1;SLC9A8;SLC39A7;SLC4A11;SLC9A4;SCN11A;SLC9A1;SLC6A2;KCND1;TRPC4AP;TRPM7;TRPM4;SLC6A7;KCNK6;ITGAV;SLC30A5;SLC39A13;ATP6V0D1;TMEM165;ABCB8;TRPM6;NNT
prerank,negative regulation of cellular catabolic process (GO:0031330),0.45504935758830506,1.232350742683376,0.17951541850220265,0.7499289012098325,1.0,20/63,15.97%,TIMP2;PTPN3;TIMP3;STAT3;EIF4G2;RIC1;EIF4G3;DAP;FOXK1;CST3;CDK5RAP3;RGP1;TAB2;KDM4A;NELL1;EIF4G1;HGF;SIRT2;TLK2;KLHL22
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.431166849198221,-1.2321316509537075,0.19844357976653695,0.5854188777321279,1.0,6/16,15.33%,PARP14;ADIPOR1;SH2B3;INPP5F;CAV1;SOCS3
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4611017250304769,1.232126824500016,0.18468468468468469,0.7497528995282828,1.0,17/52,16.21%,SRSF6;DDX5;DDX17;RBFOX2;MBNL1;CELF4;THRAP3;CELF3;HNRNPL;MBNL2;RBM25;RBM5;KHDRBS1;PTBP1;RBM4;YTHDC1;ZC3H10
prerank,cellular iron ion homeostasis (GO:0006879),0.4599614723595641,1.231842610732193,0.17245240761478164,0.7498755561143817,1.0,14/55,15.46%,SCARA5;SLC39A14;FLVCR1;HMOX2;FXN;SMAD4;ACO1;ATP6V0D1;SOD1;CUL1;CYBRD1;ABCB6;FRRS1;IREB2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5985292756185251,1.2315473951390303,0.23333333333333334,0.7499650893282133,1.0,4/10,6.67%,NEDD4;PRKCE;CAMK2D;STK39
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.3780557435104981,-1.2311649328009728,0.17791411042944785,0.5853254875787122,1.0,6/30,7.84%,ROBO1;LPAR1;ARHGEF3;NET1;F11R;PRAG1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.518995556550765,1.2304298353836152,0.21658415841584158,0.7532217879638721,1.0,12/25,26.32%,LDB1;BRD4;CDK12;HEXIM1;ZMYND11;LARP7;NELFB;HNRNPU;CDK13;EAF1;RECQL5;NELFA
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5613120843668934,1.2303082004941908,0.2226775956284153,0.7527907477372583,1.0,2/15,2.48%,LRP6;GLI2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5216707754461802,1.2300961628772356,0.21105527638190955,0.7526222982993286,1.0,10/22,27.29%,NEDD4;MVB12B;TOM1L1;RNF115;UBAP1;PTPN23;UBAP1L;MVB12A;RNF126;VPS37B
prerank,eye morphogenesis (GO:0048592),0.5418702214495354,1.2298530452511356,0.23324396782841822,0.7525559801555377,1.0,5/19,7.28%,MFAP5;VEGFA;COL5A2;STAT3;SKI
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.47710354250962655,1.2297239674038687,0.17832167832167833,0.7520922969385178,1.0,18/41,26.42%,NUP93;SEC13;RAE1;SEH1L;OGT;NUP37;RANBP2;NUP88;EIF6;PRKAG1;POM121;NUP210;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5848106684586829,1.2295817028444032,0.236986301369863,0.7516698605952078,1.0,3/12,8.56%,IRS1;TWIST1;AKT2
prerank,mRNA metabolic process (GO:0016071),0.43621883637848125,1.2295357687499204,0.15031982942430705,0.7508844778839769,1.0,39/90,29.55%,DDX5;SRSF1;SRSF5;SRSF2;SSB;HNRNPA2B1;SRSF11;ZC3H12D;SF3B2;SF3A1;TBRG4;U2AF1;DIS3L2;SFPQ;METTL16;PCBP2;LSM2;PTBP1;U2AF2;PCF11;CNOT10;NCBP1;SRSF7;CPSF6;NCBP2;PRKACA;SNRPB;GEMIN2;SRSF4;PRMT9;TP53;ERN1;RIDA;SON;LSM5;HSF1;DXO;SF3B4;SNRPF
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5577579006873856,1.22942209196868,0.2378449408672799,0.7503459350026254,1.0,3/15,8.56%,IRS1;PRKCE;AKT2
prerank,positive regulation of biosynthetic process (GO:0009891),-0.3485850687703707,-1.2293723014953386,0.1310344827586207,0.5872134120961641,1.0,12/40,15.80%,SORBS1;WNT4;APOE;PPARA;SLC5A3;ZBTB20;VIM;MTPN;SUCO;ADGRB1;GRIN1;CREBL2
prerank,telomere maintenance via recombination (GO:0000722),0.5930810679823035,1.2293637654949716,0.2145922746781116,0.7496115988276857,1.0,9/11,31.99%,ERCC4;RAD50;TPRKB;SMC5;RAD51;XRCC3;SMC6;NSMCE2;ERCC1
prerank,histone H3-K4 trimethylation (GO:0080182),0.5854725817505133,1.2292953163717637,0.2345132743362832,0.7489139963522824,1.0,6/11,22.61%,OGT;KMT2D;WDR82;SETD1A;TET2;KMT2A
prerank,glycosaminoglycan catabolic process (GO:0006027),0.45617735739753645,1.2291168072514895,0.17991169977924945,0.748597751636672,1.0,8/55,6.94%,GPC6;FGF2;GPC3;BGN;SDC1;ARSB;CSPG4;SLC9A1
prerank,stress granule assembly (GO:0034063),0.5238460259132363,1.2287254386724364,0.22697795071335927,0.7490430577902922,1.0,7/20,21.61%,DYNC1H1;ATXN2L;UBAP2L;PRRC2C;CIRBP;EIF2S1;ATXN2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.42931986148776635,1.2284308694871995,0.14345114345114346,0.7492054269340405,1.0,28/113,18.14%,ESR1;TRABD2B;VEGFA;MPP7;UNC13B;CHD1L;IL5;VCP;CDC42EP2;USP50;SLF2;ERCC5;ERCC4;CUL4A;SPIDR;ATM;MED25;ERCC3;EIF4G1;ERCC2;ABCA1;STUB1;PSMC5;PARP1;PSMC4;SUMO1;CDT1;BID
prerank,negative regulation of growth (GO:0045926),0.4296414113953446,1.2284134821820345,0.12124352331606218,0.7483258143637064,1.0,26/121,17.28%,SLIT3;SLIT2;FHL1;OSGIN2;CCN3;ACVR1B;PPP1R9B;PRDM11;TGFB2;CCAR2;SMAD4;DACT3;NDRG3;SERTAD2;DCBLD2;ING5;SESN2;INHBA;CGRRF1;RBBP7;SERTAD3;CYP27B1;ING4;MINAR1;APBB1;FLCN
prerank,artery morphogenesis (GO:0048844),0.4996233341863348,1.227860395564716,0.2,0.7494633153073844,1.0,11/30,13.14%,VEGFA;LRP1;TGFB2;JAG1;NOG;BMP4;BMPR1A;SMAD7;NRP1;TGFBR1;LRP2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.4119891007201573,1.2275826560792686,0.04809619238476954,0.7495577639424225,1.0,132/314,30.24%,WWP1;ECRG4;NEDD4;ANAPC5;FBXL7;PSMD7;UBXN8;TOPORS;CDC16;COP1;UBE2B;VCP;DNAJB14;PSMA8;ERCC8;NFE2L2;FAF2;TBX21;HUWE1;SYVN1;WWP2;SHARPIN;PSMA4;ITCH;CUL4A;FBXL4;UBE2C;FBXL12;HSPA5;PSMD12;ANAPC4;CUL1;FBXL19;PSMA6;PCBP2;LTN1;RNF103-CHMP3;UBQLN1;FBXL14;PSMD1;KCTD5;ANAPC2;ARRB1;FBXO17;STUB1;SIRT2;FBXL20;PSMC5;ANAPC1;USP19;PSMD11;KLHL22;PPP2R5C;PSMC4;PSMD14;RPS27A;UBC;RNF121;YOD1;ANAPC10;TRIM13;KCTD17;CDC20B;UBE4A;FBXL18;GID4;DNAJC18;NPLOC4;CDC20;UBR2;CDC27;ZFAND2B;CDK2;FBXW4;UBXN4;UBE2G2;DCAF12;PCNP;RMND5B;PSMA3;UCHL1;DCAF11;SMURF2;RNF4;PSMB1;PSMD4;KCTD13;APPBP2;AREL1;ECPAS;DERL1;RNF216;PSMA5;PSMA7;SGTB;TAF1;HERPUD1;FBXO9;RNF122;AMFR;ANKRD9;TMEM67;SELENOS;DNAJB12;UBE2W;UBR3;PSMC1;RNF126;JKAMP;FBXO38;SEC61B;TMUB2;SEL1L2;PSMA1;DMAC2;DDB1;FAM8A1;STT3B;UBXN2A;UBE4B;FBXL8;RBX1;SPOPL;BTRC;UBR1;TMUB1;ZFAND2A;PRKN;ANAPC11;UBE2S;PSMD2;CTNNB1
prerank,lamellipodium organization (GO:0097581),-0.36344401016505273,-1.2273404274485578,0.15228426395939088,0.5900159015600926,1.0,11/29,8.76%,ABLIM1;CDH13;KIT;CCDC88A;PARVB;PTPRO;S1PR1;WHAMM;SPATA13;SPEF1;ARHGEF6
prerank,negative regulation of transferase activity (GO:0051348),0.49952807153414214,1.2272473015697787,0.2049079754601227,0.7498385159793394,1.0,10/28,24.30%,EIF4A2;ERCC4;ABL1;SMAD7;PRDX3;CDKN1C;MEN1;HNRNPU;NPRL2;TP53
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4776331934503857,1.2271243669626408,0.19347319347319347,0.7493622405126831,1.0,9/42,12.40%,MYOC;VEGFA;COL16A1;CD3E;S100A10;GFUS;JUP;ABL1;NRP1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5389682991196285,1.2270347983589351,0.22733245729303547,0.7487688455876105,1.0,3/19,4.54%,SMOC2;ADAMTS3;XDH
prerank,positive regulation of multicellular organismal process (GO:0051240),0.41282428900556273,1.22676675584281,0.04804804804804805,0.7488944552641105,1.0,58/308,13.07%,GNAS;SIX1;CMKLR1;BMP1;VEGFA;GAS6;LRP1;LBP;FGF2;FOXD1;IL33;COL1A1;TIAM1;GADD45G;GRB10;GHR;PEMT;ACVR1B;TGFB3;TWIST1;GLMN;WWTR1;LRPAP1;SIX4;TGFB2;DYNC1H1;TLE6;ACVR1;BCL9L;SMAD4;TGFBR2;ALMS1;KMT5C;EHMT1;SOX9;NOG;ESRRB;ADIPOR2;TSKU;TRPM4;B4GALT5;OGT;BMP4;CRTAM;TMEM119;VIP;PLAC8;TERT;BMPR1A;SOD1;KAT2A;TGFB1I1;TGFBR1;AGO2;SMO;NLGN1;INHBA;F2R
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.42634297755143097,-1.2266432991747975,0.17557251908396945,0.5891440589803522,1.0,5/18,6.42%,ROCK2;EPHA4;PICALM;ABCG1;GSAP
prerank,skeletal muscle tissue development (GO:0007519),0.4983220154672154,1.2265902194408433,0.20506634499396864,0.7486018116781541,1.0,5/32,10.81%,SIX1;SIX4;SKI;SELENON;CSRP3
prerank,nerve growth factor signaling pathway (GO:0038180),0.6027054545149891,1.2264641089752761,0.22714681440443213,0.7481637913053842,1.0,2/10,4.63%,NTRK1;KIDINS220
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.4404690660742578,1.2264421397853031,0.16276595744680852,0.7473369157458504,1.0,29/84,23.58%,ECRG4;ANAPC5;PSMD7;CDC16;PSMA8;PSMA4;UBE2C;PSMD12;ANAPC4;PSMA6;PSMD1;ANAPC2;PSMC5;ANAPC1;PSMD11;PSMC4;PSMD14;RPS27A;UBC;ANAPC10;CDC20B;CDC20;CDC27;CDK2;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7
prerank,cilium organization (GO:0044782),0.419406826065196,1.225998387765523,0.07250755287009064,0.7480956162391164,1.0,79/210,26.29%,PKD1;GSN;CFAP298;EXOC4;EHD1;ABLIM3;PKHD1;DYNLT2B;RILP;ARMC9;MNS1;BBS9;ODF2;CDC14A;TMEM107;RAB8A;IFT20;GBF1;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;RFX2;TCTN1;IFT80;IQCB1;TMEM216;CCDC66;ATP6V0D1;CFAP43;PTPDC1;WDR11;CEP164;PARVA;TRAPPC14;OCRL;BBS5;TTC17;IFT46;MARK4;RAB23;FUZ;NUDCD3;CEP41;PCM1;HDAC6;IFT88;NPHP3;INPP5E;TTLL3;LZTFL1;DYNC2I1;IFT43;CCDC57;TEKT2;TMEM237;PTPN23;TTC29;KIF24;RAB1A;TMEM231;TXNDC15;SPAG16;FAM161B;BBIP1;PLK4;CEP89;DYNC2H1;TCTN3;TMEM67;TMEM138;BBS7;CEP20;FBF1;CCP110;EXOC7;INTU;ACTR2
prerank,sensory perception of light stimulus (GO:0050953),0.43896327683446174,1.2259150470603635,0.1459227467811159,0.7474824714726097,1.0,7/87,6.91%,SLC4A10;COL11A1;COL1A1;PDE6C;PITPNA;CRYZ;CHRNB2
prerank,organophosphate ester transport (GO:0015748),0.5123658842702083,1.2258449684028143,0.2138442521631644,0.7467889797938068,1.0,5/24,4.74%,TNFAIP8L3;PITPNC1;PRELID3B;PITPNA;PITPNM1
prerank,cardiolipin metabolic process (GO:0032048),0.5673975569954447,1.2256595009259559,0.2356948228882834,0.7465962491520339,1.0,5/13,15.86%,PLA2G4A;TAMM41;PGS1;PLA2G5;PLSCR3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.4308639255167298,1.2250845847484764,0.122533748701973,0.7478213370692873,1.0,29/110,18.40%,TRABD2B;VEGFA;MPP7;GSN;HJURP;MAPK15;VCP;CDC42EP2;ANKRA2;TMC8;PEX5;RAF1;SLF2;IAPP;IMPACT;SPIDR;LCMT1;HSPA5;NCLN;ABCA1;PREB;FARP2;TFIP11;HDAC6;SUMO1;NAPA;CDT1;BID;HCFC1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.5560146926159221,1.2250808910804798,0.23715415019762845,0.746918183142065,1.0,12/16,32.97%,MCMDC2;MCM2;WRN;MCM4;HMGA1;RAD51;TWNK;RECQL5;MCM7;SSBP1;BLM;PURA
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4475903905772195,1.2246722687777716,0.1532608695652174,0.7475393171606144,1.0,24/73,24.52%,EGFR;VEGFA;GAS6;NTRK3;DOCK7;PFN2;RAF1;AXIN1;TENM1;AKAP9;EIF4G1;IL6;HDAC6;ARAF;TRIM6;CNOT9;AKT1;TNKS1BP1;MAD2L2;ATP2B4;CAMK1;RPTOR;TBK1;PINK1
prerank,regulation of epithelial cell migration (GO:0010632),0.46382964352071193,1.2244912093327285,0.19777777777777777,0.747312613094324,1.0,8/51,8.24%,BMPER;RHOJ;PRKCE;ARSB;TGFB2;PFN2;DOCK5;SOX9
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.4043796184398223,1.2240274886243017,0.0,0.7480130056228157,1.0,457/1645,22.68%,TBX15;FOXP2;PLAGL1;BNC2;ESR1;EGFR;LRP6;SIX1;WWP1;FOXP1;KLF12;ZBTB7C;ID2;PRRX1;ZFHX3;HOXA5;ZFPM2;VEGFA;HIVEP3;PBX3;GAS6;NFIX;FGF2;HOXA3;ZNF423;FOXD1;NFIB;TCF7L2;PDCD4;COL1A1;TWIST2;ELF4;VSX1;DDX5;GCLC;HOXB6;MKX;SMAD9;NFIA;DDX17;ZIM3;ZFHX4;SMAD6;LDB1;ZMIZ1;PHC2;PRRX2;PRICKLE1;JDP2;GLI2;MDFIC;PRDM5;TCF20;DMTF1;LRP5;NCOR2;ACVR1B;GLIS2;TGFB3;TWIST1;JMJD1C;DKK3;APBB3;HOXC6;DEAF1;SHC1;PRDM11;TLE2;LHX9;HDAC9;SP140;CUX1;RBFOX2;NFAT5;HDAC4;CAMK2D;STAT5A;SIX5;ELF1;MAP3K5;HOXB3;RXRA;ONECUT2;MEOX2;MED13L;WWTR1;SBNO1;BAZ2A;HES5;TCEA2;KLF5;SIX4;STAT3;ZBTB25;ANXA4;TCF7L1;ZNF250;TARBP1;KMT5A;MLF2;ATF4;CCNL2;ERC1;TRIM28;MAMSTR;ZFP14;NR2F1;CHD3;TCFL5;GMEB1;TADA1;DNM2;PHF1;ACVR1;BRD4;DVL1;FOXC2;ILK;ZNF25;MIDEAS;CCAR2;RXRB;NFX1;LBX2;NFXL1;GPATCH3;SAFB;SMAD4;ERN2;MRGBP;NFE2L2;BHLHE40;HMGB1;PKNOX2;MEF2B;FZD7;ZNF471;TRRAP;RFX7;TADA2A;E2F3;FUS;TASP1;PBX1;TSHZ2;CREG1;MEIS3;BRWD1;MED27;ZNF691;HEYL;TBX21;THRAP3;MDM4;EHMT1;RPS6KA4;HOXA9;HOXA6;PURG;MAEL;CCNL1;BTAF1;IKZF3;MED31;RARA;NSD1;FOXJ3;MBTD1;MED13;PA2G4;SOX9;SRA1;ESRRB;DAP;TFE3;RCOR3;BRD3;FOXK1;ENY2;ZNF76;CDC6;CARM1;DGKQ;NFATC1;FOXL1;SMARCC2;RFX2;SLTM;WWP2;OGT;EID2B;PSIP1;RBBP8;ZIC1;SBNO2;SPINDOC;RORA;OGG1;ILF3;BMP4;SFR1;PHC3;CRABP2;FOXA1;TSC22D4;ING5;ZBTB2;UBP1;SCMH1;CSRNP1;ZFP90;SREBF1;EHF;CHUK;RUNX2;ZNF260;FADS1;KDM2A;URI1;FOXM1;ABL1;ZIC4;SPTY2D1;RFX5;CCNT2;PHF8;POU6F1;PITHD1;SETD5;MAP3K12;ID4;NFE2L1;NRF1;HSF4;AXIN1;CHEK2;MAZ;COMMD7;KAT6B;NEUROD2;KDM5B;RNF14;TAF15;NAA16;SFPQ;FOXO6;SMAD7;PHIP;FOXP4;SRF;KDM4A;NR1D2;HEY1;GLIS1;TENM1;KAT2A;ZNF112;TGFB1I1;KHDRBS1;TGFBR1;FBXL19;HDAC1;MEF2D;ZMIZ2;CDC45;HSPD1;HOXB4;ZNF740;INHBA;BAZ2B;F2R;CD80;MYPOP;MAPRE3;HR;ARID4B;KMT2D;NPAS1;MEF2A;NACC1;MAP3K10;RUNX1;NFATC3;ZBTB9;NDP;HOXA4;ERF;LIMD1;TIAL1;PIAS4;HEXIM1;ZNF148;RING1;HNRNPK;MMS19;SERTAD3;EN2;VDR;BRD2;ZKSCAN1;USP13;MED21;MAFG;YWHAQ;MBD1;L3MBTL2;TFDP1;ID1;PER1;IL6;ARRB1;ING4;GRHL1;SIRT2;BRD9;PSMC5;CAMK4;FOXO3;HDAC6;FOXN3;NKX6-2;NFE2;CREB1;MLLT3;ZFPL1;CREBBP;MED26;ERBB2;KDM5C;AATF;APBB1;HMG20A;KMT2B;SUMO1;HOXA2;DPF3;NIPBL;PRDM2;L3MBTL3;MTA3;NFYA;CBX5;CALCA;NFKB2;KLF3;MAGED1;NR3C1;RFXANK;E4F1;MED14;CDKN1C;MEN1;LCOR;ZKSCAN7;THAP7;HDGFL2;SRSF10;CITED2;HMGA1;ELP4;DAPK3;CDT1;MED12;E2F1;SUV39H2;CC2D1B;RYBP;HCFC1;BIRC5;ZMYND11;SUFU;HOXC5;BRDT;ZBTB32;AKT1;ZSCAN20;ATF2;GON4L;CHD8;ACTR8;GPBP1L1;CBFA2T2;HIPK2;KLF10;CRK;HOXB2;MLXIPL;SAFB2;FOSL2;CC2D1A;QRICH1;TEAD2;XRCC6;IRF3;CBFB;NR3C2;ZNF431;VEZF1;WWC2;TCF3;CDK5;SCML2;NFATC4;BICRAL;MAP2K3;ATF6;MAX;BPTF;CALR;IKZF4;KAT7;MRPL12;ZBTB24;HOMEZ;HOXC8;SUV39H1;MAD2L2;KLF9;NUP62;IL4;ATP2B4;ZKSCAN5;MPHOSPH8;SMURF2;MAP2K7;YEATS2;RNF4;MED20;BCL11B;SMAD5;NEK4;SAMD11;CHD2;SAP18;NFIC;CEBPD;NR2F6;CRY2;ELP3;ZBTB40;DNAJC2;USP47;TGFBRAP1;ATP8B1;LOXL2;ZNF18;ZNF177;SS18L1;ZKSCAN3;KAT8;NR2C2;CDK5RAP2;KDM3B;MNT;KMT2A;TFCP2;PEX14
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4419310196894953,1.2240008383514491,0.15059588299024917,0.7462777088326148,1.0,27/78,20.53%,SEC31A;SEC24D;SEC13;SEC23A;DYNC1H1;AP2A1;RILP;DNM2;KLC2;FCER1G;DCTN2;ARF1;DYNC1LI2;SEC24C;AP2A2;SEC24B;LAG3;CLTC;KLC1;DCTN5;SEC24A;ACTR1B;ACTR10;DYNC1I2;DCTN1;CLTA;CAPZA1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4419310196894953,1.2240008383514491,0.15059588299024917,0.7462777088326148,1.0,27/78,20.53%,SEC31A;SEC24D;SEC13;SEC23A;DYNC1H1;AP2A1;RILP;DNM2;KLC2;FCER1G;DCTN2;ARF1;DYNC1LI2;SEC24C;AP2A2;SEC24B;LAG3;CLTC;KLC1;DCTN5;SEC24A;ACTR1B;ACTR10;DYNC1I2;DCTN1;CLTA;CAPZA1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.595380018806539,1.2233522090963482,0.24393723252496433,0.7477078470812274,1.0,4/10,8.69%,EMILIN1;FAP;TNFRSF1B;CST3
prerank,cellular biogenic amine catabolic process (GO:0042402),0.605111194108324,1.2232994397433514,0.23098591549295774,0.746988705792351,1.0,4/10,12.83%,LRTOMT;CHDH;HNMT;SMOX
prerank,myelination (GO:0042552),0.4673379848508231,1.2229136925872466,0.1928406466512702,0.7475008194034741,1.0,18/46,22.79%,MYOC;LGI4;ACER3;MARVELD1;PMP22;HES5;SKI;B4GALT5;PLP1;SIRT2;CXCR4;NF1;SCN8A;ACSBG1;BCAS1;ARHGEF10;ABCD1;GPC1
prerank,regulation of monooxygenase activity (GO:0032768),0.5146369274790336,1.2224954614739167,0.2222222222222222,0.7481043967282156,1.0,8/23,18.74%,EGFR;CYGB;DNM2;DDAH1;NOSIP;VDR;AKT1;GDNF
prerank,cellular response to leucine starvation (GO:1990253),0.6015786369852875,1.2223108171730328,0.25872093023255816,0.7479020496778466,1.0,5/10,19.92%,GCN1;SESN3;IMPACT;SESN2;EIF2AK4
prerank,autophagy of peroxisome (GO:0030242),0.5892746746662287,1.2221209188092563,0.24432576769025366,0.7476485468381391,1.0,6/12,22.04%,NBR1;PEX5;ATM;SQSTM1;RB1CC1;ACBD5
prerank,response to nutrient levels (GO:0031667),0.5425745741771026,1.2220443368179028,0.23328964613368283,0.7470045901331062,1.0,3/17,5.08%,KCNB1;ATF4;MEAK7
prerank,positive regulation of rRNA processing (GO:2000234),0.5923472775295235,1.2216037766943932,0.2582496413199426,0.747644197061779,1.0,9/10,38.91%,RIOK1;WDR75;BUD23;RIOK2;TRMT112;SIRT7;UTP15;DIMT1;WDR43
prerank,positive regulation of phospholipid transport (GO:2001140),-0.48538391275080417,-1.2212547467801957,0.2425249169435216,0.6004608654942296,1.0,1/10,1.38%,APOE
prerank,RNA processing (GO:0006396),0.4171983196425995,1.2210296182254639,0.10574018126888217,0.748832746708214,1.0,67/176,25.11%,DDX17;HNRNPH1;TSEN54;SRSF1;NOL3;SRSF5;PPP1R9B;MBNL1;RBM39;DUSP11;M1AP;SRSF2;TENT4B;SNRNP48;CCAR2;FUS;HNRNPA2B1;YJU2;SRSF11;CELF3;LUC7L3;HNRNPL;CDK12;SF3B2;SF3B1;SF3A1;SNRNP25;SRRM1;U2AF1;RBM6;RBM5;PABPN1;SFPQ;ZRSR2;PTBP1;RBM4;HNRNPC;U2AF2;SRPK1;CLP1;HNRNPK;TFIP11;SCNM1;TUT7;NCBP1;SRSF7;CPSF6;NCBP2;SYNCRIP;HNRNPH3;PRKACA;ZCCHC8;TENT2;DHX8;SNRPB;GEMIN2;SRSF4;DHX16;TSEN34;PPIG;PRMT9;HNRNPU;PABPC4;RBM3;PPP2CA;SNRNP35;DDX39B
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5819630131242296,1.2208460346246433,0.2378917378917379,0.748702455975686,1.0,4/12,8.87%,CACNA1C;JUP;DLG1;TRPM4
prerank,chromatin remodeling (GO:0006338),0.4325140078636006,1.2203390683329325,0.14764397905759163,0.7497686926741735,1.0,39/100,26.75%,ESR1;HDAC4;BAZ2A;CHD1L;CHD3;EZH1;TADA2A;SOX9;SMARCC2;FOXA1;INO80B;KDM5B;PBRM1;KDM4A;KAT2A;HDAC1;BAZ2B;HNRNPC;KDM5C;KDM6B;GATAD1;SMARCAD1;SUV39H2;HCFC1;BRDT;CHD8;ACTR8;MPND;BPTF;TOP1;TAF6L;KAT2B;CHD4;SMARCA4;SRCAP;HDAC2;DAXX;ARID1A;MYSM1
prerank,substrate-dependent cell migration (GO:0006929),0.5714073666602766,1.2202827010793178,0.23381770145310435,0.7490557031446444,1.0,2/14,0.90%,NTN1;ITGA11
prerank,regulation of inclusion body assembly (GO:0090083),0.5955616675051263,1.2201879288515516,0.2672998643147897,0.7485087748878752,1.0,2/11,4.35%,HSPA2;SNCAIP
prerank,negative regulation of immune effector process (GO:0002698),-0.4477845655635648,-1.2200136224697549,0.20967741935483872,0.6009108332233164,1.0,6/13,19.63%,ENPP3;CD300A;HAVCR2;CD55;CD47;RPS19
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.45430604581810313,-1.219750878813892,0.18867924528301888,0.5990368037082066,1.0,4/14,11.94%,MOXD1;ALDH9A1;NOS1;SLC22A2
prerank,regulation of DNA replication (GO:0006275),0.4593818655796639,1.2190734544430393,0.1963677639046538,0.7515948295034863,1.0,23/49,30.61%,EGFR;GLI2;SMC3;RBBP6;CDC6;BRPF3;CDAN1;CDT1;GMNC;KAT7;PDS5A;GTPBP4;PPP2CA;S100A11;EHMT2;ESCO1;PPP2R1A;USP37;WAPL;ATR;CTC1;RAD17;GLI1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.5003719120561607,1.2189925800389834,0.22073170731707317,0.7510057783831058,1.0,17/29,34.40%,CHD1L;ERCC5;CUL4A;ERCC3;ERCC2;PARP1;RPS27A;UBC;GTF2H4;XPA;DDB1;RBX1;RAD23B;RPA3;CUL4B;CCNH;CETN2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.3122968158981507,-1.2189898292888148,0.08045977011494253,0.5983920855300072,1.0,13/66,6.89%,ROBO1;TGFBR3;MTSS1;MCC;NR2F2;APOE;CDK6;B2M;STAT1;CAV2;DUSP10;AQP11;PTPRK
prerank,phagosome acidification (GO:0090383),0.5053445808995845,1.218625613809152,0.228643216080402,0.7514588724169057,1.0,10/26,25.08%,ATP6V1C2;TCIRG1;ATP6V0A1;RAB38;ATP6V0D1;ATP6V1B2;ATP6V1E1;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,chromosome condensation (GO:0030261),0.4769209862073842,1.218567644636807,0.2026221692491061,0.7507730084926388,1.0,10/36,18.12%,SMC4;CSNK2A2;CSNK2A1;KMT5A;ERN2;MCPH1;PHF8;AIFM1;ACIN1;DFFB
prerank,lytic vacuole organization (GO:0080171),0.49592415576210924,1.2185401222482033,0.2281134401972873,0.7499999866979955,1.0,14/32,22.33%,ARSB;GAA;LAMTOR1;MBTPS1;NAGPA;TMEM106B;ABCA1;HPS4;ACP3;CLN3;SNAPIN;MYO7A;LRRK2;ZKSCAN3
prerank,positive regulation of neurogenesis (GO:0050769),0.4479426762513726,1.2184455880153167,0.17876489707475623,0.7494250933779835,1.0,8/68,4.55%,SLIT2;PLXNA4;VEGFA;TIAM1;TIAM2;CUX1;FBXW8;SERPINF1
prerank,tRNA modification (GO:0006400),0.44976896612552403,1.2184123274343475,0.1858108108108108,0.7486531464562597,1.0,24/62,26.16%,TRMT61B;TARBP1;SSB;ANKRD16;ELP5;TRMT1;PUS3;TRUB1;ALKBH1;TYW3;CTU2;THADA;TPRKB;THUMPD3;TRMT44;TRMT6;ALKBH8;TRMT61A;METTL1;NSUN6;PUS1;MTO1;PUS10;TRMT112
prerank,negative regulation of cell projection organization (GO:0031345),-0.34022007600537657,-1.2181114062599787,0.12280701754385964,0.5981871203815892,1.0,10/48,7.84%,EFNB2;LPAR1;APOE;EPHA4;RAPGEF2;PTPRO;PTPN9;GRIN2B;DCC;PRAG1
prerank,negative regulation of protein polymerization (GO:0032272),0.5011211907179407,1.2180220567986666,0.23739237392373924,0.7492101544317082,1.0,2/27,0.75%,SLIT2;PRKCD
prerank,regulation of dendrite development (GO:0050773),-0.3387365750405168,-1.2177598321951928,0.16981132075471697,0.5965921048136102,1.0,16/37,16.04%,PTN;NEDD4L;CSMD3;BMP7;TNIK;HECW2;CAMK1D;DCC;VLDLR;MFSD2A;ADGRB3;SEMA4D;SARM1;LRP8;RTN4IP1;CDKL5
prerank,nucleic acid metabolic process (GO:0090304),0.4398925511109409,1.2175705913976949,0.18073593073593072,0.7499355130171826,1.0,32/69,28.86%,HNRNPH1;RBFOX2;DUSP11;HNRNPA2B1;HNRNPL;HNRNPH2;WRN;GTF2F1;KPNA2;RAD50;HNRNPM;PCBP2;PTBP1;HNRNPC;HNRNPK;MMS19;POLR2F;NCBP1;NCBP2;ATXN2;HNRNPA3;HNRNPA1;POLR2B;TOPBP1;HNRNPU;RECQL5;METTL14;POLR2H;POLG;DNASE1L2;POLR2I;DXO
prerank,regulation of hemopoiesis (GO:1903706),-0.4967851837698418,-1.2174437603386623,0.26101694915254237,0.5949592068911739,1.0,4/10,10.56%,PTN;PRKCB;MAFB;IL17D
prerank,synaptic membrane adhesion (GO:0099560),0.5702912069432265,1.2172298944564872,0.23972602739726026,0.750247249158073,1.0,4/14,4.89%,GPC6;PTPRS;PTPRF;LRFN4
prerank,regulation of superoxide anion generation (GO:0032928),0.558992220951965,1.2169259741008973,0.25170998632010944,0.7504830174799734,1.0,3/14,16.42%,PRKCD;SOD1;AATF
prerank,production of siRNA involved in RNA interference (GO:0030422),0.5961349629216531,1.216770416923806,0.24857142857142858,0.7501922348517829,1.0,4/10,16.67%,PRKRA;TERT;AGO2;TSN
prerank,positive regulation of phospholipase activity (GO:0010518),0.5183642300664136,1.216677686868682,0.2266500622665006,0.7496453146003362,1.0,8/22,11.57%,ESR1;FGF2;NTRK3;FGFR1;ARF4;FGFR2;PLA2G5;PDPK1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5478899593593818,1.216619310839513,0.2483130904183536,0.7489696652780239,1.0,8/16,23.20%,SCD5;CBR4;PPT2;ACAT1;ACACA;HSD17B8;GCDH;PPCS
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5724596829066753,1.2164351670211269,0.23695345557122707,0.7487542262815557,1.0,1/13,0.97%,GAS6
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4386229479784096,1.2160171014302494,0.19243243243243244,0.7493187335434354,1.0,26/72,24.64%,PLAGL1;MUC1;CRADD;MDM4;NDRG1;CARM1;PCBP4;FOXM1;ATM;CHEK2;SESN2;TFDP1;ING4;CNOT8;CNOT10;RBL2;E2F1;USP10;CNOT9;HIPK2;TNKS1BP1;SFN;TRIAP1;PRMT1;TP53;RPS27L
prerank,negative regulation of angiogenesis (GO:0016525),0.43514206381329257,1.2153263726212582,0.16773504273504272,0.750976753072291,1.0,11/84,6.57%,THBS1;HOXA5;SLC12A2;EMILIN1;ISM1;SPARC;TGFB2;SERPINF1;SEMA3E;THBS2;SULF1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5990733242091804,1.2152221710203317,0.2624633431085044,0.7504705915455587,1.0,6/10,17.25%,ANXA2;RIC1;CDK5RAP3;RGP1;NELL1;EFNA1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5216634836776824,1.2149470019558295,0.23186528497409326,0.7505618243323161,1.0,6/20,17.18%,PID1;RHOQ;PPFIA1;CLTC;DAB2;LZTFL1
prerank,regulation of mitochondrion organization (GO:0010821),0.4624321963719382,1.2148269493401564,0.2009132420091324,0.7501201399703185,1.0,21/47,28.51%,PID1;CSNK2A2;MIEF2;RHOT2;FZD5;IAPP;RHOT1;SREBF1;USP36;SQSTM1;HDAC6;PLSCR3;FLCN;GOLPH3;MUL1;LRRK2;PINK1;CYRIB;HTRA2;SREBF2;FIS1
prerank,RNA stabilization (GO:0043489),0.4897020693752018,1.2147593475226788,0.234375,0.7494947693584594,1.0,17/33,28.61%,PABPC1;TENT5A;FUS;THRAP3;VIP;TAF15;E2F1;GDNF;ZCCHC17;CIRBP;TENT2;SLC11A1;HNRNPU;YBX1;RBM24;DKC1;LARP1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.593259085733152,1.2145363955198798,0.23903818953323905,0.7494406117535783,1.0,8/11,26.42%,TRIM28;RESF1;SETDB1;MPHOSPH8;TASOR;SETDB2;DNMT1;TPR
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4349387724563086,-1.214079047638947,0.22633744855967078,0.6010393401136653,1.0,4/16,8.27%,MCTP1;RIMS1;MCTP2;SYN1
prerank,urogenital system development (GO:0001655),0.5839824106844422,1.214014150841953,0.2360335195530726,0.7503775611177059,1.0,4/11,9.70%,EPHB2;EPHB3;SOX9;ANXA1
prerank,cytoplasmic translation (GO:0002181),-0.2946669126980346,-1.2139729328685414,0.07407407407407407,0.5988306089401148,1.0,47/91,24.27%,RPS14;RPS15;RPS25;RPL8;RPS8;RPL4;RPS20;EIF2B3;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;GSPT2;RPL11;RPL18A;RPS12;RPL12;RPS11;UBA52;RPL18;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;RPS3;RPS18;RPS19;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37;RWDD1;RPL14
prerank,positive regulation of heart contraction (GO:0045823),-0.4338715226950854,-1.2136206038961213,0.20425531914893616,0.5972381413500273,1.0,4/19,10.95%,ATP1A2;RYR2;EDN1;ADRA1A
prerank,inorganic anion transmembrane transport (GO:0098661),0.4473167559542456,1.2135527976704563,0.19525350593311758,0.7511884558962866,1.0,7/63,7.65%,SLC26A2;SLC5A6;SLC12A7;SLC12A2;SLC4A8;GABRA3;SLC12A4
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.42815337123946684,1.2133094900251056,0.1609442060085837,0.751196116859062,1.0,20/87,12.82%,GDF10;COL3A1;ADAM9;COL1A2;LTBP2;SMAD9;SMAD6;ZMIZ1;TGFB3;TGFB2;ACVR1;SMAD4;TGFBR2;SKI;CBL;RHOA;BMPR1A;SMAD7;TGFBR1;ZMIZ2
prerank,skeletal muscle organ development (GO:0060538),0.5105165481783076,1.213246233819944,0.2399497487437186,0.7505534931608749,1.0,4/26,10.81%,SIX1;SIX4;DISP1;CSRP3
prerank,regulation of leukocyte migration (GO:0002685),0.5456780552377453,1.2130165411214369,0.25170068027210885,0.7505261093990228,1.0,6/16,23.71%,VEGFA;ANXA1;MIA3;HMOX1;TNFSF18;BST1
prerank,regulation of cell death (GO:0010941),0.42626257314385724,1.2129065626087352,0.1643979057591623,0.7500205735613709,1.0,14/94,9.70%,SRSF6;LRP1;FGF2;SRGAP2;CCN5;CCN3;ACER3;PRR7;LRPAP1;AGR2;TNFRSF1B;IMPACT;NOA1;BMP4
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5988310868204493,1.2128805162749503,0.2874074074074074,0.7492606875250373,1.0,1/10,1.05%,LBP
prerank,regulation of smooth muscle contraction (GO:0006940),0.5340254145809797,1.2128026186767058,0.2541935483870968,0.7486485655573588,1.0,3/20,1.91%,PLCE1;CTTN;PROK2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.445892981236956,1.212541892104874,0.18490153172866522,0.7486602546753479,1.0,26/72,23.58%,CARD14;PSMD7;PSMA8;TNFSF15;PSMA4;CHUK;IRAK1;TNFRSF10B;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;NFKB2;AKT1;PSMA3;PSMB1;PSMD4;BIRC3;MAP3K14;ZFP91;PSMA5;PSMA7
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5211683357094471,1.2125331155298686,0.2398427260812582,0.7478300113340075,1.0,5/21,9.55%,ADAM9;HM13;ADAM10;BACE2;BACE1
prerank,regulation of developmental growth (GO:0048638),0.49719172596915856,1.2120448201993141,0.20246913580246914,0.7486262676724423,1.0,10/29,11.86%,SIX1;CTTN;GHR;STAT5A;SIX4;AGR2;DNM2;MUSK;ABL1;SOD1
prerank,protein complex oligomerization (GO:0051259),0.43139530823416716,1.2115792667682168,0.1504237288135593,0.7494435788375522,1.0,25/85,21.39%,PRMT8;MPP2;EHD1;TRMT61B;NOL3;ARC;ATL2;ADCY8;LRRC8D;MCU;ATL3;SLC9A1;FUS;C9;SPAST;LETM1;MICU1;G3BP2;SHMT2;CPSF7;CPSF6;TWNK;IKZF4;PDCD6IP;ATL1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.43390307100353986,1.2109883934580679,0.16881720430107527,0.7506968011926817,1.0,12/76,12.28%,RASSF2;EGFR;PDCD4;CCN3;NFAT5;ILK;DLG1;RHOA;IRAK1;C1QTNF4;CD27;EZR
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5910270643667637,1.210845803704347,0.2528248587570621,0.7503384304830613,1.0,5/11,15.81%,PRKCD;CYP1B1;MAP3K5;STK25;GSKIP
prerank,regulation of transferase activity (GO:0051338),0.5531683014857545,1.2101735655435673,0.23246753246753246,0.7518329454322391,1.0,5/17,11.27%,LDB2;LDB1;SMG6;PPP1R3F;ATM
prerank,positive regulation of synapse assembly (GO:0051965),-0.37414113429997314,-1.2101240635042159,0.15306122448979592,0.6035152173103153,1.0,12/27,12.95%,NRXN1;IL1RAPL1;GRID2;PTPRD;SRPX2;SEMA4D;CLSTN1;CUX2;IL1RAP;EPHB1;SYNDIG1;VSTM5
prerank,substantia nigra development (GO:0021762),0.4752777677627221,1.2090999115116645,0.22170361726954493,0.7548105972291721,1.0,14/37,16.86%,NDRG2;CALM2;RHOA;RAD1;HSPA5;S100A1;YWHAE;SEC16A;PLP1;ZNF148;YWHAQ;SIRT2;CKB;CALM3
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5299547807768656,1.2085846528079385,0.23809523809523808,0.755781141235567,1.0,6/20,14.06%,ZMIZ1;DCUN1D5;ITCH;DCUN1D2;TGFBR1;UBQLN1
prerank,regulation of receptor internalization (GO:0002090),0.4834216011282897,1.2084955672028577,0.2099644128113879,0.755227662209963,1.0,9/35,15.61%,VEGFA;SFRP4;LRPAP1;RSPO1;DLG4;ARF1;PICK1;ARRB1;WDR54
prerank,neuromuscular synaptic transmission (GO:0007274),0.5307217518113125,1.2082237136020795,0.24048913043478262,0.7553429596404502,1.0,6/18,19.50%,ERC1;CHRNB2;TBC1D24;STAC3;ERC2;KIF1B
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5973840360819154,1.2080470789836124,0.2539454806312769,0.755164305897901,1.0,7/11,24.64%,MUC1;FOXM1;ING4;HIPK2;MAD2L2;TP53;RPS27L
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.4970888651672016,1.2076571676784926,0.21829268292682927,0.7557041528230071,1.0,13/29,24.32%,PABPC1;TENT5A;FUS;THRAP3;VIP;TAF15;E2F1;GDNF;CIRBP;SLC11A1;HNRNPU;YBX1;RBM24
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5838063464264398,1.2073795433067143,0.27092198581560284,0.7549833613691217,1.0,4/11,20.59%,SYNJ1;INPP5B;OCRL;SYNJ2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5838063464264398,1.2073795433067143,0.27092198581560284,0.7549833613691217,1.0,4/11,20.59%,SYNJ1;INPP5B;OCRL;SYNJ2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.43485369490330195,-1.2067225886280846,0.2260536398467433,0.6095363552307641,1.0,5/14,13.30%,LIMS2;LOXL3;EMP2;CD63;PRKD1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.5706028347961293,1.2065487208753694,0.24536376604850213,0.7570014099387902,1.0,8/12,28.38%,SEC61A1;HSPA5;CHMP4A;CHMP4B;SGTB;GET3;SEC61B;SEC62
prerank,T cell migration (GO:0072678),0.5670445986596078,1.2063480874040717,0.25770308123249297,0.7568963038569022,1.0,2/13,7.22%,SLC12A2;CXCL16
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.2961687141235025,-1.205455819981646,0.12962962962962962,0.6102787922227925,1.0,44/91,23.31%,RPS14;RPS15;RPS25;RPL8;RPS8;RPL4;RPS20;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;RPL11;RPL18A;RPS12;RPL12;RPS11;UBA52;RPL18;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;SRP68;RPS3;RPS18;RPS19;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37
prerank,regulation of postsynapse organization (GO:0099175),-0.3676012786861143,-1.2054075636276111,0.18556701030927836,0.6079406248718849,1.0,11/28,10.46%,SHANK3;PPFIA2;IL1RAPL1;WNT5A;EPHA4;ARHGAP22;ABHD17C;HOMER1;ABI3;PDLIM5;KIF1A
prerank,protein heterotetramerization (GO:0051290),0.56542991437043,1.2053910709562645,0.24643874643874644,0.7595551952643624,1.0,5/13,18.09%,PKD1;CBR4;HSD17B8;CPSF7;CPSF6
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.4566361410226174,1.2052355602518652,0.20620842572062084,0.7592190727601972,1.0,9/54,9.43%,THBS1;VEGFA;FGF2;STAT5A;PRKCA;HMGB1;FGFR1;JUP;ANGPT4
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4442208132869201,1.2048936034148194,0.2175824175824176,0.7595354449449245,1.0,22/65,23.58%,FHL1;FBXL7;PSMD7;PSMA8;INTS3;CDK5RAP3;PSMA4;PSMD12;CUL1;PSMA6;ZFYVE19;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;PSMB1;PSMD4;USP47;PSMA5;PSMA7
prerank,nucleoside salvage (GO:0043174),0.5920318098577744,1.204505502412713,0.2594202898550725,0.7600632390143266,1.0,6/10,26.97%,UCK2;UPP2;TK2;TK1;DCK;UCKL1
prerank,neural crest cell differentiation (GO:0014033),0.5263990921381717,1.2044646656914726,0.24598930481283424,0.7593532173003594,1.0,1/18,0.33%,LRP6
prerank,proteoglycan metabolic process (GO:0006029),0.49232088545654884,1.2039935769463324,0.23573200992555832,0.7601700780627773,1.0,6/26,11.98%,XYLT1;CHST11;HS3ST4;SULF1;FOXL1;GAL3ST4
prerank,protein targeting to ER (GO:0045047),-0.29295830138651585,-1.2035182384508032,0.07547169811320754,0.6101609561240444,1.0,47/99,23.31%,RPS14;RPS15;RPS25;RPL8;RPS8;RPL4;RPS20;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;RPL11;RPL18A;RPS12;RPL12;SPCS3;RPS11;UBA52;RPL18;SEC61G;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;SRP68;RPS3;RPS18;RPS19;SGTA;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4339609081552864,1.2034737438954235,0.16720955483170466,0.7611987585421491,1.0,27/79,20.53%,SEC31A;SEC24D;SEC13;SEC23A;DYNC1H1;AP2A1;RILP;DNM2;KLC2;FCER1G;DCTN2;ARF1;DYNC1LI2;SEC24C;AP2A2;SEC24B;LAG3;CLTC;KLC1;DCTN5;SEC24A;ACTR1B;ACTR10;DYNC1I2;DCTN1;CLTA;CAPZA1
prerank,outflow tract septum morphogenesis (GO:0003148),0.5043240329792756,1.2034099136000993,0.24472049689440994,0.7605825958702065,1.0,12/24,13.14%,ZFPM2;SMAD6;TGFB2;ACVR1;SMAD4;TGFBR2;BMP4;FGFR2;BMPR1A;NRP1;PARVA;LRP2
prerank,T-helper cell differentiation (GO:0042093),0.5567099263530535,1.2033601227062527,0.24064171122994651,0.7599120105638087,1.0,3/14,6.48%,FOXP1;TMEM98;HMGB1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.5005075333516639,1.2012231694161268,0.2375,0.766704707297588,1.0,6/25,12.19%,HSPA2;DNAJB14;ST13;HSPA14;HSPA5;DNAJC7
prerank,cellular response to fluid shear stress (GO:0071498),-0.4680632283782534,-1.2010620722602667,0.20921985815602837,0.613871960487801,1.0,3/12,8.78%,MTSS1;KLF2;ASS1
prerank,microtubule nucleation (GO:0007020),0.5261498588544749,1.200995845437633,0.2404227212681638,0.7666724374426362,1.0,7/20,18.76%,TUBG2;CSNK1D;TUBGCP3;AKAP9;NDEL1;CCDC57;SLAIN2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.4596997498529918,1.2006203401739601,0.21768707482993196,0.767092973947669,1.0,10/46,11.86%,PDCD4;P4HB;ANXA2;PITPNA;IL12RB2;HNRNPA2B1;HNRNPDL;PAK2;ARF1;SOD1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.570573338856907,1.2002164493480247,0.24859550561797752,0.7676747951158392,1.0,7/12,26.97%,UCK2;UPP2;CAD;TK2;TK1;DCK;UCKL1
prerank,RNA interference (GO:0016246),0.541397759071264,1.2001234963255414,0.24210526315789474,0.7671421019215543,1.0,6/17,16.67%,PRKRA;AGO1;TERT;AGO2;CLP1;TSN
prerank,acylglycerol biosynthetic process (GO:0046463),0.5116697299670774,1.2001205656766938,0.2332065906210393,0.7663012834713488,1.0,6/23,16.49%,PLCE1;PLA2G4A;GPAT4;AGMO;PNPLA3;PLA2G15
prerank,regulation of urine volume (GO:0035809),0.5994736041044422,1.200066290586954,0.28093158660844253,0.7656572425478746,1.0,1/10,1.85%,NPR3
prerank,NAD biosynthetic process (GO:0009435),0.5174808951502495,1.1998855035295828,0.25287356321839083,0.7654604258697302,1.0,6/20,15.90%,PTGIS;QPRT;NNMT;NMNAT3;NMNAT2;NAPRT
prerank,peptide metabolic process (GO:0006518),0.4331837545534898,1.199752529259023,0.17297297297297298,0.7650828342421262,1.0,23/75,19.94%,PCSK5;GSTT1;CPZ;GSTM5;HM13;DMD;CPQ;BACE2;DNPEP;BACE1;SOD1;SPCS2;CARNMT1;NLN;LNPEP;CPXM2;PSEN2;GSR;GSTZ1;IDE;NPEPPS;LVRN;SEC11A
prerank,regulation of B cell proliferation (GO:0030888),-0.3263799266563502,-1.1995467906721748,0.19047619047619047,0.6154408078692616,1.0,11/44,12.43%,LYN;BCL2;TFRC;AHR;TNFRSF21;NFATC2;CD38;VAV3;CD300A;CD74;CD40
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.5666109603407464,1.199286649826943,0.27285318559556787,0.7659268026239828,1.0,6/12,27.45%,GCLC;BDH2;GCLM;CHAC2;HAGH;OPLAH
prerank,regulation of osteoblast proliferation (GO:0033688),0.5431437437312222,1.199154652363248,0.2556894243641232,0.7654999185386427,1.0,5/17,12.41%,NPR3;RHOA;FGFR2;TMEM119;NELL1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.34700102016687484,-1.1990749535952179,0.1694915254237288,0.6141346641240357,1.0,6/39,3.15%,TJP1;ROCK2;APOE;RAPGEF2;TIE1;NOTCH1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5301241769885244,1.1990158652949803,0.2618421052631579,0.7651521709712696,1.0,4/17,6.89%,IGFBP5;DOCK4;DOCK7;DOCK5
prerank,positive regulation of reproductive process (GO:2000243),0.4798258879984111,1.1989245338990726,0.257985257985258,0.7646401831574418,1.0,9/31,17.65%,VEGFA;TAC4;ACVR1B;PDE3A;VIP;AGO2;INHBA;SIRT2;LHFPL2
prerank,neural tube development (GO:0021915),0.5591772181317497,1.1988101292382212,0.24456521739130435,0.7642128392910674,1.0,4/15,5.69%,PKD1;HES5;DACT1;DVL1
prerank,regulation of mRNA stability (GO:0043488),0.41380538390903016,1.1987948181686667,0.16155419222903886,0.763434097761297,1.0,54/145,25.78%,XPO1;PRKCD;PABPC1;SAMD4A;PSMD7;PRKCA;FTO;PSMA8;PUM1;TENT5A;FUS;THRAP3;PSMA4;PCBP4;TBRG4;VIP;TAF15;METTL16;PSMD12;PSMA6;EIF4G1;PSMD1;XRN1;EXOSC4;PSMC5;PSMD11;PSMC4;PSMD14;RPS27A;UBC;RC3H2;DIS3;E2F1;AKT1;GDNF;TNPO1;FASTKD3;PSMA3;CIRBP;PSMB1;PSMD4;FXR2;SLC11A1;DCP1A;PSMA5;PSMA7;ZC3H14;HNRNPU;YBX1;RBM24;ROCK1;YWHAB;METTL14;PSMC1
prerank,histone H3-K36 demethylation (GO:0070544),0.5890482963449885,1.198501788557666,0.27095808383233533,0.7636164456519414,1.0,4/10,12.08%,RIOX2;KDM2A;PHF8;KDM4A
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4472857255777654,1.198339246171195,0.23145071982281284,0.7633482573385014,1.0,12/52,15.16%,EGFR;LRP1;PRKCE;EPHB2;EPB41L2;PLS1;AGR2;DLG1;PDPK1;SQSTM1;STAC3;STX4
prerank,blood vessel endothelial cell migration (GO:0043534),0.5132270720784142,1.1982920016323213,0.2668360864040661,0.7626802503259176,1.0,3/22,1.12%,SLIT2;VEGFA;FGF2
prerank,negative regulation of cell differentiation (GO:0045596),0.40950694443838553,1.1980748643887156,0.1263902932254803,0.762620221469779,1.0,58/181,20.89%,EGFR;GDF10;ID2;WNT9A;ZFPM2;PDCD4;TWIST2;CRIM1;COL5A2;SMAD6;LRP5;TWIST1;LDLRAD4;SPRED2;WWTR1;HES5;XDH;JAG1;NBR1;SKI;HOXA9;SOX9;SRA1;NOG;ESRRB;TSKU;TRPM4;EID2B;IQCB1;RORA;BMP4;ITGAV;FOXA1;ANP32B;SMAD7;HEY1;TGFBR1;PTBP1;ABCA1;LIMD1;BMP5;IL6;SIRT2;IL17RD;NPHP3;TRIO;NEPRO;ANKRD26;EFNA1;MEN1;E2F1;SUFU;NFKBIA;EIF2AK4;CALR;CHRD;MAD2L2;GPS2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.47281826530625154,1.1979664627453948,0.22485207100591717,0.7621880849625815,1.0,16/40,24.52%,PID1;VCP;SLC4A11;AKT2;PPA2;ABL1;SOD1;PRDX3;AKT1;LRRK2;ABCD1;PYCR1;STOML2;RNF122;BAD;PINK1
prerank,protein localization to chromatin (GO:0071168),0.5335978338456816,1.1979419947584489,0.24583866837387963,0.7614319526580822,1.0,2/18,7.50%,ESR1;SGF29
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5947171946546712,1.1977100348036271,0.27285513361462727,0.7613625960973518,1.0,1/10,0.78%,VEGFA
prerank,organelle organization (GO:0006996),0.40267565147874074,1.1973665335177661,0.056,0.7616546166922805,1.0,131/388,24.57%,MICAL2;PLCE1;ABCD3;FMNL2;SEC31A;MARK1;MAPK15;VPS13C;PEX7;ARC;ATL2;CCL13;SEC61A1;CSNK1D;LMAN2L;FGD6;RAB2A;FBXW8;GOLGA8B;GOLGA5;RAB30;RAB34;RAB43;DOP1B;PEX11A;BCAS3;SMPD4;MNS1;RAB3GAP1;MIEF2;GOLGB1;ODF2;ATL3;SIRT5;GBF1;ATP8B2;BRWD1;RHOT2;FAF2;HUWE1;TJAP1;ARHGAP21;PAK4;PALLD;PEX16;PLEKHM2;RHOT1;CENPT;PEX1;RAB38;TRAPPC12;TERT;NRF1;TMED9;PHIP;CIDEA;ZW10;LONP1;LIG4;TRIP11;PEX10;TTC17;PI4K2A;CHMP3;MARK4;NDP;LIMD1;MTFR1;LMAN2;SEC16A;PRDX3;TMEM135;PNPLA3;MIA3;SIPA1L3;STX4;CDC42BPB;PARP1;POLG2;SEC16B;BCS1L;VPS11;GOLPH3;BNIP1;SH3D19;TFB2M;TMED2;NPLOC4;COG2;BLZF1;PEX6;HCFC1;MAST2;ZMYM3;SEC23IP;CLUH;ZFYVE16;ZRANB1;TRAPPC11;TTC29;REEP5;TWNK;NIPSNAP2;FANCG;CHMP4A;CHMP4B;PDCD6IP;OPTN;SNX11;ATL1;ABI2;PEX2;LRRK2;RAB1A;LMAN1;RAB18;ABCD1;MAST4;ATP8B1;EIF2AK3;PRKCI;PEX14;FAM161B;GORASP2;STOML2;VPS13D;DYNC2H1;TMED7;VPS51;PINK1;CHMP2A
prerank,peptidyl-glutamic acid modification (GO:0018200),0.5014369352017052,1.1971157592442498,0.2445859872611465,0.761723196958218,1.0,8/24,16.46%,VKORC1L1;TTLL2;GGCX;AGBL5;TPGS1;CEP41;PARP1;TTLL3
prerank,negative regulation of RNA metabolic process (GO:0051253),0.530307671987583,1.1970297272053407,0.23576158940397351,0.7611662915431706,1.0,5/18,16.21%,ESR1;NCOR2;TERT;PTBP1;ZC3H10
prerank,cellular response to BMP stimulus (GO:0071773),0.43997466454319195,1.1969912797462436,0.18859649122807018,0.76046094406393,1.0,15/66,12.49%,TMEM100;PDCD4;DDX5;SMAD9;SMAD6;TGFB3;TGFB2;ACVR1;SMAD4;SOX9;BMP4;RUNX2;BMPR1A;SMAD7;RGMA
prerank,response to endoplasmic reticulum stress (GO:0034976),0.41480367033475224,1.1968551530410318,0.14958158995815898,0.7601037852642919,1.0,37/107,25.07%,THBS1;P4HB;MAP3K5;ATF4;VCP;AGR2;ERN2;MBTPS1;SYVN1;CDK5RAP3;HYOU1;PDIA3;NIBAN1;BCAP31;AIFM1;TNFRSF10B;HSPA5;UBA5;UBQLN1;SEC16A;USP19;UFL1;TMEM33;QRICH1;ERLEC1;RASGRF1;ATF6;EIF2S1;RCN3;EIF2AK3;DERL1;GORASP2;HERPUD1;CREB3L1;TP53;SELENOS;DNAJB12
prerank,lysosome localization (GO:0032418),0.4688127185167554,1.1966245613419262,0.2384428223844282,0.7601044995974556,1.0,14/37,19.02%,RAB34;LAMTOR1;BLOC1S2;FAM98A;KLC2;PLEKHM2;TMEM106B;NDEL1;PLEKHM1;HDAC6;SPAG9;FLCN;SYTL4;SNAPIN
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.4506664058546878,1.1965892167361538,0.22483221476510068,0.7593939588264329,1.0,22/55,27.30%,FHL1;FBXL7;PSMD7;PSMA8;PSMA4;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;PSMB1;PSMD4;USP47;PSMA5;PSMA7;PSMC1;ATF5;PSMA1
prerank,response to retinoic acid (GO:0032526),-0.3102600181638683,-1.1962928877724404,0.14473684210526316,0.6185289648014675,1.0,11/59,6.52%,LYN;WNT5B;PTK7;WNT5A;WNT6;ACER2;RBP4;BRINP3;TBX1;BRINP1;BRINP2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.4548326006683918,-1.195413638175524,0.23943661971830985,0.6182201508419843,1.0,1/12,1.21%,IL1R1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.46496631932457466,1.1947183963342716,0.23013048635824437,0.7652261398297835,1.0,4/43,1.86%,IRS1;PID1;PRKCD;GRB10
prerank,regulation of phospholipase C activity (GO:1900274),0.5347805849145447,1.1945540334160616,0.25771812080536916,0.7649591993301801,1.0,5/15,10.59%,ESR1;FGF2;NTRK3;FGFR1;ABL1
prerank,regulation of telomere capping (GO:1904353),0.5080426398542519,1.1943799059941433,0.2534332084893883,0.7647327017575054,1.0,7/23,14.20%,MAPK15;NEK7;SMG6;ATM;RAD50;USP7;TNKS2
prerank,cellular response to glucose stimulus (GO:0071333),0.4903795145009678,1.1942295722300937,0.23566084788029926,0.7644883981368295,1.0,5/30,5.38%,SLC39A14;KCNB1;GAS6;UNC13B;ADCY8
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.43072185459185314,1.1935104848557794,0.22055674518201285,0.766159357265552,1.0,30/78,25.09%,RNF144A;PRICKLE1;CSNK1D;COP1;VCP;DVL1;NFE2L2;BCAP31;FBXO22;RNF14;SMAD7;CSNK1E;UBQLN1;DAB2;DDA1;STUB1;SIRT2;SUMO1;CDC20B;HECTD1;CDC20;CLU;USP5;LRRK2;SUMO2;DET1;TAF1;HERPUD1;RCHY1;BBS7
prerank,negative regulation of cellular component organization (GO:0051129),0.4356165848298202,1.1934050856916674,0.19826652221018418,0.7656895895633257,1.0,15/74,11.91%,VEGFA;TMEFF2;RDX;HSPA2;FAP;LRSAM1;DNM2;IRAK3;TMC8;PEX5;RAF1;IAPP;IMPACT;LCMT1;HSPA5
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.451807133357801,-1.1931485391490924,0.23985239852398524,0.6215926661052248,1.0,4/13,12.41%,NOS3;MTHFD1L;GCH1;SPR
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.49348230690851513,1.1931479425192564,0.22156398104265404,0.7657700936583716,1.0,14/30,28.40%,ABLIM3;CSNK2A2;HUWE1;FZD5;USP36;HPS4;MICALL2;VPS11;NPEPPS;SAE1;PINK1;ATG13;HTRA2;SREBF2
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.422444932344661,-1.193087891778833,0.22388059701492538,0.6192915122090589,1.0,5/17,12.44%,BCL2;BCL2L1;DNM1L;BOK;MFF
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.3945426302122129,-1.192934100056682,0.22580645161290322,0.6172841967346715,1.0,6/21,4.69%,ROCK2;ENPP1;NOS3;NOTCH1;SRGN;BCOR
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.3345449416003395,-1.1928955717518377,0.13333333333333333,0.6150137326989947,1.0,10/41,7.81%,IL34;TGFA;GRM5;EPHA4;NEDD9;GPRC5B;ADRA2A;DOCK3;ACE;HBEGF
prerank,defense response to Gram-positive bacterium (GO:0050830),0.45991926727799515,1.1928456947592352,0.23543400713436385,0.7659768747129521,1.0,8/40,18.51%,LBP;RNASE7;RNASE3;GBP6;RNASE6;DEFB1;IL6;DMBT1
prerank,inner ear morphogenesis (GO:0042472),0.5100976609590406,1.1927362223685303,0.26774595267745954,0.7655623434782203,1.0,5/22,9.71%,SIX1;EPHB2;SOX9;ZIC1;FGFR2
prerank,neuron projection regeneration (GO:0031102),-0.49644997993484563,-1.1926168394063243,0.2413793103448276,0.6132964125989221,1.0,2/10,1.81%,PTN;NREP
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.4749396043127224,-1.1922867010425275,0.24390243902439024,0.6117701788925624,1.0,6/11,21.80%,CYC1;UQCRC2;UQCR11;UQCRB;UQCRC1;UQCRQ
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5932170185690786,1.1921342531139916,0.2598870056497175,0.7668938168438597,1.0,4/10,28.45%,PDE6A;SAG;GNB1;PDE6G
prerank,cilium assembly (GO:0060271),0.4048653465725459,1.1919588853680974,0.07907907907907907,0.7666874826033786,1.0,104/297,25.71%,PKD1;GSN;CFAP298;EXOC4;EHD1;GORAB;CSNK1D;ABLIM3;PKHD1;CFAP206;DYNC1H1;DYNLT2B;RILP;ARMC9;SFI1;BBS9;ODF2;CDC14A;DNAAF3;TMEM107;ALMS1;RAB8A;IFT20;GBF1;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;CCDC39;RFX2;TCTN1;IFT80;IQCB1;DCTN2;TMEM216;CKAP5;CCDC66;RPGRIP1L;ATP6V0D1;CFAP43;PTPDC1;WDR11;SDCCAG8;AKAP9;CEP164;CSNK1E;PARVA;TRAPPC14;TRIP11;OCRL;BBS5;TMEM80;YWHAE;IFT46;MARK4;RAB23;FUZ;NUDCD3;CEP41;CEP63;PCM1;HAUS5;HDAC6;LRGUK;IFT88;NPHP3;INPP5E;TTLL3;LZTFL1;DYNC2I1;IFT43;CCDC57;TEKT2;TNPO1;TMEM237;DYNC1I2;PTPN23;DCTN1;KIF24;PRKACA;IFT27;RAB1A;ACTR1A;TMEM231;CDK5RAP2;TXNDC15;SPAG16;NEDD1;NPHP4;BBIP1;PLK4;CEP89;DYNC2H1;TCTN3;CNTRL;TMEM67;TMEM138;BBS7;TUBB4B;CEP20;FBF1;CCP110;EXOC7
prerank,renal absorption (GO:0070293),0.5937418390064755,1.1917403517511744,0.2785714285714286,0.7666427103846394,1.0,2/10,6.72%,GSN;MAGED2
prerank,regulation of gene expression (GO:0010468),0.39556788108144264,1.1914031841385075,0.002,0.7669988017212215,1.0,213/903,18.89%,SLC38A2;BNC2;ESR1;SIX1;FOXP1;PID1;ID2;ZFHX3;HOXA5;VEGFA;ATP1B1;GAS6;C1D;F3;FGF2;ZNF423;FOXD1;IL33;GSN;SFRP4;SLC24A3;VSX1;AFF3;NFIA;EMILIN1;YBX3;COQ7;CLK1;NTRK3;FGF17;DRD1;HNRNPH1;LDB1;PRRX2;PRDM5;DMTF1;RDX;AHNAK;ACVR1B;AHNAK2;EPHB2;ANXA7;C1QTNF1;TWIST1;JMJD1C;APBB3;PRDM11;CLK3;PRDM10;MBNL1;HDAC4;GLMN;WWTR1;SBNO1;BAZ2A;TGFB2;STAT3;CD3E;TCF7L1;ZC3H7A;MLF2;ATF4;ERC1;XDH;FASTK;RAMP2;CHD3;TCFL5;AGR2;DNM2;PHF1;DVL1;PRDM6;SNRNP70;CCAR2;NFX1;NFXL1;FAM98A;ADAM10;PUM1;NFE2L2;BHLHE40;ANKRA2;FZD7;MATR3;TRRAP;ANK2;FUS;HNRNPDL;TBX21;RPS6KA4;TRIM27;NSD1;SOX9;NOG;ESRRB;BTNL9;TSKU;CARM1;DGKQ;WWP2;HNRNPL;HNRNPH2;SBNO2;MBNL2;EDN3;RORA;OGG1;MAPK8;PCBP4;BMP4;CRABP2;TMEM119;PRDM4;FAM98B;MUSK;FADS1;ABL1;UBR5;AGO1;SPTY2D1;TDG;TERT;ATM;BMPR1A;CHEK2;MAZ;PABPN1;KAT6B;RNF14;SFPQ;FUBP1;METTL16;KDM4A;NR1D2;HEY1;EZR;MARF1;PIK3CB;NELL1;TRAF3;PTRH2;TGFBR1;SERPINB9;HDAC1;AGO2;SMO;VTCN1;INHBA;PCBP2;KMT2D;SETDB1;CLK4;ERP29;PTBP1;RUNX1;TRIM26;LIMD1;USP36;ZNF148;CPSF4;HNRNPK;SERTAD3;VDR;YTHDC1;USP13;CAMK2N1;PER1;IL6;AFF4;UBAP2;HDAC6;FOXN3;NKX6-2;ZFPL1;CREBBP;MED26;ZC3H10;ZNF462;APBB1;HMG20A;FGF5;KDM6B;RBL2;CCN4;SEC16B;PRDM2;NFYA;SLC2A10;FLCN;NFKB2;MAGED1;NR3C1;RFXANK;PRKAG1;THAP7;SRSF10;CITED2;HMGA1;DAPK3;E2F1;TRIM6;RYBP;CLK2;HCFC1;SUFU;BRDT;AKT1;GDNF;ATF2;GON4L;ACTR8;GPBP1L1
prerank,inositol phosphate catabolic process (GO:0071545),0.5715586207091606,1.1913089466543798,0.27873563218390807,0.766527900042283,1.0,4/12,20.59%,SYNJ1;INPP5B;OCRL;SYNJ2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.4643871263933337,1.1909423411440698,0.2535211267605634,0.7669992839282036,1.0,8/39,8.96%,FHL1;FXYD5;NEDD4;PTPN3;KCNE5;STK39;ANK2;WWP2
prerank,negative regulation of chemokine production (GO:0032682),-0.4411825688060801,-1.1907824172096193,0.24701195219123506,0.6132867697654869,1.0,5/14,15.58%,APOD;C1QTNF3;LGALS9;SIGIRR;SIRPA
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.530444124792411,1.190281235788793,0.24596774193548387,0.7684396819721303,1.0,9/17,30.73%,DHDDS;ALG13;DOLPP1;ALG1;ALG3;ALG14;ALG12;ALG9;SRD5A3
prerank,response to copper ion (GO:0046688),-0.39087869758800353,-1.1902664216049037,0.22362869198312235,0.6122820490954296,1.0,10/20,18.02%,MT1B;MT1G;MT1E;MT1F;MT1A;MT1H;MT1M;MT1X;SNCA;MT3
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.46779931668033314,1.189875404423379,0.23596792668957617,0.769113915669955,1.0,7/41,10.33%,MGLL;PLA2G4A;CYP1B1;ELOVL5;SCD5;DAGLA;FADS1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.424152333568055,1.189205398681006,0.18354430379746836,0.7706486459210671,1.0,20/95,15.40%,LBP;ADAM9;PDCD4;CARD16;SHPK;TNFRSF1B;HMGB1;TRIM41;FZD5;RHOA;SBNO2;MAPK8;NFKBIB;IRAK1;GIT1;PABPN1;CD80;CASP1;IL6;SIRT2
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4905175970944103,-1.1880289231112586,0.2565789473684211,0.6155039356767311,1.0,3/10,8.39%,ACSL1;SLC2A1;SLC27A4
prerank,regulation of G0 to G1 transition (GO:0070316),0.46602194305641315,1.1878833115335923,0.23148148148148148,0.7745058042705699,1.0,14/38,20.21%,EHMT1;RBBP8;PHC3;RNF2;RBBP7;RING1;L3MBTL2;TFDP1;CBX5;PCGF2;E2F1;RYBP;RAD51;MAX
prerank,glycine metabolic process (GO:0006544),0.5612640697367018,1.187661068103792,0.27887323943661974,0.7744393425879963,1.0,5/12,26.94%,GCSH;GLYAT;SHMT2;SHMT1;RIDA
prerank,activin receptor signaling pathway (GO:0032924),0.5346602702153093,1.1876192937519232,0.2656675749318801,0.7737590157734892,1.0,4/15,13.03%,ACVR1B;ACVR1;TGFBR1;INHBA
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4335661640324405,1.1873225839966575,0.21895424836601307,0.7739457973379399,1.0,13/67,14.32%,MYOC;P4HB;VIT;CD3E;AGR2;ILK;S100A10;DOCK5;JUP;ABL1;NRP1;ARL2;NDNF
prerank,triglyceride homeostasis (GO:0070328),-0.3673149393290034,-1.1866461416851857,0.2198952879581152,0.6167516444452878,1.0,9/26,14.59%,APOE;NR1H3;PNPLA8;C1QTNF3;SCARB1;LPL;SIRT1;NR1H4;DGAT2
prerank,endocytic recycling (GO:0032456),0.44788505792538413,1.18647947991348,0.23337091319052988,0.7761295350107651,1.0,18/50,25.39%,EHD1;ANKRD27;VPS52;EHD2;VPS26A;VPS53;RAB11B;MICALL2;DENND1B;PTPN23;VPS26C;DENND1A;SNX4;VPS51;SNX3;LMTK2;RAB11FIP4;VPS35L
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.48214129408265055,-1.1864201649242323,0.2628398791540785,0.6149853579266323,1.0,3/10,11.13%,ACTN2;SEMA5A;PLEK
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5271381961765845,1.1861750000600564,0.26490066225165565,0.7763997926997589,1.0,7/18,12.41%,RDX;DACT1;RIC1;CDK5RAP3;RGP1;EZR;NELL1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4861881287058517,1.1860928074191117,0.25475285171102663,0.7758633887689935,1.0,12/29,17.61%,TCF7L2;TLE2;TCF7L1;BCL9L;TRRAP;PYGO1;TLE3;TERT;HDAC1;KMT2D;CREBBP;MEN1
prerank,folic acid metabolic process (GO:0046655),0.5320913169988528,1.185967193367686,0.24902216427640156,0.7755320563301069,1.0,9/18,19.88%,SLC25A32;PM20D2;MTRR;MTHFD2;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5188262230355088,1.185891603445137,0.2672634271099744,0.7749588473345843,1.0,3/18,8.57%,CMKLR1;FPR3;FCER1G
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.5417167459939198,1.1858901024622983,0.2735723771580345,0.7741476742330893,1.0,3/16,8.96%,KLRK1;RAET1E;PLEKHM2
prerank,regulation of integrin activation (GO:0033623),-0.44000956937611047,-1.18577424197591,0.2490842490842491,0.6142558848894129,1.0,7/15,27.06%,RASIP1;PIEZO1;PLEK;FBLIM1;KIF14;SELP;SRC
prerank,cellular response to interleukin-2 (GO:0071352),0.5765911402190032,1.1857662136384355,0.26173541963015645,0.7729533575155372,1.0,2/11,3.64%,SHC1;STAT5A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5765911402190032,1.1857662136384355,0.26173541963015645,0.7729533575155372,1.0,2/11,3.64%,SHC1;STAT5A
prerank,natural killer cell activation (GO:0030101),0.49113332561040013,1.1857152835276545,0.2599502487562189,0.7723256663298816,1.0,3/23,7.12%,ELF4;KLRK1;PBX1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5540071175364003,1.1855024713318645,0.2739541160593792,0.7722226377142437,1.0,5/13,13.78%,NFIB;SOX9;BMP4;SRF;NFATC3
prerank,icosanoid secretion (GO:0032309),-0.46216719814861296,-1.185346512877359,0.24912280701754386,0.6130432411863931,1.0,4/12,7.77%,ABCC4;BDKRB2;PNPLA8;ACE
prerank,regulation of defense response to virus (GO:0050688),0.544909088587543,1.1853392635414808,0.2503364737550471,0.7719497344157246,1.0,8/14,27.83%,IFNLR1;ITCH;TRAF3;PCBP2;RNF216;C1QBP;ILRUN;PPM1B
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3939476614820568,1.1850957189854032,0.018,0.7719984651059677,1.0,236/807,22.38%,FOXP2;ESR1;WWP1;FOXP1;KLF12;ID2;ZFHX3;ZFPM2;VEGFA;GAS6;NFIX;ZNF423;FOXD1;SKIL;TCF7L2;PDCD4;IL33;RARB;TWIST2;DDX5;GCLC;MUC1;LDB2;LDB1;PHC2;PRICKLE1;JDP2;GLI2;MDFIC;PRDM5;NCOR2;GLIS2;TWIST1;DKK3;DEAF1;SHC1;PRDM11;TLE2;LHX9;HDAC9;CUX1;RBFOX2;HDAC4;RXRA;HES5;SIX4;STAT3;PHF21A;KMT5A;ATF4;TRIM28;NR2F1;CHD3;TCFL5;USP2;TLE6;DACT1;PRDM6;FOXC2;ZNF25;MIDEAS;CCAR2;NFX1;PER3;SMAD4;ERN2;BHLHE40;HMGB1;EZH1;SKI;HEYL;TBX21;MDM4;EHMT1;MAEL;TRIM27;BTAF1;NRIP1;RARA;NSD1;MBTD1;PA2G4;SOX9;NOG;DAP;RCOR3;FOXK1;IMPACT;DLG1;SMARCC2;WWP2;EID2B;SBNO2;MCPH1;SPINDOC;ILF3;BMP4;FGFR2;PHC3;TSC22D4;ZBTB2;SCMH1;ZFP90;MIER2;RUNX2;KDM2A;URI1;FOXM1;ATN1;POU6F1;CBX2;ID4;HSF4;MAZ;COMMD7;KAT6B;SFPQ;SMAD7;RNF2;MED25;FOXP4;KDM4A;NR1D2;HEY1;GLIS1;EZR;KHDRBS1;HDAC1;MYPOP;NPAS1;MEF2A;NACC1;MAP3K10;RUNX1;ERF;LIMD1;PIAS4;TCF25;FRK;HEXIM1;DAB2;ZNF148;RING1;VDR;YWHAQ;MBD1;L3MBTL2;ID1;PER1;ING4;SIRT2;FOXO3;HDAC6;FOXN3;NKX6-2;CREB1;VPS72;CREBBP;PARP1;KDM5C;SIN3B;RPS27A;UBC;APBB1;SUMO1;DPF3;NIPBL;PRDM2;L3MBTL3;MDFI;MTA3;CBX5;CALCA;EFNA1;FLCN;NR3C1;E4F1;CDKN1C;MEN1;LCOR;ORC2;THAP7;CITED2;HMGA1;PCGF2;E2F1;SUV39H2;HCFC1;BIRC5;ZMYND11;SUFU;ZBTB32;CHD8;CBFA2T2;SARS1;KLF10;MLXIPL;XRCC6;LARP7;CBFB;ZNF431;WWC2;LEFTY1;TCF3;TAF9B;CDK5;SCML2;NOC2L;MAX;BPTF;CALR;IKZF4;KAT7;SUV39H1;MAD2L2;GPS2;IL4;MPHOSPH8;SMURF2;RITA1;YEATS2;MIER1;SAMD11;SAP18;PEX2;PAF1;NFIC;NR2F6;CRY2;USP47;ATP8B1;LOXL2;ZNF177;ZKSCAN3;KAT8;NR2C2
prerank,regulation of mitochondrial fusion (GO:0010635),0.5684013580167514,1.1847911601063257,0.2668500687757909,0.7722230763362673,1.0,2/11,7.87%,PID1;HUWE1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.547956022635861,1.1845807820950285,0.2801664355062413,0.7722235686744888,1.0,3/13,6.98%,CACNA1C;KCNE5;ANK2
prerank,UV protection (GO:0009650),0.5788198224140111,1.1844364251806203,0.28175182481751826,0.7719414136557033,1.0,6/10,26.55%,SCARA3;ERCC5;ERCC2;CAT;SDF4;XPA
prerank,lipid translocation (GO:0034204),0.5049057095535161,1.1843088553730863,0.2710526315789474,0.7715913359769475,1.0,6/21,13.71%,TMEM30B;ABCC1;ATP8B2;ATP8A1;ATP9A;ABCA1
prerank,negative regulation of chemotaxis (GO:0050922),0.47734906887644335,1.1839682555574973,0.23815461346633415,0.771936760818293,1.0,4/31,6.96%,THBS1;SLIT2;SEMA3E;SEMA4B
prerank,mitochondrion disassembly (GO:0061726),0.4744247781807434,1.1834876596157249,0.23770491803278687,0.7728263460564346,1.0,15/34,29.91%,ULK2;WIPI2;ATG3;SQSTM1;RB1CC1;CTSK;ATG9A;PINK1;ATG2B;AMBRA1;ULK1;FIS1;CISD2;USP30;PRKN
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3925585549320777,1.1834770412513433,0.049,0.7720532007801905,1.0,145/497,22.45%,FOXP2;WWP1;FOXP1;ID2;IGFBP5;ZFPM2;GAS6;ZNF423;FOXD1;TCF7L2;PDCD4;TWIST2;GCLC;LDB1;PHC2;PRICKLE1;MDFIC;PRDM5;NCOR2;GLIS2;TWIST1;DKK3;SAMD4A;DEAF1;SHC1;PRDM11;TLE2;LHX9;HDAC9;RBFOX2;HDAC4;SIX4;KMT5A;TRIM28;MIDEAS;CCAR2;SMAD4;ERN2;BHLHE40;HEYL;TBX21;EHMT1;MAEL;BTAF1;RARA;MBTD1;PA2G4;SOX9;DAP;RCOR3;FOXK1;CDC6;SMARCC2;WWP2;EID2B;CDAN1;SBNO2;SPINDOC;ILF3;BMP4;PHC3;TSC22D4;SCMH1;RUNX2;FOXM1;ID4;COMMD7;KAT6B;SFPQ;KDM4A;NR1D2;HEY1;KHDRBS1;HDAC1;NPAS1;RBM4;NACC1;MAP3K10;LIMD1;PIAS4;HEXIM1;ZNF148;RING1;VDR;YWHAQ;MBD1;L3MBTL2;ID1;PER1;ING4;SIRT2;CNOT8;HDAC6;FOXN3;NKX6-2;KDM5C;CNOT10;SUMO1;DPF3;NIPBL;L3MBTL3;MTA3;CBX5;CALCA;NR3C1;EPRS1;CDKN1C;MEN1;THAP7;CITED2;HMGA1;DAPK3;E2F1;SUV39H2;CNOT9;SHMT1;BIRC5;ZMYND11;CHD8;CBFA2T2;KLF10;MLXIPL;SYNCRIP;XRCC6;GMNC;CDK5;SCML2;CALR;IKZF4;KAT7;SUV39H1;IL4;MPHOSPH8;SMURF2;YEATS2;SAMD11;SAP18;CRY2;FXR2;USP47;ATP8B1;LOXL2;ZKSCAN3;KAT8;EIF2AK3
prerank,nuclear pore organization (GO:0006999),0.5463241271137848,1.1834600952774408,0.24647887323943662,0.7713013039340473,1.0,7/14,27.36%,NUP93;SEH1L;TMEM170A;NDC1;NUP35;TPR;AHCTF1
prerank,regulation of mitotic spindle organization (GO:0060236),0.4660161312976614,1.18345808450831,0.24499411071849234,0.7705044986666303,1.0,14/35,27.13%,PARP3;RAE1;DYNC1H1;EML3;CHMP3;CLTC;DCTN1;CHMP4B;PDCD6IP;NUP62;HNRNPU;CHMP2A;TPR;DRG1
prerank,mitochondrion morphogenesis (GO:0070584),0.5714335359778752,1.1829844854455476,0.29634831460674155,0.7713299827118539,1.0,1/11,0.49%,PID1
prerank,sensory perception of sound (GO:0007605),-0.29328818171192106,-1.1823431119491794,0.12,0.6188353982088209,1.0,14/88,5.36%,USP53;COL4A3;GRM7;EYA1;CEMIP;DCDC2;RIPOR2;ADGRV1;KIT;CACNA1D;CCDC50;CLIC5;WHRN;TBX1
prerank,negative regulation of peptidase activity (GO:0010466),0.4495614666227684,1.181905500447904,0.23766816143497757,0.774294158977088,1.0,11/47,18.73%,LRP1;SERPINH1;TIMP2;TIMP3;SERPINF1;CST3;SERPINB9;SERPINE2;CRB2;AKT1;SERPING1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4319162576639467,1.1818342179368357,0.22234392113910187,0.7737098281778928,1.0,8/66,9.70%,EGFR;PKD1;ID2;FHL1;RDX;DACT1;DLG1;ANXA1
prerank,Golgi localization (GO:0051645),0.5738783807986543,1.1816961881427415,0.2698191933240612,0.7733622083506774,1.0,4/11,12.99%,ARCN1;COPG1;ARHGAP21;STK25
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.44209571102973605,1.1809138619836776,0.24067796610169492,0.7753833081417554,1.0,8/50,11.94%,EGFR;PDCD4;NFAT5;ILK;RHOA;IRAK1;C1QTNF4;CD27
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.44786754278394286,1.180811006630364,0.2384180790960452,0.774940261727571,1.0,27/52,28.53%,ABLIM3;CSNK2A2;HUWE1;FZD5;PPP3CC;MAPK8;YWHAE;USP36;HPS4;YWHAQ;TFDP1;MICALL2;VPS11;E2F1;BID;NPEPPS;SAE1;SFN;TP53;BAD;PINK1;YWHAB;ATG13;NMT1;HTRA2;SREBF2;BBC3
prerank,'de novo' posttranslational protein folding (GO:0051084),0.4825245564444141,1.1796207380578547,0.2592137592137592,0.7781222612955575,1.0,7/30,12.19%,HSPA2;DNAJB14;ST13;HSPA14;UGGT1;HSPA5;DNAJC7
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3992365086441028,-1.1794776738371848,0.21705426356589147,0.6238434506813577,1.0,5/19,13.12%,SLCO1C1;APP;KLF2;MTPN;PAX8
prerank,C21-steroid hormone metabolic process (GO:0008207),0.5175748781513305,1.1794197627161243,0.2620599739243807,0.7780511245167698,1.0,4/20,13.20%,STARD3NL;AKR1C1;FDXR;DHRS9
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.45191131324663725,1.1791829617333036,0.22624434389140272,0.7781233687801207,1.0,19/48,26.42%,NUP93;SEC13;RAE1;SEH1L;NOA1;OGT;NUP37;RANBP2;NUP88;EIF6;PRKAG1;POM121;NUP210;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5289985810321078,1.1790626565751783,0.2772020725388601,0.7777345185109239,1.0,5/17,14.15%,MPG;ERCC5;OGG1;TDG;SMUG1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.47807256267380843,1.1788374055468458,0.24759615384615385,0.7777262801737644,1.0,2/33,0.14%,THBS1;SLIT2
prerank,regulation of lamellipodium assembly (GO:0010591),0.4777751687056824,1.1787310531838553,0.2564102564102564,0.7773223155081561,1.0,2/34,0.87%,SLIT2;PLCE1
prerank,protein deneddylation (GO:0000338),0.5914481748049616,1.178303266219566,0.28230337078651685,0.7780827758397848,1.0,7/10,34.50%,GPS1;COPS4;COPS7A;COPS3;COPS5;COPS2;COPS7B
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.4894213372245579,1.178179616016732,0.24814814814814815,0.777705737824985,1.0,7/26,17.35%,EGFR;SOX9;SYAP1;PDPK1;IQGAP1;ERBB2;GAREM1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.41339375658451916,-1.1780695534447079,0.242914979757085,0.6250361323696213,1.0,5/17,16.68%,COX8A;COX6C;COX4I1;COX10;COX5B
prerank,regulation of protein transport (GO:0051223),0.4812996858819093,1.1779610118261477,0.27023661270236615,0.7776396034105466,1.0,13/27,26.37%,P3H1;DISP1;LLGL1;WWP2;SCFD1;CHP1;STXBP5;GAPVD1;NDEL1;DNAJA1;SNX3;DNAJC1;NDFIP1
prerank,positive regulation of filopodium assembly (GO:0051491),0.48604074979287765,1.177751022603284,0.27701863354037265,0.7775634462078549,1.0,10/24,15.89%,ARAP1;RHOQ;DPYSL3;TGFB3;BCAS3;TENM1;NRP1;MIEN1;NLGN1;PALM
prerank,endocardial cushion development (GO:0003197),0.5055541764632703,1.1767132273740524,0.25735294117647056,0.7804353016347327,1.0,10/21,12.13%,TGFB2;ACVR1;HEYL;MDM4;SOX9;NOG;CRELD1;BMP4;BMPR1A;HEY1
prerank,cellular response to interleukin-6 (GO:0071354),0.4787110811573228,1.1763201016348845,0.26044226044226043,0.7809950925089894,1.0,6/26,9.20%,PID1;PTGIS;STAT3;SMAD4;CBL;SBNO2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4318911220826476,1.1760781626129848,0.22782037239868566,0.7809785375154497,1.0,17/68,19.88%,SLC23A1;SLC23A2;SLC5A6;AOX1;ABCC1;SLC25A32;MTRR;MMAB;NNMT;MTHFD2;GSTO2;ALDH1L2;MTHFD1;SHMT2;SHMT1;RFK;MTHFR
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.5595545291286262,1.1760018286040188,0.29160935350756534,0.7804582115140366,1.0,3/13,9.70%,ESR1;PLPP1;BMP4
prerank,mitotic DNA replication (GO:1902969),0.582458196421455,1.1759692291870103,0.2785515320334262,0.779774210738219,1.0,4/10,16.62%,MCMDC2;MCM2;CDC45;MCM4
prerank,regulation of cytokinesis (GO:0032465),0.4214268526404042,1.1758291223375852,0.2259100642398287,0.7794419306491991,1.0,26/78,25.59%,CIT;PRKCE;KIF13A;CALM2;CDC14A;GIPC1;CDC6;RHOA;PKN2;CDC25B;SPAST;GIT1;ZFYVE19;OPN1MW;CSPP1;CALM3;BIRC6;FLCN;KIF20B;DRD2;SETD2;UVRAG;PLK4;SVIL;RAB11FIP4;CCP110
prerank,mesoderm formation (GO:0001707),-0.40938752364577047,-1.175812377098682,0.22972972972972974,0.6284072004931285,1.0,4/17,9.14%,ITGB4;ITGA3;ITGA8;BMPR2
prerank,cellular response to topologically incorrect protein (GO:0035967),0.47335274534007676,1.175575585724049,0.2524390243902439,0.7795177900457119,1.0,15/31,27.84%,HSPA2;BAG3;DNAJB14;HSPA14;HSPA5;STUB1;HDAC6;DNAJC18;OPTN;DNAJB12;UBE2W;DAXX;HSPB8;ERN1;HSF1
prerank,insulin receptor signaling pathway (GO:0008286),0.4289376686538496,1.175422402583048,0.23296703296703297,0.779239843540352,1.0,19/69,15.93%,IRS1;SLC39A14;GRB10;RHOQ;ATP6V1C2;SHC1;TCIRG1;C2CD5;FOXC2;ATP6V0A1;AKT2;ZNF106;ATP6V0D1;PHIP;PTPN2;ATP6V1B2;ATP6V1E1;SOS1;IDE
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.45603068933656826,-1.1753764402212883,0.27666666666666667,0.6272175850748003,1.0,6/11,20.34%,PPARA;SLC30A10;TRAP1;ABCD2;ABCB7;SLC18A2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5555593265123272,1.17523135246826,0.2888283378746594,0.779127531631025,1.0,4/13,11.57%,FGF2;HMGB1;FGFR1;PDPK1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5399341661369401,1.1751485561463153,0.2938076416337286,0.7778368064302631,1.0,2/16,5.22%,THBS1;BCAS3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5399341661369401,1.1751485561463153,0.2938076416337286,0.7778368064302631,1.0,2/16,5.22%,THBS1;BCAS3
prerank,regulation of ossification (GO:0030278),0.47242394035760576,1.1748153232934209,0.2543352601156069,0.77829422521474,1.0,9/36,9.70%,LRP6;DDR2;SMAD6;TWIST1;TGFB2;ACVR1;NBR1;SOX9;BMP4
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4270293178518109,1.1734601953083559,0.21943231441048036,0.7821400988005953,1.0,10/75,6.57%,THBS1;HOXA5;EMILIN1;ISM1;SPARC;TGFB2;SERPINF1;SEMA3E;THBS2;SULF1
prerank,metanephric mesenchyme development (GO:0072075),0.5684350080059097,1.1731912770381259,0.2925764192139738,0.7822998339768386,1.0,2/10,4.17%,SIX1;SIX4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4594015996112171,1.1731785934853165,0.26450116009280744,0.7815528304357297,1.0,12/40,24.16%,XPO1;GLMN;CSNK2A2;CSNK2A1;CDK5RAP3;AXIN1;UFL1;ARAF;HIPK2;CLU;DESI1;TAF1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5815614858849912,1.1729440915373273,0.27246376811594203,0.7815649153966848,1.0,4/10,6.02%,PRKCD;RDX;C1QTNF1;CD9
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5622116631023589,1.1728872501875474,0.3009845288326301,0.7809679205783536,1.0,4/12,10.45%,MBTPS1;DGKQ;SREBF1;LPCAT3
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4197739482673702,1.1727995617462106,0.22069693769799367,0.7805187485223167,1.0,15/88,12.61%,THBS1;PGF;VEGFA;F3;FGF2;SPARC;STAT5A;XDH;PRKCA;SULF1;BMP4;AGGF1;VIP;NRP1;TGFBR1
prerank,glial cell development (GO:0021782),-0.37667184131712356,-1.1725354391603775,0.225,0.6322491082305236,1.0,12/25,19.94%,CDK6;APP;EIF2B3;CSPG5;NRROS;EIF2B1;SOX11;MT3;MXRA8;MDK;DLL1;SOX4
prerank,histone H4-K16 acetylation (GO:0043984),0.5186748065897882,1.172345310222978,0.2754569190600522,0.781387784507963,1.0,11/19,23.19%,KANSL2;OGT;WDR5;ING4;HCFC1;KANSL1;KAT7;MSL1;KAT8;KMT2A;MEAF6
prerank,endosome organization (GO:0007032),0.45558708534739883,1.172081139277733,0.26689576174112256,0.7815174497819533,1.0,12/41,21.10%,DNAJC13;RILP;LAMTOR1;USP50;LAPTM4B;EEA1;WASHC4;PI4K2A;SQSTM1;VPS11;PHETA2;ARFGEF2
prerank,cell projection organization (GO:0030030),0.47979795360673605,1.1717555933866646,0.27239709443099275,0.7818994480200232,1.0,6/30,14.92%,RHOJ;GSN;RHOQ;CYFIP1;PARVA;SCIN
prerank,response to metal ion (GO:0010038),0.4304083908398714,1.1711003595878,0.23283261802575106,0.7833397160629663,1.0,8/67,9.75%,THBS1;ADAM9;NEDD4;SEC31A;CALM2;FXN;NDRG1;SLC30A5
prerank,myeloid cell activation involved in immune response (GO:0002275),0.5129012201516132,1.1706575427341932,0.28998699609882966,0.7841081825800442,1.0,3/18,9.20%,LBP;FCER1G;SBNO2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.392098051964361,1.1706510278649769,0.05,0.7833452578707965,1.0,163/572,22.38%,FOXP2;ESR1;FOXP1;KLF12;ID2;ZFHX3;ZFPM2;VEGFA;NFIX;NFIB;SKIL;TCF7L2;IL33;RARB;NEDD4;DDX5;LDB2;LDB1;JDP2;GLI2;PRDM5;NCOR2;GLIS2;TWIST1;DEAF1;HDAC9;CUX1;HDAC4;RXRA;HES5;STAT3;PHF21A;KMT5A;ATF4;BAG3;NR2F1;CHD3;TCFL5;USP2;TLE6;DACT1;PRDM6;FOXC2;ZNF25;NFX1;PER3;SMAD4;BHLHE40;HMGB1;EZH1;SKI;TBX21;MDM4;TRIM27;NRIP1;RARA;NSD1;SOX9;NOG;IMPACT;DLG1;WWP2;MCPH1;BMP4;FGFR2;ZBTB2;ZFP90;MIER2;URI1;FOXM1;ATN1;POU6F1;CBX2;ID4;HSF4;MAZ;SFPQ;SMAD7;RNF2;MED25;FOXP4;SRF;NR1D2;HEY1;GLIS1;EZR;HDAC1;MYPOP;MEF2A;RUNX1;NFATC3;ERF;TCF25;FRK;HEXIM1;DAB2;ZNF148;VDR;ID1;PER1;SIRT2;FOXO3;VPS72;CREBBP;PARP1;SIN3B;RPS27A;UBC;APBB1;SUMO1;NIPBL;PRDM2;MDFI;MTA3;CBX5;EFNA1;FLCN;NR3C1;E4F1;MEN1;LCOR;ORC2;THAP7;CITED2;PCGF2;E2F1;SUV39H2;HCFC1;SUFU;ZBTB32;CHD8;SARS1;KLF10;CC2D1A;LARP7;CBFB;ZNF431;WWC2;LEFTY1;TCF3;TAF9B;NFATC4;NOC2L;MAX;BPTF;CALR;SUV39H1;MAD2L2;GPS2;IL4;SMURF2;RITA1;YEATS2;MIER1;PEX2;PAF1;NFIC;NR2F6;CRY2;LOXL2;ZNF177;ZKSCAN3;NR2C2
prerank,calcium ion import (GO:0070509),0.4844361101677279,1.1705910341428167,0.2672521957340025,0.7828037430148894,1.0,3/28,5.91%,CACNA1G;CACNA1C;MCU
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4291928349435342,1.1697550920447957,0.24333333333333335,0.7849211304699351,1.0,30/66,29.41%,PRKCD;IPO5;WWTR1;LIMK2;TRIM28;BAG3;MAVS;JUP;CDK5RAP3;ZIC1;UBR5;TERT;SESN2;ORMDL3;RBM22;AKT1;CCT4;LARP7;CCT6A;KAT7;CCT8;EIF2AK3;TCP1;EFCAB7;TPR;DKC1;LIF;CCT5;TESK1;MEPCE
prerank,regulation of receptor binding (GO:1900120),-0.4656493720798538,-1.1696582686279506,0.2508361204013378,0.6374874568434005,1.0,3/10,8.71%,B2M;GREM2;ATP2A3
prerank,tight junction assembly (GO:0120192),-0.3114275716142976,-1.1696177471586335,0.14912280701754385,0.6352878618278514,1.0,10/49,9.00%,PARD6G;OCLN;PECAM1;CDH5;CLDN5;ESAM;LSR;F11R;APC;CLDN1
prerank,DNA metabolic process (GO:0006259),0.39213478893823,1.1695280738567868,0.12712712712712712,0.7849327006584789,1.0,119/270,33.14%,TCF7L2;HELB;PARP3;CHD1L;UBE2B;TRIM28;MPG;POLE2;VCP;PRKDC;HMGB1;RMI2;INTS3;TRRAP;KMT5C;MCM2;ERCC5;DCTPP1;CDC6;RBBP8;RAD1;ERCC4;OGG1;WRN;TDG;KPNA2;TERT;ATM;USP45;TDP1;ERCC3;RAD50;LONP1;CSNK1E;CDC45;LIG4;ALKBH1;USP7;SUPV3L1;SMUG1;DCLRE1B;MMS19;ATRIP;UBE2V2;PARP1;RPS27A;UBC;HUS1;MCM4;TSN;SUMO1;POLB;SMARCAD1;MEN1;ORC2;CDT1;DFFB;TOP3B;UHRF2;DBF4;RAD51;CDK2;XRCC6;FANCG;XRCC3;ENDOV;UPF1;TOPBP1;TOP1;PDS5A;TOP1MT;UVRAG;PRIMPOL;ALKBH3;SMC1A;DNMT1;TOP3A;PARG;PRIM1;RECQL5;POLD1;GTF2H4;SLX4;MCM7;POLG;XPA;PARP4;ZRANB3;RTEL1;RPAIN;DNASE1L2;NOP53;PNKP;ADPRS;DDB1;ATR;SMARCAL1;IGHMBP2;MBD4;RAD52;PDS5B;TIMELESS;CTC1;RAD17;HINFP;UBE2A;MSH2;UBE2N;BLM;XRCC1;ERCC1;CHRNA4;CNBP;POLK;POLQ;GLRX2;RPA3;PURA;SIRT7
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5553982909097407,1.1686457400366097,0.3057142857142857,0.7872363398997754,1.0,1/12,1.29%,IL33
prerank,response to amyloid-beta (GO:1904645),-0.3224476033513839,-1.1683832075809861,0.14583333333333334,0.6360295644177805,1.0,13/44,14.19%,IGF1R;GRM5;EPHA4;APP;CACNA2D1;VCAM1;CASP4;GRIN2A;SNX6;ITGA4;IGF1;CACNB1;GRIN1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4598642333959512,1.1682623288359795,0.26421800947867297,0.7877339401353045,1.0,15/37,24.94%,ENTPD2;SIDT2;ENTPD6;PPP1R8;RNASE3;RNASE6;SUPV3L1;SND1;NCBP1;DFFB;ENTPD7;MTREX;ENTPD5;PABPC4;NUDT18
prerank,negative regulation of axonogenesis (GO:0050771),0.48126585440618375,1.1682081777196827,0.27784891165172854,0.7871414797881904,1.0,5/27,9.03%,FGF13;ULK2;GDI1;PTPRS;RHOA
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4597387189104743,1.1681304878934187,0.2711670480549199,0.7866161616161617,1.0,7/37,12.74%,IGFBP5;FGF2;PDCD4;TGFB3;P2RY6;BMPR1A;MEF2D
prerank,sphingosine metabolic process (GO:0006670),0.5247229928187849,1.1681199930475503,0.2963917525773196,0.7858715477738086,1.0,3/17,6.19%,ACER3;PLPP3;PLPP1
prerank,regulation of mitotic cell cycle (GO:0007346),0.40156547909620743,1.167646507536726,0.16818642350557245,0.7867527521710512,1.0,74/171,30.22%,SMOC2;TTC28;PTPN3;ANAPC5;PSMD7;GAS1;CDC16;PRKCA;USP2;PSMA8;NEK7;GBF1;CDK10;SRA1;CDK5RAP3;PKN2;PSMA4;CDC25B;FOXA1;INTS13;UBE2C;RCC1;PSMD12;ANAPC4;ERCC3;CUL1;PSMA6;ERCC2;PSMD1;ANAPC2;IQGAP1;PSMC5;ANAPC1;PSMD11;PSMC4;PSMD14;ANAPC10;CDKN1C;DAPK3;KIF20B;CDC20;CCDC57;HECA;CDC27;CKS1B;DLGAP5;PSMA3;PSMB1;PSMD4;CUL9;RNF20;PSMA5;CYLD;PSMA7;HNRNPU;RPS6KB1;CDK13;PSMC1;CCDC8;CUL7;EIF4E;NEK6;PSMA1;HSF1;USP22;DDB1;CDK9;BTRC;BTG3;PRMT5;ANAPC11;UBE2S;PSMD2;TTLL12
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5284434525735566,1.1675864043457282,0.28609625668449196,0.786181270373497,1.0,3/17,6.53%,STAT3;GNL1;JAG1
prerank,anterior/posterior axis specification (GO:0009948),-0.4296917482928273,-1.1674742360596408,0.25892857142857145,0.6361354861450489,1.0,2/15,2.98%,WLS;TBX3
prerank,nucleotide-excision repair (GO:0006289),0.4140948038382922,1.1671439467236915,0.21953781512605042,0.7869976646780595,1.0,56/101,34.68%,CHD1L;ERCC8;GPS1;ERCC5;HMGN1;ERCC4;OGG1;CUL4A;USP45;ERCC3;XAB2;LIG4;USP7;ERCC2;MMS19;POLR2F;ISY1;PARP1;RPS27A;UBC;HUS1;POLB;SLC30A9;AQR;COPS4;POLR2B;COPS7A;TP53;UVSSA;POLD1;GTF2H4;SLX4;RNF111;POLR2H;COPS3;XPA;PNKP;DDB1;POLR2I;RBX1;POLR2L;COPS5;XRCC1;ERCC1;RAD23B;ERCC6;POLR2K;POLK;RPA3;CUL4B;CCNH;COPS2;CETN2;FAN1;COPS7B;RFC4
prerank,hemopoiesis (GO:0030097),-0.2831639125676719,-1.167078241558294,0.1206896551724138,0.6349289590833614,1.0,22/87,13.04%,FLT1;TGFBR3;MECOM;TEK;WNT5A;KIT;ZBTB16;SNRK;KDR;MEIS1;NOTCH4;FLT3LG;FLT4;SH2B3;TAL1;HIPK1;PLEK;ETV6;KITLG;SFRP1;PRKX;CD34
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5339336700143508,1.1656894172727976,0.29045092838196285,0.7912151617751252,1.0,5/14,14.34%,AK5;AK3;DCTPP1;SMPDL3A;AK1
prerank,cellular response to interleukin-12 (GO:0071349),0.4448421783588953,1.1655458653353303,0.24266365688487584,0.7909639783311478,1.0,10/48,11.86%,PDCD4;P4HB;ANXA2;PITPNA;IL12RB2;HNRNPA2B1;HNRNPDL;PAK2;ARF1;SOD1
prerank,RNA methylation (GO:0001510),0.4266544412522992,1.1651066278235398,0.23363431151241534,0.7916852565121811,1.0,27/60,33.88%,TRMT61B;TARBP1;METTL16;TYW3;THADA;THUMPD3;TRMT44;TRMT6;ALKBH8;TFB2M;FBL;TRMT61A;METTL1;NSUN6;METTL8;BUD23;MTO1;METTL14;TRMT112;NSUN3;MEPCE;METTL6;RBM15;TGS1;PCIF1;METTL2A;METTL2B
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.48942059337908533,1.1649984641538844,0.28050314465408804,0.7912533830577626,1.0,3/24,1.86%,NEDD4;EMILIN1;GRB10
prerank,positive regulation of ATP metabolic process (GO:1903580),0.46743924361960987,1.1649636175001776,0.28708133971291866,0.7905813061266524,1.0,4/32,5.16%,SLC4A4;PID1;ACTN3;VCP
prerank,regulation of cellular protein localization (GO:1903827),0.44534681682094485,1.1649387048374973,0.25170068027210885,0.789891047819861,1.0,12/45,16.22%,GPC6;GPC3;VCP;DVL1;GBF1;SPIDR;CCDC66;RAB11FIP5;CSNK1E;RAB11B;NDEL1;PARP1
prerank,regulation of glucose metabolic process (GO:0010906),0.46189204711617626,1.1646796205914018,0.26954492415402564,0.7900164087898653,1.0,10/34,18.70%,IRS1;AKT2;FOXK1;DGKQ;OGT;RORA;USP7;GNMT;BCKDK;AKT1
prerank,regulation of cell cycle phase transition (GO:1901987),0.41539226628329956,1.1646048512944713,0.23885350318471338,0.7895177989128771,1.0,39/91,30.19%,ANAPC5;PSMD7;CDC16;PSMA8;PSMA4;UBE2C;PSMD12;ANAPC4;ERCC3;CUL1;PSMA6;ERCC2;PSMD1;ANAPC2;PSMC5;ANAPC1;PSMD11;PSMC4;PSMD14;ANAPC10;CDC20;DBF4;CDC27;PSMA3;ATP2B4;PSMB1;PSMD4;PSMA5;PSMA7;TAF1;TP53;PSMC1;PSMA1;DDB1;BTRC;TRIM39;ANAPC11;UBE2S;PSMD2
prerank,glycolipid biosynthetic process (GO:0009247),0.4546002107974649,1.1645905986926306,0.2734741784037559,0.7887849157410313,1.0,7/38,14.13%,ST3GAL4;ST6GALNAC5;PIGW;ST3GAL2;PIGF;PIGL;PGAP2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3952523611828998,1.164577697616048,0.12124248496993988,0.7880456947796549,1.0,42/291,12.60%,SLIT2;ESR1;EGFR;IRS1;PID1;WNT9A;IGFBP5;PRKCD;LBP;ADAM9;PDCD4;DRD1;HCN4;SLC26A6;IPO5;CARD16;SHPK;PDE3A;VCP;TNFRSF1B;LAMTOR1;HMGB1;FZD7;TRIM41;NRIP1;SOX9;IMPACT;CAPN2;RHOA;SBNO2;RORA;MAPK8;CHUK;NFKBIB;IRAK1;P2RY6;GIT1;ATM;PABPN1;EZR;AKAP9;SESN2
prerank,organelle assembly (GO:0070925),0.39310367199793966,1.1644761281474187,0.081,0.7876174108885096,1.0,143/385,28.52%,PKD1;GSN;ULK2;CFAP298;EXOC4;EHD1;CSNK1D;ABLIM3;GOLGA8B;PKHD1;RAB43;DYNC1H1;DYNLT2B;TUBGCP3;RILP;ARMC9;PACS2;ATXN2L;BBS9;CDC14A;NEK7;TMEM107;RAB8A;IFT20;GBF1;WIPI2;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;CENPC;RFX2;TCTN1;UBAP2L;IFT80;IQCB1;SH3PXD2B;PRRC2C;CENPT;TMEM216;RAB38;CCDC66;RCC1;ATP6V0D1;TRAPPC6A;CFAP43;PTPDC1;MIS12;WDR11;ATG3;PATL1;ATG16L2;CEP164;PARVA;TRAPPC14;OCRL;DHX29;STAM2;MAPRE3;BBS5;IFT46;CHMP3;LIMD1;UBQLN1;ABCB6;RAB23;HPS4;FUZ;FARP2;NUDCD3;CEP41;CEP63;PCM1;HAUS5;HDAC6;IFT88;NPHP3;INPP5E;TTLL3;LZTFL1;DYNC2I1;CDS1;IST1;IFT43;CCDC57;RB1CC1;TEKT2;TMEM237;VTA1;PTPN23;DLGAP5;CCDC61;KIF24;CIRBP;CHMP4A;CHMP4B;EIF2A;EIF2S1;PDCD6IP;NUP62;ATG16L1;RUFY4;POGZ;ATXN2;RAB1A;MVB12A;TMEM231;TXNDC15;SPAG16;RAB1B;GORASP2;BBIP1;PLK4;SYNPO;CEP89;DYNC2H1;TCTN3;ATG9A;TMEM67;CHMP2A;TMEM138;FITM2;NCOR1;BBS7;CEP20;FBF1;EXOC7;ATG13;INTU;ACTR2;GOLGA2;ATG2B;AMBRA1;NEK6;VPS37B;YTHDF1;E2F4;TTBK2;DYNC2I2;ULK1;IFT140;UBXN2A
prerank,neuron fate commitment (GO:0048663),0.5398700425035068,1.1644669770811489,0.2888283378746594,0.7868730147652934,1.0,1/14,0.58%,ID2
prerank,amyloid fibril formation (GO:1990000),0.4364495552574775,1.164346074442245,0.2648709315375982,0.7865241718439883,1.0,15/51,17.16%,GSN;TGFBI;SNCAIP;ADAM10;GGA2;IAPP;CST3;BACE1;RIPK3;UBE2L6;GGA1;RPS27A;UBC;SERF1A;CALCA
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5033358509172424,1.1643195969205946,0.2772020725388601,0.7858383949685902,1.0,7/21,14.43%,PLA2G4F;PLA2G4A;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3892707169428629,-1.164039538891711,0.23636363636363636,0.6402990750314183,1.0,5/20,9.22%,BCL2;BCL2L1;FAS;DCC;BOK
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.4887056041120605,-1.1639696395893024,0.28052805280528054,0.638202189755054,1.0,5/10,20.59%,SHQ1;PIH1D1;RUVBL1;ZNHIT6;TAF9
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.476929848385212,-1.1639416041691952,0.2847222222222222,0.6359850362605413,1.0,4/10,17.81%,CX3CR1;CEACAM1;LGALS9;ARRB2
prerank,negative regulation of myoblast differentiation (GO:0045662),0.5470434252255141,1.1637324025843345,0.30662983425414364,0.7870326935253791,1.0,5/13,9.70%,PRICKLE1;SOX9;SRA1;EID2B;BMP4
prerank,neuronal action potential (GO:0019228),0.49278338781036746,1.1635746272386087,0.29473684210526313,0.7868218116381619,1.0,2/22,6.62%,CACNA1G;SCN11A
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3977904831831227,1.1635238789992886,0.19047619047619047,0.7862332326466298,1.0,33/151,17.97%,ST3GAL4;PCSK5;ACER3;GSTT1;PLA2G4A;PEMT;PLPP3;CSNK2A2;CSNK2A1;GSTM5;LPCAT1;KDSR;DMD;ELOVL5;PLPP1;NFS1;NANP;ST3GAL2;B4GALT5;STARD7;GPAT4;LPCAT3;PCTP;GAL3ST4;INHBA;ALDH3A2;GSTO2;CHKB;GSTZ1;B3GNT6;AKR1A1;SLC25A2;GOLPH3
prerank,glycine transport (GO:0015816),-0.47110399552183735,-1.1634973207428585,0.3072289156626506,0.6348289999649944,1.0,3/10,8.57%,SLC6A9;SLC38A5;SLC6A17
prerank,response to laminar fluid shear stress (GO:0034616),0.572069322987492,1.1632166295130721,0.29036827195467424,0.786550635323531,1.0,4/10,13.71%,SMAD6;NFE2L2;SMAD7;ABCA1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5523340510718442,1.1629853992710522,0.29551820728291317,0.786577654051675,1.0,7/12,24.80%,TRIM28;RESF1;SETDB1;MPHOSPH8;TASOR;SETDB2;DNMT1
prerank,signal peptide processing (GO:0006465),0.5594398371503005,1.1625737509658178,0.3096590909090909,0.7872086045923364,1.0,3/11,13.46%,PCSK5;HM13;SPCS2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.40801286163722367,1.1622421474620779,0.2494824016563147,0.7875251057019687,1.0,16/98,13.74%,THBS1;PID1;VEGFA;SFRP4;ECE1;ANXA2;XDH;TGFBR2;IFNLR1;AKR1C1;NSF;DHRS4;EIF4G1;INHBA;ACACA;PICK1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3826428722015138,-1.1621331306402576,0.24074074074074073,0.6338795596499316,1.0,12/22,28.06%,ZDHHC14;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3826428722015138,-1.1621331306402576,0.24074074074074073,0.6338795596499316,1.0,12/22,28.06%,ZDHHC14;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,protein localization to microtubule organizing center (GO:1905508),0.5258972369000058,1.1611440500579608,0.299738219895288,0.7904807246621405,1.0,7/15,32.66%,CSNK1D;DCTN2;PCM1;NEDD1;STIL;C2CD3;PIBF1
prerank,myeloid cell development (GO:0061515),0.5138773888215339,1.1610127208374525,0.3097686375321337,0.7901806744793236,1.0,2/18,4.03%,FOXP1;ANXA2
prerank,response to interferon-beta (GO:0035456),-0.3774248409332419,-1.1609936001074792,0.2237442922374429,0.6345774896967219,1.0,7/22,13.58%,IFNAR2;STAT1;IFITM1;BST2;AIM2;IFITM3;NDUFA13
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.389947177902067,1.1609059093853438,0.086,0.7898122226924212,1.0,90/366,19.79%,BNC2;ESR1;SIX1;ZFHX3;ZNF423;VSX1;NFIA;LDB1;PRRX2;DMTF1;ACVR1B;JMJD1C;APBB3;WWTR1;SBNO1;BAZ2A;STAT3;TCF7L1;MLF2;ATF4;ERC1;CHD3;TCFL5;DNM2;PHF1;DVL1;TOM1L1;CCAR2;NFX1;NFXL1;BHLHE40;FZD7;TRRAP;FUS;TBX21;RPS6KA4;NSD1;CYFIP1;ESRRB;SMC3;RBBP6;CARM1;SBNO2;RORA;OGG1;CRABP2;FADS1;ABL1;SPTY2D1;CHEK2;KAT6B;RNF14;SFPQ;NR1D2;TGFBR1;KMT2D;NOLC1;LIMD1;SERTAD3;USP13;FOXO3;FOXN3;NKX6-2;ZFPL1;CREBBP;APBB1;HMG20A;PRDM2;NFYA;NFKB2;MAGED1;NR3C1;THAP7;SRSF10;HMGA1;DAPK3;E2F1;RYBP;HCFC1;SUFU;BRDT;ATF2;GON4L;ACTR8;GPBP1L1;MLXIPL;TEAD2;ZNF431;WWC2;TCF3
prerank,negative regulation of autophagy (GO:0010507),0.4392558896450354,1.1603593860846613,0.2550561797752809,0.7909328169736408,1.0,27/54,27.02%,STAT3;LZTS1;EIF4G2;NRBP2;SNRNP70;QSOX1;EIF4G3;DAP;FOXK1;SMG1;TAB2;KDM4A;EIF4G1;USP36;HGF;SIRT2;TLK2;KLHL22;AKT1;LRRK2;RUBCN;ZKSCAN3;SMCR8;PINK1;MET;GOLGA2;EIF4E
prerank,negative regulation of axon extension (GO:0030517),-0.3411060926813439,-1.16003088827848,0.23076923076923078,0.6348144435916845,1.0,15/30,21.23%,SEMA6A;MAP2;SEMA3D;SEMA7A;SEMA5A;SEMA4D;SEMA3G;SEMA4A;MAG;SEMA4G;SEMA5B;MT3;RTN4R;SEMA6D;SEMA3B
prerank,membrane protein proteolysis (GO:0033619),0.4539220845988633,1.1598726406568647,0.26706586826347306,0.7917863862415854,1.0,7/37,9.55%,ADAM9;HM13;ADAM10;BACE2;CLPP;MBTPS1;BACE1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4800010400635084,1.1588358693406944,0.2904761904761905,0.7944275755094147,1.0,3/27,1.12%,IRS1;TNFAIP8L3;FGF2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.4645952809436102,1.1586727602445095,0.27995255041518385,0.7942177516335025,1.0,6/33,5.88%,ADAM9;MUC1;CYP1B1;TGFB2;ADA;FOXC2
prerank,myeloid dendritic cell activation (GO:0001773),0.5583621490005137,1.1583504457963925,0.2857142857142857,0.7945908936213029,1.0,4/12,20.97%,TGFBR2;HMGB1;CAMK4;IL4
prerank,respiratory system development (GO:0060541),0.4616670855013156,1.1581087250024944,0.2835648148148148,0.7946775570268857,1.0,7/32,9.71%,VEGFA;FGF2;GLI2;DISP1;CCDC39;BMP4;FGFR2
prerank,amino acid import across plasma membrane (GO:0089718),0.4800377523900284,1.1580301261098491,0.2908622908622909,0.7942216230133832,1.0,2/24,3.80%,SLC47A1;SLC1A5
prerank,lung epithelium development (GO:0060428),0.5835389999237421,1.1578990674466412,0.31107954545454547,0.7939281839358406,1.0,2/10,9.70%,PKD1;BMP4
prerank,positive regulation of sodium ion transport (GO:0010765),-0.4507182100324962,-1.1570724633476204,0.2971246006389776,0.6402100988955011,1.0,7/12,20.86%,CNKSR3;GPD1L;NOS1;PKP2;ANK3;SCN3B;SCN5A
prerank,protein-containing complex disassembly (GO:0032984),0.4352285703199832,1.1568109557767792,0.26840317100792754,0.7967545027064006,1.0,21/54,30.24%,LRP6;VCP;DVL1;LIX1L;WIPI2;FZD5;AXIN1;VIPAS39;CHMP3;UBQLN1;CLN3;PYM1;LAMP2;UVRAG;VTI1B;DVL2;VPS16;CSNK1A1;FZD1;STX17;CTNNB1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4729098427040084,1.1565660167948855,0.28299643281807374,0.7968568001162745,1.0,3/29,1.12%,IRS1;TNFAIP8L3;FGF2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5845568410241169,1.1565418361287763,0.2991202346041056,0.796188173952079,1.0,6/10,24.64%,MUC1;FOXM1;ING4;HIPK2;TP53;RPS27L
prerank,regulation of synapse assembly (GO:0051963),0.441103671505798,1.1565051481321045,0.27586206896551724,0.7955662822919459,1.0,11/46,13.02%,SLIT1;GPC6;EPHB2;CLSTN2;LRFN4;EPHB3;CHRNB2;MUSK;SETD5;EIF4G1;NLGN1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5178531082559392,1.156439669527858,0.29815303430079154,0.7950241087908122,1.0,7/17,19.17%,PID1;HDAC4;ACTN3;GIT1;PARP1;FLCN;MLXIPL
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.41531581340233154,1.1564271173381901,0.2497331910352188,0.7943061945373178,1.0,12/80,13.71%,THBS1;VEGFA;GAS6;MAP3K5;CSNK2A1;CARD16;HMGB1;RAF1;BCAP31;F2R;YWHAE;CASP1
prerank,morphogenesis of an epithelium (GO:0002009),0.48565168801219744,1.1564088959497885,0.29171817058096416,0.7936028655055204,1.0,3/25,9.71%,LRP6;SOX9;FGFR2
prerank,neural crest cell development (GO:0014032),-0.3297380849910675,-1.1563114420183167,0.20422535211267606,0.6399122511477546,1.0,19/44,23.36%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;TBX1;ERBB4;CORO1C;CDH2;SEMA4D;SEMA3G;SEMA4A;SOX11;HTR2B;SEMA4G;SEMA5B;SEMA6D;SEMA3B;NRTN;NRG1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.41177657675318957,1.1563076792814235,0.2116788321167883,0.7932056242768909,1.0,38/95,25.59%,CSNK1D;DYNC1H1;SFI1;ODF2;ALMS1;CC2D2A;TCTN1;IQCB1;DCTN2;TMEM216;CKAP5;RPGRIP1L;SDCCAG8;AKAP9;CEP164;CSNK1E;YWHAE;MARK4;CEP41;CEP63;PCM1;HAUS5;DYNC1I2;DCTN1;KIF24;PRKACA;ACTR1A;CDK5RAP2;NEDD1;NPHP4;PLK4;CEP89;TCTN3;CNTRL;TMEM67;TUBB4B;FBF1;CCP110
prerank,negative regulation of protein secretion (GO:0050709),0.45628659659363546,1.1553268913990822,0.27985948477751754,0.7958943119912797,1.0,3/38,1.72%,IRS1;KCNB1;CCN3
prerank,mRNA modification (GO:0016556),0.4935880719865202,1.1547798499334698,0.2862644415917843,0.7970118247201161,1.0,10/22,26.91%,TRMT61B;METTL16;PUS3;TRUB1;TRMT6;TRMT61A;PUS1;METTL8;METTL14;DKC1
prerank,response to lipopolysaccharide (GO:0032496),0.40186387408438295,1.1547637839297498,0.19713993871297242,0.7963114200587094,1.0,27/138,15.26%,FOXP1;LBP;ADAM9;PDCD4;SMAD6;CARD16;SHPK;TNFRSF1B;HMGB1;IRAK3;TRIM41;LIAS;RHOA;SBNO2;MAPK8;NFKBIB;IRAK1;TAB2;GIT1;PABPN1;F2R;CD80;CASP1;SRR;PRDX3;CYP27B1;IL6
prerank,positive regulation of fat cell differentiation (GO:0045600),0.4388369159398677,1.1544731313406587,0.2679372197309417,0.7965175028468603,1.0,8/47,9.74%,SIX1;CMKLR1;ID2;LRP5;TFE3;CARM1;TRPM4;SYAP1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4154227548797434,1.1544013760583902,0.25374732334047106,0.7960160890072645,1.0,24/71,22.57%,FAP;HM13;VCP;PSMA8;CLPP;SOCS6;DDI2;CAPN2;LONP1;PSMA6;ATE1;NGLY1;STUB1;HDAC6;IDE;RPS27A;UBC;CTSZ;ZRANB1;CHMP4B;PDCD6IP;CTSB;CTSK;CTSO
prerank,negative regulation of kinase activity (GO:0033673),0.427682424156317,1.1540733999513417,0.257847533632287,0.7964275203192385,1.0,24/62,25.20%,LRP6;UBASH3B;WWTR1;DVL1;TRIM27;AKT1S1;PAK2;PDPK1;DEPTOR;CHP1;PRDX3;CAMK2N1;GSKIP;NF1;CDKN1C;AKT1;DUSP19;RTRAF;SFN;TSC2;HNRNPU;NPRL2;SMCR8;QARS1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.41394799539224547,1.1540283597655874,0.2589771490750816,0.7958155997178291,1.0,31/77,27.88%,THBS1;TCF7L2;NOL3;CSNK2A2;CSNK2A1;FXN;ACVR1;BMP4;ITGAV;URI1;BCL2L2;MAZ;PHIP;TGFBR1;HGF;SLC35F6;BIRC6;ZMYND11;AKT1;NOC2L;CLU;IL4;SH3RF1;TRIAP1;HERPUD1;PINK1;QARS1;RIPK1;PLAUR;SLC25A5;SCG2
prerank,mitotic metaphase plate congression (GO:0007080),0.43230252196585606,1.153827291293719,0.25733634311512416,0.7957039332376815,1.0,15/51,20.88%,RRS1;SEH1L;CENPC;MAD1L1;DCTN2;EML3;MIS12;ZW10;CHMP3;RMDN1;CDT1;CHMP4A;CHMP4B;PDCD6IP;NUP62
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5348683159554887,1.1533802141577525,0.31923601637107774,0.7964756078168611,1.0,3/14,8.56%,IRS1;TWIST1;AKT2
prerank,regulation of TOR signaling (GO:0032006),0.4193611459215551,1.1522728010468961,0.24565217391304348,0.7994207411126368,1.0,24/67,24.48%,GAS6;NPRL3;SEC13;PKHD1;LAMTOR1;SEH1L;AKT1S1;DGKQ;TELO2;DEPTOR;TMEM127;TBCK;MINAR1;FLCN;ARAF;GOLPH3;UBR2;RHEB;TSC2;RPTOR;NPRL2;SMCR8;FBXO9;FAM83D
prerank,telomere capping (GO:0016233),0.520469364983735,1.1518297892841995,0.3204272363150868,0.8001491922843038,1.0,5/16,15.19%,PRKDC;TEN1;RAD50;DCLRE1B;TFIP11
prerank,regulation of protein modification process (GO:0031399),-0.31186558496740496,-1.1515110157751751,0.2396694214876033,0.6503310596228756,1.0,14/50,16.18%,LYN;GRM5;CDH5;PPP1R16B;CCDC88A;CORO1C;HSPB1;SPRED1;PLXNB2;FN1;CCDC88C;CADM4;PTK2;PML
prerank,negative regulation of bone remodeling (GO:0046851),0.557914686556761,1.1513553467766193,0.29796511627906974,0.8009816930197894,1.0,4/11,17.16%,UBASH3B;TMEM119;IL6;CALCA
prerank,positive regulation of DNA repair (GO:0045739),0.4449965807372228,1.1512775823894674,0.2623138602520046,0.8004565544137663,1.0,11/46,16.88%,EGFR;EYA2;TRIM28;ERCC8;HMGB1;SLF2;SPIDR;FOXM1;SPIRE2;PARP1;FAM168A
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5258448551800112,1.1512174036851666,0.32486631016042783,0.7999156386877625,1.0,5/15,16.23%,EGFR;MVB12B;PTPN18;WDR54;ERBB2
prerank,negative regulation of blood coagulation (GO:0030195),-0.3438609507147576,-1.1511607255822378,0.22857142857142856,0.6490157255637172,1.0,10/38,10.56%,VTN;APOE;NOS3;TFPI;PLAT;F8;PDGFRA;A2M;EDN1;SERPINE1
prerank,Golgi inheritance (GO:0048313),0.5590823877531242,1.1507620453288816,0.3136427566807314,0.800731137295787,1.0,3/11,12.99%,STX5;GBF1;STK25
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.39534471236550217,-1.1505811407031306,0.2600896860986547,0.6482670845556868,1.0,4/19,3.85%,GRM5;RYR2;KDR;VCAM1
prerank,gene silencing by miRNA (GO:0035195),0.46041551996437025,1.1504225659327263,0.29832935560859186,0.8011138700711523,1.0,9/32,15.73%,ZC3H7A;PUM1;PRKRA;AGO1;AGO2;RBM4;LIMD1;CNOT8;EIF6
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.41719400268654516,1.1501331556915178,0.24835886214442013,0.8013315379487513,1.0,24/72,22.06%,FGF2;FGF17;HNRNPH1;SPRED2;RBFOX2;FGFR1;NOG;CBL;FGFR2;GTF2F1;FLRT2;SHOC2;HNRNPM;PTBP1;TIAL1;POLR2F;GALNT3;FGF5;NCBP1;NCBP2;FGF18;FGFR3;HNRNPA1;POLR2B
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.39763801809095756,1.1500137040292988,0.21558704453441296,0.8009912725191419,1.0,21/151,13.07%,BMPER;EGFR;TNFAIP8L3;GAS6;FGF2;NTRK3;NTRK1;FSHR;CCL13;SHC1;CCL15;PRKCA;HMGB1;ROR1;FGFR2;PLA2G5;MAP3K12;P2RY6;ARHGAP8;NRP1;F2R
prerank,P-body assembly (GO:0033962),0.5399531240225132,1.1498839759602062,0.30694444444444446,0.8007202246216588,1.0,4/12,21.61%,DYNC1H1;PATL1;LIMD1;ATXN2
prerank,cardiac atrium morphogenesis (GO:0003209),-0.4085300419448171,-1.149864187273456,0.25,0.6478753012237065,1.0,7/16,18.01%,ENG;NOTCH1;PROX1;BMPR2;HEY2;BMP2;DLL4
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.45724220399677173,1.1497155082363932,0.28688524590163933,0.8005700534622273,1.0,12/37,19.33%,FHIT;CSNK2A2;CSNK2A1;CCAR2;GIPC1;OGT;USP7;TLK2;N4BP1;RYBP;HIPK2;UCHL5
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4458337765679413,-1.1491645010207705,0.28013029315960913,0.647426614999166,1.0,4/12,9.47%,PPARA;ABCG1;NR1H3;ABCA5
prerank,positive regulation of cell junction assembly (GO:1901890),0.42741666646900667,1.1487280970952933,0.28619528619528617,0.8031482139776027,1.0,7/56,5.98%,MYOC;VEGFA;COL16A1;EPHB2;CLSTN2;EPHB3;S100A10
prerank,negative regulation of interleukin-1 production (GO:0032692),0.48740086785443504,1.1483218862817355,0.3052109181141439,0.8037677869260755,1.0,3/23,11.17%,GAS6;CARD16;GIT1
prerank,DNA alkylation (GO:0006305),0.5043394600014722,1.1481015116874371,0.30474934036939316,0.8030468562519477,1.0,8/19,26.55%,BAZ2A;TEX15;EHMT1;MTRR;FOS;DNMT1;EHMT2;DNMT3A
prerank,DNA methylation or demethylation (GO:0044728),0.5043394600014722,1.1481015116874371,0.30474934036939316,0.8030468562519477,1.0,8/19,26.55%,BAZ2A;TEX15;EHMT1;MTRR;FOS;DNMT1;EHMT2;DNMT3A
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.40168502200889067,1.1479426275420437,0.20264765784114053,0.8028187279306801,1.0,51/146,25.78%,FHL1;FBXL7;PSMD7;CSNK1D;DYNC1H1;SFI1;PSMA8;BRD4;ODF2;ALMS1;DCTN2;PSMA4;CDC25B;CKAP5;PSMD12;RCC2;SDCCAG8;AKAP9;CUL1;CEP164;CSNK1E;PSMA6;YWHAE;PSMD1;CEP41;CEP63;PCM1;PSMC5;HAUS5;PSMD11;PSMC4;PSMD14;CDC25A;CDK2;DYNC1I2;PSMA3;DCTN1;PRKACA;PSMB1;PSMD4;USP47;ACTR1A;CDK5RAP2;NEDD1;PSMA5;PSMA7;PLK4;CNTRL;TUBB4B;CCP110;PSMC1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.44348256532058816,-1.147382490211105,0.30935251798561153,0.6498977434222866,1.0,4/12,13.56%,CYP26B1;CNOT1;KLF2;TRIM16
prerank,proteoglycan biosynthetic process (GO:0030166),0.4584985821143882,1.1473171287224948,0.29952267303102625,0.8042834420077537,1.0,3/31,2.94%,EXT1;XYLT1;CHST11
prerank,vitamin D metabolic process (GO:0042359),0.5270071988050089,1.1468243519128445,0.3153526970954357,0.8051953205398067,1.0,4/13,14.77%,LRP2;PIAS4;VDR;CYP27B1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.41781212768602266,1.1467758060275794,0.26652221018418204,0.8046083121962762,1.0,24/74,23.58%,VEGFA;PSMD7;PSMA8;NFE2L2;PSMA4;PSMD12;PSMA6;LIMD1;PSMD1;SIRT2;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;RPS27A;UBC;HIGD1A;CITED2;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7
prerank,aminoglycan metabolic process (GO:0006022),0.5769047078476993,1.1467490374900648,0.31486880466472306,0.8039369912362828,1.0,1/10,0.50%,XYLT1
prerank,renal filtration (GO:0097205),0.5681196323139683,1.1460695457728245,0.32023289665211063,0.8054402212867664,1.0,3/10,6.57%,TBC1D8B;MYO1E;SULF1
prerank,sphingolipid catabolic process (GO:0030149),0.5254056616789115,1.1458877440960942,0.3224115334207077,0.80530738649494,1.0,4/15,9.61%,ACER3;PDXDC1;SMPD4;SMPDL3A
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4785847599858196,1.1456826282707235,0.29615861214374223,0.80521417173742,1.0,7/25,11.28%,ZNF423;FOXD1;HES5;SMAD4;SULF1;BMP4;BMPR1A
prerank,aorta development (GO:0035904),-0.4236345384297912,-1.1454959437512202,0.2980392156862745,0.652571379237359,1.0,8/14,14.97%,ROBO1;ROBO2;PDGFRB;TBX1;PDE2A;TBX2;EFEMP2;APLNR
prerank,protein kinase A signaling (GO:0010737),0.5528083184408771,1.145388461108606,0.31761442441054094,0.8054504797550119,1.0,3/12,12.28%,TCP11;RDX;EZR
prerank,V(D)J recombination (GO:0033151),0.555524773436873,1.1453369223894838,0.31671554252199413,0.8048637319972237,1.0,4/11,19.79%,PRKDC;HMGB1;LIG4;TCF3
prerank,vasculogenesis (GO:0001570),-0.3379341218349691,-1.1452973782556377,0.2275449101796407,0.6508935656963518,1.0,13/32,15.10%,TGFBR3;ENG;NOTCH1;KDR;RASIP1;PDGFRB;SOX17;SPRED1;CAV1;SOX18;HEY2;APLNR;ITGB8
prerank,homotypic cell-cell adhesion (GO:0034109),0.44519133722135507,1.1452500422572554,0.2868663594470046,0.8044259977083791,1.0,4/39,5.92%,GNAS;UBASH3B;PLPP3;ILK
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5422842856667934,1.1451856029499188,0.3106796116504854,0.8039014813229313,1.0,8/13,14.45%,NUP93;TGFB3;SMAD4;BMP4;SH2B1;BMPR1A;TGFBR1;DAB2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5004773040838337,1.1450977536171352,0.3150326797385621,0.8034326170950847,1.0,7/19,22.54%,DLG2;CLIC4;CRB1;DLG1;CRB2;ERBIN;PRKCI
prerank,peptidyl-lysine methylation (GO:0018022),0.4815989268069464,1.1449637357884463,0.33496932515337424,0.8031267118656499,1.0,12/26,26.51%,EEF1AKMT3;KMT5A;EHMT1;EEF1AKMT2;SETD4;SUV39H2;SUV39H1;SETD2;SMYD2;TRMT112;EHMT2;SETD7
prerank,regulation of protein targeting to membrane (GO:0090313),0.468159624303857,1.1448886185521123,0.32598039215686275,0.8026739719045543,1.0,7/28,16.23%,KCNB1;GDI1;C2CD5;MIEF2;AKT2;CHP1;ERBB2
prerank,regulation of intracellular transport (GO:0032386),0.44457223465002227,1.1448461900328148,0.30409356725146197,0.8021020701914879,1.0,14/38,21.66%,GAS1;DYNC1H1;DYNLT2B;CAPN10;SCFD1;ATP9A;RAB11B;RBM4;NDEL1;RINT1;GRIPAP1;REEP5;LAMP1;LRRK2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.39497399354635043,1.1446128554800743,0.23323013415892674,0.8021142650491663,1.0,21/140,13.07%,ESR1;CACNA1C;CMKLR1;PLCE1;PROK2;TAC4;DRD1;C1QTNF1;EDNRA;ADCY8;HMGB1;FPR3;DLG4;GPR20;IAPP;ACKR4;TRPM4;ABL1;BCAP31;GLP1R;F2R
prerank,kidney development (GO:0001822),0.4250507143603879,1.144587194168414,0.26991150442477874,0.801462255948804,1.0,16/65,19.34%,SIX1;PKD1;VEGFA;PCSK5;GLI2;TGFB2;SULF1;PYGO1;BMP4;TGFBR1;IFT88;NPHP3;NF1;NIPBL;GDNF;SULF2
prerank,female gonad development (GO:0008585),0.4999309746385696,1.1442990123326198,0.32020997375328086,0.8017161474458527,1.0,5/19,13.03%,VEGFA;FSHR;CYP19A1;SOD1;INHBA
prerank,negative regulation of catabolic process (GO:0009895),0.43785351972132747,1.1441918031159397,0.2826086956521739,0.801329247062237,1.0,11/47,16.82%,EGFR;HDAC4;ACTN3;RILP;IRAK3;MDM4;CST3;GIT1;CIDEA;SIRT2;AZIN1
prerank,intracellular cholesterol transport (GO:0032367),0.5290149204417498,1.1440943908076047,0.3204272363150868,0.8009439556491583,1.0,4/15,13.71%,LRP6;NPC1;OSBP;ABCA1
prerank,Rho protein signal transduction (GO:0007266),-0.3104851558233346,-1.1439946579123559,0.2247191011235955,0.6521453984173441,1.0,15/53,9.23%,ARHGAP29;ROCK2;ARHGAP6;CDH13;ARHGEF3;EPS8;CDC42EP4;ADRA2A;ARHGDIA;GNA13;CDC42EP3;AGTR1;CDC42;EPS8L2;RHOU
prerank,establishment of epithelial cell polarity (GO:0090162),0.5049001989392422,1.1437501006120965,0.3040103492884864,0.8013648756267421,1.0,10/19,26.52%,CYTH3;RHOA;SYNE4;MYO9A;EZR;SIPA1L3;GOLPH3;CAMSAP3;FBF1;PARD3
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4646746013727284,1.1436080724630582,0.29891956782713086,0.8011175429310994,1.0,9/33,15.69%,HOXA5;ACVR1B;RAB7B;STAT3;PRKDC;PITHD1;INHBA;SCIN;FOXO3
prerank,regulation of actin filament-based process (GO:0032970),0.4149780721085754,1.1435927880071444,0.26275787187839306,0.8004564520784025,1.0,14/70,15.54%,PRKCD;RHOBTB1;EFNA5;LRP1;RHOQ;RND3;ARHGAP17;CDK10;RHOA;ABL1;EZR;ARHGAP44;RHOB;IQGAP1
prerank,neurotransmitter secretion (GO:0007269),-0.31834993939223116,-1.1434514937891522,0.23140495867768596,0.6513969723863114,1.0,17/44,22.23%,NRXN1;LIN7A;RIMS2;RIMS1;PIP5K1C;SYN2;SYN1;STXBP3;SYT10;SNCA;GAD1;SNAP25;SLC32A1;PTPRN2;GRM4;CPLX2;PDZD11
prerank,transferrin transport (GO:0033572),0.45762746311577507,1.1432915511658872,0.2961165048543689,0.8007774938871947,1.0,14/33,25.08%,ATP6V1C2;TCIRG1;DNM2;ATP6V0A1;ATP6V0D1;ATP6V1B2;RAB11B;CLTC;ATP6V1E1;ATP6V1C1;STEAP3;ATP6V0E1;LMTK2;ATP6V0B
prerank,regulation of phosphorylation (GO:0042325),0.3963178655417134,1.1432332626083328,0.24768756423432683,0.8002449182410224,1.0,29/120,18.15%,THBS1;EGFR;NUP93;LDB2;LDB1;SEC13;GLMN;RAE1;ILK;SEH1L;FZD7;OGT;BMP4;ROPN1L;NUP37;PHIP;NRP1;SESN2;INHBA;RANBP2;KCTD20;NUP88;SIRT2;EIF6;FLCN;CDKN1C;PRKAG1;POM121;NUP210
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.47050136340218235,1.1431525964855442,0.3075030750307503,0.7998042026803089,1.0,11/26,25.07%,CARD16;TRAFD1;IRAK3;ITCH;MAPKBP1;PCBP2;SIRT2;ACOD1;MUL1;C1QBP;ILRUN
prerank,phospholipid transport (GO:0015914),0.4295386552778596,1.1430023151349837,0.2819332566168009,0.7996025583330949,1.0,11/52,11.37%,TNFAIP8L3;TMEM30B;PITPNC1;PRELID3B;ABCC1;PITPNA;PITPNM1;ATP8B2;ATP8A1;PCTP;ATP9A
prerank,actin cytoskeleton reorganization (GO:0031532),-0.29374094993233013,-1.1428558651282605,0.25316455696202533,0.6507772115924576,1.0,21/63,13.73%,AUTS2;PHACTR1;PTK7;KIT;TNIK;NEDD9;PARVB;RICTOR;CXADR;S1PR1;WHAMM;MYH9;SYDE1;GAB1;PAK1;CDC42BPG;PLEK;DTNBP1;PTPN1;THSD7A;FGF7
prerank,regulation of cholesterol storage (GO:0010885),-0.40662612834676876,-1.142823155400773,0.26838235294117646,0.6486725826017136,1.0,8/15,17.37%,PPARA;ABCG1;NR1H3;PPARD;SCARB1;LPL;MSR1;TTC39B
prerank,defense response to symbiont (GO:0140546),-0.2749875602090163,-1.1427946116940726,0.10344827586206896,0.6465751612507936,1.0,20/92,12.63%,SERINC3;BCL2;BCL2L1;IFNAR2;STAT1;AGBL4;ABCC9;SAMHD1;IFITM1;NLRC5;BST2;IFIT3;IFIT2;RNASEL;IFIT1;PQBP1;CD40;RSAD2;IFITM3;OAS2
prerank,limb development (GO:0060173),0.47347091895141347,1.1424452941407228,0.28973105134474325,0.8007586638543303,1.0,3/28,2.64%,SMOC1;PCSK5;COMP
prerank,regulation of protein export from nucleus (GO:0046825),0.4801077982765028,1.1423614364639867,0.3125778331257783,0.8003034199701239,1.0,7/23,13.56%,GAS6;TCF7L2;BAG3;ANP32B;XPO4;UHMK1;YWHAE
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3818365058112572,1.1423203548706493,0.055,0.7997306305955572,1.0,200/834,20.43%,PLAGL1;ESR1;EGFR;LRP6;SIX1;MICAL2;PKD1;PID1;ZFHX3;HOXA5;ZFPM2;VEGFA;NFIX;FGF2;NFIB;TCF7L2;IL33;RARB;ELF4;SMAD9;NFIA;GALR1;DDX17;RHOQ;MUC1;LDB2;LDB1;ZMIZ1;GLI2;TCF20;LRP5;GNL3;GLIS2;TGFB3;TWIST1;PRDM10;NFAT5;HDAC4;ELF1;HOXB3;GCN1;RXRA;ONECUT2;MEOX2;WWTR1;KLF5;TGFB2;STAT3;DCAF6;ATF4;NR2F1;MAVS;BCAS3;KMT2C;ACVR1;BRD4;DVL1;FOXC2;BCL9L;RXRB;PRKDC;SMAD4;NFE2L2;HMGB1;JAG1;MEF2B;SLC9A1;E2F3;PBX1;MEIS3;SKI;HEYL;THRAP3;JUP;ARF4;RPS6KA4;NRIP1;RARA;FOXJ3;MED13;FZD5;SOX9;ESRRB;TFE3;ZNF76;NFATC1;OGT;SBNO2;CDK12;RORA;BMP4;FGFR2;FOXA1;UBP1;CSRNP1;PRDM4;SREBF1;EHF;CHUK;RUNX2;GTF2F1;FOXM1;ABL1;AGO1;RFX5;CCNT2;CSRP3;PLAC8;TERT;NRF1;ATM;BMPR1A;KAT6B;PAXBP1;SFPQ;TAF6;SMAD7;MED25;PHIP;SRF;NR1D2;HEY1;GLIS1;KAT2A;SSBP3;RGMA;HDAC1;AGO2;PTOV1;MEF2D;ZMIZ2;HOXB4;INHBA;KMT2D;MEF2A;RUNX1;NFATC3;SQSTM1;DAB2;BMP5;VDR;MED21;TFDP1;PER1;HGF;IL6;ARRB1;GRHL1;SIRT2;CRTC2;FOXO3;CREB1;CREBBP;PARP1;AATF;ZNF462;RPS27A;UBC;APBB1;KDM6B;DPF3;PRDM2;FLCN;NFKB2;SLC30A9;NR3C1;RFXANK;E4F1;MED14;MEN1;CITED2;HMGA1;ATAD2B;MED12;E2F1;HCFC1;GDNF;ATF2;CCDC62;CHD8;HIPK2;KLF10;HOXB2;MLXIPL;BRD8;FOSL2;XRCC6;LARP7;IRF3;VEZF1;MPND;NFKBIA;TCF3;DLGAP5;ATF6;MAX;BPTF;TET2;RTRAF;KAT7
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.4969076477236701,1.1422483322410162,0.301460823373174,0.7992511517953996,1.0,3/20,1.20%,KCNJ2;ATP1B1;SLC12A2
prerank,negative regulation of defense response to virus (GO:0050687),0.5669992515574198,1.1420708128933936,0.32215743440233235,0.7991422130950022,1.0,6/10,27.83%,ITCH;PCBP2;MUL1;C1QBP;ILRUN;PPM1B
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.5603231680304828,1.1419805381306758,0.32703488372093026,0.7987365638462681,1.0,1/10,0.33%,LRP6
prerank,oligosaccharide metabolic process (GO:0009311),0.43858078875853823,1.141959412574707,0.2866817155756208,0.7980707435332582,1.0,9/46,11.98%,ST3GAL4;ST8SIA2;ST6GALNAC5;B4GALT1;ST3GAL2;FUT8;MAN2C1;FUT4;GAL3ST4
prerank,fatty acid catabolic process (GO:0009062),0.4183968031354212,1.1414620285464723,0.27044711014176664,0.798944225303832,1.0,30/67,29.64%,ABCD3;EHHADH;ECHDC2;CEL;ECI2;PEX13;AUH;ACAT1;ALDH3A2;BDH2;HACL1;PLA2G15;MCEE;PHYH;SLC27A2;PCCB;PEX2;ABCD1;ACBD5;ECHDC1;MCAT;HADHA;ACOT8;FAAH;MTLN;ACAT2;ABHD3;SCP2;ECI1;CPT2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.5353966535521071,1.141130108098322,0.32,0.7993157897479497,1.0,3/13,8.27%,CHRDL1;FSTL1;NOG
prerank,sodium-independent organic anion transport (GO:0043252),0.5699282233241281,1.1410657429273792,0.3313521545319465,0.7988125277740132,1.0,2/10,1.18%,SLCO3A1;SLCO2A1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5086387608587212,1.1407934081260873,0.3059299191374663,0.7990143890637866,1.0,9/16,31.92%,PIGW;PIGF;PIGL;PIGX;PIGV;PIGQ;PIGB;PIGN;PIGC
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4070442786764326,1.1402237533865733,0.2711864406779661,0.8000689170425742,1.0,27/76,27.14%,PRICKLE1;GNL3;HDAC4;DCUN1D5;HUWE1;CDK5RAP3;WDR48;AXIN1;SMAD7;DCUN1D2;TANK;PHF23;UBQLN1;PIAS4;STUB1;RWDD3;SAE1;MYCBP2;MUL1;LRRK2;BIRC3;DERL1;PINK1;RCHY1;XIAP;NDFIP1;RIPK2
prerank,DNA-dependent DNA replication (GO:0006261),0.3976198092541815,1.1400704868606626,0.26278118609406953,0.7998684900361096,1.0,47/128,27.40%,HELB;REV3L;PSMD7;MCMDC2;POLE2;PSMA8;MCM2;CDC6;PSMA4;WRN;PSMD12;PSMA6;CDC45;GINS4;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;RPS27A;UBC;MCM4;POLG2;POLB;ORC2;HMGA1;CDT1;DBF4;RAD51;CDK2;TWNK;PSMA3;PSMB1;PSMD4;TOPBP1;PSMA5;PSMA7;PRIMPOL;PRIM1;RECQL5;POLD1;PSMC1;MCM7;POLG;RPAIN;PSMA1;PNKP
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.37064095752090115,-1.1400387886595378,0.26903553299492383,0.6517002609598338,1.0,6/24,11.86%,PECAM1;VCAM1;F11R;SYK;SEMA4D;ITGA4
prerank,dicarboxylic acid transport (GO:0006835),0.4707596104449716,1.1396664427285499,0.3026634382566586,0.8005066068395714,1.0,4/28,7.58%,SLC26A7;SLC26A6;SLC25A32;GIPC1
prerank,peptidyl-methionine modification (GO:0018206),0.542368315936736,1.1394190202890255,0.3184979137691238,0.8006476869138999,1.0,8/12,33.34%,NAA60;NAA16;METAP1D;METAP2;NAA15;NAA25;METAP1;NAA20
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5663754987322446,1.1390240079920728,0.32220609579100146,0.8012405418053518,1.0,6/10,29.79%,BAG3;IMPACT;SIRT2;CITED2;NCK1;DNAJB1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5575780954388718,1.1388944439603557,0.3089080459770115,0.800956544936994,1.0,7/11,32.29%,TENT4B;EXOSC4;LARP7;FBL;DKC1;EXOSC2;EXOSC3
prerank,positive regulation of translation (GO:0045727),0.4020004745041278,1.1385134781177613,0.271474019088017,0.8014941004540413,1.0,32/94,27.87%,THBS1;YBX3;RCC1L;SAMD4A;MPV17L2;PRKDC;RMND1;CDC123;NIBAN1;KHDRBS1;UHMK1;AGO2;IL6;EIF6;ERBB2;EIF3D;FASTKD3;PYM1;CIRBP;FXR2;UPF3A;RPS6KB1;EIF5A2;RPS9;RPS27L;UPF3B;RBM3;C1QBP;METTL14;USP16;FXR1;YTHDF1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5438381670183275,1.1384697108762267,0.32167832167832167,0.8009301669596655,1.0,6/11,33.37%,IPO4;CABIN1;UBN1;H3-3A;HIRA;HAT1
prerank,calcium-mediated signaling (GO:0019722),0.4017527666421093,1.1383138140790159,0.25026178010471206,0.8007090248116907,1.0,17/93,13.87%,EGFR;CACNA1C;PLCE1;ATP1B1;PPP1R9B;MCU;SLC9A1;ANK2;ACKR4;TRPM4;PPP3CC;RCAN1;BCAP31;PDPK1;DEFB1;STIMATE;DMPK
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.38231069787915134,1.1382771631424053,0.14614614614614616,0.8001114929397785,1.0,119/341,26.37%,WWP1;RNF144A;NEDD4;FBXO10;ANAPC5;FBXL7;PSMD7;TOPORS;CDC16;MVB12B;COP1;UBE2B;UBR4;VCP;PSMA8;TOM1L1;UBE2R2;ERCC8;UBE3C;NFE2L2;RNF115;TBX21;TRPC4AP;HUWE1;SYVN1;NTAN1;CBL;RBBP6;WWP2;SHARPIN;PSMA4;ITCH;CUL4A;FBXL4;RNF114;UBE2C;FBXO22;RNF14;PSMD12;ANAPC4;MYLIP;TGFB1I1;FBXL19;PSMA6;PCBP2;USP33;UBQLN1;SQSTM1;FBXL14;RNF11;UBAP1;ATE1;PSMD1;KCTD5;UBE2L6;ANAPC2;ARRB1;STUB1;SIRT2;PSMC5;ANAPC1;PSMD11;KLHL22;PPP2R5C;PSMC4;PSMD14;UBL7;RC3H2;BIRC6;ANAPC10;TRIM13;KCTD17;UBE4A;GID4;NPLOC4;CDC20;RNF7;CDC27;ZFAND2B;ZRANB1;FBXW4;PTPN23;UBE2G2;PCNP;RMND5B;PSMA3;UCHL1;UBAP1L;DCAF11;SMURF2;RNF4;PSMB1;PSMD4;KCTD13;MVB12A;APPBP2;AREL1;TTC3;RNF20;RNF216;PSMA5;RNF146;FBXO11;PSMA7;TAF1;HERPUD1;RNF122;AMFR;ANKRD9;PINK1;RCHY1;UBE2W;UBR3;RNF111;PSMC1;COPS3;RNF126;RNF166;NDFIP1
prerank,regulation of ion transport (GO:0043269),0.41004407701769874,1.138229124383141,0.2849462365591398,0.7995643907695547,1.0,5/76,2.08%,KCNJ2;KCNJ15;NEDD4;SYT8;DRD1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.42153516643869116,1.13801062460168,0.29741863075196406,0.7995802277618356,1.0,32/59,33.57%,TCF7L2;TWIST1;TRIM28;MED27;MED31;MED13;SOX9;RUNX2;AGO1;MED25;IL6;MED26;MED14;MED12;CBFB;MED20;BCLAF1;TP53;MED23;CCNC;MED24;TNRC6A;MED8;SETX;MECP2;MED15;CTNNB1;MOV10;NFKB1;MED1;CEBPB;RELA
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.47075300865401865,1.1377728943735013,0.31774580335731417,0.7996611605126367,1.0,5/29,6.33%,SLIT2;PRKCD;LIMA1;PFN2;SMAD4
prerank,activation of protein kinase activity (GO:0032147),0.4023482589836689,1.1377425254396205,0.27150259067357513,0.7990534793250692,1.0,23/106,11.90%,PRKCD;VEGFA;GAS6;CARD14;NTRK3;GHR;PRRC1;STRADA;TGFB2;ADCY2;ADCY8;TOM1L1;TNFSF15;TGFBR2;ADCY9;PAK4;PAK2;RIPK3;ABL1;IRAK1;AXIN1;PDPK1;TNFRSF10B
prerank,positive regulation of vasculogenesis (GO:2001214),0.5603738476062708,1.1377165276514623,0.34054834054834054,0.7984328158377926,1.0,1/10,0.56%,TMEM100
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.4033533889632923,-1.1377021781445285,0.32083333333333336,0.6553815887001646,1.0,8/15,26.04%,DDX3X;GBP5;DHX33;MYD88;TREM2;CPTP;CD36;TLR6
prerank,intracellular pH reduction (GO:0051452),0.45726246675189347,1.1375095079723743,0.29759036144578316,0.7983872774720941,1.0,13/33,28.03%,ATP6V1C2;TCIRG1;ATP6V0A1;RAB38;ATP6V0D1;ATP6V1B2;ATP6V1E1;ATP6V1C1;SLC11A1;ATP6V0E1;ATP6V0B;GPR89A;GPR89B
prerank,nucleosome disassembly (GO:0006337),0.5255276698908171,1.1374013317567135,0.31799729364005414,0.7973063644908798,1.0,7/14,29.70%,SMARCC2;NFE2;HMGA1;SMARCA4;ARID1A;SMARCD2;SMARCC1
prerank,chromatin disassembly (GO:0031498),0.5255276698908171,1.1374013317567135,0.31799729364005414,0.7973063644908798,1.0,7/14,29.70%,SMARCC2;NFE2;HMGA1;SMARCA4;ARID1A;SMARCD2;SMARCC1
prerank,phosphate ion homeostasis (GO:0055062),0.5605578412499828,1.137323416686699,0.3265602322206096,0.7968671312086336,1.0,1/10,1.33%,SFRP4
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3547103220765079,-1.1371869631003786,0.22988505747126436,0.6544548995766487,1.0,6/28,4.15%,PTN;APOE;SHANK3;EPHA4;APP;ADCY1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.37742423426220323,1.1371328624062291,0.014,0.7967671535601814,1.0,419/1667,21.64%,TBX15;FOXP2;PLAGL1;ESR1;EGFR;LRP6;SIX1;FOXP1;PKD1;PID1;KLF12;ZBTB7C;ID2;PRRX1;ZFHX3;HOXA5;ZFPM2;VEGFA;HIVEP3;PBX3;NFIX;FGF2;HOXA3;FOXD1;NFIB;SKIL;TCF7L2;IL33;RARB;TWIST2;ELF4;DDX5;HOXB6;MKX;SMAD9;NFIA;GALR1;DDX17;RHOQ;ZIM3;MUC1;ZFHX4;SMAD6;LDB2;LDB1;ZMIZ1;PRRX2;JDP2;GLI2;PRDM5;TCF20;DMTF1;LRP5;NCOR2;GLIS2;TGFB3;TWIST1;JMJD1C;HOXC6;DEAF1;LHX9;HDAC9;SP140;CUX1;PRDM10;NFAT5;HDAC4;CAMK2D;STAT5A;SIX5;ELF1;HOXB3;RXRA;ONECUT2;MEOX2;MED13L;WWTR1;HES5;KLF5;SIX4;STAT3;ZBTB25;DCAF6;ANXA4;TCF7L1;ZNF250;PHF21A;TARBP1;KMT5A;ATF4;CCNL2;TRIM28;MAMSTR;ZFP14;NR2F1;MAVS;CHD3;TCFL5;BCAS3;GMEB1;USP2;TLE6;TADA1;KMT2C;DACT1;ACVR1;BRD4;DVL1;PRDM6;FOXC2;ZNF25;MIDEAS;BCL9L;RXRB;NFX1;PRKDC;LBX2;PER3;SAFB;SMAD4;MRGBP;NFE2L2;BHLHE40;HMGB1;PKNOX2;JAG1;MEF2B;ZNF471;SLC9A1;RFX7;EZH1;TADA2A;E2F3;FUS;PBX1;TSHZ2;CREG1;MEIS3;BRWD1;SKI;MED27;ZNF691;HEYL;TBX21;THRAP3;MDM4;JUP;ARF4;RPS6KA4;HOXA9;HOXA6;PURG;CCNL1;TRIM27;IKZF3;MED31;NRIP1;RARA;NSD1;FOXJ3;MED13;FZD5;SOX9;SRA1;NOG;ESRRB;TFE3;RCOR3;BRD3;FOXK1;ENY2;ZNF76;IMPACT;DGKQ;DLG1;NFATC1;FOXL1;SMARCC2;RFX2;SLTM;WWP2;OGT;PSIP1;RBBP8;ZIC1;SBNO2;CDK12;MCPH1;RORA;BMP4;FGFR2;FOXA1;ZBTB2;UBP1;CSRNP1;ZFP90;PRDM4;MIER2;SREBF1;EHF;CHUK;RUNX2;ZNF260;KDM2A;URI1;GTF2F1;FOXM1;ABL1;ZIC4;AGO1;ATN1;RFX5;CCNT2;PHF8;POU6F1;CSRP3;CBX2;PLAC8;ID4;NFE2L1;NRF1;ATM;BMPR1A;HSF4;MAZ;KAT6B;PAXBP1;NEUROD2;KDM5B;RNF14;SFPQ;FOXO6;TAF6;SMAD7;RNF2;MED25;PHIP;FOXP4;SRF;NR1D2;HEY1;GLIS1;EZR;KAT2A;ZNF112;SSBP3;RGMA;FBXL19;HDAC1;AGO2;PTOV1;MEF2D;ZMIZ2;HSPD1;HOXB4;ZNF740;INHBA;BAZ2B;MYPOP;HR;ARID4B;KMT2D;NPAS1;MEF2A;NACC1;RUNX1;NFATC3;ZBTB9;HOXA4;ERF;TIAL1;PIAS4;TCF25;FRK;HEXIM1;SQSTM1;DAB2;BMP5;ZNF148;HNRNPK;EN2;VDR;BRD2;ZKSCAN1;MED21;MAFG;TFDP1;ID1;PER1;HGF;IL6;ARRB1;GRHL1;SIRT2;BRD9;PSMC5;CRTC2;FOXO3;NKX6-2;NFE2;CREB1;VPS72;CREBBP;MED26;PARP1;ERBB2;RPRD1A;AATF;SIN3B;ZNF462;RPS27A;UBC;APBB1;KDM6B;SUMO1;HOXA2;DPF3;NIPBL;PRDM2;MDFI;MTA3;NFYA;CBX5;EFNA1;FLCN;NFKB2;SLC30A9;KLF3;NR3C1;RFXANK;E4F1;MED14;MEN1;LCOR;ZKSCAN7;ORC2;THAP7;HDGFL2;CITED2;HMGA1;ELP4;PCGF2;ATAD2B;MED12;E2F1;SUV39H2;CC2D1B;HCFC1;SUFU;HOXC5;ZBTB32;ZSCAN20;GDNF;ATF2;CCDC62;CHD8;SARS1;HIPK2;KLF10;CRK;HOXB2;MLXIPL;BRD8;SAFB2;FOSL2;CC2D1A;TEAD2;XRCC6;LARP7;IRF3;CBFB;NR3C2;ZNF431;VEZF1;MPND;NFKBIA;WWC2;LEFTY1;TCF3;TAF9B;NFATC4;NOC2L;ATF6;MAX;BPTF;TET2;RTRAF;CALR;IKZF4;KAT7;ZBTB24;HOMEZ;BCL2L12;HOXC8;SUV39H1;MAD2L2;KLF9;GPS2;IL4;ATP2B4;ZKSCAN5;SMURF2;RITA1;YEATS2;RNF4;MED20;BCL11B;SMAD5;IER2;MIER1;CHD2;SENP1;SAP18;POGZ;PEX2;PAF1;NFIC;CEBPD;NR2F6
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.2754976976041047,-1.13693880870308,0.15384615384615385,0.6529754314972153,1.0,26/107,11.55%,ATP1A2;GRM7;GRM5;MCTP1;GRM3;LRRC4C;APP;RIMS2;GRM8;GRID2;NRG3;GRM1;GRIK2;RIMS1;EIF4EBP2;OPHN1;MCTP2;CDH2;SLC8A3;HOMER1;SYN1;LGI1;NMU;CX3CR1;CNTNAP4;CLSTN1
prerank,sodium ion export across plasma membrane (GO:0036376),0.5279845735211853,1.1363744863414584,0.34396671289875175,0.7985811149741816,1.0,3/13,6.94%,SLC4A4;ATP1B1;SLC9A1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.46872789153925243,1.1363636122777594,0.3305785123966942,0.7979009445382682,1.0,9/25,24.57%,RILP;VCP;LAPTM4B;CHMP3;VTA1;CHMP4A;CHMP4B;MVB12A;CHMP2A
prerank,protein-DNA complex assembly (GO:0065004),0.39865673908881105,1.1363548576903124,0.265770423991727,0.7972280737039703,1.0,45/116,26.55%,CHAF1B;PSMD7;CHD1L;PSMA8;NAA60;MCM2;ERCC5;SOX9;CDC6;PSMA4;CUL4A;ANP32B;SPTY2D1;KAT6B;PSMD12;ERCC3;PSMA6;ERCC2;BRD2;PSMD1;PSMC5;PSMD11;PARP1;PSMC4;PSMD14;RPS27A;UBC;MCM4;ORC2;NAP1L3;CDT1;NAP1L2;RAD51;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;H3-3A;GTF2H4;DAXX;PSMC1;MCM7;CHAF1A;XPA
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.44550120358828504,-1.1358915732156418,0.29042904290429045,0.653428470647233,1.0,2/11,3.01%,NOVA1;NOVA2
prerank,epidermal cell differentiation (GO:0009913),0.4416002885043998,1.1355299190647439,0.30786773090079816,0.7992809004943214,1.0,14/41,26.23%,ADAM9;CLIC4;JAG1;BCR;ANXA1;ERCC3;HDAC1;ERCC2;PIP5K1A;ASAH1;OPN3;HDAC2;KRT10;CERS3
prerank,positive regulation of myoblast differentiation (GO:0045663),0.516749649356483,1.135397982234881,0.33884297520661155,0.7990390475434568,1.0,1/16,0.03%,BOC
prerank,autophagy of mitochondrion (GO:0000422),0.4481846876632588,1.1352668547364795,0.3014789533560865,0.7987889173636972,1.0,16/38,29.91%,ULK2;WIPI2;ATG3;SQSTM1;RB1CC1;CTSK;ATG9A;PINK1;ATG13;ATG2B;AMBRA1;ULK1;FIS1;CISD2;USP30;PRKN
prerank,regulation of spindle assembly (GO:0090169),0.4731564335017877,1.1347948294093746,0.3110285006195787,0.7995910548957612,1.0,11/25,27.13%,DYNC1H1;EML3;CHMP3;CHMP4B;PDCD6IP;RNF4;SENP6;HNRNPU;CHMP2A;TPR;DRG1
prerank,glutathione biosynthetic process (GO:0006750),0.5452849688778548,1.1347428616935178,0.32336182336182334,0.7990490560823289,1.0,6/11,32.06%,GCLC;GCLM;CHAC2;HAGH;OPLAH;GSS
prerank,DNA strand elongation (GO:0022616),0.49993267084673254,1.1342735734697402,0.3089960886571056,0.7999641116098514,1.0,6/18,16.62%,MCMDC2;TERT;RAD50;DCLRE1B;GINS4;MCM4
prerank,negative regulation of viral release from host cell (GO:1902187),0.528447761642274,1.1340173980870958,0.3356353591160221,0.8001336789518347,1.0,6/13,22.10%,TRIM28;MID2;CHMP3;TRIM26;TRIM13;TRIM8
prerank,positive regulation of transport (GO:0051050),0.40199999629658384,1.1338639219190403,0.26652452025586354,0.7999382585841145,1.0,17/85,14.92%,GAS6;LRP1;GPC3;RXRA;ANXA2;C2CD5;DYNC1H1;CAPN10;AKT2;FCER1G;ANXA1;PLA2G5;CHP1;LMAN2;DAB2;ACSL3;SCIN
prerank,histone H3 acetylation (GO:0043966),0.44171548634712016,1.1337586317828923,0.29638273045507585,0.7996055641016245,1.0,21/40,27.96%,LDB1;TADA1;NAA60;TADA2A;SGF29;KAT14;BRPF3;ING5;KAT6B;WDR5;KAT2A;PER1;ING4;KAT7;YEATS2;TAF6L;MEAF6;KAT2B;BRD1;TAF10;TAF5L
prerank,positive regulation of ERAD pathway (GO:1904294),0.5240089719610798,1.1333592721369166,0.32926829268292684,0.8002263982650669,1.0,6/13,25.04%,NFE2L2;BCAP31;UBQLN1;USP13;HERPUD1;RNFT1
prerank,mitotic sister chromatid segregation (GO:0000070),0.40190185423086067,1.1331357240841307,0.25898520084566595,0.8002266694842599,1.0,28/98,24.57%,TUBG2;SMC4;CSNK2A2;CSNK2A1;KMT5A;RRS1;SEH1L;DCTN2;MCPH1;EML3;PHF8;DIS3L2;MIS12;ZW10;CHMP3;KLHL22;HASPIN;NIPBL;DLGAP5;CHMP4A;CHMP4B;PDCD6IP;NUP62;POGZ;PDS5A;WRAP73;SMC1A;CHMP2A
prerank,regulation of vasoconstriction (GO:0019229),-0.3522452056154138,-1.1330590995017011,0.23115577889447236,0.6588956223705074,1.0,10/27,11.99%,ATP2B1;BDKRB2;ACE;AGTR1;BMPR2;TBXA2R;CAV1;ADRA1A;CHRM3;ACE2
prerank,zinc ion transmembrane transport (GO:0071577),0.48876385486195983,1.1321578518894198,0.3278061224489796,0.8027735119912249,1.0,7/22,16.54%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13;SLC39A3;SLC30A6
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4736031615555742,1.1315766449122153,0.3074027603513174,0.8039040308293661,1.0,4/24,4.67%,PDE11A;TCP11;UBE2B;PDE3A
prerank,Wnt signaling pathway (GO:0016055),0.40320206849009343,1.1315577835713628,0.27263157894736845,0.8032616970459181,1.0,18/92,12.58%,LRP6;WNT9A;TCF7L2;SFRP4;PLPP3;LRP5;NXN;TCF7L1;DVL1;BCL9L;FZD7;FZD5;VPS26A;CSNK1G1;AXIN1;USP34;CUL1;CSNK1E
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3344510878846019,-1.1313918797505658,0.25595238095238093,0.6609066572239554,1.0,11/32,17.93%,MCTP1;RIMS2;RIMS1;MCTP2;SYN1;DTNBP1;SLC30A1;GPER1;PREPL;CAMK2A;SYT11
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.532194111612887,1.1311088524673183,0.34493192133131617,0.8040497396289833,1.0,7/11,33.44%,ATF4;HSPA5;ATF6;CREB3L1;TP53;ATF6B;CEBPB
prerank,negative regulation of protein binding (GO:0032091),0.4110844854357033,1.1306454067410974,0.279144385026738,0.8048768509265111,1.0,22/71,22.68%,PRKCD;LRPAP1;PTPRF;CARD16;DACT1;DVL1;TMC8;SYMPK;EFHB;MAPK8;GTF2F1;CSNK1E;USP33;DAB2;MITD1;TFIP11;STYX;AKT1;CTSZ;LRRK2;CAMK1;PEX14
prerank,purine ribonucleotide transport (GO:0015868),-0.40900118931045903,-1.130591867525071,0.2723735408560311,0.6608111454199103,1.0,2/16,2.40%,ABCC4;LRRC8C
prerank,innate immune response in mucosa (GO:0002227),0.5565750555022041,1.130059444475921,0.3467966573816156,0.8060738425782674,1.0,3/10,20.97%,RNASE3;DEFB1;IL4
prerank,negative regulation of hippo signaling (GO:0035331),0.5396755000509841,1.1289805455485318,0.3424068767908309,0.8088386019085501,1.0,5/12,23.46%,CIT;LIMD1;WWC2;MAP2K3;DLG5
prerank,double-strand break repair via break-induced replication (GO:0000727),0.5457522305244868,1.128876136953867,0.32821229050279327,0.8084418944921972,1.0,5/12,16.62%,MCMDC2;MCM2;CDC45;GINS4;MCM4
prerank,dicarboxylic acid metabolic process (GO:0043648),0.43161528623138806,1.1287842848231258,0.31007751937984496,0.8080398700153812,1.0,27/52,33.96%,ME1;GCLC;SLC25A32;MTRR;MTHFD2;MDH1B;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR;GCLM;PHYH;ACOT8;HOGA1;L2HGDH;ACLY;FPGS;MDH2;NIT2;DGLUCY;IDH2;IDH1;SDHA;ALDH18A1;SDHAF3;DHFR
prerank,platelet aggregation (GO:0070527),0.4527077807296217,1.12870714621974,0.29523809523809524,0.8076128415018446,1.0,3/33,5.92%,GNAS;UBASH3B;ILK
prerank,inositol phosphate metabolic process (GO:0043647),-0.3021439567092077,-1.1283851018133622,0.21374045801526717,0.664372967837663,1.0,10/46,8.82%,PLCB1;INPP4B;ITPKB;INPP5D;ISYNA1;NUDT4;PLCB4;PLCH1;IP6K2;PLCD1
prerank,receptor clustering (GO:0043113),0.4651757670152533,1.1281116344229196,0.31901840490797545,0.8088262908739505,1.0,8/27,13.74%,DLG2;DVL1;DLG4;DLG1;NRXN2;MUSK;NLGN1;PICK1
prerank,apical protein localization (GO:0045176),-0.4565373592106603,-1.1281095226776923,0.3104575163398693,0.6629627751343352,1.0,6/10,20.24%,SHROOM2;MAL;INSC;VANGL2;SHROOM3;ACTB
prerank,response to organophosphorus (GO:0046683),-0.40162606653137406,-1.1278872137917586,0.29545454545454547,0.6614003950276846,1.0,6/16,13.56%,STAT1;TRPC3;ABCC9;TYMS;RFC3;TRIM16
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.4686455876565769,-1.1278376863245552,0.33448275862068966,0.6594182985266986,1.0,4/10,3.11%,ATP1A2;NEDD4L;OSR1;HECW2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.3429929371342375,-1.1278047896663288,0.2565217391304348,0.6573605795066682,1.0,1/26,0.01%,ATP1A2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4569008108749699,1.1274008053964777,0.31736526946107785,0.8103976421010108,1.0,12/30,24.28%,FHIT;CCAR2;GIPC1;OGT;USP7;TLK2;N4BP1;STYX;RYBP;UCHL5;USP14;CAMLG
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4367074763966751,1.126918749666024,0.3079584775086505,0.8113127193075419,1.0,18/46,17.43%,ZNF423;NPR3;DOCK7;ATF4;ACTN3;FOXC2;ACOT11;PGAM5;TFE3;TLE3;IP6K1;PCTP;ABHD6;CIDEA;LNPEP;ID1;FLCN;ACOT13
prerank,lymphocyte migration (GO:0072676),0.4559296862539002,1.126793272114138,0.3048065650644783,0.8110098286215875,1.0,4/32,9.77%,CCL13;CCL15;TBX21;CRTAM
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5481178793467386,1.1265655738642673,0.35244755244755244,0.8110784601889506,1.0,8/11,35.59%,ATL2;LPCAT3;BNIP1;ATL1;ARL6IP1;VCPIP1;STX18;MOSPD3
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3923245033928748,1.1264008808870738,0.23139653414882771,0.8108921815925252,1.0,51/152,22.11%,EGFR;GPC3;COL1A1;SFRP4;RSPO3;PLEKHA4;ATP6V1C2;PSMD7;CSNK1D;CSNK2A1;UBE2B;VCP;PSMA8;DACT1;ILK;CCAR2;LBX2;SULF1;SKI;RSPO1;JUP;TRPM4;PSMA4;FGFR2;CSNK1G1;UBR5;TERT;AXIN1;PSMD12;USP34;CSNK1E;PSMA6;WNK1;TNKS2;PSMD1;PSMC5;GSKIP;PSMD11;PSMC4;PSMD14;DAPK3;SULF2;ZRANB1;PSMA3;DEPDC1B;SMURF2;PSMB1;PSMD4;LRRK2;CSNK1G3;USP47
prerank,regulation of hippo signaling (GO:0035330),0.5038843182594394,1.1261399897650728,0.32113821138211385,0.8110476411435239,1.0,7/17,23.46%,CIT;MOB3B;LIMD1;WWC2;MAP2K3;NEK8;DLG5
prerank,cell differentiation in hindbrain (GO:0021533),-0.447165292094465,-1.1261318757798686,0.31353135313531355,0.6595924310488462,1.0,7/11,24.35%,GRID2;PROX1;OPHN1;FAIM2;LHX1;CBLN1;CEND1
prerank,protein localization to vacuole (GO:0072665),-0.4373966202445343,-1.1259928744893788,0.2676056338028169,0.6578201529143969,1.0,7/13,27.44%,LAMTOR5;SH3BP4;ATP13A2;LAMTOR4;LMBRD1;RTN4;MFSD1
prerank,ncRNA 3'-end processing (GO:0043628),0.507875085296349,1.1258392117543294,0.33962264150943394,0.8114206116365514,1.0,8/14,33.18%,INTS14;SSB;ELAC2;TOE1;INTS7;ERI1;INTS6;TRNT1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.39631211796798504,1.1255212145528848,0.29283489096573206,0.8117606459420619,1.0,18/101,13.71%,LBP;ADAM9;PDCD4;PRKCE;CARD16;SHPK;TNFRSF1B;HMGB1;TRIM41;RHOA;SBNO2;MAPK8;NFKBIB;IRAK1;GIT1;PABPN1;CD80;CASP1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3788815599557263,1.1254231204117313,0.16716716716716717,0.8113706039331214,1.0,59/348,13.74%,SLC38A2;PID1;ID2;HOXA5;VEGFA;GAS6;F3;FGF2;FOXD1;IL33;GSN;SFRP4;SLC24A3;EMILIN1;NTRK3;ECE1;FGF17;DRD1;RDX;EPHB2;C1QTNF1;TWIST1;ANXA2;STAT3;CD3E;ATF4;TRIM28;RAMP2;AGR2;FAM98A;NFE2L2;ANK2;SOX9;NOG;DGKQ;NSF;MAPK8;BMP4;ITCH;TMEM119;FAM98B;MUSK;RESF1;UBR5;AGO1;ATM;MAZ;FUBP1;HEY1;EZR;PIK3CB;TGFBR1;SERPINB9;AGO2;SMO;INHBA;SETDB1;ERP29;PICK1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.558766708960313,1.1251937523281452,0.36486486486486486,0.810750203984027,1.0,5/10,20.46%,AP2A1;MYLIP;AP2A2;CLTC;CLTA
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.558766708960313,1.1251937523281452,0.36486486486486486,0.810750203984027,1.0,5/10,20.46%,AP2A1;MYLIP;AP2A2;CLTC;CLTA
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4174777074995061,1.1248410747375563,0.30406852248394006,0.8112200992603821,1.0,20/68,24.67%,RHOQ;SULT1C2;SULT1C4;ACSF2;ACOT11;AK3;GPAT4;BPNT1;ACAT1;AMPD3;RAB23;GLYAT;EFL1;ACOT13;ACSL6;ENTPD7;LRRK2;MFN1;BAD;ACOT8
prerank,cellular response to lipid (GO:0071396),0.38596778544055566,1.1247785754788753,0.22828282828282828,0.810752288465525,1.0,28/191,11.42%,ESR1;EGFR;IRS1;PID1;WNT9A;LBP;ADAM9;PDCD4;CARD16;SHPK;ADCY2;ADCY8;TNFRSF1B;HMGB1;FZD7;TRIM41;NRIP1;SOX9;RHOA;SBNO2;RORA;MAPK8;URI1;NFKBIB;IRAK1;GIT1;ATM;PABPN1
prerank,GPI anchor biosynthetic process (GO:0006506),0.4602070210868724,1.1243429301547088,0.31365313653136534,0.8114573128795631,1.0,15/30,32.31%,PIGW;GPAA1;PIGF;PIGL;PGAP2;PIGT;DPM3;PIGX;PIGV;PGAP1;PIGQ;PIGB;PIGN;PIGC;PIGO
prerank,atrial septum development (GO:0003283),0.5269318737873913,1.1238430560329338,0.3484848484848485,0.8123571581712874,1.0,4/13,16.20%,TGFB2;ANK2;MDM4;NPHP3
prerank,mucosal immune response (GO:0002385),0.5059320463910914,1.123672088515289,0.3419354838709677,0.8122204966563937,1.0,4/15,20.97%,IFNLR1;RNASE3;DEFB1;IL4
prerank,body fluid secretion (GO:0007589),0.5147577164534147,1.1230357856175321,0.33703190013869627,0.8134926713902821,1.0,3/15,10.43%,VEGFA;GPAT4;VIP
prerank,keratinocyte differentiation (GO:0030216),0.4606567866565837,1.122775077503135,0.3313180169286578,0.8136612014096265,1.0,10/29,26.23%,ADAM9;CLIC4;JAG1;BCR;ANXA1;PIP5K1A;ASAH1;OPN3;KRT10;CERS3
prerank,RNA metabolic process (GO:0016070),0.39092281619023134,1.1226898028050778,0.26557711950970375,0.8132484333946647,1.0,52/127,25.90%,DDX17;HNRNPH1;SIDT2;RBFOX2;RBM39;DUSP11;M1AP;FTO;PPP1R8;HNRNPA2B1;RNASE3;HNRNPL;HNRNPH2;RNASE6;TBRG4;GTF2F1;AGO1;RBM6;RBM5;PABPN1;AGO2;HNRNPM;PCBP2;ALKBH1;PTBP1;RBM4;HNRNPC;SUPV3L1;CLP1;SND1;HNRNPK;POLR2F;TFIP11;TP53RK;NCBP1;NCBP2;SYNCRIP;MTREX;HNRNPH3;TENT2;DHX8;ATXN2;HNRNPA3;HNRNPA1;POLR2B;HNRNPU;PABPC4;RBM3;DDX39B;METTL14;POLR2H;DDX20
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.40815344944000914,1.1223691479683318,0.3042071197411003,0.8136078679068662,1.0,26/76,25.09%,RNF144A;PRICKLE1;CSNK1D;COP1;VCP;DVL1;CDK5RAP3;AXIN1;FBXO22;RNF14;SMAD7;CSNK1E;DAB2;DDA1;STUB1;SIRT2;SUMO1;HECTD1;CLU;USP5;LRRK2;SUMO2;DET1;TAF1;RCHY1;BBS7
prerank,membrane repolarization (GO:0086009),0.5169374470167217,1.1221879650228774,0.33111702127659576,0.8134942642260545,1.0,4/15,6.99%,KCNJ2;ATP1B1;KCNE5;KCNIP2
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.39560468155212475,-1.1221589770157776,0.30223880597014924,0.665834002317956,1.0,5/16,20.76%,TNFRSF21;CD274;TYROBP;DLL1;AGER
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4448538826580173,1.1217419706553633,0.32505910165484636,0.8142619219430612,1.0,2/35,0.54%,PCDHB16;CDH11
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.46417297875492786,1.121735889844665,0.33171324422843257,0.8135966004090794,1.0,6/29,12.60%,TOPORS;DCUN1D5;ABL1;AXIN1;SMAD7;DCUN1D2
prerank,neuron development (GO:0048666),0.38462375218196587,1.121631083515228,0.2619775739041794,0.8132510298254825,1.0,31/141,15.53%,MYOC;PBX3;NEDD4;VSX1;LGI4;STMND1;EHD1;GLI2;LRP12;DOCK7;PPP1R9B;TGFB2;BLOC1S2;HMGB1;GPRIN1;PBX1;TBC1D23;TBC1D24;B4GALT5;SRF;TENM1;UHMK1;NLGN1;BLOC1S3;MANF;RUNX1;WNK1;PLP1;IL6;MICALL2;THOC2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.44633768964253806,1.1214640528058932,0.31092436974789917,0.8130945444635047,1.0,9/33,17.46%,FGF2;GNL3;KLF5;TGFB2;STAT3;TERT;SRF;FOXO3;NR3C1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.40043937253995354,1.1213574291477404,0.28753993610223644,0.8127625345406028,1.0,10/88,7.68%,TRABD2B;VEGFA;MPP7;EMILIN1;SDC1;PRKCA;VCP;CDC42EP2;PFN2;SLF2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.500684112445067,1.12123134121055,0.32754010695187163,0.8124695566455208,1.0,9/16,32.75%,HELB;RMI2;MAD2L2;CGAS;FBH1;SHLD3;SHLD1;PARPBP;POLQ
prerank,filopodium assembly (GO:0046847),0.4995679879824084,1.1211569473650858,0.34959349593495936,0.8120191278442189,1.0,3/16,3.62%,SRGAP2;PPP1R9B;FGD6
prerank,calcium ion transport (GO:0006816),0.3877640972651588,1.1209879213050866,0.29356846473029047,0.8119034463130671,1.0,19/113,11.59%,CACNA1G;PKD1;CACNA1C;GAS6;SLC24A3;GRIN3A;CRACR2A;TRPV3;RAMP2;CHRNB2;ANK2;TRPC4AP;TRPM7;TRPM4;STIM1;ITGAV;RAMP1;TMEM165;TRPM6
prerank,inflammatory response (GO:0006954),0.38089305419640523,1.1205370086450026,0.23272357723577236,0.8126506010092011,1.0,20/195,10.27%,THBS1;MGLL;CMKLR1;PROK2;TAC4;CCL13;HDAC9;HDAC4;CCL15;STAT3;ADCY8;NOX4;NFX1;HMGB1;ABCF1;FPR3;LIAS;ANXA1;ITCH;CHUK
prerank,kinetochore organization (GO:0051383),0.5282382141198791,1.1205046020233467,0.3254847645429363,0.8120611121263897,1.0,6/13,21.57%,CENPC;CENPT;MIS12;CDT1;DLGAP5;POGZ
prerank,iron ion homeostasis (GO:0055072),0.4167569880863172,1.1204819733700788,0.3034330011074197,0.8114417941290134,1.0,15/58,15.46%,SCARA5;NEO1;FLVCR1;HMOX2;FXN;SMAD4;ACO1;ATP6V0D1;SOD1;CUL1;CYBRD1;BDH2;ABCB6;FRRS1;IREB2
prerank,DNA replication (GO:0006260),0.39411782860228917,1.1202366714420882,0.27319587628865977,0.8115250423290932,1.0,43/105,30.56%,HELB;REV3L;POLE2;RMI2;MCM2;CDC6;RBBP8;RAD1;WRN;ING5;ATM;RAD50;CDC45;ING4;ATRIP;HUS1;MCM4;POLG2;POLB;REV1;ORC2;DBF4;CDK2;KAT7;TBRG1;UPF1;TOPBP1;PTMS;TOP1;DONSON;TOP1MT;TOP3A;RECQL5;POLD1;MCM7;POLG;RPAIN;PNKP;ATR;IGHMBP2;TIMELESS;RAD17;RHNO1
prerank,protein localization to plasma membrane (GO:0072659),0.39210955140007187,1.1201012230850294,0.25181347150259065,0.8113171310434681,1.0,22/129,7.67%,LRP6;KCNB1;ATP1B1;GAS6;FGF13;TTC7A;EHD1;RDX;RAB34;C2CD5;NECTIN3;RAMP2;PIGW;PACS2;S100A10;PRAM1;RAB8A;SLMAP;ANK2;EHD2;FCHO2;JUP
prerank,regulation of B cell apoptotic process (GO:0002902),0.5317077407912209,1.1199192150210222,0.3491847826086957,0.8112009542493939,1.0,1/12,0.44%,FOXP1
prerank,receptor-mediated endocytosis (GO:0006898),0.38525835855740886,1.1199095859716481,0.26251276813074564,0.8105553686435171,1.0,29/132,16.07%,LRP6;LRP1;NEDD4;CTTN;COLEC11;IGF2R;PDLIM7;SPARC;DNAJC13;RAMP2;AP2A1;DNM2;CD9;CXCL16;FCHO2;FCER1G;SNX1;HYOU1;RAMP1;RABEPK;SNX9;LRP2;AP2A2;SNAP91;CLTC;COLEC12;DAB2;GPR107;PI4KB
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.42018474117641313,-1.1197497322071959,0.3127413127413127,0.6699616513329514,1.0,6/14,12.92%,ZEB1;OSR1;NOTCH4;SPRED1;CAV1;SPRY1
prerank,acyl-CoA metabolic process (GO:0006637),0.44564929461924013,1.1192945757799375,0.32,0.811836740757043,1.0,11/35,24.67%,ACSF2;ACOT11;SUCLA2;GPAT4;ACACA;GLYAT;MCEE;ACOT13;ACSL6;HMGCS2;ACOT8
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4422302479715295,1.1192496944401555,0.3353080568720379,0.8112936332350049,1.0,18/36,29.38%,KIF13A;RAB34;NECTIN3;GGA2;GOLGA4;NSF;GGA1;SPTBN1;GOLPH3;BLZF1;OPTN;VAMP4;GORASP2;AFDN;VAMP2;GCC2;GGA3;ARFRP1
prerank,positive regulation of telomere maintenance (GO:0032206),0.4559745473059441,1.1189326261352148,0.3365500603136309,0.8116291364865561,1.0,12/31,27.40%,GNL3;MAPK15;NEK7;HNRNPA2B1;ATM;RAD50;TNKS2;PPP1R10;MAP2K7;SLX4;RTEL1;PNKP
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4238965294640385,1.1185458271959516,0.30813287514318444,0.8121609874606355,1.0,6/51,5.51%,DCLK1;SRGAP2;CTTN;ANKRD27;SNX2;DNM2
prerank,positive regulation of cell differentiation (GO:0045597),0.37920962424800697,1.118256976306613,0.23015075376884422,0.8124547061772582,1.0,52/237,16.05%,BOC;CDON;CMKLR1;TMEM100;PKDCC;ID2;HOXA5;DDR2;COL1A1;TIAM1;LRP5;TGFB3;TWIST1;WWTR1;TGFB2;ACVR1;BCL9L;SMAD4;TGFBR2;FGFR1;HEYL;PA2G4;SOX9;IMPACT;CARM1;TRPM4;RHOA;EDN3;BMP4;SYAP1;PLA2G5;TMEM119;RUNX2;ABL1;BMPR1A;MAPK12;NEUROD2;SRF;NELL1;TGFB1I1;TGFBR1;HOXB4;MEF2A;RBM4;WDFY2;DAB2;NBL1;HGF;IL6;CRB2;CREB1;SPAG9
prerank,regulation of hydrolase activity (GO:0051336),0.3998842957359808,1.1180209352067656,0.3143483023001095,0.812529057146005,1.0,15/71,13.09%,PLXNA4;EFNA5;RDX;VAV2;SIPA1L1;FGD6;RAB3GAP1;EPHB3;CDK5RAP3;ADAP1;WRN;TDG;SOD1;ARHGAP44;OCRL
prerank,RNA catabolic process (GO:0006401),0.42769378921324885,1.1179601350518409,0.3159722222222222,0.8120561265725221,1.0,18/46,28.86%,SIDT2;PPP1R8;RNASE3;ZC3H12D;RNASE6;DIS3L2;METTL16;LSM2;SUPV3L1;SND1;CNOT10;NCBP1;MTREX;PABPC4;ERN1;RIDA;LSM5;DXO
prerank,positive regulation of receptor internalization (GO:0002092),0.479068164295137,1.1177888778321008,0.3337531486146096,0.8119410285955876,1.0,2/22,1.33%,VEGFA;SFRP4
prerank,coenzyme A metabolic process (GO:0015936),0.5217054160218473,1.1177565236366223,0.34375,0.811369675892445,1.0,10/14,33.10%,PANK4;DCAKD;ACAT1;PANK3;PPCS;PANK2;ACLY;PPCDC;CROT;COASY
prerank,amino acid import (GO:0043090),0.4764915950258415,1.1175202611729003,0.3260025873221216,0.8114348001494166,1.0,1/21,0.01%,SLC47A1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5214283964655653,1.1173491290469506,0.34075104311543813,0.8113221467846075,1.0,2/12,4.20%,VEGFA;STAT3
prerank,regulation of protein localization to cell periphery (GO:1904375),0.49619504758889343,1.1172110367256103,0.3432258064516129,0.811128314890291,1.0,6/18,19.98%,MISP;MMP14;SPTBN1;CLN3;CDK5;APPL1
prerank,positive regulation of double-strand break repair (GO:2000781),0.4387845637540583,1.1170518085138221,0.3306264501160093,0.8109528692359016,1.0,20/39,30.17%,PARP3;PRKDC;FUS;KMT5C;SLF2;SPIDR;FOXM1;WDR48;MMS19;SPIRE2;PARP1;MAD2L2;SLF1;ACTR2;WAS;SHLD3;PNKP;SHLD1;DDX11;TIMELESS
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.4363536009669384,1.1169130551883972,0.3190255220417633,0.8107128928232056,1.0,21/39,34.68%,CHD1L;ERCC5;ERCC4;OGG1;CUL4A;ERCC3;ERCC2;PARP1;RPS27A;UBC;POLD1;GTF2H4;XPA;DDB1;RBX1;ERCC1;POLK;RPA3;CUL4B;FAN1;RFC4
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.48323818898218085,1.116852628207044,0.3451910408432148,0.8102404794134872,1.0,2/20,2.21%,LBP;PRKCE
prerank,protein-containing complex assembly (GO:0065003),0.37739664371572584,1.1168214081900338,0.20520520520520522,0.8096648112092922,1.0,104/259,27.15%,TCF7L2;TIAM1;SEC31A;SEC24D;COL16A1;STX5;NOL3;FBXL7;SEC13;TLE2;CSNK1D;SEC23A;HES5;CD3E;TCF7L1;TRAPPC10;ADCY8;DNAJB14;DMD;MCU;BCL9L;CNIH2;GPAA1;ADAM10;SPG7;SLC9A1;TRRAP;LLGL1;MDM4;DLG4;SOX9;PPP6R1;PYGO1;BET1;PPP6R3;TLE3;SH3PXD2B;NSF;ST13;SCFD1;CDC123;WIPF1;TERT;TRAPPC6A;AXIN1;SNX9;SHANK1;USO1;ZW10;CUL1;HDAC1;SEC24C;SEC24B;KMT2D;PREB;SEC16A;SEC22B;FARP2;CNIH1;CREBBP;KPNA3;SEC16B;SEC24A;EPRS1;MEN1;NAPA;TMED2;TRAPPC3;SEC23IP;CTSZ;TEAD2;TRAPPC6B;DARS1;CAPZA1;LRRK2;RAB1A;LMAN1;REPS2;KLHL12;KMT2A;PEX14;RAB1B;AFG3L2;NIFK;STOML2;DET1;ANKRD28;TP53;BAD;SMARCA4;DNAJB12;TRADD;AFDN;TBC1D20;VAMP2;TFG;PPID;RIPK1;GOLGA2;PARD3;PPP2R1A;WAS;CAND1;WDCP
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5501389733035829,1.1166345257541466,0.35294117647058826,0.8096049169358467,1.0,5/10,25.70%,HMGB1;RUNX1;CBFB;SH3RF1;SOCS1
prerank,regulation of cholesterol transport (GO:0032374),0.479851312101508,1.116477749074666,0.33858267716535434,0.8094396235879993,1.0,2/20,5.93%,LRP1;LAMTOR1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.48667250095355946,1.1163473534844028,0.3474240422721268,0.8091920708675605,1.0,1/18,0.08%,MYOC
prerank,response to X-ray (GO:0010165),0.5204421806140616,1.1163306557081,0.36027397260273974,0.808584862311594,1.0,6/14,20.56%,ANXA1;ATM;LIG4;NIPBL;XRCC6;BRCC3
prerank,negative regulation of binding (GO:0051100),0.40292273443768223,1.1161725378320555,0.30434782608695654,0.8083767594564563,1.0,30/81,25.07%,PRKCD;LRPAP1;CARD16;DACT1;DVL1;TMC8;BTAF1;SYMPK;EFHB;MAPK8;GTF2F1;CSNK1E;SMO;USP33;DAB2;MITD1;TFIP11;STYX;SUMO1;MDFI;E2F1;AKT1;CTSZ;NFKBIA;LRRK2;CAMK1;PEX14;ROCK1;GTPBP4;ILRUN
prerank,oxoacid metabolic process (GO:0043436),0.4606776113593514,1.1161596966825278,0.32043530834340994,0.8077500212483166,1.0,9/27,18.59%,SULT1C2;SULT1C4;LIAS;PPA2;BPNT1;LIPT1;GNMT;PPA1;DAO
prerank,myeloid cell differentiation (GO:0030099),-0.30666108932481445,-1.1157002596878367,0.2642857142857143,0.6783761303634923,1.0,6/47,3.82%,LYN;MFHAS1;KIT;ZBTB16;SNRK;RPS14
prerank,nuclear envelope organization (GO:0006998),0.48703200759838233,1.115490806008428,0.34424083769633507,0.8091905992147344,1.0,5/20,17.77%,NUP93;TMEM43;DMPK;REEP3;TMEM170A
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.41006365800288275,1.1153691134798043,0.314543404735062,0.8089304286583517,1.0,30/60,33.57%,TCF7L2;TRIM28;MED27;MED31;MED13;SOX9;RUNX2;AGO1;MED25;SRF;IL6;MED26;MED14;MED12;CBFB;MED20;TP53;MED23;CCNC;MED24;TNRC6A;MED8;MECP2;MED15;CTNNB1;MOV10;NFKB1;MED1;CEBPB;RELA
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5225292014121963,1.1153149751123062,0.33152909336941816,0.8084495122353573,1.0,3/15,5.55%,AK5;ENTPD2;ENTPD6
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.43476035795014534,-1.1152273157020272,0.3016949152542373,0.6774398797960852,1.0,6/12,23.25%,CEACAM1;SIRT1;BRCA1;ERLIN2;TRIB3;APOC1
prerank,phospholipid metabolic process (GO:0006644),0.40600921742501295,1.1150693549812876,0.3042071197411003,0.8085681687457021,1.0,15/71,17.92%,TNFAIP8L3;PLA2G4F;PLA2G4A;PLPP3;LPCAT1;PLPP1;LPCAT4;PLA2G5;PIP4K2B;FADS1;LGALS13;PNPLA3;PIP5K1A;PLA2G15;AGPAT5
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5503256329841545,1.1148045819592132,0.35502958579881655,0.808732092461549,1.0,3/10,4.20%,GHR;STAT5A;STAT3
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.37880264701250893,1.1144873922374356,0.2606060606060606,0.8090766330238532,1.0,47/166,24.95%,THBS1;SMOC2;EGFR;IRS1;FGF2;AGXT2;LDB1;GLI2;SAMD4A;ELOVL5;PRKDC;GIPC1;DDAH1;AKT2;BRPF3;SREBF1;NNMT;NIBAN1;CNEP1R1;CHP1;PTPN2;ARPP19;HGF;IL6;EIF6;ERBB2;EIF3D;CDT1;AKT1;MLXIPL;EPM2AIP1;APPL1;KAT7;PYM1;CLU;CIRBP;FXR2;LDLR;OPN3;UPF3A;SLC25A37;PRMT1;ABCB10;RPS6KB1;RPS27L;UPF3B;RBM3
prerank,regulation of trans-synaptic signaling (GO:0099177),0.44112240884524806,1.1140307708109733,0.3419506462984724,0.8098785326780438,1.0,8/33,15.57%,GRIK4;ARC;SLC4A8;CEL;BCR;IQSEC2;NLGN1;PSMC5
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.49222150466377873,1.1139795702117083,0.3390501319261214,0.8093866550256537,1.0,6/17,14.06%,P4HB;NOL3;NFE2L2;SFPQ;SOD1;UBQLN1
prerank,regulation of mitochondrial translation (GO:0070129),0.4712125098057756,1.1135192565382002,0.3337696335078534,0.8101967073836065,1.0,6/21,18.98%,RCC1L;MPV17L2;RMND1;ALKBH1;SHMT2;FASTKD3
prerank,positive regulation of intracellular transport (GO:0032388),0.44382089660376384,1.1133698633677669,0.3341176470588235,0.8099980486932785,1.0,14/38,26.42%,NEDD4;EHD1;DYNC1H1;BCAS3;EHD2;CAPN10;TENM1;PCM1;KIF20B;ICE1;PGAP1;TBC1D20;VAMP2;TPR
prerank,regulation of membrane repolarization (GO:0060306),0.5201699492483195,1.1130456767007169,0.3368560105680317,0.8103983263038064,1.0,4/13,13.56%,KCNJ2;KCNE5;AKAP9;YWHAE
prerank,response to tumor necrosis factor (GO:0034612),0.3956172149088667,1.1129593325969633,0.28988529718456724,0.8100456532048448,1.0,10/91,7.22%,PID1;ADAM9;AFF3;YBX3;CCL13;CCL15;SMPD4;ADAM10;NFE2L2;CXCL16
prerank,ovarian follicle development (GO:0001541),0.5188189431752803,1.112618941386,0.3695955369595537,0.810498474252969,1.0,3/13,13.03%,VEGFA;SOD1;INHBA
prerank,regulation of nervous system development (GO:0051960),0.43691195012092765,1.112169418715962,0.3287037037037037,0.8112221434812548,1.0,10/37,16.20%,LGI4;DOCK7;HES5;TNFRSF1B;BHLHE40;HEYL;HEY1;SIRT2;NKX6-2;NPHP3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5021176370024515,1.1120063122107753,0.360054347826087,0.8110782143385776,1.0,5/15,17.75%,ZC3H12D;ZC3H12C;LACTB2;RPP40;KHNYN
prerank,regulation of T cell differentiation (GO:0045580),0.44385146945901754,1.1115057708499598,0.33451536643026003,0.8119869055274803,1.0,11/33,20.97%,ZMIZ1;TBX21;CRTAM;ABL1;SOD1;CLPTM1;KAT2A;RUNX1;CAMK4;CBFB;IL4
prerank,cortical actin cytoskeleton organization (GO:0030866),0.47755285990131935,1.1114530743888849,0.3520408163265306,0.8114969021887701,1.0,4/20,8.78%,FMNL2;RHOQ;LLGL1;DLG1
prerank,modification-dependent protein catabolic process (GO:0019941),0.38009734411966045,1.1110438427471803,0.2699696663296259,0.8120872957490326,1.0,79/193,30.07%,RNF144A;NEDD4;FBXO10;ANAPC5;FBXL7;TOPORS;CDC16;UBE2B;UBR4;UBE2R2;UBE3C;TRPC4AP;SYVN1;NTAN1;CBL;RBBP6;ITCH;FBXL4;RNF114;UBE2C;FBXO22;RNF14;ANAPC4;MYLIP;LONP1;USP33;UBQLN1;SQSTM1;FBXL14;RNF11;UBE2L6;ANAPC2;ARRB1;STUB1;ANAPC1;PSMD11;PSMD14;RPS27A;UBC;UBL7;RC3H2;BIRC6;ANAPC10;UBE4A;NPLOC4;CDC20;RNF7;PCYOX1L;CDC27;FBXW4;UBE2G2;SMURF2;AREL1;TTC3;RNF20;RNF146;FBXO11;TAF1;HERPUD1;AMFR;PINK1;RCHY1;UBR3;RNF111;COPS3;RNF126;RNF166;NDFIP1;RNF167;DDB1;UBE4B;RBX1;BTRC;ADRM1;PRKN;UBE2H;TRIP12;ANAPC11;UBE2S
prerank,histone H4-K5 acetylation (GO:0043981),0.5155071776952526,1.1108077664760891,0.339572192513369,0.8115104892055005,1.0,9/15,23.19%,KANSL2;OGT;WDR5;ING4;HCFC1;KANSL1;KAT7;KAT8;MEAF6
prerank,histone H4-K8 acetylation (GO:0043982),0.5155071776952526,1.1108077664760891,0.339572192513369,0.8115104892055005,1.0,9/15,23.19%,KANSL2;OGT;WDR5;ING4;HCFC1;KANSL1;KAT7;KAT8;MEAF6
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.42312255091754875,1.1107600603209213,0.32447397563676633,0.811001614412723,1.0,21/51,30.51%,MAPK15;TENT4B;NEK7;SMG6;ATM;TEN1;HNRNPC;TNKS2;XRN1;CCT4;CCT6A;CCT8;MAP2K7;HNRNPA1;TCP1;HNRNPU;PNKP;CCT5;ATR;CTNNB1;CTC1
prerank,cell part morphogenesis (GO:0032990),0.5223669927003814,1.1107482598506235,0.37193460490463215,0.8103894692726937,1.0,1/13,0.49%,PID1
prerank,focal adhesion assembly (GO:0048041),-0.36542599490934285,-1.1107404152427778,0.2825112107623318,0.6872624492435973,1.0,6/21,6.89%,SORBS1;ACTN2;PEAK1;THSD1;WHAMM;PTPRK
prerank,positive regulation of cellular component movement (GO:0051272),0.46475876716550096,1.1105689280097972,0.3595092024539877,0.8103327413348487,1.0,6/24,12.61%,NTN1;VEGFA;TWIST1;AKT2;CCDC25;TGFBR1
prerank,positive regulation of vascular permeability (GO:0043117),-0.4178047949400083,-1.1105150807674098,0.31654676258992803,0.6856985488599822,1.0,5/12,9.54%,TJP1;OCLN;BMP6;PDE2A;ANGPT1
prerank,regulation of telomere maintenance (GO:0032204),0.456917269658103,1.1104823947053852,0.3427172582619339,0.8099595408456703,1.0,8/26,21.97%,GNL3;SMG6;ERCC4;SMG1;RAD50;USP7;PPP1R10;UPF1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.44927168958886976,1.1101089981211003,0.3464285714285714,0.8104799550396096,1.0,17/30,33.42%,ERCC3;ERCC2;POLR2F;POLR1G;CAVIN1;POLR1C;TAF1C;TBP;GTF2H4;POLR2H;UBTF;TAF1D;POLR2L;TAF1B;POLR2K;TAF1A;CCNH
prerank,selective autophagy (GO:0061912),0.423223709671908,1.1099544368452514,0.3422222222222222,0.8103019767842777,1.0,32/56,33.10%,ULK2;DYNC1H1;STBD1;NBR1;PEX5;LGALS8;ATM;DYNC1LI2;UBA5;UBQLN1;SQSTM1;HDAC6;IFT88;RPS27A;UBC;UFL1;RB1CC1;TEX264;DYNC1I2;ACBD5;ATG13;ATG2B;AMBRA1;UFC1;UBE2V1;ULK1;USP30;PRKN;UBE2N;DYNLL2;MAP1LC3B;UFM1
prerank,positive regulation of histone deacetylation (GO:0031065),0.528824565675849,1.1096488005958602,0.3487394957983193,0.8106888999855127,1.0,5/12,27.92%,VEGFA;NIPBL;AKAP8;SAP30BP;PRKD2
prerank,cellular glucan metabolic process (GO:0006073),0.5362574406198741,1.1091345089268736,0.35497237569060774,0.8116744277211644,1.0,3/11,7.74%,PPP1R3C;PHKA1;PHKB
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5353182474669352,1.1091232223836056,0.3660968660968661,0.8110588050309739,1.0,3/11,10.66%,VCP;UGGT2;UGGT1
prerank,smoothened signaling pathway (GO:0007224),0.45349121697195227,1.1086619761069694,0.3377885783718105,0.8119032358988112,1.0,16/32,31.35%,GLI2;HES5;CC2D2A;SMO;MAP3K10;EVC2;PKD2L1;HIPK2;IFT27;TMEM231;TCTN3;GLI3;TTBK2;STIL;GLI1;ULK3
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.47449798172258284,1.1085931909986575,0.32051282051282054,0.8114609144006865,1.0,4/21,4.29%,BGN;CHST11;CHPF2;CSPG4
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3212857777018844,-1.108449862542261,0.27461139896373055,0.6891982068553323,1.0,8/29,12.94%,IFNAR2;WNT5A;SAMHD1;USP18;NLRC5;RNASEL;CACTIN;PTPN1
prerank,base conversion or substitution editing (GO:0016553),-0.44688356634139814,-1.1081358694593761,0.2931596091205212,0.687888322575463,1.0,6/11,41.33%,ADARB2;ADAR;METTL3;APOBEC2;ADAD1;A1CF
prerank,inner dynein arm assembly (GO:0036159),0.5306068254067249,1.1079220208132046,0.351931330472103,0.8128914537669379,1.0,4/11,24.63%,CCDC39;DNAAF4;CFAP73;DNAAF5
prerank,angiogenesis involved in wound healing (GO:0060055),0.5400975236250478,1.1077895842659948,0.38354253835425384,0.8126609572263895,1.0,4/11,14.32%,VEGFA;ADIPOR2;SRF;NDNF
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.39315420663002226,1.107695580113083,0.308411214953271,0.8123229764155793,1.0,16/113,10.43%,PGF;EGFR;SRSF6;VEGFA;F3;FGF2;TCF7L2;STAT5A;PKHD1;PRKCA;FZD7;SOX9;BMP4;FGFR2;AGGF1;VIP
prerank,AMP metabolic process (GO:0046033),0.5210530458288939,1.10767386592681,0.3622994652406417,0.8117383064506077,1.0,3/13,12.82%,XDH;AK3;AMPD3
prerank,histone H3-K9 demethylation (GO:0033169),0.5279852820510772,1.1074365660015693,0.3651026392961877,0.8118109413422883,1.0,4/11,13.22%,JMJD1C;PHF8;KDM4A;HR
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5304585022423908,1.1073389423080406,0.35555555555555557,0.8114831458892329,1.0,2/13,1.98%,SULT1C2;SULT1C4
prerank,bicellular tight junction assembly (GO:0070830),-0.3010402924916912,-1.1072813124989536,0.24369747899159663,0.688052252766318,1.0,9/46,9.00%,PARD6G;OCLN;PECAM1;CDH5;CLDN5;ESAM;F11R;APC;CLDN1
prerank,mRNA stabilization (GO:0048255),0.4326957543850376,1.1070811458269503,0.3240418118466899,0.8116222707256023,1.0,16/40,24.32%,YBX3;PABPC1;TENT5A;FUS;THRAP3;VIP;TAF15;HNRNPC;E2F1;GDNF;SYNCRIP;CIRBP;SLC11A1;HNRNPU;YBX1;RBM24
prerank,nucleus organization (GO:0006997),0.42273048066291913,1.1070756053009794,0.33716915995397007,0.8109957816548242,1.0,15/47,26.66%,NUP93;SEH1L;CHMP3;DMPK;REEP3;USP36;TMEM170A;CHMP4A;CHMP4B;PDCD6IP;NDC1;NUP35;CHMP2A;TPR;ATXN7
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4494160068095261,1.107017136503348,0.3467153284671533,0.81053602998662,1.0,19/32,33.42%,ERCC3;ERCC2;POLR2F;POLR1G;CAVIN1;POLR1C;TAF1C;TBP;TAF1;GTF2H4;POLR2H;UBTF;TAF1D;POLR2L;TAF1B;RRN3;POLR2K;TAF1A;CCNH
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5332702815144601,1.1069854711748768,0.3555858310626703,0.8099776405816,1.0,6/11,29.23%,STAT3;PUM1;LIMD1;XPO5;FXR1;PUM2
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3809547425734724,-1.1068205184443156,0.2892561983471074,0.6871948403173687,1.0,6/17,7.53%,ADCY5;ADCY1;PRKAR2B;PRKACB;PRKAR1B;ADCY4
prerank,glutathione derivative biosynthetic process (GO:1901687),0.47833296077878096,1.106498070895182,0.33111702127659576,0.8102044184301977,1.0,5/20,16.64%,GSTT1;GSTM5;GSTO2;GSTZ1;AKR1A1
prerank,glutathione derivative metabolic process (GO:1901685),0.47833296077878096,1.106498070895182,0.33111702127659576,0.8102044184301977,1.0,5/20,16.64%,GSTT1;GSTM5;GSTO2;GSTZ1;AKR1A1
prerank,ribosomal small subunit assembly (GO:0000028),0.5000672640733819,1.1062121001813225,0.37142857142857144,0.8104548269182245,1.0,3/16,6.24%,RPSA;PRKDC;RRP7A
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.47482366178880475,1.1060729244719347,0.34974093264248707,0.8102221540318361,1.0,5/20,6.67%,NEDD4;PRKCE;CAMK2D;GOPC;STK39
prerank,DNA geometric change (GO:0032392),0.4559493892637173,1.1060320684906786,0.3551980198019802,0.8097117775639773,1.0,13/24,35.18%,HMGB1;HNRNPA2B1;ANXA1;WRN;RAD50;SUPV3L1;RECQL5;ZRANB3;RTEL1;DDX11;BLM;DHX9;MRE11
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.455782174013417,1.105931133464736,0.3398773006134969,0.8093725282523992,1.0,10/26,21.03%,ACTN3;SLC9A1;CHERP;EFHB;RCAN1;CHP1;STIMATE;PTBP1;HOMER2;ATP2B4
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4225060020400778,1.105930041671594,0.3318077803203661,0.8087389274786332,1.0,12/45,14.52%,GDF10;INHBC;TGFB3;TGFB2;ACVR1;SMAD4;BMP4;BMPR1A;TGFBR1;INHBA;DAB2;BMP5
prerank,N-terminal protein amino acid modification (GO:0031365),0.5154505020311476,1.1059003679135857,0.35356200527704484,0.8081752869039214,1.0,7/14,26.41%,NAA60;NAA40;NAA16;NTMT1;METAP1D;METAP2;NAA15
prerank,activation of adenylate cyclase activity (GO:0007190),0.43824957657455427,1.105788849280736,0.3401688781664656,0.8078889462529975,1.0,9/35,12.88%,DRD1;FSHR;EDNRA;ADCY2;ADCY8;ADCY9;RAF1;CAP1;GLP1R
prerank,chondrocyte differentiation (GO:0002062),0.4479414380015692,1.1046321780670465,0.3422007255139057,0.8108023780974841,1.0,8/32,10.29%,SLC39A14;NFIB;CCN3;HES5;SULF1;SOX9;BMP4;RUNX2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.44765530561068895,1.104597315290894,0.3520097442143727,0.8102681533006921,1.0,4/29,13.03%,THBS1;PAK2;LTBR;INHBA
prerank,positive regulation of mitochondrial translation (GO:0070131),0.5070608506916154,1.1045140002742129,0.3603988603988604,0.8098816319806734,1.0,3/14,8.35%,RCC1L;MPV17L2;RMND1
prerank,positive regulation of nervous system development (GO:0051962),-0.30806672064267643,-1.104277920767962,0.25735294117647056,0.6919906817725315,1.0,14/42,12.29%,NRXN1;IL1RAPL1;TGM2;GRID2;PTPRD;OPRM1;FAIM;SRPX2;CX3CR1;CLSTN1;CUX2;IL1RAP;EPHB1;SYNDIG1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4898970502510194,1.1039969283877025,0.36209150326797385,0.8108515834495607,1.0,9/17,26.14%,EMC2;EMC9;EMC1;CAMLG;EMC8;GET4;EMC4;MMGT1;GET3
prerank,protein dephosphorylation (GO:0006470),-0.25849604961637884,-1.1038373075072052,0.2857142857142857,0.6910137922816082,1.0,27/135,10.32%,PTPRG;PTPRB;PPP2R2B;PTPN13;EYA1;PPM1E;PTPN14;PPP1CB;DUSP16;PTPRD;PTPRO;PPP4R1;PTPN9;DUSP10;CTTNBP2NL;PPP2R2C;EYA4;PTPN4;DUSP3;MTMR3;PTPRK;SSH2;PPP2R3A;CTDSP1;PPP2CB;PPM1G;DUSP22
prerank,pharyngeal system development (GO:0060037),0.5053716638824429,1.1037025966390488,0.363395225464191,0.8111508017884906,1.0,7/15,14.52%,SIX4;TGFB2;NOG;BMP4;BMPR1A;TGFBR1;BMP5
prerank,autophagosome assembly (GO:0000045),0.42000348970044127,1.103512807625292,0.3477777777777778,0.8110926062298576,1.0,21/52,30.06%,ULK2;RAB43;PACS2;WIPI2;ATG3;ATG16L2;UBQLN1;RAB23;RB1CC1;ATG16L1;RUFY4;RAB1A;RAB1B;ATG9A;ATG13;ATG2B;AMBRA1;ULK1;UBXN2A;STX17;IRGM
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3911916978040673,1.10311783894865,0.33121693121693124,0.8116831967186434,1.0,16/93,13.67%,RASSF2;VEGFA;SH3RF3;GADD45G;MAP3K5;TGFB2;XDH;MID1;HMGB1;FZD7;LTBR;AXIN1;CD27;TRAF3;STK25;MAP3K10
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5439078881985059,1.1030578887128728,0.3436185133239832,0.8106098870904063,1.0,5/10,19.94%,NFAT5;NFATC1;PPP3CC;NFATC3;NFATC4
prerank,calcineurin-mediated signaling (GO:0097720),0.5439078881985059,1.1030578887128728,0.3436185133239832,0.8106098870904063,1.0,5/10,19.94%,NFAT5;NFATC1;PPP3CC;NFATC3;NFATC4
prerank,piRNA metabolic process (GO:0034587),0.4812393913810863,1.1029833941476823,0.3586666666666667,0.8101956896118262,1.0,4/19,20.44%,TEX15;MAEL;TDRD12;TDRKH
prerank,cAMP metabolic process (GO:0046058),-0.4122555908860239,-1.102971673680523,0.3371212121212121,0.6911630740776868,1.0,4/13,7.53%,ADCY5;PDE4D;ADCY1;ADCY4
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4301502674298996,1.1028644297297576,0.34466588511137164,0.8099265331602485,1.0,13/39,16.07%,TTC7A;PIK3C2B;SOCS7;SOCS4;SOCS6;SOCS2;SMG1;PIP4K2B;IP6K1;PIK3CB;PI4K2A;TTC7B;PI4KB
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.42862978483904707,1.1027704013047896,0.3340909090909091,0.8095856557512503,1.0,6/41,12.28%,GAS6;LBP;IRAK3;TRIM27;RARA;CIDEA
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.44592682432036146,1.1026228812720773,0.3469135802469136,0.8094173827055829,1.0,16/30,29.38%,KIF13A;RAB34;GGA2;GOLGA4;NSF;SEC16A;GGA1;SPTBN1;GOLPH3;BLZF1;OPTN;VAMP4;VAMP2;GCC2;GGA3;ARFRP1
prerank,mesenchyme morphogenesis (GO:0072132),0.49455252586894677,1.102312423872818,0.3581699346405229,0.8097721591901147,1.0,8/17,12.13%,TGFB2;ACVR1;HEYL;MDM4;SOX9;NOG;BMPR1A;HEY1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5006582054991006,1.102212525894611,0.3572395128552097,0.809453092962614,1.0,8/16,26.12%,LRP1;LRPAP1;SRF;HDAC1;CLU;IL4;ROCK1;HMGCR
prerank,axon guidance (GO:0007411),0.37359530368199845,1.1021692506012921,0.26713709677419356,0.808958211604477,1.0,25/201,8.25%,SLIT3;SLIT2;SLIT1;PLXNA4;EMB;NTN1;VEGFA;EFNA5;NFIB;GRB10;GAB2;GLI2;TMEFF1;PDLIM7;EPHB2;SHC1;NTN4;SEMA3E;PRKCA;EPHB3;EPHB6;GAP43;SEMA4B;PALLD;CYFIP1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3792092927956077,-1.1021001675938096,0.3482142857142857,0.6912741176980879,1.0,7/18,13.89%,NRXN1;SHANK3;CACNG7;CACNG8;CACNG3;CACNG4;RELN
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4217002427206354,-1.1016441652876479,0.32781456953642385,0.6904075272650305,1.0,5/12,26.04%,SLC5A3;ADGRB1;GRIN1;CD36;TLR6
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5363396121355744,1.1014813155878747,0.3574468085106383,0.8092387276515057,1.0,8/11,33.10%,PANK4;DCAKD;ACAT1;PANK3;PPCS;PANK2;PPCDC;COASY
prerank,coenzyme A biosynthetic process (GO:0015937),0.5363396121355744,1.1014813155878747,0.3574468085106383,0.8092387276515057,1.0,8/11,33.10%,PANK4;DCAKD;ACAT1;PANK3;PPCS;PANK2;PPCDC;COASY
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5363396121355744,1.1014813155878747,0.3574468085106383,0.8092387276515057,1.0,8/11,33.10%,PANK4;DCAKD;ACAT1;PANK3;PPCS;PANK2;PPCDC;COASY
prerank,central nervous system myelination (GO:0022010),0.5167338658580424,1.101224249088539,0.36507936507936506,0.8093761411882423,1.0,4/11,20.48%,HES5;B4GALT5;PLP1;CLU
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.48571548522552777,1.1006597952528208,0.34067357512953367,0.8104353914583688,1.0,5/18,12.69%,CCN3;HDAC4;FZD7;TMEM119;HDAC1
prerank,nitric oxide metabolic process (GO:0046209),-0.3976051257547013,-1.1005772785900225,0.28793774319066145,0.6912097194425164,1.0,6/14,12.41%,NOS3;CYB5B;GCH1;NOS1;DDAH2;SPR
prerank,endodermal cell fate commitment (GO:0001711),-0.4438147486918423,-1.100577145260017,0.31456953642384106,0.689130845236416,1.0,4/10,16.69%,SOX17;LEO1;SOX2;CTR9
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3680345131388201,-1.1001096728175492,0.2982456140350877,0.6882385423845537,1.0,3/18,2.72%,FLT1;COL4A3;AKT3
prerank,cellular response to organonitrogen compound (GO:0071417),0.3903748019325288,1.100069443259548,0.32398753894080995,0.8116184638101335,1.0,15/99,12.60%,SLIT2;IGFBP5;HCN4;SLC26A6;IPO5;PDE3A;LAMTOR1;JUP;SOX9;IMPACT;CAPN2;P2RY6;EZR;AKAP9;SESN2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5217927154247407,1.0998809557510432,0.37206085753803597,0.8109027590398382,1.0,5/12,21.03%,ACTN3;RCAN1;CHP1;HOMER2;ATP2B4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5217927154247407,1.0998809557510432,0.37206085753803597,0.8109027590398382,1.0,5/12,21.03%,ACTN3;RCAN1;CHP1;HOMER2;ATP2B4
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.30475334375857055,-1.099818306524659,0.28205128205128205,0.68684596979579,1.0,15/38,18.71%,INSR;ROCK2;SMAD3;KLF2;ASS1;ZC3H12A;EDN1;CAV1;CX3CR1;DDAH2;CD34;SIRPA;NOS1AP;CD47;GLA
prerank,cellular response to UV (GO:0034644),0.398383949376311,1.0997213661347454,0.31256830601092894,0.8107910864548032,1.0,24/76,26.57%,PRKCD;NEDD4;CARD16;ATF4;IMPACT;ERCC4;SDE2;N4BP1;CREBBP;PARP1;CDC25A;EIF2AK4;NOC2L;EIF2S1;USP47;TRIAP1;OPN3;MMP2;TAF1;TP53;POLD1;PPID;XPA;YY1
prerank,response to sterol (GO:0036314),0.5382625134050847,1.0996709301064054,0.36046511627906974,0.8103296843668853,1.0,3/11,12.61%,TGFBR2;RORA;TGFBR1
prerank,regulation of coagulation (GO:0050818),0.5315315599610531,1.0996679623376098,0.365034965034965,0.809714112901864,1.0,2/11,13.07%,EPHB2;F2R
prerank,protein polyubiquitination (GO:0000209),0.3702583226401786,1.0996248165814488,0.22868605817452356,0.8092373962569089,1.0,118/297,30.24%,WWP1;RNF144A;NEDD4;FBXO10;ANAPC5;FBXL7;PSMD7;FBXW8;TOPORS;CDC16;UBE2B;LRSAM1;PSMA8;UBE2R2;ERCC8;UBE3C;RNF115;HUWE1;TRIM27;SYVN1;RBBP6;WWP2;SHARPIN;PSMA4;ITCH;FBXL4;RNF114;UBR5;UBE2C;FBXO22;RNF14;FBXL12;PSMD12;ANAPC4;MYLIP;TRAF3;CUL1;FBXL19;PSMA6;TNKS2;FBXL14;LNPEP;PSMD1;DDA1;UBE2L6;ANAPC2;FBXO17;STUB1;FBXL20;PSMC5;ANAPC1;PSMD11;UBE2V2;PSMC4;PSMD14;TRAF3IP2;RPS27A;UBC;RC3H2;ANAPC10;UBE4A;FBXL18;TRIM6;HECTD1;TPP2;FBXW2;NPEPPS;UBR2;CDC27;FBXW4;RUSC1;CBFB;UBE2G2;PSMA3;UBOX5;SMURF2;MUL1;RNF4;PSMB1;PSMD4;AREL1;TTC3;RNF20;RNF216;ZFP91;PSMA5;RNF146;FBXO11;PSMA7;TAF1;FBXO9;AMFR;UBE2W;SHPRH;PSMC1;RNF126;RNF166;FBXO38;FBXW10;PSMA1;RNF167;UBE2V1;UBE4B;FBXL8;FBXO41;RBX1;BTRC;RNF135;UBE2Q2;TRAF5;PRKN;UBE2H;BLMH;TRIP12;ANAPC11;UBE2S;PSMD2;CTNNB1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.39219621058260934,1.099400306616124,0.3270042194092827,0.8092812264290326,1.0,16/86,15.26%,EGFR;PRKCD;VEGFA;EFNA5;GHR;CSPG4;IL5;ACVR1;DGKQ;ANGPT4;PAK2;ABL1;NRP1;CD80;HGF;IL6
prerank,organelle disassembly (GO:1903008),0.4362506159719458,1.0992713938055598,0.3581907090464548,0.8090297116845789,1.0,9/33,19.32%,ULK2;STX5;VCP;GBF1;UBA5;KLC1;UFL1;RB1CC1;TEX264
prerank,bile acid and bile salt transport (GO:0015721),-0.3509238728324705,-1.0991498401612156,0.3073394495412844,0.6864943596099288,1.0,3/24,2.24%,ABCC4;SLCO2B1;SLCO1C1
prerank,proteasomal protein catabolic process (GO:0010498),0.37172996030009303,1.0985474028484479,0.2809667673716012,0.8106375547630742,1.0,77/201,30.24%,WWP1;NEDD4;PSMD7;TOPORS;COP1;UBE2B;VCP;PSMA8;ERCC8;NFE2L2;TBX21;HUWE1;SYVN1;SOCS6;DDI2;WWP2;SHARPIN;PSMA4;ITCH;CUL4A;PSMD12;FBXL19;PSMA6;PCBP2;ATE1;PSMD1;KCTD5;ARRB1;STUB1;SIRT2;PSMC5;PSMD11;KLHL22;PPP2R5C;PSMC4;PSMD14;TRIM13;KCTD17;GID4;ZFAND2B;ERLEC1;PCNP;RMND5B;PSMA3;UCHL1;RCN3;DCAF11;SMURF2;RNF4;PSMB1;PSMD4;KCTD13;APPBP2;AREL1;DERL1;RNF216;PSMA5;PSMA7;RNF122;ANKRD9;DNAJB12;UBE2W;PSMC1;RNF126;PSMA1;CCDC47;DDB1;NR1D1;UBXN2A;UBE4B;RBX1;SPOPL;BTRC;ZFAND2A;PRKN;PSMD2;CTNNB1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3389230343607238,-1.0984301673122445,0.3023255813953488,0.6861996717891876,1.0,11/29,13.00%,DPP10;CACNA1D;KCNIP3;KCNIP4;KCNIP1;FGF12;KCNN2;HOMER1;DPP6;KCNAB1;CD63
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.41310871760311774,-1.0983243798030502,0.3371647509578544,0.6844064343102034,1.0,6/14,22.19%,PPP2R2B;PPP2R2C;PPP2CB;PPP5C;PPP1R15B;PPP1CA
prerank,mRNA methylation (GO:0080009),0.49600434074634997,1.0980810222095605,0.3687074829931973,0.8113912993837344,1.0,6/15,25.65%,TRMT61B;METTL16;TRMT6;TRMT61A;METTL8;METTL14
prerank,transcription by RNA polymerase I (GO:0006360),0.439724923523316,1.098068524538446,0.34813925570228094,0.81081361842743,1.0,20/34,34.01%,ERCC3;ERCC2;POLR2F;POLR1G;CAVIN1;POLR1C;TAF1C;TBP;TAF1;GTF2H4;POLR2H;UBTF;TAF1D;POLR2L;TAF1B;RRN3;POLR2K;TAF1A;CCNH;TCOF1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.41328064300050765,1.098046002137568,0.3413830954994512,0.8102566516322353,1.0,22/60,30.44%,SMOC2;FGF2;MAPK15;NEK7;NVL;ATM;TNKS2;HGF;POLG2;CCT4;CCT6A;CCT8;MAP2K7;HNRNPA1;TCP1;DKC1;PNKP;CCT5;PRKD2;ATR;CTNNB1;HSP90AA1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.4627556384981234,1.0975885746817613,0.36455696202531646,0.8110714423932814,1.0,3/22,4.54%,VEGFA;GADD45G;XDH
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5508517903811913,1.0974111887246367,0.38857142857142857,0.811023781842603,1.0,4/10,9.71%,LRP5;TGFBR2;SOX9;FGFR2
prerank,glycoprotein biosynthetic process (GO:0009101),0.39240512887863355,1.0973656450295286,0.3343915343915344,0.8105295631905244,1.0,13/79,13.44%,ST3GAL4;XYLT1;ST8SIA2;CHST11;B3GNT7;PMM2;ST3GAL2;FOXL1;B4GALT5;NPC1;FUT4;GAL3ST4;B3GNT9
prerank,dopamine metabolic process (GO:0042417),0.4906932947257765,1.0968893906524733,0.3486238532110092,0.8113483588284676,1.0,4/18,4.35%,DRD1;LRTOMT;TGFB2;SNCAIP
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.40646636251290885,1.0967326132989743,0.33146067415730335,0.8111911979984954,1.0,16/56,19.95%,EGFR;RDX;ANAPC5;CDC16;BRD4;ANXA1;CDC25B;UBE2C;ANAPC4;RCC2;EIF4G1;TFDP1;CDC25A;AKT1;CDC27;DLGAP5
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.3686067710147112,-1.0964535083765972,0.3142857142857143,0.6872052568309158,1.0,2/19,2.53%,APOE;PICALM
prerank,lymphocyte mediated immunity (GO:0002449),0.521560850285202,1.0963019241941694,0.36,0.8119315665606958,1.0,2/12,6.53%,GNL1;JAG1
prerank,atrial septum morphogenesis (GO:0060413),0.537501791632131,1.0959067085857843,0.3744740532959327,0.8125410937575535,1.0,2/10,5.63%,TGFB2;ACVR1
prerank,protein autoubiquitination (GO:0051865),0.40574081158234954,1.0958927026896086,0.3355629877369008,0.8119642252712752,1.0,19/61,25.04%,SH3RF3;UBE2B;LRSAM1;ERCC8;NFX1;RNF115;WWP2;ITCH;RNF11;STUB1;TRIM13;UHRF2;RNF141;SH3RF1;RNF4;RNF146;RNF122;AMFR;RNFT1
prerank,nuclear migration (GO:0007097),0.5158093260343152,1.0958873790587191,0.37517241379310345,0.8113602119231664,1.0,6/13,20.24%,DOCK7;DYNC1H1;CLMN;TMEM201;PCM1;DCTN1
prerank,positive regulation of macroautophagy (GO:0016239),0.41769497108729464,1.095694786219483,0.34689265536723163,0.811314892231266,1.0,23/48,28.61%,SESN3;BAG3;LRSAM1;RAB3GAP1;PIP4K2B;SESN2;PAFAH1B2;TRIM13;RAB3GAP2;OPTN;IL4;RUFY4;TSC2;UVRAG;VPS13D;SMCR8;TBK1;PINK1;GPSM1;HSPB8;PIP4K2C;SLC25A5;LARP1
prerank,regulation of glycolytic process (GO:0006110),0.39966728089170683,1.0956431122947698,0.34419109663409336,0.8108695896003679,1.0,27/68,26.42%,SLC4A4;NUP93;SEC13;HDAC4;RAE1;ACTN3;SEH1L;OGT;GIT1;NUP37;RANBP2;NUP88;EIF6;PRKAG1;POM121;NUP210;MLXIPL;NUP62;NDC1;NUP35;PFKFB4;ENTPD5;NCOR1;PFKFB1;NUP85;NUP160;TPR
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.5220552760031837,1.095521376748891,0.3712660028449502,0.8106327721630866,1.0,5/12,25.00%,TMEFF2;AP2A1;CLTC;SELENOS;HDAC2
prerank,regulation of neuron death (GO:1901214),-0.265626446280322,-1.094864643326541,0.24242424242424243,0.6893082642368823,1.0,20/82,15.02%,EFNB2;WNT5A;PICALM;RRAS2;GRID2;GRIN2B;PPARGC1A;LANCL1;DCC;CSF1;CD200;EGR1;FAIM2;EPHB1;SARM1;BTBD10;CD34;C1QA;SNCA;TYROBP
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.5120021890859092,1.0945912983300912,0.36754507628294036,0.8127937355289342,1.0,6/13,24.33%,TSR1;RRS1;RPP40;ABT1;TBL3;KRI1
prerank,telomere maintenance (GO:0000723),0.41042904974140726,1.0938015609689822,0.3416572077185017,0.8144904077909637,1.0,21/50,28.72%,PARP3;PRKDC;ERCC4;WRN;TERT;ATM;TEN1;RAD50;DCLRE1B;PARP1;TPRKB;HUS1;SMC5;RAD51;XRCC6;XRCC3;POLD1;SMC6;RTEL1;NSMCE2;ATR
prerank,positive regulation of protein localization to membrane (GO:1905477),0.38155900788642033,1.0936186232313048,0.3378238341968912,0.8144572117547084,1.0,26/98,18.70%,EGFR;KCNB1;LRP1;PRKCE;EPHB2;PLS1;C2CD5;AGR2;MIEF2;AKT2;DLG1;PPP3CC;MAPK8;PDPK1;CHP1;YWHAE;SQSTM1;STAC3;YWHAQ;TFDP1;STX4;ERBB2;SPTBN1;E2F1;BID;AKT1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.532236554908631,1.0932189807162231,0.39355742296918766,0.8151269669069348,1.0,4/11,12.70%,NECAB3;SOAT1;BACE2;AGO2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5196759843305089,1.0932086635966192,0.3781965006729475,0.8145355093748307,1.0,5/12,13.64%,NEDD4;BMP4;KHDRBS1;UHMK1;RBM4
prerank,positive regulation of synaptic transmission (GO:0050806),-0.2768463945915607,-1.0930750670635727,0.25,0.6920280420421758,1.0,22/72,11.64%,NRXN1;SHANK3;APP;RIMS2;SLC24A2;CACNG7;ADCY1;GRIK2;RIMS1;GRIN2B;CACNG8;SLC8A3;ZDHHC3;LGI1;GRIN2A;NMU;CACNG3;ADRA1A;CACNG4;DTNBP1;CLSTN1;PLK2
prerank,response to calcium ion (GO:0051592),0.3846549859331281,1.0930448571031202,0.3233160621761658,0.8143865099930259,1.0,15/102,13.48%,THBS1;ADAM9;NEDD4;SEC31A;SYT8;CAMK2D;CLIC4;CALM2;ADCY8;KCNIP2;STIM1;NEUROD2;NLGN1;ADD1;MEF2A
prerank,melanosome organization (GO:0032438),0.45849585023840095,1.092916960450571,0.35917312661498707,0.8141535489477616,1.0,8/26,14.45%,KIF13A;BLOC1S2;RAB38;TRAPPC6A;AP3D1;BLOC1S3;ABCB6;HPS4
prerank,negative regulation of cellular process (GO:0048523),0.3640650121939317,1.0925987632614511,0.19019019019019018,0.8145691400543953,1.0,97/521,15.40%,SLIT3;SLIT2;PLXNA4;ZBTB7C;SRSF6;FHL1;WNT9A;FGF2;SRGAP2;OSGIN2;PDCD4;SFRP4;CCN5;TGFBI;CCN3;EMILIN1;NTRK1;SMAD6;ACVR1B;VPS13C;EPHB2;TGFB3;P3H3;SPN;PPP1R9B;PRDM11;CYP1B1;SLURP1;GLMN;PKHD1;LMNA;LRPAP1;PTPRU;TGFB2;P3H1;CLMN;AGR2;TMEM98;TNFRSF1B;TMEM115;NOX4;CD9;CCAR2;PLPP1;SMAD4;ADAM10;PRKRA;ABI1;IFNLR1;SKI;TEX15;CDK10;MDM4;RAF1;TES;P3H2;CHERP;DACT3;DDAH1;CDC6;IMPACT;NDRG3;SERTAD2;DCBLD2;BMP4;ING5;ANP32B;LPCAT3;FOXM1;DIS3L2;RBM5;TAF6;PBRM1;TENM1;TGFB1I1;SESN2;PTPN2;PIP4P2;INHBA;F2R;CGRRF1;RBBP7;GSDME;FRK;FUZ;BMP5;TMEM127;SERTAD3;RHOB;VDR;CYP27B1;MIA3;SCIN;CAMK2N1;IL6;ING4;SIRT2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.40551087625602966,-1.092464595566125,0.3333333333333333,0.6916404091047442,1.0,5/13,13.58%,ERRFI1;CBLB;SNX6;SOCS5;GPRC5A
prerank,response to peptide (GO:1901652),0.4324702364377315,1.092301308125675,0.34134615384615385,0.8148385002133542,1.0,3/33,4.20%,IRS1;STAT5A;STAT3
prerank,monocyte chemotaxis (GO:0002548),-0.327339638532133,-1.0921222938527704,0.28901734104046245,0.690482941803136,1.0,3/32,4.47%,FLT1;IL6R;PTPRO
prerank,protein export from nucleus (GO:0006611),0.45625273560416385,1.092024212317482,0.38423028785982477,0.8150549563225252,1.0,14/27,27.34%,PKD1;XPO1;STRADA;XPO6;XPO4;CHP1;STYX;CALR;CCHCR1;DESI1;NUTF2;TPR;XPO7;XPO5
prerank,autophagosome organization (GO:1905037),0.4186897231606145,1.0918879342540957,0.3536036036036036,0.8148821460128154,1.0,19/50,28.52%,ULK2;RAB43;PACS2;WIPI2;ATG3;ATG16L2;UBQLN1;RAB23;RB1CC1;ATG16L1;RUFY4;RAB1A;RAB1B;ATG9A;ATG13;ATG2B;AMBRA1;ULK1;UBXN2A
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4455782324905873,1.0915355411913878,0.3617021276595745,0.815334127472615,1.0,7/26,15.12%,EGFR;RDX;CDK10;CDC6;ANXA1;EIF4G1;TFDP1
prerank,response to steroid hormone (GO:0048545),0.43876134724000354,1.0913966956252172,0.36004784688995217,0.8151112327184562,1.0,5/31,10.49%,THBS1;TGFB3;TGFB2;CATSPER3;URI1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4768489394069624,1.0913399727772646,0.3741851368970013,0.8146763227457219,1.0,6/19,15.26%,EMILIN1;TGFB3;BMP4;F2R;RUNX1;IL6
prerank,negative regulation of metabolic process (GO:0009892),0.4104000300349778,1.0913195308056407,0.3524774774774775,0.8141210278351825,1.0,18/54,17.43%,ZNF423;NPR3;DOCK7;ATF4;ACTN3;FOXC2;ACOT11;PGAM5;TFE3;TLE3;IP6K1;PCTP;ABHD6;CIDEA;LNPEP;ID1;FLCN;ACOT13
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5253604898951136,1.0911924993110467,0.3870056497175141,0.8139167174012306,1.0,3/12,8.39%,F3;IFT20;CBL
prerank,tRNA metabolic process (GO:0006399),0.4901524929465198,1.0910210696600833,0.3748395378690629,0.8138432687415619,1.0,8/17,27.07%,SSB;DTD1;DARS2;YARS2;ADAT1;SARS1;RPP21;POP5
prerank,"DNA-templated transcription, termination (GO:0006353)",0.397669200406248,1.0905900464915794,0.34130434782608693,0.8144594905550712,1.0,37/68,34.60%,SYMPK;MAZ;PABPN1;ERCC3;ERCC2;CLP1;CPSF4;POLR2F;PCF11;NCBP1;SMN1;CPSF7;NCBP2;POLR1G;CAVIN1;CSTF2;POLR3K;CSTF2T;SNRPB;POLR1C;TAF1C;TBP;GTF2H4;POLR2H;UBTF;SETX;TAF1D;SNRPF;PRMT5;POLR2L;TTF2;TAF1B;POLR2K;TAF1A;CCNH;CPSF3;MTERF2
prerank,maintenance of protein localization in organelle (GO:0072595),0.47720699425576263,1.090043410445559,0.3777490297542044,0.8155075832066982,1.0,9/19,28.24%,TOPORS;MORC3;HSPA5;ARL2;AKT1;HNRNPU;PINK1;TAPT1;TAF3
prerank,protein localization to chromosome (GO:0034502),0.4359279547109892,1.089929105946287,0.356651376146789,0.8152351103638793,1.0,3/34,7.68%,ESR1;PARP3;SLF2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3205987818241893,-1.0898532732838857,0.3006535947712418,0.6943362498786542,1.0,11/34,13.60%,PTPRB;PTPN13;DUSP16;PTPRO;PTPN9;DUSP10;DUSP3;DUSP22;DUSP6;PTPN1;PTPRT
prerank,adenine nucleotide transport (GO:0051503),-0.3856365410675098,-1.089544824298911,0.31451612903225806,0.6931895762569815,1.0,2/17,2.40%,ABCC4;LRRC8C
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4282645771748603,1.0891288341481535,0.3578313253012048,0.8169712995617643,1.0,3/37,2.75%,EFNA5;STMND1;PHLDB1
prerank,polyamine metabolic process (GO:0006595),0.5211623998334332,1.0890906751586376,0.3734087694483734,0.8164707079792997,1.0,5/13,18.59%,SAT2;SMOX;SRM;HDAC6;AOC1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.38724756625566115,-1.0885553266491628,0.31932773109243695,0.693701955933259,1.0,6/18,8.59%,IL34;PTN;NOTCH1;TNFRSF21;TENM4;SLC45A3
prerank,generation of neurons (GO:0048699),0.37435267513074594,1.088432264781337,0.3231707317073171,0.81788105499335,1.0,35/190,16.33%,SIX1;WNT9A;CIT;FGF13;MAP1B;MARK1;LDB1;LRP12;NAV1;DOCK7;LHX9;HES5;SIX4;TGFB2;NRBP2;BHLHE40;FZD7;FGFR1;HEYL;FZD5;PEX13;MYEF2;RUNX2;CTF1;NEUROD2;HEY1;SDCCAG8;NRP1;RUNX1;NDNF;ACSL3;EN2;THOC2;ERBB2;DNAAF4
prerank,histone mRNA metabolic process (GO:0008334),0.45619145656061544,1.088301505744693,0.3683559950556242,0.817664768474602,1.0,11/27,21.97%,TENT4B;SSB;ATM;XRN1;EXOSC4;TUT7;NCBP1;NCBP2;TENT2;SNRPB;UPF1
prerank,regulation of translation (GO:0006417),0.37053677580314803,1.0881570646764858,0.3107287449392713,0.8175118387720594,1.0,60/173,28.61%,THBS1;IGFBP5;SAMD4A;EIF4A2;EIF4G2;PRKDC;EIF4G3;CYFIP1;GSPT1;IMPACT;ILF3;NIBAN1;EIF4G1;ALKBH1;LTN1;RBM4;NOLC1;ETF1;IL6;FOXO3;CNOT8;EIF6;ERBB2;EIF3D;CNOT10;NCBP1;SHMT2;EPRS1;DAPK3;NCBP2;CNOT9;SHMT1;GLE1;SYNCRIP;EIF2AK4;CALR;PYM1;CIRBP;EIF2A;ATXN2;FXR2;UPF1;SHFL;EIF2AK3;EIF4B;UPF3A;YBX1;RPS6KB1;RPS27L;UPF3B;RBM3;METTL14;MRPL13;RIDA;EIF4E;FXR1;YTHDF1;EIF4H;NSUN3;LARP1
prerank,striated muscle cell development (GO:0055002),-0.3979101983274305,-1.0880971276129183,0.31868131868131866,0.6929660376049981,1.0,4/14,8.20%,PGM5;TMOD3;TMOD1;LMOD1
prerank,sodium ion transmembrane transport (GO:0035725),0.38546013942948837,1.0879821359738413,0.3544973544973545,0.8174895576846503,1.0,13/84,9.01%,SLC4A4;ATP1B1;SLC12A2;SLC24A3;SLC5A2;HCN4;SLC4A8;SLC9A4;SCN11A;SLC9A1;SLC6A2;TRPM4;SLC6A7
prerank,megakaryocyte differentiation (GO:0030219),-0.42464186361516887,-1.0877247121589946,0.3333333333333333,0.6918863176647297,1.0,3/11,9.76%,KIT;SH2B3;TAL1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5413276874363493,1.0875815085405427,0.3830703012912482,0.8180633921100715,1.0,4/10,12.28%,RHOA;SYNE4;MYO9A;EZR
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.45040822601735525,1.0875546051614915,0.3643122676579926,0.8175361056306852,1.0,4/24,9.33%,PID1;GFPT1;GFPT2;COQ10B
prerank,regulation of actin filament polymerization (GO:0030833),0.3962945657690137,1.0874712123433192,0.35032537960954446,0.817165611106625,1.0,6/69,6.31%,SLIT2;PRKCD;CTTN;PRKCE;CDC42EP2;PFN2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3641881912968294,1.0870846137034604,0.218,0.8177509672458653,1.0,117/476,19.97%,ESR1;EGFR;LRP6;SIX1;ID2;ZFHX3;HIVEP3;FGF2;ZNF423;NFIB;COL1A1;ELF4;ZMIZ1;GLI2;MDFIC;LRP5;GLIS2;TGFB3;DEAF1;SHC1;PRDM11;HDAC4;ELF1;MAP3K5;RXRA;HES5;SIX4;STAT3;ATF4;TRIM28;DNM2;ACVR1;BRD4;FOXC2;ILK;RXRB;GPATCH3;SMAD4;FZD7;TASP1;TBX21;THRAP3;RARA;NSD1;MED13;SOX9;ESRRB;TFE3;FOXK1;ENY2;NFATC1;SMARCC2;ZIC1;RORA;ILF3;BMP4;SFR1;ING5;ZFP90;EHF;CHUK;RUNX2;FOXM1;PHF8;PITHD1;MAP3K12;AXIN1;CHEK2;MAZ;KAT6B;RNF14;TAF15;NAA16;PHIP;NR1D2;HEY1;KAT2A;TGFB1I1;TGFBR1;HDAC1;INHBA;F2R;CD80;MAPRE3;RUNX1;NDP;MMS19;SERTAD3;IL6;PSMC5;CAMK4;FOXO3;NFE2;CREB1;MLLT3;CREBBP;APBB1;KMT2B;NFYA;MED14;CDKN1C;CITED2;HMGA1;MED12;E2F1;RYBP;HCFC1;AKT1;CHD8;HIPK2;MLXIPL;QRICH1;TEAD2;XRCC6;TCF3;BICRAL;MAP2K3
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4472981550661866,1.0865701084389203,0.37236533957845436,0.8180551941515414,1.0,7/29,18.78%,ACSF2;ACOT11;GPAT4;ACAT1;GLYAT;ACOT13;ACSL6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4472981550661866,1.0865701084389203,0.37236533957845436,0.8180551941515414,1.0,7/29,18.78%,ACSF2;ACOT11;GPAT4;ACAT1;GLYAT;ACOT13;ACSL6
prerank,defense response to virus (GO:0051607),-0.25814638637445153,-1.086365201038095,0.2777777777777778,0.693489152280444,1.0,27/100,18.43%,SERINC3;BCL2;BCL2L1;IFNAR2;STAT1;AGBL4;ABCC9;SAMHD1;IFITM1;NLRC5;BST2;IFIT3;IFIT2;RNASEL;IFIT1;PQBP1;CD40;RSAD2;IFITM3;OAS2;IFI27;MLKL;SERINC5;PYCARD;MYD88;PHB2;ZBP1
prerank,I-kappaB phosphorylation (GO:0007252),0.5307085475609085,1.0863311090204881,0.3868194842406877,0.8181608954797223,1.0,2/10,10.27%,ERC1;CHUK
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.4316904184547641,-1.085626201272143,0.39492753623188404,0.6934815932096475,1.0,7/11,16.08%,WNT4;FGFR4;EGR1;SIRT1;NR1H4;BMP2;STAR
prerank,mammary gland development (GO:0030879),0.4644430461530164,1.0856249762639332,0.3858267716535433,0.8196631010200333,1.0,3/21,2.89%,VEGFA;GLI2;TGFB3
prerank,positive regulation of apoptotic process (GO:0043065),0.3671700890790298,1.085319898064056,0.27354709418837675,0.8199963797595509,1.0,66/293,18.27%,SLIT2;RASSF2;HOXA5;SFRP4;PTGIS;TIAM1;GADD45G;PRR7;TIAM2;UNC13B;VAV2;TGFB3;PRDM11;CYP1B1;FAP;MAP3K5;CRADD;TGFB2;ATF4;DNM2;CCAR2;HMGB1;ING3;IAPP;KALRN;BACE1;MAPK8;BMP4;FOXA1;ING5;ABL1;RBM5;ATM;AIFM1;SOD1;TNFRSF10B;ERCC3;PTRH2;TGFBR1;PDCD2;HSPD1;MAP3K10;SOS2;SQSTM1;ARHGEF1;RHOB;SCIN;AKAP13;PSEN2;SOS1;IL6;ING4;SIRT2;LATS2;FOXO3;TRIO;RPS27A;UBC;APBB1;NF1;NGEF;FLCN;DAPK3;E2F1;BID;RYBP
prerank,regulation of vasculogenesis (GO:2001212),0.49395841072155994,1.0852992924356053,0.37935656836461124,0.8194457750384401,1.0,3/14,12.13%,TMEM100;XDH;HEY1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.448892788073302,1.0852752446475575,0.375,0.81890921425731,1.0,6/27,8.78%,FXYD5;PTPN3;CAMK2D;SLMAP;SNTA1;DLG1
prerank,regulation of interleukin-13 production (GO:0032656),-0.41057901759394333,-1.0851688692676247,0.3202846975088968,0.6927547149843484,1.0,4/13,14.89%,LEF1;TNFRSF21;LGALS9;PRKCZ
prerank,macrophage activation (GO:0042116),0.42394962919934004,1.0846762771184806,0.39229843561973526,0.8200891428896617,1.0,2/34,1.05%,FOXP1;LBP
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4688662059829794,1.0846645250849825,0.38756613756613756,0.8195176712426818,1.0,10/20,25.93%,MCU;SPG7;MICU2;LETM1;MICU1;PMPCA;AFG3L2;SLC8B1;STOML2;PMPCB
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.47867342595379975,1.0846393779266124,0.3711340206185567,0.8189917784100963,1.0,6/19,23.74%,TENT4B;TEN1;HNRNPC;XRN1;HNRNPA1;HNRNPU
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5136535698735307,1.0846334074947326,0.3792633015006821,0.8184051024721493,1.0,8/13,31.62%,NFE2L2;HGF;LRRK2;PYCR1;MET;GPR37;GPR37L1;NR4A3
prerank,protein heterooligomerization (GO:0051291),0.48425935237746487,1.0842638067170618,0.35802469135802467,0.818903088518087,1.0,5/17,18.09%,PKD1;CBR4;HSD17B8;CPSF7;CPSF6
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5221648160779593,1.0840658769148421,0.39748953974895396,0.8188968928312341,1.0,5/11,20.97%,TBX21;ANXA1;SMAD7;RC3H2;IL4
prerank,regulation of platelet activation (GO:0010543),-0.3589909767359496,-1.0840238792178016,0.32653061224489793,0.6937727744162737,1.0,8/21,11.13%,LYN;APOE;TEC;NOS3;PDGFRA;SYK;PRKCQ;PLEK
prerank,positive regulation of programmed cell death (GO:0043068),0.3666571084187828,1.0839286675429398,0.2902902902902903,0.8187020517512449,1.0,61/272,18.27%,SLIT2;RASSF2;HOXA5;SFRP4;TIAM1;GADD45G;NTRK1;PRR7;TIAM2;UNC13B;VAV2;TGFB3;CYP1B1;MAP3K5;CRADD;ATF4;DNM2;CCAR2;HMGB1;ING3;IAPP;KALRN;MAPK8;BMP4;FOXA1;ING5;ABL1;RBM5;ATM;AIFM1;SOD1;TNFRSF10B;ERCC3;PDCD2;HSPD1;MAP3K10;MARK4;SOS2;SQSTM1;ARHGEF1;RHOB;SCIN;AKAP13;PSEN2;SOS1;IL6;ING4;LATS2;FOXO3;HDAC6;TRIO;RPS27A;UBC;APBB1;NF1;NGEF;FLCN;DAPK3;E2F1;BID;RYBP
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3811210214344825,1.0834096905286663,0.34536082474226804,0.8196568593742066,1.0,33/101,25.65%,THBS1;RDX;SAMD4A;DACT1;PRKDC;OGT;NIBAN1;EZR;EIF4G1;INHBA;TBC1D10A;IL6;STUB1;EIF6;ERBB2;EIF3D;PERP;VPS11;IST1;AKT1;NFKBIA;PYM1;CIRBP;FXR2;CYFIP2;UPF3A;RPS6KB1;BAD;RPS27L;UPF3B;RBM3;HDAC2;METTL14
prerank,positive regulation of lyase activity (GO:0051349),0.5049603276042937,1.0832617449463675,0.3983516483516483,0.8194748890408904,1.0,3/14,9.17%,CACNA1C;FXN;STIM1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.417817989052553,1.083144137164262,0.37485448195576254,0.8192100102302741,1.0,21/42,32.75%,HELB;RMI2;FUS;SPIDR;WDR48;MMS19;PARP1;RAD51;MAD2L2;SETD2;ACTR2;CGAS;WAS;FBH1;RTEL1;SHLD3;SHLD1;TIMELESS;PARPBP;ERCC6;POLQ
prerank,vasodilation (GO:0042311),-0.40639582892958487,-1.0831272482981156,0.3563636363636364,0.6941715411337634,1.0,5/13,17.49%,NOS3;KLF2;NOS1;GPER1;SOD2
prerank,regulation of DNA metabolic process (GO:0051052),0.4157066238860706,1.0830655896973922,0.364367816091954,0.8188558436203311,1.0,19/44,31.49%,HELB;TOM1L1;SMG6;SMG1;KPNA2;UBE2V2;SMARCAD1;CDT1;WDR70;USP1;KAT7;MPHOSPH8;UPF1;PARG;UBE2V1;CDK9;MPV17;IL7R;UBE2N
prerank,nitric oxide biosynthetic process (GO:0006809),-0.40293453776987476,-1.082680229138806,0.34558823529411764,0.693341608560355,1.0,6/13,12.41%,NOS3;CYB5B;GCH1;NOS1;DDAH2;SPR
prerank,macrophage activation involved in immune response (GO:0002281),0.5085439066388875,1.0826538201858955,0.4,0.819487182761519,1.0,2/13,9.20%,LBP;SBNO2
prerank,positive regulation of phosphorylation (GO:0042327),0.3667917091659137,1.0824460682715764,0.30784708249496984,0.8194944233665907,1.0,39/240,12.40%,THBS1;SLC4A4;PGF;EGFR;SLCO3A1;VEGFA;EFNA5;GAS6;DDR2;FGF2;CARD14;NTRK3;NTRK1;FGF17;EPHB2;CSNK1D;GLMN;LIMK2;MAVS;EPHB3;EPHB6;ILK;FZD7;FGFR1;RSPO1;SOX9;AKT2;ROR1;BMP4;FGFR2;TMEM119;MUSK;ABL1;LMO4;NIBAN1;AXIN1;DDR1;RAD50;NRP1
prerank,positive regulation of ruffle assembly (GO:1900029),0.4958143555004444,1.0824275796564595,0.3902777777777778,0.818952410014001,1.0,5/13,14.67%,EPS8L1;FAM98A;NLGN1;NDEL1;PLEKHM1
prerank,positive regulation of protein modification process (GO:0031401),0.36741450536488435,1.0823828912772822,0.3011077542799597,0.8184831564232085,1.0,45/203,17.28%,PGF;EGFR;TRABD2B;PRKCD;SLCO3A1;VEGFA;EFNA5;GAS6;FGF2;CARD14;NTRK3;NTRK1;FGF17;CSNK1D;LIMK2;CALM2;MAVS;RAB3GAP1;ILK;RSPO1;SOX9;SYMPK;AKT2;BMP4;TMEM119;RAMP1;MUSK;ABL1;NNMT;NIBAN1;AXIN1;CNEP1R1;CHP1;ERP29;PTBP1;WDFY2;DAB2;HGF;ARRB1;NSMF;ERBB2;FGF5;CALM3;EFNA1;FLCN
prerank,protein localization to cell periphery (GO:1990778),0.3778840213242941,1.0823233007055917,0.32541322314049587,0.8180705220886996,1.0,21/133,7.67%,LRP6;KCNB1;ATP1B1;GAS6;FGF13;TTC7A;EHD1;RDX;RAB34;C2CD5;RAMP2;PIGW;PACS2;S100A10;PRAM1;RAB8A;SLMAP;ANK2;EHD2;FCHO2;JUP
prerank,T cell activation (GO:0042110),-0.27976187159493454,-1.0819240839690112,0.2911392405063291,0.6931611013484439,1.0,19/69,20.76%,LEPR;CHD7;KIT;DPP4;CXADR;JAG2;RHOH;CD74;PIK3CD;LCP1;LFNG;CTPS1;CD44;PTPN22;DLL4;MDK;CD276;SOX4;NHEJ1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.32841992655100494,-1.0818375934344813,0.31125827814569534,0.6914189975707061,1.0,12/32,15.08%,CDH5;MAP2;NAV3;CAMSAP1;APC;SPEF1;EML2;ARHGEF2;MID1IP1;CLASP2;SNCA;TUBB4A
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.4688425775397711,1.0813762040050612,0.385297845373891,0.8202535170189069,1.0,9/19,29.91%,CSNK2A2;FZD5;SREBF1;USP36;HDAC6;PINK1;HTRA2;SREBF2;PRKN
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5210705753455336,1.0808756142558835,0.37780898876404495,0.8199873568913976,1.0,5/12,19.95%,ANAPC5;CDC16;ANAPC4;CDC27;DLGAP5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5210705753455336,1.0808756142558835,0.37780898876404495,0.8199873568913976,1.0,5/12,19.95%,ANAPC5;CDC16;ANAPC4;CDC27;DLGAP5
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5210705753455336,1.0808756142558835,0.37780898876404495,0.8199873568913976,1.0,5/12,19.95%,ANAPC5;CDC16;ANAPC4;CDC27;DLGAP5
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4608289188906993,1.080376203507646,0.3790931989924433,0.8208381053257777,1.0,2/23,5.91%,SLIT2;MCU
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.325014224945311,-1.080333683922904,0.32044198895027626,0.6933522450694137,1.0,7/30,12.39%,FLT1;KIT;KDR;ACE;FLT4;PLEK;SFRP1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3981288567852739,1.0798824939074458,0.36363636363636365,0.821702081149386,1.0,30/64,29.94%,ELOF1;TCEA2;CDK12;GTF2F1;CCNT2;ERCC3;ERCC2;POLR2F;AFF4;MLLT3;NCBP1;SSRP1;ELP4;NCBP2;PAF1;POLR2B;SETD2;NELFB;CDK13;EAF1;CTDP1;RTF1;GTF2H4;POLR2H;NELFA;POLR2I;CDK9;MLLT1;ADRM1;POLR2L
prerank,rRNA modification (GO:0000154),0.4605365143816771,1.0792676888813335,0.37890625,0.8229312184408397,1.0,14/21,41.21%,TFB2M;TSR3;FBL;BUD23;TRMT112;DKC1;NSUN3;NOP10;THUMPD1;MRM2;ZCCHC4;DIMT1;NSUN4;MTERF4
prerank,lipoprotein transport (GO:0042953),0.5324015503459555,1.0792328985105675,0.3968481375358166,0.8224267550018992,1.0,1/10,1.02%,LRP1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5338689966073881,1.0790439622432968,0.3918722786647315,0.8224036543038046,1.0,1/10,1.29%,IL33
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4356884999970171,1.078767717798147,0.3773364485981308,0.8225745748992682,1.0,16/35,30.24%,MAPK15;NEK7;HNRNPA2B1;ATM;TNKS2;CCT4;CCT6A;CCT8;MAP2K7;HNRNPA1;TCP1;RTEL1;PNKP;CCT5;ATR;CTNNB1
prerank,regulation of glycogen metabolic process (GO:0070873),0.5166701233973592,1.0786605224049997,0.3814866760168303,0.8223027861013625,1.0,4/12,23.12%,PPP1R3C;PPP1R3F;AKT1;PPP1R3B
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5046549442073279,1.0783890599292365,0.3850415512465374,0.8225116974956773,1.0,3/13,11.27%,DDX5;SPRED2;ATM
prerank,protein modification by small protein conjugation (GO:0032446),0.3620289187330549,1.0780241624864186,0.27655310621242485,0.8229692808106164,1.0,119/361,25.87%,WWP1;RNF144A;NEDD4;NUP93;FBXO10;FBXL7;FBXW8;TOPORS;CDC16;UBE2B;TRIM28;RAE1;VCP;RNF182;DTX3;DCUN1D5;UBE2R2;NFX1;PRKDC;SEH1L;KLHL7;NFE2L2;TRIM41;PEX5;TRPC4AP;HUWE1;TRIM27;SYVN1;CBL;CDK5RAP3;LZTR1;TRPM4;WWP2;PEX13;ITCH;CUL4A;FBXO25;UCHL3;RNF25;UBE2C;NEUROD2;RNF14;NUP37;SDE2;ATG3;MYLIP;CUL1;DCUN1D2;RNF38;DTX2;PEX10;USP7;RNF103-CHMP3;UBA5;TRIM26;RANBP2;PIAS4;NUP88;ARRB1;STX1A;STUB1;UBE2V2;RPS27A;UBC;OTULIN;SUMO1;BIRC6;UFL1;TRIM13;VPS11;TRIM6;POM121;NUP210;UHRF2;RNF7;UBR2;CDC27;ASB5;SAE1;MYCBP2;UBE2G2;PCNP;TRAIP;TRIM47;NUP62;USP5;SMURF2;TRIM43;MUL1;PEX2;PAF1;KCTD13;CUL9;UBA3;SUMO2;NDC1;AREL1;PEX14;DERL1;RNF20;NUP35;FBXO11;DET1;UBE2Z;FBXO9;AMFR;ANKRD9;PINK1;RCHY1;SELENOS;RNF138;UBE2W;RTF1;UVSSA;UBR3;RNF111;SHPRH;NUP85;CUL7
prerank,inhibitory synapse assembly (GO:1904862),0.522460909286838,1.0780136860965346,0.38795518207282914,0.8224008250331365,1.0,2/11,5.23%,FGF13;LGI2
prerank,actin-myosin filament sliding (GO:0033275),-0.31097256369009063,-1.0779290550744398,0.3006134969325153,0.6957597526071998,1.0,8/38,11.61%,ACTN2;TPM1;MYL6;TMOD1;DES;TPM3;VIM;TPM2
prerank,muscle filament sliding (GO:0030049),-0.31097256369009063,-1.0779290550744398,0.3006134969325153,0.6957597526071998,1.0,8/38,11.61%,ACTN2;TPM1;MYL6;TMOD1;DES;TPM3;VIM;TPM2
prerank,axonemal dynein complex assembly (GO:0070286),0.44165874539114336,1.0774778727849312,0.36888331242158096,0.8234190061001854,1.0,9/28,26.05%,DNAH8;DNAAF3;ODAD2;CCDC39;DNAAF4;CFAP73;TTC12;DNAAF5;DNAL1
prerank,renal water homeostasis (GO:0003091),-0.34343680375120145,-1.0770176570156014,0.3415841584158416,0.6960853396907803,1.0,6/23,7.53%,ADCY5;ADCY1;PRKAR2B;PRKACB;PRKAR1B;ADCY4
prerank,positive regulation of cartilage development (GO:0061036),0.4821487857363513,1.0766439230526441,0.3984476067270375,0.8253684249930376,1.0,4/17,9.70%,PKDCC;BMP1;SOX9;BMP4
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3812651790208601,1.076610006317268,0.3516597510373444,0.8248647613423693,1.0,41/91,29.88%,STON2;ARFGAP1;GAS1;DNAJC13;RAB21;RAB8A;MBTPS1;STON1;NSF;ITGAV;SCFD1;ABL1;ATP9A;RAB3D;NRP1;STXBP5;RAB11B;USP7;CHMP3;RINT1;STX4;RAB3B;RAB4B;HIP1;RAB5B;RUFY2;ZFYVE16;RAB4A;LRRK2;TSC2;BET1L;VAMP2;RAB5A;LGI3;RALA;FES;ABL2;RAB3A;RAB5C;PACSIN2;RUFY1
prerank,regulation of microtubule polymerization (GO:0031113),-0.29884714325933764,-1.0762139163472426,0.30656934306569344,0.6962953976219918,1.0,11/40,15.08%,OCLN;CDH5;MAP2;NAV3;CAMSAP1;EML2;PAK1;CLIP1;PRUNE1;SNCA;TUBB4A
prerank,ethanol metabolic process (GO:0006067),-0.41272402870537594,-1.0759712072601364,0.31095406360424027,0.6949676497051291,1.0,5/12,15.15%,ALDH1A1;ACSS2;ALDH2;SULT1A1;ADH1A
prerank,positive regulation of calcium ion import (GO:0090280),-0.4170035817253317,-1.0759323067585544,0.3758620689655172,0.6931185320966304,1.0,2/12,4.50%,CXCL12;PDGFRB
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.4230846753081433,1.0753922135599796,0.373536299765808,0.8278893889414464,1.0,15/40,28.54%,PRKCD;KMT5A;SMG1;ABL1;UBE2V2;ARMT1;USP1;NEK4;FXR2;BCLAF1;SMYD2;PARG;FXR1;UBE2V1;CDK9
prerank,negative regulation of cell migration (GO:0030336),0.3723281480311314,1.0753775318121397,0.35655737704918034,0.8273344820009022,1.0,18/137,6.57%,SLIT2;IGFBP5;LRP1;FGF2;COL3A1;SRGAP3;SRGAP2;TMEFF2;DPYSL3;MAPK15;LDLRAD4;CYP1B1;SLURP1;CLIC4;PTPRU;PFN2;JAG1;SULF1
prerank,DNA repair (GO:0006281),0.3584956773056425,1.0750894398077657,0.30120481927710846,0.8276173223921651,1.0,122/284,33.50%,PARP3;CHD1L;UBE2B;TRIM28;MPG;POLE2;FTO;VCP;ERCC8;PRKDC;RMI2;INTS3;TRRAP;KMT5C;HUWE1;ERCC5;FAAP20;RBBP8;RAD1;ERCC4;OGG1;MAPK8;WRN;ABL1;WDR48;TDG;KPNA2;ATM;USP45;CHEK2;PMS2;TDP1;KDM4A;ERCC3;RAD50;CSNK1E;LIG4;ALKBH1;ERCC2;SMUG1;PIAS4;DCLRE1B;MMS19;FANCE;ATRIP;UBE2V2;FAAP24;PARP1;RPS27A;UBC;HUS1;APBB1;SUMO1;POLB;SLC30A9;MEN1;ACTR8;RAD51;USP1;TEX264;TNKS1BP1;TRAIP;FANCG;BRCC3;XRCC3;MAD2L2;APEX2;ENDOV;UPF1;USP47;TOPBP1;SETD2;PDS5A;UVRAG;PRIMPOL;ALKBH3;SMC1A;TP53;RECQL5;POLD1;GTF2H4;SLX4;XPA;PARP4;ZRANB3;FBH1;RPAIN;NOP53;PNKP;ADPRS;UBE2V1;SETX;DDB1;ATR;SMARCAL1;IGHMBP2;MBD4;RAD52;PDS5B;TIMELESS;RAD17;RHNO1;HINFP;TDP2;UBE2A;MSH2;UBE2N;MTA1;BLM;XRCC1;ERCC1;RAD23B;ERCC6;HERC2;CHRNA4;POLK;POLQ;RPA3;VCPIP1;ALKBH5;CUL4B;FANCA
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4543307527024914,1.0750859536654636,0.3629441624365482,0.8270383693045563,1.0,4/24,5.27%,MYOC;ARAP1;TMEFF2;PPFIA1
prerank,regulation of extracellular matrix organization (GO:1903053),0.4897661323546659,1.074782062577627,0.40620782726045884,0.8273267352851341,1.0,7/15,17.11%,LRP1;DDR2;FAP;RIC1;DDR1;RUNX1;SLC2A10
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.38324006823117734,-1.0746714436117244,0.33617021276595743,0.694364149077589,1.0,3/16,3.71%,SOX5;PTN;SOX6
prerank,DNA integrity checkpoint signaling (GO:0031570),0.42160028843291764,1.074561858933584,0.3793939393939394,0.8273603572085415,1.0,19/36,32.31%,CDC6;TIPRL;RAD1;ATM;CHEK2;CDC45;CEP63;ATRIP;HUS1;CDT1;E2F1;DONSON;ATR;INTS7;TIMELESS;RAD17;RHNO1;HINFP;ERCC6
prerank,negative regulation of nervous system development (GO:0051961),0.46914529720014514,1.0743893520346177,0.41289437585733885,0.8272946992429361,1.0,1/17,0.27%,SLIT1
prerank,response to muscle stretch (GO:0035994),0.48824516524760153,1.074286976935882,0.38095238095238093,0.8270029926235091,1.0,4/15,10.81%,GSN;DMD;SLC9A1;CSRP3
prerank,pre-replicative complex assembly (GO:0036388),0.39791359010880495,1.0740137453882033,0.38419319429198684,0.8272071509653582,1.0,25/64,27.30%,PSMD7;PSMA8;MCM2;CDC6;PSMA4;PSMD12;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;RPS27A;UBC;MCM4;ORC2;CDT1;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;PSMC1;MCM7;PSMA1
prerank,platelet degranulation (GO:0002576),0.3774920799038982,1.073994822727541,0.35427394438722964,0.8266765712248381,1.0,14/118,7.26%,THBS1;VEGFA;GAS6;CHID1;TIMP3;TGFB3;SPARC;PCDH7;TOR4A;TGFB2;CD9;MAGED2;QSOX1;FAM3C
prerank,regulation of mRNA catabolic process (GO:0061013),0.37827439870899837,1.0737260256348142,0.3492723492723493,0.8269127043040485,1.0,38/121,24.67%,XPO1;PRKCD;PABPC1;SAMD4A;PSMD7;PRKCA;PSMA8;PUM1;PSMA4;PCBP4;PSMD12;PSMA6;EIF4G1;PSMD1;XRN1;EXOSC4;PSMC5;CNOT8;PSMD11;PSMC4;PSMD14;RPS27A;UBC;RC3H2;DIS3;AKT1;TNPO1;PSMA3;PSMB1;PSMD4;FXR2;UPF1;DCP1A;PSMA5;PSMA7;ZC3H14;RBM24;YWHAB
prerank,regulation of cilium assembly (GO:1902017),0.39926462655293055,1.0733248350775122,0.3835920177383592,0.8274814082051349,1.0,29/62,30.12%,MAPK15;TBC1D2B;LIMK2;DYNLT2B;IFT20;CDK10;TBC1D24;ATG3;EVI5L;SDCCAG8;TBC1D9B;MARK4;FUZ;TBC1D10A;TBC1D17;IFT88;KCTD17;EVI5;TBC1D22B;CYLD;RABGAP1;ARHGAP35;TBC1D20;CCP110;TAPT1;IFT140;TESK1;TBC1D19;TCHP
prerank,aorta morphogenesis (GO:0035909),-0.3818047996692904,-1.0732523037495074,0.36254980079681276,0.696311487174917,1.0,10/17,14.31%,ENG;MYLK;PDGFRB;TBX1;PROX1;RBPJ;TBX2;ACVRL1;HEY2;EFEMP2
prerank,snRNA metabolic process (GO:0016073),0.47963940276665035,1.0729351565766894,0.3790849673202614,0.8280457449174674,1.0,11/17,38.04%,INTS3;INTS4;MTREX;ZCCHC8;INTS9;INTS7;MEPCE;INTS6;INTS10;RBM7;INTS8
prerank,positive regulation of protein kinase activity (GO:0045860),0.37027318034480355,1.0728422325411102,0.3575076608784474,0.8277227872913714,1.0,23/148,11.47%,RASSF2;PRKCD;VEGFA;GAS6;DDR2;SRCIN1;CAMKK1;STRADA;TGFB2;CALM2;TOM1L1;NOX4;TGFBR2;DLG4;PAK4;RHOA;PAK2;SYAP1;RIPK3;TAB2;TELO2;AXIN1;SNX9
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.45958260304824594,1.0721662730261439,0.3886743886743887,0.8291279926410965,1.0,8/21,28.13%,TWIST1;MED13;SRF;MED14;MED12;BCLAF1;MED24;SETX
prerank,regulation of axon extension (GO:0030516),0.41782912911268644,1.072055973326099,0.3763440860215054,0.8288487012449619,1.0,6/37,10.59%,NTN1;CTTN;PTPRS;DNM2;GOLGA4;ABL1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4096905317373614,1.0719620284014657,0.3811710677382319,0.8285350763833977,1.0,5/49,6.48%,LBP;F3;STAT3;MAVS;HMGB1
prerank,regulation of cell population proliferation (GO:0042127),0.35628801779026603,1.0718979581208359,0.215,0.8281298188500744,1.0,133/691,15.71%,THBS1;PGF;EGFR;SIX1;IRS1;ZBTB7C;ID2;WNT9A;ELN;VEGFA;ECRG4;FGF2;TCF7L2;SFRP4;TIAM1;ACER3;NPR3;NTRK3;PROK2;NTRK1;FGF17;BRICD5;SMAD6;GAB2;LRP5;GNL3;MAPK15;TGFB3;P3H3;PPP1R9B;SHC1;CYP1B1;SLURP1;RBFOX2;HDAC4;STAT5A;GLMN;PKHD1;LMNA;WWTR1;PTPRU;HES5;CSNK2A1;SIX4;TGFB2;STAT3;TCIRG1;P3H1;MEAK7;DNAJA2;CLMN;TCFL5;FXN;TMEM115;NOX4;PRKDC;PLPP1;FAM98A;ADAM10;IL12RB2;TGFBR2;JAG1;PRKRA;ABI1;IFNLR1;FGFR1;MEIS3;SKI;CDK10;MDM4;RAF1;JUP;TES;P3H2;RARA;S100B;BEX4;CHERP;SOX9;DDAH1;AKT2;CDC6;TRPM4;RHOA;EDN3;BMP4;FGFR2;ITGAV;CDC25B;TBRG4;ING5;CDC123;FAM98B;VIP;FOXM1;CTF1;DIS3L2;CHTOP;RBM5;BMPR1A;MAZ;PHIP;PBRM1;TENM1;TGFB1I1;TGFBR1;HDAC1;TRAPPC14;PTPN2;INHBA;F2R;CGRRF1;KMT2D;GSDME;NACC1;RUNX1;SETD4;FRK;FUZ;BMP5;CLCF1;TMEM127;PRDX3;VDR;CYP27B1;SCIN;CAMK2N1;STX4;IL6;ING4;SIRT2;SLC35F6;CNOT8
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.37894243410136524,1.0714643579392373,0.35500515995872034,0.8288094865449761,1.0,33/129,16.38%,EGFR;GPC3;COL1A1;SFRP4;PLEKHA4;PSMD7;CSNK1D;UBE2B;VCP;PSMA8;DACT1;ILK;CCAR2;RSPO1;JUP;TRPM4;PSMA4;FGFR2;CSNK1G1;UBR5;AXIN1;PSMD12;USP34;CSNK1E;PSMA6;WNK1;TNKS2;PSMD1;PSMC5;GSKIP;PSMD11;PSMC4;PSMD14
prerank,regulation of neuron differentiation (GO:0045664),0.3892362083839585,1.0708879889790919,0.38699360341151384,0.8299620755955176,1.0,13/76,13.02%,SIX1;ID2;ZFHX3;TIAM1;HES5;FGFR1;HEYL;IMPACT;CDK5RAP3;RHOA;NEUROD2;HEY1;NLGN1
prerank,regulation of stem cell differentiation (GO:2000736),0.3854273430451386,1.070881242269095,0.3741935483870968,0.8293898647715845,1.0,34/89,24.32%,LDB1;PSMD7;HES5;PSMA8;SLC4A11;PRKDC;JAG1;ESRRB;PSMA4;ITCH;ABL1;BMPR1A;PSMD12;PSMA6;HOXB4;RUNX1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;GDNF;SETD1A;CBFB;TCF3;PSMA3;PSMB1;PSMD4;KMT2A;NELFB;PSMA5;PSMA7;HNRNPU;RBM24
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5277418059625483,1.0706750734289907,0.41897810218978104,0.8294011568952802,1.0,6/10,31.55%,NFE2L2;LRRK2;PYCR1;RIPK1;GPR37;GPR37L1
prerank,pentose-phosphate shunt (GO:0006098),0.5250198171265957,1.0705886175757817,0.4117647058823529,0.8290800059863664,1.0,4/11,16.24%,SHPK;TKT;DERA;PGD
prerank,epiboly involved in wound healing (GO:0090505),0.47422472548819516,1.0705442495536532,0.40482573726541554,0.8286175474699293,1.0,4/16,17.44%,TMEFF2;RHOA;DDR1;CD151
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3106437761453901,-1.0703262041307315,0.33793103448275863,0.7019971872386213,1.0,6/32,8.38%,AUTS2;OCLN;PIK3R1;ENPP2;CORO1C;CDC42
prerank,negative regulation of type I interferon production (GO:0032480),0.41448711777217695,1.0702749954148623,0.38425925925925924,0.8287872357665326,1.0,19/40,28.95%,PTPRS;TAX1BP1;MAVS;GPATCH3;ITCH;PCBP2;UBE2L6;OTUD5;ACOD1;NPLOC4;IKBKE;IRF3;RNF216;CYLD;TBK1;ILRUN;YY1;PPM1B;RNF135
prerank,neuron projection development (GO:0031175),0.3655817354885994,1.070225372865396,0.3448275862068966,0.8283397254401166,1.0,22/168,7.83%,MYOC;DCLK1;CTNND2;SRGAP2;NEDD4;CTTN;STMND1;EHD1;ANKRD27;LRP12;EPHB2;ARC;DOCK7;PPP1R9B;DNM2;EPHB3;BLOC1S2;HMGB1;GPRIN1;TBC1D23;TBC1D24;DLG4
prerank,regulation of protein autophosphorylation (GO:0031952),0.4211600726433703,1.0701743509112605,0.37995337995337997,0.8278963674915613,1.0,9/36,16.86%,RASSF2;VEGFA;CALM2;TOM1L1;IMPACT;RAD50;CHP1;PPP2R5C;CALM3
prerank,negative regulation of protein metabolic process (GO:0051248),0.4055265209700604,1.0701704181284992,0.3812154696132597,0.8273186041739446,1.0,15/48,24.47%,EGFR;RILP;IRAK3;MDM4;IAPP;ITGAV;SIRT2;VBP1;AZIN1;CLU;MAD2L2;LDLR;PFDN4;SNX3;ROCK1
prerank,regulation of glucose import (GO:0046324),0.4363533264114203,1.0701501874731025,0.39611178614823817,0.8267964756543198,1.0,6/30,8.56%,IRS1;PID1;GRB10;RHOQ;CAPN10;AKT2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3558917999533299,1.0699812861822797,0.167,0.8267161294713042,1.0,279/1082,22.68%,PLAGL1;ESR1;EGFR;LRP6;SIX1;PKD1;PID1;ID2;ZFHX3;HOXA5;ZFPM2;VEGFA;HIVEP3;NFIX;FGF2;ZNF423;NFIB;TCF7L2;IL33;COL1A1;RARB;ELF4;NFIA;GALR1;DDX17;RHOQ;LDB2;LDB1;ZMIZ1;GLI2;MDFIC;TCF20;LRP5;GLIS2;TGFB3;TWIST1;DEAF1;SHC1;PRDM11;PRDM10;NFAT5;HDAC4;ELF1;ELOF1;MAP3K5;HOXB3;RXRA;ONECUT2;MEOX2;WWTR1;HES5;KLF5;SIX4;STAT3;DCAF6;ATF4;TRIM28;NR2F1;MAVS;BCAS3;DNM2;KMT2C;ACVR1;BRD4;DVL1;FOXC2;ILK;BCL9L;RXRB;PRKDC;GPATCH3;SMAD4;NFE2L2;HMGB1;JAG1;MEF2B;FZD7;SLC9A1;E2F3;TASP1;PBX1;MEIS3;SKI;HEYL;TBX21;THRAP3;JUP;ARF4;RPS6KA4;NRIP1;RARA;NSD1;FOXJ3;MED13;FZD5;SOX9;ESRRB;TFE3;FOXK1;ENY2;ZNF76;NFATC1;HMGN1;SMARCC2;OGT;SERTAD2;ZIC1;SBNO2;RORA;ILF3;BMP4;FGFR2;SFR1;FOXA1;ING5;UBP1;CSRNP1;ZFP90;PRDM4;SREBF1;EHF;CHUK;RUNX2;GTF2F1;FOXM1;ABL1;AGO1;RFX5;CCNT2;PHF8;CSRP3;PITHD1;MAP3K12;PLAC8;NRF1;ATM;BMPR1A;AXIN1;CHEK2;MAZ;KAT6B;PAXBP1;RNF14;TAF15;NAA16;SFPQ;TAF6;SMAD7;MED25;PHIP;SRF;NR1D2;HEY1;GLIS1;KAT2A;SSBP3;RGMA;TGFB1I1;TGFBR1;HDAC1;AGO2;PTOV1;MEF2D;ZMIZ2;HOXB4;INHBA;F2R;CD80;MAPRE3;KMT2D;MEF2A;RUNX1;NFATC3;NDP;SQSTM1;DAB2;BMP5;MMS19;SERTAD3;VDR;MED21;TFDP1;PER1;HGF;IL6;ARRB1;GRHL1;SIRT2;PSMC5;CAMK4;CRTC2;FOXO3;NFE2;CREB1;MLLT3;CREBBP;PARP1;ERBB2;AATF;ZNF462;RPS27A;UBC;APBB1;KMT2B;KDM6B;DPF3;PRDM2;NFYA;FLCN;NFKB2;SLC30A9;NR3C1;RFXANK;E4F1;MED14;CDKN1C;MEN1;CITED2;HMGA1;ATAD2B;MED12;E2F1;RYBP;HCFC1;AKT1;GDNF;ATF2;CCDC62;CHD8;HIPK2;KLF10;HOXB2;MLXIPL;BRD8;FOSL2;QRICH1;TEAD2;XRCC6;IRF3;VEZF1;MPND;NFKBIA;TCF3;BICRAL;MAP2K3;ATF6;MAX;BPTF;TET2;RTRAF;KAT7;MRPL12;BCL2L12;MAD2L2;NUP62;GPS2;IL4;MAP2K7;RNF4;BCL11B;SMAD5;IER2;NEK4;SENP1;POGZ;NFIC;DNAJC2;CAMK1;SS18L1;ZKSCAN3;KAT8;NR2C2;EIF2AK3;CDK5RAP2;TRIAP1;KMT2A;SLC11A1;ICE1;TFCP2
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3389811549538444,-1.0697758735443372,0.34134615384615385,0.7015416802187522,1.0,6/24,12.75%,DACH1;NIBAN2;BMPR2;H1-0;ACVRL1;TERF2IP
prerank,endothelial cell migration (GO:0043542),0.420167804581532,1.0695425681325978,0.3810650887573965,0.8273447198611606,1.0,10/37,12.40%,VEGFA;FSTL1;CCN3;CYP1B1;FAP;GIPC1;RHOA;LGALS8;ABL1;NRP1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.49448933536961504,1.0694944390267809,0.3817204301075269,0.8269176531343113,1.0,4/14,12.28%,RHOA;SYNE4;MYO9A;EZR
prerank,regulation of cell size (GO:0008361),0.4512038393970463,1.069490774634492,0.3829236739974127,0.8263461194292453,1.0,6/23,12.29%,RDX;VAV2;AKT1S1;RHOA;EZR;DEPTOR
prerank,protein localization to membrane (GO:0072657),0.36483917487764655,1.0693335882643111,0.3333333333333333,0.8262242973798813,1.0,39/187,14.25%,LRP6;KCNB1;ATP1B1;GAS6;FGF13;DLG2;TTC7A;EHD1;RDX;RAB34;C2CD5;TM9SF4;RAMP2;PIGW;PACS2;DVL1;S100A10;PRAM1;RAB8A;SLMAP;ANK2;EHD2;FCHO2;JUP;DLG4;DLG1;SH3PXD2B;NRXN2;NPC1;RAMP1;RAB38;RAB3D;AP3D1;EZR;NLGN1;RAB11B;PICK1;SEC16A;TTC7B
prerank,maturation of SSU-rRNA (GO:0030490),0.42328913835859017,1.0691266377366693,0.3968253968253968,0.8262461118568621,1.0,12/34,24.72%,HELB;TSR1;SRFBP1;WDR3;RIOK1;DCAF13;TSR2;NOB1;TSR3;NGDN;WDR46;RIOK2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.4063408431567904,1.069057849177583,0.4077777777777778,0.8258846587302395,1.0,23/48,33.08%,ZMIZ1;ELOF1;SERTAD2;SF3B1;KAT2A;ZMIZ2;POLR2F;HMGA1;ATAD2B;POLR1G;POLR1C;TAF1C;TBP;KAT2B;POLR2H;ARID1A;SPHK2;TAF1D;POLR2L;TAF1B;ERCC6;POLR2K;TAF1A
prerank,negative regulation of cytokine production (GO:0001818),0.3698269354518312,1.068997443586267,0.36493374108053006,0.8254775897834934,1.0,37/163,19.91%,THBS1;CMKLR1;GAS6;PDCD4;CHID1;HDAC9;ANXA4;TAX1BP1;MAVS;GPATCH3;HMGB1;IRAK3;TBX21;RPS6KA4;TRIM27;RARA;ANXA1;ITCH;MAPKBP1;CIDEA;EZR;INHBA;PCBP2;UBE2L6;IL6;ARRB1;N4BP1;OTUD5;SLC2A10;ACOD1;NPLOC4;ADCY7;SARS1;IKBKE;IRF3;HOMER2;APPL2
prerank,response to peptide hormone (GO:0043434),0.41410422106191097,1.0684361808964447,0.3758782201405152,0.8265034191472245,1.0,7/43,9.70%,IRS1;IGFBP5;STAT5A;STAT3;MEAK7;OGT;ANXA1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.38173564289814016,1.0682147609971395,0.3816631130063966,0.8265794099981338,1.0,11/90,9.02%,GNAS;CMKLR1;VEGFA;GADD45G;GRB10;PEMT;DYNC1H1;ALMS1;EHMT1;ADIPOR2;OGT
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.41269407984290796,1.067857019581674,0.39160045402951194,0.8270527984608461,1.0,5/43,8.07%,GAS6;LBP;IRAK3;TRIM27;RARA
prerank,regulation of macrophage migration (GO:1905521),0.5250460335175122,1.0678234580266186,0.4044943820224719,0.8265756663696832,1.0,2/10,10.12%,EMILIN1;MTUS1
prerank,neuron migration (GO:0001764),0.4116012709502267,1.0676200833272778,0.38819523269012485,0.8265762358845389,1.0,11/48,14.32%,VEGFA;FGF13;MAP1B;MARK1;LRP12;NAV1;FGFR1;PEX13;SDCCAG8;NRP1;NDNF
prerank,phosphatidylserine metabolic process (GO:0006658),0.4271289701456017,1.0673102065606637,0.3828502415458937,0.8269720824612543,1.0,9/32,17.33%,PLA2G4F;PLA2G4A;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A;PLA2G15;PTDSS1
prerank,metal ion homeostasis (GO:0055065),0.4110684608422155,1.0672776535654747,0.3947990543735225,0.8264841855650383,1.0,8/40,14.77%,SLC12A7;SLC12A2;CNNM2;SLC12A4;SELENON;SCNN1A;LETM1;CYP27B1
prerank,cellular response to starvation (GO:0009267),0.3648202256558814,1.0669655548068548,0.36438075742067555,0.8268454912070059,1.0,52/147,26.40%,NPRL3;ATP6V1C2;SEC13;MAP3K5;GCN1;SESN3;TCIRG1;ATF4;LAMTOR1;SEH1L;WIPI2;DAP;CLEC16A;IMPACT;CASTOR2;MAPK8;WRN;SREBF1;FADS1;ATP6V0D1;HSPA5;SESN2;ATP6V1B2;USP33;PICK1;ATP6V1E1;VPS41;FOXO3;FLCN;SIK2;PRKAG1;AOC1;ATF2;KLF10;KPTN;ATP6V1C1;RHEB;EIF2AK4;EIF2S1;LAMP2;LRRK2;HNRNPA1;EIF2AK3;RPTOR;NPRL2;ATP6V0E1;TP53;ATP6V0B;STK24;LAMTOR2;NIM1K;EHMT2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4366044494274416,1.0668459501608125,0.40458937198067635,0.8266319789330493,1.0,8/29,16.62%,ZC3H7A;PUM1;PRKRA;HNRNPA2B1;AGO1;DGCR8;AGO2;TUT7
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.42948051018594624,1.0664915729040976,0.38954869358669836,0.8271377167359356,1.0,3/34,1.12%,IRS1;TNFAIP8L3;FGF2
prerank,positive regulation of secretion by cell (GO:1903532),0.3928548599006219,1.0659723349719408,0.3759318423855165,0.8280380357804729,1.0,16/70,17.97%,KCNB1;SLC12A2;ADAM9;UNC13B;TGFB3;APBB3;TGFB2;RAB2B;EDN3;EZR;STXBP5;STX1A;APBB1;SYTL4;IER3IP1;GOLPH3
prerank,positive regulation of gene expression (GO:0010628),0.35775798226951594,1.0654881494120687,0.282,0.8288823528678914,1.0,62/442,13.03%,THBS1;SLC38A2;EGFR;PID1;ID2;HOXA5;VEGFA;GAS6;F3;FGF2;FOXD1;IL33;GSN;SFRP4;SLC24A3;DDX5;EMILIN1;NTRK3;FGF17;DRD1;RDX;EPHB2;C1QTNF1;TWIST1;SAMD4A;GLMN;STAT3;CD3E;ATF4;RAMP2;AGR2;TENT4B;PRKDC;FAM98A;NFE2L2;ANK2;SOX9;NOG;DGKQ;SF3B1;MAPK8;BMP4;CRTAM;TMEM119;FAM98B;MUSK;UBR5;AGO1;NIBAN1;ATM;MAZ;FUBP1;SOD1;HEY1;EZR;KAT2A;PIK3CB;TGFBR1;SERPINB9;AGO2;SMO;INHBA
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5331513763095799,1.0654790772172922,0.4295977011494253,0.8283300674429857,1.0,2/10,7.90%,GFPT1;GFPT2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.4188266925194539,1.0652544696427313,0.3990719257540603,0.8284276818349462,1.0,19/37,34.68%,CHD1L;ERCC5;ERCC4;CUL4A;ERCC3;ERCC2;PARP1;RPS27A;UBC;POLD1;GTF2H4;XPA;DDB1;RBX1;ERCC1;POLK;RPA3;CUL4B;RFC4
prerank,calcium ion transport into cytosol (GO:0060402),-0.3486533108702659,-1.0651704638838966,0.3677685950413223,0.7113653174283565,1.0,10/21,14.19%,SLC8A1;RYR2;CACNA2D1;ITPR3;GRIN2B;GRIN2A;ADRA1A;JPH1;JPH2;GRIN1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.38152593261043527,1.064957484276349,0.37725823591923485,0.8287319357743497,1.0,28/85,25.09%,RNF144A;PRICKLE1;CSNK1D;COP1;OSBPL7;VCP;DVL1;FBXO22;RNF14;SMAD7;CSNK1E;DAB2;USP13;DDA1;STUB1;SIRT2;PSMC5;SUMO1;HECTD1;CLU;USP5;LRRK2;SUMO2;DET1;TAF1;RCHY1;RNFT1;BBS7
prerank,regulation of T cell cytokine production (GO:0002724),0.48267219677408363,1.064752889868665,0.40675675675675677,0.8287503526038767,1.0,4/15,11.76%,TNFRSF1B;FZD5;TRPM4;SMAD7
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3659479367109455,1.0645413151176522,0.38422131147540983,0.8287632190886246,1.0,24/142,15.84%,ESR1;CACNA1C;CMKLR1;SLC35G1;PLCE1;PROK2;TAC4;C1QTNF1;EDNRA;ADCY8;HMGB1;FPR3;DLG4;IAPP;ACKR4;TRPM4;ABL1;BCAP31;GLP1R;F2R;YWHAE;PTGDR;CALB2;CXCR4
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.36045978622084646,1.0643684711764434,0.34437751004016065,0.828680141524436,1.0,68/260,18.93%,PKD1;NTN1;SRGAP2;FXYD5;GSN;CFAP298;EXOC4;EHD1;PMP22;PPP1R9B;ABLIM3;FGD6;PKHD1;DYNLT2B;RILP;ARMC9;BBS9;CDC14A;TMEM107;RAB8A;IFT20;GBF1;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;CYFIP1;RFX2;TCTN1;IFT80;IQCB1;ABLIM2;TMEM216;ARFIP2;CCDC66;ATP6V0D1;CFAP43;PTPDC1;WDR11;EZR;NRP1;CEP164;PARVA;TRAPPC14;OCRL;BBS5;IFT46;EMP3;RAB23;FUZ;NUDCD3;CEP41;PCM1;HDAC6;PIP5K1A;IFT88;NPHP3;INPP5E;EMP1;TTLL3;LZTFL1;DYNC2I1;GOLPH3;IFT43;CCDC57;TEKT2;TMEM237
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3896027749004649,1.0643089108924348,0.38858988159311086,0.8282875317682862,1.0,14/75,12.61%,PGF;VEGFA;F3;FGF2;STAT5A;PRKCA;HMGB1;FGFR1;BMP4;AGGF1;VIP;PDPK1;NRP1;TGFBR1
prerank,lipid transport (GO:0006869),0.37660771838247376,1.0641789960008707,0.3879492600422833,0.828126334763503,1.0,10/97,4.74%,SLCO3A1;TNFAIP8L3;ABCD3;LBP;SLCO2A1;PITPNC1;RXRA;PRELID3B;PITPNA;PITPNM1
prerank,response to interleukin-4 (GO:0070670),-0.4448603501096353,-1.0640696519069133,0.38650306748466257,0.7123942416018086,1.0,2/10,3.71%,LEF1;TCF7
prerank,DNA biosynthetic process (GO:0071897),-0.37603758254265085,-1.063802685892629,0.36059479553903345,0.7111348612455679,1.0,10/16,22.73%,PPIA;TYMS;RFC3;SIRT1;POLD2;WRNIP1;POLE;CDKN2D;POLD4;POLL
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4938236287554407,1.0631670805991629,0.39783491204330174,0.830496270032465,1.0,5/13,19.78%,EDEM2;BCAP31;YOD1;ERLEC1;UBE2G2
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.27192774406630293,-1.0631264868114882,0.3,0.7109444977522891,1.0,13/66,8.96%,FLT1;ROBO1;IL34;PDGFD;KIT;FGF1;TPD52L1;PDGFRB;SASH1;ADRA2A;PIK3R6;PDGFC;PAK1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.4380601085479708,1.0630006577078854,0.3938618925831202,0.8304197933649506,1.0,5/26,9.01%,ST3GAL4;B3GNT7;B4GALT1;ST3GAL2;B4GALT5
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.385750802081008,1.0625175610031146,0.3756786102062975,0.8312333453384751,1.0,15/78,18.70%,EGFR;PKD1;IPO5;CDC6;CDK5RAP3;CCNT2;MAPRE3;CCNG2;CCNE2;HEXIM1;LATS2;CDC25A;CDKN1C;MEN1;AKT1
prerank,cardiac muscle cell development (GO:0055013),-0.3589580700154601,-1.0624124046713357,0.36363636363636365,0.7109206833372183,1.0,7/20,9.87%,SORBS2;SLC8A1;PDGFRB;CXADR;PDGFRA;MYH11;PDLIM5
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3374439430455644,-1.0622101337330125,0.3598130841121495,0.7094828295619808,1.0,8/26,12.24%,PRKAA2;PRKAG2;LPGAT1;NR1H3;ADIPOR1;SLC45A3;MID1IP1;CEACAM1
prerank,positive regulation of neuron migration (GO:2001224),-0.4108746330568024,-1.0621273503130526,0.34121621621621623,0.7078084763739404,1.0,3/11,9.31%,SEMA6A;RAPGEF2;ARHGEF2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3826350837444813,1.0619396890373825,0.38477801268498946,0.8323412924555966,1.0,13/85,9.71%,EGFR;SRSF6;VEGFA;FGF2;TCF7L2;DEAF1;PKHD1;SIX4;TGFB2;PRKDC;SOX9;BMP4;FGFR2
prerank,keratan sulfate metabolic process (GO:0042339),0.4255561818477579,1.061574393484641,0.40694789081885857,0.8328309805629758,1.0,9/31,18.00%,ST3GAL4;B3GNT7;B4GALT1;ST3GAL2;B4GALT5;HEXA;B4GAT1;CHST5;GLB1
prerank,regulation of fat cell differentiation (GO:0045598),0.3859107956609924,1.0605733724238948,0.3774193548387097,0.8351695882957907,1.0,19/74,18.70%,CMKLR1;ID2;ZFPM2;LRP5;WWTR1;FTO;CARM1;TRPM4;RORA;SYAP1;WDFY2;IL6;SIRT2;CREB1;TRIO;ANKRD26;E2F1;CDS1;AKT1
prerank,positive regulation of cell communication (GO:0010647),-0.32994689327336413,-1.0603572521231077,0.3556701030927835,0.7106639163695864,1.0,9/28,11.55%,WLS;RIMS2;GRIK2;RIMS1;HOMER1;LGI1;NMU;EDN1;CLSTN1
prerank,regulation of tube diameter (GO:0035296),-0.39730020663131943,-1.0603418286232464,0.38022813688212925,0.7069246195943684,1.0,6/13,11.99%,ROCK2;NOS3;ACE;AGTR1;NPR1;ACE2
prerank,vascular process in circulatory system (GO:0003018),-0.39730020663131943,-1.0603418286232464,0.38022813688212925,0.7069246195943684,1.0,6/13,11.99%,ROCK2;NOS3;ACE;AGTR1;NPR1;ACE2
prerank,axonal transport (GO:0098930),0.42347501694619566,1.06031734820116,0.4035928143712575,0.8353157914204604,1.0,12/36,22.21%,DYNC1H1;RAB21;BLOC1S2;SYBU;SPAST;AP3D1;SOD1;BLOC1S3;SNAPIN;KIF1B;DCTN1;NEFL
prerank,regulation of necroptotic process (GO:0060544),0.4483010092274472,1.0602898073899913,0.40523690773067333,0.8348244079087318,1.0,10/23,30.58%,YBX3;OGT;RIPK3;STUB1;PDCD6IP;BIRC3;CYLD;RIPK1;HSP90AA1;SPATA2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.44856092293231037,1.0602897089726435,0.4082914572864322,0.8342494599694008,1.0,3/23,5.16%,GPC3;GLIS2;VCP
prerank,regulation of myeloid cell differentiation (GO:0045637),0.39485186308353837,1.060140534565672,0.38555555555555554,0.8340962198589689,1.0,20/62,23.44%,THBS1;HOXA5;KMT2C;HOXA9;AGO1;WDR5;HDAC1;KMT2D;RUNX1;EIF6;NFE2;CREBBP;KMT2B;SETD1A;CBFB;DPY30;PAF1;KMT2A;PRMT1;KAT2B
prerank,neuromuscular junction development (GO:0007528),-0.34034963422386283,-1.0601048045716426,0.3607305936073059,0.7055680165086394,1.0,6/24,4.19%,UNC13C;PPFIBP1;PDZRN3;CACNB2;CACNB4;PPFIBP2
prerank,regulation of axon regeneration (GO:0048679),-0.41144113134332344,-1.0599767773454074,0.34172661870503596,0.7040209344438627,1.0,7/12,25.05%,PTN;EPHA4;INPP5F;SCARF1;RTN4R;RTN4RL1;GRN
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3637404905415318,-1.059958714257283,0.33992094861660077,0.7022065671452622,1.0,8/17,17.08%,BMP6;SASH1;LY86;CD180;CACTIN;CX3CL1;SIGIRR;CD55
prerank,methylguanosine-cap decapping (GO:0110156),0.5213045661406268,1.0597672862979899,0.40976331360946744,0.8346059344525583,1.0,6/10,36.25%,PNRC2;PATL1;DCP1A;EDC4;DCPS;DCP1B
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.37155525982325915,-1.059673941658264,0.3512396694214876,0.701048159474851,1.0,5/15,15.93%,PRKCH;AGTR1;CSF1;LPL;MSR1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.46607593034134015,1.0593319401329524,0.43073047858942065,0.8353097391209791,1.0,8/19,19.88%,SLC25A32;MTRR;MTHFD2;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR
prerank,central nervous system development (GO:0007417),0.3586430808105619,1.0592734357412397,0.36036036036036034,0.8348985929876416,1.0,36/250,13.47%,DCLK1;SLC23A1;WWP1;PKD1;ZFHX3;ECRG4;PBX3;NFIB;GSN;VIT;ADGRL2;GLIS2;HES5;STAT3;PITPNM1;RAB3GAP1;AMIGO3;TGFBR2;PBX1;MEIS3;TBC1D23;S100B;SOX9;CDK5RAP3;HAPLN4;ZIC1;SYNJ1;ZIC4;ATN1;PHF8;POU6F1;SMO;LIG4;PAFAH1B2;NPAS1;ALDH3A2
prerank,regulation of apoptotic process (GO:0042981),0.35259118187594685,1.0591384196010811,0.296,0.8347050583089906,1.0,165/676,20.48%,THBS1;SLIT2;RASSF2;EGFR;HOXA5;VEGFA;FSTL1;GAS6;SFRP4;GCLC;TIAM1;GADD45G;CARD14;PROK2;NTRK1;SMAD6;PRR7;TIAM2;FBXO10;UNC13B;VAV2;COMP;TGFB3;NOL3;SHC1;GAS1;CYP1B1;TOPORS;MAP3K5;PKHD1;CRADD;SIX4;CD3E;ANXA4;ATF4;ERC1;ACTN3;BAG3;TAX1BP1;HYPK;VCP;DNM2;FXN;CCAR2;GLO1;PRKDC;ADAM10;HMGB1;ANGPTL4;ING3;RAF1;ARF4;NDRG1;IKZF3;ERCC5;PA2G4;SOX9;SRA1;IAPP;CBL;SOCS2;AKT2;AKT1S1;KALRN;RBM25;ANGPT4;PAK2;MAPK8;ANXA1;BMP4;WRN;ITCH;FOXA1;ING5;ANP32B;MADD;VIP;RIPK3;ABL1;IRAK1;RBM5;LCMT1;BCL2L2;ATM;AIFM1;NAA16;SOD1;PHIP;TNFRSF10B;HSPA5;CD27;ERCC3;CIDEA;MIEN1;SERPINB9;HDAC1;PDCD2;VTCN1;HSPD1;LRP2;MAP3K10;CASP1;SUPV3L1;SOS2;USP36;SQSTM1;ARHGEF1;DAB2;PRDX3;HNRNPK;RHOB;SCIN;CAT;AKAP13;PSEN2;HGF;SOS1;IL6;ING4;TOMM70;LATS2;FOXO3;PLSCR3;NSMF;CREBBP;TRIO;AATF;HIP1;RPS27A;UBC;HIGD1A;APBB1;NF1;PERP;NGEF;BIRC6;FLCN;MAGED1;PRLR;IER3IP1;CITED2;DAPK3;ARAF;GOLPH3;BNIP1;E2F1;BID;RYBP;CLN3;BIRC5;AKT1;GDNF;DNAJA1;PRDX2;QRICH1;IRF3;NFKBIA;STEAP3;TAF9B;CDK5;ATF6;RTKN;CALR;TNFSF18;CLU
prerank,regulation of insulin secretion (GO:0050796),0.3734858103453766,1.0587792959728854,0.39162303664921466,0.8351638478941913,1.0,11/101,7.96%,IRS1;CACNA1C;EFNA5;KCNB1;TCF7L2;CCN3;LRP5;PRKCA;MCU;AACS;CAPN10
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4900095589414434,1.0586666752863125,0.4038199181446112,0.8349097340966545,1.0,5/13,17.11%,IL33;SOAT1;RAMP1;CHP1;SLC2A10
prerank,negative regulation of cartilage development (GO:0061037),0.49047476995034645,1.058038939989778,0.4060356652949246,0.8361313079271318,1.0,3/13,12.61%,WNT9A;SOX9;TGFBR1
prerank,negative regulation of response to stimulus (GO:0048585),0.3927777731642453,1.057626932725286,0.40486725663716816,0.8367406491486556,1.0,9/60,11.07%,SLIT2;COL3A1;UBASH3B;VPS13C;TWIST1;ACVR1;DDAH1;LPCAT3;TERT
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5219151543225409,1.057250204869047,0.42775393419170243,0.8373226288525976,1.0,2/11,4.91%,ID2;PRKCA
prerank,dorsal/ventral pattern formation (GO:0009953),0.4572347972533682,1.0565968557799905,0.4184852374839538,0.8386304537276296,1.0,7/20,19.62%,GLI2;ACVR1;NOG;BMPR1A;NBL1;MDFI;AIDA
prerank,phospholipid dephosphorylation (GO:0046839),0.41821090229643815,1.0565375319224732,0.40423031727379555,0.8382383057325028,1.0,9/37,13.09%,PLPP3;PLPP5;PLPP1;MTMR11;SYNJ1;INPP5B;MTMR10;PIP4P2;OCRL
prerank,actin filament capping (GO:0051693),0.4629381809746569,1.0561738193128587,0.4106910039113429,0.8381176821517765,1.0,8/18,25.88%,GSN;VILL;ADD1;SCIN;CAPZA1;ADD3;SVIL;TWF1
prerank,barbed-end actin filament capping (GO:0051016),0.4629381809746569,1.0561738193128587,0.4106910039113429,0.8381176821517765,1.0,8/18,25.88%,GSN;VILL;ADD1;SCIN;CAPZA1;ADD3;SVIL;TWF1
prerank,cellular macromolecule catabolic process (GO:0044265),0.40222848026891556,1.056161667380217,0.4132882882882883,0.8375829739322148,1.0,22/49,28.41%,SIDT2;PPP1R8;RNASE3;RNASE6;CHEK2;SUPV3L1;SND1;NGLY1;FBXO17;IDE;NCBP1;DFFB;UBE2G2;MTREX;PABPC4;OGA;ADAMTS9;HTRA2;RIPK1;DNASE1L2;MANBA;STT3B
prerank,positive regulation of neuron projection development (GO:0010976),-0.26681062684404017,-1.0561390531500485,0.28846153846153844,0.708432916748864,1.0,23/85,14.43%,LYN;PTN;APOE;ITGA6;PTK7;WNT5A;BMP7;RAPGEF2;CAMK1D;SERPINI1;ROR2;TENM3;ATP1B2;VLDLR;PLXNB2;CUX2;CX3CL1;STYXL1;PRKD1;LRP8;RELN;SCARF1;RIT2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.48662255725043657,1.0560670302239417,0.4013986013986014,0.8372698342933568,1.0,4/13,11.28%,ZFPM2;FGF2;FGFR2;BMPR1A
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5088307178889336,1.0557847632994528,0.41884057971014493,0.837500721839746,1.0,5/11,12.61%,TGFB2;ACVR1;TGFBR2;SMAD7;TGFBR1
prerank,regulation of cytoskeleton organization (GO:0051493),0.36894995424856963,1.0557218246395992,0.39067357512953366,0.8371231200087078,1.0,18/108,13.08%,PRKCD;RHOBTB1;EFNA5;LRP1;RHOQ;RND3;PHLDB1;SORBS3;CLIC4;ARHGAP17;CDK10;CAPN2;RHOA;PAK2;ABL1;KATNBL1;EZR;ARHGAP44
prerank,apoptotic mitochondrial changes (GO:0008637),-0.31252723708151686,-1.055650475116896,0.3391812865497076,0.7078590737264717,1.0,12/32,19.67%,BCL2;BCL2L1;DNM1L;ERBB4;HK2;IFIT2;BOK;MFF;CAMK2A;SOD2;BIK;NDUFS1
prerank,sulfur amino acid metabolic process (GO:0000096),0.4465423409850885,1.0550400473497232,0.4229828850855746,0.8385118534022417,1.0,4/24,7.73%,GCLC;MPST;NOX4;MTRR
prerank,N-glycan processing (GO:0006491),0.46193777594193264,1.0549907711372402,0.3940182054616385,0.8381023253164581,1.0,4/18,9.51%,ST8SIA2;PRKCSH;MGAT4B;FUT8
prerank,glucose transmembrane transport (GO:1904659),-0.3665390236060702,-1.054794795453247,0.35864978902953587,0.7082742983786776,1.0,4/18,6.83%,SLC2A1;SLC5A3;SORT1;PPARD
prerank,response to growth factor (GO:0070848),0.40896325699826447,1.054345198243273,0.39815880322209435,0.8393791382454576,1.0,11/41,18.70%,ACVR1B;SHC1;ACVR1;TGFBR2;URI1;BMPR1A;TGFBR1;LRP2;HDAC6;ERBB2;AKT1
prerank,metal ion transport (GO:0030001),-0.2546811953107682,-1.054298040728897,0.35135135135135137,0.7077065225110564,1.0,22/86,14.24%,ITPR1;SLC8A1;CALCRL;CACNA1D;RYR2;TRPC3;CACNA1E;CACNA2D1;CACNG7;SLC39A8;TUSC3;SLC41A1;CACNG8;SLC8A3;ATP2A3;CAV1;CACNG3;NDFIP2;SLC30A1;TRPC4;TPT1;NIPAL4
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.43541159621676123,1.0542935308514574,0.41646489104116224,0.8389668787756286,1.0,7/28,21.23%,EGFR;MMP14;WWP2;HEY1;ARRB1;AKT1;RITA1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.4536637866232771,1.054113820376182,0.40973111395646605,0.8388889116150253,1.0,7/22,25.11%,BRD4;HMGN1;CDK12;CCNT2;KAT7;CDK13;DDX39B
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3356293615683643,-1.0540732536787856,0.3526570048309179,0.706482413561574,1.0,4/23,7.10%,PARP14;STAT1;NR1H3;NLRC5
prerank,embryonic hemopoiesis (GO:0035162),-0.4055046240180836,-1.0539541495194786,0.3592592592592593,0.7049119962613631,1.0,6/12,12.21%,KIT;KDR;FLT3LG;SH2B3;TAL1;KITLG
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4493167431472753,1.0539401868478426,0.4140127388535032,0.8388285676512347,1.0,9/22,27.30%,PSMA8;NFE2L2;PSMA4;PSMA6;PSMA3;PSMB1;PSMA5;PSMA7;PSMA1
prerank,establishment of vesicle localization (GO:0051650),0.46157902203327766,1.0538380994477345,0.4116883116883117,0.8385265922174029,1.0,6/18,19.84%,LIMK2;DNM2;SYNJ1;CCDC186;SNAPIN;CDK5
prerank,polarized epithelial cell differentiation (GO:0030859),0.49125599001263254,1.053758290005898,0.41975308641975306,0.8381860006776182,1.0,4/13,12.28%,RHOA;SYNE4;MYO9A;EZR
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.46775482101173704,1.0536775518040922,0.4183535762483131,0.8378371286990183,1.0,7/18,24.30%,MORC3;SKI;MED25;NF1;PEX2;B4GALT7;TP53
prerank,artery development (GO:0060840),-0.3416095905875353,-1.0535230589994677,0.35789473684210527,0.7041430925005416,1.0,11/23,17.44%,ROBO1;ENG;ROBO2;TBX1;PDE2A;BMPR2;ACVRL1;EFEMP2;APLNR;ACVR2B;STRA6
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5210521094348506,1.0533416485096312,0.4175977653631285,0.8382459943853748,1.0,3/10,12.31%,DLGAP3;DLGAP4;AKAP9
prerank,regulation of signal transduction (GO:0009966),0.36067315980199777,1.0530271790876442,0.37550607287449395,0.8385844742864037,1.0,52/190,21.71%,ESR1;MGLL;IGFBP5;PLCE1;RSPO3;UBASH3B;MDFIC;GAS1;ELF1;WWTR1;CD3E;TCF7L1;ACVR1;ILK;SULF1;LLGL1;SOCS2;CASTOR2;DGKQ;FOXL1;OGT;ZIC1;SHARPIN;RORA;FGFR2;IRAK1;GIT1;AXIN1;GRK6;WDR11;NCLN;PTPN2;CD80;SRMS;RUNX1;USP33;FUZ;GSKIP;CREBBP;SIK2;IGFBP6;GDNF;DHRS3;TMEM237;ZFAND2B;CRK;CBFB;CLU;GRK4;NUP62;LRRK2;MTCH1
prerank,negative regulation of cell cycle process (GO:0010948),0.39072504036666195,1.0527555368204589,0.3969465648854962,0.8387976868996897,1.0,27/61,32.08%,TOM1L1;EHMT1;RBBP8;BMP4;PHC3;RNF2;ZFYVE19;RBBP7;RING1;L3MBTL2;TFDP1;CBX5;PCGF2;E2F1;RYBP;RAD51;MAX;PPP1R10;CHMP2A;CCP110;EHMT2;E2F8;WAPL;FOXO4;SUZ12;CHMP4C;MGA
prerank,response to glucagon (GO:0033762),-0.3515815417646403,-1.052654046610858,0.3487394957983193,0.7045256137912137,1.0,6/19,7.53%,ADCY5;ADCY1;PRKAR2B;PRKACB;PRKAR1B;ADCY4
prerank,superoxide metabolic process (GO:0006801),0.42705506536869947,1.0526367295908872,0.4252163164400494,0.8385646817804188,1.0,4/29,11.86%,SH3PXD2A;NOX4;SH3PXD2B;SOD1
prerank,positive regulation of dendrite development (GO:1900006),-0.4299100522254684,-1.0526055875624292,0.39375,0.7028276296162675,1.0,4/10,13.75%,PTN;BMP7;VLDLR;LRP8
prerank,apoptotic DNA fragmentation (GO:0006309),-0.38243499666014075,-1.0523773396442444,0.3826086956521739,0.7015398733130472,1.0,4/16,10.89%,CECR2;KPNA1;H1-0;KPNB1
prerank,anion transmembrane transport (GO:0098656),0.38468359366535726,1.0519640998244038,0.40773480662983425,0.839956361193212,1.0,6/67,5.40%,SLC23A1;SLC23A2;SLC5A6;ABCC1;SFXN3;LRRC8D
prerank,positive regulation of monooxygenase activity (GO:0032770),0.4330024504165255,1.0517020348180883,0.4132841328413284,0.8401595135527379,1.0,8/26,18.74%,NPR3;TERT;PIK3CB;S100A1;VDR;CYP27B1;AKT1;GDNF
prerank,positive regulation of cell motility (GO:2000147),0.35761964695577586,1.051598526413352,0.3776435045317221,0.839901970550561,1.0,24/205,7.57%,THBS1;MYOC;EGFR;NTN1;VEGFA;F3;ADAM9;COL1A1;TWIST2;TIAM1;NTRK3;DRD1;RDX;EPHB2;TWIST1;STAT3;SEMA3E;PRKCA;ACVR1;ADAM10;MMP14;SEMA4B;CXCL16;ELP5
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3618537236406234,-1.05145587750082,0.3951612903225806,0.7020334392559401,1.0,4/18,5.21%,APOE;CTSC;VGLL4;FAF1
prerank,mitotic spindle organization (GO:0007052),0.36293598334243515,1.0513484169320853,0.3983656792645557,0.8400761292303627,1.0,37/153,21.35%,XPO1;TUBG2;PPP1CC;TBCE;SEC13;DYNC1H1;MISP;VCP;WDR62;SEH1L;CENPC;MAD1L1;SMC3;RHOA;DCTN2;SPAST;CENPT;CKAP5;INTS13;RCC1;CHEK2;NUP37;MIS12;RCC2;ZW10;DYNC1LI2;RANBP2;NDEL1;RMDN1;CDC20;BIRC5;DYNC1I2;DLGAP5;STAG1;CCDC61;ARHGEF10;SBDS
prerank,positive regulation of cyclase activity (GO:0031281),0.4874080676214903,1.0512013002147036,0.42916093535075656,0.8399199045118615,1.0,3/14,9.65%,CACNA1C;STIM1;MAPK8
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.38464613854853313,1.051146498801666,0.42505353319057815,0.8395074277006381,1.0,40/72,34.68%,ERCC8;GPS1;ERCC5;HMGN1;ERCC4;CUL4A;ERCC3;XAB2;USP7;ERCC2;POLR2F;ISY1;RPS27A;UBC;AQR;COPS4;POLR2B;COPS7A;UVSSA;POLD1;GTF2H4;POLR2H;COPS3;XPA;DDB1;POLR2I;RBX1;POLR2L;COPS5;XRCC1;ERCC1;ERCC6;POLR2K;POLK;RPA3;CUL4B;CCNH;COPS2;COPS7B;RFC4
prerank,synaptic vesicle localization (GO:0097479),0.4883269489224066,1.0509818182945054,0.4143258426966292,0.8394118622826231,1.0,5/13,19.84%,DNM2;SYNJ1;NLGN1;SNAPIN;CDK5
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.39132430844950356,1.0509508892241708,0.4140625,0.8389515904161299,1.0,28/58,32.75%,ERCC8;PRKDC;HMGB1;ERCC4;KDM2A;ATM;RAD50;LIG4;PIAS4;DCLRE1B;UBE2V2;PSMD14;SMC5;SUMO1;POLB;XRCC6;BRCC3;UVRAG;IFFO1;ATP23;NSMCE2;SMARCAL1;ZBTB7A;UBE2N;ERCC1;ERCC6;HERC2;POLQ
prerank,regulation of actin filament depolymerization (GO:0030834),-0.412959362143689,-1.0508197597476656,0.3655913978494624,0.7018769773413392,1.0,4/12,11.13%,PLEKHH2;SEMA5A;MTPN;PLEK
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.37187907200713255,1.0502265455907496,0.39345991561181437,0.8404188642576564,1.0,32/88,28.91%,IGFBP5;SAMD4A;RIC1;CST3;CDK5RAP3;ILF3;RGP1;NELL1;SERPINE2;RBM4;CAMK2N1;CNOT8;HDAC6;CNOT10;EPRS1;DAPK3;CLN3;CNOT9;SHMT1;AKT1;SYNCRIP;CDK5;CALR;FXR2;EIF2AK3;YBX1;DNAJC1;MRPL13;RIDA;FXR1;LARP1;ATRAID
prerank,ncRNA catabolic process (GO:0034661),0.426137665552894,1.049985136898403,0.4323040380047506,0.8405433529648895,1.0,9/28,20.93%,TENT4B;ERN2;DIS3L2;SND1;XRN1;EXOSC4;DIS3;MTREX;ZCCHC8
prerank,positive regulation of protein metabolic process (GO:0051247),0.3677398440586812,1.0496252752891553,0.40667361835245047,0.840989842089373,1.0,32/110,23.29%,WWP1;GPC3;NEDD4;LDB1;STX5;CSNK2A1;RILP;VCP;DACT1;HUWE1;WWP2;NSF;MAPK8;ITCH;VIP;AXIN1;EIF4G1;INHBA;CD80;SEC22B;IDE;AKT1;ASB5;NFKBIA;CLU;SMURF2;RAB1A;AREL1;SLC25A37;RAB1B;PRMT1;ABCB10
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.36588455735020575,1.049393053768007,0.3967280163599182,0.8410658887092131,1.0,27/124,15.43%,MYOC;NEDD4;CTTN;STMND1;EHD1;LRP12;LIMA1;DOCK7;PPP1R9B;MNS1;ODF2;BLOC1S2;HMGB1;GPRIN1;TBC1D23;TBC1D24;CYFIP1;ARFIP2;UHMK1;NLGN1;BLOC1S3;MANF;TTC17;MARK4;PLP1;IL6;MICALL2
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3747020091100129,-1.0491624692172066,0.37786259541984735,0.7042188185750098,1.0,6/17,11.07%,ROCK2;CDH5;CLDN5;F11R;S1PR3;TNFRSF1A
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.4690932804728058,1.0491299630717221,0.4064245810055866,0.8412063138841923,1.0,8/15,27.28%,CDC16;CDC6;UBE2C;ANAPC1;CDC27;RIOK2;TPR;NEK6
prerank,defense response to bacterium (GO:0042742),0.36820134935378807,1.048245878481286,0.3922594142259414,0.8431375056062483,1.0,10/105,9.28%,PRKCD;LBP;SPN;SHC1;RNASE7;MAVS;RNASE3;GBP6;FCER1G;RNASE6
prerank,potassium ion transport (GO:0006813),0.36371662160217766,1.0482449327625332,0.40145985401459855,0.8425759911937647,1.0,12/120,7.45%,KCNJ2;KCNJ15;KCNK5;KCNB1;SLC24A3;HCN4;KCNN1;SLC9A8;SLC9A4;SLC9A1;KCNIP2;KCND1
prerank,positive regulation of cell population proliferation (GO:0008284),0.35073315611335315,1.0481990415456153,0.348,0.8421525527014733,1.0,89/423,18.74%,THBS1;PGF;EGFR;IRS1;FOXP1;PID1;ID2;ZFPM2;VEGFA;GAS6;DDR2;FGF2;TCF7L2;TIAM1;ACER3;NTRK3;PROK2;FGF17;GAB2;LRP5;MAPK15;TGFB3;SHC1;HDAC4;PKHD1;WWTR1;HES5;CSNK2A1;TGFB2;TCIRG1;DNAJA2;FXN;FAM98A;ADAM10;IL12RB2;TGFBR2;FGFR1;MEIS3;RARA;S100B;SOX9;AKT2;TRPM4;EDN3;BMP4;FGFR2;ITGAV;CDC25B;TBRG4;CDC123;TMEM119;FAM98B;VIP;FOXM1;CTF1;CHTOP;TERT;BMPR1A;MAZ;PHIP;TGFBR1;HDAC1;LIG4;F2R;KMT2D;NACC1;BMP5;CLCF1;PRDX3;STX4;IL6;MAP3K3;SLC35F6;CNOT8;ERBB2;FGF5;CCN4;SSR1;GAREM1;UFL1;PRLR;HMOX1;E2F1;KIF20B;BIRC5;SAAL1;AKT1;OSMR;GDNF
prerank,serine family amino acid catabolic process (GO:0009071),0.5188643531059983,1.0481803169683623,0.43515850144092216,0.8416514481094127,1.0,4/10,18.59%,GCSH;SHMT2;SHMT1;DAO
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.4094203482045848,1.0481391831239801,0.42671394799054374,0.8412166017029735,1.0,17/40,31.69%,TONSL;WRN;RAD51;TRAIP;DONSON;PRIMPOL;BOD1L1;POLD1;ZRANB3;FBH1;RTEL1;CDK9;ATR;SMARCAL1;DDX11;TIMELESS;BLM
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.38143198099671305,1.0478750215660249,0.4028384279475983,0.8414060222673811,1.0,14/72,13.07%,MYOC;FGF2;NEDD4;NTRK3;NTRK1;FSHR;TGFB2;FGFR1;SOX9;CBL;ROR1;MAZ;PIK3CB;F2R
prerank,striated muscle tissue development (GO:0014706),0.42882548390423464,1.0475629447969907,0.4227441285537701,0.8417030394977156,1.0,3/29,4.17%,SIX1;SGCD;SIX4
prerank,response to organonitrogen compound (GO:0010243),0.40461274247589657,1.0472982572486342,0.4142857142857143,0.8419018028738715,1.0,12/38,25.07%,MEAK7;VCP;IRAK3;SYVN1;IL6;ERLEC1;GLRB;KAT7;RCN3;DRD2;DERL1;DNAJB12
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.4102503349837565,-1.047173508435407,0.41496598639455784,0.7076501854858425,1.0,6/11,17.41%,CACNB2;CACNA2D1;SESTD1;NOS1;CACNB1;NOS1AP
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.36751618084320414,-1.046979932360494,0.3605150214592275,0.7063198811606926,1.0,7/17,21.03%,ITGA1;PDGFRB;CD300A;PTPA;PPP1R12A;PPP1R15B;PPP1R15A
prerank,heart process (GO:0003015),0.4832687040192124,1.046969578373897,0.4351464435146444,0.8422483144442395,1.0,3/14,11.86%,SGCD;NOX4;SOD1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.40281216439555173,1.0463584076306738,0.42790697674418604,0.84348251046943,1.0,24/42,32.31%,CHD3;SMARCC2;INO80B;SPTY2D1;ACTR6;PBRM1;ZNHIT1;HDAC1;HNRNPC;VPS72;SMARCAD1;CHD8;ACTR8;CHD4;SMARCA4;SRCAP;HDAC2;ANP32E;ARID1A;SMARCD2;SMARCC1;MBD3;GATAD2B;ERCC6
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5123755596159592,1.0458040382428575,0.43888070692194403,0.8444253757783247,1.0,2/10,3.46%,MUC1;CYP1B1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.4342025134539495,1.0454223432511032,0.4246575342465753,0.8448981182331045,1.0,6/27,16.72%,AK5;AK6;DTYMK;AK1;GSR;RRM2B
prerank,protein phosphorylation (GO:0006468),0.34948220029279914,1.0453047398983588,0.349,0.844670357225557,1.0,145/479,22.63%,DCLK1;EGFR;PKD1;PKDCC;PRKCD;GAS6;CIT;DDR2;ULK2;NTRK1;MARK1;PRKCE;ACVR1B;MAPK15;EPHB2;CLK3;CSNK1D;CAMK2D;MAP3K5;STRADA;TNK1;CSNK2A2;CSNK2A1;TGFB2;LIMK2;MORC3;ERC1;FASTK;PRKCA;DYRK4;NRBP2;ACVR1;EPHB3;ILK;NEK7;PRKDC;ERN2;ADAM10;TGFBR2;TLK1;STK39;ABI1;BCR;FGFR1;IRAK3;CDK10;RPS6KA4;RARA;PAK4;AKT2;DGKQ;CDK12;GMFB;PKN2;PAK2;ILF3;MAPK8;BMP4;FGFR2;CDC25B;SMG1;CSNK1G1;CHUK;MUSK;TNNI3K;RIPK3;ABL1;IRAK1;MAP4K5;MAP3K12;ATM;BMPR1A;CHEK2;MAPK12;PDPK1;GRK6;DDR1;SMAD7;NRBP1;UHMK1;CSNK1E;TGFBR1;STK25;STK19;SRMS;MAP3K10;PICK1;DMPK;MARK4;WNK1;FRK;SRPK1;TBCK;BRD2;EEF2K;MAP3K3;LATS2;CAMK4;CDC42BPB;TLK2;CREB1;COQ8B;ERBB2;TP53RK;STK16;HASPIN;MKNK2;BIRC6;SIK2;PRKAG1;DAPK3;BCKDK;CAD;VRK2;CLK2;BIRC5;CDK20;MAST2;CDKL2;AKT1;HIPK2;CDK2;IKBKE;CDK5;PRKAB1;EIF2AK4;SGK3;FGFR3;MAPK9;GRK4;PRKACA;VRK3;NEK4;ABI2;LRRK2;CSNK1G3;MAST4;JAK1;CAMK1;CDKL3;STK38;EIF2AK3;PRKCI;TOP1;FAM20A
prerank,regulation of wound healing (GO:0061041),0.4069820671655925,1.0452719983088636,0.41509433962264153,0.844213052993748,1.0,4/42,2.84%,SRSF6;FGF2;PRKCE;EPHB2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4697326707361671,1.0452059989006146,0.42002600780234073,0.8438405966862478,1.0,5/17,23.74%,LTBP3;TERT;PDCD2;KAT7;HNRNPU
prerank,cellular response to calcium ion (GO:0071277),-0.2634493856373475,-1.0451727601007539,0.3382352941176471,0.7093073300710154,1.0,25/67,20.86%,ADGRV1;WNT5A;ITPKB;CPNE4;PRKAA2;ADCY1;KCNH1;RASGRP2;BRAF;PRKAA1;MCOLN1;SYT10;SYT13;SLC25A24;SYT3;SYT2;CPNE7;SYT11;SYT12;HPCA;ECT2;SYT7;SYT15;PPIF;SCN5A
prerank,regulation of viral release from host cell (GO:1902186),0.4476939271256768,1.0451264646255627,0.40533672172808133,0.8434863912217648,1.0,9/21,28.34%,TRIM28;MID2;CHMP3;TRIM26;TRIM13;TRIM8;CHMP2A;VPS37B;DDB1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5170208007927288,1.0450128260835991,0.4143258426966292,0.8432627945251578,1.0,6/10,26.02%,EMC2;EMC9;EMC1;EMC8;EMC4;MMGT1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4928659622473246,1.04477264296487,0.42876165113182424,0.8433771096711967,1.0,4/13,12.40%,VEGFA;SEMA3E;TGFBR2;NRP1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.4113598967028375,-1.0443758052864158,0.3728813559322034,0.7095830960247799,1.0,3/11,12.41%,NOS3;GCH1;SPR
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4540501114197426,1.044372891768479,0.4253028263795424,0.8439612619079017,1.0,7/19,13.69%,ZFPM2;FGF2;NOG;FGFR2;BMPR1A;TGFBR1;RUNX1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.4231361145103835,1.0443295706846618,0.4064748201438849,0.8435278824978956,1.0,8/31,22.41%,CYP19A1;LIAS;NFS1;FDXR;LSS;PRLR;NOXRED1;PYCR1
prerank,protein ubiquitination (GO:0016567),0.34926318209642004,1.0440759943168434,0.3483483483483483,0.8437204619214116,1.0,179/471,30.24%,WWP1;RNF144A;SH3RF3;NEDD4;FBXO10;FBXL7;PSMD7;FBXW8;TOPORS;CDC16;UBE2B;VCP;RNF182;DTX3;LRSAM1;PSMA8;UBE2R2;ERCC8;NFX1;PRKDC;KLHL7;UBE3C;NFE2L2;RNF115;TRIM41;PEX5;TRPC4AP;HUWE1;TRIM27;SYVN1;CBL;RBBP6;LZTR1;WWP2;PEX13;PSMA4;ITCH;CUL4A;FBXO25;UCHL3;FBXL4;RNF114;UBR5;RNF25;UBE2C;FBXO22;NEUROD2;RNF14;FBXL12;SDE2;ATG3;PSMD12;MYLIP;CUL1;FBXL19;RNF38;PSMA6;DTX2;PEX10;USP7;RNF103-CHMP3;TRIM26;TNKS2;FBXL14;RNF11;LNPEP;PSMD1;DDA1;UBE2L6;ARRB1;FBXO17;STUB1;FBXL20;PSMC5;PSMD11;KLHL22;UBE2V2;PSMC4;PSMD14;RPS27A;UBC;OTULIN;RC3H2;BIRC6;TRIM13;VPS11;UBE4A;FBXL18;TRIM6;TPP2;UHRF2;RNF7;FBXW2;NPEPPS;UBR2;CDC27;RNF141;ASB5;MYCBP2;FBXW4;RUSC1;CBFB;UBE2G2;PCNP;TRAIP;PSMA3;TRIM47;USP5;UBOX5;SMURF2;TRIM43;MUL1;SH3RF1;RNF4;PSMB1;PEX2;PAF1;PSMD4;KCTD13;KLHL12;CUL9;AREL1;PEX14;DERL1;RNF20;PSMA5;RNF146;FBXO11;DET1;UBE2Z;PSMA7;TAF1;FBXO9;RNF122;AMFR;ANKRD9;PINK1;RCHY1;SELENOS;RNF138;RNFT1;UBE2W;RTF1;UVSSA;UBR3;RNF111;SHPRH;PSMC1;CUL7;RNF126;RNF166;FBXW10;FBH1;CAND1;PSMA1;RNF167;UBE2V1;USP22;TRIM7;DDB1;UBE4B;FBXL8;FBXO41;RBX1;BTRC;RNF135;UBE2Q2;UBR1;TRIM39;KLHL9;VPS18;PRKN;UBE2H;BLMH;TRIP12;ANAPC11;UBE2S;PSMD2;CTNNB1
prerank,positive regulation of kinase activity (GO:0033674),0.3667511996017496,1.0440259876575075,0.4074844074844075,0.843308120556363,1.0,20/107,13.19%,RASSF2;EGFR;GAS6;DDR2;NTRK3;NTRK1;EPHB2;CAMKK1;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;TAB2;LMO4;SNX9;DDR1;RAD50;MAPRE3
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.32995430211143983,-1.043959505779328,0.350253807106599,0.7087954197222929,1.0,9/25,17.18%,VCAM1;CTNNA3;CXADR;CD200;ITGA7;ITGA4;PKP2;DSP;NINJ1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3480767955256941,1.043806317789732,0.38738738738738737,0.843399770482679,1.0,131/336,30.17%,FOXP1;HELB;MAPK15;PARP3;TOPORS;CHD1L;UBE2B;TRIM28;POLE2;VCP;CBX1;TNFRSF1B;PHF1;GNL1;DCUN1D5;ERCC8;PRKDC;RMI2;INTS3;OTUB1;TRRAP;KMT5C;SLF2;RBBP6;FAAP20;RBBP8;RAD1;ERCC4;OGG1;WRN;CUL4A;SPIDR;ABL1;UBR5;WDR48;BCL2L2;ATM;USP45;CHEK2;MAPK12;ZDHHC16;TDP1;ERCC3;RAD50;CSNK1E;TANK;ALKBH1;MMS19;CEP63;TLK2;ATRIP;PARP1;AATF;HUS1;APBB1;SMC5;SUMO1;POLB;NIPBL;CBX5;UFL1;MEN1;ALKBH8;E2F1;BID;USP10;ATF2;RAD51;IKBKE;IRF3;MTREX;TRAIP;FANCG;XRCC3;SUV39H1;ENDOV;SLF1;NEK4;SFN;UPF1;ZBTB40;USP47;TOPBP1;PDS5A;UVRAG;ALKBH3;BOD1L1;TAOK3;SMC1A;TAF1;TP53;RBM24;TAOK2;XIAP;RECQL5;POLD1;GTF2H4;SMC6;SLX4;SHPRH;TAOK1;HTRA2;MCM7;CGAS;SETD7;XPA;YY1;PARP4;USP16;ZRANB3;FBH1;RTEL1;RPAIN;NOP53;PNKP;ADPRS;SETX;DDB1;ATR;SMARCAL1;IGHMBP2;GRB2;BCL6;HMCES;MBD4;DDX11;RAD52;PDS5B;CASP2;TRIP12;TIMELESS
prerank,regulation of proteolysis (GO:0030162),0.3984123058593815,1.0436283648674856,0.42921348314606744,0.8433395141447075,1.0,21/48,28.94%,CST3;OGT;ITCH;TRAF3;SERPINE2;TBC1D10A;CAMK2N1;STUB1;HDAC6;PERP;IST1;CLN3;AKT1;CDK5;CYFIP2;BAD;DNAJC1;HDAC2;PLAUR;SPOPL;BTRC
prerank,organonitrogen compound catabolic process (GO:1901565),0.39017645455572336,1.0434757306637172,0.4119601328903654,0.8432250701084375,1.0,15/57,19.40%,PLA2G4A;PDXDC1;LRSAM1;MPST;CPQ;GNPDA1;PLA2G5;UCHL3;LNPEP;IDE;PLA2G15;RENBP;BCKDK;NPEPPS;LVRN
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3646261943253148,-1.043344487814145,0.416,0.7084734133338181,1.0,8/18,26.50%,PLCB1;OPRM1;CHRM3;RGS8;CHRM2;CHRM1;GNAQ;GNA15
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4828071699928415,1.0433268596564382,0.42047026279391425,0.8430892146259966,1.0,1/13,0.43%,IRS1
prerank,protein insertion into membrane (GO:0051205),0.418639466622157,1.0432600259435456,0.43012048192771085,0.8427413255971238,1.0,11/32,27.76%,EGFR;STX5;TRAM2;ALDH3A2;STX1A;HMOX1;COX18;VAMP2;GET4;SEC61B;CCDC47
prerank,cellular response to alcohol (GO:0097306),0.3999453500791051,1.043069974143028,0.4317673378076063,0.8426973202163085,1.0,14/42,20.86%,LRP6;GRAMD1A;OSBPL7;ADCY2;ADCY8;JUP;SPIDR;SMO;GRAMD1C;GOLPH3;ADCY7;RAD51;KLF9;GNB1
prerank,regulation of axon guidance (GO:1902667),0.5117468345912293,1.04293843023141,0.42528735632183906,0.8424942592910095,1.0,3/10,19.10%,VEGFA;NRP1;MYCBP2
prerank,regulation of protein dephosphorylation (GO:0035304),0.4068565116255098,1.0428744770678604,0.4270334928229665,0.8421344105408813,1.0,13/37,18.29%,PRKCD;CALM2;PPP1R8;PPP6R1;SYMPK;TIPRL;PPP6R3;CNEP1R1;PTBP1;ARPP19;NSMF;CALM3;PPP6R2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.37789982671179806,1.0426318841002147,0.413135593220339,0.842237420188287,1.0,36/73,33.08%,HDAC4;GLMN;PHF1;TRIM27;SF3B1;TDG;KAT2A;RBBP7;POLR2F;HDAC6;POLR1G;MPHOSPH8;POLR1C;TASOR;TAF1C;TBP;KAT2B;DNMT1;H3-3A;POLR2H;IGF2;DNMT3A;SPHK2;MECP2;TAF1D;POLR2L;SUZ12;TAF1B;MTF2;CTCF;SPI1;MTA1;ERCC6;POLR2K;CREBZF;TAF1A
prerank,synaptic vesicle transport (GO:0048489),0.4971596066518494,1.0425153153956355,0.4507042253521127,0.8420168358748491,1.0,4/11,19.84%,DNM2;SYNJ1;SNAPIN;CDK5
prerank,hyaluronan metabolic process (GO:0030212),0.43748196929475736,1.042513127143891,0.42515723270440253,0.8414713413208583,1.0,5/23,13.28%,FGF2;SLC9A1;ABCC5;CHP1;HEXA
prerank,signal release from synapse (GO:0099643),-0.2895406476946534,-1.0424646861943134,0.36363636363636365,0.7089231879476867,1.0,16/43,22.23%,NRXN1;LIN7A;RIMS1;PIP5K1C;SYN2;SYN1;STXBP3;SYT10;SNCA;GAD1;SNAP25;SLC32A1;PTPRN2;GRM4;CPLX2;PDZD11
prerank,regulation of programmed cell death (GO:0043067),0.3573467472496929,1.0422972415007792,0.40628166160081053,0.8415154348739287,1.0,72/161,30.44%,ACER3;NTRK1;FBXO10;GAS1;CRADD;CD3E;ACTN3;VCP;RAF1;NDRG1;IKZF3;SOX9;SRA1;AKT1S1;RBM25;WRN;ANP32B;MADD;RIPK3;ABL1;LCMT1;ATM;TNFRSF10B;CIDEA;CASP1;MARK4;USP36;TOMM70;PSMC5;PLSCR3;CREBBP;HIP1;PERP;MAGED1;DAPK3;BID;BIRC5;AKT1;PRDX2;ASAH1;IRF3;STEAP3;CDK5;RTKN;CALR;CLU;NUP62;CTSB;LRRK2;HS1BP3;BIRC3;TRIAP1;FBXO11;TP53;PINK1;ANP32E;FANK1;DAXX;RIPK1;SGK1;RABGGTB;OSGIN1;NOP53;KANK2;BCL6;BCAR1;CASP2;PRKN;ZBTB7A;DFFA;CASP6;HSP90AA1
prerank,synaptic vesicle endocytosis (GO:0048488),0.4183999116190994,1.0422887965293304,0.4419161676646707,0.8409924154990713,1.0,10/33,15.34%,STON2;SYT8;CEL;DNM2;FCHO2;STON1;SYNJ1;NLGN1;SNAP91;STX1A
prerank,glycoprotein metabolic process (GO:0009100),0.389899675618109,1.0419651497540046,0.4153498871331828,0.8413710629248189,1.0,17/53,24.59%,ST3GAL4;ST8SIA2;PRKCSH;ST3GAL2;B4GALT5;MGAT4B;FUT8;GAL3ST4;NGLY1;FBXO17;B3GNT6;GOLPH3;GANAB;MAN2B1;B4GALT7;OGA;ADAMTS9
prerank,snRNA processing (GO:0016180),0.46527872713346746,1.041766641086332,0.4283837056504599,0.8413703752684235,1.0,3/16,9.08%,INTS14;INTS3;INTS4
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5161079314580332,1.0414888797585158,0.4218978102189781,0.8415894546181782,1.0,1/10,0.64%,BMP1
prerank,activation of phospholipase C activity (GO:0007202),0.4167523180274499,1.0414352204546509,0.42823250296559906,0.8411837160338212,1.0,2/29,3.19%,EGFR;EDNRA
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3683181456688938,1.0414275975008116,0.4282744282744283,0.8406567882572964,1.0,41/95,32.96%,REV3L;MCMDC2;TONSL;MCM2;ERCC5;MORF4L1;RBBP8;ERCC4;SFR1;WRN;SPIDR;SWI5;SFPQ;RAD50;CDC45;GINS4;PARP1;PSMD14;HUS1;MCM4;SMC5;NIPBL;RAD51;XRCC3;RNF138;RECQL5;SMC6;SLX4;MCM7;YY1;FBH1;SWSAP1;NSMCE2;RAD52;AP5Z1;UBE2N;ZFYVE26;BLM;XRCC1;POLQ;RPA3
prerank,sulfur amino acid catabolic process (GO:0000098),0.5243639417130421,1.041407956946753,0.45014245014245013,0.8401661318128866,1.0,2/10,7.73%,MPST;MTRR
prerank,protein K48-linked deubiquitination (GO:0071108),0.4401113510096664,1.0413118081846238,0.4309252217997465,0.8398888420436921,1.0,8/23,21.03%,OTUB1;USP50;OTUB2;USP34;USP33;OTUD5;YOD1;USP5
prerank,recombinational repair (GO:0000725),0.37501033876936657,1.0411785480866707,0.43386243386243384,0.8396978534271742,1.0,40/77,35.51%,REV3L;TONSL;ERCC5;MORF4L1;RBBP8;ERCC4;SFR1;WRN;SPIDR;SWI5;SFPQ;RAD50;PARP1;PSMD14;HUS1;SMC5;RAD51;XRCC3;RNF138;RECQL5;SMC6;SLX4;YY1;FBH1;SWSAP1;NSMCE2;RAD52;RHNO1;AP5Z1;UBE2N;ZFYVE26;BLM;XRCC1;POLQ;RPA3;MMS22L;FAN1;MRE11;NSMCE1;SEM1
prerank,phospholipid biosynthetic process (GO:0008654),0.41320594298417757,1.041064267725094,0.4136690647482014,0.8394864487885406,1.0,16/36,30.73%,DHDDS;LPCAT1;DOLPP1;FADS1;FAR1;HDHD5;PIP5K1A;AGPAT5;CLN3;MBOAT1;FITM2;PCYT2;SPHK2;AGPAT3;SGMS2;SRD5A3
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.348152931310353,1.0405447996808819,0.381,0.8404220749181209,1.0,84/390,17.48%,PGF;EGFR;IRS1;SLC39A14;VEGFA;EFNA5;DDR2;FGF2;ARHGEF28;COL1A1;TIAM1;UBASH3B;GRB10;NTRK3;RHOQ;ATP6V1C2;NTRK1;FGF17;GHR;HNRNPH1;VAV2;EPHB2;SIPA1L1;SHC1;SPRED2;RBFOX2;TNK1;STAT3;CD3E;TCIRG1;ARPC1B;CLNK;AP2A1;EPHB3;EPHB6;FOXC2;ATP6V0A1;GIGYF1;SULF1;ABI1;FGFR1;CYFIP1;CBL;SOCS2;AKT2;KALRN;RHOA;ROR1;PAK2;ZNF106;FGFR2;ITGAV;MUSK;GTF2F1;FLRT2;ATP6V0D1;GIT1;SHOC2;DDR1;PHIP;PIK3CB;NRP1;PTPN2;AP2A2;HNRNPM;ATP6V1B2;PTBP1;SRMS;TIAL1;FRK;ATP6V1E1;POLR2F;PSEN2;HGF;SOS1;SIRT2;IDE;GALNT3;ERBB2;FGF5;NCBP1;NGEF;EFNA1;PRLR
prerank,positive regulation of protein phosphorylation (GO:0001934),0.34869069521895946,1.0404323833915219,0.3813813813813814,0.8401956417821917,1.0,77/348,18.70%,RASSF2;PGF;EGFR;GDF10;SLCO3A1;VEGFA;EFNA5;GAS6;DDR2;FGF2;CARD14;NTRK3;NTRK1;FGF17;GHR;INHBC;TGFB3;CAMKK1;DOCK7;CSNK1D;TGFB2;CSPG4;LIMK2;IL5;CALM2;MAVS;ACVR1;TOM1L1;ILK;PFN2;SMAD4;RSPO1;RAF1;RPS6KA4;SOX9;AKT2;DGKQ;ANGPT4;PAK2;BMP4;TMEM119;MUSK;ABL1;TAB2;NIBAN1;BMPR1A;AXIN1;SNX9;TENM1;AKAP9;RAD50;NRP1;TGFBR1;EIF4G1;INHBA;CD80;MAPRE3;ERP29;WDFY2;DAB2;BMP5;HGF;IL6;ARRB1;IQGAP1;HDAC6;ERBB2;FGF5;CALM3;EFNA1;FLCN;PRKAG1;ARAF;TRIM6;CNOT9;RB1CC1;AKT1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4690656343345635,1.0403434816610497,0.43213296398891965,0.8399089194875475,1.0,4/17,12.31%,KCNE5;ANK2;SNTA1;AKAP9
prerank,mitochondrion localization (GO:0051646),0.46767223764217647,1.039930254554198,0.42038216560509556,0.8404837021112125,1.0,7/19,23.27%,MARK1;TLE6;MEF2A;MUL1;LRRK2;MFN1;MTM1
prerank,regulation of translational initiation (GO:0006446),0.37982774934681535,1.0397976931754982,0.43281938325991187,0.840296288485566,1.0,24/63,28.61%,EIF4A2;ATF4;EIF4G2;EIF4G3;IMPACT;CDC123;KHDRBS1;UHMK1;AGO2;EIF4G1;ALKBH1;RBM4;NCBP1;NCBP2;GLE1;EIF2AK4;EIF2AK3;EIF4B;RPS6KB1;NCK1;TPR;YTHDF1;EIF4H;LARP1
prerank,inositol lipid-mediated signaling (GO:0048017),0.3954241292227458,1.0397733333953643,0.43119266055045874,0.8398209432358364,1.0,11/50,12.37%,IRS1;PLCE1;TNFAIP8L3;NTRK1;GAB2;PIK3C2B;FGFR1;OGT;RHOA;EZR;PIK3CB
prerank,cardiac muscle contraction (GO:0060048),0.4110453365871203,1.0393963370312043,0.42857142857142855,0.8403400275472113,1.0,6/34,6.20%,ATP1B1;GSN;CAMK2D;DMD;GAA;KCNE5
prerank,negative regulation of inclusion body assembly (GO:0090084),0.5154265473071866,1.0392784034567486,0.438957475994513,0.8401106705734716,1.0,1/10,3.32%,HSPA2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.42252579734994733,1.0391872208613464,0.43239951278928135,0.8398353857421083,1.0,11/29,24.33%,HELB;TSR1;RRS1;DCAF13;RPP40;TSR2;ABT1;NGDN;WDR46;TBL3;KRI1
prerank,regulation of organelle organization (GO:0033043),0.3735020786692386,1.0389744686513884,0.4528101802757158,0.8398780410441843,1.0,35/80,28.51%,RDX;MAPK15;STX5;CLIC4;MAVS;MIEF2;RHOT2;CLEC16A;CAPN2;RHOT1;PAK2;TMED9;EZR;AKAP9;TBC1D25;PREB;SQSTM1;VPS11;CDT1;GOLPH3;CLN3;TMEM33;ARMH3;MUL1;LMAN1;CAMSAP3;CAPN6;MTM1;PINK1;SCARB2;TAOK1;SAR1A;SURF4;MYO5A;FIS1
prerank,regulation of neuron projection arborization (GO:0150011),-0.365732728884513,-1.0387655550948178,0.4163568773234201,0.7164917108623163,1.0,5/15,9.27%,WNT5A;GRIP1;NTNG1;MACF1;MFSD2A
prerank,positive regulation of protein transport (GO:0051222),0.38173652809940173,1.0387550640996484,0.4232861806311208,0.8399206413426472,1.0,18/67,18.37%,ADAM9;UNC13B;TGFB3;APBB3;TGFB2;BCAS3;TENM1;EZR;CHP1;ACSL3;PCM1;APBB1;CNST;SYTL4;IER3IP1;GOLPH3;KIF20B;CLN3
prerank,regulation of establishment of planar polarity (GO:0090175),0.37172632522300525,1.0387468184677382,0.4437299035369775,0.8393993188891008,1.0,22/88,16.38%,TIAM1;PRICKLE1;PSMD7;PKHD1;AP2A1;PSMA8;DACT1;DVL1;FZD7;FZD5;RHOA;PSMA4;PSMD12;PSMA6;AP2A2;CLTC;PSMD1;PSMC5;PSMD11;NPHP3;PSMC4;PSMD14
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5087692767011557,1.0387208453263232,0.43948126801152737,0.8389305358631071,1.0,3/11,15.61%,MAVS;STX4;CAMK4
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.43057394903454316,-1.0386626958721452,0.4219269102990033,0.7150047265815364,1.0,2/10,2.33%,SHANK3;APP
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.36798349563590116,1.03833972442918,0.4440894568690096,0.8394196978267775,1.0,18/94,12.55%,PRKCD;DDX5;FHIT;CYP1B1;TOPORS;MAP3K5;ATF4;TNFRSF1B;PRKDC;ERN2;CUL4A;ABL1;BCL2L2;ATM;CHEK2;AIFM1;TNFRSF10B;CUL1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.3458655170715636,-1.0381079128402348,0.40707964601769914,0.7147187621186706,1.0,2/20,6.19%,WNT4;C1QTNF3
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.42729744080725035,1.0380239597430547,0.4261501210653753,0.8397016647998351,1.0,9/32,19.84%,ID2;BRD4;ESRRB;CDC6;CDC45;TFDP1;CDT1;E2F1;CDK5
prerank,negative regulation of interferon-gamma production (GO:0032689),0.44148098854334383,1.0380094776116306,0.44487179487179485,0.8391984401422601,1.0,4/23,13.03%,GAS6;HMGB1;RARA;INHBA
prerank,plasma membrane invagination (GO:0099024),0.42188100572194565,1.0379104984112748,0.41291108404384896,0.8389257943391147,1.0,5/29,15.31%,GSN;SNX18;RHOA;SNX9;SPIRE2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.37063600615400405,1.0378075902240673,0.44126984126984126,0.8386752004349446,1.0,20/80,15.89%,PLCE1;ARAP1;RHOQ;DPYSL3;TGFB3;BCAS3;EPS8L1;CDC42EP2;FAM98A;CYFIP1;TENM1;NRP1;MIEN1;CDC42EP5;NLGN1;MARK4;NDEL1;FUZ;PLEKHM1;PALM
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.41376220224328175,-1.0376745297268029,0.38596491228070173,0.7141327418386898,1.0,2/11,1.32%,NEDD4L;ACTN2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.3604894590906424,1.0376725383906487,0.44132917964693663,0.8384950950180251,1.0,22/112,12.82%,GDF10;COL3A1;ADAM9;COL1A2;LTBP2;SMAD9;SMAD6;ZMIZ1;TGFB3;TGFB2;PDE3A;ACVR1;SMAD4;TGFBR2;SKI;SOX9;CBL;RHOA;BMPR1A;SMAD7;TGFBR1;ZMIZ2
prerank,positive regulation of signal transduction (GO:0009967),0.3502441415621209,1.037576754358272,0.4126506024096386,0.8381909132738778,1.0,43/238,13.12%,SMOC2;ADAMTS3;IRS1;SLC39A14;GAS6;F3;RSPO3;PTGIS;CCN3;GRB10;NTRK3;ATP6V1C2;ZMIZ1;RAB34;CSNK2A1;CRADD;TGFB2;STAT3;PRKCA;ARMC9;DACT1;ILK;POGLUT1;JAG1;SULF1;SKI;RSPO1;DLG4;TEDC1;EVC;FGFR2;ITGAV;ING5;TERT;P2RY6;SHANK1;PHIP;PDCL;NRP1;TGFBR1;SMO;NLGN1;CD80
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.3046856356098188,-1.0375236379311128,0.37341772151898733,0.712748518902228,1.0,16/35,18.53%,SEMA6A;PLXNA2;SEMA3D;SEMA7A;SEMA5A;PLXND1;NRP2;ARHGDIA;PLXNB2;SEMA4D;SEMA3G;SEMA4A;PLXNB1;SEMA4G;SEMA5B;PLXNA3
prerank,secretion (GO:0046903),-0.38636794070875824,-1.0374983877887418,0.39338235294117646,0.7110635657139959,1.0,5/14,13.05%,SLC22A6;RIMS1;NPR1;SLC22A2;SLC22A4
prerank,lipid biosynthetic process (GO:0008610),0.37681659700125086,1.0374317861624816,0.4291845493562232,0.8380553063129752,1.0,20/77,18.78%,ABCD3;CYP19A1;ACSF3;LPCAT1;SCD5;DOLPP1;GPAT4;SREBF1;OLAH;FADS1;CBR4;FDXR;ACACA;PIP5K1A;LSS;HSD17B8;PRLR;AGPAT5;AGPS;ACSL6
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.41239800883363686,-1.0373118408541102,0.4067796610169492,0.7097917591403505,1.0,4/11,19.07%,EFNB2;MYOCD;GPER1;TGFB1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5086017420992951,1.0372468727146367,0.4546762589928058,0.8380198280952363,1.0,3/10,16.49%,PLA2G4A;PLA2G5;PLA2G15
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3537976184086579,1.0369118583744987,0.41708542713567837,0.8384424948618212,1.0,30/214,13.07%,BMPER;EGFR;TNFAIP8L3;GAS6;FGF2;EMILIN1;NTRK3;NTRK1;FSHR;TIMP3;EPHB2;CCL13;SHC1;SPRED2;PKHD1;CCL15;PRKCA;SMAD4;HMGB1;DLG1;ROR1;FGFR2;PLA2G5;MAP3K12;P2RY6;ARHGAP8;EZR;NRP1;PTPN2;F2R
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3634534225394997,1.03681587834248,0.4367816091954023,0.8376289900046581,1.0,29/104,23.82%,PRKCD;MUC1;PSMD7;PSMA8;RAF1;MUC13;FCER1G;PAK2;PSMA4;CHUK;TAB2;PDPK1;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;PSMA3;PRKACA;PSMB1;PSMD4;PSMA5;PSMA7;NRAS;KRAS
prerank,cellular response to lectin (GO:1990858),0.3634534225394997,1.03681587834248,0.4367816091954023,0.8376289900046581,1.0,29/104,23.82%,PRKCD;MUC1;PSMD7;PSMA8;RAF1;MUC13;FCER1G;PAK2;PSMA4;CHUK;TAB2;PDPK1;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;PSMA3;PRKACA;PSMB1;PSMD4;PSMA5;PSMA7;NRAS;KRAS
prerank,cell-matrix adhesion (GO:0007160),0.368040875628196,1.036743604023662,0.4395833333333333,0.8373062057983056,1.0,12/95,6.78%,PKD1;ITGA11;COL3A1;ADAM9;TIAM1;CTTN;EMILIN1;ACTN3;PPFIA1;THBS3;ILK;BCR
prerank,RNA biosynthetic process (GO:0032774),0.41424175843351274,1.0367259338552215,0.4217016029593095,0.8368226387417841,1.0,12/31,30.88%,HELB;TCEA2;TERT;TAF6;TAF13;SMN1;TBP;PRIM1;TAF10;SETX;PRMT5;TTF2
prerank,regulation of cellular respiration (GO:0043457),0.4595300813136857,1.0358094576285892,0.4217506631299735,0.838744652879253,1.0,7/17,20.97%,ACTN3;VCP;IFNLR1;NOA1;IDE;SHMT2;IL4
prerank,negative regulation of programmed cell death (GO:0043069),0.34730536714773447,1.0356864792155351,0.398,0.8385536085856734,1.0,83/355,19.83%,THBS1;EGFR;VEGFA;FSTL1;GAS6;GCLC;CARD14;PROK2;NTRK1;SMAD6;COMP;NOL3;SHC1;TOPORS;PKHD1;SIX4;ANXA4;ERC1;BAG3;TAX1BP1;HYPK;FXN;GLO1;PRKDC;ADAM10;ANGPTL4;RAF1;ARF4;ERCC5;PA2G4;SOX9;CBL;SOCS2;AKT2;ANGPT4;PAK2;MAPK8;ANXA1;BMP4;ITCH;VIP;RIPK3;IRAK1;BCL2L2;NAA16;PHIP;HSPA5;CD27;MIEN1;SERPINB9;HDAC1;VTCN1;HSPD1;LRP2;SUPV3L1;SQSTM1;DAB2;PRDX3;HNRNPK;CAT;PSEN2;HGF;IL6;PSMC5;AATF;RPS27A;UBC;HIGD1A;BIRC6;PRLR;CITED2;ARAF;GOLPH3;BNIP1;BID;CLN3;BIRC5;AKT1;GDNF;DNAJA1;PRDX2;NFKBIA;TAF9B
prerank,regulation of cell motility (GO:2000145),0.36167449348124026,1.0356664073414785,0.4306269270298047,0.8380752383197285,1.0,20/121,12.03%,EGFR;PLXNA4;NTN1;FGF2;SRCIN1;FGF17;LDB2;LDB1;TWIST1;LMNA;MEAK7;RAF1;BEX4;AKT2;RHOA;PKN2;ABL1;LMO4;CCDC25;RCC2
prerank,striated muscle contraction (GO:0006941),-0.2744227622780908,-1.0355709784136804,0.3559322033898305,0.7123466884692986,1.0,4/53,3.25%,ATP1A2;SLC8A1;TPM1;RYR2
prerank,negative regulation of ossification (GO:0030279),-0.32252798130583543,-1.0355709186065973,0.4019138755980861,0.7106050095243859,1.0,5/23,7.37%,ENPP1;NOTCH1;SRGN;BCOR;RBPJ
prerank,positive regulation of insulin secretion (GO:0032024),0.40781241287799286,1.0355673331802362,0.43457943925233644,0.8378063701747112,1.0,6/36,8.87%,TCF7L2;ADCY8;MCU;AACS;CAPN10;TRPM4
prerank,immunoglobulin mediated immune response (GO:0016064),0.5109012194520799,1.0354912886857328,0.44227886056971516,0.8374790116708984,1.0,2/10,11.94%,FCER1G;CD27
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.49140923217457183,1.0349062803561673,0.4366998577524893,0.8385220567806687,1.0,1/12,0.43%,IRS1
prerank,receptor internalization (GO:0031623),0.39415457209771804,1.0348030241579704,0.4440639269406393,0.8382584716399697,1.0,10/44,15.27%,LRP1;NEDD4;RAMP2;DNM2;CD9;FCER1G;SNX1;RAMP1;CLTC;ARRB1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.36147464289047027,1.034773279343154,0.4253347064881565,0.8378102204798369,1.0,22/125,14.16%,XPO1;TUBG2;PPP1CC;TBCE;SEC13;DYNC1H1;WDR62;SEH1L;CENPC;MAD1L1;DCTN2;CENPT;CKAP5;INTS13;RCC1;NUP37;MIS12;RCC2;ZW10;DYNC1LI2;RANBP2;NDEL1
prerank,cholesterol homeostasis (GO:0042632),0.3785377561344288,1.0345811001159864,0.4375690607734807,0.8378061319928544,1.0,12/64,13.71%,EHD1;LRP5;LIMA1;HDAC9;SOAT1;LAMTOR1;TSKU;AKR1C1;RORA;NPC1;RALY;ABCA1
prerank,regulation of neuroinflammatory response (GO:0150077),0.45789905304933576,1.03456794013273,0.45515394912985274,0.8373101798734932,1.0,3/19,7.99%,IL33;TNFRSF1B;DAGLA
prerank,tRNA wobble uridine modification (GO:0002098),0.47982607857629356,1.034366819269712,0.44600280504908835,0.837318387278009,1.0,7/14,24.88%,TRMU;CTU2;ELP1;ELP4;ALKBH8;ELP3;MTO1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3804986885276233,1.034134230526642,0.44298245614035087,0.8374071989829415,1.0,12/68,15.26%,LBP;IL33;TWIST1;RAB7B;STAT3;MAVS;HMGB1;C1QTNF4;HSPD1;F2R;SETD4;IL6
prerank,leukotriene metabolic process (GO:0006691),0.4610974223961454,1.0340559949507662,0.44605263157894737,0.8370836388416482,1.0,3/19,9.99%,PLA2G4A;ABCC1;PLA2G5
prerank,nuclear transport (GO:0051169),0.4701525745152937,1.0338747733019893,0.4351851851851852,0.8370636687100725,1.0,2/16,9.12%,XPO1;PSIP1
prerank,histone exchange (GO:0043486),0.4009917128661276,1.0334255724150723,0.441588785046729,0.8378200547027393,1.0,8/37,16.11%,HJURP;CENPC;CENPT;SPTY2D1;ACTR6;ZNHIT1;RBBP7;VPS72
prerank,regulation of macrophage differentiation (GO:0045649),0.4763281747202427,1.0333353634501914,0.44097693351424694,0.8375244882255207,1.0,4/15,13.03%,ID2;PRKCA;PTPN2;INHBA
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.362281428589457,1.0331793848362842,0.4408376963350785,0.8374094776427004,1.0,29/105,23.82%,PRKCD;MUC1;PSMD7;PSMA8;RAF1;MUC13;FCER1G;PAK2;PSMA4;CHUK;TAB2;PDPK1;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;PSMA3;PRKACA;PSMB1;PSMD4;PSMA5;PSMA7;NRAS;KRAS
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.3980559573969418,-1.0330144328710502,0.41237113402061853,0.7156817330883994,1.0,2/12,4.76%,AXIN2;RB1
prerank,DNA damage checkpoint signaling (GO:0000077),0.41286056495875467,1.0329612048578751,0.4331288343558282,0.8374727989534947,1.0,15/28,32.31%,TIPRL;RAD1;ATM;CHEK2;CEP63;ATRIP;HUS1;E2F1;DONSON;ATR;INTS7;RAD17;RHNO1;HINFP;ERCC6
prerank,DNA conformation change (GO:0071103),0.45815917555387686,1.032680264002722,0.44591029023746703,0.8377191310148657,1.0,7/17,24.81%,HMGB1;ABL1;ERCC3;TOP3B;TOP1;TOP1MT;TOP3A
prerank,epithelial structure maintenance (GO:0010669),-0.39929290266146517,-1.0323039217872076,0.411214953271028,0.7157657508949161,1.0,2/11,5.80%,RBP4;CXADR
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3706695511707005,1.032201502965754,0.4307692307692308,0.83850467892198,1.0,17/74,18.74%,THBS1;EYA2;TCF7L2;NOL3;ACVR1;BMP4;ITGAV;TERT;PHIP;TNFRSF10B;TGFBR1;BMP5;BIRC6;HMOX1;ZMYND11;AKT1;GDNF
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.514557030483725,1.032176616706494,0.4577259475218659,0.8380399028289178,1.0,4/10,16.62%,DIS3L2;RPS27A;UBC;TUT7
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.38284666909174014,1.0321606704255606,0.43942731277533037,0.8375569365637978,1.0,29/62,29.94%,ELOF1;CDK12;GTF2F1;CCNT2;ERCC3;ERCC2;POLR2F;AFF4;MLLT3;NCBP1;SSRP1;ELP4;NCBP2;PAF1;POLR2B;SETD2;NELFB;CDK13;EAF1;CTDP1;RTF1;GTF2H4;POLR2H;NELFA;POLR2I;CDK9;MLLT1;ADRM1;POLR2L
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4313357213914561,1.0321427656615645,0.4289185905224787,0.8370795813649379,1.0,13/26,30.05%,ANAPC5;CDC16;CDC6;UBE2C;LCMT1;ANAPC4;CDC27;DLGAP5;CDK5RAP2;RIOK2;NEK6;NSMCE2;ANAPC11
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4534666493806112,1.032007509392735,0.4321148825065274,0.8369059764923111,1.0,13/21,33.17%,RAB34;ARMC9;TEDC1;EVC;PDCL;SMO;UCHL5;TXNDC15;DLG5;TUBD1;GLI1;ULK3;GAS8
prerank,hippo signaling (GO:0035329),-0.32739464058214995,-1.0319070205228875,0.3910891089108911,0.7150047389406511,1.0,3/26,4.46%,TJP1;TEAD4;AMOTL2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.42629936245705485,1.0316672408678405,0.442002442002442,0.8372866626531242,1.0,11/29,25.01%,LDLRAD4;SPRED2;FOXA1;SMAD7;FUZ;BMP5;IL17RD;EFNA1;MAD2L2;ZNF750;PPP2CA
prerank,reticulophagy (GO:0061709),0.4907662783500166,1.031642787951429,0.4672364672364672,0.8368234857056249,1.0,8/12,28.39%,ULK2;UBA5;UFL1;RB1CC1;TEX264;ATG2B;UFC1;ULK1
prerank,cellular response to acid chemical (GO:0071229),0.4255310815666604,1.0314170026143434,0.43105590062111804,0.8368986707550291,1.0,6/27,15.93%,VEGFA;IPO5;LAMTOR1;CAPN2;SESN2;NSMF
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.37618480348974515,1.0313170213425589,0.44842562432138977,0.8366333389657107,1.0,27/73,25.78%,LDB1;PSMD7;PSMA8;PRKDC;PSMA4;ITCH;ABL1;PSMD12;PSMA6;PDCD2;RUNX1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;SETD1A;CBFB;TCF3;PSMA3;PSMB1;PSMD4;KMT2A;PSMA5;PSMA7;METTL14;PSMC1
prerank,carbohydrate homeostasis (GO:0033500),0.3782169944812654,1.030786617192039,0.45544554455445546,0.8376232507724124,1.0,9/67,8.46%,IRS1;KCNB1;TCF7L2;STAT3;ADCY8;TENT4B;MCU;BACE2;ADIPOR2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.38878846951615115,-1.0305770300483519,0.425531914893617,0.7165372386855386,1.0,3/12,4.47%,PODXL;PROM1;PTPRO
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3586033443059394,-1.030377669513709,0.4279835390946502,0.715313269554691,1.0,2/16,0.76%,AUTS2;ARHGAP24
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.44719301777315984,1.0302882290709505,0.4529032258064516,0.8384624739702845,1.0,9/20,24.82%,SCD5;CBR4;FAR1;PPT2;ACACA;ACSL3;HSD17B8;GCDH;FITM2
prerank,neurotransmitter transport (GO:0006836),0.3773668136742196,1.030099125083567,0.4413347685683531,0.8384437203785505,1.0,9/73,9.82%,SLC38A2;SLC38A1;UNC13B;PPFIA1;DVL1;SLC6A2;SLC28A2;SYNJ1;NRXN2
prerank,dendritic cell chemotaxis (GO:0002407),0.4651494116851346,1.0300888422361374,0.4299191374663073,0.8379467300252968,1.0,3/14,15.84%,HMGB1;TRPM4;CXCR4
prerank,presynapse assembly (GO:0099054),-0.3584192077575622,-1.0297905688534466,0.39615384615384613,0.7150644251563721,1.0,4/16,4.79%,IL1RAPL1;WNT5A;PTPRD;BSN
prerank,regulation of feeding behavior (GO:0060259),-0.4132113208523215,-1.0296994037511356,0.4158415841584158,0.7135915498596366,1.0,2/11,2.51%,LEPR;SGIP1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.4720867209358933,1.0295444897666464,0.4469496021220159,0.8389296169661213,1.0,4/15,14.77%,SFRP4;BMP4;VDR;CYP27B1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3519176544727907,1.0294882391399685,0.43425076452599387,0.8385453717443404,1.0,56/148,26.72%,CSNK2A2;CSNK2A1;KMT5A;RRS1;CHD3;USP2;RMI2;MDM4;EHMT1;CDK5RAP3;RBBP8;RAD1;WRN;ING5;PIP4K2B;ATM;CHEK2;PDPK1;TAF15;TAF6;RAD50;HDAC1;TAF13;RBBP7;USP7;HEXIM1;ATRIP;TTC5;PPP2R5C;TP53RK;HUS1;SSRP1;BOP1;PRKAG1;AKT1;HIPK2;CDK2;TAF9B;CDK5;PRKAB1;NOC2L;MAPKAP1;PAK1IP1;TOPBP1;TBP;MEAF6;TAF1;SMYD2;TP53;CHD4;TOP3A;HDAC2;DAXX;EHMT2;SGK1;TAF10
prerank,receptor catabolic process (GO:0032801),0.4214226751644444,1.0294831354368614,0.45420326223337515,0.8380386957083122,1.0,9/24,23.07%,NEDD4;AP2A1;MYLIP;AP2A2;CLTC;GPRASP1;CLTA;MVB12A;UVRAG
prerank,liver development (GO:0001889),-0.30287327601088004,-1.0292574342677825,0.36813186813186816,0.7130510459011671,1.0,5/32,5.87%,TGFBR3;WNT4;ARID5B;LSR;PROX1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.45899029430153926,1.0292046463674145,0.4573333333333333,0.8382373955131616,1.0,3/16,8.32%,SIX1;FTO;TFE3
prerank,cellular response to unfolded protein (GO:0034620),0.4227569174831943,1.0291649932859472,0.4396551724137931,0.8378313610248983,1.0,12/26,29.91%,HSPA2;BAG3;HSPA14;HSPA5;HSPD1;OPTN;ABCB10;DAXX;HSPB8;ERN1;HSF1;PRKN
prerank,glucose metabolic process (GO:0006006),0.3844211215234788,1.029034620545158,0.441834451901566,0.8376550844646948,1.0,13/58,18.38%,SLC39A14;LRP5;ATF4;SORD;GAA;ADPGK;CRTC2;AKR1A1;HECTD4;PGK1;SLC37A4;ENO2;GDPGP1
prerank,negative regulation of apoptotic process (GO:0043066),0.34346099357587656,1.0288585729881037,0.418,0.8375750056132801,1.0,96/444,18.74%,THBS1;EGFR;SIX1;PRKCD;VEGFA;FSTL1;GAS6;GCLC;CARD14;PROK2;NTRK1;SMAD6;COMP;TGFB3;NOL3;SHC1;TOPORS;PKHD1;CSNK2A2;CSNK2A1;SIX4;CARD16;ANXA4;ERC1;BAG3;TAX1BP1;PRKCA;HYPK;NRBP2;FXN;GLO1;PRKDC;ADAM10;ANGPTL4;RAF1;ARF4;TRIM27;ERCC5;PA2G4;SOX9;CBL;SOCS2;AKT2;ANGPT4;PAK2;MAPK8;ANXA1;BMP4;ITCH;VIP;IRAK1;BCL2L2;MAZ;NAA16;SFPQ;SOD1;PHIP;HSPA5;CD27;CIDEA;PTRH2;MIEN1;SERPINB9;HDAC1;VTCN1;HSPD1;LIG4;F2R;LRP2;YWHAE;SUPV3L1;NDNF;SQSTM1;DAB2;CLCF1;PRDX3;HNRNPK;CAT;PSEN2;HGF;IL6;AATF;RPS27A;UBC;HIGD1A;BIRC6;PRLR;CITED2;ARAF;GOLPH3;BNIP1;BID;CLN3;BIRC5;AKT1;GDNF
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5125857504720867,1.0277771041035728,0.4703389830508475,0.8400247984857079,1.0,5/10,23.95%,TBX21;SMAD7;RC3H2;IL4;NFKBID
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5029454503948456,1.0276371590751898,0.4744318181818182,0.8398734613670719,1.0,3/10,10.20%,ETFDH;ETFA;ETFB
prerank,regulation of centrosome cycle (GO:0046605),0.43930886940614855,1.0274451728125673,0.44015444015444016,0.8398514868124421,1.0,8/21,26.64%,PKHD1;CHMP3;MARK4;CHMP4B;PDCD6IP;XRCC3;CHMP2A;ATF5
prerank,positive regulation of binding (GO:0051099),0.3683188556911069,1.0273605196949174,0.43217665615141954,0.8395454087402914,1.0,20/84,19.01%,PKD1;LRP1;TCF7L2;TIAM1;DACT1;HMGB1;SKI;RARA;BMP4;NVL;TERT;MED25;ADD1;USP33;SIRT2;IDE;NCBP1;MEN1;CDT1;HIPK2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.45976508802513405,1.0271592953930901,0.45883940620782726,0.8395897153724975,1.0,5/16,6.98%,CACNA1C;CAMK2D;CALM2;DMD;ANK2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3522959640548153,1.026958054999471,0.4465725806451613,0.8396271810309779,1.0,51/234,20.48%,ESR1;LRP6;SLCO3A1;VEGFA;DDR2;CARD14;NTRK1;PLPP3;RAB7B;HDAC4;CARD16;STAT3;ERC1;MAVS;ADCY8;IRAK3;TRIM41;JUP;RPS6KA4;TRIM27;ROR1;FOXA1;CHUK;RIPK3;NFKBIB;IRAK1;TAB2;RNF25;NEUROD2;SRF;MID2;PSMA6;SMO;TRIM26;PRDX3;TFDP1;IL6;CRTC2;RPS27A;UBC;NFKB2;TRIM13;TRIM6;AKT1;ATF2;HIPK2;IKBKE;NFKBIA;TCF3;TNFSF18;CLU
prerank,myeloid leukocyte differentiation (GO:0002573),0.37685972607397544,1.0268118494755212,0.4351145038167939,0.8395154007305552,1.0,15/65,19.14%,FOXP1;VEGFA;GAB2;RXRA;GLO1;TGFBR2;RARA;SBNO2;BMP4;RUNX1;FARP2;CAMK4;PARP1;E2F1;CDK2
prerank,regulation of myoblast differentiation (GO:0045661),0.4145329734974816,1.026802613040372,0.428927680798005,0.8390186683871093,1.0,5/32,9.70%,BOC;SOX9;SRA1;EID2B;BMP4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4760550889309029,1.026738196237874,0.43333333333333335,0.8386789550896787,1.0,5/12,24.64%,PRKDC;SDE2;CDK2;TP53;RPS27L
prerank,mitotic recombination (GO:0006312),0.4667276561736667,1.0267020653168506,0.452445652173913,0.8382485856439625,1.0,9/15,31.99%,RAD50;TPRKB;SMC5;RAD51;XRCC3;SMC6;NSMCE2;RAD52;ERCC1
prerank,regulation of interleukin-8 production (GO:0032677),0.37930781770164984,1.0265760706326368,0.4420131291028446,0.8380684392206055,1.0,11/69,15.27%,LBP;F3;STAT3;ANXA4;MAVS;HMGB1;ANXA1;MAPKBP1;F2R;IL6;ARRB1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.4484327136016387,1.0265718098280066,0.45324675324675323,0.8365299656126435,1.0,7/20,20.81%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,spindle assembly checkpoint signaling (GO:0071173),0.4484327136016387,1.0265718098280066,0.45324675324675323,0.8365299656126435,1.0,7/20,20.81%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.4484327136016387,1.0265718098280066,0.45324675324675323,0.8365299656126435,1.0,7/20,20.81%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,autophagosome maturation (GO:0097352),0.4105836406562865,1.0263364112086957,0.45868263473053894,0.8366396615067271,1.0,17/32,36.63%,VCP;LIX1L;WIPI2;VIPAS39;CHMP3;UBQLN1;CLN3;LAMP2;UVRAG;VTI1B;VPS16;STX17;MAP1LC3B;GABARAPL2;TSG101;EPG5;ATG14
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.465566982338726,1.0262243395283148,0.4607977991746905,0.8364426691651629,1.0,1/15,0.75%,PRKCD
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.3269580703701138,-1.0261188989358703,0.3783783783783784,0.7196481269184768,1.0,13/28,17.63%,PRKAA2;PRKAG2;MITF;ADIPOR1;FGFR4;CX3CR1;SIRT1;NR1H4;SIRPA;AVIL;C3;NOS1AP;CD47
prerank,ribosome assembly (GO:0042255),0.3944459099233075,1.0259775390933892,0.4600456621004566,0.8365798564381981,1.0,13/47,21.35%,RPSA;MRPS2;RRS1;MPV17L2;RRP7A;NLE1;DHX29;EIF6;PPAN;EFL1;BOP1;EIF2A;SBDS
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3585782926367267,1.0257942301854557,0.4687819856704197,0.8365282706858462,1.0,35/140,17.28%,SLIT2;RHOJ;PLCE1;SRGAP3;SRGAP2;TIAM1;ARAP1;RHOQ;TIAM2;VAV2;ARHGAP17;BCR;RHOT2;ARHGAP21;KALRN;RHOA;RHOT1;ITGAV;INPP5B;FOXM1;MYO9A;ARHGAP20;ARHGAP8;ARHGAP44;OCRL;SOS2;SQSTM1;ARHGEF1;RHOB;AKAP13;SOS1;TAGAP;TRIO;NGEF;FLCN
prerank,cytosolic calcium ion transport (GO:0060401),0.420678485969465,1.0257738915514103,0.44375,0.8360642779049858,1.0,3/28,5.91%,CACNA1C;SLC35G1;MCU
prerank,DNA methylation (GO:0006306),0.43697873663104425,1.0257722856777243,0.441025641025641,0.8355537628184005,1.0,9/23,26.55%,BAZ2A;TEX15;EHMT1;MTRR;PICK1;FOS;DNMT1;EHMT2;DNMT3A
prerank,glutathione metabolic process (GO:0006749),0.4045043681020911,1.0257204480550497,0.4489311163895487,0.8351795665231545,1.0,10/38,23.51%,GCLC;GSTT1;GSTM5;SOD1;GSR;GSTZ1;GCLM;CHAC2;HAGH;DPEP1
prerank,maturation of 5.8S rRNA (GO:0000460),0.46934697528144953,1.0256626096078905,0.455026455026455,0.834824155318926,1.0,9/17,26.99%,C1D;PRKDC;LAS1L;EXOSC4;EIF6;MTREX;WDR12;RRP15;MAK16
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.37287825888485493,1.0250318499283844,0.4532608695652174,0.835956899185195,1.0,24/70,23.61%,PSMD7;PSMA8;FCER1G;PSMA4;ITGAV;PDIA3;CHUK;PSMD12;PSMA6;SEC22B;LNPEP;SNAP23;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;CALR;PSMB1;PSMD4;PSMA5;PSMA7;ITGB5
prerank,regulation of microtubule-based movement (GO:0060632),0.49746590398406265,1.0249626698877972,0.4718019257221458,0.835626461147662,1.0,2/11,4.94%,CFAP298;DYNLT2B
prerank,regulation of cellular localization (GO:0060341),0.39490127846198386,1.0248325078194787,0.4548532731376975,0.835472638190174,1.0,7/46,8.04%,EFNA5;GSN;LRP5;CAMK2D;DYNC1H1;DVL1;MAD1L1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.49801693290413385,1.0248089043747746,0.44680851063829785,0.8345133441290413,1.0,8/11,29.41%,CCT4;LARP7;CCT6A;CCT8;TCP1;DKC1;CCT5;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),0.49801693290413385,1.0248089043747746,0.44680851063829785,0.8345133441290413,1.0,8/11,29.41%,CCT4;LARP7;CCT6A;CCT8;TCP1;DKC1;CCT5;MEPCE
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4355967580944824,1.024548480680044,0.4467005076142132,0.8346958252491663,1.0,6/22,14.77%,VKORC1L1;UBIAD1;LRP2;PIAS4;VDR;CYP27B1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.4127940073202452,1.024277978093365,0.4366028708133971,0.8348993712393892,1.0,13/31,22.64%,DLG2;CRB1;DLG1;RHOA;SYNE4;MYO9A;EZR;CRB2;WDR1;ERBIN;PDCD6IP;PRKCI;CAMSAP3
prerank,long-term memory (GO:0007616),0.44838844294344493,1.0239967333193745,0.46835443037974683,0.8351136098637018,1.0,8/19,21.93%,ARC;SHANK1;KAT2A;CAMK4;EIF2AK4;NFATC4;RASGRF1;LDLR
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3854107329493301,1.0237632360337514,0.4394977168949772,0.8351909019430278,1.0,9/48,13.07%,UBASH3B;DRD1;CAMK2D;CALM2;DMD;ANK2;SELENON;PDPK1;F2R
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.3706319043573111,1.0237045164864458,0.44667370644139387,0.8348443318944794,1.0,30/83,26.64%,CSNK1D;DYNC1H1;SFI1;ODF2;ALMS1;DCTN2;CKAP5;SDCCAG8;AKAP9;CEP164;CSNK1E;YWHAE;CEP41;CEP63;PCM1;HAUS5;CDK2;DYNC1I2;DCTN1;PRKACA;ACTR1A;CDK5RAP2;NEDD1;PLK4;CNTRL;TP53;TUBB4B;CCP110;PPP2R1A;ATF5
prerank,negative regulation of cell motility (GO:2000146),0.35747425990161813,1.02366594777595,0.4494264859228363,0.8344253751453532,1.0,14/108,6.57%,SLIT2;IGFBP5;SRGAP3;SRGAP2;TMEFF2;DPYSL3;MAPK15;LDLRAD4;CYP1B1;SLURP1;CLIC4;PTPRU;JAG1;SULF1
prerank,pyruvate metabolic process (GO:0006090),0.38699259141211667,1.0236649715982835,0.4601366742596811,0.8339190046918571,1.0,4/52,6.10%,ME1;SLC16A1;LDHC;GLO1
prerank,embryonic axis specification (GO:0000578),0.45922729483369895,1.0236251733884696,0.44804318488529016,0.8335144545932269,1.0,3/15,8.13%,SMAD6;COBL;FZD5
prerank,regulation of cell migration (GO:0030334),0.3427736933829092,1.0234805856573161,0.434,0.8333738498455064,1.0,48/382,8.56%,THBS1;MYOC;SLIT2;EGFR;PLXNA4;IGFBP5;VEGFA;F3;FGF2;SRGAP3;SRGAP2;ADAM9;COL1A1;TWIST2;SRCIN1;TIAM1;NTRK3;FGF17;DRD1;TMEFF2;LDB2;LDB1;DPYSL3;RDX;MAPK15;EPHB2;LDLRAD4;CYP1B1;SLURP1;ARSB;LMNA;CLIC4;PTPRU;STAT3;SEMA3E;PRKCA;MEAK7;ACVR1;ADAM10;JAG1;SULF1;MMP14;SEMA4B;CXCL16;ELP5;BEX4;NOG;AKT2
prerank,nuclear pore complex assembly (GO:0051292),0.5011447938108262,1.0230366722924407,0.45664739884393063,0.8340614249834919,1.0,5/10,27.36%,NUP93;TMEM170A;NDC1;TPR;AHCTF1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.42618778500308635,1.0228825570117035,0.44710327455919396,0.8339509036492435,1.0,6/24,16.23%,KCNB1;C2CD5;MIEF2;AKT2;CHP1;ERBB2
prerank,translesion synthesis (GO:0019985),0.3920964214571404,1.0225197007990026,0.45308924485125857,0.8343833879043822,1.0,14/42,25.48%,REV3L;POLE2;VCP;FAAP20;UBE2L6;RPS27A;UBC;REV1;NPLOC4;USP10;MAD2L2;PRIMPOL;RCHY1;POLD1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4869246474072028,1.022471873040972,0.46685082872928174,0.8340087845519356,1.0,4/12,18.28%,ADCY8;TRPM4;STX4;C2CD2L
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.4165412830259402,1.0224255955415953,0.4802955665024631,0.8336201449021218,1.0,7/27,17.75%,ZC3H12D;RNASE6;ZC3H12C;LACTB2;XRN1;PCF11;KHNYN
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.3999026030713516,1.02241772599565,0.464922711058264,0.8331318069972863,1.0,4/35,6.57%,THBS1;SPARC;XDH;SULF1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.49624652310583683,1.02240388254873,0.4531024531024531,0.8326627564600968,1.0,4/10,16.02%,PLS1;TSKU;SOD1;IFT88
prerank,negative regulation of lyase activity (GO:0051350),-0.35930005235239126,-1.0223428721374275,0.4156378600823045,0.7276304728233978,1.0,2/16,1.93%,GRM3;ADGRV1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.4842637094446766,1.0222568574448108,0.44367176634214184,0.832532390138987,1.0,3/13,15.90%,PTGIS;NNMT;NAPRT
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.36878732312675755,1.0221074848308063,0.4607948442534909,0.8324232635256258,1.0,14/76,12.99%,CTTN;NTRK3;PRKCE;SORBS3;DYNC1H1;BCAS3;CDC42EP2;PFN2;ABL1;KATNBL1;SNX9;TENM1;NRP1;CDC42EP5
prerank,protein localization to cell surface (GO:0034394),0.4277537123122857,1.0218995861494748,0.47858942065491183,0.8324575383784923,1.0,12/26,30.24%,PTPRU;RIC3;GGA2;ANK2;GGA1;FBLN5;UNC50;USP4;PRRT1;WNT11;GGA3;CTNNB1
prerank,regulation of neuron apoptotic process (GO:0043523),0.35978600091300744,1.0216857985345758,0.4582010582010582,0.8325350875300283,1.0,22/96,19.94%,SIX1;KCNB1;NTRK1;TGFB3;SIX4;TGFB2;ATF4;NRBP2;AKT1S1;BACE1;SOD1;LIG4;F2R;NDNF;CLCF1;FOXO3;NSMF;NF1;CLN3;GDNF;CDK5;NFATC4
prerank,cellular response to oxidative stress (GO:0034599),0.3590744286099318,1.021582713772898,0.45211122554067973,0.8323095158495529,1.0,39/118,24.91%,EGFR;PRKCD;VKORC1L1;ATF4;SLC4A11;NOX4;NFE2L2;MAPK8;STX2;CHUK;ABL1;SOD1;LONP1;SESN2;SRXN1;PRDX3;CAT;STX4;SIRT2;GSR;TXNRD2;FOXO3;PARP1;HMOX1;VRK2;AKT1;PRDX2;EIF2S1;MAPK9;LRRK2;PYCR1;PRDX1;GPX7;FOS;PYROXD1;PXN;TP53;PINK1;SELENOS
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.2847944351273398,-1.0211919879293012,0.40476190476190477,0.7288417514231288,1.0,10/47,10.38%,GRM5;APOE;APP;WDR91;NR1H3;AGTR1;CSF1;EDNRB;EDN1;MTPN
prerank,acute-phase response (GO:0006953),0.47857178867452976,1.0209730631480238,0.4473684210526316,0.8333725053653936,1.0,1/12,1.05%,LBP
prerank,double-strand break repair (GO:0006302),0.3487320051142661,1.0205780552756731,0.47196738022426094,0.8338751287942484,1.0,42/158,20.81%,REV3L;PARP3;VCP;PRKDC;HMGB1;TONSL;ERCC5;MORF4L1;RBBP8;ERCC4;MAPK8;SFR1;WRN;SPIDR;KDM2A;SWI5;KPNA2;ATM;CHEK2;SFPQ;TDP1;KDM4A;RAD50;LIG4;PIAS4;DCLRE1B;UBE2V2;PARP1;PSMD14;HUS1;APBB1;SMC5;SUMO1;POLB;SMARCAD1;ACTR8;RAD51;XRCC6;TNKS1BP1;BRCC3;XRCC3;MAD2L2
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.454523277249689,1.0205028158610574,0.4594240837696335,0.8335747375000263,1.0,3/18,10.12%,SLIT2;EDN3;MTUS1
prerank,mammary gland epithelium development (GO:0061180),0.4763703449548895,1.0202775156899042,0.43561643835616437,0.833671172154738,1.0,2/14,8.56%,ID2;AKT2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.38400687518859805,1.0202732420985192,0.44932432432432434,0.8331812459598951,1.0,17/54,26.25%,GAS6;CARD16;TAX1BP1;SHARPIN;MADD;CHUK;PTPN2;CASP1;OTULIN;TRAIP;CCDC3;GPS2;BIRC3;CYLD;SPPL2A;TRADD;RIPK1
prerank,detection of calcium ion (GO:0005513),0.4737180047991886,1.019970440007791,0.44157608695652173,0.8334790893259281,1.0,4/13,16.86%,CALM2;KCNIP2;STIM1;CALM3
prerank,regulation of catecholamine secretion (GO:0050433),0.4191689784841172,1.0199662910690106,0.45787545787545786,0.8329922635324274,1.0,3/29,6.91%,KCNB1;SYT8;CHRNB2
prerank,peptidyl-proline modification (GO:0018208),0.4217413562335817,1.0198566463722816,0.4438964241676942,0.8328004118154593,1.0,12/25,30.69%,FKBP5;FKBP10;P3H2;PPIL3;NKTR;NTMT1;FKBP4;PPIG;FKBP1B;PPID;PPIC;PPIH
prerank,regulation of endocytic recycling (GO:2001135),0.5046306704083628,1.0198423565648076,0.4695898161244696,0.8323390972072053,1.0,4/11,13.45%,EHD1;EHD2;ATP9A;RAB11B
prerank,L-amino acid transport (GO:0015807),0.4112398343019203,1.0196667563415607,0.45041816009557945,0.8322913000301688,1.0,1/28,0.09%,SLC38A2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5058096753645637,1.0194792041583656,0.43898809523809523,0.8317935581312171,1.0,3/10,13.50%,MPG;FTO;ALKBH1
prerank,DNA dealkylation (GO:0035510),0.5058096753645637,1.0194792041583656,0.43898809523809523,0.8317935581312171,1.0,3/10,13.50%,MPG;FTO;ALKBH1
prerank,ameboidal-type cell migration (GO:0001667),0.3830713018633425,1.0191756970949193,0.464326160815402,0.83205459337202,1.0,8/51,9.52%,SRGAP2;GPC3;CCN3;PDXDC1;SEMA3E;FAT2;SEMA4B;PKN2
prerank,negative regulation of hydrolase activity (GO:0051346),0.3816965322178938,1.0190236593046778,0.4512471655328798,0.8319242098946212,1.0,11/49,13.93%,SLC39A14;RDX;KLRK1;BCAS3;CST3;ZCCHC9;URI1;RCC2;CHP1;ARL2;WNK1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.41755664347063653,-1.0188733307294187,0.4270833333333333,0.731264063858424,1.0,4/10,8.38%,CDC42EP4;APC;CDC42EP3;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),-0.41755664347063653,-1.0188733307294187,0.4270833333333333,0.731264063858424,1.0,4/10,8.38%,CDC42EP4;APC;CDC42EP3;CDC42
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.37356127152248075,1.0181965330155467,0.4580152671755725,0.8335743541771474,1.0,24/70,23.58%,LDB1;PSMD7;PSMA8;PRKDC;PSMA4;ITCH;ABL1;PSMD12;PSMA6;RUNX1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;SETD1A;CBFB;TCF3;PSMA3;PSMB1;PSMD4;KMT2A;PSMA5;PSMA7
prerank,microtubule anchoring at centrosome (GO:0034454),0.5072193315839761,1.0181909124761641,0.47467438494934877,0.8330894994671425,1.0,3/10,20.24%,NIN;PCM1;DCTN1
prerank,lipid oxidation (GO:0034440),-0.38199867880317334,-1.0180517961949564,0.42391304347826086,0.7317129306470092,1.0,4/12,19.41%,PPARGC1A;ADIPOR1;ALOX12;PLA2G7
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.4564720973380073,1.018048903328158,0.4791666666666667,0.8329724186677524,1.0,5/16,21.67%,SRSF1;PSIP1;RBM22;NCBP2;SFSWAP
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.38007317934588336,-1.017716049066649,0.4426877470355731,0.7307885991164548,1.0,6/14,11.99%,NOS3;ENPEP;ACE;AGTR1;EDN1;ACE2
prerank,regulation of autophagy (GO:0010506),0.3446250528884503,1.01742639630643,0.46586345381526106,0.8340497789749123,1.0,95/216,28.89%,NEDD4;ATP6V1C2;EXOC4;MAPK15;CSNK2A2;STAT3;OSBPL7;EIF4G2;LAMTOR1;ATP6V0A1;HMGB1;RAB8A;EIF4G3;TRIM27;FZD5;DAP;FOXK1;MAPK8;PIP4K2B;VPS26A;SREBF1;ABL1;TAB2;ATP6V0D1;ATM;MID2;KDM4A;PIK3CB;SNX32;EIF4G1;ATP6V1B2;USP33;WDR41;UBQLN1;USP36;TRIM65;ATP6V1E1;USP13;HGF;SIRT2;FOXO3;TLK2;HDAC6;KLHL22;ORMDL3;FLCN;UFL1;PRKAG1;DAPK3;TRIM6;USP10;RB1CC1;AKT1;ATP6V1C1;DCAF12;CDK5;PRKAB1;RHEB;ATF6;UCHL1;PRKACA;OPTN;CAPNS1;LRRK2;TRIM8;RUBCN;ZKSCAN3;KAT8;RPTOR;NPRL2;ATP6V0E1;SMCR8;BAD;ROCK1;PINK1;ATP6V0B;LAMTOR2;EXOC7;ATG13;MET;HTRA2;GOLGA2;ERN1;EIF4E;PIP4K2C;CAPN1;LAMTOR3;ABL2;SNX5;TFEB;ULK1;SREBF2;PLEKHF1;CISD2;DRAM1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5105566310701619,1.017140064204495,0.47540983606557374,0.8342799974737991,1.0,2/10,11.51%,ADAM9;IQSEC1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.4960818144542322,1.0169305944905365,0.45545977011494254,0.834303801807846,1.0,1/11,0.97%,GAS6
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3808632451818983,-1.0167506312109087,0.44223107569721115,0.7314556181067456,1.0,8/14,12.43%,ADGRV1;WNT5A;DGKD;DGKG;GPD1L;FLT4;ADRA1A;CD40
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3597721719032692,1.0165795356498877,0.4624338624338624,0.8347075496745289,1.0,17/100,13.07%,MYOC;EGFR;FGF2;NEDD4;NTRK3;NTRK1;FSHR;TWIST1;TGFB2;FGFR1;SOX9;CBL;ROR1;PIP4K2B;MAZ;PIK3CB;F2R
prerank,regulation of secretion by cell (GO:1903530),0.38268018118136043,1.0164261727162531,0.45730337078651684,0.8345791724028466,1.0,13/54,15.41%,SNCAIP;P3H1;RAB21;RIC1;RAB8A;DISP1;LLGL1;NSF;ANXA1;RAB3D;STXBP5;STX4;RAB3B
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.4475359002344954,1.0157966023094407,0.46183699870633893,0.8357602880910145,1.0,11/18,35.53%,ATF4;PHF8;ERBB2;EIF2AK3;WDR75;UBTF;POLR2L;POLR2K;SIRT7;LYAR;UTP15
prerank,cellular response to ketone (GO:1901655),-0.2940599013442254,-1.0155163047367861,0.40718562874251496,0.7328042301062045,1.0,4/35,4.23%,ADCY5;ROCK2;ADCY1;AHR
prerank,protein localization to synapse (GO:0035418),0.4703506107248777,1.015313633286572,0.4628330995792426,0.8364380259289126,1.0,5/12,13.02%,DLG4;MPP4;NRXN2;SHANK1;NLGN1
prerank,mitotic cytokinetic process (GO:1902410),0.4429668711934609,1.0152141663986018,0.45789473684210524,0.8361809123614244,1.0,7/20,24.57%,RHOA;CHMP3;MITD1;CHMP4A;CHMP4B;PDCD6IP;CHMP2A
prerank,diterpenoid metabolic process (GO:0016101),0.38548328162505285,1.0151134080767925,0.46756152125279643,0.8359424549966584,1.0,8/55,13.51%,GPC6;LRP1;GPC3;SDC1;AKR1C1;LRP2;ALDH3A2;OPN1MW
prerank,clathrin coat assembly (GO:0048268),-0.37577195431391075,-1.015077245983446,0.3855932203389831,0.7322313897527424,1.0,5/15,12.54%,SGIP1;PICALM;HIP1R;NSG1;PIK3C2A
prerank,myotube differentiation (GO:0014902),-0.3528891587208105,-1.0147617419054396,0.41245136186770426,0.7313503552134815,1.0,9/17,17.40%,JAM2;KCNH1;SORT1;ADGRB3;NOS1;ADAMTS15;IGF1;PLD3;ADAMTS5
prerank,sterol homeostasis (GO:0055092),0.3705690496999298,1.014679256199232,0.47414741474147415,0.8365999441541814,1.0,12/65,13.71%,EHD1;LRP5;LIMA1;HDAC9;SOAT1;LAMTOR1;TSKU;AKR1C1;RORA;NPC1;RALY;ABCA1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.45664918158437473,1.014376709415518,0.4621733149931224,0.8368398305979199,1.0,9/15,30.33%,SEC61A1;RAB3GAP1;SPCS2;ZFAND2B;RAB3GAP2;SPCS1;SRPRA;ZFAND2A;SRP14
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.46287010384907606,1.0140857164564931,0.45369127516778524,0.8370794319716124,1.0,3/14,12.61%,WNT9A;SOX9;TGFBR1
prerank,macrophage differentiation (GO:0030225),0.4729269011205862,1.013895679077936,0.45491803278688525,0.8370707248530541,1.0,3/13,16.22%,VEGFA;BMP4;PARP1
prerank,lipoprotein localization (GO:0044872),0.49087165943360256,1.013806380522269,0.48044692737430167,0.8367970360361578,1.0,1/11,1.02%,LRP1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.34194111091223406,-1.0137451847449517,0.4166666666666667,0.7321768473486254,1.0,10/20,15.96%,TGFBR3;ENG;TBX3;NOTCH1;RBPJ;ACVRL1;SPRY1;HEY2;OLFM1;BMP2
prerank,negative regulation of cell death (GO:0060548),0.36221528867883185,1.0137155744800042,0.47058823529411764,0.8365301600389623,1.0,27/88,26.38%,SRSF6;FGF2;SRGAP2;CCN5;CCN3;LRPAP1;AGR2;TNFRSF1B;IMPACT;BMP4;EIF4G1;PSMC5;CCN4;AKT1;CDK5;CLU;CHMP4A;CHMP4B;NUP62;LRRK2;GPNMB;PINK1;CHMP2A;NENF;HTRA2;NCK1;WNT11
prerank,connective tissue development (GO:0061448),0.40607399352245066,1.0131570487078467,0.4534746760895171,0.8374867776971843,1.0,8/35,12.96%,PKD1;LRP5;HES5;SULF1;SOX9;SH3PXD2B;SLC39A13;TRIP11
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.35920901062022503,-1.013144153200049,0.43902439024390244,0.731954590579591,1.0,5/17,10.89%,APOE;FGF1;ABCG1;PRKAA1;KPNB1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.329338332868574,-1.0129372837495234,0.40186915887850466,0.7307929956173985,1.0,2/23,3.43%,ATP1A2;CACNA2D1
prerank,regulation of oxidoreductase activity (GO:0051341),0.471982949634956,1.0128529573427998,0.46802721088435373,0.837807175686742,1.0,3/13,15.82%,ECSIT;ABL1;HDAC6
prerank,regulation of cell development (GO:0060284),0.4016400612190899,1.0127469310459225,0.457280385078219,0.8375902223691405,1.0,7/36,12.13%,DOCK7;HDAC9;HES5;BHLHE40;HEYL;FBXO22;HEY1
prerank,regulation of cell aging (GO:0090342),0.4922964140325249,1.0125938292974233,0.48226950354609927,0.8374706178399167,1.0,5/11,27.28%,LMNA;FOXM1;NEK4;VASH1;NEK6
prerank,negative regulation of viral entry into host cell (GO:0046597),0.47937191454835243,1.0124743965765157,0.4633093525179856,0.8372835245797519,1.0,3/12,13.94%,GSN;MID2;TRIM26
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4929784629775146,1.012337853421366,0.48324022346368717,0.8371466104590751,1.0,2/11,14.06%,P4HB;UBQLN1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.42579427515513624,1.0121699746720405,0.4553686934023286,0.8370779957708696,1.0,6/23,22.48%,PKHD1;MISP;ZW10;NDEL1;DCTN1;CDK5RAP2
prerank,ganglioside biosynthetic process (GO:0001574),0.46579111844677895,1.0119258189479192,0.4811715481171548,0.8372448679943377,1.0,4/15,9.01%,ST8SIA2;ST6GALNAC5;ST3GAL2;B4GALT5
prerank,regulation of synapse organization (GO:0050807),-0.3158042170479332,-1.0117819991414538,0.42788461538461536,0.7319893678449021,1.0,8/26,10.58%,IL1RAPL1;WNT5A;EPHA4;ARHGAP22;CTNNA2;ABHD17C;PDLIM5;YWHAZ
prerank,regulation of lymphocyte migration (GO:2000401),0.49876844102974494,1.0116814159891165,0.47360912981455067,0.8374045029088494,1.0,4/10,23.25%,SPN;MIA3;AKT1;SLC8B1
prerank,response to unfolded protein (GO:0006986),0.38445680765437756,1.0116770612983896,0.45894263217097864,0.836923650060886,1.0,19/48,31.20%,SERPINH1;HSPA2;BAG3;HSPA14;HSPA5;HSPD1;DNAJA1;OPTN;DERL1;HERPUD1;DAXX;HSPB8;ERN1;HSF1;STT3B;DNAJB1;PRKN;HSP90AA1;HSPH1
prerank,response to reactive oxygen species (GO:0000302),0.384676195998468,1.0116607849287436,0.4582392776523702,0.8364750084266825,1.0,12/54,18.70%,EGFR;ADAM9;COA8;MAPK8;CHUK;SOD1;STK25;PRDX3;CAT;TXNRD2;HMOX1;AKT1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.44805681370887207,1.0114251108336914,0.46895640686922063,0.836569220299559,1.0,5/18,17.73%,DDR2;EMILIN1;RUNX1;IL6;IER3IP1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.3997027891136212,-1.0113737926980984,0.41721854304635764,0.7312750701964859,1.0,5/10,28.08%,ANO6;CD300A;C3;TREM2;NCKAP1L
prerank,triglyceride catabolic process (GO:0019433),-0.3541651111870024,-1.0110372723102314,0.43724696356275305,0.7305192573821042,1.0,9/19,36.69%,LPL;FABP5;FABP7;FABP3;LIPH;LIPC;FABP4;FABP12;PNPLA2
prerank,positive regulation of cell projection organization (GO:0031346),0.35676136391221297,1.0107672526598919,0.48606811145510836,0.8377877200544882,1.0,16/115,9.47%,SLIT2;PLXNA4;TIAM1;NTRK3;NTRK1;TIAM2;DPYSL3;CUX1;ARSB;FBXW8;KIDINS220;P3H1;DVL1;DLG4;RHOA;ROR1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3355439648991787,-1.0107166072180396,0.39814814814814814,0.7296845703608922,1.0,4/21,7.03%,PDE4D;NT5C2;NUDT4;PDE2A
prerank,nervous system development (GO:0007399),0.33873495209854165,1.0105699018428578,0.46046046046046046,0.8377956425262515,1.0,67/429,13.89%,DCLK1;PCDHB16;NAV2;WWP1;PKD1;ST8SIA2;VEGFA;EFNA5;ECRG4;FGF13;FGF2;GSN;CRIM1;FARP1;FGF17;DRD1;LDB2;LDB1;CNTFR;ACVR1B;GLIS2;EPHB2;NAV1;PMP22;RBFOX2;MBNL1;HDAC4;WWTR1;HES5;STAT3;PCDHB12;DACT1;DVL1;WDR62;SPG7;JAG1;SCD5;DLG4;DAGLA;S100B;FZD5;CHERP;NOG;RBM45;HAPLN4;KALRN;ZIC1;GMFB;NRXN2;ZIC4;ATN1;NEUROD2;BPNT1;TENM1;MYLIP;NELL1;TGFBR1;SMO;RAPGEFL1;LIG4;NLGN1;INHBA;DCHS1;NPAS1;ALDH3A2;MARK4;NDP
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.33801178811839033,-1.0102966278445162,0.3907563025210084,0.7290062956565535,1.0,6/21,10.31%,PLTP;APOE;PTCH1;NR1H3;CAV1;EEPD1
prerank,protein targeting to membrane (GO:0006612),0.3628961731761183,1.0102633508334982,0.4817204301075269,0.8381040561746342,1.0,33/83,30.33%,ABCD3;PXMP2;SEC61A1;RABGEF1;PEX5;SSR2;PEX16;PEX13;ATG3;ALDH3A2;SIL1;SSR1;ZDHHC4;ZDHHC20;CHMP4A;CHMP4B;PEX2;ABCD1;ACBD5;PRKCI;PEX14;ZDHHC9;SGTB;TAOK2;GET3;PARD3;VPS37B;SEC62;FIS1;SRPRA;PIKFYVE;ATAD1;SRP14
prerank,cellular amide metabolic process (GO:0043603),0.3586038581151203,1.0101906943894554,0.478125,0.8378038637994389,1.0,27/102,21.30%,SLC5A6;PLPP3;CPZ;ATF4;ACSF2;SLC25A32;ACOT11;PLPP1;MTRR;DNPEP;GPAT4;NNMT;MTHFD2;NLN;CPXM2;GLYAT;PLA2G15;ALDH1L2;MTHFD1;ORMDL3;SHMT2;ACOT13;SHMT1;ACSL6;MTHFR;ORMDL1;PCCB
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.36765216069665824,1.0099683996237026,0.4790996784565916,0.8378830040908674,1.0,8/72,8.29%,SLIT2;PRKCD;FGF13;EMILIN1;LIMA1;PFN2;SMAD4;IAPP
prerank,cellular response to interleukin-4 (GO:0071353),-0.4186330834762378,-1.0099669339943453,0.42424242424242425,0.728146101938609,1.0,2/10,3.71%,LEF1;TCF7
prerank,protein localization to kinetochore (GO:0034501),0.4715538080432021,1.0099348719444823,0.4689655172413793,0.8374747438026449,1.0,5/14,16.57%,CENPT;MIS12;RCC2;ZW10;IK
prerank,protein insertion into ER membrane (GO:0045048),0.3984607808381313,1.0095297667202618,0.477751756440281,0.8380147594859659,1.0,17/37,27.76%,STX5;TRAM2;EMC2;ALDH3A2;STX1A;EMC9;EMC1;HMOX1;CAMLG;EMC8;VAMP2;GET4;EMC4;MMGT1;GET3;SEC61B;CCDC47
prerank,regulation of keratinocyte migration (GO:0051547),0.48261269716392374,1.0094532645497847,0.47419804741980476,0.837737474182634,1.0,2/12,11.51%,ADAM9;IQSEC1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.348467467814081,1.009164172467918,0.47058823529411764,0.8379807544523628,1.0,45/170,23.95%,FOXP1;ATP1B1;C1D;AFF3;YBX3;COQ7;PRDM5;PRDM11;PRDM10;PRDM6;LAMTOR1;ANKRA2;HNRNPDL;RSPO1;TRIM27;TSKU;EDN3;PCBP4;PRDM4;ARF1;FUBP1;MARF1;NELL1;PCBP2;TRIM26;HNRNPK;AFF4;UBAP2;ZNF462;HMG20A;KDM6B;PRDM2;RFXANK;TRIM6;GDNF;CDK2;MTMR1;AFF2;TRIM43;POGZ;LDLR;ZNF711;CAVIN4;YBX1;NFKBID
prerank,membrane lipid biosynthetic process (GO:0046467),0.3755421730575679,1.0091629350312787,0.4816870144284129,0.837492462342854,1.0,7/58,8.59%,ST3GAL4;ACER3;PLPP3;KDSR;ELOVL5;PLPP1;ST3GAL2
prerank,respiratory electron transport chain (GO:0022904),0.46642671070895425,1.0086839704453583,0.4774281805745554,0.8382302116741602,1.0,4/14,10.20%,ETFRF1;ETFDH;ETFA;ETFB
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.36125595847559827,1.0086342511146709,0.48462354188759277,0.8378598187537017,1.0,33/88,28.94%,FBXL7;PSMD7;PSMA8;PSMA4;CUL4A;FBXL4;FBXL12;PSMD12;CUL1;PSMA6;FBXL14;PSMD1;FBXO17;FBXL20;PSMC5;PSMD11;PSMC4;PSMD14;FBXL18;FBXW4;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;FBXO9;PSMC1;FBXO38;PSMA1;DMAC2;FBXL8;RBX1;BTRC
prerank,pre-miRNA processing (GO:0031054),0.4741420035931245,1.0084917046357287,0.48637602179836514,0.8377107202633598,1.0,4/14,16.62%,PRKRA;AGO1;AGO2;TUT7
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.37910988839731996,1.0084429709908462,0.4716981132075472,0.8373608132332339,1.0,15/53,24.52%,PKD1;XPO1;GLMN;OSBPL7;PSMC5;USP19;DNAAF4;PSMD14;UFL1;ARAF;UCHL5;PRKACA;DESI1;USP14;PINK1
prerank,hyaluronan catabolic process (GO:0030214),0.435518829833402,1.0082910788518988,0.47455470737913485,0.8372574619203728,1.0,4/18,13.28%,FGF2;SLC9A1;CHP1;HEXA
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.47586194088303596,1.0082880517085104,0.5,0.836779423868699,1.0,4/14,12.31%,ATP1B1;ANK2;KCNIP2;AKAP9
prerank,regulation of kinase activity (GO:0043549),0.3586548288612029,1.006975899991715,0.4726315789473684,0.839618155809234,1.0,18/89,12.34%,EGFR;PLCE1;DDR2;NTRK3;NTRK1;LDB2;LDB1;EPHB2;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;LMO4;DDR1;SOD1;RAD50
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4712332745814456,1.0066505231500797,0.44712182061579653,0.8399523670289961,1.0,2/13,5.16%,PID1;VCP
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4802455306634906,1.0063938159593442,0.4613220815752461,0.8401106963897846,1.0,3/12,20.24%,NIN;PCM1;DCTN1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.44833864957660075,1.0062715434781677,0.47551546391752575,0.8399475817650893,1.0,7/16,24.52%,ACTN3;VCP;SHMT2;MLXIPL;ABCD1;COX7A2L;PINK1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.45414709547451965,1.00598532155676,0.4747340425531915,0.8401763078592064,1.0,5/15,13.52%,EGFR;NTRK1;ABL1;DDR1;SRMS
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.41315783221304825,-1.005928667181318,0.4697986577181208,0.7366413863531935,1.0,3/10,3.54%,LYN;RAPGEF2;CXCL12
prerank,regulation of chemokine production (GO:0032642),0.4028345581273202,1.0054932082255787,0.47754137115839246,0.8409083568240546,1.0,2/36,1.29%,FOXP1;IL33
prerank,signal transduction in response to DNA damage (GO:0042770),0.37512888758534146,1.0054120937143176,0.4647727272727273,0.8406242950710563,1.0,24/49,30.66%,MDM4;NDRG1;TIPRL;RAD1;ABL1;ATM;CHEK2;SESN2;CEP63;ATRIP;HUS1;E2F1;BID;USP10;MAD2L2;TRIAP1;DONSON;TP53;ATR;GRB2;INTS7;RAD17;RHNO1;HINFP
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.31460939620106443,-1.0053580093622705,0.4393939393939394,0.736425173290315,1.0,12/25,25.71%,DNM1L;PDCD5;FAM162A;BCL2L11;MFF;GPER1;PYCARD;BIK;PPIF;BNIP3;HRK;PMAIP1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4589218073030399,1.0053525184918701,0.4697173620457604,0.8402776155582112,1.0,7/13,23.05%,IPO5;RGPD1;KPNA2;RANBP2;KPNA3;KPNA4;NUP35
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3656478527032031,-1.0051958417546913,0.4461538461538462,0.7351283075527856,1.0,1/15,0.50%,LEF1
prerank,DNA recombination (GO:0006310),0.3977913965219111,1.0051290127609127,0.48413631022326675,0.8403151541714143,1.0,18/37,31.99%,HMGB1;WRN;RAD50;LIG4;SUPV3L1;TSN;RAD51;XRCC3;RECQL5;FBH1;RTEL1;RPAIN;IGHMBP2;RAD52;RHNO1;MSH2;BLM;ERCC1
prerank,cell cycle G1/S phase transition (GO:0044843),0.37018267710386665,1.0049197251738595,0.47729789590254706,0.8403468809193303,1.0,18/61,21.05%,ACVR1B;ACVR1;E2F3;GSPT1;CUL4A;PHF8;RCC1;CUL1;KHDRBS1;INHBA;CCNE2;LATS2;CDC25A;E2F1;DBF4;CDK2;MAX;BCAT1
prerank,cellular response to radiation (GO:0071478),0.3862167028682633,1.0046415024497108,0.475,0.8405665090043697,1.0,19/40,31.69%,RAD1;SPIDR;SWI5;LIG4;TANK;OPN1MW;OPN1MW3;RHOB;HUS1;RAD51;TNKS1BP1;OPN3;TP53;RRH;GPR52;GRB2;INTS7;RHNO1;BLM
prerank,protein localization to phagophore assembly site (GO:0034497),0.4910813290886556,1.0046240931762207,0.4812239221140473,0.8401198378228496,1.0,5/11,29.80%,PACS2;WIPI2;ATG9A;ATG13;STX17
prerank,intermediate filament organization (GO:0045109),-0.3556111399811912,-1.004614316151185,0.42127659574468085,0.7349977348765879,1.0,6/17,16.84%,DES;VIM;PKP2;KLHL24;DSP;GFAP
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3288689073225872,-1.004422018686228,0.4541284403669725,0.7338836347412635,1.0,4/23,3.97%,CEMIP;BMP7;APP;PRKAG2
prerank,protein oxidation (GO:0018158),0.4853933058165803,1.0043488758143453,0.4957983193277311,0.8403047932476426,1.0,4/11,22.20%,LOXL1;LOX;PRDX3;LOXL2
prerank,cardiac cell development (GO:0055006),0.4865005941279878,1.004096963395128,0.47514619883040937,0.8404705432210502,1.0,3/11,9.62%,VEGFA;JAG1;ALPK3
prerank,mononuclear cell differentiation (GO:1903131),0.42097406057864906,1.0039339535587806,0.47542997542997545,0.8403807288297275,1.0,2/24,0.97%,VEGFA;GAS6
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.28939398851480896,-1.003395372989294,0.4161490683229814,0.7346944614400647,1.0,8/33,10.47%,TGFA;AFAP1L2;CCDC88A;DGKD;HIP1R;ADRA2A;HBEGF;SHKBP1
prerank,negative regulation of neurogenesis (GO:0050768),-0.294713264129915,-1.0029555734749367,0.4656084656084656,0.7341116351822541,1.0,5/34,6.92%,PTN;B2M;RAPGEF2;NOTCH1;ARHGDIA
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.4727454621121384,1.0028233390914485,0.4929378531073446,0.8426886389083944,1.0,6/13,28.74%,TGFBR2;RUNX1;CBFB;GLI3;SOCS1;NKAP
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.2896795897709905,-1.0026974197736362,0.45098039215686275,0.7330783358865517,1.0,13/37,19.72%,BCL2;BCL2L1;DNM1L;NUPR1;BOK;CAV1;RPS7;BCL2L11;STYXL1;EIF5A;RACK1;RPS3;MSX1
prerank,alanine transport (GO:0032328),0.5003419752597857,1.0024821305896086,0.5007173601147776,0.8430888435796337,1.0,3/10,13.62%,SLC7A10;SLC38A3;SLC1A4
prerank,positive regulation of cell cycle process (GO:0090068),0.35710417801639516,1.0022712723284308,0.4779874213836478,0.8431136548402127,1.0,23/91,21.33%,CIT;PRKCE;LRP5;DYNC1H1;CDC14A;GIPC1;CDC6;RHOA;EDN3;PKN2;CDC25B;SPAST;PHIP;RCC2;OPN1MW;CSPP1;SIRT2;USP19;KIF20B;DBF4;XRCC3;NUP62;DRD2
prerank,anion transport (GO:0006820),0.40449744440556845,1.0022657200627363,0.4821002386634845,0.8426420692945313,1.0,6/33,12.01%,SLC26A7;LRRC8D;SLC4A2;SLC26A4;VDAC2;SLC17A5
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.35964125182622,1.0018231362803147,0.48089171974522293,0.8432474967597606,1.0,24/83,21.05%,ACVR1B;ACVR1;BRD4;E2F3;GSPT1;CDC6;CUL4A;PHF8;RCC1;CUL1;KHDRBS1;CDC45;INHBA;CCNE2;TFDP1;LATS2;CDC25A;CDT1;E2F1;DBF4;CDK2;CDK5;MAX;BCAT1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.39737270099653554,1.0013918538383364,0.466903073286052,0.8439336171126995,1.0,6/35,13.08%,MYOC;EPHB2;TGFB2;LZTR1;SCAI;ARHGAP44
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3963339705767831,1.0011578298426194,0.4578313253012048,0.8440054306677558,1.0,7/34,11.76%,ATP1B1;HCN4;CALM2;SLC9A1;ANK2;TNNI3K;SMAD7
prerank,cellular response to osmotic stress (GO:0071470),0.4333818624149477,1.0010286097880605,0.4846547314578005,0.8438447206100469,1.0,4/21,6.67%,YBX3;LRRC8D;SLC4A11;STK39
prerank,negative regulation of transport (GO:0051051),-0.2682705998954313,-1.0009875359392044,0.47706422018348627,0.7357259477838016,1.0,16/51,18.91%,MCTP1;NR1H3;CTTNBP2NL;BST2;DYSF;PACSIN3;NDFIP2;YRDC;PRKD1;SNCA;SIRPA;CRYAB;ERBB3;SYT11;PXK;RACK1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.34306653174799695,1.000974623403601,0.4959839357429719,0.84349937967411,1.0,58/248,16.61%,EGFR;LRP6;CTNND2;TCF7L2;GPC3;COL1A1;SFRP4;PLEKHA4;PRICKLE1;DKK3;PSMD7;TLE2;CSNK1D;WWTR1;PTPRU;UBE2B;VCP;TLE6;PSMA8;DACT1;DVL1;ILK;CCAR2;FZD7;RSPO1;JUP;SOX9;NOG;DACT3;TRPM4;TLE3;PSMA4;FGFR2;CSNK1G1;TPBG;UBR5;AXIN1;INVS;PSMD12;USP34;CSNK1E;HDAC1;PSMA6;WNK1;LIMD1;TNKS2;DAB2;FUZ;PSMD1;PSMC5;LATS2;GSKIP;PSMD11;MLLT3;NPHP3;PSMC4;PSMD14;OTULIN
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4325239665306539,1.0008379985271474,0.4827144686299616,0.8433683101118612,1.0,10/20,30.58%,OGT;RIPK3;STUB1;ASAH1;PDCD6IP;BIRC3;CYLD;RIPK1;HSP90AA1;SPATA2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4273185361412262,1.000794206032623,0.48120300751879697,0.8429836329935506,1.0,14/23,33.91%,MTMR11;SYNJ1;INPP5B;MTMR10;PIP4P2;OCRL;MTMR1;SYNJ2;MTM1;SACM1L;MTMR2;MTMR12;MTMR9;MTMR4
prerank,termination of RNA polymerase II transcription (GO:0006369),0.39716989739573144,1.0007540866600715,0.49761336515513127,0.842600540177332,1.0,12/33,21.76%,SYMPK;MAZ;PABPN1;CLP1;CPSF4;PCF11;NCBP1;CPSF7;NCBP2;CSTF2;CSTF2T;SNRPB
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4149871676686329,1.0007212119299789,0.47766749379652607,0.8421990484383166,1.0,4/27,5.27%,MYOC;ARAP1;TMEFF2;PPFIA1
prerank,dendrite morphogenesis (GO:0048813),0.40280651352658076,1.0006986154082758,0.4700122399020808,0.8417717723747151,1.0,10/35,13.48%,CTNND2;FARP1;EPHB2;ARC;DVL1;EPHB3;DLG4;TMEM106B;SHANK1;MEF2A
prerank,negative regulation of protein ubiquitination (GO:0031397),0.38166681256779794,1.0006145458912112,0.48597081930415265,0.84149096177124,1.0,22/50,29.58%,PRR7;NXN;OGT;ABL1;SMAD7;CHP1;U2AF2;SQSTM1;ARRB1;N4BP1;MINAR1;UFL1;AKT1;DNAJA1;USP4;TAF1;CAMLG;GTPBP4;SVBP;PER2;SPOPL;PRMT3
prerank,positive regulation of bone resorption (GO:0045780),0.4840952874506917,1.000423613354481,0.48911465892597966,0.8414959878471303,1.0,3/11,14.67%,PRKCA;MC4R;PLEKHM1
prerank,cellular protein catabolic process (GO:0044257),0.36928462551264507,1.0003955529685642,0.4938820912124583,0.8410818094374187,1.0,18/59,22.57%,FAP;TCIRG1;AP2A1;CLPP;CAPN2;CHEK2;MYLIP;LONP1;PSMA6;AP2A2;CLTC;IDE;CTSZ;UBE2G2;CLTA;CTSB;CTSK;CTSO
prerank,positive regulation of cellular process (GO:0048522),0.3331160960299464,1.00008970864372,0.508,0.8413523286212751,1.0,115/565,18.74%,THBS1;PGF;EGFR;LRP6;IRS1;ZFHX3;PRKCD;VEGFA;GAS6;LRP1;LBP;FGF2;P4HB;TIAM1;ACER3;NTRK3;PROK2;FGF17;PRR7;GAB2;LRP5;MAPK15;TGFB3;SHC1;HDAC4;PKHD1;LMNA;WWTR1;HES5;CSNK2A1;TGFB2;TCIRG1;DYNC1H1;PRKCA;DNAJA2;EIF4G2;TNFRSF1B;FXN;FAM98A;ADAM10;IL12RB2;TGFBR2;FZD7;MMP14;FGFR1;MEIS3;CXCL16;CAPN10;RARA;S100B;PA2G4;SOX9;TFE3;AKT2;FCER1G;CDC6;TRPM4;EDN3;MAPK8;BMP4;FGFR2;ITGAV;CDC25B;TBRG4;PLA2G5;CDC123;FAM98B;VIP;FOXM1;CTF1;CHTOP;ATM;MAZ;PHIP;SRF;TGFBR1;HDAC1;NCMAP;EIF4G1;F2R;KMT2D;ACACA;NACC1;SUPV3L1;LMAN2;COLEC12;BMP5;CLCF1;PRDX3;CSPP1;STX4;IL6;EXOSC4;SIRT2;SLC35F6;CNOT8;KLHL22;ERBB2;SMC5;FGF5;NCBP1;SSR1;FLCN;GAREM1;UFL1;PRLR;TRIM13;HDGFL2;CITED2;KIF20B;HCFC1;BIRC5;AKT1;OSMR;GDNF
prerank,regulation of establishment of cell polarity (GO:2000114),-0.3562634207166655,-1.0000722595526197,0.46153846153846156,0.7363170371796993,1.0,3/16,1.91%,ROCK2;CDH5;RIPOR2
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.49697231535497166,0.9999099010692075,0.4971671388101983,0.8413392202026748,1.0,2/10,12.92%,LRP1;PTPN2
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.38052323118745685,-0.9999019021904524,0.47470817120622566,0.7351326689860973,1.0,5/13,16.01%,CNOT1;PRR5L;ZC3H12A;ZC3HAV1;GTPBP1
prerank,protein-DNA complex disassembly (GO:0032986),0.4509141415083884,0.9998735449506864,0.4633821571238349,0.8409417622748123,1.0,7/16,29.70%,SMARCC2;NFE2;HMGA1;SMARCA4;ARID1A;SMARCD2;SMARCC1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3420177568801296,0.9992653340172903,0.4944500504540868,0.8419915526950924,1.0,42/186,16.38%,LRP6;TRABD2B;LRP1;TCF7L2;SFRP4;GRB10;PRICKLE1;NXN;DKK3;PSMD7;TLE2;WWTR1;PTPRU;TLE6;PSMA8;DACT1;DVL1;SOX9;NOG;DACT3;TSKU;NFATC1;TLE3;PSMA4;TPBG;AXIN1;INVS;PSMD12;HDAC1;PSMA6;LIMD1;DAB2;FUZ;WIF1;PSMD1;PSMC5;LATS2;PSMD11;MLLT3;NPHP3;PSMC4;PSMD14
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.40185317770211326,-0.9985172477590011,0.4601449275362319,0.7370673353978549,1.0,2/10,2.55%,ZEB2;RAPGEF2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.43200756793525436,0.998450210521106,0.47509578544061304,0.8430499419274574,1.0,1/20,0.21%,SLC4A4
prerank,positive regulation of glycolytic process (GO:0045821),0.43200756793525436,0.998450210521106,0.47509578544061304,0.8430499419274574,1.0,1/20,0.21%,SLC4A4
prerank,response to histamine (GO:0034776),-0.4150929534265809,-0.9983200774559665,0.44660194174757284,0.7359002101737461,1.0,3/10,8.61%,GABRB1;GABRB3;GABRB2
prerank,protein K63-linked ubiquitination (GO:0070534),0.3854063107347007,0.9983170838219765,0.47453703703703703,0.8429099643048927,1.0,19/41,30.07%,NEDD4;UBE2B;RNF115;TRIM27;WWP2;ITCH;TRAF3;STUB1;UBE2V2;TRAF3IP2;HECTD1;RNF4;ZFP91;RNF126;UBE2V1;RNF135;TRAF5;PRKN;UBE2S
prerank,regulation of microtubule depolymerization (GO:0031114),0.41260262026808314,0.9983158282029732,0.4878640776699029,0.8424311007981959,1.0,2/25,1.27%,FGF13;MAP1B
prerank,neuron projection morphogenesis (GO:0048812),0.34266981629483456,0.9982441422876286,0.503061224489796,0.8421182426590489,1.0,24/137,13.48%,DCLK1;CTNND2;SRGAP2;MAP1B;FARP1;CTTN;ANKRD27;EPHB2;ARC;DOCK7;DNM2;DVL1;EPHB3;RAB8A;LLGL1;DLG4;S100B;IMPACT;FGFR2;TMEM106B;SHANK1;NLGN1;LRP2;MEF2A
prerank,cellular transition metal ion homeostasis (GO:0046916),0.35666319407507835,0.9974894280431257,0.47674418604651164,0.8435182924147436,1.0,20/91,17.54%,SCARA5;SLC39A14;FLVCR1;HMOX2;FXN;SLC39A7;SMAD4;ACO1;SLC30A5;SLC39A13;ATP6V0D1;ARF1;SOD1;CUL1;CYBRD1;ABCB6;FRRS1;IREB2;SLC30A9;HMOX1
prerank,steroid catabolic process (GO:0006706),0.49645807371965417,0.9972609952948719,0.5014880952380952,0.8436041999619548,1.0,2/10,14.77%,CYP19A1;CYP27B1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.34149545519940405,0.9972594723670799,0.513622603430878,0.8431305565241957,1.0,34/199,12.28%,EGFR;SRSF6;GAS6;ZNF423;NFIB;NPR3;SMAD6;DOCK7;LDLRAD4;HDAC9;SPRED2;PARP3;TRPV3;LRPAP1;ATF4;ACTN3;FOXC2;ACOT11;PFN2;RPS6KA4;PGAM5;SOX9;TFE3;TLE3;BMP4;FOXA1;IP6K1;PCTP;RAB11FIP5;ABHD6;SMAD7;SRF;HEY1;CIDEA
prerank,error-prone translesion synthesis (GO:0042276),0.4290679632088965,0.9970718890619155,0.465,0.8430859900275096,1.0,7/21,23.63%,REV3L;POLE2;RPS27A;UBC;REV1;MAD2L2;PRIMPOL
prerank,proton transmembrane transport (GO:1902600),-0.2934426747864409,-0.9969325611362263,0.44936708860759494,0.7377610530855232,1.0,1/36,0.01%,ATP1A2
prerank,cellular response to leucine (GO:0071233),0.49753818483085255,0.9967474613189244,0.4765957446808511,0.8428863253247779,1.0,5/10,23.02%,SESN3;SESN2;KLHL22;UBR2;RPTOR
prerank,response to leucine (GO:0043201),0.49753818483085255,0.9967474613189244,0.4765957446808511,0.8428863253247779,1.0,5/10,23.02%,SESN3;SESN2;KLHL22;UBR2;RPTOR
prerank,organic hydroxy compound transport (GO:0015850),-0.28013716896356883,-0.9966952622999897,0.44171779141104295,0.7367220962213779,1.0,4/36,2.34%,ABCC4;SLCO2B1;SLCO1C1;RBP4
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.28836105305588244,-0.9964574575786727,0.4444444444444444,0.7356538361971247,1.0,3/34,1.46%,LYN;MFHAS1;LGR4
prerank,neutrophil degranulation (GO:0043312),0.3326077988122709,0.9962001185019146,0.526,0.8437873291085902,1.0,122/425,28.49%,PRKCD;PYGB;GSN;TIMP2;IGF2R;CRACR2A;PSMD7;ARSB;CEACAM3;ANXA2;TCIRG1;HMOX2;DNAJC13;COPB1;RAB24;DYNC1H1;UBR4;LPCAT1;VCP;STBD1;TNFRSF1B;GAA;LAMTOR1;ATP6V0A1;ADAM10;HMGB1;ARSA;QSOX1;PTGES2;CREG1;CKAP4;FAF2;RNASE3;B4GALT1;JUP;HUWE1;GDI2;PA2G4;CYFIP1;FCER1G;CST3;RHOA;ATP8A1;ITGAV;COMMD9;PLAC8;GHDC;GLIPR1;RAB3D;PSMD12;CAP1;AMPD3;AP2A2;PAFAH1B2;DERA;TOM1;FRK;SNAP23;MLEC;PSMD1;CAT;RAB4B;IQGAP1;NAPRT;PSMD11;STOM;PSMD14;ACP3;ORMDL3;ACTR1B;GLB1;RAB5B;IST1;AOC1;ACTR10;CTSZ;PTAFR;ASAH1;XRCC6;HVCN1;DOK3;SLC27A2;LAIR1;LAMP1;CCT8;CTSB;PSMB1;LAMP2;RAB18;SLC11A1;MAGT1;VNN1;PSMA5;MAN2B1;PYGL;BST1;NRAS;SCAMP1;ROCK1;CDK13;GNS;KCMF1;S100A11;TUBB4B;VPS35L;VAMP2;GUSB;LAMTOR2;ACTR2;CYSTM1;CAND1;CAPN1;PLAUR;LAMTOR3;NPC2;SURF4;CANT1;QPCT;ABCA13;MANBA;ACLY;RAB3A
prerank,regulation of ATP biosynthetic process (GO:2001169),0.44879302252263514,0.9959182997063531,0.48010269576379977,0.8439878622485452,1.0,8/16,28.37%,PID1;VCP;PARP1;FLCN;IL4;PINK1;DNAJC30;SPHK2
prerank,cardiac muscle tissue development (GO:0048738),0.37688364355430365,0.9958778027414572,0.4888143176733781,0.8436007388414678,1.0,11/50,16.74%,CACNA1G;SGCD;HCN4;SMAD4;BMP4;CSRP3;BMPR1A;HEY1;BMP5;AKAP13;KDM6B
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3899503812496555,0.9958645594604116,0.47497089639115253,0.8431560205833816,1.0,7/39,13.17%,EGFR;PTPN3;RNF115;CBL;PTPN18;PTPN2;STAM2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.45827184555852735,0.9953765069247986,0.47319034852546915,0.8438554888120928,1.0,2/13,5.14%,GAS6;MAVS
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.42946955423775285,0.9952498587718162,0.4928104575163399,0.8436835222729268,1.0,6/21,20.11%,SAMD4A;CNOT8;TUT7;CNOT10;CNOT9;TNKS1BP1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4065942916717262,0.9950716408516598,0.4821852731591449,0.8436788056858984,1.0,14/32,30.24%,MAPK15;NEK7;ATM;TNKS2;CCT4;CCT6A;CCT8;MAP2K7;HNRNPA1;TCP1;PNKP;CCT5;ATR;CTNNB1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.41828724308682497,0.9948146806421184,0.47297297297297297,0.8438804064901505,1.0,1/23,0.21%,SLC4A4
prerank,motile cilium assembly (GO:0044458),0.48135536863238926,0.9943395601205725,0.49228611500701264,0.8446042912500841,1.0,3/12,13.29%,DNAAF3;CCDC39;BBS5
prerank,ceramide biosynthetic process (GO:0046513),-0.284850576772426,-0.993790494379952,0.4744525547445255,0.7406139531373169,1.0,6/40,5.40%,ST6GALNAC3;CERS4;SGMS1;ST8SIA4;DEGS2;ST8SIA6
prerank,ncRNA transcription (GO:0098781),0.4677651229890513,0.9937624367942302,0.4828532235939643,0.845509853611746,1.0,10/13,36.13%,USPL1;POLR1G;CAVIN1;GTF3C1;GTF3A;NIFK;RPAP2;SIRT7;BRF1;SNAPC3
prerank,axoneme assembly (GO:0035082),0.39923642082991284,0.9936736707609725,0.48668280871670705,0.8452571861667878,1.0,8/31,22.73%,CFAP206;DNAAF3;CCDC39;LRGUK;TTLL3;SPAG17;TTC12;SPAG16
prerank,establishment of spindle localization (GO:0051293),0.46892982223350044,0.993518502546734,0.4993270524899058,0.8451657791497272,1.0,3/14,7.48%,DYNC1H1;TLE6;LLGL1
prerank,prostanoid metabolic process (GO:0006692),-0.3770027677043965,-0.993486185431634,0.42379182156133827,0.7398095154035533,1.0,5/13,16.50%,PTGS1;HPGD;GSTM1;PTGR2;CYP2S1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4818777964198073,0.9934809882506357,0.48637015781922527,0.8447762499434387,1.0,4/11,15.40%,PTGIS;FAP;CIDEA;SIRT2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.35979210361766767,0.9934759117275531,0.5191256830601093,0.8443132055945217,1.0,33/88,25.44%,VPS13A;EXOC4;VPS13C;DOP1B;AP2A1;GOPC;DNM2;GOLGB1;PUM1;GBF1;MON2;LLGL1;SCFD1;STEAP2;ARF1;BLOC1S3;CLTC;SNAP23;STX4;ARRB1;SCAMP2;NAPA;SH3D19;SCAMP3;CORO7;CLTA;ARFGEF2;CLINT1;SCAMP1;CHMP2A;ACBD3;VPS35L;VAMP2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3033243700001921,-0.9933128307823297,0.48130841121495327,0.7386427556164409,1.0,6/25,12.05%,INSR;SMAD3;KLF2;ASS1;EDN1;DDAH2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4033896056417625,0.992845206540619,0.4924433249370277,0.8453714864804467,1.0,6/27,8.09%,AHNAK;CAMK2D;CALM2;DMD;ANK2;SELENON
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.2814292229584868,-0.9925005820351153,0.5142857142857142,0.7389838527747948,1.0,5/41,5.22%,TJP1;PODXL;GCNT2;BMP7;PIEZO1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.39880182776083134,0.9924996601560663,0.4809976247030879,0.8457195283898089,1.0,4/34,4.72%,PGF;VEGFA;GAS1;RAMP2
prerank,GPI anchor metabolic process (GO:0006505),0.41136533144652654,0.9924335257413708,0.49318463444857497,0.8453976815850551,1.0,12/26,32.31%,PIGW;PIGF;PIGL;PGAP2;DPM3;PIGV;PGAP1;PIGQ;PIGB;PIGN;PIGC;PIGO
prerank,acylglycerol homeostasis (GO:0055090),-0.3331058465615401,-0.9920305345185607,0.4528301886792453,0.7386240058748893,1.0,5/20,11.93%,APOE;NR1H3;PNPLA8;SCARB1;LPL
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4546276214074122,0.9920017150643775,0.4883720930232558,0.8459745067663407,1.0,3/13,14.67%,GLRX5;ISCA2;MMS19
prerank,wound healing (GO:0042060),0.37061179077622036,0.9917920975426371,0.50764192139738,0.8459964691159381,1.0,16/62,17.54%,FGF2;COL3A1;AHNAK2;TGFB2;FZD7;RAF1;NOG;TSKU;DCBLD2;SRF;TGFBR1;MIA3;ERBB2;NF1;SYTL4;HMOX1
prerank,regulation of viral entry into host cell (GO:0046596),0.40028744749620543,0.9915512021515064,0.498159509202454,0.8461016040064552,1.0,5/30,13.94%,GSN;P4HB;TRIM27;MID2;TRIM26
prerank,phosphorylation (GO:0016310),0.33181358435081715,0.9912172773354463,0.531062124248497,0.8464622110781344,1.0,145/385,27.52%,DCLK1;PRKCD;GAS6;NTRK1;MARK1;PRKCE;ACVR1B;EPHB2;CLK3;CSNK1D;CAMK2D;MAP3K5;NADK;STRADA;TNK1;CSNK2A1;TGFB2;STAT3;LIMK2;MORC3;SHPK;FASTK;PRKCA;NRBP2;ACVR1;ILK;NEK7;PRKDC;ERN2;ADAM10;TGFBR2;TLK1;STK39;BCR;FGFR1;IRAK3;CDK10;RPS6KA4;RARA;PAK4;DGKQ;CDK12;GMFB;PKN2;PAK2;ILF3;MAPK8;CDC25B;CHUK;TNNI3K;ABL1;IRAK1;MAP4K5;MAP3K12;ATM;BMPR1A;CHEK2;PDPK1;GRK6;NRBP1;PIK3CB;CSNK1E;TGFBR1;STK25;STK19;PICK1;DMPK;MARK4;WNK1;LIMD1;FRK;SRPK1;TBCK;BRD2;LATS2;CAMK4;CDC42BPB;TLK2;CREB1;COQ8B;ERBB2;TP53RK;HASPIN;PGK1;MKNK2;BIRC6;SIK2;PRKAG1;DAPK3;BCKDK;VRK2;CLK2;BIRC5;CDK20;MAST2;CDKL2;AKT1;HIPK2;CDK2;IKBKE;CDK5;PRKAB1;EIF2AK4;SGK3;MAPK9;GRK4;PRKACA;NEK4;LRRK2;PANK3;JAK1;CAMK1;CDKL3;STK38;EIF2AK3;PRKCI;TOP1;FAM20A;PLK4;TAOK3;TAF1;CSK;TBK1;ROCK1;PINK1;LMTK2;CDK13;TAOK2;TYK2;STK3;STK24;TKFC;PRRT1;TAOK1;NIM1K;WNT11;SGK1;ERN1;CCL2;NEK6;MAP3K11;MEX3B;PNKP;CSNK1A1;PI4KA
prerank,regulation of acute inflammatory response (GO:0002673),0.43410150172775686,0.9909851174568952,0.49493670886075947,0.846542983826522,1.0,4/18,20.97%,IL6;PTGES;OSMR;IL4
prerank,positive regulation of lipid localization (GO:1905954),0.4759724330626117,0.9903719945581481,0.49375866851595007,0.8475244753780113,1.0,1/11,1.02%,LRP1
prerank,neutrophil activation involved in immune response (GO:0002283),0.33067741382244825,0.9902299272925362,0.545,0.847403999590361,1.0,122/428,28.49%,PRKCD;PYGB;GSN;TIMP2;IGF2R;CRACR2A;PSMD7;ARSB;CEACAM3;ANXA2;TCIRG1;HMOX2;DNAJC13;COPB1;RAB24;DYNC1H1;UBR4;LPCAT1;VCP;STBD1;TNFRSF1B;GAA;LAMTOR1;ATP6V0A1;ADAM10;HMGB1;ARSA;QSOX1;PTGES2;CREG1;CKAP4;FAF2;RNASE3;B4GALT1;JUP;HUWE1;GDI2;PA2G4;CYFIP1;FCER1G;CST3;RHOA;ATP8A1;ITGAV;COMMD9;PLAC8;GHDC;GLIPR1;RAB3D;PSMD12;CAP1;AMPD3;AP2A2;PAFAH1B2;DERA;TOM1;FRK;SNAP23;MLEC;PSMD1;CAT;RAB4B;IQGAP1;NAPRT;PSMD11;STOM;PSMD14;ACP3;ORMDL3;ACTR1B;GLB1;RAB5B;IST1;AOC1;ACTR10;CTSZ;PTAFR;ASAH1;XRCC6;HVCN1;DOK3;SLC27A2;LAIR1;LAMP1;CCT8;CTSB;PSMB1;LAMP2;RAB18;SLC11A1;MAGT1;VNN1;PSMA5;MAN2B1;PYGL;BST1;NRAS;SCAMP1;ROCK1;CDK13;GNS;KCMF1;S100A11;TUBB4B;VPS35L;VAMP2;GUSB;LAMTOR2;ACTR2;CYSTM1;CAND1;CAPN1;PLAUR;LAMTOR3;NPC2;SURF4;CANT1;QPCT;ABCA13;MANBA;ACLY;RAB3A
prerank,neutrophil mediated immunity (GO:0002446),0.33035399878097077,0.9898123555089653,0.54,0.8479562819425963,1.0,109/432,25.64%,PRKCD;PYGB;GSN;TIMP2;IGF2R;CRACR2A;PSMD7;ARSB;CEACAM3;ANXA2;TCIRG1;HMOX2;DNAJC13;COPB1;RAB24;DYNC1H1;UBR4;LPCAT1;VCP;STBD1;TNFRSF1B;GAA;LAMTOR1;ATP6V0A1;ADAM10;HMGB1;ARSA;QSOX1;PTGES2;CREG1;CKAP4;FAF2;RNASE3;B4GALT1;JUP;HUWE1;GDI2;PA2G4;CYFIP1;FCER1G;CST3;RHOA;ATP8A1;ITGAV;COMMD9;PLAC8;GHDC;GLIPR1;RAB3D;PSMD12;CAP1;AMPD3;AP2A2;PAFAH1B2;DERA;TOM1;FRK;SNAP23;MLEC;PSMD1;CAT;IL6;RAB4B;IQGAP1;NAPRT;PSMD11;STOM;PSMD14;ACP3;ORMDL3;ACTR1B;GLB1;RAB5B;IST1;AOC1;ACTR10;CTSZ;PTAFR;ASAH1;XRCC6;HVCN1;DOK3;SLC27A2;LAIR1;LAMP1;CCT8;CTSB;PSMB1;LAMP2;RAB18;SLC11A1;MAGT1;VNN1;PSMA5;MAN2B1;PYGL;BST1;NRAS;SCAMP1;ROCK1;CDK13;GNS;KCMF1;S100A11;TUBB4B;VPS35L;VAMP2;GUSB;LAMTOR2
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3406706347216357,-0.9897607724112861,0.49387755102040815,0.7425848698638908,1.0,4/18,7.68%,APOE;ABCG1;TMCC2;NSG1
prerank,negative regulation of cell development (GO:0010721),-0.3100155505456187,-0.989609183859938,0.46311475409836067,0.7413176491700009,1.0,5/25,13.95%,B2M;NOTCH1;RFLNA;RFLNB;IGF1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.41220669429668355,0.9895967162339749,0.49564134495641343,0.8480137779836687,1.0,4/26,8.87%,EFNA5;LRP5;ADCY8;TRPM4
prerank,lipoprotein biosynthetic process (GO:0042158),-0.3889783676711882,-0.9895855455539466,0.44086021505376344,0.7397562077257277,1.0,1/11,1.38%,APOE
prerank,translational termination (GO:0006415),0.34962400667514876,0.9894634962436869,0.5247108307045215,0.8478337189379092,1.0,30/95,28.46%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;GSPT1;MRPS18B;MTRF1L;MRPL39;ABCE1;MRPS14;MRPL35;ETF1;MRPS17;MRPL45;PTCD3;MRPL12;MRPL47;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;TRMT112;MRPL30;MRPL4;MRPL11
prerank,lymphocyte differentiation (GO:0030098),-0.24645029578536803,-0.9888593760710063,0.4782608695652174,0.7399405607648893,1.0,20/68,20.76%,LEPR;CHD7;KIT;VCAM1;KLF6;JAG2;RHOH;IKZF1;HHEX;PIK3CD;ITGA4;LFNG;AXL;CR2;PTPN22;DLL4;ADGRG3;TOX;SOX4;NHEJ1
prerank,negative regulation of viral transcription (GO:0032897),0.4667028573787179,0.9883781566431686,0.5006934812760055,0.8500313325331751,1.0,6/13,19.47%,TRIM27;UBP1;MID2;HEXIM1;TRIM13;LARP7
prerank,oligodendrocyte development (GO:0014003),0.43679832919475614,0.9881392352418008,0.49463806970509383,0.8501159066813885,1.0,3/15,14.28%,HES5;B4GALT5;PLP1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.41327790340082804,0.9880635398796025,0.4980891719745223,0.8498372510227508,1.0,9/25,29.95%,SF3B1;SRRM1;WDR83;SRSF10;TRA2B;GEMIN2;SRSF4;SF3B4;KHSRP
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.26458047308553084,-0.9878015690476335,0.4878048780487805,0.7409022298212357,1.0,19/55,19.03%,BCL2;BCL2L1;WWOX;TPD52L1;DNM1L;FAS;TNFSF12;NUPR1;BOK;CAV1;BCL2L11;STYXL1;TRAF7;GPER1;HYAL2;PML;PYCARD;RACK1;RPS3
prerank,regulation of multicellular organism growth (GO:0040014),0.4505096744535476,0.9876590810000269,0.5054054054054054,0.8503619088822005,1.0,3/15,11.86%,GHR;STAT5A;SOD1
prerank,cellular protein modification process (GO:0006464),0.32838076270538663,0.9876364578403506,0.563,0.8499392221401115,1.0,213/983,18.70%,PLOD2;THBS1;DCLK1;ST3GAL4;ST8SIA2;IGFBP5;CHRDL1;PRKCD;FSTL1;GAS6;COL3A1;GPC3;P4HB;NTRK1;MARK1;PRKCE;PTPN3;FBXO10;PPP1CC;LOXL1;DMP1;ACVR1B;TGM5;TGM6;FBXL7;PSMD7;CLK3;CSNK1D;PARP3;CAMK2D;RAB2A;FBXW8;CEL;MAP3K5;STRADA;PTPRS;PTPRF;PTP4A2;DUSP11;TNK1;PTPRU;CSNK2A1;COP1;TGFB2;DCAF6;LIMK2;MORC3;GGCX;P3H1;FASTK;PRKCA;PSMA8;NRBP2;ACVR1;B3GNT7;PRKCSH;ILK;ERCC8;NEK7;GPAA1;PRKDC;PPM1H;ERN2;ADAM10;TGFBR2;SIRT5;TLK1;STK39;BCR;RAB8A;LOX;QSOX1;FGFR1;IRAK3;CKAP4;WIPI2;CDK10;ARF4;RPS6KA4;GPS1;MBTPS1;NAGPA;RARA;SOCS6;PAK4;PMM2;SOCS2;AKT2;ST3GAL2;CST3;WWP2;PPM1M;B4GALT5;DAPP1;CDK12;PTPN18;GMFB;PPP3CC;PKN2;PAK2;ILF3;CALU;MAPK8;PSMA4;ANXA1;BMP4;CDC25B;CUL4A;NPC1;CHUK;TNNI3K;RIPK3;UCHL3;RAB38;RCN1;FBXL4;ABL1;IRAK1;MAP4K5;MAP3K12;LCMT1;FUT4;ATM;BMPR1A;CHEK2;FBXO22;FBXL12;PDPK1;GRK6;ATG3;PSMD12;NRBP1;WDR5;TULP4;CUL1;CSNK1E;TGFBR1;FBXL19;PSMA6;PPEF2;STK25;RBBP7;B3GNT9;RAB11B;STK19;PICK1;DMPK;MARK4;NUCB1;WNK1;DCAF13;TNKS2;FRK;SRPK1;FBXL14;TBCK;ATE1;BRD2;PSMD1;MIA3;NGLY1;DDA1;UBE2L6;IL6;FBXO17;SIRT2;FBXL20;PSMC5;LATS2;CAMK4;CDC42BPB;TLK2;PSMD11;KLHL22;CREB1;COQ8B;PPP2R5C;B3GNT6;PARP1;ILKAP;ERBB2;TP53RK;PSMC4;PSMD14;VCAN;LIPT1;HASPIN;STT3A;MKNK2;GNMT;BIRC6;NTAQ1;UFL1;SIK2;ALG1;MEN1;PRKAG1;CHST5;DAPK3;ARAF;FBXL18;BCKDK;SUMF2;SENP8;VRK2;CLK2;BIRC5;RNF7;CDK20;MAST2;CDKL2;FBXW2;AKT1
prerank,peptidyl-lysine acetylation (GO:0018394),0.491088800789789,0.9873301849598655,0.5269286754002911,0.8501877390632682,1.0,5/10,26.60%,KAT2A;CREBBP;KAT7;KAT2B;ESCO1
prerank,regulation of lymphocyte activation (GO:0051249),0.4741309641909669,0.9873246515758203,0.5027932960893855,0.8497285012722438,1.0,3/12,12.33%,IKZF3;CRTAM;KAT2A
prerank,positive regulation of protein binding (GO:0032092),0.3696757605588373,0.9865969028307644,0.5083986562150056,0.8510671079500287,1.0,11/56,13.73%,PKD1;LRP1;TCF7L2;TIAM1;DACT1;BMP4;ABL1;NVL;TERT;ADD1;USP33
prerank,positive regulation of actin nucleation (GO:0051127),0.48806571437962687,0.9865900899493428,0.48707482993197276,0.850612319112548,1.0,4/11,21.51%,GSN;CYFIP1;SCIN;ABI2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.31532385303405497,-0.9862632115370658,0.4816753926701571,0.7430574935762817,1.0,5/24,10.39%,ITPR1;RYR2;ITPR3;HTR2C;ITPR2
prerank,protein tetramerization (GO:0051262),0.36130070527357927,0.9859770365953248,0.5206971677559913,0.8516027101912845,1.0,16/67,19.91%,KCNJ2;PKD1;CRYZ;TRPM4;CBR4;ACACA;PKD2L1;SHMT2;GNMT;ACOT13;HSD17B8;CPSF7;CPSF6;SHMT1;TK1;APPL2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.45693631424776604,0.9859763865708443,0.509641873278237,0.8511326512901871,1.0,8/14,32.31%,FUS;WDR48;MMS19;PARP1;ACTR2;WAS;TIMELESS;ERCC6
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.332026964181643,-0.9859387730226622,0.448559670781893,0.7422320850718545,1.0,9/17,29.31%,CXCL12;ANO6;SERPINE1;PLA2G7;CREB3;CCR2;CXCL10;LGMN;CCL5
prerank,regulation of GTPase activity (GO:0043087),0.3349345458799623,0.9853845326984381,0.5399393326592518,0.8520945815082983,1.0,33/177,14.16%,PLXNA4;SGSM2;EFNA5;SRGAP2;ASAP3;ARAP1;NTRK1;RDX;VAV2;CCL13;SIPA1L1;FGD6;CCL15;KLRK1;BCAS3;SNX18;RAB3GAP1;EPHB3;S100A10;RIC1;ADAP1;RGP1;ZC3H15;SNX9;SOD1;RCC2;EVI5L;F2R;ARHGAP44;OCRL;ARL2;WNK1;NDEL1
prerank,positive regulation of organelle assembly (GO:1902117),0.3776895950883623,0.9852009268641433,0.49825783972125437,0.852051046598815,1.0,18/44,27.19%,SDC1;IL5;DYNC1H1;LRSAM1;RAB3GAP1;PIP4K2B;MARK4;G3BP2;FUZ;KCTD17;RAB3GAP2;PDCD6IP;NUP62;PLK4;ARHGAP35;CCP110;TAPT1;PIP4K2C
prerank,positive regulation of chromosome organization (GO:2001252),0.4481324535985277,0.985090782329848,0.5112881806108898,0.8518453121671767,1.0,6/15,29.21%,GNL3;RAD50;LIG4;PPP1R10;RTEL1;DDX11
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.45255491456592517,0.9848065986148872,0.4986979166666667,0.8520297569761589,1.0,3/15,7.40%,ADAM9;EHD1;EHD2
prerank,regulation of interleukin-6 production (GO:0032675),0.35282911767694886,0.9846907344391973,0.5231578947368422,0.8518402487286777,1.0,15/96,15.27%,GAS6;LBP;IL33;TWIST1;RAB7B;STAT3;MAVS;HMGB1;IRAK3;C1QTNF4;HSPD1;F2R;SETD4;IL6;ARRB1
prerank,carboxylic acid catabolic process (GO:0046395),0.4675321332861159,0.9844481935639104,0.5310810810810811,0.8519644388384122,1.0,6/12,31.48%,GNPDA1;RENBP;BCKDK;ACOT8;PON3;NAGK
prerank,negative regulation of DNA recombination (GO:0045910),0.38052010114256773,0.98435880840157,0.5022883295194508,0.8517250682819731,1.0,21/43,32.75%,HELB;PARP3;RMI2;POLR2F;MAD2L2;POLR2B;DAXX;POLR2H;CGAS;ZRANB3;FBH1;RTEL1;SHLD3;SHLD1;POLR2I;POLR2L;PARPBP;MSH2;BLM;POLR2K;POLQ
prerank,ribosomal small subunit biogenesis (GO:0042274),0.3805071462079763,0.9842647694839641,0.4964788732394366,0.851482660644181,1.0,7/39,10.42%,RPSA;LTV1;RRP7A;EMG1;SRFBP1;WDR3;RIOK1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.47357988216862706,0.9840580016619043,0.497134670487106,0.851472634659699,1.0,2/11,6.36%,STAT3;IL12RB2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.42962531969634077,0.9839313415361974,0.5064599483204134,0.8512883560011489,1.0,7/21,20.81%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4641521515642146,0.9837608919723054,0.5134751773049645,0.8512520760827855,1.0,1/13,0.51%,PLXNA4
prerank,central nervous system neuron development (GO:0021954),-0.34780080505717537,-0.9837418183460935,0.49295774647887325,0.7458950953185383,1.0,2/15,2.55%,MAP2;RAPGEF2
prerank,positive regulation of cell migration (GO:0030335),0.3316318535165015,0.9836571494634351,0.5420841683366734,0.8510395684388931,1.0,29/253,8.56%,THBS1;MYOC;EGFR;VEGFA;F3;DDR2;ADAM9;COL1A1;TWIST2;TIAM1;NTRK3;DRD1;PRKCE;RDX;ACVR1B;EPHB2;TGFB2;STAT3;SEMA3E;PRKCA;ACVR1;ADAM10;MMP14;DOCK5;SEMA4B;CXCL16;ELP5;SOX9;AKT2
prerank,positive regulation of JNK cascade (GO:0046330),0.35740076499141105,0.9831160852580898,0.5301204819277109,0.8518969412423085,1.0,11/70,13.67%,RASSF2;SH3RF3;GADD45G;MAP3K5;HMGB1;FZD7;LTBR;AXIN1;CD27;TRAF3;MAP3K10
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.35981456829394437,0.9830281414831142,0.5153172866520788,0.851654692520685,1.0,22/67,23.61%,PSMD7;PSMA8;PSMA4;ITGAV;PDIA3;CHUK;PSMD12;PSMA6;SEC22B;SNAP23;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;CALR;PSMB1;PSMD4;PSMA5;PSMA7;ITGB5
prerank,midbody abscission (GO:0061952),0.44372484089080544,0.9829509893478088,0.5099601593625498,0.8513715949338345,1.0,6/17,24.57%,CHMP3;MITD1;CHMP4A;CHMP4B;PDCD6IP;CHMP2A
prerank,positive regulation of TOR signaling (GO:0032008),0.3804914611061494,0.9825158569192505,0.4988038277511962,0.8519424541127899,1.0,18/40,32.54%,GAS6;SEC13;LAMTOR1;SEH1L;CLEC16A;TELO2;KLHL22;FLCN;GOLPH3;RHEB;RPTOR;SMCR8;LAMTOR2;LAMTOR3;GPR137B;HTR6;HDAC3;PIK3CA
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.355085465877567,0.9823908834118786,0.5405117270788913,0.8517969596947998,1.0,12/76,17.16%,ESR1;CMKLR1;PLCE1;DRD1;FPR3;GPR20;VIP;P2RY6;F2R;GNA11;GPR157;CALCA
prerank,regulation of mast cell degranulation (GO:0043304),-0.351316610868069,-0.9820167943937081,0.4715447154471545,0.7484422287020533,1.0,5/14,13.02%,LYN;CD300A;SYK;CD84;LGALS9
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3490193672440408,-0.9815530534612779,0.4473684210526316,0.7479627010868308,1.0,4/15,12.81%,SAMHD1;USP18;NLRC5;CACTIN
prerank,regulation of DNA repair (GO:0006282),0.37506086217428336,0.9812830097382531,0.5090702947845805,0.8539787772081352,1.0,4/44,6.12%,EGFR;EYA2;TRIM28;ERCC8
prerank,regulation of actin filament bundle assembly (GO:0032231),0.40539217765931046,0.9812648813640391,0.5031055900621118,0.853556631474357,1.0,6/26,11.52%,ASAP3;RDX;PFN2;ALMS1;SLC9A1;SHANK1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4642539881821998,0.9811153996226495,0.508130081300813,0.8534372782002277,1.0,4/13,21.00%,GAB2;STX4;IL4;LAMP1
prerank,positive regulation of viral life cycle (GO:1903902),0.41413130019095623,0.9809350529148386,0.4873417721518987,0.8533940064360419,1.0,7/22,28.34%,P4HB;KPNA2;CHMP3;CHMP2A;VPS37B;KPNA6;DDB1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.30725293160859063,-0.9805627378881246,0.43317972350230416,0.7487051053731311,1.0,7/27,10.31%,PLTP;APOE;PTCH1;NR1H3;ABCA5;CAV1;EEPD1
prerank,regulation of chemotaxis (GO:0050920),0.3982932030615813,0.9805054012265185,0.5060532687651331,0.8539236467153396,1.0,1/30,0.08%,THBS1
prerank,regulation of immune response (GO:0050776),0.34220652675192975,0.9804876713937758,0.5348360655737705,0.8535008205972964,1.0,24/135,21.30%,FOXP1;COL3A1;COL1A2;COL1A1;SPN;TGFB2;CD3E;KLRK1;NPDC1;RAET1E;CRTAM;RIPK3;TRAF3;LAG3;COLEC12;N4BP1;DENND1B;ADCY7;CLEC2D;APPL2;APPL1;LAIR1;IL4;CD300LB
prerank,fat cell differentiation (GO:0045444),0.36488761905402844,0.9803315850881793,0.5193798449612403,0.8534019435516531,1.0,5/57,8.56%,PID1;TCF7L2;SMAD6;BBS9;AKT2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.46618629900289543,0.9802156519896196,0.5085714285714286,0.8532175774003034,1.0,5/12,22.07%,B3GNT7;B3GNT9;B4GAT1;B3GNT6;B3GNT2
prerank,cytoskeleton organization (GO:0007010),0.34019056110435253,0.9801798486979526,0.5278925619834711,0.8528334319066527,1.0,13/114,9.03%,MICAL2;RHOBTB1;PLCE1;FMNL2;MARK1;RND3;ARC;CCL13;FGD6;BRWD1;PAK4;PALLD;RHOA
prerank,keratan sulfate catabolic process (GO:0042340),-0.38928756560351796,-0.9798812654494917,0.4738562091503268,0.7487954187069171,1.0,3/11,9.19%,FMOD;LUM;OGN
prerank,positive regulation of cellular respiration (GO:1901857),0.4741574066895276,0.9798000677506747,0.5,0.8533167262775964,1.0,5/11,24.52%,VCP;IFNLR1;IL4;ISCU;PINK1
prerank,cellular response to insulin stimulus (GO:0032869),0.3413387105074584,0.9795270039814021,0.5300207039337475,0.8535055631612442,1.0,26/124,16.22%,IRS1;SLC39A14;GRB10;RHOQ;ATP6V1C2;SHC1;HDAC9;TCIRG1;C2CD5;FOXC2;ATP6V0A1;PRKDC;RAB8A;CAPN10;AKT2;ZNF106;SYAP1;ATP6V0D1;PDPK1;PHIP;PTPN2;ATP6V1B2;ATP6V1E1;SOS1;IDE;PARP1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3556187705803401,0.9794665992026808,0.5284810126582279,0.8531877162731281,1.0,13/85,13.61%,PIEZO2;COL11A1;COL1A1;LRTOMT;LHFPL5;CDC14A;CHRNB2;TIMM9;ROR1;SLC26A4;SOD1;LRP2;GSDME
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.334287902653672,-0.9788465975589851,0.497737556561086,0.7497306455587534,1.0,6/18,14.42%,VCAM1;JAM2;SLC39A8;CX3CR1;ITGA4;GCNT1
prerank,response to insulin (GO:0032868),0.35522295964916434,0.978510108599763,0.5240128068303095,0.8550032175810565,1.0,12/80,9.74%,IRS1;SLC39A14;RHOQ;HDAC9;C2CD5;MEAK7;PRKDC;RAB8A;CAPN10;AKT2;OGT;SYAP1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.3341417936636333,-0.9781725966888485,0.45934959349593496,0.7499181496805383,1.0,2/18,1.64%,BCL2;BCL2L1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3753146153026202,0.9777199359640694,0.5227790432801822,0.8564434054750317,1.0,18/50,27.30%,PSMD7;PSMA8;PSMA4;PSMD12;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;AZIN1;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;PSMC1;PSMA1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3274340993806766,-0.9777152236504417,0.488,0.7494622088460116,1.0,3/18,6.98%,PTN;ELAVL1;CNOT1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4722205685045318,0.9770268891458331,0.5330459770114943,0.8576023120090873,1.0,7/12,27.68%,GNL3;CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.3971549193647004,-0.9767225842084205,0.459546925566343,0.7502972621948271,1.0,3/10,10.27%,CACNB2;CACNA2D1;PDE4B
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3908124614030432,0.9766895409041831,0.5379901960784313,0.8579316003681753,1.0,14/33,30.51%,PPP6R3;TERT;TELO2;RAD50;DCLRE1B;RAD51;CDK2;TNKS1BP1;ANKRD28;DKC1;RTEL1;NOP10;HSP90AA1;CTC1
prerank,regulation of cell communication (GO:0010646),0.3869852004997483,0.9766159983860424,0.5137724550898204,0.857638247301211,1.0,7/35,11.94%,MGLL;CAMK2D;ANK2;SOCS2;ANXA1;GRK6;NCLN
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.45863898054140784,0.9763523024787183,0.5407303370786517,0.8573115471466125,1.0,3/13,4.20%,SHC1;STAT5A;STAT3
prerank,cellular response to interleukin-15 (GO:0071350),0.45863898054140784,0.9763523024787183,0.5407303370786517,0.8573115471466125,1.0,3/13,4.20%,SHC1;STAT5A;STAT3
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4710617212504934,0.9762314695563166,0.514324693042292,0.8571181319334046,1.0,8/12,34.22%,ACO1;IREB2;IDH3B;ACLY;IDH3G;IDH2;IDH1;GLUD1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.35754732740452694,-0.9761330805545244,0.47520661157024796,0.7501268635232851,1.0,6/17,14.89%,SLC7A5;SYK;PRKCQ;HAVCR2;LGALS9;PRKCZ
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4462013351112846,0.9759756300060026,0.513262599469496,0.8572540674033585,1.0,7/16,28.67%,NAA60;NAA40;NAA16;CREBBP;KAT2B;NAA15;NAA25
prerank,regulation of protein neddylation (GO:2000434),0.48959560442319916,0.9756907897235744,0.5319148936170213,0.8574185308359141,1.0,2/10,12.60%,DCUN1D5;DCUN1D2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.33752032958858763,0.9753458205004573,0.5410677618069816,0.8577931710916884,1.0,39/132,24.47%,SLC4A4;IRS1;PRKCD;ADAM9;RDX;TWIST1;TNFRSF1B;DACT1;HMGB1;TRIM27;AKT2;ITCH;SNX9;MID2;EZR;PIK3CB;SUPV3L1;TRIM65;FOXO3;CNOT8;ORMDL3;FLCN;UFL1;VPS11;SH3D19;TRIM6;MLXIPL;ATF6;DAGLB;OPTN;LRRK2;UPF1;ABCD1;TRIM8;PFKFB4;NPRL2;ENTPD5;BAD;ROCK1
prerank,peptidyl-amino acid modification (GO:0018193),0.4803845219802646,0.9750891380200757,0.5232558139534884,0.8579258157274943,1.0,6/10,34.33%,FKBP10;METAP1D;METAP2;ATP7A;METAP1;FKBP7
prerank,secretory granule organization (GO:0033363),0.4851802400681178,0.9750251845876119,0.5161290322580645,0.8576105131339156,1.0,4/10,13.71%,BLOC1S2;F2R;BLOC1S3;ABCA1
prerank,negative regulation of receptor internalization (GO:0002091),0.45431806258752655,0.9748113869439867,0.5183098591549296,0.857647554256545,1.0,4/12,21.61%,LRPAP1;DLG4;WDR54;ATXN2
prerank,microvillus organization (GO:0032528),-0.3675120371381216,-0.9746856067412583,0.5,0.7520923039974732,1.0,3/13,2.55%,MAP4K4;TNIK;RAPGEF2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4547653823046007,0.9746492659223148,0.49514563106796117,0.857561529468866,1.0,5/13,22.07%,B3GNT7;B3GNT9;B4GAT1;B3GNT6;B3GNT2
prerank,DNA double-strand break processing (GO:0000729),0.43455484612271933,0.9745784557839441,0.5375647668393783,0.8572631162080561,1.0,10/18,31.69%,RBBP8;ATM;RAD50;UBE2V2;SMARCAD1;RNF138;SLX4;RAD52;UBE2N;BLM
prerank,post-translational protein modification (GO:0043687),0.33048212192859866,0.9744616891926924,0.5865865865865866,0.857070131731978,1.0,113/332,29.04%,IGFBP5;CHRDL1;FSTL1;GAS6;GPC3;P4HB;FBXO10;DMP1;FBXL7;PSMD7;RAB2A;FBXW8;PTP4A2;COP1;DCAF6;PSMA8;PRKCSH;ERCC8;ADAM10;RAB8A;QSOX1;CKAP4;GPS1;MBTPS1;SOCS6;SOCS2;CST3;CALU;PSMA4;BMP4;CUL4A;UCHL3;RAB38;RCN1;FBXL4;FBXO22;FBXL12;PSMD12;WDR5;TULP4;CUL1;FBXL19;PSMA6;RBBP7;RAB11B;NUCB1;DCAF13;FBXL14;PSMD1;MIA3;DDA1;IL6;FBXO17;FBXL20;PSMC5;PSMD11;KLHL22;PSMC4;PSMD14;VCAN;STT3A;MEN1;FBXL18;SUMF2;SENP8;RNF7;FBXW2;ASB5;FBXW4;APLP2;PSMA3;DCAF11;PENK;PSMB1;PSMD4;RAB1A;COPS4;CUL9;UBA3;ASB6;RAB1B;PSMA5;FBXO11;PSMA7;VGF;COPS7A;FBXO9;ANKRD9;PSMC1;CCDC8;CUL7;COPS3;RAB5A;DCAF5;FBXW10;ESCO1;DCAF4;RABGGTB;SDC2;DCAF17;CAND1;PSMA1;SCG2;KCTD7;DDB1;STT3B;RAB3A;FBXL8;FBXO41;RBX1;BTRC;ANO8;WDTC1
prerank,aerobic electron transport chain (GO:0019646),-0.2465811793976344,-0.9742105136309352,0.5056179775280899,0.7516699592579055,1.0,21/68,24.19%,COX8A;COX6C;NDUFC2;COX4I1;CYC1;UQCRC2;UQCR11;COX10;NDUFA13;NDUFB2;UQCRB;NDUFAF1;NDUFB7;COX5B;UQCRC1;NDUFS1;NDUFA8;NDUFB11;UQCRQ;NDUFS6;NDUFA4
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3742496796064825,0.9741170339463732,0.5264937993235626,0.8574144497739162,1.0,11/45,18.91%,EGFR;PLCE1;SHC1;SOX9;CBL;PDPK1;SOS1;IQGAP1;GAREM1;AKT1;ERBIN
prerank,cellular response to growth factor stimulus (GO:0071363),0.33900085252206813,0.9739541269905573,0.5603271983640081,0.8573206612265406,1.0,32/151,15.54%,EGFR;TMEM100;VEGFA;SMAD9;NTRK3;NTRK1;EHD1;ACVR1B;SHC1;GAS1;KIDINS220;PDE3A;RAMP2;ACVR1;SMAD4;TGFBR2;SOX9;ANXA1;BMP4;SYAP1;RUNX2;URI1;BMPR1A;PDPK1;SMAD7;NRP1;TGFBR1;LRP2;NDNF;HGF;SIRT2;IQGAP1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3158902093756516,-0.9738668522960253,0.4472573839662447,0.7509624638178813,1.0,8/21,21.03%,ITGA1;PDGFRB;CD300A;PLEK;BMP2;PTPA;PPP1R15B;PPP1R15A
prerank,regulation of stress fiber assembly (GO:0051492),0.3510577785195707,0.9734391393861354,0.5371367061356297,0.8580578415654844,1.0,16/74,12.61%,MYOC;ASAP3;ARAP1;TMEFF2;TGFB3;SORBS3;PPFIA1;S100A10;PFN2;ALMS1;SLC9A1;RHOA;PAK2;ABL1;NRP1;TGFBR1
prerank,regulation of cell cycle process (GO:0010564),0.33988412399969126,0.9734346871751979,0.53099173553719,0.8576007675311533,1.0,33/104,27.36%,KIF13A;CSNK2A2;CSNK2A1;DYNC1H1;CALM2;HORMAD1;RMI2;MAD1L1;SOX9;RCC1;GIT1;MARK4;SND1;USP19;CALM3;BIRC6;FLCN;E4F1;DAPK3;KIF20B;DBF4;CUL9;SETD2;UVRAG;TXLNG;PLK4;RAB11FIP4;CDK13;CCP110;CCDC8;CUL7;ATF5;AHCTF1
prerank,pseudouridine synthesis (GO:0001522),0.45722208371991496,0.9733342405486314,0.5312066574202496,0.8573575929106901,1.0,8/13,34.70%,PUS3;TRUB1;PUS1;PUS10;DKC1;NOP10;PUS7;PUS7L
prerank,translational elongation (GO:0006414),0.3433416423521561,0.9729489893268389,0.5359749739311783,0.8577867862660107,1.0,49/101,37.69%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;MRPS18B;MRPL39;MRPS14;EEF1G;MRPL35;LTN1;MRPS17;EEF2K;EEF1B2;MRPL45;TUFM;EEFSEC;PTCD3;MRPL12;MRPL47;GTPBP2;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;MRPL28;MRPL24;MRPS10;CHCHD1;MRPS31;EEF1D;MRPL15;MRPS33;MRPL50;AURKAIP1;MRPL41;MRPL14;MRPL32;MRPL38;MRPL46;MRPL2;NEMF
prerank,regulation of small molecule metabolic process (GO:0062012),-0.2938417653189269,-0.9729486301378503,0.4846938775510204,0.7516937900446652,1.0,5/28,7.50%,APOE;PDK1;PPARA;FMO5;ADIPOR1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4469379690614144,0.9727618761558487,0.5163487738419619,0.8577564116672758,1.0,5/14,27.98%,ETNK1;ETNPPL;CHKB;PCYT2;SELENOI
prerank,glial cell differentiation (GO:0010001),0.40515687072696654,0.9726991252168372,0.5289855072463768,0.8574695394406554,1.0,9/28,23.14%,NFIB;HES5;STAT3;SOX9;PICK1;GPR157;CDK5;GPC1;SOX8
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.3033508356094056,-0.9726493774299769,0.48554913294797686,0.7508761832716924,1.0,3/24,2.56%,AUTS2;OCLN;PIK3R1
prerank,protein N-linked glycosylation (GO:0006487),0.35807171916406416,0.9719758368499634,0.5341278439869989,0.8586880730822077,1.0,23/66,25.48%,PGM3;GFPT1;B4GALT1;GFPT2;PMM2;MGAT4B;UGGT2;ALG13;FUT8;DOLPP1;UGGT1;TMEM165;STT3A;ALG1;ALG3;DPM3;LMAN1;ALG14;MAGT1;B4GALT7;ENTPD5;ALG12;MGAT5
prerank,growth hormone receptor signaling pathway (GO:0060396),0.4516346778993661,0.9718552150662771,0.5160839160839161,0.8585039383169287,1.0,4/14,8.51%,GHR;STAT5A;STAT3;SOCS2
prerank,regulation of aerobic respiration (GO:1903715),0.44218264308185207,0.9715959729610801,0.5217948717948718,0.8586875655972297,1.0,8/15,27.36%,ACTN3;VCP;IDE;SHMT2;ABCD1;COX7A2L;PINK1;NOP53
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.39134855965492665,-0.9714814564091391,0.48184818481848185,0.7522281002513159,1.0,3/10,3.71%,SOX5;ZBTB16;SOX6
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.3916017298167234,-0.9713433566250673,0.47335423197492166,0.7510050830303089,1.0,3/10,5.22%,PODXL;DPP4;PIEZO1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.35944700580023153,0.9712117077630675,0.5229050279329609,0.8591510712849011,1.0,12/56,22.12%,LBP;HMGB1;ALPK1;IRAK1;TAB2;TRAF3;S100A1;RPS27A;UBC;CTSB;TLR1;CTSK
prerank,regulation of establishment of protein localization (GO:0070201),0.45422919474937984,0.9711346327251741,0.523943661971831,0.8588695727289181,1.0,5/14,24.21%,SCFD1;SPIDR;GAPVD1;DNAJA1;PTP4A3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4747604701647916,0.970997038359084,0.5164520743919886,0.8587349512298457,1.0,1/10,0.78%,VEGFA
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4086227200874678,0.970927071494039,0.5107731305449936,0.8584320582357978,1.0,12/22,35.53%,ATF4;PHF8;ERBB2;EIF2AK3;WDR75;SMARCA4;UBTF;PWP1;DDX11;NCL;LYAR;UTP15
prerank,regulation of gluconeogenesis (GO:0006111),0.40064407264512236,0.9709176128878387,0.5232974910394266,0.8579942957894197,1.0,8/27,18.34%,DGKQ;OGT;NNMT;PTPN2;USP7;ARPP19;GNMT;CLK2
prerank,amide transport (GO:0042886),0.40102059841499704,0.9708530198622023,0.5012406947890818,0.857681444301479,1.0,3/26,7.03%,SLC5A6;SLC25A32;DISP1
prerank,cellular response to organic cyclic compound (GO:0071407),0.3369472668826673,0.9707660689360256,0.5666327568667345,0.8574233756390712,1.0,19/141,12.31%,ESR1;EGFR;IGFBP5;DRD1;HCN4;SLC26A6;CYP1B1;PDE3A;ADCY2;ADCY8;JUP;NRIP1;IMPACT;RORA;SPIDR;URI1;P2RY6;EZR;AKAP9
prerank,cellular response to oxygen levels (GO:0071453),0.4782915886449847,0.9705220172054653,0.5230352303523035,0.8575219668388085,1.0,2/10,13.74%,ATP6V0D1;PICK1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.39570126328351063,-0.9703888155202083,0.4791666666666667,0.7516603370755497,1.0,2/10,2.19%,VTN;PRKCB
prerank,regulation of potassium ion transport (GO:0043266),0.39131780986485104,0.9702524671536502,0.5191846522781774,0.8576641764629619,1.0,7/31,10.43%,FHL1;DRD1;KCNE5;ANK2;KCNIP2;DLG1;VIP
prerank,regulation of chondrocyte differentiation (GO:0032330),0.40408130614265536,0.9702053278822383,0.5229813664596273,0.8573153999661411,1.0,6/24,14.92%,PKDCC;WNT9A;MBOAT2;SOX9;TGFBR1;SCIN
prerank,regulation of actin filament-based movement (GO:1903115),-0.3954292818774616,-0.9699793586653324,0.47266881028938906,0.7511265735986655,1.0,5/10,23.28%,PDE4D;PDE4B;SCN5A;STC1;SRI
prerank,positive regulation of metabolic process (GO:0009893),0.34088823767113147,0.9697277540315663,0.5417536534446764,0.8579662487960311,1.0,11/103,9.02%,GNAS;CMKLR1;VEGFA;GADD45G;GRB10;PEMT;DYNC1H1;ALMS1;EHMT1;ADIPOR2;OGT
prerank,neuron cell-cell adhesion (GO:0007158),-0.3602890898317025,-0.9696766163324554,0.48134328358208955,0.7502953522630581,1.0,6/14,15.18%,NRXN1;ASTN2;NCAM2;CNTN4;NRXN3;ASTN1
prerank,phospholipid translocation (GO:0045332),0.3924251037872724,0.9692771606784512,0.5251533742331288,0.8585610348238022,1.0,7/28,15.86%,TMEM30B;ABCC1;ATP8B2;ATP8A1;ATP9A;ABCA1;PLSCR3
prerank,negative regulation of response to wounding (GO:1903035),0.41953675733933493,0.9692162238190054,0.512853470437018,0.858246391432232,1.0,5/19,19.12%,FGF2;PTPRS;GIT1;CD109;CRK
prerank,regulation of transport (GO:0051049),-0.2818924157512729,-0.9687499636324501,0.4966442953020134,0.7510301532348423,1.0,4/36,2.87%,LEPR;EPB41;ICA1;MYO6
prerank,regulation of primary metabolic process (GO:0080090),0.3411902091193361,0.968717301729653,0.5729166666666666,0.8589685542663397,1.0,35/126,23.76%,ID2;TNFAIP8L3;CHD9;NCOR2;PSMD7;RXRA;PSMA8;PLPP1;CARM1;PSMA4;SREBF1;PSMD12;NR1D2;PSMA6;ACACA;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;SIN3B;AZIN1;NFYA;LSS;PRKAB1;PSMA3;SC5D;GPS2;PSMB1;PSMD4;LDLR;PSMA5;PSMA7;TM6SF2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4140499535491872,0.9686373150423494,0.5254658385093167,0.8586938927594864,1.0,7/22,21.83%,MDFIC;GDI1;CHP1;RAB23;SUFU;LRRK2;LMAN1
prerank,glucose homeostasis (GO:0042593),0.3470843148757189,0.9685028534865712,0.5584415584415584,0.8585252389640295,1.0,10/83,8.58%,IRS1;KCNB1;TCF7L2;STAT3;ADCY8;LRRC8D;MCU;BACE2;ADIPOR2;FOXK1
prerank,regulation of myelination (GO:0031641),0.4032579284447474,0.9684916535681175,0.5195121951219512,0.8580902314395031,1.0,7/25,15.95%,LGI4;HES5;TMEM98;TNFRSF1B;NCMAP;SIRT2;NKX6-2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.47431430968527916,0.9684522873509988,0.5242718446601942,0.8577119381878971,1.0,4/11,9.71%,LRP5;TGFBR2;SOX9;FGFR2
prerank,positive regulation of catalytic activity (GO:0043085),0.38188867373030794,0.9681187916752533,0.5338078291814946,0.8580389201752033,1.0,9/37,15.16%,BCAS3;FXN;MAPK8;WRN;ABL1;CHTOP;SOD1;PSEN2;STX4
prerank,regulation of intracellular signal transduction (GO:1902531),0.3237583429707855,0.9677744807523523,0.626,0.8584037203935501,1.0,108/420,20.98%,MYOC;RASSF2;EGFR;CMKLR1;RHOJ;VEGFA;SRGAP3;SRGAP2;TIAM1;ARAP1;NTRK3;RHOQ;NTRK1;TIAM2;TCP11;FSHR;VAV2;PRDM11;PKHD1;ARHGAP17;CSNK2A2;CSNK2A1;KMT5A;RRS1;CHD3;USP2;RMI2;MOB3B;BCR;RHOT2;MDM4;EHMT1;ARHGAP21;PAK4;CASTOR2;DLG1;KALRN;RHOA;RHOT1;RBBP8;RAD1;PAK2;ITGAV;WRN;ING5;PIP4K2B;INPP5B;MYO9A;ARHGAP20;ULK4;ATM;TELO2;CHEK2;PDPK1;TAF15;TAF6;ARHGAP8;EZR;RAD50;TRAF3;HDAC1;TAF13;NLGN1;ARHGAP44;OCRL;RBBP7;USP7;SOS2;SQSTM1;ARHGEF1;TMEM127;TBCK;RHOB;AKAP13;SOS1;WDR54;PIP5K1A;ATRIP;TTC5;TAGAP;PPP2R5C;TRIO;TP53RK;HUS1;SSRP1;NGEF;FLCN;UFL1;BOP1;PRKAG1;ARAF;TRIM6;VRK2;AKT1;HIPK2;CRK;CDK2;NFKBIA;WWC2;TAF9B;CDK5;PRKAB1;NOC2L;MAPKAP1;DEPDC1B;RCN3;OPTN;PRKAR2A
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3467319551146453,0.9676718154381888,0.5462274176408076,0.8582112990861652,1.0,24/87,22.06%,FGF2;FGF17;HNRNPH1;SPRED2;RBFOX2;FGFR1;CBL;FGFR2;GTF2F1;FLRT2;SHOC2;HNRNPM;PTBP1;TIAL1;NDNF;POLR2F;GALNT3;FGF5;NCBP1;NCBP2;FGF18;FGFR3;HNRNPA1;POLR2B
prerank,phospholipid homeostasis (GO:0055091),0.4625760963332394,0.9671662742224498,0.5240793201133145,0.8589346405424749,1.0,5/11,26.43%,TLCD2;ABCA1;TLCD1;RCN3;ANGPTL3
prerank,membrane lipid metabolic process (GO:0006643),-0.30747978270971654,-0.9670901666497828,0.5144230769230769,0.7536386723429026,1.0,5/22,9.47%,ST3GAL6;CERK;SERINC1;GAL3ST1;SPHK1
prerank,regulation of telomerase activity (GO:0051972),0.37294866201807503,0.9669658905971132,0.5114155251141552,0.8589427266585612,1.0,16/45,30.44%,MAPK15;NEK7;SMG6;ERCC4;NVL;ATM;MEN1;CCT4;MAP2K7;TCP1;TP53;PARP4;DKC1;PNKP;CTNNB1;HSP90AA1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.46481886476525547,0.9669506730932156,0.507628294036061,0.8585170512791251,1.0,3/12,8.29%,HES5;JAG1;ESRRB
prerank,membrane raft organization (GO:0031579),0.4347713524337669,0.9667797688688345,0.5351351351351351,0.8584767117144925,1.0,3/15,9.93%,ANXA2;S100A10;NPC1
prerank,ephrin receptor signaling pathway (GO:0048013),0.3457033899772042,0.9666693011783577,0.5573593073593074,0.8582773651708038,1.0,12/82,9.03%,EFNA5;ARHGEF28;TIAM1;VAV2;EPHB2;SIPA1L1;ARPC1B;AP2A1;EPHB3;EPHB6;KALRN;RHOA
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.3681477032466671,0.9661052492698236,0.5535512965050733,0.8591445131029629,1.0,17/53,23.58%,PSMD7;PSMA8;PSMA4;PSMD12;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;AZIN1;BCKDK;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3463179275850964,0.9660056095004222,0.5535524920466596,0.8589334111553124,1.0,8/87,4.61%,PRKCD;RHOBTB1;EFNA5;LRP1;RHOQ;RND3;ARHGAP17;SEMA3E
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.39479565147406626,0.9657473520746392,0.51278928136419,0.8590680875087344,1.0,13/29,34.14%,NT5C3B;PATL1;LSM2;EXOSC4;CNOT8;DIS3;DCP1A;LSM5;EDC4;EXOSC2;DCPS;EXOSC3;CNOT6
prerank,microvillus assembly (GO:0030033),-0.3565709436332528,-0.9657341889331269,0.518796992481203,0.7553808018829075,1.0,3/14,2.55%,MAP4K4;TNIK;RAPGEF2
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3546868817317675,0.9656907588427022,0.5394594594594595,0.8587407201549367,1.0,20/64,27.56%,MGLL;PLA2G4A;CYP1B1;ELOVL5;DAGLA;FADS1;ACAD9;ACSL3;PNPLA3;HACL1;ACSL6;ACSBG1;SLC27A2;DAGLB;ABCD1;ACOT8;FAAH;ALOXE3;ELOVL1;SLC27A3
prerank,regulation of NMDA receptor activity (GO:2000310),-0.28460632963105836,-0.9652770993678835,0.5314285714285715,0.7549013991300314,1.0,11/32,14.19%,ACTN2;APP;GRIA1;SLC6A9;GRIN2B;GRIA4;OPRM1;GRIN2A;GRIA3;RELN;GRIN1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3934815033248494,0.9652484627940612,0.5304659498207885,0.8592895815696441,1.0,13/31,32.07%,TOPORS;DCUN1D5;UBE2C;AXIN1;DCUN1D2;CDC20;RAB1A;PINK1;GOLGA2;BTRC;UBE2S;UBE2N;GORASP1
prerank,anterograde axonal transport (GO:0008089),0.3786921724948668,0.9652177225829537,0.5357142857142857,0.858904503875185,1.0,11/37,22.21%,DLG2;RAB21;BLOC1S2;SPAST;AP3D1;SOD1;BLOC1S3;SNAPIN;KIF1B;MAPK8IP3;NEFL
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4276370654244006,0.9651792462126644,0.5053333333333333,0.858537733074525,1.0,4/16,11.28%,ZFPM2;FGF2;FGFR2;BMPR1A
prerank,cardiac muscle cell differentiation (GO:0055007),0.41405595723972355,0.9649801366399802,0.525065963060686,0.8585533484869768,1.0,5/21,16.74%,VEGFA;ACVR1;ALPK3;AKAP13;KDM6B
prerank,cilium movement (GO:0003341),0.36673739447237513,0.9646424265390926,0.5443181818181818,0.8588702823123671,1.0,12/48,24.63%,CFAP251;CFAP206;ODAD2;CCDC39;ROPN1L;DNAAF4;TEKT2;TTC29;CFAP73;SPAG17;CAMSAP3;DNAAF5
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.41227416358630536,0.9646339506037362,0.5203562340966921,0.8584436657827883,1.0,5/22,14.30%,DDX5;SPRED2;CDK5RAP3;ATM;HEXIM1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.32931823002590144,0.9645411512907617,0.5799595141700404,0.8581919109754544,1.0,37/182,18.31%,ESR1;FOXP1;ID2;VEGFA;FGF2;SLC24A3;EMILIN1;ANXA7;LRPAP1;TGFB2;CD3E;XDH;ADAM10;DLG4;DGKQ;WWP2;BMP4;AGO1;TERT;BMPR1A;KDM4A;PTRH2;HDAC1;AGO2;SMO;SETDB1;ERP29;RUNX1;ZNF148;VDR;WDR54;RBL2;SLC2A10;FLCN;CITED2;TRIM6;TRAT1
prerank,positive regulation of histone acetylation (GO:0035066),0.4132530890154148,0.9642440896155576,0.5148883374689827,0.8584213741738436,1.0,4/23,7.76%,MUC1;SMAD4;TADA2A;RPS6KA4
prerank,negative regulation of TOR signaling (GO:0032007),0.38659169565875035,0.9641674413301135,0.5227817745803357,0.8581441826205645,1.0,14/36,23.77%,NPRL3;SESN3;CASTOR2;AKT1S1;ATM;DEPTOR;SESN2;TMEM127;MINAR1;FLCN;UBR2;KPTN;TSC2;NPRL2
prerank,negative regulation of T cell proliferation (GO:0042130),0.4024997697075834,0.963688719116141,0.5144927536231884,0.8588276486156513,1.0,5/28,13.12%,SPN;GLMN;CRTAM;VTCN1;CD80
prerank,regulation of platelet aggregation (GO:0090330),0.43115267993681144,0.9626227719410321,0.5312916111850865,0.860848744535026,1.0,4/17,6.02%,PRKCD;C1QTNF1;PRKCA;CD9
prerank,regulation of lipid metabolic process (GO:0019216),0.3423885912035828,0.9618617730974559,0.5590717299578059,0.8620833569994074,1.0,15/88,17.15%,ID2;TNFAIP8L3;CHD9;NCOR2;RXRA;PLPP1;CARM1;RORA;SREBF1;NR1D2;ACACA;CREBBP;SIN3B;NFYA;LSS
prerank,cellular response to cadmium ion (GO:0071276),0.4070357356937442,0.960870217157991,0.5314861460957179,0.8638989952181106,1.0,9/24,27.84%,EGFR;MAPK8;CHUK;SUMO1;AKT1;MAPK9;FOS;DAXX;HSF1
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.32634177926068375,-0.9608353048667033,0.5321888412017167,0.7640676696336071,1.0,7/18,15.10%,LTBP1;SMAD3;CD200;FN1;LGALS9;CD34;ITGB8
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.43682141291049315,0.9606374188456233,0.5316622691292876,0.8639771315860044,1.0,5/17,13.74%,CYFIP1;GMFB;ARFIP2;ARF1;PICK1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.4123193542141524,0.9601430076311287,0.5383631713554987,0.8646583471919927,1.0,7/22,23.51%,FXN;NFS1;GLRX5;ISCA2;MMS19;ISCU;NUBP2
prerank,gene expression (GO:0010467),0.32308319820433334,0.9600957572610804,0.607,0.8643056978408448,1.0,118/348,28.79%,SRSF6;RRBP1;RPSA;NUP93;DDX17;HNRNPH1;SRSF1;SRSF5;SEC13;TOPORS;RBM39;BAZ2A;DUSP11;RAE1;M1AP;SRSF2;CASC3;NOX4;SEH1L;ABCF1;TASP1;HNRNPA2B1;SMG6;SRSF11;SYMPK;HARS2;LMF1;GSPT1;HNRNPL;MRPS18B;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;NFKBIB;RBM6;CHTOP;RBM5;PABPN1;NUP37;MRPS14;XAB2;AGO2;EIF4G1;MRPL35;HSPD1;MEF2A;RBM4;RANBP2;U2AF2;CLP1;CPSF4;HNRNPK;MMS19;NUP88;YTHDC1;POLR2F;MRPS17;SARNP;TFIP11;STUB1;THOC2;SRSF3;FYTTD1;RPS27A;YARS2;NCBP1;SRSF7;GOLPH3;E2F1;POM121;NUP210;NCBP2;SARS1;GLE1;SYNCRIP;RPL7A;HNRNPH3;DARS1;NUP62;DHX8;MED20;UPF1;SRSF4;POLR2B;MRPS21;ASMT;NDC1;NUP35;GALNT2;HNRNPU;MRPS18A;RPS9;MRPL37;PABPC4;UPF3B;RBM3;DDX39B;NUP85;POLR2H;DDX20;MRPL13;NUP160;TPR;DKC1;SRBD1;EIF4E;DRG1;RPL41;RPL30;SETX;DEDD2;MRPL11;POLR2I;PWP1;WARS1;IGHMBP2
prerank,nuclear membrane organization (GO:0071763),0.4212997173894332,0.9600584757688192,0.5327225130890052,0.8639346064592182,1.0,8/19,28.98%,SPAST;TMEM43;DCTN1;CHMP4B;NEMP1;CHMP2A;UBXN2A;TOR1AIP1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.4009777879736116,0.9600118106070571,0.5336597307221542,0.8635894975447943,1.0,2/27,1.09%,GAS6;DDR2
prerank,cGMP metabolic process (GO:0046068),-0.3805384461314263,-0.9598918171586082,0.5,0.7647398400525351,1.0,5/12,21.18%,GUCY1B1;PDE2A;NPR1;PDE9A;NPPC
prerank,regulation of mRNA polyadenylation (GO:1900363),0.42159025588944354,0.9596860314929392,0.5463087248322148,0.8638889299470444,1.0,8/17,28.54%,NCBP1;CPSF7;CPSF6;NCBP2;RNF20;ZC3H14;HSF1;CDK9
prerank,cranial nerve development (GO:0021545),-0.3811823384551398,-0.9595420215363418,0.4965034965034965,0.7640321525483181,1.0,2/11,8.85%,CHD7;SALL1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.43270538045178614,0.9594262088908441,0.5268817204301075,0.8640064787199129,1.0,3/15,11.47%,ADAM9;TNFRSF1B;SNX9
prerank,RNA modification (GO:0009451),0.3554946577558532,0.959409737953478,0.5416666666666666,0.8635873037234347,1.0,23/54,35.08%,SSB;ANKRD16;ELP5;TRMT1;PUS3;TRUB1;ALKBH1;CTU2;TRMT6;TSR3;TRMT61A;METTL1;NSUN6;DTWD1;NSUN3;MEPCE;NOP10;RBM15;THUMPD1;PUS7;PUS7L;AARS1;MRM2
prerank,regulation of type I interferon production (GO:0032479),0.3451069920528242,0.9592473998125118,0.5552016985138004,0.8635031812906526,1.0,38/84,32.38%,TAX1BP1;MAVS;PRKDC;GPATCH3;POLR3H;ITCH;IRAK1;TRAF3;CRCP;PCBP2;POLR3GL;POLR2F;UBE2L6;CREBBP;OTUD5;NFKB2;ACOD1;NPLOC4;IKBKE;XRCC6;IRF3;POLR3K;POLR1C;RNF216;CYLD;TBK1;ILRUN;POLR2H;CGAS;DDX41;POLR3E;RNF135;POLR2L;CTNNB1;NFKB1;POLR3F;POLR2K;IFIH1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.34404956356217914,0.958932105643157,0.5527747551686616,0.8637801523816535,1.0,22/80,25.65%,THBS1;PRKCD;SLC2A13;SAMD4A;PRKDC;NIBAN1;IL6;EIF6;ERBB2;EIF3D;EFNA1;PYM1;CLU;CIRBP;FXR2;UPF3A;NSMAF;RPS6KB1;RPS27L;UPF3B;RBM3;METTL14
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3713076413929078,0.9588862223902197,0.5435294117647059,0.8634263159323393,1.0,6/38,13.25%,HJURP;IPO4;CENPC;CENPT;CABIN1;RBBP7
prerank,cellular response to amino acid stimulus (GO:0071230),0.38487100101877225,0.9587792136856057,0.5402160864345739,0.8632086705727666,1.0,9/33,18.73%,IPO5;SESN3;LAMTOR1;CASTOR2;CAPN2;SESN2;NSMF;KLHL22;UBR2
prerank,long-chain fatty acid transport (GO:0015909),-0.28852669763492633,-0.9587479669224592,0.5472636815920398,0.7644857609844156,1.0,8/30,10.23%,APOE;ACSL1;PRKAA2;PRKAG2;CPT1A;SLC27A4;MFSD2A;MID1IP1
prerank,vacuolar acidification (GO:0007035),0.4118940963969265,0.9584154170785858,0.5127226463104325,0.8635711799185621,1.0,8/21,30.41%,TCIRG1;ATP6V0A1;ATP6V0D1;CLN3;SLC11A1;ATP6V0E1;CLN5;ATP6V1H
prerank,positive regulation of growth (GO:0045927),0.3524838129531488,0.9583997344813838,0.5556768558951966,0.8631592654475214,1.0,22/64,23.02%,EGFR;CSNK2A1;TGFB2;AGR2;EIF4G2;FXN;ADAM10;MMP14;CXCL16;TGFBR1;EIF4G1;SUPV3L1;EXOSC4;KLHL22;ERBB2;NCBP1;HDGFL2;AKT1;TAF9B;DDX49;USP47;RPTOR
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.45143487832682266,0.9580350859961637,0.5299860529986054,0.8635515568946227,1.0,2/13,8.32%,SIX1;TFE3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.3924585850236183,0.9579297689677511,0.5160905840286055,0.8633431288321651,1.0,8/26,22.45%,CYP1B1;ATF4;SULF1;RORA;IL6;SARS1;SULF2;EIF2AK3
prerank,heme catabolic process (GO:0042167),0.44224491648592973,0.9576792465761768,0.5347885402455662,0.8629782820425694,1.0,2/14,4.28%,ABCC1;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.44224491648592973,0.9576792465761768,0.5347885402455662,0.8629782820425694,1.0,2/14,4.28%,ABCC1;HMOX2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3377608095590501,0.9574609504171367,0.5685654008438819,0.8630333517332097,1.0,14/102,9.74%,IRS1;SLC39A14;PRKCD;RHOQ;HDAC9;C2CD5;ADCY2;ADCY8;PRKDC;RAB8A;ADCY9;CAPN10;AKT2;SYAP1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3692697238568392,0.9574194370860227,0.5518433179723502,0.8626743088840789,1.0,12/43,16.81%,DDR2;LRP5;WWTR1;ACVR1;BMP4;TMEM119;RUNX2;BMPR1A;NELL1;HGF;IL6;CCN4
prerank,ERBB signaling pathway (GO:0038127),0.35562337488877704,0.9572934674633023,0.5644104803493449,0.862536803320819,1.0,15/64,18.91%,EGFR;PLCE1;SHC1;PRKCA;SOX9;CBL;PTPN18;PDPK1;SOS1;STUB1;IQGAP1;ERBB2;GAREM1;AKT1;ERBIN
prerank,regulation of histone deacetylation (GO:0031063),0.453006374923812,0.9571932757662567,0.5343618513323983,0.8623010822547383,1.0,5/13,28.37%,CAMK2D;NIPBL;AKAP8;SAP30BP;SPHK2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.38356864499063714,0.9571498649539616,0.5355892648774796,0.8619553986077381,1.0,9/31,13.14%,ZFPM2;TGFB2;SMAD4;NOG;FGFR2;BMPR1A;SMAD7;TGFBR1;LRP2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.4492618655801234,0.956863111915439,0.5394021739130435,0.862175307160673,1.0,2/13,7.26%,TWIST1;YJU2
prerank,negative regulation of B cell activation (GO:0050869),0.41747540008948697,0.9566540992217695,0.5353535353535354,0.8622037452236568,1.0,4/21,13.03%,ID2;PARP3;ATM;INHBA
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2371206087200276,-0.9564052090366472,0.5853658536585366,0.7685860220041548,1.0,19/86,12.97%,OCLN;APOE;APP;EVL;SEMA5A;NAV3;RB1;PROX1;CDC42EP4;BAIAP2;SYNPO2;CDC42EP3;LMOD1;PAK1;CLIP1;EDN1;PLEK;GPX1;CX3CL1
prerank,mitotic cell cycle phase transition (GO:0044772),0.3260701293574704,0.9563895739227756,0.6,0.8623380570444127,1.0,66/204,25.59%,ACVR1B;FBXL7;CSNK1D;PPP1R12B;CDC16;DYNC1H1;SFI1;DNM2;ACVR1;ODF2;ALMS1;E2F3;GSPT1;DCTN2;CDC25B;CUL4A;SPAST;CKAP5;FOXM1;PHF8;UBE2C;RCC1;LCMT1;CHEK2;FBXL12;SDCCAG8;AKAP9;CUL1;CEP164;KHDRBS1;CSNK1E;INHBA;YWHAE;CCNG2;CCNE2;PPP2R2D;ARPP19;CEP41;CEP63;PCM1;LATS2;HAUS5;ANAPC1;CDC25A;E2F1;CCDC57;DBF4;CDC27;CDK2;DYNC1I2;MAX;DCTN1;CHMP4B;PRKACA;OPTN;BCAT1;ACTR1A;CDK5RAP2;NEDD1;PLK4;RPS6KB1;CNTRL;CHMP2A;CTDP1;TUBB4B;CCP110
prerank,hydrogen peroxide catabolic process (GO:0042744),0.46098438706495964,0.9562296223762311,0.544179523141655,0.8622574347579862,1.0,6/11,30.52%,PRDX3;CAT;PRDX2;PRDX1;PXDN;PRDX5
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.39332167301344173,0.9561629670689897,0.5591531755915318,0.861954988064627,1.0,13/26,31.55%,NOL3;ATF4;NFE2L2;AKT1;LRRK2;PYCR1;VNN1;PINK1;HTRA2;NME5;PRKN;GPR37;GPR37L1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.4513215631141171,0.9558536327907955,0.5166666666666667,0.8622176535301237,1.0,3/13,15.16%,TM9SF4;RIC3;STX4
prerank,TOR signaling (GO:0031929),0.40588758969106276,0.9555091791715441,0.5504926108374384,0.8625682023351273,1.0,11/26,24.52%,NPRL3;MEAK7;TIPRL;SYAP1;SMG1;FLCN;AKT1;MAPKAP1;RPTOR;RPS6KB1;PINK1
prerank,granulocyte chemotaxis (GO:0071621),0.3572422722663613,0.9552834815315063,0.545556805399325,0.8626138673636267,1.0,7/55,9.70%,CCL13;CCL15;TGFB2;GBF1;FCER1G;EDN3;ANXA1
prerank,snRNA transcription (GO:0009301),0.34786558656252947,0.955271886375505,0.5656455142231948,0.8621949584338965,1.0,33/70,34.41%,INTS14;INTS3;INTS4;GTF2F1;CCNT2;INTS13;TAF6;TAF13;SNAPC4;POLR2F;RPRD1A;NCBP1;USPL1;NCBP2;POLR2B;TBP;ICE1;POLR2H;INTS9;SRRT;POLR2I;CDK9;INTS7;POLR2L;INTS6;SNAPC1;GTF2A2;RPAP2;POLR2K;RPRD2;ZC3H8;GTF2E2;INTS10
prerank,purine-containing compound catabolic process (GO:0072523),-0.35032273240201894,-0.955190821695422,0.5104895104895105,0.7698970077753483,1.0,4/13,12.79%,NT5C2;DPYD;GDA;GPX1
prerank,B cell mediated immunity (GO:0019724),0.4695411967685804,0.9549813303914153,0.5202898550724637,0.862387982085462,1.0,2/10,11.94%,FCER1G;CD27
prerank,regulation of endocytosis (GO:0030100),0.35570919934126,0.9549460900445893,0.552026286966046,0.8620220987139986,1.0,18/61,22.78%,STON2;LRP1;GPC3;ARFGAP1;LRPAP1;LRSAM1;STON1;ABL1;DAB2;RAB4B;HIP1;CD151;RAB5B;RUFY2;ZFYVE16;RAB4A;RUBCN;TSC2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4693592654803165,0.9548626159683957,0.5345821325648416,0.8617589190030643,1.0,4/10,13.74%,PLPP1;GAP43;F2R;PICK1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3837136607221249,-0.9548403841166415,0.5109717868338558,0.7691660586484292,1.0,4/10,15.33%,PARP14;SH2B3;INPP5F;SOCS3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.3713979397549265,0.9548076445349976,0.5466200466200466,0.8614358813027949,1.0,10/40,16.45%,VEGFA;SFRP4;ANXA2;RAB21;CBL;PICK1;DAB2;HNRNPK;ARRB1;HIP1
prerank,cellular metal ion homeostasis (GO:0006875),0.335088607530046,0.9545215735829566,0.5733752620545073,0.8616309528954431,1.0,15/102,11.18%,KCNJ2;ATP1B1;SLC12A2;SLC24A3;CCL13;PKHD1;CCL15;SLC10A7;SLC9A1;ANK2;CHERP;STIM1;EDN3;CSRP3;TMEM165
prerank,response to cadmium ion (GO:0046686),0.39780907045162545,0.9544552962969303,0.5565217391304348,0.8613206364290287,1.0,9/26,27.84%,EGFR;MAPK8;CHUK;SUMO1;AKT1;MAPK9;FOS;DAXX;HSF1
prerank,positive regulation of response to stimulus (GO:0048584),0.3637299040547795,0.95444625740294,0.5414235705950992,0.8608946714374259,1.0,5/40,8.09%,PRKCD;TGFB2;MAVS;ILK;SELENON
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.42516849637293763,0.9544426350044709,0.5269382391590013,0.8604599141243338,1.0,2/16,2.56%,PDCD4;CHID1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.4545851048237069,0.9544104352306821,0.532967032967033,0.8600825044072695,1.0,4/12,27.89%,TMEM165;CLN3;LRRK2;CLN5
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.3614146738087488,-0.954361876635654,0.5125448028673835,0.7687593051933981,1.0,3/12,4.13%,APP;CXCL12;JAM2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.32675646454959895,0.9540971174633406,0.600609756097561,0.8603402766062966,1.0,42/175,23.58%,PID1;CARD14;YBX3;CCL13;PSMD7;CCL15;PSMA8;SMPD4;TNFRSF1B;ILK;TNFSF15;NFE2L2;TXNDC17;PSMA4;LTBR;CHUK;COMMD7;CD27;PSMD12;TRAF3;PSMA6;TANK;GSDME;PSMD1;PSMC5;FOXO3;PSMD11;PSMC4;PSMD14;ACOD1;AKT1;ERBIN;ASAH1;NFKBIA;PSMA3;TNFSF18;PSMB1;PSMD4;BIRC3;MAP3K14;PSMA5;PSMA7
prerank,mitotic nuclear division (GO:0140014),0.3486794041308236,0.9539461774136361,0.5595628415300546,0.8602582748090072,1.0,24/71,26.50%,TUBG2;SMC4;MISP;SMC3;RHOA;SPAST;UBE2C;CHEK2;MIS12;ZW10;NDEL1;PPP2R2D;KLHL22;STAG1;CCDC61;CHMP4B;NUP62;ARHGEF10;WRAP73;SMC1A;CHMP2A;CTDP1;SPICE1;GOLGA2
prerank,regulation of cellular senescence (GO:2000772),-0.28882552336790557,-0.95393260184114,0.532967032967033,0.7682205981455873,1.0,6/28,9.40%,CDK6;B2M;SLC30A10;AKT3;NUAK1;ABI3
prerank,regulated exocytosis (GO:0045055),0.32841514938693367,0.9538726232331881,0.5936863543788188,0.8599890328827654,1.0,38/173,21.50%,THBS1;VEGFA;GAS6;SYT8;CHID1;TIMP3;TGFB3;SPARC;PCDH7;TOR4A;ARHGAP17;TGFB2;CD9;MAGED2;QSOX1;FAM3C;BRPF3;STEAP2;RAB11FIP5;SOD1;RAB11B;MANF;SCIN;HGF;STX1A;CD109;WDR1;SYTL4;LHFPL2;SERPING1;PCYOX1L;SNAPIN;TEX264;CDK5;APLP2;CLU;LAMP2;GTPBP2
prerank,regulation of fatty acid oxidation (GO:0046320),-0.33697735388388167,-0.9530566549284873,0.5163934426229508,0.7688572612378611,1.0,3/16,6.43%,PPARA;PRKAG2;PPARGC1A
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.34256180646502477,0.9527266609994293,0.5772532188841202,0.8621422685373712,1.0,31/85,28.11%,TIAM1;PRICKLE1;PSMD7;AP2A1;PSMA8;DVL1;FZD7;FZD5;RHOA;PSMA4;PSMD12;PSMA6;AP2A2;CLTC;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;SMURF2;PSMB1;PSMD4;PSMA5;PSMA7;PSMC1;DVL2;WNT11;CELSR3;PSMA1;FZD1
prerank,positive regulation of cell death (GO:0010942),-0.25433730186627956,-0.9526719024750361,0.6,0.768279573785467,1.0,16/59,15.02%,SLC6A13;EFNB2;WNT5A;ACER2;PICALM;AXIN2;FAF1;GRIN2B;APC;PRODH;ZC3H12A;EGR1;SARM1;C1QA;SNCA;TYROBP
prerank,cell chemotaxis (GO:0060326),0.35408959727075306,0.9526509066784287,0.5540691192865106,0.8618549509931998,1.0,11/60,15.88%,PRKCD;VEGFA;CCN3;DOCK4;ABCC1;ACKR4;NRP1;PARVA;HGF;CXCR4;PIP5K1A
prerank,polyol biosynthetic process (GO:0046173),0.4333888940853991,0.9522972769913923,0.5448460508701473,0.8621918922740212,1.0,2/16,1.73%,FGF2;ACER3
prerank,homocysteine metabolic process (GO:0050667),0.46611036164386166,0.9521169572028152,0.5552486187845304,0.8621387743744126,1.0,3/11,7.73%,MPST;NOX4;MTRR
prerank,dendritic spine organization (GO:0097061),0.3916684278020119,0.9521109306937571,0.5402010050251256,0.8617135550687777,1.0,8/26,13.74%,CTNND2;EPHB2;ARC;EPHB3;DLG4;ARF1;SHANK1;PICK1
prerank,positive regulation of hydrolase activity (GO:0051345),0.3281130743002503,0.9515436103763318,0.5906313645621182,0.8625204915842956,1.0,29/137,17.72%,SGSM2;SRGAP2;ASAP3;ARAP1;NTRK1;CCL13;CCL15;CALM2;BCAS3;SNX18;RAB3GAP1;S100A10;RIC1;RHOA;MAPK8;WRN;RGP1;RIPK3;ZC3H15;MAPK12;SNX9;EVI5L;F2R;NDEL1;ERBB2;CALM3;NF1;FLCN;SNX13
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3239860673271344,0.9515304066284879,0.6173212487411883,0.8621108120001925,1.0,13/190,4.67%,THBS1;SLIT2;ESR1;PDE11A;CIT;CCN3;NPRL3;TWIST1;PKHD1;PHLPP2;UBE2B;XDH;PDE3A
prerank,sympathetic nervous system development (GO:0048485),0.4375885644964689,0.9514961048645376,0.5358090185676393,0.8617428394613229,1.0,4/15,18.74%,NTRK1;NRP1;NF1;GDNF
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.41742405521338766,0.9513532290842331,0.5462962962962963,0.8616116314658994,1.0,3/19,8.43%,RIC3;CHRNB2;CHRNA5
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3387700787347239,-0.9511775803468511,0.5277777777777778,0.7702741358549736,1.0,8/17,20.86%,NEDD4L;RYR2;GPD1L;KCNJ8;PKP2;SCN3B;KCNQ1;SCN5A
prerank,negative regulation of developmental growth (GO:0048640),0.3840214411116157,0.9510810337738569,0.5653798256537983,0.8617651978461759,1.0,3/30,3.93%,FGF13;ULK2;PTPRS
prerank,alcohol catabolic process (GO:0046164),-0.3844322426240919,-0.9508781425217107,0.5124223602484472,0.7694798135429586,1.0,5/10,20.71%,APOE;CYP27A1;SCARF1;MT3;CYP46A1
prerank,negative regulation of JNK cascade (GO:0046329),0.38522936132383023,0.9508635245076095,0.5495169082125604,0.8618168201612871,1.0,15/31,25.15%,PDCD4;DACT1;ITCH;PER1;MEN1;ZMYND11;DNAJA1;AIDA;DUSP19;GPS2;CYLD;TAOK3;PINK1;NCOR1;MAPK8IP1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3856324313356026,0.95077518866842,0.5392986698911729,0.8615540290760397,1.0,14/31,34.14%,NT5C3B;DIS3L2;PATL1;LSM2;EXOSC4;CNOT8;DIS3;DCP1A;LSM5;EDC4;EXOSC2;DCPS;EXOSC3;CNOT6
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3227903743818059,0.9507675519928824,0.5845213849287169,0.8611313562722435,1.0,51/166,25.86%,ESR1;RARB;NCOR2;HDAC9;RXRA;WWTR1;NR2F1;RXRB;E2F3;POLR3H;MED27;RARA;ESRRB;RORA;GTF2F1;MAZ;TAF15;TAF6;NRBP1;ERCC3;NR1D2;HDAC1;TAF13;CRCP;ERCC2;VDR;POLR2F;NRBF2;CREBBP;MED26;NR3C1;TFB2M;POLR1G;TEAD2;CAVIN1;GTF3C1;NR3C2;TAF9B;NR2F6;POLR1C;POLR2B;TAF1C;NR2C2;TBP;KAT2B;NR5A1;TAF1;NCOR1;MED23;GTF2H4;POLR2H
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.24842933860563923,-0.9505783143629912,0.5483870967741935,0.7686845800551776,1.0,19/57,17.19%,ACTN2;APP;GRIA1;CACNG7;GRIN2B;CACNG8;GRIA4;OPRM1;GRIN2A;CACNG3;GRIA3;CACNG4;SHISA6;RELN;GRIN1;DLGAP1;DLGAP2;CAMK2A;CNIH3
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.34424644767563817,0.9501751513419308,0.579004329004329,0.8620023679759323,1.0,11/75,14.03%,MGLL;SLC39A14;PLCE1;PPP1R9B;PDE6A;DGKQ;RPGRIP1L;GIT1;GRK6;USP33;GUCY2D
prerank,membrane assembly (GO:0071709),0.37765304205044753,0.9501700874206874,0.554641598119859,0.8615758347757543,1.0,11/34,17.38%,CEL;ANXA2;TLCD2;S100A10;NRXN2;SPAST;STX2;NLGN1;STX4;SPTBN1;TLCD1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.4532022210007704,0.9501268324452926,0.5326704545454546,0.8612268976245993,1.0,2/12,6.98%,UBASH3B;ANK2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3861358185460972,0.9493026623249999,0.5664251207729468,0.8625709243874542,1.0,8/28,23.32%,MAP1B;STMND1;ABL1;MAPRE3;ARL2;STMN2;CAMSAP3;FKBP4
prerank,telomere organization (GO:0032200),0.36469579737670665,0.9492827881045209,0.5616279069767441,0.86217568796046,1.0,11/43,19.46%,PARP3;PRKDC;ERCC4;WRN;TERT;ATM;RAD50;DCLRE1B;PARP1;HUS1;XRCC6
prerank,regulation of erythrocyte differentiation (GO:0045646),0.38354259132391455,0.9491814021089593,0.5650118203309693,0.8619491316965676,1.0,5/35,6.18%,HOXA5;LDB1;ACVR1B;STAT3;PRKDC
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.3938753719807488,0.9489994597943803,0.5408163265306123,0.8619127816513974,1.0,7/25,13.93%,ATP1B1;DMD;STK39;ANK2;COA8;AKAP9;WNK1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.2893173943494472,-0.9488238532855399,0.580952380952381,0.7712086684601989,1.0,6/26,12.05%,INSR;SMAD3;KLF2;ASS1;EDN1;DDAH2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4522410417678305,0.9481684304592783,0.5429740791268759,0.8628214921854724,1.0,1/12,0.86%,EFNA5
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4522410417678305,0.9481684304592783,0.5429740791268759,0.8628214921854724,1.0,1/12,0.86%,EFNA5
prerank,mesoderm development (GO:0007498),0.4211185109185823,0.94811392278479,0.5497311827956989,0.8625232408075024,1.0,3/18,8.03%,VEGFA;FOXC2;IKZF3
prerank,cell cycle G2/M phase transition (GO:0044839),0.3308164811226261,0.9480843417763971,0.5993852459016393,0.8621474347744307,1.0,40/130,24.00%,FBXL7;CSNK1D;PPP1R12B;DYNC1H1;SFI1;DNM2;ODF2;ALMS1;DCTN2;CDC25B;CKAP5;FOXM1;LCMT1;CHEK2;FBXL12;SDCCAG8;AKAP9;CUL1;CEP164;KHDRBS1;CSNK1E;YWHAE;ARPP19;CEP41;CEP63;PCM1;HAUS5;CDC25A;CCDC57;CDK2;AKAP8;DYNC1I2;DCTN1;PRKACA;OPTN;ACTR1A;CDK5RAP2;NEDD1;PLK4;CNTRL
prerank,glucan biosynthetic process (GO:0009250),0.45142707622408346,0.9480542792765617,0.5668523676880223,0.8613449469730678,1.0,1/12,2.86%,PPP1R3C
prerank,glycogen biosynthetic process (GO:0005978),0.45142707622408346,0.9480542792765617,0.5668523676880223,0.8613449469730678,1.0,1/12,2.86%,PPP1R3C
prerank,vasoconstriction (GO:0042310),-0.37673718437160064,-0.9479824249267778,0.5236486486486487,0.7716535007517261,1.0,6/11,16.74%,SLC8A1;EDNRB;EDN1;ACTA2;PIK3C2A;HTR2B
prerank,C4-dicarboxylate transport (GO:0015740),-0.349687358852311,-0.9477803274705304,0.4939759036144578,0.7706604622789144,1.0,6/14,16.40%,SLC25A13;SLC1A1;SLC1A2;SLC25A14;SLC13A5;SLC25A30
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3333073390542716,0.9477782631769252,0.5865979381443299,0.861503381145356,1.0,18/117,15.66%,ME1;SLC5A6;SLC16A1;AGXT2;LDHC;ACSF3;CPT1C;ACSF2;ACOT11;GLO1;AKR1C1;NPC1;DLAT;ACSL3;GLYAT;CKB;SCPEP1;HACL1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4571181041854469,0.9475766222834102,0.5426573426573427,0.8615113001941036,1.0,6/12,26.32%,HEXIM1;LARP7;NELFB;HNRNPU;RECQL5;NELFA
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.372494900462176,0.947440483442232,0.5601851851851852,0.8613598558961965,1.0,9/36,19.33%,FHIT;CCAR2;GIPC1;OGT;USP7;TLK2;N4BP1;RYBP;UCHL5
prerank,glycerophospholipid catabolic process (GO:0046475),0.39506362686296315,0.9472479678075397,0.5388471177944862,0.8613582630280396,1.0,7/27,16.49%,PLA2G4F;PLA2G4A;SMPD4;PLA2G5;ENPP6;GDPD3;PLA2G15
prerank,striated muscle cell differentiation (GO:0051146),0.4322766949972349,0.9468937065562154,0.5511288180610889,0.8616508781496544,1.0,5/16,16.74%,SDC1;SKI;MYEF2;AKAP13;KDM6B
prerank,negative regulation of phosphatase activity (GO:0010923),0.39315063956054785,0.9468150808242513,0.5647348951911221,0.8613787477101019,1.0,10/25,24.18%,TGFB2;TIPRL;ZCCHC9;URI1;CHP1;PPP1R35;CRY2;PPP1R36;BOD1L1;FKBP1B
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.29525294432557236,-0.946298095046716,0.5333333333333333,0.7727256405356588,1.0,4/26,7.02%,ITPR1;RYR2;ITPR3;HTR2C
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.32457581774097227,0.9462265478904013,0.6070320579110652,0.8622533375386194,1.0,43/138,25.86%,ESR1;RARB;NCOR2;HDAC9;RXRA;WWTR1;NR2F1;RXRB;E2F3;MED27;RARA;ESRRB;RORA;GTF2F1;MAZ;TAF15;TAF6;NRBP1;ERCC3;NR1D2;HDAC1;TAF13;ERCC2;VDR;POLR2F;NRBF2;CREBBP;MED26;NR3C1;TEAD2;NR3C2;TAF9B;NR2F6;POLR2B;NR2C2;TBP;KAT2B;NR5A1;TAF1;NCOR1;MED23;GTF2H4;POLR2H
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4142753310986675,0.946051486625122,0.5601552393272963,0.8621838921350786,1.0,3/20,7.78%,HOXA5;LDB1;HOXA9
prerank,cellular response to cAMP (GO:0071320),0.39255525014351467,0.945759119417435,0.5700245700245701,0.8624091338865357,1.0,3/30,2.98%,IGFBP5;HCN4;SLC26A6
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.44665850220979353,0.9453111016526522,0.5641379310344827,0.8629381636710806,1.0,1/13,1.29%,IL33
prerank,transcription by RNA polymerase II (GO:0006366),0.31572068392219743,0.944978851795571,0.6416416416416416,0.8632225648818569,1.0,97/305,25.90%,ESR1;PRRX1;NFIX;RARB;DDX5;NCOR2;DEAF1;HDAC9;ELOF1;RXRA;WWTR1;ATF4;INTS14;NR2F1;TCFL5;RXRB;NFX1;INTS3;E2F3;MED27;RARA;ESRRB;SYMPK;INTS4;HSF2BP;CDK12;RORA;GTF2F1;CCNT2;INTS13;MAZ;PABPN1;TAF15;TAF6;NRBP1;ERCC3;NR1D2;HDAC1;TAF13;TRIP11;ERCC2;CLP1;CPSF4;VDR;SNAPC4;POLR2F;MBD1;TFDP1;AFF4;NRBF2;PCF11;MLLT3;CREBBP;MED26;PARP1;RPRD1A;NCBP1;SSRP1;NFYA;NR3C1;ELP4;CPSF7;NCBP2;TEAD2;CSTF2;CBFB;NR3C2;TAF9B;ABT1;CSTF2T;MED20;PAF1;NFIC;CEBPD;NR2F6;SNRPB;POLR2B;TAF1C;NR2C2;MNT;SETD2;TBP;ICE1;TFCP2;NELFB;KAT2B;NR5A1;TAF1;CDK13;EAF1;NCOR1;CTDP1;MED23;RTF1;GTF2H4;POLR2H;RNMT
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4609642482626427,0.944971637331825,0.5755894590846047,0.8628068938819745,1.0,2/11,10.46%,YBX3;RIPK3
prerank,epithelium development (GO:0060429),0.3323048442927745,0.9448191984962065,0.5966735966735967,0.8627087449330558,1.0,13/107,10.26%,SIX1;PKD1;VEGFA;ANXA7;MEOX2;HES5;ANXA4;DACT1;DVL1;SOX9;AKR1C1;FGFR2;EHF
prerank,regulation of biomineral tissue development (GO:0070167),0.3965982349891724,0.9447586294221897,0.5353658536585366,0.8624161162317349,1.0,7/26,14.77%,GAS6;DDR2;TWIST1;NBR1;SOX9;HEY1;CYP27B1
prerank,positive regulation of cell growth (GO:0030307),0.3345127182566332,0.9446729014976237,0.5841995841995842,0.8621764125969227,1.0,24/96,23.02%,EGFR;NTN1;CSNK2A1;TGFB2;EIF4G2;FXN;ADAM10;MMP14;CXCL16;GOLGA4;TGFBR1;EIF4G1;SUPV3L1;EXOSC4;KLHL22;ERBB2;NCBP1;HDGFL2;AKT1;TAF9B;DDX49;SHTN1;USP47;RPTOR
prerank,regulation of viral life cycle (GO:1903900),-0.3184652182644614,-0.9444088893430367,0.5630630630630631,0.7755845508481318,1.0,6/21,14.58%,PPIA;TRIM14;NECTIN2;TRIM21;TRIM68;AXL
prerank,mitochondrial translational termination (GO:0070126),0.3349923971325457,0.9443163304724279,0.5816649104320337,0.8625085758726336,1.0,41/88,37.65%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;MRPS18B;MTRF1L;MRPL39;MRPS14;MRPL35;MRPS17;MRPL45;PTCD3;MRPL12;MRPL47;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;MRPL28;MRPL24;MRPS10;CHCHD1;MRPS31;MRPL15;MRPS33;MRPL50;AURKAIP1;MRPL41;MRPL14;MRPL32;MRPL38;MRPL46;MRPL2
prerank,iron-sulfur cluster assembly (GO:0016226),0.3982373095675488,0.9441797969759158,0.5414572864321608,0.8623647072818931,1.0,7/24,23.51%,FXN;NFS1;GLRX5;ISCA2;MMS19;ISCU;NUBP2
prerank,homeostasis of number of cells (GO:0048872),0.4498233964589564,0.9438456773450767,0.5572625698324022,0.8626518985545134,1.0,4/12,13.07%,CCN3;UBAP2L;LPCAT3;F2R
prerank,macroautophagy (GO:0016236),0.3317977418466382,0.9438370196364939,0.5985477178423236,0.8622344766282507,1.0,41/118,27.29%,CSNK2A2;CSNK2A1;TCIRG1;VCP;LIX1L;TOMM40;NBR1;WIPI2;PGAM5;PIP4K2B;ATG3;STAM2;VIPAS39;CHMP3;UBQLN1;SQSTM1;PLEKHM1;VPS41;TOMM70;YOD1;PRKAG1;CLN3;RB1CC1;VTA1;PRKAB1;CHMP4A;CHMP4B;ATG16L1;LAMP2;MFN1;ACBD5;MVB12A;UVRAG;PINK1;CHMP2A;ILRUN;ATG13;VTI1B;AMBRA1;VPS16;VPS37B
prerank,tRNA 5'-leader removal (GO:0001682),0.44777980149702357,0.9437965414917686,0.5520974289580515,0.8619004709148731,1.0,6/13,30.84%,SSB;RPP40;RPP14;RPP21;POP5;PRORP
prerank,protein deacylation (GO:0035601),0.39960022171328785,0.9436746767504672,0.5670103092783505,0.8617492014465823,1.0,5/23,15.82%,HDAC4;SIRT5;HDAC1;SIRT2;HDAC6
prerank,early endosome to late endosome transport (GO:0045022),0.40696656687388166,0.9434478667083285,0.5456852791878173,0.8618063656616569,1.0,3/20,8.53%,ANKRD27;RILP;EEA1
prerank,negative regulation of cellular senescence (GO:2000773),-0.35450662640983277,-0.9429276320016802,0.49812734082397003,0.777660091221099,1.0,3/13,2.72%,CDK6;SLC30A10;AKT3
prerank,DNA replication checkpoint signaling (GO:0000076),0.4223321090237688,0.9428983368359111,0.5546448087431693,0.8625808600002944,1.0,7/16,30.54%,CDC6;CDC45;HUS1;CDT1;TOPBP1;TIMELESS;RAD17
prerank,negative regulation of potassium ion transport (GO:0043267),-0.35678430674885075,-0.9423106394391116,0.5444444444444444,0.7776323622790768,1.0,5/13,15.29%,NEDD4L;ACTN2;CAV1;NOS1;CASQ2
prerank,prostanoid biosynthetic process (GO:0046457),0.42976237714532894,0.9422305266419225,0.5620736698499318,0.863626019709369,1.0,2/15,1.79%,PTGIS;PLA2G4A
prerank,integrin-mediated signaling pathway (GO:0007229),0.34609405920623587,0.9421071190473382,0.593952483801296,0.8634617201923102,1.0,12/73,12.40%,ITGA11;COL3A1;ADAM9;PLPP3;COL16A1;ILK;PRAM1;ADAM10;ITGAV;ABL1;RCC2;NRP1
prerank,positive regulation of dephosphorylation (GO:0035306),0.3888912241902997,0.9417000575700546,0.5659203980099502,0.863881299745296,1.0,8/27,16.86%,PRKCD;CALM2;SYMPK;RIPK3;CNEP1R1;PTBP1;NSMF;CALM3
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3577919123217741,0.9415661290459811,0.5622895622895623,0.8637524109629825,1.0,9/47,18.73%,SERPINH1;TIMP2;TIMP3;SERPINF1;SERPINB9;SERPINE2;CRB2;AKT1;SERPING1
prerank,second-messenger-mediated signaling (GO:0019932),-0.22956154498552,-0.9413695185820633,0.625,0.7782656995866468,1.0,18/82,12.05%,APOE;MCTP1;NOS3;CCR9;RYR2;GUCY1B1;DGKD;NUDT4;MCTP2;AGTR1;SPHK1;KSR2;EDNRB;EDN1;CX3CR1;NOS1;CHRM3;DDAH2
prerank,tRNA 5'-end processing (GO:0099116),0.4373961122677926,0.9412742704725036,0.5649263721552878,0.8639438497605172,1.0,6/15,30.84%,SSB;RPP40;RPP14;RPP21;POP5;PRORP
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3281170553301029,0.941209736306098,0.6037344398340249,0.8636473248076001,1.0,35/114,26.52%,CARD14;PSMD7;PSMA8;TNFRSF1B;ILK;TNFSF15;TXNDC17;PSMA4;LTBR;CHUK;COMMD7;CD27;PSMD12;TRAF3;PSMA6;PSMD1;PSMC5;FOXO3;PSMD11;PSMC4;PSMD14;NFKBIA;PSMA3;TNFSF18;PSMB1;PSMD4;BIRC3;MAP3K14;PSMA5;PSMA7;TP53;TRADD;PSMC1;RIPK1;CDIP1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.42614925542521037,0.9408823396828914,0.5596707818930041,0.863933642873998,1.0,6/15,21.85%,ATL2;REEP3;TMEM170A;TMEM33;ATL1;RAB18
prerank,mitochondrial translational elongation (GO:0070125),0.3347128153174549,0.9408755809407489,0.5812236286919831,0.8635170901492802,1.0,41/88,37.65%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;MRPS18B;MRPL39;MRPS14;MRPL35;MRPS17;MRPL45;TUFM;PTCD3;MRPL12;MRPL47;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;MRPL28;MRPL24;MRPS10;CHCHD1;MRPS31;MRPL15;MRPS33;MRPL50;AURKAIP1;MRPL41;MRPL14;MRPL32;MRPL38;MRPL46;MRPL2
prerank,regulation of chromatin binding (GO:0035561),0.47062950374479523,0.9408593700001948,0.5466666666666666,0.8631168571430741,1.0,5/10,29.21%,BTAF1;MED25;CDT1;WAPL;DDX11
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3627672745881367,0.9408172461735222,0.5627157652474108,0.8627741481723783,1.0,7/43,13.17%,EGFR;PTPN3;SOCS4;RNF115;CBL;PTPN2;STAM2
prerank,phospholipid catabolic process (GO:0009395),0.3966589230305647,0.9406999152723978,0.562807881773399,0.862613494614608,1.0,6/24,16.32%,PLA2G4F;PLA2G4A;SMPD4;SMPDL3A;ENPP6;GDPD3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4641681829421407,0.9400201786873614,0.5726027397260274,0.8636280893116779,1.0,5/11,36.40%,ATF4;PINK1;PRKN;NR4A3;NONO
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3826986944422171,0.9399602498311426,0.5611866501854141,0.863331269127619,1.0,2/30,1.45%,PRKCD;SRCIN1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.40999564632045665,0.9398659776701564,0.5584756898817346,0.8631046444558343,1.0,9/18,33.69%,FXN;EDN3;ABL1;GDNF;RFK;ABL2;PDP2;ATP7A;PDP1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.2523631471764571,-0.939828862099798,0.5851851851851851,0.7802338874095576,1.0,14/45,18.88%,WNT5A;APP;AIM2;GBP5;HSPB1;EGR1;LPL;LGALS9;TRIM16;TYROBP;NOD2;PYCARD;MYD88;P2RX7
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.38409439842192306,0.9398179753245688,0.5578562728380024,0.8627771647005215,1.0,3/33,2.89%,IGFBP5;PDCD4;TGFB3
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3627291797703994,0.9388721974680104,0.5614035087719298,0.8644032689746955,1.0,9/44,12.61%,MYOC;TGFB3;SORBS3;S100A10;PFN2;RHOA;ABL1;NRP1;TGFBR1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.32638344766356,0.9383200436262171,0.6224489795918368,0.865173876979711,1.0,39/129,24.00%,FBXL7;CSNK1D;PPP1R12B;DYNC1H1;SFI1;DNM2;ODF2;ALMS1;DCTN2;CDC25B;CKAP5;FOXM1;LCMT1;CHEK2;FBXL12;SDCCAG8;AKAP9;CUL1;CEP164;KHDRBS1;CSNK1E;YWHAE;ARPP19;CEP41;CEP63;PCM1;HAUS5;CDC25A;CCDC57;CDK2;DYNC1I2;DCTN1;PRKACA;OPTN;ACTR1A;CDK5RAP2;NEDD1;PLK4;CNTRL
prerank,stem cell differentiation (GO:0048863),0.36533914604186124,0.9382453839548882,0.5589622641509434,0.8648987953323577,1.0,8/39,17.35%,LRP6;TGFB2;PUM1;FGFR2;HOXB4;PSMD11;MLLT3;UFL1
prerank,defense response to tumor cell (GO:0002357),-0.3860662068952425,-0.9379351454071387,0.5478547854785478,0.7832597819683538,1.0,2/10,9.40%,RBMS3;ABI3
prerank,Golgi to plasma membrane transport (GO:0006893),0.35517481229705217,0.9378189632149833,0.5815028901734104,0.8653489376410435,1.0,21/47,28.27%,KIF13A;EXOC4;RAB34;GOPC;GGA2;LLGL1;GOLGA4;NSF;STEAP2;GGA1;SPTBN1;GOLPH3;BLZF1;OPTN;ARFGEF2;VAMP4;VPS35L;VAMP2;GCC2;OSBPL5;GGA3
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.3878729338315191,0.9369444688131991,0.5357575757575758,0.8668316428860466,1.0,7/24,22.45%,CYP1B1;ATF4;SULF1;RORA;IL6;SULF2;EIF2AK3
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.38512917853555934,0.9368385180615789,0.5604938271604938,0.866635190516137,1.0,6/27,16.53%,IRAK3;IRAK1;TAB2;HSPD1;RPS27A;UBC
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.2809961546118459,-0.9367314587923867,0.5773809523809523,0.784607258094334,1.0,11/32,18.88%,CEMIP;TRPC3;AKAP6;CAV1;CX3CL1;GRIN1;APLNR;SNCA;GPER1;THY1;P2RX7
prerank,small GTPase mediated signal transduction (GO:0007264),0.33129360519900924,0.9364652486390739,0.6162790697674418,0.8669825767761895,1.0,19/103,15.25%,NTN1;PLCE1;FGF2;TIAM1;MRAS;TIAM2;SHC1;TRIM28;BCR;USP50;RRAD;ARFIP2;RAB38;SHOC2;CHP1;SETDB1;NUCB1;G3BP2;SOS1
prerank,response to cAMP (GO:0051591),0.3709893255156274,0.9364034086173675,0.5731272294887039,0.866687538996988,1.0,6/37,12.31%,IGFBP5;HCN4;SLC26A6;DGKQ;EZR;AKAP9
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.390936830204683,0.936272697873898,0.5571245186136072,0.8665437384095201,1.0,4/24,10.05%,IRS1;PPP1R3C;AKT2;PPP1R3F
prerank,peptide catabolic process (GO:0043171),0.3942785193194407,0.9362338167151868,0.571969696969697,0.8661964556742792,1.0,9/23,23.51%,ECE1;CPQ;XPNPEP1;LNPEP;IDE;NPEPPS;LVRN;CHAC2;DPEP1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.431121297713777,0.9360337207879341,0.5604395604395604,0.8661905304215224,1.0,4/14,18.57%,AGR2;HSPA5;UFL1;TMEM33
prerank,neuropeptide signaling pathway (GO:0007218),-0.2389505179598404,-0.9358643178309717,0.6704545454545454,0.7850909679763175,1.0,15/58,23.92%,SORCS1;RAPGEF2;GLRA2;SORT1;OPRM1;CYSLTR1;NMU;NTS;GLRA1;NXPH2;PNOC;NMUR2;CYSLTR2;NXPH4;KISS1R
prerank,membrane organization (GO:0061024),0.31790629146001964,0.9355481549936053,0.6536144578313253,0.8667786259815741,1.0,68/227,26.29%,EGFR;STON2;NUP93;CTTN;IGF2R;TLCD2;STX11;AP2A1;DNM2;ANK2;FCHO2;HUWE1;CBL;SYNJ1;NPC1;SPAST;LPCAT3;SNX9;AP3D1;USO1;TMEM43;CHP1;REPS1;OCRL;LRP2;AP2A2;STAM2;GAPVD1;PICK1;CHMP3;DMPK;REEP3;CLTC;DAB2;SNAP23;MITD1;ARRB1;HIP1;RPS27A;UBC;SPTBN1;TLCD1;TMEM170A;NAPA;CLN3;TMEM33;COX18;CLTA;CHMP4A;CHMP4B;SYNJ2;PDCD6IP;ARPC1A;MTCH1;LDLR;REPS2;PRKCI;VAMP4;NEMP1;SNX3;CHMP2A;PLEKHA3;SCARB2;VAMP2;VTI1B;DVL2;RAB5A;ACTR2
prerank,axonogenesis (GO:0007409),0.3145642219672171,0.9352222850721154,0.6616465863453815,0.8670308789728531,1.0,25/237,8.25%,SLIT3;SLIT2;SLIT1;EMB;EFNA5;MAP1B;ULK2;GRB10;GAB2;GLI2;PDLIM7;EPHB2;DOCK7;SHC1;NTN4;SEMA3E;PRKCA;EPHB3;EPHB6;RAB8A;SEMA4B;LLGL1;S100B;PALLD;CYFIP1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.41230480992894464,0.9351196611984788,0.549407114624506,0.8668188676092412,1.0,12/19,38.61%,EML3;CHMP3;CHMP4B;PDCD6IP;HNRNPU;CHMP2A;TPR;DRG1;CHMP4C;CCSAP;VPS4B;CHMP1B
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4145018343049485,0.9350838688595499,0.543010752688172,0.8664614875504164,1.0,2/17,0.95%,CACNA1C;ATP1B1
prerank,peptidyl-tyrosine modification (GO:0018212),0.35055125710475604,0.9350188050846748,0.5914702581369248,0.8661683656631141,1.0,9/56,10.59%,EGFR;PKDCC;DDR2;NTRK1;EPHB2;ABI1;FGFR1;FGFR2;ABL1
prerank,oligodendrocyte differentiation (GO:0048709),-0.30633684026897007,-0.9349334389064448,0.56,0.7857632184588474,1.0,4/19,8.51%,SOX13;SOX6;SLC8A3;EIF2B3
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.4164020645693325,0.9347258285239122,0.5611702127659575,0.8663570396945777,1.0,5/16,19.01%,IGFBP5;PHIP;BMP5;IGFBP6;ZFAND2B
prerank,mesenchymal to epithelial transition (GO:0060231),0.46111766256777975,0.9347202222580917,0.5446685878962536,0.8659449239472181,1.0,2/10,9.70%,FZD7;BMP4
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.28824565893627574,-0.9346629645185488,0.5759493670886076,0.7848748777702791,1.0,4/31,13.02%,PLCB1;SYK;CD40;LGALS9
prerank,fatty acid biosynthetic process (GO:0006633),0.344975582705603,0.934645284843634,0.6043956043956044,0.8656613263297168,1.0,8/63,10.36%,ABCD3;ACSF3;ELOVL5;SCD5;LIAS;OLAH;FADS1;CBR4
prerank,cell proliferation in forebrain (GO:0021846),0.45662167980347995,0.9344038461207099,0.5482954545454546,0.865747925266875,1.0,2/10,15.08%,DOCK7;PCM1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.40937602249850835,0.9343737132455514,0.5704960835509139,0.8653999764449051,1.0,1/20,0.38%,PSTPIP1
prerank,neurotransmitter uptake (GO:0001504),0.4472534948472101,0.9342835416546645,0.5661971830985916,0.8651636283278358,1.0,1/12,0.11%,SLC38A1
prerank,stabilization of membrane potential (GO:0030322),0.42253946794785247,0.9339129856054148,0.5555555555555556,0.8655026330262826,1.0,1/16,0.40%,KCNK5
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3403971971342305,0.933785938082966,0.5958378970427163,0.8653643950077985,1.0,32/69,34.41%,INTS14;INTS3;INTS4;GTF2F1;CCNT2;INTS13;TAF6;TAF13;SNAPC4;POLR2F;RPRD1A;NCBP1;NCBP2;POLR2B;TBP;ICE1;POLR2H;INTS9;SRRT;POLR2I;CDK9;INTS7;POLR2L;INTS6;SNAPC1;GTF2A2;RPAP2;POLR2K;RPRD2;ZC3H8;GTF2E2;INTS10
prerank,receptor metabolic process (GO:0043112),0.34921878867194583,0.933586490045542,0.6146067415730337,0.8653594094558574,1.0,16/53,23.07%,LRP1;NEDD4;RAMP2;DNM2;CD9;FCER1G;SNX1;RAMP1;RAB11B;CLTC;PHETA2;GRK4;ARFGEF2;ACKR3;MVB12A;UVRAG
prerank,organelle fusion (GO:0048284),0.4017163633083826,0.933532687824625,0.5750636132315522,0.8650491943273874,1.0,11/22,30.36%,MIEF2;SPG7;EEA1;STX4;VPS11;MFN1;AFG3L2;FIS1;USP30;VPS18;MIEF1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.3186912624288171,-0.9333747544176189,0.5766129032258065,0.7849720335710477,1.0,4/21,5.72%,EYA1;BCL2;BCL2L1;EYA4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.3186912624288171,-0.9333747544176189,0.5766129032258065,0.7849720335710477,1.0,4/21,5.72%,EYA1;BCL2;BCL2L1;EYA4
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.31963086288043874,0.9331787551200731,0.6323828920570265,0.8653944334531434,1.0,42/172,18.37%,FGF2;PLEKHA4;PLA2G4A;PEMT;PIK3C2B;CSNK2A2;CSNK2A1;PITPNM1;LPCAT1;GPD1;TAMM41;LPCAT4;DGKQ;ETNK1;PGS1;STARD7;SYNJ1;GPAT4;PLA2G5;PIP4K2B;LPCAT3;PCTP;FAR1;ARF1;INPP4A;ETNPPL;PIK3CB;OCRL;PI4K2A;PLA2G12A;CDIPT;PNPLA3;HDHD5;CHKB;PIP5K1A;PI4KB;INPP5E;PTDSS1;VAC14;AGPAT5;CDS1;CLN3
prerank,spindle assembly (GO:0051225),0.3398033525683073,0.9331452459131538,0.6034669555796316,0.8650444344732358,1.0,27/67,32.66%,CSNK1D;GOLGA8B;MISP;TUBGCP3;NEK7;SMC3;RHOA;RCC1;CHEK2;MAPRE3;CEP63;HAUS5;STAG1;CCDC61;ARHGEF10;WRAP73;SMC1A;NCOR1;SPICE1;GOLGA2;NEK6;TOGARAM1;TUBGCP2;KIF2A;BCCIP;HDAC3;PIBF1
prerank,cellular calcium ion homeostasis (GO:0006874),0.3198477102703223,0.9330439685789621,0.6325486182190379,0.8648510791627174,1.0,36/133,24.43%,SLC35G1;ATP1B1;SLC24A3;CCL13;CAMK2D;PKHD1;CCL15;PACS2;ADCY8;SLC10A7;MCU;ANK2;CHERP;STIM1;EDN3;CSRP3;TMEM165;MICU2;LETM1;YWHAE;DMPK;MICU1;CALB2;CALCA;KCTD17;CLN3;CALR;PRKACA;ATP2B4;ANXA6;AFG3L2;SLC8B1;STOML2;FKBP1B;HERPUD1;STIM2
prerank,male meiosis I (GO:0007141),0.4185525501604311,0.9330204015647909,0.5594125500667557,0.8644767925057133,1.0,3/16,18.61%,FOXJ3;HSF2BP;BRDT
prerank,prostaglandin biosynthetic process (GO:0001516),0.41245964230285875,0.9329784473330085,0.5610079575596817,0.8641409338594241,1.0,3/18,7.02%,PTGIS;PLA2G4A;PTGES2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.37670862099543095,0.9320199022550363,0.5630952380952381,0.8657484748223093,1.0,8/33,14.32%,GAS6;TCF7L2;PKHD1;RAMP2;NFE2L2;PAK4;PDPK1;NDNF
prerank,positive regulation of developmental process (GO:0051094),0.31954993502757767,0.9316698456356723,0.6551724137931034,0.8660514074897859,1.0,31/164,13.02%,BMP1;VEGFA;FOXD1;ACVR1B;PHLDB1;LMNA;COBL;AGR2;TLE6;ACVR1;DVL1;MIEF2;MCU;FGFR1;KMT5C;DLG4;PA2G4;SOX9;ESRRB;TRPM4;B4GALT5;EDN3;BMP4;TMEM119;BMPR1A;NEUROD2;SHANK1;FOXO6;SRF;AGO2;NLGN1
prerank,SNARE complex assembly (GO:0035493),-0.3701339696499904,-0.9316139095953189,0.5290102389078498,0.7875819911120328,1.0,1/10,1.48%,STXBP6
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.32828658206699496,0.9314957842151416,0.6138509968520461,0.8659686360774237,1.0,32/109,23.96%,GAB2;VAV2;PSMD7;SHC1;PSMA8;FCER1G;NFATC1;PAK2;MAPK8;PSMA4;CHUK;TAB2;PDPK1;PSMD12;PIK3CB;CUL1;PSMA6;NFATC3;PSMD1;SOS1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;MAPK9;MAP2K7;PSMB1;PSMD4;PSMA5;PSMA7;FOS
prerank,cellular response to cytokine stimulus (GO:0071345),0.31199340486517624,0.9313126955856933,0.731,0.8659424379528955,1.0,86/416,19.78%,PID1;VEGFA;GAS6;LBP;F3;FGF2;SLC12A2;COL1A2;PTGIS;YBX3;GRB10;GHR;MUC1;GAB2;CNTFR;DPYSL3;SLC26A6;TWIST1;CCL13;SDC1;SHC1;NFAT5;STAT5A;CCL15;STAT3;IL5;SHPK;SMPD4;TNFRSF1B;TXLNA;IL12RB2;NFE2L2;STK39;IFNLR1;IRAK3;SOCS6;SOX9;CBL;GBP6;SOCS2;RHOA;SBNO2;PTPN18;RORA;MAPK8;ANXA1;CHUK;CTF1;IRAK1;IL20RB;PIK3CB;PTPN2;TANK;CD80;GSDME;CASP1;WNK1;CLCF1;STX4;HGF;SOS1;IL6;STX1A;FOXO3;CXCR4;RPS27A;UBC;PRLR;HMOX1;EPRS1;DAPK3;TRIM6;ACOD1;USP10;SHMT1;BIRC5;AKT1;OSMR;ERBIN;CRK;PLP2;SYNCRIP;PTAFR;ASAH1;PTPN23;UBE2G2
prerank,copper ion transport (GO:0006825),0.45439664438784666,0.9306145111121796,0.5702127659574469,0.8669530717534044,1.0,4/11,31.56%,STEAP2;STEAP3;SLC31A2;ATP7A
prerank,regulation of DNA binding (GO:0051101),0.35904919907467153,0.9305896746402034,0.5877689694224235,0.8665790385279111,1.0,11/44,19.73%,HJURP;HMGB1;SKI;MAPK8;SMO;SIRT2;SUMO1;MDFI;CDT1;E2F1;NFKBIA
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3093716878827875,0.9305248616817995,0.737,0.8662822045235443,1.0,88/532,16.53%,IRS1;PRKCD;VEGFA;LBP;F3;FGF2;COL1A2;PDCD4;IL33;P4HB;CARD14;GRB10;GHR;MUC1;GAB2;CNTFR;TWIST1;CCL13;SDC1;PSMD7;SHC1;CAMK2D;STAT5A;ANXA2;CCL15;STAT3;PITPNA;IL5;MID1;PSMA8;TNFRSF1B;ILK;TXLNA;TNFSF15;SMAD4;IL12RB2;IFNLR1;IRAK3;BRWD1;HNRNPA2B1;HNRNPDL;RPS6KA4;SOCS6;CBL;ADIPOR2;SOCS2;FCER1G;JAGN1;TXNDC17;RORA;PAK2;PSMA4;ANXA1;LTBR;CHUK;CTF1;IRAK1;TAB2;ARF1;COMMD7;SOD1;CD27;PSMD12;IL20RB;PIK3CB;TRAF3;CUL1;PSMA6;CD80;CASP1;TRIM26;SQSTM1;CLCF1;PSMD1;STX4;HGF;SOS1;IL6;STX1A;MAP3K3;PSMC5;FOXO3;PSMD11;PSMC4;PSMD14;TRAF3IP2;RPS27A;UBC
prerank,diacylglycerol metabolic process (GO:0046339),0.3958797814136402,0.9298718691812139,0.5690322580645162,0.8672012711829232,1.0,4/23,9.37%,PLCE1;DAGLA;DGKQ;PGS1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.32932684600174056,-0.9296672314063683,0.5517241379310345,0.7906750087724443,1.0,6/16,18.51%,AUTS2;BCOR;PIH1D1;CTR9;BRCA1;KDM1A
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3932151350132277,0.9295569823376304,0.56575682382134,0.8674499904780781,1.0,3/22,14.76%,SRSF6;FGFR2;VDR
prerank,cytoplasmic microtubule organization (GO:0031122),0.34354149949446094,0.9291318362677455,0.5876404494382023,0.8679252304659567,1.0,16/54,22.64%,LIMK2;DYNC1H1;CLIP4;TUBGCP3;DLG1;RHOA;SPAST;EZR;CHP1;PCM1;KATNA1;SLAIN2;DCTN1;CLIP2;CRIPT;CAMSAP3
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.45180419163567737,0.9287950047080963,0.543731778425656,0.8673529509442705,1.0,6/10,31.99%,WRN;XRCC3;SLX4;SMARCAL1;BLM;ERCC1
prerank,t-circle formation (GO:0090656),0.45180419163567737,0.9287950047080963,0.543731778425656,0.8673529509442705,1.0,6/10,31.99%,WRN;XRCC3;SLX4;SMARCAL1;BLM;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.45180419163567737,0.9287950047080963,0.543731778425656,0.8673529509442705,1.0,6/10,31.99%,WRN;XRCC3;SLX4;SMARCAL1;BLM;ERCC1
prerank,regulation of monocyte differentiation (GO:0045655),0.4280802229258049,0.9283495976282393,0.5761772853185596,0.8678636589723766,1.0,1/14,0.44%,FOXP1
prerank,regulation of TORC1 signaling (GO:1903432),0.3682009369984469,0.9282170060647525,0.6022167487684729,0.8677189707836636,1.0,11/33,19.28%,SESN3;SEH1L;CLEC16A;CASTOR2;DGKQ;ATM;TELO2;SESN2;KLHL22;FLCN;KPTN
prerank,cellular response to chemokine (GO:1990869),0.3510226337209908,0.9281653967481841,0.5688282138794084,0.8674296606272635,1.0,5/46,9.03%,SLC12A2;CCL13;CCL15;STK39;RHOA
prerank,regulation of double-strand break repair (GO:2000779),0.36033662417564927,0.9274774767900364,0.6002331002331003,0.8683668880959108,1.0,17/39,30.17%,TWIST1;OTUB1;SLF2;SPIDR;FOXM1;UBR5;OTUB2;SPIRE2;RAD51;SLF1;SETD2;ACTR2;WAS;RTEL1;DDX11;TRIP12;TIMELESS
prerank,defense response to Gram-negative bacterium (GO:0050829),0.36158731752153067,0.9274444308563754,0.5926365795724465,0.8680122466617207,1.0,9/42,22.65%,LBP;RNASE7;RNASE3;RNASE6;DEFB1;IL6;DMBT1;OPTN;SLC11A1
prerank,negative regulation of protein kinase activity (GO:0006469),0.33177186771731504,0.9271823278146648,0.6165413533834586,0.8681365661206782,1.0,21/88,20.31%,LRP6;SRCIN1;UBASH3B;LRP5;WWTR1;DVL1;TRIM27;AKT1S1;CDK5RAP3;PAK2;ABL1;PDPK1;DEPTOR;CHP1;CAMK2N1;GSKIP;NF1;CDKN1C;AKT1;DUSP19;RTRAF
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.4508408350205391,0.9271235703750516,0.5773638968481375,0.8674077722299,1.0,4/11,15.73%,AGO1;AGO2;RBM4;EIF6
prerank,miRNA mediated inhibition of translation (GO:0035278),0.4508408350205391,0.9271235703750516,0.5773638968481375,0.8674077722299,1.0,4/11,15.73%,AGO1;AGO2;RBM4;EIF6
prerank,tryptophan catabolic process (GO:0006569),0.44956033045966404,0.9270647689764708,0.5791788856304986,0.8671131800868033,1.0,3/11,20.64%,IDO2;AFMID;KYAT1
prerank,regulation of cellular component organization (GO:0051128),0.32451389117597274,0.9265409046259953,0.6409465020576132,0.8677144166478323,1.0,48/135,26.64%,PLCE1;STON2;NEDD4;ARFGAP1;HJURP;CAMK2D;SNCAIP;DCUN1D5;LAMTOR1;ANKRA2;IRAK3;TMC8;PAK4;SOCS2;STON1;ITCH;URI1;ABL1;SETD5;NCLN;MARK4;RAB4B;MLLT3;HIP1;SSRP1;SLC2A10;RAB5B;RUFY2;HCFC1;SLITRK2;SETD1A;ZFYVE16;SGK3;MAD2L2;RAB4A;CAMSAP3;TSC2;RPTOR;HNRNPU;ROCK1;PINK1;IL17RB;TAOK2;PTPN11;LAMTOR2;RAB5A;SGK1;ATF5
prerank,steroid hormone biosynthetic process (GO:0120178),0.37841910391937383,0.926523971238801,0.5925925925925926,0.8673389387727217,1.0,5/29,21.97%,CYP19A1;STARD3NL;FDXR;HSD17B8;STARD3
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3583494864751142,0.9264764663813163,0.5979614949037373,0.8670202241184229,1.0,8/44,13.29%,MICAL2;ACVR1;TGFBR2;TBX21;CCDC39;SRF;SMO;BBS5
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.33267172133619144,0.9264512437079557,0.60828025477707,0.8666488190888788,1.0,23/87,23.58%,FHL1;FBXL7;PSMD7;PSMA8;DACT1;DLG1;PSMA4;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;RBL2;PSMA3;PSMB1;PSMD4;USP47;GPNMB;PSMA5;PSMA7
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.38990538109480427,0.9263466782413962,0.5954198473282443,0.8664554759275024,1.0,6/25,18.86%,EXT1;B3GNT7;B3GNT9;B4GAT1;B3GNT6;EXT2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.42452279225134204,0.9258299488990429,0.5729585006693441,0.8671470312268656,1.0,3/16,7.59%,PARP3;PRKDC;KMT5C
prerank,brain development (GO:0007420),0.3186684227430947,0.9253334842144043,0.6506147540983607,0.8677570906240134,1.0,31/136,20.91%,SLC23A1;ZFHX3;PBX3;NFIB;ADGRL2;HES5;PITPNM1;RAB3GAP1;AMIGO3;TGFBR2;PBX1;MEIS3;TBC1D23;CDK5RAP3;ZIC1;SYNJ1;PHF8;POU6F1;PAFAH1B2;ABCB6;CXCR4;PHGDH;NF1;NIPBL;IER3IP1;CHD8;PAFAH1B3;SETD1A;BPTF;SYNJ2;AFF2
prerank,protein neddylation (GO:0045116),0.4289569050216012,0.925275629569494,0.5735694822888283,0.8674629883072695,1.0,5/13,28.91%,DCUN1D5;DCUN1D2;RNF7;UBA3;RBX1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.2161078420028248,-0.9249023639824718,0.6190476190476191,0.8004774397421472,1.0,48/110,23.31%,RPS14;RPS15;RPS25;RPL8;SMG7;RPS8;RPL4;RPS20;CTIF;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;GSPT2;RPL11;RPL18A;RPS12;RPL12;SMG8;RPS11;UBA52;RPL18;RPS15A;RPS28;EIF4A3;RPL21;RPL7;RPL10;RPL15;RPS3;RPS18;RPS19;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37
prerank,signal transduction by p53 class mediator (GO:0072331),0.374318254124829,0.9245732412978743,0.5716004813477737,0.8684313483038445,1.0,5/30,12.60%,DDX5;FHIT;MDM4;NDRG1;SESN2
prerank,female gamete generation (GO:0007292),-0.28064520697055734,-0.9242173827339295,0.5968586387434555,0.8005555001634677,1.0,13/29,22.56%,DIAPH2;PTN;FMN2;TOB2;SPO11;MEI4;MCM8;PRDM9;DMC1;MDK;NANOS3;NANOS1;TRIP13
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.30720128355314036,-0.924129003175827,0.5829596412556054,0.7992269501016073,1.0,7/22,14.31%,AEBP1;APOE;MAP2;CAMSAP1;PRUNE1;GPX1;EFEMP2
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2933401652627712,-0.9240404485686046,0.5789473684210527,0.7979054106743012,1.0,4/26,5.04%,DNAJC6;SGIP1;PICALM;PIP5K1C
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4442362956186237,0.9237895092164571,0.5738636363636364,0.8695803693382891,1.0,2/11,6.33%,LMNA;SMAD4
prerank,DNA replication initiation (GO:0006270),0.36665835251380696,0.9230757065227744,0.5768321513002365,0.8706672975724523,1.0,12/37,26.11%,POLE2;MCM2;CDC6;CDC45;MCM4;ORC2;CDT1;DBF4;CDK2;TOPBP1;PRIM1;MCM7
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.36720386962085133,0.9230523913533276,0.5842293906810035,0.8703018057276907,1.0,7/38,17.54%,THBS1;TMC8;MADD;TNFRSF10B;BMP5;STX4;HMOX1
prerank,heart looping (GO:0001947),0.3631230299554877,0.9228759621065965,0.5934959349593496,0.8702408084619963,1.0,8/40,16.20%,MICAL2;TGFBR2;TBX21;CCDC39;SRF;SMO;BBS5;NPHP3
prerank,organophosphate biosynthetic process (GO:0090407),0.3614921589130981,0.9228030572769489,0.5830388692579506,0.8699708133036702,1.0,12/37,26.44%,FGF2;LPCAT1;TKT;NFS1;FADS1;IP6K1;PIP5K1A;AGPAT5;MBOAT1;PPIP5K1;FITM2;PCYT2
prerank,establishment of spindle orientation (GO:0051294),0.37769982486556514,0.9227969560282878,0.5779702970297029,0.8695596976266556,1.0,7/28,22.48%,PKHD1;MISP;LLGL1;ZW10;NDEL1;DCTN1;CDK5RAP2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.368949329367517,-0.9227934213105466,0.527972027972028,0.7992312724183577,1.0,4/11,22.80%,C1QTNF3;C1QTNF12;SIK1;EP300
prerank,negative regulation of translation (GO:0017148),0.3280590834691803,0.9227698251953267,0.6396588486140725,0.8692016708683162,1.0,30/87,28.61%,IGFBP5;SAMD4A;FTO;PUM1;ILF3;METTL16;AGO2;RBM4;CNOT8;CNOT10;EPRS1;DAPK3;CNOT9;SHMT1;SYNCRIP;EIF2AK4;UNK;CALR;FXR2;EIF2AK3;YBX1;RBM24;ROCK1;METTL14;MRPL13;TPR;RIDA;FXR1;YTHDF1;LARP1
prerank,regulation of microtubule-based process (GO:0032886),0.3619010618877217,0.9227017911360157,0.5778834720570749,0.8689296932236885,1.0,10/36,26.64%,EFNA5;PHLDB1;MARK4;HDAC6;ERBB2;CAMSAP3;CYLD;ROCK1;TAOK1;ATF5
prerank,myelin assembly (GO:0032288),0.4518097418576458,0.9224601371387954,0.5701754385964912,0.8690183367140448,1.0,3/10,12.75%,PMP22;CD9;NCMAP
prerank,membrane depolarization (GO:0051899),0.3671284666954958,0.922308520348074,0.5805658056580566,0.8689193877246976,1.0,4/32,10.59%,CACNA1G;SCN11A;CHRNB2;ABL1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3685749018774482,-0.9223026661879452,0.5520833333333334,0.79884306057878,1.0,4/10,18.25%,MTMR3;MFSD2A;DNAJC19;PHB2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.35888616325439204,0.9219684686734652,0.5835240274599542,0.8691934555734335,1.0,12/44,20.29%,PRKCD;PDCD4;IRAK3;CDK5RAP3;BMP4;PAQR3;PIK3CB;NF1;DNAJA1;AIDA;DUSP19;UCHL1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.4424832640475303,0.92191429492491,0.5736543909348442,0.8688799516600991,1.0,3/11,6.23%,IRS1;GHR;GIGYF1
prerank,base-excision repair (GO:0006284),0.3512849913674577,0.921630922595937,0.6015625,0.869048693174895,1.0,24/48,34.68%,MPG;HUWE1;ERCC5;OGG1;WRN;TDG;SMUG1;PARP1;POLB;APEX2;USP47;PARG;POLD1;POLG;XPA;PNKP;ADPRS;MBD4;XRCC1;ERCC6;POLQ;RPA3;PRMT6;RFC4
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.43483282671286067,0.9213213661272104,0.590782122905028,0.8692244339142533,1.0,4/13,15.26%,NFAT5;RHOA;IRAK1;IL6
prerank,proteasome assembly (GO:0043248),0.4493849352271938,0.9212181187986068,0.5827439886845828,0.8690087125994715,1.0,5/11,29.86%,PSMD11;OTUD6B;PSMD4;PSMG2;ADRM1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.3728795035469097,0.9209207660746384,0.5940119760479042,0.8692195988449252,1.0,11/31,21.66%,SRCIN1;ARC;SIPA1L1;TANC2;NLGN1;ARHGAP44;NGEF;EFNA1;CDK5;ABI2;LRRK2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3494375529935865,0.9205369650730971,0.6065759637188208,0.8695966615132736,1.0,24/52,37.01%,SAMD4A;NT5C3B;PATL1;LSM2;EXOSC4;CNOT8;TUT7;CNOT10;RC3H2;DIS3;CNOT9;TNKS1BP1;DCP1A;LSM5;EDC4;EXOSC2;DCPS;EXOSC3;CNOT4;CNOT6;PAN2;RC3H1;DCP1B;PNLDC1
prerank,actin filament organization (GO:0007015),0.31838790914360915,0.9203496654711063,0.681586978636826,0.8695511828385581,1.0,20/151,9.03%,RHOBTB1;GSN;RND3;DPYSL3;VILL;PLS1;PPP1R9B;COBL;ARHGAP17;CORO6;FAT1;TLE6;MYO1E;CDC42EP2;MCU;ABI1;ELMO3;DLG1;GAS2;RHOA
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.44854533074682623,0.9202194775452107,0.5813630041724618,0.8694023965025771,1.0,3/12,21.97%,STARD3NL;FDXR;STARD3
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.33392203945126453,0.9201452953829975,0.6267682263329706,0.8691499748198976,1.0,11/71,13.13%,PRKCD;PRKCE;VAV2;ARPC1B;ABI1;CYFIP1;FCER1G;WIPF1;ABL1;PIK3CB;MYH2
prerank,muscle tissue development (GO:0060537),-0.35291826753805877,-0.920106365943605,0.575091575091575,0.8024397616632757,1.0,3/13,3.22%,ENG;PTCH1;PGM5
prerank,cellular response to catecholamine stimulus (GO:0071870),0.38588761127433213,0.9200976299010927,0.5869837296620776,0.8688230913958145,1.0,9/23,21.66%,DRD1;ATF4;SLC9A1;ABL1;SIRT2;PRKACA;GNB1;ATP2B4;LRRK2
prerank,calcium import into the mitochondrion (GO:0036444),0.4473853237858973,0.9199889116561011,0.5718432510885341,0.868601625930761,1.0,4/10,23.19%,MCU;MICU2;MICU1;AFG3L2
prerank,transcription by RNA polymerase III (GO:0006383),0.3782193294077148,0.9197668017831744,0.5772946859903382,0.8686337402776133,1.0,10/27,22.66%,POLR3H;CRCP;POLR3GL;SNAPC4;GTF3C1;GTF3C4;POLR3K;GTF3A;TBP;ICE1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.26007976602060673,-0.9197153422427199,0.631578947368421,0.801849607794748,1.0,6/38,8.74%,BMP6;SASH1;LY86;CD180;DDX60;GBP5
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3870988807245594,0.919616198967065,0.5807259073842302,0.8685204325835338,1.0,7/24,20.97%,GHR;CYP1B1;HES5;F2R;IL6;PRLR;IL4
prerank,regulation of biosynthetic process (GO:0009889),-0.36479143065444963,-0.9195955967485252,0.5888501742160279,0.8006398667115348,1.0,3/11,15.01%,SLC25A33;MID1IP1;SNCA
prerank,negative regulation of ATPase activity (GO:0032780),-0.3161308157051481,-0.9193487857641998,0.5396825396825397,0.7997103093451162,1.0,5/16,20.66%,IFIT1;SIRT1;VCPKMT;PXK;PPIF
prerank,JNK cascade (GO:0007254),0.3568531656088067,0.9191297627501028,0.5983796296296297,0.8690896762504643,1.0,16/40,28.99%,MAP3K5;GPS1;MAPK8;IRAK1;TAB2;MAP3K12;MAP3K10;RPS27A;UBC;MAPK9;GPS2;MAP2K7;RIPK2;MAP3K11;UBE2V1;MAP2K4
prerank,monocyte differentiation (GO:0030224),0.4475305041650772,0.9186287299819597,0.6022889842632332,0.8697020471895331,1.0,2/10,9.70%,VEGFA;BMP4
prerank,negative regulation of MAPK cascade (GO:0043409),0.33041231448968084,0.9184993925025396,0.638682252922423,0.8695570779486412,1.0,16/87,12.92%,PRKCD;EMILIN1;TIMP3;EPHB2;SPRED2;SMAD4;IRAK3;CDK5RAP3;DLG1;BMP4;PAQR3;FOXM1;EZR;PIK3CB;PPEF2;PTPN2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3922208775298017,0.9169500994898544,0.5740498034076016,0.8722685272038329,1.0,5/21,6.98%,CACNA1C;CAMK2D;CALM2;DMD;ANK2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4050587913371401,0.9167831763810534,0.5826771653543307,0.8721940472833654,1.0,2/18,2.58%,GRIK4;UNC13B
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.4381043861075582,0.9167277178957451,0.5824022346368715,0.8714784592660699,1.0,4/12,13.52%,SLC9A1;CHERP;STIMATE;PTBP1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4381043861075582,0.9167277178957451,0.5824022346368715,0.8714784592660699,1.0,4/12,13.52%,SLC9A1;CHERP;STIMATE;PTBP1
prerank,negative regulation of developmental process (GO:0051093),0.33706522568540564,0.916660915337665,0.6220043572984749,0.8711947783360259,1.0,13/69,12.13%,GAS6;NFIB;GRIN3A;PARP3;PTPRS;HUWE1;SOX9;CST3;BMP4;ANP32B;FOXM1;NEUROD2;HEY1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.33292866179216085,0.9166141514648826,0.62486602357985,0.8708867660803449,1.0,37/72,37.43%,CHD1L;HORMAD1;PNRC2;ERCC5;ERCC4;RNASE6;OGG1;CUL4A;ERCC3;RAD50;ERCC2;PARP1;RPS27A;UBC;DCP1A;POLD1;GTF2H4;XPA;FBH1;DNASE1L2;DDB1;EDC4;DXO;RBX1;RNASE1;IHO1;ERCC1;POLK;RPA3;CUL4B;FAN1;RFC4;MRE11;DCP1B;POLD3;REXO4;MUS81
prerank,epithelial cell development (GO:0002064),0.3974097454449906,0.9163083440653296,0.5818181818181818,0.87108927976273,1.0,2/20,3.83%,LRTOMT;PKHD1
prerank,positive regulation of neuron death (GO:1901216),-0.25714475686141114,-0.9161659484995415,0.5895522388059702,0.8053253034317499,1.0,11/46,15.02%,EFNB2;WNT5A;PICALM;EPHA7;GRIN2B;NUPR1;EGR1;SARM1;C1QA;SNCA;TYROBP
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.2850276377505106,-0.9156353838232665,0.5945945945945946,0.804962672176254,1.0,5/27,7.99%,IL1RAPL1;CCDC88A;CTNNA2;NTNG1;HOMER1
prerank,regulation of protein secretion (GO:0050708),0.32076904188330607,0.9155981766105001,0.6438923395445134,0.8721286659879185,1.0,25/119,17.97%,CACNA1C;KCNB1;SLC12A2;ADAM9;UNC13B;TGFB3;APBB3;TGFB2;P3H1;PRKCA;DISP1;LLGL1;CACNA2D2;EZR;STXBP5;GLP1R;ERP29;PICK1;IL6;STX1A;APBB1;SLC2A2;SYTL4;IER3IP1;GOLPH3
prerank,response to hydroxyurea (GO:0072710),0.4525515114651081,0.9152961591768634,0.5832127351664255,0.8723157520595143,1.0,6/11,31.69%,DDI2;SPIDR;KAT7;DDX11;TIMELESS;BLM
prerank,hexose metabolic process (GO:0019318),0.3592660551497946,0.9151461553725683,0.5983213429256595,0.8721952568232477,1.0,11/39,20.88%,FUOM;SORD;GAA;PMM2;ADPGK;AKR1A1;HECTD4;SLC37A4;SLC35A2;GDPGP1;FPGT
prerank,regulation of ruffle assembly (GO:1900027),0.38329209159644395,0.9150199316513644,0.5788146279949559,0.8720347578247499,1.0,7/23,14.67%,RDX;EPS8L1;PFN2;FAM98A;NLGN1;NDEL1;PLEKHM1
prerank,heterochromatin assembly (GO:0031507),0.3942105170931439,0.9126522346912307,0.5810635538261998,0.8764287261457754,1.0,6/20,20.80%,BAZ2A;EZH1;HDAC1;SIRT2;HMGA1;SUV39H1
prerank,regulation of synapse maturation (GO:0090128),-0.3666603021081151,-0.9124880344877526,0.5411392405063291,0.8107902130647094,1.0,4/10,13.89%,NRXN1;ARHGEF15;YWHAZ;RELN
prerank,response to nitric oxide (GO:0071731),-0.35068065166232126,-0.9123358746921769,0.5699300699300699,0.8096209798180524,1.0,6/13,27.33%,GUCY1B1;KCNC2;FOXO1;MT3;MMP3;AQP1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4525874448265165,0.9121750840669344,0.5933908045977011,0.8769397175894614,1.0,5/10,19.88%,MTHFD2;MTHFD1;SHMT2;SHMT1;MTHFR
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.3525607955304082,-0.9121573345398583,0.547945205479452,0.808490480080354,1.0,2/11,8.10%,ABCG1;AGTR1
prerank,melanosome transport (GO:0032402),0.402628094543945,0.9120407089679046,0.589095744680851,0.8763670427757195,1.0,7/18,31.15%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,pigment granule transport (GO:0051904),0.402628094543945,0.9120407089679046,0.589095744680851,0.8763670427757195,1.0,7/18,31.15%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,cholesterol transport (GO:0030301),0.3493206236757965,0.9120306021387449,0.6180555555555556,0.8759746975740917,1.0,16/45,28.05%,LIMA1;SOAT1;CEL;TSKU;AKR1C1;NPC1;OSBP;ABCA1;CLU;STARD5;LDLR;STARD3;SERAC1;SOAT2;NPC2;OSBPL5
prerank,response to cytokine (GO:0034097),0.3128394802226254,0.9114670452167307,0.6812182741116751,0.8766788393718606,1.0,20/141,10.69%,PID1;COL3A1;ADAM9;AFF3;TIMP2;TIMP3;DPYSL3;NFAT5;HDAC4;STAT3;PRKCA;ADAM10;IFNLR1;IRAK3;CXCL16;RHOA;PTPN18;MAPK8;ANXA1;IRAK1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.35494958950655264,0.9113749879495997,0.6125592417061612,0.8764603010962091,1.0,4/39,7.96%,TCF7L2;MCU;AACS;CAPN10
prerank,rRNA methylation (GO:0031167),0.3871897657301665,0.9110191833779583,0.6133162612035852,0.8767516585127831,1.0,12/22,38.20%,EMG1;METTL16;TFB2M;FBL;BUD23;TRMT112;NSUN3;METTL15;MRM2;ZCCHC4;NSUN5;DIMT1
prerank,"phototransduction, visible light (GO:0007603)",0.4247055855412071,0.9109592118414187,0.5922330097087378,0.8764529274037529,1.0,4/14,20.86%,PDE6A;GNA11;SAG;GNB1
prerank,glycerolipid metabolic process (GO:0046486),-0.349366523960738,-0.9109454659582906,0.5445205479452054,0.8099105097847046,1.0,5/11,14.57%,DGKB;DGKG;GAL3ST1;DGKZ;DGKA
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.3486106778612708,-0.9108911401670517,0.5510204081632653,0.808509731078679,1.0,2/12,3.61%,SEMA6A;ADAMTS12
prerank,cellular lipid catabolic process (GO:0044242),0.3727460338226301,0.9107414885994795,0.5896168108776267,0.8764598151263621,1.0,9/27,26.43%,CYP1B1;CEL;SIRT2;PLA2G15;ACBD5;ABHD12;ACOT8;FAAH;ANGPTL3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.45075301018651137,0.9103058097250758,0.6096866096866097,0.8768836361813122,1.0,5/11,30.27%,NRP1;HGF;SIRT2;BCAR1;RAC1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.43044268749070635,0.9102427658407587,0.5934065934065934,0.8765969983530654,1.0,4/13,9.61%,ENTPD2;ENTPD6;DCTPP1;SMPDL3A
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3342434668585882,0.9102156674629907,0.6195175438596491,0.8762285412566136,1.0,11/67,12.40%,PGF;VEGFA;VAV2;SULF1;ABI1;CYFIP1;RHOA;PAK2;ITGAV;PIK3CB;NRP1
prerank,retinoid metabolic process (GO:0001523),0.33472006353269795,0.9099860474311874,0.6521739130434783,0.8762781882908055,1.0,5/71,3.46%,GPC6;LRP1;GPC3;SDC1;CYP1B1
prerank,macromolecule catabolic process (GO:0009057),0.3698762122869298,0.9096586213359219,0.5864197530864198,0.8764796284683808,1.0,7/26,23.52%,NEDD4;LRSAM1;UCHL3;IDE;MVB12A;UVRAG;USE1
prerank,apoptotic process (GO:0006915),0.3095170237018504,0.9096164766878213,0.7198795180722891,0.8761557788987041,1.0,43/203,20.16%,PLAGL1;PRKCD;EFNA5;CIT;PDCD4;PRKCE;MAGI3;FAP;RELT;TGFBR2;RAF1;MCM2;PAK4;IAPP;DAP;OGT;CSRNP1;ATN1;YARS1;AIFM1;TNFRSF10B;ERCC3;HSPD1;LIG4;ERCC2;MAP3K10;CASP1;DMPK;RHOB;ING4;CXCR4;PLSCR3;PARP1;HIP1;DAPK3;BNIP1;BID;AKT1;RFK;IRF3;NFKBIA;CDK5;TRAIP
prerank,neutrophil chemotaxis (GO:0030593),0.341814419894343,0.9093788118758965,0.6218961625282167,0.8762358230994174,1.0,6/53,9.29%,CCL13;CCL15;TGFB2;GBF1;FCER1G;EDN3
prerank,cellular protein metabolic process (GO:0044267),0.30489774409412074,0.9093103026299907,0.755,0.8759648068398718,1.0,94/396,24.21%,PLOD2;ST8SIA2;IGFBP5;CHRDL1;FSTL1;PCSK5;GAS6;RRBP1;RPSA;GPC3;P4HB;DMP1;TGM5;PAPPA;GGCX;HM13;PRKCSH;PRKDC;ADAM10;SPG7;LOX;ABCF1;QSOX1;CKAP4;MBTPS1;NAGPA;HARS2;AKT2;GSPT1;CST3;WWP2;CALU;BMP4;MRPS18B;RIPK3;RCN1;ABL1;LCMT1;FDXR;CHEK2;FBXO22;ATG3;MRPS14;AGO2;EIF4G1;CCDC59;MRPL35;SPCS2;NUCB1;MIA3;MRPS17;UBE2L6;PSEN2;IL6;IDE;VCAN;LIPT1;RPS27A;YARS2;GNMT;NTAQ1;PCMT1;MEN1;NAPSA;ARAF;IGFBP6;DMBT1;FBXW2;SARS1;UBE2G2;RPL7A;APLP2;SEC11A;DARS1;PENK;CSNK1G3;MRPS21;LOXL2;ASMT;CDKL3;STK38;UBA3;MMP2;AFG3L2;MAN2B1;B4GALT7;STOML2;FBXO11;MRPS18A;VGF;RPS9;PHEX;PHKA2;MRPL37
prerank,positive regulation of nuclear division (GO:0051785),-0.28879399433528646,-0.9092861522301291,0.6089108910891089,0.810674503791128,1.0,3/25,4.50%,INSR;TGFA;PDGFRB
prerank,protein K63-linked deubiquitination (GO:0070536),0.3692557690522405,0.9091732591601441,0.6056860321384425,0.8758278249069672,1.0,12/31,23.23%,USP50;OTUB2;USP7;USP33;USP13;PSMD14;OTUD5;SHMT2;YOD1;ZRANB1;BRCC3;CYLD
prerank,regulation of response to biotic stimulus (GO:0002831),0.37159285913656187,0.9091588433583137,0.6031363088057901,0.8754455132096581,1.0,8/28,25.60%,FOXP1;TRAF3;N4BP1;APPL2;APPL1;BIRC3;XIAP;TKFC
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.41959082366132094,0.9091067990329128,0.5986111111111111,0.8751350608520497,1.0,3/14,13.12%,RARA;ANXA1;CD80
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.38476718769493184,0.9085246106654623,0.6228070175438597,0.8758912915300475,1.0,5/23,15.26%,GHR;CYP1B1;HES5;F2R;IL6
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.2297832204264881,-0.9084798971438615,0.7303370786516854,0.8109927800738456,1.0,21/69,24.19%,COX8A;COX6C;NDUFC2;COX4I1;CYC1;UQCRC2;UQCR11;COX10;NDUFA13;NDUFB2;UQCRB;NDUFAF1;NDUFB7;COX5B;UQCRC1;NDUFS1;NDUFA8;NDUFB11;UQCRQ;NDUFS6;NDUFA4
prerank,determination of heart left/right asymmetry (GO:0061371),0.35288053397283575,0.9084695206299656,0.6143344709897611,0.8755827889178879,1.0,8/43,16.20%,MICAL2;TGFBR2;TBX21;CCDC39;SRF;SMO;BBS5;NPHP3
prerank,regulation of actomyosin structure organization (GO:0110020),0.4250636760580863,0.9083835173087643,0.592741935483871,0.875338041947781,1.0,3/13,6.94%,ASAP3;ALMS1;SLC9A1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.34566642426591626,0.9081549361313408,0.6109839816933639,0.8754004444903971,1.0,10/46,12.71%,SRGAP2;SRCIN1;TMEFF2;NTN4;EPHB3;ILK;RHOA;ITGAV;NRP1;PARVA
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.30709546870579424,0.9080645303371148,0.75,0.8751639383181645,1.0,73/306,22.97%,ST3GAL4;EXT1;RRBP1;RPSA;HELB;TOPORS;BAZ2A;POLE2;EIF4G2;RMI2;ABCF1;MCM2;HARS2;ST3GAL2;GSPT1;CDC6;B4GALT5;RBBP8;RAD1;WRN;MRPS18B;ING5;NFKBIB;TERT;ATM;GAL3ST4;RAD50;MRPS14;EEF1G;XAB2;AGO2;EIF4G1;CDC45;MRPL35;INHBA;MEF2A;MMS19;POLR2F;MRPS17;ING4;EEF2K;ATRIP;B3GNT6;RPS27A;HUS1;MCM4;EEF1B2;YARS2;REV1;TUFM;ORC2;GOLPH3;E2F1;EEFSEC;DBF4;EXT2;SARS1;CDK2;RPL7A;DARS1;KAT7;TBRG1;MED20;GTPBP2;UPF1;POLR2B;TOPBP1;MRPS21;ASMT;PTMS;TOP1;DONSON;TOP1MT
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.37303935379238085,0.9078422126060269,0.6076555023923444,0.8751625210729183,1.0,10/29,26.25%,CHUK;TRAF3;TANK;RPS27A;UBC;IKBKE;IRF3;BIRC3;TBK1;RIPK1
prerank,regulation of Notch signaling pathway (GO:0008593),0.3292707208026429,0.9078372124008136,0.6292372881355932,0.8747623904377132,1.0,10/76,8.96%,EGFR;CCN3;ZMIZ1;TGFB2;STAT3;POGLUT1;JAG1;MMP14;LLGL1;WWP2
prerank,negative regulation of gene expression (GO:0010629),0.3056707331434414,0.9076332658399553,0.756,0.8747509199666279,1.0,57/302,18.44%,ESR1;FOXP1;ID2;IGFBP5;VEGFA;FGF2;SLC24A3;EMILIN1;NCOR2;ANXA7;SAMD4A;HDAC9;TGFB2;CD3E;XDH;PHF1;ADAM10;RPS6KA4;TRIM27;DGKQ;ZC3H12D;WWP2;ILF3;BMP4;AGO1;DIS3L2;TERT;BMPR1A;METTL16;KDM4A;CIDEA;PTRH2;HDAC1;AGO2;SMO;RBBP7;SETDB1;LSM2;ERP29;PTBP1;RBM4;RUNX1;ZNF148;VDR;CNOT8;N4BP1;ZC3H10;CNOT10;RBL2;SLC2A10;FLCN;EPRS1;CITED2;DAPK3;TRIM6;CNOT9;SHMT1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.427891487501662,0.9074852217509533,0.5859598853868195,0.8746207953956183,1.0,4/12,22.13%,CDC6;CHEK2;HUS1;TOPBP1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4129015064104328,0.9072253744686288,0.5799207397622193,0.8747117315024631,1.0,5/16,18.70%,NPR3;TERT;PIK3CB;S100A1;AKT1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.32865438695291993,0.9064715961628045,0.6395222584147665,0.875853295414479,1.0,11/73,13.13%,PRKCD;PRKCE;VAV2;ARPC1B;ABI1;CYFIP1;FCER1G;WIPF1;ABL1;PIK3CB;MYH2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.2864630622021031,-0.9064292173939963,0.6197916666666666,0.8141438493456884,1.0,5/23,7.31%,ACSL1;ELOVL7;HACD1;FAR2;HSD17B12
prerank,response to interferon-alpha (GO:0035455),0.41209853684955583,0.9063928608229382,0.5966620305980529,0.8755955103512172,1.0,1/16,0.97%,GAS6
prerank,negative regulation of protein transport (GO:0051224),0.3761646007872789,0.9055928131252731,0.6161490683229813,0.876781114414054,1.0,8/25,26.37%,PKDCC;WWP2;ERP29;DRD2;CSK;SNX3;HMGCR;NDFIP1
prerank,positive regulation of protein secretion (GO:0050714),0.3321532935684958,0.9051876421619176,0.6579520697167756,0.8772005010400811,1.0,9/69,7.96%,ADAM9;TCF7L2;UNC13B;TGFB3;APBB3;TGFB2;MCU;AACS;CAPN10
prerank,regulation of rRNA processing (GO:2000232),0.4079220463030204,0.9050882064306203,0.5930388219544847,0.8769893171866668,1.0,12/16,38.91%,RIOK1;USP36;KAT2B;WDR75;BUD23;RIOK2;TRMT112;SIRT7;UTP15;DIMT1;YTHDF2;WDR43
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3666493442794022,0.9048432558802745,0.6113116726835138,0.8770515279428813,1.0,11/29,22.72%,ACSF3;ELOVL5;SCD5;CBR4;PPT2;ACACA;ACSL3;HSD17B8;ACSL6;ACSBG1;GCDH
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.34380164768984606,-0.904744196641393,0.5687732342007435,0.8165052928950091,1.0,10/13,36.62%,UNC93B1;MYD88;PIK3R4;TLR7;PIK3AP1;IRAK2;TNIP2;TRAF6;IRAK4;PIK3C3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.42713965356426026,0.9046291419848184,0.6040268456375839,0.8770357930856725,1.0,4/13,14.77%,DKK3;SOD1;BMP5;CYP27B1
prerank,histone H2A ubiquitination (GO:0033522),0.41380681880985215,0.9044479055032062,0.6048064085447263,0.8769890250474627,1.0,5/17,18.73%,UBE2B;RNF2;RING1;RYBP;UBR2
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.31382848803362123,0.9043381613767535,0.6772867420349434,0.8768079769714073,1.0,26/124,16.38%,TCF7L2;SFRP4;TIAM1;PRICKLE1;PSMD7;PDE6A;AP2A1;PSMA8;DVL1;FZD7;FZD5;NFATC1;RHOA;PSMA4;AGO1;PSMD12;AGO2;PSMA6;AP2A2;CLTC;GNAO1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14
prerank,modified amino acid transport (GO:0072337),0.40807446573547335,0.9042936708758841,0.575197889182058,0.8764784843540961,1.0,2/15,5.92%,SLC5A6;SLC25A32
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4284316733992581,0.9041601740131264,0.5876436781609196,0.8763237565556611,1.0,4/12,21.42%,RDX;BRD8;KLF9;CTSB
prerank,regulation of dendritic spine development (GO:0060998),0.3988542991025291,0.9039967659140001,0.6078431372549019,0.8762279150841612,1.0,6/19,13.02%,GRIN3A;PTPRS;TANC2;SHANK1;FOXO6;NLGN1
prerank,regulation of cell adhesion (GO:0030155),0.31552978918317903,0.9038975807496591,0.6810699588477366,0.876013345586049,1.0,12/129,6.35%,PLXNA4;ZFHX3;VEGFA;EFNA5;P4HB;TGFBI;EPHB2;SPN;PKHD1;PRKCA;EPHB3;ADAM10
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3382999107284242,0.9038472183729132,0.6224944320712695,0.8757102506377723,1.0,15/57,21.82%,XPO1;LTV1;RRS1;EMG1;CUL4A;RIOK1;NVL;MRTO4;BYSL;BOP1;METTL17;NOC2L;WDR12;GTF3A;PAK1IP1
prerank,protein homotetramerization (GO:0051289),0.3449656646444801,0.9037763636012484,0.6259798432250839,0.875467021575662,1.0,12/49,19.91%,KCNJ2;CRYZ;TRPM4;CBR4;ACACA;PKD2L1;SHMT2;GNMT;ACOT13;SHMT1;TK1;APPL2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.4498865018877636,0.9034396059730679,0.6185133239831697,0.8757101669690721,1.0,3/10,13.93%,ADAM10;STK39;WNK1
prerank,sulfur compound catabolic process (GO:0044273),0.35226423281654623,0.9027770371091594,0.6158392434988179,0.8765866786461,1.0,12/38,25.12%,BGN;ARSB;CSPG4;MPST;ACAT1;HEXA;VCAN;GLB1;CHAC2;DPEP1;FITM2;GNS
prerank,negative regulation of neuron death (GO:1901215),0.31923157583912826,0.9026987801343921,0.6534446764091858,0.8763350789985661,1.0,23/93,22.98%,SIX1;NTRK1;TGFB3;SIX4;ATF4;TNFRSF1B;NRBP2;SOD1;EIF4G1;LIG4;F2R;NDNF;CLCF1;CLN3;AKT1;GDNF;CDK5;NFATC4;CHMP4A;CHMP4B;LRRK2;PRKCI;GPNMB
prerank,synapse organization (GO:0050808),0.31059867249005724,0.9026318951274884,0.6705020920502092,0.8760698815131595,1.0,13/125,5.69%,PCDHB16;GPC6;CTNND2;NEDD4;FARP1;DRD1;UNC13B;PTPRS;PTPRF;SEMA3E;LRFN4;PPFIA1;DVL1
prerank,negative regulation of receptor binding (GO:1900121),0.4514133238231136,0.9025670251940922,0.6017069701280228,0.8757980174509121,1.0,2/10,8.27%,PTPRF;NOG
prerank,neuromuscular process (GO:0050905),0.3984484610285097,0.9025191582804212,0.5897435897435898,0.8754854109056727,1.0,6/16,20.24%,PRRT2;SHANK1;UBA5;CLN3;MYCBP2;DCTN1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4173687996278822,0.9022658017996426,0.6114130434782609,0.8755768621150872,1.0,4/14,18.37%,ADAM10;BACE1;PSEN2;CLN3
prerank,blood circulation (GO:0008015),0.3460402385412884,0.9020003716127288,0.622876557191393,0.8756788129210761,1.0,5/49,3.89%,ELN;SGCD;GCLC;HCN4;MEOX2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.3993432494098305,0.9017948902595947,0.607741935483871,0.875662916774269,1.0,2/17,2.89%,PDCD4;TGFB3
prerank,heterocycle biosynthetic process (GO:0018130),0.4166255104175793,0.9015400045648678,0.5879945429740792,0.8757279528393885,1.0,4/14,22.41%,LIAS;NFS1;NOXRED1;PYCR1
prerank,cellular response to drug (GO:0035690),-0.2902753933249885,-0.9015163871459504,0.5953488372093023,0.8222658790003119,1.0,5/25,10.27%,PPM1E;ACER2;TFRC;AIM2;PDE4B
prerank,pancreas development (GO:0031016),0.4286756509092613,0.9014023615556982,0.6096904441453567,0.8755976216865793,1.0,3/12,16.20%,TCF7L2;CCDC39;NPHP3
prerank,Fc receptor signaling pathway (GO:0038093),0.3175072795340297,0.9012899523492555,0.669109947643979,0.8754054008580977,1.0,32/110,23.96%,GAB2;VAV2;PSMD7;SHC1;PSMA8;FCER1G;NFATC1;PAK2;MAPK8;PSMA4;CHUK;TAB2;PDPK1;PSMD12;PIK3CB;CUL1;PSMA6;NFATC3;PSMD1;SOS1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;MAPK9;MAP2K7;PSMB1;PSMD4;PSMA5;PSMA7;FOS
prerank,genitalia development (GO:0048806),0.43089117690404766,0.9012833014956386,0.6145251396648045,0.8750163942598919,1.0,1/12,0.46%,PKD1
prerank,regulation of cartilage development (GO:0061035),0.4000186432332065,0.9012349068390139,0.6391752577319587,0.8747048435603839,1.0,6/18,14.92%,BMP1;MBOAT2;SOX9;BMP4;KAT2A;SCIN
prerank,actin filament network formation (GO:0051639),0.43973716399304963,0.9010955907889188,0.6112676056338028,0.8745596290435954,1.0,2/11,4.03%,PLS1;COBL
prerank,positive regulation of transferase activity (GO:0051347),0.3135922343547394,0.9008103263774584,0.7093142272262026,0.8747084384607486,1.0,23/142,12.60%,EGFR;DDR2;NTRK3;NTRK1;MAPK15;EPHB2;TOPORS;EPHB3;EPHB6;DCUN1D5;NEK7;FGFR1;HNRNPA2B1;ROR1;FGFR2;MUSK;NVL;LMO4;AXIN1;PABPN1;DDR1;RAD50;DCUN1D2
prerank,epidermis development (GO:0008544),0.3366313824698306,0.9007330525141307,0.6269487750556793,0.8744561196566621,1.0,9/56,16.37%,KRTDAP;TGM5;PLOD1;FGFR2;CRABP2;HDAC1;ALDH3A2;GRHL1;EMP1
prerank,neuron projection extension (GO:1990138),-0.26614738512747105,-0.9005010097795397,0.6325301204819277,0.8231211653175313,1.0,6/32,7.63%,ALCAM;AUTS2;SEMA5A;NRP2;FLRT1;SH3GL2
prerank,regulation of T cell proliferation (GO:0042129),0.33258355213897667,0.9000823312222473,0.6286031042128604,0.8753212524144112,1.0,13/61,23.46%,SPN;GLMN;CD3E;TNFRSF1B;ANXA1;RIPK3;VTCN1;CD80;IL6;TNFSF18;IL4;GPNMB;DLG5
prerank,leukotriene biosynthetic process (GO:0019370),0.4150930562782862,0.8999236371663942,0.6043360433604336,0.8752327953667609,1.0,2/14,9.99%,PLA2G4A;PLA2G5
prerank,regulation of centriole replication (GO:0046599),0.39504485111074567,0.8998486234187659,0.5971128608923885,0.8749728036754253,1.0,8/18,28.54%,ALMS1;KAT2A;NUP62;CDK5RAP2;KAT2B;PLK4;SPICE1;STIL
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.30959100692785346,0.8994882243203013,0.7137055837563452,0.8752715760235238,1.0,16/159,6.39%,PCDHB16;PKD1;CDH11;GPC6;EMB;HMCN1;PTPRS;PTPRF;TGFB2;NECTIN3;LRFN4;CRB1;ACVR1;AMIGO3;FAT2;TGFBR2
prerank,positive regulation of cellular protein localization (GO:1903829),0.3275476215985309,0.8988032345679581,0.6469945355191257,0.8761909811162176,1.0,16/69,20.88%,GNL3;WWTR1;LIMK2;TM9SF4;MEAK7;RIC3;CDK5RAP3;TRAPPC12;SESN2;MARK4;STX4;ORMDL3;CDT1;AKT1;KAT7;NUP62
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.32527422130490896,0.8986230685957658,0.6476906552094522,0.876136105861123,1.0,16/70,17.25%,SRGAP2;SRCIN1;TMEFF2;PKHD1;NTN4;ATF4;EPHB3;ILK;RHOA;ITGAV;NRP1;PARVA;SIPA1L3;MICALL2;TBCD;EFNA1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.4252974013650951,0.8984945587707299,0.5947802197802198,0.8759885502231062,1.0,6/13,26.32%,HEXIM1;LARP7;NELFB;HNRNPU;RECQL5;NELFA
prerank,ether lipid metabolic process (GO:0046485),0.4160019523476117,0.8983887440284243,0.6010854816824966,0.8757931878985539,1.0,6/14,27.71%,PEX7;FAR1;AGMO;AGPS;NCEH1;TMEM86B
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.30153558491472504,-0.8972304786326328,0.6,0.8290174879859714,1.0,2/20,2.11%,IL1R1;B2M
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3489365048997992,0.8966690211120918,0.6280137772675086,0.8787904017123396,1.0,4/39,6.53%,VEGFA;FXYD5;RDX;JAG1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.30234348326485494,-0.8961240965579947,0.6069651741293532,0.8298910170004224,1.0,5/21,9.38%,ADCY5;GUCY1B1;ADCY1;ADCY4;NPR1
prerank,negative regulation of transposition (GO:0010529),0.3977184540529583,0.8958975788580223,0.5989010989010989,0.879836093335728,1.0,6/16,34.00%,TEX15;TUT7;UBR2;MOV10;SIRT7;DDX4
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.41207379643399816,0.8958321808600941,0.6021798365122616,0.8795612657434181,1.0,5/15,16.22%,CAMK2D;PRKCA;SLC9A1;MEF2A;PARP1
prerank,embryonic heart tube development (GO:0035050),-0.3257580259554086,-0.8957702906516432,0.5910780669144982,0.8291765438694434,1.0,5/14,17.06%,RYR2;SOX17;TBX2;SOX18;NDRG4
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3360562638747613,0.8957690736060612,0.6420454545454546,0.8792725616441174,1.0,9/51,12.61%,MYOC;TGFB3;SORBS3;S100A10;PFN2;RHOA;ABL1;NRP1;TGFBR1
prerank,regulation of protein ubiquitination (GO:0031396),0.3161949780024227,0.8956405583465148,0.6825726141078838,0.8791134972325911,1.0,40/108,30.44%,PRR7;PRICKLE1;NXN;HUWE1;CDK5RAP3;OGT;AXIN1;SMAD7;CHP1;TGFBR1;PHF23;UBQLN1;U2AF2;SQSTM1;ARRB1;STUB1;N4BP1;MINAR1;UFL1;AKT1;DNAJA1;MYCBP2;LRRK2;BIRC3;DERL1;USP4;CAMLG;GTPBP4;PINK1;RCHY1;XIAP;DAXX;NDFIP1;RIPK2;SVBP;PER2;SPOPL;PRMT3;PRKN;HSP90AA1
prerank,regulation of Golgi organization (GO:1903358),0.4012421949103512,0.8956184419100754,0.594488188976378,0.878753774494925,1.0,7/17,33.63%,STX5;AKAP9;ARMH3;CAMSAP3;MYO5A;EHD3;STX18
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.4157590678057247,0.8954690381200333,0.5970350404312669,0.8786387855387067,1.0,6/13,23.15%,UBA5;SAE1;DESI2;DESI1;UBA3;SENP6
prerank,outer dynein arm assembly (GO:0036158),0.41514527750709607,0.8954105891700487,0.6317204301075269,0.878342388208572,1.0,5/15,26.05%,DNAH8;ODAD2;DNAAF4;DNAAF5;DNAL1
prerank,regulation of lipid storage (GO:0010883),0.37790751002259104,0.8953991761599208,0.6361290322580645,0.8779557739977517,1.0,7/22,19.73%,FTO;ITGAV;PTPN2;IL6;MEST;IKBKE;NFKBIA
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.39755609544004167,0.89464343798623,0.5746971736204576,0.8790012052462304,1.0,2/16,4.39%,ST8SIA2;ST6GALNAC5
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2993972781448233,-0.8941023441895027,0.6186046511627907,0.8314043904743171,1.0,4/18,7.31%,ACSL1;ELOVL7;HACD1;HSD17B12
prerank,regulation of Rho protein signal transduction (GO:0035023),0.32430427677415835,0.8940061157809441,0.6648648648648648,0.8798280726874824,1.0,14/72,15.27%,MYOC;COL3A1;ARHGEF28;EPS8L1;BCR;RAF1;GPR20;ABL1;NRP1;SCAI;F2R;ABCA1;AKAP13;ARRB1
prerank,negative regulation of cation channel activity (GO:2001258),0.3694634126739945,0.893861344823891,0.6185044359949303,0.8796992330056944,1.0,7/26,24.26%,EPHB2;CALM2;UBQLN1;CALM3;DRD2;FKBP1B;CBARP
prerank,regulation of RNA export from nucleus (GO:0046831),0.43155590370531893,0.8934194526646612,0.6187150837988827,0.8801564740027801,1.0,5/11,26.42%,KHDRBS1;CPSF6;NCBP2;SETD2;TPR
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.39279088529301576,0.893278854305239,0.6175710594315246,0.8800167138326617,1.0,1/21,0.44%,FOXP1
prerank,glycolipid metabolic process (GO:0006664),0.34380110510690504,0.8932274591272679,0.6601830663615561,0.8797102044744382,1.0,10/47,19.42%,ST3GAL4;PIGW;SMPD4;ARSA;ST3GAL2;GALC;HEXA;GLB1;SUMF2;ASAH1
prerank,isotype switching (GO:0045190),0.44410676243663055,0.893133712004344,0.6129496402877698,0.8794814824049826,1.0,6/10,38.42%,HSPD1;LIG4;MSH2;EXOSC3;RNF8;RNF168
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.31325387959919015,0.8926868565781186,0.6846473029045643,0.8799139773976994,1.0,16/107,11.18%,SLC39A14;ATP1B1;SLC24A3;CCL13;PKHD1;CCL15;SLC39A7;SLC10A7;ANK2;CHERP;STIM1;EDN3;SLC30A5;SLC39A13;CSRP3;TMEM165
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3621882093753941,-0.8924471454872808,0.5945945945945946,0.8335402290118298,1.0,5/10,16.30%,LPGAT1;NR1H3;SLC45A3;MID1IP1;ABCD2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3081009536851198,0.8922341446064291,0.729757085020243,0.8803823064697622,1.0,35/161,16.38%,LRP6;TCF7L2;SFRP4;PRICKLE1;DKK3;PSMD7;TLE2;WWTR1;PTPRU;TLE6;PSMA8;DACT1;DVL1;SOX9;NOG;DACT3;TLE3;PSMA4;TPBG;AXIN1;INVS;PSMD12;HDAC1;PSMA6;LIMD1;DAB2;FUZ;PSMD1;PSMC5;LATS2;PSMD11;MLLT3;NPHP3;PSMC4;PSMD14
prerank,retrograde axonal transport (GO:0008090),0.40330941923541624,0.8922089493167495,0.6147757255936676,0.8800300191160011,1.0,5/16,22.21%,DLG2;DYNC1H1;SOD1;ACTR10;NEFL
prerank,regulation of interleukin-1 beta production (GO:0032651),0.32951376379374225,0.8919584734644783,0.6695842450765864,0.8800884132214102,1.0,9/66,15.26%,FOXP1;CARD16;STAT3;USP50;FZD5;GIT1;F2R;CASP1;IL6
prerank,regulation of macrophage cytokine production (GO:0010935),0.4207649907440695,0.8916975648916318,0.631432545201669,0.8801806716063799,1.0,3/13,7.14%,TGFB3;TGFB2;IRAK3
prerank,toll-like receptor signaling pathway (GO:0002224),0.31917226345649463,0.8915855969050781,0.6847710330138446,0.8800052465524105,1.0,17/84,22.34%,LBP;SCARA3;HMGB1;IRAK3;CHUK;IRAK1;TAB2;TRAF3;HSPD1;S100A1;COLEC12;RPS27A;UBC;CTSB;TLR1;CTSK;BIRC3
prerank,positive regulation of DNA recombination (GO:0045911),0.36552847635250146,0.8915789882517159,0.6164383561643836,0.8796212396365988,1.0,13/27,30.17%,FUS;KMT5C;WDR48;ERCC2;MMS19;PARP1;MAD2L2;ACTR2;WAS;SHLD3;SHLD1;HMCES;TIMELESS
prerank,autonomic nervous system development (GO:0048483),0.39199847042901714,0.8909236485186188,0.6086956521739131,0.8804772666989639,1.0,5/17,23.14%,NTRK1;NRP1;NF1;GDNF;SOX8
prerank,protein acetylation (GO:0006473),0.3639577220286653,0.8907718049362581,0.6214285714285714,0.880379588549562,1.0,9/30,26.60%,NAA60;NAA40;ING5;NAA16;ING4;CREBBP;KAT2B;NAA15;ESCO1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.4105912518948285,0.8905660252977143,0.6131578947368421,0.8803519359552838,1.0,3/15,12.70%,PABPC1;TENT4B;AGO2
prerank,lipid modification (GO:0030258),0.3470212434303058,0.8905181544420323,0.6380510440835266,0.8800338636095063,1.0,6/37,10.45%,PLPP3;PLPP5;PLPP1;MBOAT2;DGKQ;LPCAT3
prerank,negative regulation of T cell differentiation (GO:0045581),0.4464905468734809,0.8905176678527991,0.6193181818181818,0.8796358377945002,1.0,3/10,24.24%,BMP4;LAG3;GLI3
prerank,positive chemotaxis (GO:0050918),0.4012439405623036,0.8904373941113227,0.6138743455497382,0.8793873188217812,1.0,1/17,0.78%,VEGFA
prerank,protein polyglutamylation (GO:0018095),0.4240030753530609,0.8902151870018614,0.6283687943262412,0.8794263728327912,1.0,3/11,14.97%,TTLL2;TPGS1;CEP41
prerank,positive regulation of cation channel activity (GO:2001259),0.3486121967093203,0.8902007921033802,0.6471277842907386,0.8790552732847329,1.0,8/40,16.86%,EPHB2;ARC;CALM2;ANK2;KCNIP2;P2RY6;STAC3;CALM3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3694351726113455,0.890114719790466,0.6155717761557178,0.8788312033561902,1.0,5/26,8.56%,IRS1;RHOQ;C2CD5;CAPN10;AKT2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3644265871288093,0.8897672928926231,0.6336515513126492,0.8790589126334974,1.0,10/30,26.25%,CHUK;TRAF3;TANK;RPS27A;UBC;IKBKE;IRF3;BIRC3;TBK1;RIPK1
prerank,positive regulation of cellular component organization (GO:0051130),0.31440625686507345,0.8892626944411809,0.6818181818181818,0.8795961725627347,1.0,31/107,22.66%,TRABD2B;VEGFA;LRP1;MPP7;GPC3;TGFB3;TGFB2;VCP;CDC42EP2;SLF2;PLEKHM2;SPIDR;NEUROD2;TMED9;TGFBR1;ADD1;RUNX1;DAB2;ANAPC2;SUMO1;CD151;CDT1;BID;CDC20;PTPN23;DCTN1;CLU;SLF1;LMAN1;CAMK1;ICE1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3987643244767968,0.8886989344432177,0.617157490396927,0.8802933723625612,1.0,3/18,7.76%,VEGFA;ADCY8;RPS6KA4
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.3268266284550265,-0.8885561741182364,0.6111111111111112,0.8406145151538781,1.0,6/14,17.88%,GMPS;ADK;IMPDH1;ADSS1;LHPP;PPAT
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.32786987970267745,-0.8881475283542403,0.6022304832713755,0.8399972169328794,1.0,12/14,43.80%,PAEP;IL17D;CD84;RASGRP1;IL18;ISL1;CARD9;IL23A;IL23R;IL12B;IL17F;IL1B
prerank,negative regulation of interleukin-8 production (GO:0032717),0.40469608014264413,0.887883288344125,0.6241787122207622,0.881408566886539,1.0,4/17,15.27%,ANXA4;ANXA1;MAPKBP1;ARRB1
prerank,T cell proliferation (GO:0042098),-0.3341028689844914,-0.8875561469939058,0.5957446808510638,0.8397437118002598,1.0,1/13,0.49%,CADM1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.34736315882308966,0.8868216362639545,0.6620370370370371,0.8829923720313061,1.0,7/38,18.49%,ESR1;RORA;MAPKBP1;TANK;PER1;USP10;ZMYND11
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.39208038553609403,0.8867067001423963,0.62109375,0.882798545501015,1.0,4/19,9.84%,VEGFA;PTPRU;DENND6A;FOXA1
prerank,regulation of myoblast fusion (GO:1901739),0.43277737674136757,0.8863953387948815,0.6232876712328768,0.8829664333065247,1.0,2/11,7.40%,EHD1;EHD2
prerank,lysine catabolic process (GO:0006554),0.43112701827292427,0.8858009925893688,0.6301369863013698,0.8832869658188605,1.0,4/12,24.48%,HYKK;PHYKPL;GCDH;CRYM
prerank,lysine metabolic process (GO:0006553),0.43112701827292427,0.8858009925893688,0.6301369863013698,0.8832869658188605,1.0,4/12,24.48%,HYKK;PHYKPL;GCDH;CRYM
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3411525410302245,0.8857631014492031,0.649643705463183,0.8829540421354581,1.0,19/43,32.51%,INTS3;CDC6;CDK5RAP3;ATM;RINT1;FOXN3;HUS1;BRCC3;TOPBP1;DONSON;TAOK3;TAOK2;TAOK1;NOP53;TRIM39;PABIR1;RAD17;BLM;CHFR
prerank,protein catabolic process (GO:0030163),0.3279634987085235,0.8856470901038416,0.6596916299559471,0.8827629079742854,1.0,25/59,30.44%,VCP;LRSAM1;PSMA8;SOCS6;DDI2;UCHL3;CHEK2;ATE1;NGLY1;FBXO17;IDE;UBE2G2;LAMP2;USE1;OGA;ADAMTS9;HTRA2;RIPK1;CLN5;MANBA;DDB1;STT3B;NR1D1;PRKN;HSP90AA1
prerank,regulation of centrosome duplication (GO:0010824),0.35727442577668406,0.8855681865017363,0.6364749082007344,0.8825182397563971,1.0,9/30,25.36%,PKHD1;ALMS1;CHMP3;CHMP4B;PDCD6IP;XRCC3;TMEM67;CHMP2A;SPICE1
prerank,positive regulation of type I interferon production (GO:0032481),0.3199884838169245,0.8851098872398002,0.6837606837606838,0.8829765776668432,1.0,33/73,32.38%,MAVS;PRKDC;POLR3H;CHUK;IRAK1;CRCP;HSPD1;POLR3GL;POLR2F;TOMM70;CREBBP;NFKB2;XRCC6;IRF3;POLR3K;POLR1C;SETD2;TBK1;PTPN11;POLR2H;CGAS;DDX41;RIPK2;POLR3E;RNF135;POLR2L;CTNNB1;HSP90AA1;RIOK3;NFKB1;POLR3F;POLR2K;IFIH1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3561410620714348,0.8847923311759394,0.6426829268292683,0.8831747102318146,1.0,4/30,6.33%,FSTL1;SFRP4;DKK3;SMAD4
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3684641185995402,0.8846588351256356,0.636919315403423,0.8830110842942701,1.0,2/27,7.14%,GAS6;IRAK3
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.2622024506065238,-0.884599817974789,0.6862745098039216,0.8448065723737953,1.0,9/34,18.25%,WNT5A;RBP4;SLC7A5;LACC1;GPI;NOD2;PTPN22;XBP1;PHB2
prerank,T cell differentiation in thymus (GO:0033077),0.40677563651481496,0.8843894958755587,0.6146540027137042,0.8831049313913732,1.0,5/14,31.07%,RIPK3;LIG4;GLI3;ZFP36L1;PTPRC
prerank,regulation of defense response (GO:0031347),0.3188492620785379,0.8843700701814019,0.6781115879828327,0.8827494689715583,1.0,22/76,25.60%,MGLL;FOXP1;SHPK;BRD4;SBNO2;ANXA1;NR1D2;TRAF3;PSMA6;CASP1;N4BP1;PTGES;UFL1;APPL2;APPL1;DAGLB;BIRC3;AREL1;CYLD;BST1;XIAP;TKFC
prerank,negative regulation of cell aging (GO:0090344),-0.3143580986451972,-0.8843679597959864,0.6194331983805668,0.8438211039056226,1.0,3/16,2.72%,CDK6;SLC30A10;AKT3
prerank,ganglioside metabolic process (GO:0001573),0.38663213440236105,0.8841299460564448,0.6112565445026178,0.8828036244942554,1.0,2/20,4.39%,ST8SIA2;ST6GALNAC5
prerank,negative regulation of response to external stimulus (GO:0032102),0.3113664692428562,0.883843947875103,0.7033195020746889,0.8829304531075635,1.0,25/105,21.33%,PRKCD;FGF2;PTGIS;CCN3;DRD1;PTPRS;CARD16;TRAFD1;IRAK3;SHARPIN;RORA;ITCH;MAPKBP1;LPCAT3;PTPN2;PCBP2;SIRT2;CD109;OTULIN;ACOD1;CRK;GPS2;IL4;MUL1;DRD2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.30780803548580443,0.8834634502679867,0.7061855670103093,0.8832199379805435,1.0,22/121,15.26%,VEGFA;EFNA5;GAS6;SRCIN1;GHR;HES5;STAT3;CSPG4;IL5;ACVR1;NOX4;DLG4;DGKQ;ANGPT4;PAK2;ABL1;CTF1;NRP1;CD80;CLCF1;HGF;IL6
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.34367249890166496,-0.8831081312155273,0.6006944444444444,0.8450447464742807,1.0,3/11,6.40%,PARP14;PARP16;PARP11
prerank,protein autophosphorylation (GO:0046777),0.3057446868359196,0.8830116806121346,0.7259713701431493,0.8836312975652849,1.0,40/157,18.70%,EGFR;DDR2;ULK2;NTRK1;ACVR1B;MAPK15;CAMK2D;TNK1;EPHB3;STK39;FGFR1;CDK12;PAK2;FGFR2;SMG1;MUSK;RIPK3;ABL1;IRAK1;MAP3K12;ATM;CHEK2;PDPK1;DDR1;UHMK1;STK25;SRMS;MAP3K10;EEF2K;MAP3K3;CAMK4;ERBB2;STK16;MKNK2;SIK2;DAPK3;CAD;VRK2;CLK2;AKT1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.35669386807360925,0.8828070361510544,0.6432098765432098,0.8832313270581365,1.0,4/29,13.25%,HJURP;CENPC;CENPT;RBBP7
prerank,CENP-A containing chromatin organization (GO:0061641),0.35669386807360925,0.8828070361510544,0.6432098765432098,0.8832313270581365,1.0,4/29,13.25%,HJURP;CENPC;CENPT;RBBP7
prerank,positive regulation of dendritic spine development (GO:0060999),-0.2980420021826007,-0.8826892073134643,0.6651376146788991,0.8444342354383005,1.0,5/20,13.89%,APOE;SHANK3;CUX2;LRP8;RELN
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.308145767962812,0.8826280207136579,0.7178423236514523,0.8831435647704335,1.0,57/119,32.54%,FGF2;PLEKHA4;TTC7A;PIK3C2B;PITPNM1;PIGW;SOCS7;SOCS4;SOCS6;SOCS2;PIGF;SYNJ1;SMG1;PIP4K2B;IP6K1;ARF1;INPP4A;PIK3CB;OCRL;PIGL;PI4K2A;PGAP2;TTC7B;CDIPT;PIP5K1A;PI4KB;INPP5E;VAC14;CDS1;MTMR1;SYNJ2;DPM3;RAB4A;PIGV;MTM1;TMEM150A;PLEKHA3;PIGQ;SOCS1;RAB5A;PIGB;PIP4K2C;PI4KA;PIK3C2G;SACM1L;RUFY1;FIG4;PIKFYVE;SBF1;PIGN;PLEKHA1;MTMR2;PIGC;MTMR12;MTMR9;PIGO;PIK3CA
prerank,positive regulation of telomere capping (GO:1904355),0.39740223123064816,0.8826051383140158,0.6311584553928096,0.8827920270992078,1.0,6/17,27.40%,MAPK15;NEK7;TNKS2;MAP2K7;RTEL1;PNKP
prerank,regulation of store-operated calcium entry (GO:2001256),0.43940831922614576,0.8825692528879662,0.6438953488372093,0.8824643755377959,1.0,5/10,23.25%,STIM1;EFHB;SARAF;HOMER2;SLC8B1
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.36218701890927646,-0.8822633728252547,0.6013745704467354,0.8438314290183409,1.0,2/10,11.29%,RB1;EGR1
prerank,nucleocytoplasmic transport (GO:0006913),0.3487581682349928,0.882220738653755,0.6544378698224852,0.8826931486867361,1.0,12/40,25.90%,XPO1;SNUPN;GEMIN7;NCBP1;SMN1;NCBP2;RITA1;SNRPB;GEMIN2;HNRNPA1;NUTF2;DDX20
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.36459269223561225,-0.8821495244856414,0.6032786885245902,0.8425741399688152,1.0,5/10,17.21%,PRKAA2;PRKAA1;MYOCD;SIRT1;KLF15
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2899976867682991,-0.8820149314362968,0.6542553191489362,0.841350643953947,1.0,6/23,17.82%,CECR2;KPNA1;H1-0;KPNB1;DNASE1L1;FOXL2
prerank,positive regulation of cellular senescence (GO:2000774),-0.3593605750967241,-0.8818855371103903,0.6151419558359621,0.8400986198992949,1.0,3/10,14.05%,B2M;ABI3;SIRT1
prerank,mitochondrial translation (GO:0032543),0.3094991796607887,0.8818750585687548,0.708768267223382,0.8829443792995715,1.0,44/104,37.65%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;NOA1;MRPS18B;MTRF1L;MRPL39;MRPS14;MRPL35;MRPS17;MRPL45;TUFM;PTCD3;MRPL12;MRPL47;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;NDUFA7;MRPL28;MRPL24;MRPS10;CHCHD1;MRPS31;MRPL15;MRPS33;MRPL50;AURKAIP1;MRPL41;MRPL14;MRPL32;MRPL38;MRPL46;MRPL2
prerank,response to interleukin-1 (GO:0070555),0.3206716475079592,0.8818443744296425,0.6976495726495726,0.8826091039601932,1.0,10/73,13.04%,PTGIS;CCL13;HDAC4;CCL15;PRKCA;IRAK3;SOX9;ANXA1;IRAK1;TANK
prerank,protein localization to mitochondrion (GO:0070585),0.43075180657464096,0.8809919008684343,0.6524216524216524,0.8838244167337087,1.0,6/11,27.28%,AKT1;DNAJA1;COX18;LRRK2;PINK1;RALA
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.2003516776208371,-0.8809721246558668,0.9285714285714286,0.8406790985742113,1.0,29/163,11.76%,PDE4D;BCL2;TEC;PRKCB;PIK3R1;RFTN1;INPP5D;PSMC6;FYB1;PAG1;TNFRSF21;BMX;PAK3;NFATC2;CD38;SKP1;THEMIS;EIF2B3;VAV3;PAK1;PSME3;ZC3H12A;PSME1;SPPL3;PDE4B;SYK;PRKCQ;PIK3CD;SH2B2
prerank,defense response to fungus (GO:0050832),0.393777058411958,0.8808044632339741,0.6243243243243243,0.8837663955983843,1.0,1/17,4.59%,RNASE7
prerank,tRNA wobble base modification (GO:0002097),0.4081408740261562,0.8806089583372352,0.6370056497175142,0.8837274992310991,1.0,6/14,24.88%,ALKBH1;CTU2;ELP4;ALKBH8;ELP3;MTO1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.25167693564311483,-0.8805604552263759,0.7019867549668874,0.840020954605016,1.0,18/36,22.43%,PARP14;WNT5A;TRIM44;NLRC5;CASP4;CSF1;EDN1;CD74;AGPAT2;AXL;HSPA1A;AGPAT1;ZBP1;TXK;HSPA1B;IL7;CD300LF;PARP9
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.32301331130311806,0.8805323067117062,0.6812705366922235,0.8834678439614544,1.0,11/67,11.74%,EGFR;PKDCC;DDR2;NTRK1;GHR;EPHB2;ABI1;FGFR1;FGFR2;ABL1;DDR1
prerank,vesicle organization (GO:0016050),0.3351167011102764,0.8804062010226237,0.6651634723788049,0.8833050296554744,1.0,12/46,21.10%,DNAJC13;LAMTOR1;USP50;LAPTM4B;WASHC4;PI4K2A;SQSTM1;VPS11;PHETA2;ZFYVE16;SNX11;ARFGEF2
prerank,negative regulation of wound healing (GO:0061045),0.3619545951649011,0.8794272947246171,0.6345679012345679,0.8846364834859426,1.0,2/28,1.20%,FGF2;SLC12A2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.23203519109983514,-0.8793624763788501,0.7851239669421488,0.8411303386954754,1.0,12/49,13.58%,SGMS1;BCL2;BCL2L1;DNM1L;DAPK2;DDX3X;NUPR1;BOK;CAV1;BCL2L11;STYXL1;NDUFA13
prerank,aggrephagy (GO:0035973),0.36780617589965714,0.8792057302289058,0.652014652014652,0.884632690469419,1.0,10/27,22.04%,DYNC1H1;DYNC1LI2;UBQLN1;SQSTM1;HDAC6;IFT88;RPS27A;UBC;DYNC1I2;ACBD5
prerank,negative regulation of blood pressure (GO:0045776),-0.348494497659836,-0.878595930859255,0.6023622047244095,0.8412921519754807,1.0,7/13,29.23%,NOS3;BMPR2;NOS1;APLN;PRCP;NOS2;DRD3
prerank,negative regulation of neuron projection development (GO:0010977),-0.23354627734049022,-0.8785651245864436,0.7678571428571429,0.839881032714882,1.0,20/56,20.00%,EFNB2;LPAR1;APOE;EPHA4;PTPRO;PTPN9;ARHGDIA;DCC;PRAG1;BAG5;MCF2;DENND5A;SPOCK1;MAG;TRPV4;MT3;LRP4;THY1;RTN4R;BCL11A
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3466895618192375,0.8783996269899526,0.6517647058823529,0.8856512406777066,1.0,10/37,22.00%,PDCD4;CHID1;STAT3;PER1;IL6;ADCY7;APPL2;APPL1;IL17RA;ABCD1
prerank,positive regulation of B cell proliferation (GO:0030890),-0.2685433400845574,-0.8782668871520465,0.6378378378378379,0.8389920660716411,1.0,7/29,12.43%,BCL2;TFRC;NFATC2;CD38;VAV3;CD74;CD40
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.35578445206749226,-0.8777707646309392,0.6140350877192983,0.8385015486595132,1.0,9/11,42.08%,PRKCQ;NFKBIZ;MALT1;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,microtubule bundle formation (GO:0001578),0.338635825603285,0.8777109429474315,0.6709451575262544,0.8865268824913387,1.0,11/42,22.75%,NAV1;CFAP206;SPAST;CCDC66;CHP1;MARK4;LRGUK;TTLL3;CDK5RAP2;SPAG16;CAPN6
prerank,androgen metabolic process (GO:0008209),0.38881246345921505,0.8773726288475356,0.6465968586387435,0.8867362680345442,1.0,2/18,13.20%,CYP19A1;DHRS9
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3215230756674967,0.8773495374032897,0.6767001114827201,0.8863929908723418,1.0,23/57,32.81%,PRKDC;CDK5RAP3;ATM;CHEK2;SDE2;RINT1;FOXN3;HUS1;ATF2;CDK2;BRCC3;TOPBP1;DONSON;TAOK3;TP53;RPS27L;TAOK2;TAOK1;NOP53;TRIM39;RAD17;BLM;WAC
prerank,cognition (GO:0050890),0.33696403619222315,0.8769616494622602,0.6415313225058005,0.8866936993369494,1.0,9/42,16.94%,ST3GAL4;DOP1B;SOBP;CHRNB2;CYFIP1;SETD5;SLC1A4;NF1;NIPBL
prerank,catecholamine biosynthetic process (GO:0042423),-0.3489722162865878,-0.8767757809278245,0.6,0.8392344511777518,1.0,3/11,15.01%,MOXD1;GCH1;SNCA
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.43492808014464934,0.8766771769373864,0.6223479490806223,0.8867914515087529,1.0,4/10,27.84%,NCBP1;NCBP2;PAF1;HSF1
prerank,positive regulation of T cell migration (GO:2000406),0.37933471246821937,0.8766765019904497,0.6362484157160964,0.8863978467810527,1.0,5/20,13.93%,SPN;ADAM10;STK39;RHOA;WNK1
prerank,central nervous system neuron differentiation (GO:0021953),0.34650189503778656,0.8765349613758264,0.6379310344827587,0.8862507791835006,1.0,1/33,0.33%,LRP6
prerank,axonal transport of mitochondrion (GO:0019896),0.4350781328648641,0.8758447983700546,0.6499302649930265,0.8870815418276321,1.0,4/11,22.21%,SYBU;SPAST;ACTR10;NEFL
prerank,zinc ion homeostasis (GO:0055069),0.3590768183507596,0.8757028228144208,0.6507936507936508,0.8869479665322022,1.0,5/28,9.86%,SLC39A14;SLC39A7;TMC8;SLC30A5;SLC39A13
prerank,retinal metabolic process (GO:0042574),0.4167336228004367,0.875053897212165,0.6413502109704642,0.8877115925389537,1.0,2/12,8.81%,CYP1B1;AKR1C1
prerank,chloride transmembrane transport (GO:1902476),0.3313166267292053,0.8748083965032116,0.6618464961067854,0.8877482972651969,1.0,5/48,7.65%,SLC12A7;SLC12A2;SLC4A8;GABRA3;SLC12A4
prerank,steroid metabolic process (GO:0008202),0.3207902548550859,0.8747990490115044,0.6990185387131952,0.8873685210094735,1.0,13/72,17.48%,CYP19A1;CYP1B1;AKR1C1;NPC1;FDXR;DHRS4;LRP2;DHRS9;PIAS4;VDR;CYP27B1;LSS;PRLR
prerank,regulation of exosomal secretion (GO:1903541),0.37607342036765284,0.8742479592003636,0.6394904458598726,0.8879791384358108,1.0,5/19,24.57%,SDC1;ATP9A;CHMP3;PDCD6IP;CHMP2A
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3373491497412265,0.8741285561808716,0.6585365853658537,0.8877992792860323,1.0,10/42,16.86%,VIT;PKHD1;AGR2;FZD7;RHOA;PIK3CB;ARL2;NDNF;TBCD;NF1
prerank,regulation of water loss via skin (GO:0033561),-0.3102363770975062,-0.8740651340192966,0.6038461538461538,0.8421020750797533,1.0,3/15,12.66%,LSR;CLDN1;ALOX12
prerank,establishment of skin barrier (GO:0061436),-0.3102363770975062,-0.8740651340192966,0.6038461538461538,0.8421020750797533,1.0,3/15,12.66%,LSR;CLDN1;ALOX12
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.3836854810998425,0.8739654593453534,0.6553966189856957,0.8876943173746652,1.0,8/18,29.23%,GPATCH3;PUM1;NPLOC4;BIRC3;SEC14L1;C1QBP;NOP53;PUM2
prerank,telomere maintenance via telomerase (GO:0007004),0.3577905582553055,0.8732973568734097,0.6592039800995025,0.8884977753951119,1.0,11/28,30.44%,PPP6R3;TERT;TELO2;RAD50;CDK2;TNKS1BP1;ANKRD28;DKC1;RTEL1;NOP10;HSP90AA1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.31752992853570333,0.8732612238307765,0.681917211328976,0.8881782445771705,1.0,10/70,13.13%,PRKCD;PRKCE;VAV2;ARPC1B;ABI1;CYFIP1;WIPF1;ABL1;PIK3CB;MYH2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3464395469135307,0.8732123618447125,0.6560283687943262,0.8878655817192417,1.0,16/36,25.20%,DACT1;DLG1;ITCH;FOXM1;EZR;PER1;MEN1;ZMYND11;AIDA;DUSP19;GPS2;CYLD;TAOK3;PINK1;NCOR1;QARS1
prerank,regulation of amyloid fibril formation (GO:1905906),-0.31608385760436253,-0.8728743112979823,0.6221374045801527,0.8430721779874681,1.0,2/15,2.33%,APOE;APP
prerank,"transcription, DNA-templated (GO:0006351)",0.29551996890360965,0.8724413719088578,0.7865055387713998,0.8888614379191709,1.0,80/207,29.56%,NFIX;DDX5;DEAF1;TOPORS;BAZ2A;TCEA2;ATF4;TCFL5;NFX1;POLR3H;HSF2BP;GTF2F1;NFKBIB;CCNT2;TAF15;TAF6;ERCC3;XAB2;TAF13;CRCP;TRIP11;MEF2A;ERCC2;POLR3GL;MMS19;POLR2F;MBD1;TFDP1;AFF4;FOXO3;MLLT3;PARP1;NCBP1;SSRP1;NFYA;SMN1;E2F1;TFB2M;NCBP2;GTF3C1;GTF3C4;CBFB;TAF9B;POLR3K;TWNK;MRPL12;ABT1;MED20;PAF1;NFIC;CEBPD;GTF3A;POLR1C;POLR2B;TAF1C;MNT;TBP;NELFB;TAF1;TP53;EAF1;CTDP1;RTF1;GTF2H4;POLR2H;RNMT;NELFA;TAF10;UBTF;DRG1;HSF1;TAF5L;SETX;TAF3;POLR2I;CDK9;PWP1;NFE2L3;MLLT1;PRMT5
prerank,rRNA pseudouridine synthesis (GO:0031118),0.4297723744697506,0.8719736873959388,0.6466380543633763,0.8892773752491481,1.0,4/10,30.39%,RPUSD1;TSR3;DKC1;NOP10
prerank,response to thyroid hormone (GO:0097066),0.4059928473498168,0.8719235805991076,0.649645390070922,0.8889786724922746,1.0,4/13,21.42%,RDX;BRD8;KLF9;CTSB
prerank,organelle transport along microtubule (GO:0072384),0.35198211401897533,0.8716968052976526,0.6446886446886447,0.8889914119923635,1.0,9/31,22.68%,COPG1;RHOT2;ARHGAP21;RHOT1;TMEM201;NDEL1;CLN3;RAB1A;PEX14
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.33678902075048167,-0.8716164562167015,0.6125827814569537,0.8442464484199614,1.0,3/12,9.62%,LYN;ELF2;CD300A
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.3409695325843528,-0.8716072154645466,0.6293706293706294,0.842807006411071,1.0,5/11,27.06%,ENPP2;CORO1C;CD44;CORO1B;SRC
prerank,eosinophil migration (GO:0072677),0.40869179288971547,0.8715764110650999,0.6532593619972261,0.8884300790331231,1.0,1/14,3.10%,CCL13
prerank,eosinophil chemotaxis (GO:0048245),0.40869179288971547,0.8715764110650999,0.6532593619972261,0.8884300790331231,1.0,1/14,3.10%,CCL13
prerank,regulation of viral transcription (GO:0046782),0.3416761502677789,0.8714587208769597,0.6556991774383079,0.8882482659937905,1.0,17/39,29.94%,MDFIC;TRIM27;UBP1;GTF2F1;MID2;HEXIM1;POLR2F;TRIM13;LARP7;POLR2B;NELFB;CTDP1;POLR2H;NELFA;POLR2I;CDK9;POLR2L
prerank,sensory perception (GO:0007600),0.3347108030887621,0.8713629668869314,0.6724738675958188,0.8880246120711337,1.0,2/45,1.91%,GNAS;PROK2
prerank,mitochondrial transcription (GO:0006390),0.42494818819205316,0.8712242519522747,0.6118326118326118,0.8878877435322552,1.0,4/10,20.44%,FOXO3;TFB2M;TWNK;MRPL12
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.42201640268051105,0.870681684654254,0.6493506493506493,0.8880473671502025,1.0,3/11,24.18%,CALM2;CALM3;FKBP1B
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.42201640268051105,0.870681684654254,0.6493506493506493,0.8880473671502025,1.0,3/11,24.18%,CALM2;CALM3;FKBP1B
prerank,response to ATP (GO:0033198),-0.29700260579256926,-0.8704060061652987,0.6378600823045267,0.843990128780553,1.0,5/18,18.88%,TRPC3;ABCC9;CIB2;P2RY1;P2RX7
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3161556086035316,0.8703092938517685,0.6843243243243243,0.8883137803191553,1.0,18/75,20.98%,LRP6;PRKCD;LRP5;IPO5;IRAK3;CDK5RAP3;BMP4;PAQR3;ABL1;PIK3CB;HEXIM1;LATS2;NF1;CDKN1C;MEN1;AKT1;UCHL1;PRKAR2A
prerank,cell cycle checkpoint signaling (GO:0000075),-0.3322673590740788,-0.8701444293383467,0.6493055555555556,0.8431221699075045,1.0,4/12,11.64%,PRCC;ZWILCH;NABP2;PLK2
prerank,regulation of protein kinase A signaling (GO:0010738),-0.28824096207926536,-0.8701127002295286,0.6680851063829787,0.8417099456672088,1.0,4/20,6.40%,ADGRV1;AKAP6;PRKAR2B;PRKAR1B
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.3077764298822329,-0.8699814779176794,0.6475409836065574,0.8405456271839831,1.0,4/18,8.78%,PPARA;PAG1;DUSP3;ASS1
prerank,regulation of cellular component movement (GO:0051270),0.3283527799356231,0.8698957058316348,0.6651634723788049,0.8886589748950577,1.0,9/49,10.59%,EGFR;VEGFA;ARAP1;PKHD1;CD9;RAF1;RHOA;PKN2;ABL1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3603278370750282,0.8694275111385626,0.6622114216281896,0.8891007378141736,1.0,11/28,27.84%,PARP3;PRKDC;KMT5C;TFIP11;MAD2L2;ACTR2;WAS;SHLD3;PNKP;SHLD1;HSF1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.43513831280795195,0.8692282722265212,0.6605633802816901,0.8890557884386482,1.0,5/10,25.15%,PDCD4;DNAJA1;AIDA;DUSP19;MAPK8IP1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3767456011668402,0.8689830057281102,0.6488250652741514,0.8890963294786917,1.0,5/20,15.73%,AGO1;AGO2;LIMD1;CNOT8;EIF6
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.34461143752133117,0.8684130102989235,0.6603098927294399,0.8897438813456241,1.0,2/33,2.63%,EGFR;RDX
prerank,chromatin remodeling at centromere (GO:0031055),0.3471549521203066,0.8678460155723319,0.6666666666666666,0.8903616812283797,1.0,4/31,13.25%,HJURP;CENPC;CENPT;RBBP7
prerank,anterograde trans-synaptic signaling (GO:0098916),0.29419358612176344,0.8677820251845584,0.8105369807497467,0.8900933327431436,1.0,20/224,8.78%,PCDHB16;LRP6;GRIK4;SLC12A7;DLG2;EXOC4;UNC13B;CAMKK1;PMP22;CEL;KCNN1;GABRA3;CHRNB2;KCNIP2;SLC6A2;GIPC1;SLC12A4;DLG4;CHRNA5;DLG1
prerank,regulation of T cell chemotaxis (GO:0010819),0.4238527608621441,0.8677060002994811,0.6416666666666667,0.8898421923774841,1.0,3/11,13.93%,ADAM10;STK39;WNK1
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.22637901331643223,-0.8674699796774273,0.7982456140350878,0.8442991184058476,1.0,15/51,18.88%,WNT5A;APP;AIM2;GBP5;HSPB1;EGR1;LPL;LGALS9;TRIM16;TYROBP;S100A13;NOD2;PYCARD;MYD88;P2RX7
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.36543047560426967,0.8667524997538046,0.6426799007444168,0.8911447314839644,1.0,1/22,0.58%,ID2
prerank,lipid droplet organization (GO:0034389),0.37396846836544245,0.8666887455800883,0.6553398058252428,0.890882915076994,1.0,10/22,29.51%,RAB3GAP1;FAF2;CIDEA;PNPLA3;CDS1;RAB18;FITM2;PPID;ZFYVE1;SQLE
prerank,heart contraction (GO:0060047),0.3315355883458479,0.8659606187830536,0.6639150943396226,0.8917900762920373,1.0,7/41,11.86%,SGCD;ATP1B1;DMD;GAA;KCNE5;CSRP3;SOD1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4233591187743808,0.865940842935418,0.6599131693198264,0.8914439232597063,1.0,2/11,10.98%,FGF2;IP6K1
prerank,regulation of pH (GO:0006885),0.4163734181531918,0.865902344235584,0.6462585034013606,0.8911167457704924,1.0,2/11,10.28%,SLC9A1;SLC26A4
prerank,regulation of catabolic process (GO:0009894),-0.2896687397967916,-0.8653987976750472,0.6745098039215687,0.8471239892730927,1.0,3/18,8.32%,NEDD4L;FAF1;HPGD
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.29271991502612876,-0.8653947724611861,0.6234817813765182,0.8456704891744644,1.0,1/20,0.15%,PLCB1
prerank,regulation of cation channel activity (GO:2001257),0.3073313043397155,0.8653013990754388,0.7238095238095238,0.8918238122622922,1.0,13/89,8.78%,FGF13;DLG2;AHNAK;CAMK2D;CALM2;DMD;CNIH2;KCNE5;SLMAP;ANK2;DLG4;SELENON;DLG1
prerank,dendritic cell differentiation (GO:0097028),0.3755721872460196,0.8652448225257505,0.655483870967742,0.8915358039147596,1.0,2/22,6.39%,GAS6;TGFBR2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.31241220770635314,0.8648523897636197,0.6941431670281996,0.8918166181846717,1.0,24/72,26.25%,GAS6;ELF1;TAX1BP1;IRAK3;SHARPIN;MADD;CHUK;IRAK1;ABCE1;PTPN2;RUNX1;OTULIN;SUMO1;VRK2;CBFB;JAK1;BIRC3;CYLD;SPPL2A;TRADD;PTPN11;SOCS1;IFNGR2;RIPK1
prerank,interstrand cross-link repair (GO:0036297),0.3246687206907051,0.8644512235350177,0.7050847457627119,0.8921327349460377,1.0,14/53,20.74%,VCP;FAAP20;ERCC4;WDR48;DCLRE1B;FANCE;ATRIP;FAAP24;RPS27A;UBC;RAD51;USP1;FANCG;XRCC3
prerank,activation of GTPase activity (GO:0090630),0.30978081211861347,0.8643243576856536,0.7357293868921776,0.8919684632392135,1.0,18/89,15.88%,SGSM2;TIAM1;NTRK3;TIAM2;TBC1D8B;TBC1D2B;DOCK7;SIPA1L1;BCAS3;BCR;EVI5L;TBC1D9B;TBC1D25;TBCK;TBC1D10A;SIPA1L3;TBC1D17;PIP5K1A
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.30237364103174097,-0.8642943123871544,0.6090534979423868,0.8465261504985934,1.0,14/18,41.06%,IGFBP2;IGF1;PYCARD;RPS3;AGER;FADD;IL27RA;IL18;IL12RB1;TNFSF9;IL23A;IL23R;IL12B;IL2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.40414270921543827,0.8640779343464621,0.6334269662921348,0.8920070377077176,1.0,2/14,5.55%,ENTPD2;ENTPD6
prerank,response to amino acid (GO:0043200),0.34541015630146493,0.863567988925953,0.6462829736211031,0.8924854432731193,1.0,10/31,27.43%,IPO5;MEAK7;LAMTOR1;CAPN2;SESN2;NSMF;GLRB;RPTOR;LAMTOR2;LAMTOR3
prerank,hydrogen peroxide metabolic process (GO:0042743),0.377443632628752,0.8631187570319798,0.6475195822454308,0.8929028475719711,1.0,9/19,31.03%,SOD1;PRDX3;CAT;PRDX2;PRDX1;PXDN;NOX1;PRDX5;CYBA
prerank,plasma membrane organization (GO:0007009),0.3169593183817916,0.8629253852796529,0.7070484581497798,0.8928765136769193,1.0,18/61,22.15%,AHNAK2;TLCD2;ANK2;EHD2;NSF;STX2;SNX9;STX4;CXCR4;PLSCR3;SPTBN1;SYTL4;TLCD1;CLN3;CHMP4A;ANXA6;ABCD1;PLSCR4
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3716009247615599,0.8625295394624183,0.651595744680851,0.8931891830968398,1.0,4/21,12.31%,KCNE5;ANK2;SNTA1;AKAP9
prerank,ESCRT complex disassembly (GO:1904896),0.42836214960486463,0.8624852528683773,0.6385372714486639,0.8925000031064976,1.0,3/10,24.57%,IST1;VTA1;CHMP2A
prerank,ESCRT III complex disassembly (GO:1904903),0.42836214960486463,0.8624852528683773,0.6385372714486639,0.8925000031064976,1.0,3/10,24.57%,IST1;VTA1;CHMP2A
prerank,positive regulation of GTPase activity (GO:0043547),0.29509912563705915,0.8623381514733831,0.8032290615539859,0.8923538467611417,1.0,38/188,17.72%,SGSM2;SRGAP2;ASAP3;TIAM1;ARAP1;NTRK3;NTRK1;TIAM2;TBC1D8B;TBC1D2B;CCL13;DOCK7;SIPA1L1;CCL15;BCAS3;SNX18;RAB3GAP1;S100A10;RIC1;BCR;RGP1;ZC3H15;SNX9;EVI5L;TBC1D9B;F2R;TBC1D25;NDEL1;TBCK;TBC1D10A;SIPA1L3;TBC1D17;PIP5K1A;ERBB2;NF1;NGEF;FLCN;SNX13
prerank,regulation of dephosphorylation (GO:0035303),-0.30580419377751517,-0.8622108732647779,0.6486486486486487,0.8493642877741103,1.0,3/15,6.61%,PPP1R16B;SMG7;MTMR3
prerank,positive regulation of TORC1 signaling (GO:1904263),0.38367279906950635,0.8618001777239709,0.6744186046511628,0.8929061822207448,1.0,5/16,17.28%,SEH1L;CLEC16A;TELO2;KLHL22;FLCN
prerank,cellular response to ionizing radiation (GO:0071479),0.32389706834938853,0.861749805916441,0.6499416569428238,0.8926124256792485,1.0,22/47,31.81%,RAD1;WRN;SPIDR;SWI5;ATM;LIG4;TANK;RHOB;TLK2;HUS1;NIPBL;RAD51;XRCC6;TNKS1BP1;TP53;HSF1;ATR;GRB2;INTS7;RHNO1;BLM;YAP1
prerank,gluconeogenesis (GO:0006094),0.3402997763112234,0.8615415935674015,0.6718009478672986,0.8925875914080982,1.0,12/39,29.33%,SLC39A14;ATF4;CRTC2;PGK1;SLC37A4;ENO2;SLC25A11;SLC25A12;PFKFB1;PER2;MDH2;GAPDHS
prerank,negative regulation of cell adhesion (GO:0007162),0.3150832501838449,0.8610159214068083,0.7255113024757804,0.8931097951446756,1.0,9/72,6.70%,PLXNA4;TGFBI;MUC1;EPHB2;SPN;CYP1B1;ADAM10;JAG1;FZD7
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.31475527077565923,0.860823236757585,0.697524219590958,0.8930563291927572,1.0,25/67,28.43%,RDX;MAPK15;TBC1D2B;DYNLT2B;GAP43;IFT20;TBC1D24;ATG3;SDCCAG8;TBC1D9B;TBC1D10A;TBC1D17;IFT88;EVI5;TBC1D22B;FXR2;ATP8B1;CYLD;RABGAP1;TBC1D20;TWF1;RAB5A;WAS;FXR1;IFT140
prerank,response to ethanol (GO:0045471),0.3933338695363593,0.8606487165022405,0.637466307277628,0.892962424909845,1.0,4/14,18.49%,GRIN3A;CHRNB2;SOD1;ADCY7
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.3991286979999584,0.860252124910717,0.6526610644257703,0.8932444295075027,1.0,2/12,5.71%,ATP1B1;DMD
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.40006535006815813,0.8599706206832954,0.6566951566951567,0.8933402939919484,1.0,2/13,8.56%,IRS1;AKT2
prerank,cellular response to virus (GO:0098586),0.3496468959825788,0.8598683020047185,0.6830985915492958,0.8931315443376411,1.0,8/30,19.55%,GBF1;LGALS8;CHUK;ARF1;GSDME;IL6;TOMM70;IRF3
prerank,ruffle organization (GO:0031529),0.38221796359679255,0.8598452452714821,0.643979057591623,0.8927841036382983,1.0,4/16,15.88%,LIMA1;CYFIP1;ARFIP2;PIP5K1A
prerank,dicarboxylic acid catabolic process (GO:0043649),0.40933104189980196,0.8596358475614516,0.6431535269709544,0.8927519751634797,1.0,3/13,7.23%,ACSF3;PM20D2;QPRT
prerank,manganese ion transport (GO:0006828),0.3915023195178092,0.859396439984782,0.6483050847457628,0.8927787257309037,1.0,1/14,0.72%,SLC39A14
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.3732263276456674,0.859003705877687,0.6641123882503193,0.8930514913452003,1.0,1/21,0.78%,VEGFA
prerank,secondary alcohol metabolic process (GO:1902652),0.33512472483343797,0.8589408317984352,0.6790266512166859,0.8927780783146664,1.0,19/42,33.42%,SOAT1;RXRA;TSKU;NSDHL;ABCA1;EBP;IL4;IDH3B;STARD3;APOF;ANGPTL3;SOAT2;OSBPL5;SQLE;OSBPL1A;IDH3G;IDH2;IDH1;GBA2
prerank,cellular response to chemical stress (GO:0062197),0.30687086386896345,0.8588508002077548,0.7282157676348547,0.8925529509207077,1.0,41/96,31.03%,VKORC1L1;ATF4;LRRC8D;SLC4A11;NOX4;NFE2L2;STX2;ABL1;ATM;SOD1;LONP1;SESN2;SRXN1;PRDX3;CAT;STX4;SIRT2;GSR;TXNRD2;FOXO3;PARP1;VRK2;PRDX2;EIF2S1;LRRK2;PYCR1;PRDX1;GPX7;PYROXD1;PINK1;SELENOS;HTRA2;AIF1;SETX;NOX1;RAD52;PRDX5;PRDX6;KEAP1;ADNP2;CYBA
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.36158588764181376,0.8587190985769033,0.6670886075949367,0.8923901981034862,1.0,6/24,19.84%,TGFB2;ATF4;BACE1;FOXO3;NF1;CDK5
prerank,phosphatidic acid metabolic process (GO:0046473),0.32371273036777903,0.8583400822507395,0.7206703910614525,0.8926643754835508,1.0,9/48,14.82%,PLA2G4A;LPCAT1;GPD1;LPCAT4;DGKQ;GPAT4;PLA2G5;PLA2G12A;PNPLA3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.32054925291935094,-0.8583099349146746,0.6322314049586777,0.8559513116107851,1.0,5/15,15.91%,DGKD;HIP1R;AAK1;TNK2;BMP2K
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.3803726817608976,0.8581887895714994,0.6587301587301587,0.8925501309896577,1.0,4/17,12.40%,NTRK3;BCAS3;ABL1;NRP1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.41083690579873505,0.8578049186505627,0.6627906976744186,0.8928334254175763,1.0,2/12,8.24%,MUC13;SOX9
prerank,mRNA destabilization (GO:0061157),0.33487247963464123,0.8577413195571284,0.6795321637426901,0.8925471135031935,1.0,18/38,31.78%,FTO;PUM1;ZC3H12D;DIS3L2;METTL16;TUT7;RC3H2;UPF1;RBM24;ROCK1;METTL14;RIDA;YTHDF1;ZFP36L1;KHSRP;PLEKHN1;MOV10;DCPS
prerank,Notch signaling pathway (GO:0007219),0.31923350796988076,0.8573180327986875,0.6796440489432704,0.892915747001337,1.0,14/59,16.12%,ZNF423;HES5;GMDS;DTX3;ADAM10;JAG1;PBX1;HEYL;NLE1;ITCH;HEY1;DTX2;PSEN2;CREBBP
prerank,negative regulation of cell population proliferation (GO:0008285),0.2905226854184112,0.8570710054036598,0.8664658634538153,0.8929743913586334,1.0,74/351,18.04%,ZBTB7C;WNT9A;IGFBP5;SFRP4;CCN3;NTRK1;SMAD6;TGFB3;P3H3;CYP1B1;SLURP1;GLMN;FAP;LMNA;PTPRU;TGFB2;MORC3;P3H1;CLMN;TMEM115;NOX4;PLPP1;PRKRA;ABI1;IFNLR1;E2F3;SKI;CDK10;MDM4;RAF1;TES;P3H2;CHERP;SOX9;NOG;DDAH1;CDC6;BMP4;ING5;VIP;DIS3L2;RBM5;MED25;PBRM1;TENM1;NELL1;TGFB1I1;PTPN2;INHBA;F2R;CGRRF1;GSDME;FRK;FUZ;BMP5;TMEM127;VDR;CYP27B1;SCIN;TFDP1;CAMK2N1;IL6;ING4;SIRT2;PPP2R5C;MINAR1;NF1;FLCN;MAGED1;HMOX1;CDKN1C;MEN1;HMGA1;E2F1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.31430754066809363,0.856965703040555,0.700218818380744,0.8927798816584875,1.0,17/69,20.26%,IRS1;PLCE1;NTRK1;GAB2;PIK3C2B;FGFR1;OGT;RHOA;EZR;PIK3CB;SIRT2;PI4KB;ERBB2;NF1;AKT1;PTAFR;PLCB2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3272273279440606,0.8568359135445599,0.7042093287827076,0.892625710616515,1.0,9/46,14.82%,PLA2G4A;LPCAT1;GPD1;LPCAT4;DGKQ;GPAT4;PLA2G5;PLA2G12A;PNPLA3
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3230920331351919,-0.8568340548420607,0.6425992779783394,0.8574474331644892,1.0,6/13,21.72%,NOTCH1;RYR2;RBPJ;HEY2;FOXF1;NPY5R
prerank,transition metal ion homeostasis (GO:0055076),0.3502922192304535,0.8568308342564598,0.6798029556650246,0.8922474063998561,1.0,8/28,17.54%,SLC39A14;NEO1;HMOX2;TMC8;CYBRD1;BDH2;IREB2;HMOX1
prerank,sterol transport (GO:0015918),0.3686435458027397,0.8562588211773039,0.6561712846347607,0.8928549181268834,1.0,6/19,28.05%,NPC1;OSBP;LDLR;STARD3;NPC2;OSBPL5
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3017279688225685,-0.8559038220493073,0.688212927756654,0.8578082345948043,1.0,9/16,20.34%,PPARA;SLC30A10;ASXL3;TRAP1;CEACAM1;GPER1;ABCD2;ABCB7;SLC18A2
prerank,amyloid-beta metabolic process (GO:0050435),0.386962238798456,0.855467568788856,0.6785714285714286,0.8938246934382374,1.0,4/16,15.93%,BACE2;BACE1;PSEN2;IDE
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.30994646856692065,0.8551652045140852,0.703862660944206,0.8939642818698865,1.0,10/69,14.53%,SIX1;NTRK1;TGFB3;SIX4;NRBP2;SOD1;LIG4;F2R;NDNF;CLCF1
prerank,epithelial cell migration (GO:0010631),0.3310493862243867,0.8544508206295357,0.6746126340882003,0.8948078028650935,1.0,9/37,12.40%,FSTL1;CYP1B1;FAP;FAT2;GIPC1;RHOA;PKN2;ABL1;NRP1
prerank,neuron projection organization (GO:0106027),-0.3138802574158978,-0.8543300186139956,0.6626506024096386,0.8593938883718338,1.0,2/15,2.33%,INSR;APP
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3658556386449165,0.8542610059226349,0.6867007672634271,0.8947524769944724,1.0,4/21,16.24%,SHPK;TKT;DERA;PGD
prerank,cellular component assembly (GO:0022607),0.2898523169168257,0.8542243800012831,0.8353413654618473,0.8944330323504859,1.0,62/253,23.54%,RHOJ;GAS6;CHAF1B;GSN;RHOQ;DPYSL3;PLS1;LIMA1;CFAP206;TLCD2;HES5;CD3E;M1AP;HORMAD1;DVL1;ILK;GPAA1;SPG7;QSOX1;LLGL1;MDM4;DLG4;SOX9;CYFIP1;RHOA;CDAN1;ST13;WIPF1;MYO9A;SNX9;SHANK1;EZR;ZW10;PARVA;STK25;NLGN1;ADD1;SCIN;LRGUK;CREBBP;TTLL3;KPNA3;SPTBN1;TLCD1;EPRS1;TEAD2;NOC2L;DARS1;CAPZA1;TEX11;CALD1;SPAG17;REPS2;KMT2A;BAIAP2L1;PEX14;SPAG16;AFG3L2;NIFK;GORASP2;DET1;GPM6B
prerank,negative regulation of cilium assembly (GO:1902018),0.40524321130104424,0.854080636144233,0.6577086280056577,0.8942833663423571,1.0,3/12,12.05%,LIMK2;CDK10;EVI5L
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.36922393555151484,0.8540051110245073,0.6767810026385225,0.8940274010486119,1.0,4/21,9.03%,EFNA5;LDB1;SLC9A1;RHOA
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.4229489674220073,0.8539538698588125,0.6862170087976539,0.8933434370579991,1.0,10/10,57.73%,CEP250;TULP1;GRM6;RPE65;CACNA2D4;CNGB1;CACNA1F;GNAT2;REEP6;GNAT1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.4229489674220073,0.8539538698588125,0.6862170087976539,0.8933434370579991,1.0,10/10,57.73%,CEP250;TULP1;GRM6;RPE65;CACNA2D4;CNGB1;CACNA1F;GNAT2;REEP6;GNAT1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3182924736634002,0.853947507591037,0.7146017699115044,0.8929738328855643,1.0,18/61,23.58%,NCOR2;PSMD7;PSMA8;SIRT5;PSMA4;PSMD12;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;AZIN1;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.4017642363550446,0.8539024211316771,0.6475644699140402,0.892673391696253,1.0,2/12,8.56%,IRS1;AKT2
prerank,positive regulation of response to external stimulus (GO:0032103),0.29794898243459056,0.8537060998290009,0.7733333333333333,0.8926200162458965,1.0,7/128,6.37%,THBS1;PDCD4;IL33;ABCC1;PRKCA;LRSAM1;PUM1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.3427750127558654,-0.8536722974207844,0.6401273885350318,0.8592096339360794,1.0,4/11,17.38%,SEMA5A;NES;PLEK;TRPV4
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.28375246867578613,0.8534496457917934,0.915,0.8926898259058014,1.0,62/509,13.14%,THBS1;MYOC;ESR1;EGFR;IRS1;VEGFA;TNFAIP8L3;GAS6;F3;FGF2;TCF7L2;PDCD4;NEDD4;NTRK3;NTRK1;FGF17;GAB2;FSHR;SHC1;SEC13;NFAT5;CARD16;TGFB2;MAVS;BRD4;ILK;LAMTOR1;SEH1L;PUM1;HMGB1;FGFR1;TRIM27;S100B;SOX9;IAPP;CBL;AKT2;CDK5RAP3;RHOA;SHARPIN;ROR1;FGFR2;ITGAV;LTBR;CHUK;ALPK1;IRAK1;TAB2;BCAP31;MAZ;C1QTNF4;NEUROD2;PDPK1;TNFRSF10B;CD27;MID2;PIK3CB;TGFBR1;NLGN1;F2R;CD80;LRP2
prerank,erythrocyte differentiation (GO:0030218),0.32853240346108914,0.853267571863271,0.6955017301038062,0.8926212092407576,1.0,10/44,19.01%,ID2;VEGFA;FLVCR1;CDK5RAP3;PTPN2;INHBA;UBA5;UFL1;ACIN1;HIPK2
prerank,error-free translesion synthesis (GO:0070987),0.36037455333467344,0.8528531991306573,0.6531862745098039,0.8929595133582341,1.0,7/22,25.48%,VCP;RPS27A;UBC;REV1;NPLOC4;RCHY1;POLD1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.3328639531376926,0.852705947470158,0.6781214203894617,0.8928289251364142,1.0,12/37,24.97%,LRPAP1;SIRT5;DLG4;ITGAV;SIRT2;WDR54;AATF;TRAT1;OPTN;ATXN2;PINK1;NCOR1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.40285962484840987,0.8527009335226694,0.6426592797783933,0.8924585236288832,1.0,2/12,2.58%,SYT8;UNC13B
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3549280641515062,0.8524210532384574,0.6721518987341772,0.8925392699519714,1.0,4/24,8.09%,CAMK2D;CALM2;DMD;SELENON
prerank,synapse assembly (GO:0007416),0.30635218305926154,0.852402215182036,0.7112068965517241,0.8921913310792567,1.0,8/67,9.82%,PCDHB16;FGF13;FARP1;DRD1;LGI2;DVL1;FZD5;NRXN2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.37731851074883455,0.8523384056946987,0.6753246753246753,0.8919220088862038,1.0,6/17,25.88%,TGFB2;MID1;STK25;TAOK3;TAOK2;TAOK1
prerank,positive regulation of immune effector process (GO:0002699),0.3506948472616071,0.8521954820594343,0.653416149068323,0.8918090669451052,1.0,2/27,9.99%,LBP;PLA2G5
prerank,hexose biosynthetic process (GO:0019319),0.3318341870728786,0.851757979367522,0.6910569105691057,0.8921932385135767,1.0,13/42,29.33%,SLC39A14;ATF4;SORD;CRTC2;PGK1;SLC37A4;ENO2;SLC25A11;SLC25A12;PFKFB1;PER2;MDH2;GAPDHS
prerank,positive regulation of proteolysis (GO:0045862),0.319716745466183,0.8517432121153963,0.7198228128460686,0.8918380050353027,1.0,17/55,25.00%,ADAM9;TNFRSF1B;OGT;WDR48;MAPK12;SNX9;TANK;TBC1D10A;STUB1;PERP;SH3D19;IST1;RCN3;CYFIP2;BAD;PINK1;HDAC2
prerank,regulation of fibroblast proliferation (GO:0048145),0.32713208691326906,0.851633711279,0.6971751412429379,0.8916580439828864,1.0,8/45,18.04%,GAS6;DDR2;MORC3;SKI;MED25;LIG4;NF1;E2F1
prerank,positive regulation of signaling (GO:0023056),0.33683272249257656,0.851564313653167,0.6887816646562123,0.8913950122954191,1.0,7/37,9.50%,ECE1;CLSTN2;ANXA2;ILK;DLG4;EDN3;NSF
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3251502855167549,0.8511341336764123,0.6977272727272728,0.8917233891248884,1.0,10/46,17.28%,EMILIN1;TIMP3;EPHB2;SPRED2;SMAD4;DLG1;EZR;PTPN2;CAMK2N1;FLCN
prerank,negative regulation of viral life cycle (GO:1903901),0.3829986143414835,0.8511250229448502,0.6611111111111111,0.8913546069268795,1.0,3/15,13.94%,GSN;MID2;TRIM26
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.31220302769255237,-0.8510712533925217,0.6644295302013423,0.8629302109906758,1.0,5/13,21.17%,ELOVL7;HACD1;TECRL;ELOVL6;HACD4
prerank,regulation of protein localization to nucleus (GO:1900180),0.32852592779812007,0.8509938507225211,0.7099415204678362,0.8912017371290446,1.0,17/43,28.81%,WWTR1;LIMK2;CDK5RAP3;BMP4;NVL;SESN2;LATS2;BYSL;ORMDL3;FLCN;AKT1;KAT7;EIF2AK3;ILRUN;TPR;LIF;TESK1
prerank,cellular protein-containing complex assembly (GO:0034622),0.28737990987287304,0.8503394751268025,0.7882472137791287,0.8919009074509648,1.0,55/160,27.84%,NUP93;TIAM1;TBCE;CD3E;DNAJB14;DMD;DNAAF3;SMAD4;FCHO2;CENPC;CCDC39;CENPT;AXIN1;SNX9;AIFM1;MIS12;LONP1;HSPD1;ARL2;CHMP3;CLTC;PTGES3L;PSMD11;TBCD;HIP1;HIGD1A;VBP1;PRLR;TMEM170A;DLGAP5;OTUD6B;CLTA;CLU;CHMP4A;CHMP4B;POGZ;PSMD4;TTC12;NDC1;COX7A2L;EIF4B;UVRAG;VAMP4;TCP1;PSMG2;PXN;CHMP2A;DNAJB12;VAMP2;NCK1;TPR;EID2;AHCTF1;RAB5IF;HSF1
prerank,triglyceride biosynthetic process (GO:0019432),-0.2943010051789501,-0.8500008312132864,0.673469387755102,0.863597245712315,1.0,6/18,18.30%,LPGAT1;GK;MOGAT3;LPIN2;DGAT2;DGAT1
prerank,protein localization to lysosome (GO:0061462),0.34198376996906105,0.8499987436098553,0.6692015209125475,0.8921155351888526,1.0,7/28,28.27%,NEDD4;NAGPA;KPTN;ZFYVE16;SCARB2;GCC2;GGA3
prerank,positive regulation of developmental growth (GO:0048639),0.3234016195251952,0.8499816797619498,0.7076222980659841,0.8917670167627982,1.0,5/49,7.80%,NTN1;GHR;ACTN3;AGR2;GOLGA4
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.322787100873353,0.8499232082520276,0.7150776053215078,0.8914937675170326,1.0,21/54,30.24%,PRR7;NXN;OGT;SMAD7;CHP1;U2AF2;SQSTM1;ARRB1;N4BP1;MINAR1;UFL1;AKT1;DNAJA1;USP4;CAMLG;GTPBP4;SVBP;PER2;SPOPL;PRMT3;CTNNB1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3135669801235328,-0.8498335122871363,0.6666666666666666,0.8624683219438347,1.0,3/14,9.05%,TFRC;RIF1;NECTIN2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.29779399023166614,0.8495335204572727,0.7505219206680585,0.8917356615619301,1.0,18/108,13.71%,F3;GSN;PRR7;MAP3K5;CRADD;XDH;VCP;TNFSF15;HMGB1;DAP;ANP32B;BCAP31;AIFM1;TNFRSF10B;PDCD2;HSPD1;F2R;CASP1
prerank,mesenchymal cell differentiation (GO:0048762),0.3211728621666325,0.8494462788803596,0.7093153759820426,0.891498849569249,1.0,10/51,9.71%,LRP6;DDX5;DDX17;TGFB2;TRIM28;FGFR1;HEYL;SOX9;NOG;FGFR2
prerank,cellular response to hydroxyurea (GO:0072711),0.42289921940868375,0.8492759787748638,0.6502177068214804,0.891413678207286,1.0,6/10,36.15%,DDI2;SPIDR;DDX11;TIMELESS;BLM;RTF2
prerank,regulation of p38MAPK cascade (GO:1900744),0.33581324923959294,0.849097928862364,0.6936829558998808,0.891333624746785,1.0,7/35,15.24%,VEGFA;GADD45G;XDH;DLG1;ULK4;EZR;PER1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.36386357613302656,0.8490092549650691,0.6628205128205128,0.8911056891826122,1.0,2/21,3.75%,AGXT2;CEL
prerank,positive regulation of viral process (GO:0048524),0.313193029734366,0.848984573497163,0.7130044843049327,0.8907699717016428,1.0,24/60,30.69%,MDFIC;PABPC1;TMEM39A;PKN2;GTF2F1;KPNA2;SRPK1;POLR2F;POLR2B;NELFB;STAU1;CTDP1;TBC1D20;POLR2H;PPID;NELFA;KPNA6;HACD3;DDB1;POLR2I;CDK9;LARP1;POLR2L;PPIH
prerank,positive regulation of innate immune response (GO:0045089),0.3475677591193541,0.8487408685491848,0.694047619047619,0.8908091392881216,1.0,3/30,9.99%,LBP;MAVS;PLA2G5
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3774909086989509,0.8483868988999518,0.6547619047619048,0.890992258207804,1.0,4/18,16.78%,BRD4;CDC25B;RCC2;CDC25A
prerank,endothelial tube morphogenesis (GO:0061154),0.42698745531116306,0.8479041125228677,0.6651982378854625,0.8914064235574821,1.0,6/10,30.24%,RHOA;BMP4;RHOB;PRKD2;CCM2;CTNNB1
prerank,regulation of MAP kinase activity (GO:0043405),0.3037728305050802,0.8478186947230855,0.7413249211356467,0.8911772602613813,1.0,15/92,12.79%,EGFR;PRKCD;VEGFA;FGF2;FGFR1;IRAK3;CDK5RAP3;EDN3;CDK12;BMP4;PAQR3;IRAK1;TENM1;PIK3CB;PPEF2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.33917413244753736,-0.84775254168331,0.6801346801346801,0.8650561586428577,1.0,3/10,13.56%,PRKCH;NME2;TRIM16
prerank,mitochondrial RNA metabolic process (GO:0000959),0.38909023685423016,0.8474428771245556,0.6794520547945205,0.8914232989357226,1.0,4/14,20.44%,FOXO3;TFB2M;TWNK;MRPL12
prerank,positive regulation of MAPK cascade (GO:0043410),0.2887048129566815,0.8467766485344375,0.842685370741483,0.8921778836513742,1.0,31/245,13.07%,BMPER;EGFR;VEGFA;TNFAIP8L3;GAS6;FGF2;NTRK3;NTRK1;FSHR;CCL13;SHC1;CCL15;TGFB2;MID1;PRKCA;LAMTOR1;HMGB1;FGFR1;IAPP;EDN3;ROR1;FGFR2;PLA2G5;IRAK1;MAP3K12;P2RY6;ARHGAP8;TENM1;NRP1;STK25;F2R
prerank,pore complex assembly (GO:0046931),0.37443772813022863,0.8466841257568443,0.6781002638522428,0.8919415637614637,1.0,8/19,27.36%,NUP93;ADAM10;TMEM170A;NDC1;BAD;AFDN;TPR;AHCTF1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.39639648318072307,0.846315328214585,0.6870838881491345,0.8921375609847898,1.0,3/14,13.93%,ADAM10;STK39;WNK1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.2890963558209201,-0.8461720423484075,0.6828193832599119,0.8667414338667765,1.0,6/18,17.07%,SLC25A13;ASPG;ASS1;SMS;MSRA;FOLH1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3624251615762187,0.8449453946207931,0.6709346991037132,0.894017191182707,1.0,6/22,16.22%,CAMK2D;PRKCA;SMAD4;SLC9A1;MEF2A;PARP1
prerank,regulation of striated muscle contraction (GO:0006942),0.3495537683933316,0.8449113854678866,0.6666666666666666,0.8936912836316598,1.0,7/27,11.76%,HCN4;CALM2;TNNT3;DMD;ANK2;TNNI3K;SMAD7
prerank,mesenchyme development (GO:0060485),0.3872497313650489,0.8443658533293461,0.6723016905071522,0.8941911589303426,1.0,4/15,12.61%,CRELD1;BMP4;FGFR2;TGFBR1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.4060516998453222,0.8441665353065123,0.6581920903954802,0.8941242035685675,1.0,6/11,31.69%,DONSON;ZRANB3;FBH1;SMARCAL1;TIMELESS;BLM
prerank,cellular response to nutrient levels (GO:0031669),0.31039107039343217,0.8440713743604081,0.7248618784530386,0.8939052109178346,1.0,20/62,29.19%,KCNB1;WIPI2;CLEC16A;WRN;SREBF1;FADS1;EIF4G1;USP33;VPS41;FLCN;KLF10;LAMP2;LRRK2;RPTOR;STK24;EHMT2;TFEB;ULK1;SREBF2;ZFYVE1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.35375698334433264,0.843706166553164,0.6921052631578948,0.893760436745992,1.0,13/23,28.53%,PPP3CC;MAPK8;YWHAE;YWHAQ;TFDP1;E2F1;BID;SFN;TP53;BAD;YWHAB;NMT1;BBC3
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.35375698334433264,0.843706166553164,0.6921052631578948,0.893760436745992,1.0,13/23,28.53%,PPP3CC;MAPK8;YWHAE;YWHAQ;TFDP1;E2F1;BID;SFN;TP53;BAD;YWHAB;NMT1;BBC3
prerank,regulation of muscle contraction (GO:0006937),0.3501791772196512,0.8434604269127167,0.6825,0.8938160473491857,1.0,3/26,5.09%,PLCE1;PPP1R12B;TNNT3
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.37728677111209463,0.8432536316157618,0.6450276243093923,0.8933921645350932,1.0,5/15,24.98%,BLOC1S2;AP3D1;BLOC1S3;SNAPIN;AP3B1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.37728677111209463,0.8432536316157618,0.6450276243093923,0.8933921645350932,1.0,5/15,24.98%,BLOC1S2;AP3D1;BLOC1S3;SNAPIN;AP3B1
prerank,positive regulation of protein polymerization (GO:0032273),0.3085011258303515,0.84294937476766,0.7281659388646288,0.8935320508829139,1.0,22/65,30.44%,CTTN;PRKCE;CDC42EP2;PFN2;SNX9;TENM1;AKAP9;CDC42EP5;ARL2;SLAIN2;DCTN1;CDK5RAP2;BAIAP2L1;PINK1;MET;NCK1;DRG1;FES;TOGARAM1;VASP;RAC1;HSP90AA1
prerank,regulation of isotype switching (GO:0045191),0.3923505356247058,0.8429314323044028,0.6861702127659575,0.8931872978274764,1.0,7/14,29.09%,PARP3;KMT5C;MAD2L2;IL4;SHLD3;SHLD1;HMCES
prerank,muscle cell development (GO:0055001),0.34032597909185286,0.842898338974117,0.687041564792176,0.8928661541296063,1.0,6/30,9.62%,VEGFA;SDC1;RAMP2;DMD;ANK2;ALPK3
prerank,protein kinase B signaling (GO:0043491),0.3544636256537819,0.8427249543460257,0.6907730673316709,0.8927804691903234,1.0,7/23,29.78%,GAS6;SIRT2;AKT1;TSC2;CCL2;SETX;ZFP36L1
prerank,regulation of regulated secretory pathway (GO:1903305),-0.2435628794874417,-0.8420235996706543,0.7610062893081762,0.8735142771061172,1.0,14/34,20.11%,RIMS2;RIMS1;SYN1;DTNBP1;SYT10;SYT13;SYT3;SYT2;PREPL;RAB15;SYT11;SYT12;SYT7;SYT15
prerank,oogenesis (GO:0048477),-0.30413597965200545,-0.8419081346772632,0.667953667953668,0.8722522016313164,1.0,7/15,22.56%,PTN;FMN2;MEI4;MDK;NANOS3;NANOS1;TRIP13
prerank,negative regulation of centrosome duplication (GO:0010826),0.4127025575119748,0.8417429791415401,0.6780141843971631,0.8940500648354168,1.0,4/11,24.47%,KAT2A;CDK5RAP2;KAT2B;TMEM67
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3338756491585847,-0.8417079076890716,0.6872852233676976,0.8712437886580879,1.0,5/10,19.55%,APC;CDC42;RACGAP1;ECT2;KNSTRN
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.34077879579667364,0.8415882081095031,0.7036144578313253,0.893916125946361,1.0,3/31,8.78%,FHL1;DACT1;DLG1
prerank,intraciliary retrograde transport (GO:0035721),0.40250912620518,0.8410701109909776,0.6822033898305084,0.8944117343261245,1.0,7/12,32.89%,DYNLT2B;DYNC2I1;IFT43;DYNC2H1;DYNC2I2;IFT140;WDR35
prerank,positive regulation of cilium assembly (GO:0045724),0.3704885485727775,0.8408969624814238,0.6815856777493606,0.8942927167454643,1.0,8/18,29.61%,MARK4;FUZ;KCTD17;WRAP73;ARHGAP35;CCP110;TAPT1;SEPTIN9
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.40192851831769655,0.840830961392268,0.6842105263157895,0.894021348288931,1.0,7/12,32.07%,UBE2C;CDC20;RAB1A;GOLGA2;BTRC;UBE2S;GORASP1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.39354715145433505,0.8406331936322445,0.6803977272727273,0.893950343682917,1.0,8/13,33.74%,ALG13;ALG1;ALG3;ALG14;ALG12;ALG9;SRD5A3;ALG8
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3354756041288167,0.8403576740014415,0.6994152046783626,0.8940470782178754,1.0,19/37,34.27%,IFT20;IFT80;TRIP11;IFT46;PCM1;IFT88;DYNC2I1;IFT43;TNPO1;IFT27;DYNC2H1;KIF17;DYNC2I2;IFT140;KIFAP3;DYNLL2;IFT52;WDR35;DYNLRB1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3320259727174664,0.8401286241331101,0.7093425605536332,0.8940375237751936,1.0,5/38,7.83%,GAS6;SRCIN1;SHC1;NOX4;DLG4
prerank,negative regulation of nuclear division (GO:0051784),0.4088818477986269,0.8396604110161915,0.6690042075736325,0.8944277510168519,1.0,2/11,9.70%,TOM1L1;BMP4
prerank,protein prenylation (GO:0018342),0.41318135216892693,0.8387351014786827,0.678726483357453,0.8955754140653269,1.0,7/10,41.92%,RABGGTB;PTAR1;FNTB;RABGGTA;CHM;FNTA;PGGT1B
prerank,response to chemokine (GO:1990868),0.3874606685873728,0.8387167642294405,0.6830985915492958,0.8952320913783857,1.0,4/13,13.93%,SLC12A2;STK39;RHOA;WNK1
prerank,negative regulation of ion transport (GO:0043271),-0.2670923669965879,-0.8378526808829827,0.6926605504587156,0.8772125256153459,1.0,10/24,18.74%,ACTN2;WNK2;ADRA2A;PACSIN3;NOS1;WNK4;SNCA;CASQ2;SYT11;PXK
prerank,regulation of histone methylation (GO:0031060),0.3926685112058481,0.8375651774944494,0.6788218793828892,0.8966857886044398,1.0,5/13,21.59%,NSD1;NNMT;CHTOP;MTHFR;PAF1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3027739988198133,0.8374059116363862,0.7371244635193133,0.8965828307315489,1.0,24/73,25.17%,F3;CRADD;XDH;VCP;TNFSF15;DAP;ANP32B;AIFM1;TNFRSF10B;PDCD2;HSPD1;F2R;CASP1;HIP1;BID;MUL1;SENP1;DIABLO;MTCH1;EIF2AK3;BAD;RPS27L;BCL2L13;TRADD
prerank,regulation of protein localization to cell surface (GO:2000008),0.3342409431440813,0.836719223110815,0.6757396449704142,0.8973200540309685,1.0,7/33,15.16%,TM9SF4;RIC3;GOPC;GBF1;RAB11FIP5;RAB11B;STX4
prerank,negative regulation of cell activation (GO:0050866),0.39063844924704266,0.8366303659375667,0.6616847826086957,0.8970808212066329,1.0,2/14,2.99%,EMILIN1;C1QTNF1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3540764511659782,0.836234325151681,0.6947637292464879,0.8973508008906239,1.0,12/24,32.46%,PHF1;TRIM27;RBBP7;MPHOSPH8;TASOR;DNMT1;H3-3A;DNMT3A;SUZ12;MTF2;SPI1;CREBZF
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.2930257208474746,-0.8362128495581932,0.7109004739336493,0.878746746252568,1.0,9/20,21.05%,PRKAA2;RPS6KA5;PPARGC1A;PRKAA1;NOS1;BRCA1;MAPK3;SOX4;GLYR1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.3293617668627727,-0.8359900640224819,0.673992673992674,0.8777308202547265,1.0,3/11,15.60%,FAS;CAV1;FOXO1
prerank,synaptonemal complex assembly (GO:0007130),0.37727942708153184,0.8358988873806461,0.676,0.8971526102189433,1.0,4/15,28.84%,HORMAD1;TEX11;P3H4;SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.37727942708153184,0.8358988873806461,0.676,0.8971526102189433,1.0,4/15,28.84%,HORMAD1;TEX11;P3H4;SYCP2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.31545950244207865,-0.8355166580297344,0.6791044776119403,0.877165953359535,1.0,3/13,4.15%,SHANK3;APP;ADCY1
prerank,response to UV-B (GO:0010224),-0.3137673425827108,-0.8354456000335918,0.6943396226415094,0.8758677673866788,1.0,12/12,68.65%,CRIP1;HYAL2;MME;STK11;CDKN1A;IL12A;IL12B;MFAP4;HYAL1;HYAL3;RELA;MSH2
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.27853144459081414,-0.8348448852782597,0.7012448132780082,0.87557354298289,1.0,9/21,25.69%,PAG1;DUSP3;TNFAIP3;PTPN22;SOX11;SAMSN1;LST1;LAX1;IL4I1
prerank,regulation of JNK cascade (GO:0046328),0.2922067759267884,0.8348059078309527,0.7791666666666667,0.8984897791976151,1.0,14/101,12.52%,RASSF2;EGFR;SH3RF3;GADD45G;MAP3K5;DACT1;HMGB1;FZD7;ITCH;LTBR;ULK4;AXIN1;CD27;TRAF3
prerank,endothelial cell differentiation (GO:0045446),0.39382653139362,0.8345780802871464,0.6899862825788752,0.8984965917527992,1.0,2/12,6.53%,FSTL1;JAG1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.2930591544439953,-0.8344061611044511,0.7163636363636363,0.8750065738665553,1.0,8/17,30.36%,ADRA2A;PRKAA1;MFSD2A;BSCL2;ALK;APOC1;GPLD1;PDE3B
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.28914030481328623,0.8342800112192733,0.8004073319755601,0.8986024318015835,1.0,29/149,20.48%,SLCO3A1;CARD14;NTRK1;RAB7B;CARD16;STAT3;ERC1;IRAK3;RPS6KA4;TRIM27;ROR1;CHUK;RIPK3;NFKBIB;IRAK1;TAB2;RNF25;MID2;PSMA6;PRDX3;IL6;RPS27A;UBC;NFKB2;TRIM13;TRIM6;NFKBIA;TNFSF18;CLU
prerank,regulation of interferon-gamma production (GO:0032649),0.303871362629695,0.8339335852995724,0.7408207343412527,0.8988009891198815,1.0,10/71,13.03%,GAS6;IL12RB2;HMGB1;TRIM27;RARA;FZD5;CRTAM;RIPK3;HSPD1;INHBA
prerank,ATP transport (GO:0015867),-0.3413926598245193,-0.8336524241816411,0.6920529801324503,0.8749829298260112,1.0,3/10,28.50%,SLC25A24;CD47;SLC17A9
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3328076376882783,0.8335558913708324,0.7071428571428572,0.8990406113928436,1.0,3/33,8.78%,FHL1;DACT1;DLG1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.39210635528232507,0.8331390187000579,0.6767537826685007,0.899305586812234,1.0,8/13,39.85%,LCMT1;XRCC3;CDK5RAP2;TPR;DYNC1LI1;PCID2;NDC80;DUSP1
prerank,regulation of neurogenesis (GO:0050767),0.309822376224593,0.8329871928616782,0.7188888888888889,0.8991769262745721,1.0,10/55,15.26%,DOCK7;HES5;SERPINF1;BHLHE40;HEYL;HEY1;LIG4;LRP2;PCM1;IL6
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.31622234199247884,-0.8329462507789698,0.6690647482014388,0.874800080296178,1.0,2/13,1.29%,SLC8A1;PDE4D
prerank,neuron projection fasciculation (GO:0106030),0.408262502155433,0.8321312013618948,0.6828193832599119,0.9001325990071662,1.0,2/10,5.73%,EPHB2;EPHB3
prerank,negative regulation of immune system process (GO:0002683),0.3801804560790664,0.8316187606335023,0.6733601070950469,0.9005918981469148,1.0,2/16,8.24%,COL3A1;SOX9
prerank,RNA destabilization (GO:0050779),0.36284393766327927,0.831560655896526,0.6926174496644295,0.9003168028275034,1.0,10/18,28.86%,FTO;PUM1;METTL16;RBM24;ROCK1;METTL14;RIDA;YTHDF1;ZC3H18;DXO
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3385389488667103,-0.8314959376614414,0.6686567164179105,0.8759982685201458,1.0,5/10,20.15%,SIRT1;SNCA;KLF15;BRCA1;TAF7
prerank,tetrapyrrole metabolic process (GO:0033013),0.3693412762161852,0.8312527824119788,0.6832214765100671,0.9004458050275921,1.0,4/18,14.15%,ABCC1;MTRR;MMAB;ABCB6
prerank,negative regulation of fat cell differentiation (GO:0045599),0.331271860667268,0.8309789215985348,0.717208182912154,0.9005023464643471,1.0,9/34,18.04%,ZFPM2;WWTR1;RORA;IL6;SIRT2;TRIO;ANKRD26;FLCN;E2F1
prerank,regulation of protein processing (GO:0070613),0.3537438455192183,0.8308170373723628,0.7102922490470139,0.9003657026640278,1.0,5/21,21.66%,GAS1;SERPINE2;RUNX1;CLN3;LRRK2
prerank,positive regulation of DNA binding (GO:0043388),0.3337547136904679,0.8304990035925832,0.7065727699530516,0.9005158845014204,1.0,5/31,18.06%,TWIST1;HMGB1;SKI;SIRT2;TRIM6
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3598148733218819,0.8301317511041086,0.7100130039011704,0.9007234254369657,1.0,2/21,3.71%,FOXP1;ELF1
prerank,replication fork processing (GO:0031297),0.3246199743985396,0.8294297077492699,0.7224824355971897,0.9014524442301753,1.0,16/38,35.18%,TONSL;WRN;RAD51;TRAIP;PRIMPOL;BOD1L1;ZRANB3;FBH1;RTEL1;CDK9;ATR;SMARCAL1;DDX11;BLM;MMS22L;MRE11
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2910650783582805,0.8293561483967344,0.762303664921466,0.9011946087676613,1.0,30/109,21.26%,FGF2;PLA2G4F;PLEKHA4;PLA2G4A;PIK3C2B;PITPNM1;PIGW;MTMR11;SYNJ1;PLA2G5;PIP4K2B;INPP5B;ARF1;MTMR10;INPP4A;PIK3CB;PIP4P2;OCRL;PI4K2A;PLA2G12A;CDIPT;PIP5K1A;PI4KB;INPP5E;VAC14;CDS1;PLCB2;MTMR1;SYNJ2;RAB4A
prerank,negative regulation of platelet activation (GO:0010544),0.3763026833427133,0.8290861522167756,0.6950067476383266,0.90123757878023,1.0,3/16,6.02%,PRKCD;C1QTNF1;CD9
prerank,organophosphate catabolic process (GO:0046434),-0.33586033916572766,-0.828603603513257,0.6866666666666666,0.8799994805032655,1.0,2/11,8.97%,ENPP2;PLBD2
prerank,negative regulation of immune response (GO:0050777),0.28400691058331884,0.8282581271925287,0.8225152129817445,0.9021753614691296,1.0,31/154,21.22%,COL3A1;GPR27;DRD1;FSHR;RAMP2;TRAFD1;ADCY2;ADCY8;IRAK3;ADCY9;TRIM27;GPR20;IAPP;ITCH;MAPKBP1;RAMP1;VIP;GLP1R;MC4R;PCBP2;PTGDR;IL6;SIRT2;CREB1;CALCA;ACOD1;ADCY7;PRKACA;GNB1;PRKAR2A;MUL1
prerank,placenta development (GO:0001890),0.39659709031422746,0.8279331346530225,0.6890982503364738,0.9023289336182453,1.0,4/12,27.83%,SOD1;PLAC1;CUL7;E2F8
prerank,positive regulation of glial cell differentiation (GO:0045687),0.367732494461287,0.8278724857088883,0.6861979166666666,0.9020404435072541,1.0,5/17,15.84%,ID2;TNFRSF1B;SERPINE2;CLCF1;CXCR4
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2938212236380735,0.8275495243331636,0.774468085106383,0.9021820718506598,1.0,32/84,34.38%,IGFBP5;SAMD4A;ILF3;RBM4;CNOT8;CNOT10;ORMDL3;EPRS1;DAPK3;CNOT9;SHMT1;SYNCRIP;CALR;CLU;ORMDL1;FXR2;EIF2AK3;YBX1;ROCK1;MRPL13;RIDA;FXR1;GGA3;LARP1;CAPRIN1;DAPK1;PRNP;NCL;PCIF1;PUS7;DHFR;RTN3
prerank,lipid catabolic process (GO:0016042),-0.29232424140293345,-0.8274862149915294,0.6987951807228916,0.8805477966396953,1.0,8/18,26.88%,PLA1A;PLAAT3;LPL;LIPE;MT3;LIPH;LIPC;HSD17B14
prerank,cobalamin metabolic process (GO:0009235),0.36891357934952973,0.8271072144191047,0.6854082998661312,0.9025130626340612,1.0,3/17,9.57%,ABCC1;MTRR;MMAB
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3295237600662721,-0.8257111947461955,0.696113074204947,0.8824056467203397,1.0,1/11,1.25%,CDH13
prerank,purine-containing compound salvage (GO:0043101),0.38753800458637233,0.8252378464329658,0.6790633608815427,0.9051178210943486,1.0,3/12,12.98%,ADA;AMPD3;DGUOK
prerank,7-methylguanosine RNA capping (GO:0009452),0.3311377594560486,0.8249441799787666,0.7451690821256038,0.9048274851200334,1.0,15/31,33.42%,GTF2F1;ERCC3;ERCC2;POLR2F;NCBP1;NCBP2;RAMAC;POLR2B;GTF2H4;POLR2H;RNMT;POLR2I;POLR2L;POLR2K;CCNH
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3311377594560486,0.8249441799787666,0.7451690821256038,0.9048274851200334,1.0,15/31,33.42%,GTF2F1;ERCC3;ERCC2;POLR2F;NCBP1;NCBP2;RAMAC;POLR2B;GTF2H4;POLR2H;RNMT;POLR2I;POLR2L;POLR2K;CCNH
prerank,centromere complex assembly (GO:0034508),0.32309629190912964,0.824858537674681,0.7188612099644128,0.9045885251023922,1.0,5/36,13.25%,HJURP;CENPC;CENPT;MIS12;RBBP7
prerank,nucleic acid-templated transcription (GO:0097659),0.31998489495849586,0.824812706562672,0.7301038062283737,0.9042913599295457,1.0,17/42,30.91%,TOPORS;BAZ2A;NFKBIB;TERT;XAB2;MEF2A;MMS19;POLR2F;E2F1;MED20;POLR2B;POLR2H;DRG1;POLR2I;PWP1;POLR2L;TAF1B
prerank,epithelial cell morphogenesis (GO:0003382),0.35905920174498573,0.8246669539883523,0.686777920410783,0.9041471182243992,1.0,2/17,3.83%,COL15A1;PKHD1
prerank,positive regulation of viral transcription (GO:0050434),0.3454531059747338,0.8246418675011971,0.7016229712858927,0.9038103875479185,1.0,14/25,35.35%,MDFIC;GTF2F1;POLR2F;POLR2B;NELFB;CTDP1;POLR2H;NELFA;POLR2I;CDK9;POLR2L;POLR2K;DHX9;SUPT4H1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3271466830002243,0.8241039294968805,0.7333333333333333,0.904290139080189,1.0,6/32,16.86%,DRD1;CALM2;P2RY6;PDPK1;F2R;CALM3
prerank,positive regulation of endocytosis (GO:0045807),0.31446883345372567,0.823630272009663,0.7382319173363949,0.9046822426077127,1.0,13/45,20.97%,LRP1;GPC3;RAB21;CBL;NLGN1;DAB2;HNRNPK;HIP1;CD151;CLN3;APPL2;CLU;IL4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.3936166874414079,0.8235314011167879,0.7002840909090909,0.904455749098412,1.0,3/11,19.65%,HMGB1;RUNX1;CBFB
prerank,regulation of neuroblast proliferation (GO:1902692),0.3764093519212048,0.8229200122528776,0.7111111111111111,0.9050430144253219,1.0,1/15,0.78%,VEGFA
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.38733570592940325,0.8221297369568349,0.7090909090909091,0.905885539785379,1.0,6/13,32.32%,PGM3;RENBP;CHST5;OGA;NAGK;CHST7
prerank,fibrinolysis (GO:0042730),-0.31197600059943,-0.8215863761635249,0.6832740213523132,0.888401745438286,1.0,2/13,10.56%,PLAT;SERPINE1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3176051352944478,0.8213250116533843,0.7235294117647059,0.9067237118210824,1.0,15/37,27.14%,SPRED2;CALM2;DGKQ;AXIN1;SMAD7;PPEF2;EIF4G1;SIRT2;CALM3;TRIM6;TNKS1BP1;RPTOR;S1PR2;PARD3;RIPK2
prerank,regulation of inflammatory response (GO:0050727),0.2809441093022787,0.8207597471890017,0.8480885311871227,0.9072495143562268,1.0,27/190,17.35%,MGLL;FOXP1;PRKCD;PDCD4;IL33;PTGIS;CCN3;ABCC1;SHPK;TNFRSF1B;BRD4;DAGLA;SBNO2;SHARPIN;RORA;ANXA1;LPCAT3;NR1D2;PSMA6;PTPN2;CASP1;SETD4;IL6;PTGES;OTULIN;CCN4;UFL1
prerank,neutrophil migration (GO:1990266),0.3049368899925231,0.8207357895197557,0.7511160714285714,0.9069203444766722,1.0,6/58,9.29%,CCL13;CCL15;TGFB2;GBF1;FCER1G;EDN3
prerank,axonal fasciculation (GO:0007413),0.3890782962712904,0.8203715531159538,0.7002840909090909,0.9071053418357848,1.0,2/12,5.73%,EPHB2;EPHB3
prerank,regulation of cell-cell adhesion (GO:0022407),0.3203239148707768,0.8200161551607255,0.7286549707602339,0.9072889687951113,1.0,7/39,11.76%,EFNA5;PKHD1;ADA;EPHB3;JAG1;FUT4;SMAD7
prerank,cAMP biosynthetic process (GO:0006171),0.4070392561188372,0.8198865929084953,0.703125,0.9071173982800416,1.0,3/10,7.53%,ADCY2;ADCY8;ADCY9
prerank,positive regulation of glucose import (GO:0046326),0.3571328594547896,0.8198713479489945,0.7352185089974294,0.906771359110132,1.0,4/21,8.56%,IRS1;RHOQ;CAPN10;AKT2
prerank,regulation of immunoglobulin production (GO:0002637),0.3471195557699961,0.8193346865054048,0.727735368956743,0.9072353752442248,1.0,5/23,20.97%,EPHB2;CLCF1;STX4;IL6;IL4
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3525742141510171,0.8191549946287212,0.6987179487179487,0.9071427492940475,1.0,10/22,32.29%,ERI3;RRS1;RPP40;WDR12;ABT1;KRI1;ERI1;EXOSC2;NOP14;EXOSC3
prerank,negative regulation of GTPase activity (GO:0034260),0.3511647341964821,0.8182444966020591,0.7287917737789203,0.9081598386527359,1.0,6/22,13.93%,RDX;KLRK1;BCAS3;RCC2;ARL2;WNK1
prerank,sister chromatid segregation (GO:0000819),0.33386649966045034,0.8170962395719815,0.7132352941176471,0.9095365035729733,1.0,5/31,15.97%,TUBG2;SMC4;MIS12;ZW10;KLHL22
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3466836703276461,0.8167450410965514,0.7087628865979382,0.9096983540681207,1.0,8/21,23.25%,MCU;BCAP31;MICU2;LETM1;MICU1;ANXA6;AFG3L2;SLC8B1
prerank,membrane fusion (GO:0061025),0.32292100075169883,0.8163742249370798,0.7330960854092526,0.9098884279232313,1.0,8/33,17.80%,STX11;DNM2;HUWE1;NSF;USO1;CHP1;SNAP23;NAPA
prerank,rRNA transcription (GO:0009303),0.3626249921285266,0.8163699320738137,0.7039473684210527,0.9095248356412997,1.0,10/17,35.74%,POLR1G;CAVIN1;GTF3C1;GTF3C4;GTF3A;NIFK;TAF1B;SIRT7;TCOF1;BRF1
prerank,defense response to protozoan (GO:0042832),-0.32567148002374513,-0.8159008731889785,0.704225352112676,0.8971885685107912,1.0,5/12,18.14%,GBP7;GBP4;CD40;BATF;MYD88
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3267662773216272,0.8152260162793721,0.718978102189781,0.9109104413922506,1.0,2/32,2.82%,DDX5;FHIT
prerank,multivesicular body assembly (GO:0036258),0.33253334311947763,0.8150160365612918,0.7362110311750599,0.9108772710944057,1.0,12/30,32.86%,STAM2;CHMP3;IST1;VTA1;CHMP4A;CHMP4B;PDCD6IP;MVB12A;CHMP2A;VPS37B;CHMP4C;VPS37C
prerank,synaptic vesicle exocytosis (GO:0016079),0.315907518205596,0.8144599936819801,0.730593607305936,0.9113593531939359,1.0,15/40,26.92%,SYT8;UNC13B;STX11;PRRT2;STX2;SNAP23;STX4;STX1A;SNAPIN;CDK5;STX1B;VAMP2;STX19;PCLO;SNPH
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3532441761387083,0.8143985281305611,0.735897435897436,0.9110782214184437,1.0,9/20,30.69%,FKBP5;PPIL3;NKTR;FKBP4;PPIG;FKBP1B;PPID;PPIC;PPIH
prerank,regulation of response to external stimulus (GO:0032101),0.2862699743744524,0.8143426348915173,0.8162839248434238,0.9107855995924915,1.0,34/121,26.03%,MGLL;FOXP1;EPHB2;SHPK;PDE6A;BRD4;SBNO2;ANXA1;NR1D2;TRAF3;PSMA6;F2R;CASP1;GUCY2D;CXCR4;N4BP1;PTGES;UFL1;SAG;APPL2;APPL1;GRK4;DAGLB;BIRC3;AREL1;CYLD;BST1;USP14;METAP2;XIAP;STK24;TKFC;NMT1;CYRIB
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.284408629099301,0.8140018536198141,0.7991587802313355,0.9109242010698126,1.0,16/104,16.86%,LRP6;LRP5;CALM2;CDC6;CDK5RAP3;RHOA;CDK12;SYAP1;ABL1;CCNT2;TELO2;PPEF2;CCNG2;CCNE2;CDC25A;CALM3
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.27239715797485897,-0.813735994074935,0.7412280701754386,0.8995795935566011,1.0,5/20,13.95%,RB1;LAMTOR5;NIBAN2;H1-0;IGF1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.344413154734647,0.8135211382030602,0.7048969072164949,0.9112944475347868,1.0,5/22,16.86%,CACNA1C;STIM1;CAP1;PALM;NF1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2934958566294772,0.8131169611731439,0.7997870074547391,0.9115279783961904,1.0,20/80,27.14%,PRICKLE1;TOPORS;DCUN1D5;HUWE1;CDK5RAP3;AXIN1;SMAD7;DCUN1D2;PHF23;UBQLN1;STUB1;MYCBP2;LRRK2;BIRC3;DERL1;PINK1;RCHY1;XIAP;NDFIP1;RIPK2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.2548617281836737,-0.8129376005952289,0.7189189189189189,0.8995278517346761,1.0,10/24,20.59%,BCL2;BCL2L1;CXCL12;CD74;TPT1;SIRT1;CD44;KDM1A;CDKN2D;TAF9
prerank,rRNA 3'-end processing (GO:0031125),0.40159312352543575,0.8129083412964401,0.6953455571227081,0.9114643944334838,1.0,1/10,2.55%,ERI3
prerank,mitotic cytokinesis (GO:0000281),0.30869506334330776,0.812859389896683,0.7424412094064949,0.9111705962509635,1.0,16/47,27.73%,CIT;SNX18;SPAST;SNX9;RHOB;MITD1;SPTBN1;TTC19;RTKN;CHMP4B;PDCD6IP;ROCK1;JTB;CUL7;EFHC1;SON
prerank,L-serine metabolic process (GO:0006563),0.4011877905603017,0.8127295879080461,0.7126436781609196,0.9109991767979866,1.0,5/10,19.03%,SRR;PHGDH;SHMT2;SHMT1;PSAT1
prerank,positive regulation of ion transport (GO:0043270),0.3062939470776344,0.8124336864100135,0.7517401392111369,0.9110724813140513,1.0,8/48,13.07%,FHL1;DRD1;CRACR2A;CHRNB2;ANK2;DLG1;PRSS8;F2R
prerank,negative regulation of complement activation (GO:0045916),-0.3378397967170574,-0.8122469909066884,0.6793103448275862,0.8993059764965929,1.0,4/10,23.39%,A2M;CR2;CD55;SUSD4
prerank,positive regulation of autophagy (GO:0010508),0.2928238957709859,0.8119037386724206,0.7935483870967742,0.9115070179423022,1.0,37/81,31.59%,SESN3;HMGB1;TRIM27;MID2;PIK3CB;SESN2;PAFAH1B2;TRIM65;FOXO3;ORMDL3;FLCN;UFL1;TRIM13;TRIM6;EIF2AK4;ATF6;OPTN;IL4;RUFY4;LRRK2;TRIM8;TSC2;NPRL2;BAD;TBK1;ROCK1;PINK1;GPSM1;TFEB;ULK1;LARP1;PLEKHF1;PRKN;IRGM;MTDH;PIM2;DAPK1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.35250820513746084,0.8117571376835425,0.727741935483871,0.9113574116718038,1.0,4/20,10.45%,MBTPS1;DGKQ;SREBF1;LPCAT3
prerank,regulation of calcium ion import (GO:0090279),-0.27386733721480416,-0.8109720796099505,0.7433628318584071,0.9000499651305014,1.0,4/21,11.88%,CXCL12;PDGFRB;PLPP4;SLC30A1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.358279844016164,0.8107125064751753,0.7117962466487936,0.9125207235431859,1.0,6/18,18.53%,MDFIC;CHP1;RAB23;LATS2;FLCN;SUFU
prerank,lymphocyte proliferation (GO:0046651),0.3422668169570348,0.810489125385099,0.7241830065359477,0.9124742164535639,1.0,1/22,1.42%,ELF4
prerank,regulation of cytoplasmic translation (GO:2000765),0.3762083434433113,0.8104803862717452,0.7005420054200542,0.9121185120025695,1.0,1/14,1.81%,YBX3
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.31862032179808203,-0.8104554776390883,0.7250859106529209,0.8995333990681023,1.0,9/12,43.80%,PRKCQ;CCR2;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.30080685628842435,0.8092435319021275,0.7763300760043431,0.913621372653716,1.0,7/65,8.39%,EGFR;ARAP1;PTPN3;MVB12B;AGR2;RNF115;CBL
prerank,extracellular transport (GO:0006858),0.38237238184554,0.8092060362881935,0.71900826446281,0.9133048686561694,1.0,4/13,21.82%,WWP2;ROPN1L;DNAAF4;SPAG17
prerank,T cell mediated immunity (GO:0002456),0.38833581826352237,0.8090501084378029,0.7019498607242339,0.9131922512254227,1.0,3/13,9.77%,GNL1;JAG1;CRTAM
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.2934777485214696,-0.8088294263173638,0.688,0.9010040007615675,1.0,9/15,34.49%,KLHL18;STXBP4;PHB2;CUL3;CRNN;DYRK3;ATAD5;CDC73;NPM1
prerank,regulation of peptidase activity (GO:0052547),0.35590778667557715,0.8088246166274373,0.7212681638044914,0.9131732688025805,1.0,7/19,27.77%,CST3;MAPK12;HDAC1;PSMA3;RCN3;PINK1;SVBP
prerank,positive regulation of protein deacetylation (GO:0090312),0.3704783833474311,0.8087202572670078,0.7121212121212122,0.9129588614364376,1.0,4/14,24.33%,NNMT;NIPBL;AKAP8;SAP30BP
prerank,regulation of interferon-alpha production (GO:0032647),0.34450230409100924,0.8082787903400578,0.735330836454432,0.9132215977579866,1.0,8/23,27.14%,PTPRS;MAVS;CHUK;HSPD1;IRF3;SETD2;TBK1;RIPK2
prerank,negative regulation of glycolytic process (GO:0045820),0.40812038832516806,0.8079200451749119,0.7089871611982882,0.9130373677168254,1.0,3/10,11.17%,HDAC4;ACTN3;GIT1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.40812038832516806,0.8079200451749119,0.7089871611982882,0.9130373677168254,1.0,3/10,11.17%,HDAC4;ACTN3;GIT1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3465751291295477,0.8077496584696868,0.7324120603015075,0.912917517613363,1.0,6/24,14.32%,GAS6;RAMP2;NFE2L2;PAK4;PDPK1;NDNF
prerank,regulation of dendrite morphogenesis (GO:0048814),0.32945911919761034,0.8076812351291967,0.7628128724672228,0.9126567857281844,1.0,5/32,6.91%,NEDD4;CUX1;FBXW8;LZTS1;CHRNB2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.30284802392089377,0.8073348036577628,0.7555803571428571,0.9128078187932941,1.0,4/49,4.20%,VEGFA;GHR;HES5;STAT3
prerank,glycerophospholipid metabolic process (GO:0006650),0.2908415980069729,0.8072108090487975,0.7898706896551724,0.9126293786676437,1.0,20/75,22.85%,PLA2G4F;PLA2G4A;PIGW;SMPD4;PIGF;SYNJ1;FAR1;ABHD6;PIGL;ENPP6;PNPLA3;HDHD5;PIP5K1A;GDPD3;PLA2G15;CLN3;PLCB2;PIGX;ABHD12;PIGV
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.34188642484021414,0.80720879455495,0.7211302211302212,0.912267071393133,1.0,3/23,11.76%,ID2;FGFR2;SMAD7
prerank,Ras protein signal transduction (GO:0007265),0.2802257641717238,0.8066920080364616,0.8543788187372708,0.9126839874848992,1.0,22/137,15.25%,NTN1;PLCE1;FGF2;COL1A2;TIAM1;MRAS;GDI1;SHC1;TRIM28;EPS8L1;CDC42EP2;USP50;CYFIP1;RHOA;SHOC2;CDC42EP5;SETDB1;ARHGEF1;G3BP2;RHOB;FARP2;SOS1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.264527836895175,-0.8066441236867072,0.8075117370892019,0.9032793326154535,1.0,4/22,10.60%,WNT5A;SLC7A5;LACC1;TRIL
prerank,Notch signaling involved in heart development (GO:0061314),0.3902393065611224,0.8063050244102096,0.7229629629629629,0.9128939226513779,1.0,3/11,12.13%,JAG1;HEYL;HEY1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3126924977599056,0.8060894770582656,0.756601607347876,0.9128767497701427,1.0,9/41,12.13%,TGFB2;TGFBR2;JAG1;HEYL;BMP4;FGFR2;BMPR1A;SMAD7;HEY1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2738799569235585,0.8060852976459673,0.8653266331658291,0.9125149251695259,1.0,28/198,14.37%,ALPL;PLCE1;TNFAIP8L3;PLA2G4F;PLA2G4A;PLPP3;EPHB2;NADK;GFPT1;STAT3;LIMK2;SHPK;PLPP1;LPCAT4;GFPT2;PAK2;SYNJ1;PLA2G5;PIP4K2B;PPA2;INPP5B;IP6K1;LGALS13;INPP4A;PIK3CB;OCRL;LIMD1;DUSP18
prerank,cilium-dependent cell motility (GO:0060285),0.34125977656250506,0.8059214919583146,0.7366459627329193,0.9123849388683322,1.0,4/22,18.64%,DNAH8;CCDC39;DNAH2;TEKT2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2998605078440131,0.8057653250980037,0.7772877618522602,0.9122422869657384,1.0,19/56,27.73%,CIT;SNX18;RHOA;SPAST;SNX9;RHOB;MITD1;SPIRE2;SPTBN1;IST1;TTC19;RTKN;CHMP4B;PDCD6IP;ROCK1;JTB;CUL7;EFHC1;SON
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.34366149729829576,0.805602255275228,0.726797385620915,0.9121129132071274,1.0,2/22,3.26%,LBP;RAB7B
prerank,peripheral nervous system development (GO:0007422),0.34249820938815995,0.8054718825256273,0.7105263157894737,0.9119270220998439,1.0,8/23,23.14%,PMP22;ALDH3A2;GFRA3;NF1;SCN8A;GDNF;GPC1;SOX8
prerank,cyclooxygenase pathway (GO:0019371),0.3925247804150127,0.8051125763947371,0.7040816326530612,0.9120956178917234,1.0,2/10,7.02%,PTGIS;PTGES2
prerank,cellular respiration (GO:0045333),0.3093299545111745,0.8045804119252623,0.7608440797186401,0.9125322156641295,1.0,8/41,14.02%,ETFRF1;COQ10B;ETFDH;ETFA;ETFB;NDUFS7;SURF1;MTFR1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3718155434369349,0.8045535184070227,0.721399730820996,0.9122157503458427,1.0,4/15,20.27%,STAT3;IL6;APPL1;IL17RA
prerank,mitochondrion organization (GO:0007005),0.27600714221083117,0.8041289069148491,0.8689516129032258,0.9124739990436973,1.0,44/165,24.89%,PID1;VPS13C;DNM2;MIEF2;SPG7;TOMM40;SIRT5;RHOT2;TIMM9;RHOT1;RAB38;TERT;NRF1;BCAP31;AIFM1;LONP1;HSPD1;MEF2A;SUPV3L1;MTFR1;PRDX3;TOMM70;PARP1;HIGD1A;POLG2;BCS1L;TFB2M;BID;HCFC1;CLUH;TWNK;NIPSNAP2;FANCG;MUL1;LRRK2;MFN1;COX7A2L;AFG3L2;MTM1;STOML2;VPS13D;PINK1;TIMM17B;TIMM22
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.32223226033181507,0.8039034059087089,0.7436517533252721,0.9124427369946817,1.0,8/30,20.03%,NTRK1;SHC1;ITGAV;SHOC2;STK19;LRRC59;ERBIN;RASGRF1
prerank,cellular response to glucose starvation (GO:0042149),0.3104014338096477,0.8037469664603983,0.7531572904707233,0.912315236435148,1.0,14/41,26.33%,SESN3;ATF4;IMPACT;HSPA5;SESN2;PICK1;FOXO3;SIK2;PRKAG1;KPTN;HNRNPA1;EIF2AK3;TP53;NIM1K
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.38655141844676166,0.8034390211407479,0.7312414733969986,0.912400169100144,1.0,6/12,28.84%,ELOVL5;FADS1;ABCD1;ACOT8;ELOVL1;SCP2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.35710486467792435,0.8028206460151547,0.7257217847769029,0.9129623895413034,1.0,2/17,7.26%,TWIST1;YJU2
prerank,ribosome biogenesis (GO:0042254),0.27449246643963554,0.8025768868828781,0.863773965691221,0.9129572045502133,1.0,54/187,27.93%,XPO1;C1D;LTV1;RRS1;RRP7A;LAS1L;EMG1;CUL4A;WDR3;RIOK1;NVL;ABCE1;WDR55;ESF1;RRP12;DHX29;NOLC1;UTP14A;DCAF13;EXOSC4;NOC4L;MRTO4;EIF6;BYSL;DIS3;BOP1;METTL17;NOB1;RPL7A;NOC2L;MTREX;EIF2A;WDR12;NOP56;DDX49;FBL;SBDS;WDR36;GTF3A;PAK1IP1;WDR46;WDR75;RPS9;TBL3;SENP3;RIOK2;UTP11;NOP58;DKC1;POP5;FCF1;NOP53;RPL41;RPL30
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3475292846296486,0.8023877877410884,0.7217948717948718,0.9128745798980503,1.0,4/19,13.69%,ELF1;MAVS;IRAK1;RUNX1
prerank,neurotrophin signaling pathway (GO:0038179),0.3492330048358031,0.802384541796159,0.7399497487437185,0.9125153197671877,1.0,2/21,4.63%,NTRK1;KIDINS220
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3576947914046523,0.802368455642937,0.7280927835051546,0.912173410078438,1.0,6/18,21.66%,SLC4A8;RAB3GAP1;RIMS4;NLGN1;SNAPIN;LRRK2
prerank,negative regulation of mitochondrion organization (GO:0010823),0.32047727068303067,0.8019401995584541,0.7602409638554217,0.9124224184440534,1.0,12/33,24.52%,NOL3;FXN;HUWE1;IAPP;HGF;SLC35F6;FLCN;AKT1;CLU;MUL1;TRIAP1;PINK1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.32090547671233816,0.8018195184865922,0.7541371158392435,0.9122421997707808,1.0,11/35,20.97%,LRPAP1;RAB21;RSPO1;CBL;ARF1;PIK3CB;SNAP91;HNRNPK;HIP1;CLU;IL4
prerank,regulation of chromosome organization (GO:0033044),0.3455805514092757,0.8017929463424894,0.7265822784810126,0.9119063567456432,1.0,6/22,21.97%,RMI2;SMG6;SMG1;LIG4;CDT1;UPF1
prerank,multivesicular body organization (GO:0036257),0.32642500653745093,0.8016348717369023,0.7529976019184652,0.911766107109953,1.0,10/31,27.29%,STAM2;CHMP3;IST1;VTA1;CHMP4A;CHMP4B;PDCD6IP;MVB12A;CHMP2A;VPS37B
prerank,toxin transport (GO:1901998),0.39679399384760783,0.8014030037052371,0.7249283667621776,0.9117550784058857,1.0,4/10,30.21%,ADAM10;SLC22A3;ANTXR1;RAB40B
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.3510329284468402,0.8013704154767394,0.7332490518331226,0.9114372492326456,1.0,5/19,21.82%,CCDC39;ROPN1L;NPHP3;DNAAF4;SPAG17
prerank,regulation of blood circulation (GO:1903522),0.3206515152854358,0.8011146415944604,0.7585365853658537,0.9114346704013182,1.0,6/34,13.87%,ECE1;CAMK2D;KCNE5;KCNIP2;S100A1;DMPK
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.31270619555731144,-0.8008236887716619,0.7368421052631579,0.911918399911486,1.0,5/12,17.88%,GMPS;IMPDH1;ADSS1;LHPP;PPAT
prerank,response to ionizing radiation (GO:0010212),0.2903572090592739,0.7999616670639514,0.7876787678767877,0.9127746512797309,1.0,19/70,22.13%,COP1;INTS3;RAD1;ANXA1;SPIDR;SWI5;ATM;LIG4;TANK;RHOB;AEN;HUS1;TRIM13;MEN1;CLK2;RAD51;TNKS1BP1;BRCC3;TOPBP1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.34493350117356564,0.79970741370177,0.727735368956743,0.9127762876570913,1.0,13/20,35.95%,CAMK2D;PACS2;BCAP31;THADA;KCTD17;HERPUD1;CCDC47;FIS1;TMCO1;SELENOK;RAP1GDS1;WFS1;BAK1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.21309107418146878,-0.799583559811324,0.8771929824561403,0.9126376569079675,1.0,20/48,29.79%,IL1R1;PDE4D;SLC7A5;PDE4B;LGALS9;PTPN22;PYCARD;TXK;CD276;ISG15;TLR7;CCR2;TLR3;RASGRP1;FADD;ZFPM1;CD14;SLAMF6;IL18;TLR8
prerank,activation of protein kinase A activity (GO:0034199),0.36239145969234343,0.7995072708106236,0.7218543046357616,0.9127170536918064,1.0,4/16,7.53%,PRRC1;ADCY2;ADCY8;ADCY9
prerank,calcium ion homeostasis (GO:0055074),0.2831475581161797,0.7994386904615619,0.820021299254526,0.9124425392092864,1.0,13/95,11.18%,ATP1B1;SLC24A3;CCL13;PKHD1;CCL15;SLC10A7;ANK2;SELENON;CHERP;STIM1;EDN3;CSRP3;TMEM165
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.3864154143369368,0.799308567693995,0.720112517580872,0.9122610535688586,1.0,2/11,4.91%,RDX;PRKCA
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.39530349889154903,0.7990549174931946,0.720112517580872,0.9122640755856634,1.0,5/10,30.83%,CDT1;DBF4;STOML2;E2F8;SSBP1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.366158357173944,0.7990021870362429,0.7216216216216216,0.9119813858844096,1.0,3/15,7.13%,TGFB2;CELF4;FGFR1
prerank,regulation of protein localization (GO:0032880),0.29492800184974377,0.797604282319294,0.7948717948717948,0.9136377385180361,1.0,15/58,22.43%,DVL1;TRIM27;DLG1;PLEKHM2;MAPK8;SLC26A4;VIP;CSNK1E;PARP1;SUMO1;UFL1;TRIM6;TRIM46;CAMK1;TMEM231
prerank,maintenance of protein location in nucleus (GO:0051457),0.3485942562562192,0.7974333788600393,0.73046875,0.913515608103237,1.0,3/20,13.59%,TOPORS;MORC3;ARL2
prerank,regulation of JUN kinase activity (GO:0043506),0.3199486830102104,0.7973064070354741,0.7523474178403756,0.9133261736725797,1.0,11/33,27.37%,PDCD4;MAP3K5;PPEF2;MAP3K10;DNAJA1;AIDA;DUSP19;TAOK3;MAPK8IP1;DVL2;MAP3K11
prerank,cardiocyte differentiation (GO:0035051),0.39374561332529057,0.7965860671548951,0.735632183908046,0.914006842969334,1.0,3/10,16.74%,TGFB2;AKAP13;KDM6B
prerank,positive regulation of transmembrane transport (GO:0034764),0.370321532933199,0.7964988167311184,0.7162534435261708,0.913759862711935,1.0,2/13,4.37%,SLC26A6;C2CD5
prerank,positive regulation of leukocyte migration (GO:0002687),0.3254027544552381,0.7961318940185635,0.7509025270758123,0.9139339313085452,1.0,6/27,20.97%,VEGFA;EDN3;MIA3;IL6;TNFSF18;IL4
prerank,protein monoubiquitination (GO:0006513),0.31559989404639405,0.7960615230688318,0.7611044417767107,0.9136820594484899,1.0,12/36,29.91%,TOPORS;UBE2B;UBE2R2;HUWE1;KLHL22;PAF1;KLHL12;RNF20;UBE2W;RNF126;RBX1;PRKN
prerank,fatty acid metabolic process (GO:0006631),0.27995847615119096,0.7959202909129867,0.840625,0.9135240106551682,1.0,32/115,28.48%,ABCD3;CEL;ACSF3;CPT1C;ACSF2;ACOT11;ADIPOR2;CBR4;SLC27A6;ACAD9;ACACA;ACSL3;PNPLA3;CRAT;HACL1;PLA2G15;HSD17B8;ACSL6;ACSBG1;SLC27A2;PEX2;ACBD5;MCAT;ACOT8;FA2H;FAAH;ANGPTL3;ALOXE3;SLC27A3;PON3;PER2;ACLY
prerank,retina homeostasis (GO:0001895),-0.25567210440744403,-0.7958810589655426,0.7566137566137566,0.9174749382541253,1.0,4/23,9.30%,B2M;WHRN;ATP1B2;HSPB1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.3921458875009864,0.7957937136697562,0.7263464337700145,0.9133401342142774,1.0,6/10,27.68%,CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.32380075064956093,0.7955926025766533,0.7420537897310513,0.9132735369010684,1.0,9/30,24.30%,TENT4B;ERCC4;TEN1;HNRNPC;XRN1;MEN1;HNRNPA1;HNRNPU;TP53
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3366634482260817,0.7952757144955026,0.729936305732484,0.9133712290296313,1.0,6/22,17.61%,IPO5;HEXIM1;CAMK2N1;LATS2;CDKN1C;MEN1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.33874207042091486,0.7952046185991116,0.7443890274314214,0.9131169347362256,1.0,3/23,8.39%,SRCIN1;SOCS4;CBL
prerank,positive regulation of collagen metabolic process (GO:0010714),0.35689894342676,0.7950178388623736,0.7373333333333333,0.9130124221366722,1.0,4/17,13.69%,TGFB3;BMP4;F2R;RUNX1
prerank,positive regulation of chemokine production (GO:0032722),0.3076141961741564,0.7948140027606874,0.7792946530147895,0.9129323236697461,1.0,4/44,6.48%,IL33;TWIST1;MAVS;HMGB1
prerank,cellular response to superoxide (GO:0071451),-0.3164400658626021,-0.7947314525033354,0.7402597402597403,0.9179241761104661,1.0,2/10,4.81%,NOS3;SOD3
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.36060283078308764,0.7945395247395487,0.7369127516778523,0.9129735063363382,1.0,4/16,13.69%,TGFB3;BMP4;F2R;RUNX1
prerank,embryonic digit morphogenesis (GO:0042733),0.3403062094143033,0.7941188521315398,0.7,0.913233468623027,1.0,5/18,16.12%,ECE1;TWIST1;NOG;HDAC1;CREBBP
prerank,mRNA polyadenylation (GO:0006378),0.3323103034037415,0.7940615440823996,0.7521472392638037,0.9125878758716266,1.0,7/26,21.59%,PABPC1;TENT4B;SYMPK;CLP1;PCF11;TENT2;PAF1
prerank,RNA polyadenylation (GO:0043631),0.3323103034037415,0.7940615440823996,0.7521472392638037,0.9125878758716266,1.0,7/26,21.59%,PABPC1;TENT4B;SYMPK;CLP1;PCF11;TENT2;PAF1
prerank,establishment of protein localization to membrane (GO:0090150),0.2894746099020751,0.7937052755851923,0.812981298129813,0.9127156890630769,1.0,19/66,27.29%,EGFR;NECTIN3;RABGEF1;RAB3GAP1;NPC1;ATG3;RAB11B;ZDHHC4;BID;RAB3GAP2;COX18;ZDHHC20;PRKCI;ZDHHC9;GORASP2;TAOK2;AFDN;PARD3;VPS37B
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.33326416453803187,0.7936178113956862,0.7391304347826086,0.912492992252678,1.0,3/24,6.96%,VEGFA;SEMA3E;SEMA4B
prerank,cellular zinc ion homeostasis (GO:0006882),0.33082602610071177,0.793264309998971,0.7546933667083855,0.9126019566760443,1.0,4/26,9.86%,SLC39A14;SLC39A7;SLC30A5;SLC39A13
prerank,regulation of presynapse assembly (GO:1905606),0.35669629069052117,0.7927777259875757,0.757123473541384,0.9125728714875043,1.0,2/18,4.89%,GPC6;LRFN4
prerank,regulation of presynapse organization (GO:0099174),0.35669629069052117,0.7927777259875757,0.757123473541384,0.9125728714875043,1.0,2/18,4.89%,GPC6;LRFN4
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.32063272864226977,-0.7926799171082181,0.7395498392282959,0.9198232749722871,1.0,10/10,67.96%,NCKAP1L;IL12A;FOXP3;TLR4;IL12B;VSIR;IFNG;TNFSF4;DDIT3;PRNP
prerank,mitochondrion distribution (GO:0048311),-0.3107591711863526,-0.7926669580744774,0.7573529411764706,0.9183665470769957,1.0,4/12,13.09%,DNM1L;TRAK2;TRAK1;ARMC1
prerank,negative regulation of defense response (GO:0031348),0.2892296955170189,0.7925398992151172,0.8087606837606838,0.9125608869136065,1.0,18/77,21.22%,PRKCD;PTGIS;CCN3;TRAFD1;IRAK3;SHARPIN;RORA;ITCH;MAPKBP1;LPCAT3;PTPN2;PCBP2;SIRT2;OTULIN;ACOD1;GPS2;IL4;MUL1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.3708310979679351,0.791546140456167,0.7409470752089137,0.9136269900352694,1.0,4/13,12.60%,SESN3;CASTOR2;ATM;SESN2
prerank,pinocytosis (GO:0006907),0.38363588373718477,0.7912442012227094,0.7181688125894135,0.9137188900243388,1.0,1/10,3.99%,RAB34
prerank,sphingolipid biosynthetic process (GO:0030148),0.28745536131144567,0.7909773616079165,0.8147751605995718,0.9137744066681807,1.0,7/71,6.19%,ACER3;PLPP3;ST6GALNAC5;KDSR;SMPD4;ELOVL5;PLPP1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3160888167420133,0.7906442089794766,0.7659831121833535,0.9138899843308819,1.0,12/32,29.23%,CDK5RAP3;ATM;RINT1;FOXN3;BRCC3;TOPBP1;DONSON;TAOK3;TAOK2;TAOK1;NOP53;TRIM39
prerank,chemokine-mediated signaling pathway (GO:0070098),0.304300602623302,0.7905795155858438,0.7878787878787878,0.9136207967529985,1.0,3/42,6.67%,CCL13;CCL15;STK39
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.34923425639698263,0.7904197483067995,0.7379679144385026,0.9134965041706323,1.0,4/16,20.79%,DPYSL3;UPP2;TET2;NT5C
prerank,regulation of cell division (GO:0051302),0.2886179425976492,0.7903800089220956,0.7878128400435256,0.9131976649269885,1.0,25/72,31.74%,KIF13A;CALM2;TLE6;ESRRB;FGFR2;GIT1;CSPP1;SIRT2;MLLT3;CALM3;BIRC6;FLCN;SFN;SETD2;UVRAG;PLK4;RAB11FIP4;CCP110;EFHC1;AHCTF1;PRDM15;KLHL9;ZFYVE26;BLM;RAB11FIP3
prerank,leukocyte tethering or rolling (GO:0050901),-0.27326978522167955,-0.7903140832087444,0.7777777777777778,0.9207246661442315,1.0,5/17,14.42%,VCAM1;JAM2;CX3CR1;ITGA4;GCNT1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.20493674329832615,-0.7896047343863626,0.9,0.920433834259806,1.0,15/57,17.84%,UACA;DDX3X;GRIN2B;PDCD5;AIM2;GRIN2A;SOX7;SYK;ACVR1C;NDUFA13;SIRT1;GRIN1;GPER1;FOXL2;PYCARD
prerank,negative regulation of viral process (GO:0048525),0.2924289841912262,0.7895151811948934,0.7973273942093542,0.914066534698106,1.0,16/57,22.10%,TRIM28;MAVS;TRIM27;ILF3;UBP1;MID2;CHMP3;TRIM26;SRPK1;HEXIM1;N4BP1;TRIM13;TRIM6;LARP7;SHFL;TRIM8
prerank,regulation of cholesterol efflux (GO:0010874),0.3174280160975814,0.7893766411382388,0.7641154328732748,0.9139176734886624,1.0,3/30,5.93%,LRP1;RXRA;LAMTOR1
prerank,carbohydrate derivative transport (GO:1901264),0.34638615564626796,0.7892702547654079,0.7218543046357616,0.9137011780020144,1.0,2/18,5.76%,LBP;SLC10A7
prerank,granulocyte differentiation (GO:0030851),-0.28154439825703537,-0.7891983699250239,0.7735849056603774,0.9196174754300902,1.0,3/18,4.57%,LEF1;CBFA2T3;DEK
prerank,cardiac ventricle development (GO:0003231),-0.26428882353834937,-0.7889731077598219,0.7522123893805309,0.9185425447262379,1.0,9/20,21.71%,ENG;NOTCH1;PDE2A;SALL1;HEY2;STRA6;DLL4;SCN5A;GJA5
prerank,positive regulation of transporter activity (GO:0032411),0.3667475425595558,0.7889298926597478,0.7457865168539326,0.9138219167586363,1.0,2/13,6.67%,RXRA;STK39
prerank,establishment of mitotic spindle localization (GO:0040001),0.3207530684668974,0.7888132846140122,0.7460122699386503,0.913604850001252,1.0,6/28,22.48%,PKHD1;MISP;ZW10;NDEL1;DCTN1;CDK5RAP2
prerank,histone H2B ubiquitination (GO:0033523),-0.3189832589904311,-0.7883671034191944,0.7170418006430869,0.918046339128213,1.0,4/10,16.69%,RNF40;UBE2E1;LEO1;CTR9
prerank,arachidonic acid secretion (GO:0050482),-0.32480127482480364,-0.7881610641971553,0.7213114754098361,0.9155039342594347,1.0,3/10,7.77%,BDKRB2;PNPLA8;ACE
prerank,arachidonate transport (GO:1903963),-0.32480127482480364,-0.7881610641971553,0.7213114754098361,0.9155039342594347,1.0,3/10,7.77%,BDKRB2;PNPLA8;ACE
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.2758668091503449,-0.787877285131202,0.775,0.9145039728402693,1.0,2/16,9.00%,CLDN5;CLDN1
prerank,prostaglandin metabolic process (GO:0006693),0.326000911687341,0.7871749492310067,0.7578027465667915,0.9155689931665822,1.0,2/26,1.79%,PTGIS;PLA2G4A
prerank,positive regulation of inflammatory response (GO:0050729),0.28094827030366115,0.7869111234126526,0.8108974358974359,0.9155990556935535,1.0,4/86,3.96%,LBP;PDCD4;IL33;ABCC1
prerank,cochlea morphogenesis (GO:0090103),-0.32530369308365786,-0.7860253904636729,0.7420494699646644,0.9160399724363764,1.0,2/10,5.36%,TBX18;TBX1
prerank,necroptotic process (GO:0070266),0.35853371456247307,0.7857431663833797,0.7335127860026918,0.9168555538823412,1.0,7/16,32.22%,PGAM5;TRPM7;RIPK3;CYLD;RIPK1;ITPK1;IPMK
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.34218687546450033,0.7857245038516728,0.7386804657179818,0.9165207147875324,1.0,4/21,16.78%,BRD4;CDC25B;RCC2;CDC25A
prerank,acylglycerol metabolic process (GO:0006639),0.3059176885449919,0.7852032610916909,0.792654028436019,0.916883927406815,1.0,6/37,14.82%,MGLL;LMF1;DGKQ;PGS1;ABHD6;PNPLA3
prerank,blood vessel diameter maintenance (GO:0097746),0.3172075610604743,0.7851746934720543,0.7540603248259861,0.9165683583117937,1.0,3/34,3.19%,GCLC;ECE1;EDNRA
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.373814554451204,0.7851570123668146,0.7257142857142858,0.9162367392395463,1.0,2/12,5.05%,CAMK2D;CALM2
prerank,positive regulation of myelination (GO:0031643),0.3726899225907011,0.7849825570990702,0.7424242424242424,0.9161163714582908,1.0,2/11,12.75%,TNFRSF1B;NCMAP
prerank,translation (GO:0006412),0.2671684289501778,0.784768942494884,0.90625,0.916061231612647,1.0,58/208,28.79%,RRBP1;RPSA;VARS1;MRPS2;MRPS28;WARS2;ABCF1;HARS2;GSPT1;NOA1;MRPS18B;PPA2;ZC3H15;YARS1;ABCE1;DARS2;MRPS14;EEF1G;AGO2;EIF4G1;MRPL35;ETF1;MRPS17;EEF2K;RPS27A;EEF1B2;YARS2;TUFM;EPRS1;PPA1;EEFSEC;SARS2;SARS1;DRG2;PTCD3;RPL7A;DARS1;MRPL47;GTPBP2;MRPS24;MRPS21;ASMT;MRPS18A;RPS9;MRPL37;PABPC4;TMA7;QARS1;CARS1;MRPL13;TRMT112;SRBD1;DRG1;RPL41;RPL30;MRPL11;WARS1;IGHMBP2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.37933456128691356,0.7846665763591225,0.7369186046511628,0.9158631281395613,1.0,5/10,25.60%,GPATCH3;NPLOC4;SEC14L1;C1QBP;TKFC
prerank,male gonad development (GO:0008584),0.3137676741553208,0.7843984476535414,0.7538829151732378,0.9159057549093954,1.0,6/34,13.14%,FSHR;SIX4;TGFB2;SOX9;INHBA;LRP2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.35182093258805464,0.7841702439779706,0.7328947368421053,0.9158720602420979,1.0,3/16,9.77%,KLRK1;RAET1E;CRTAM
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.2517813150294411,-0.783508605611048,0.8054298642533937,0.9187223352378777,1.0,9/24,19.49%,BCL2L1;NR1H3;AQP11;UBXN1;OPA1;HSPA1A;XBP1;RACK1;CREB3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3455679787737693,0.7833402309051383,0.7533512064343163,0.9166555582243653,1.0,5/17,25.58%,DRD1;ADCY9;AKAP13;DRD2;ADRB1
prerank,nucleotide catabolic process (GO:0009166),0.3497787149009069,0.7831474049407201,0.7394270122783083,0.9165581384590716,1.0,3/16,13.68%,XDH;VCP;DERA
prerank,MAPK cascade (GO:0000165),0.26553774304621836,0.7830565702034737,0.9348697394789579,0.9163265755450367,1.0,74/295,23.88%,EGFR;IRS1;FGF13;FGF2;DLG2;FGF17;MRAS;PTPN3;PPP1CC;PSMD7;SHC1;MAP3K5;IL5;PSMA8;FGFR1;RAF1;DLG4;PDE6D;SOX9;DLG1;MAPK8;PSMA4;FGFR2;ITGAV;CHUK;PAQR3;SHOC2;PABPN1;MAPK12;PSMD12;PIK3CB;CUL1;PSMA6;MEF2A;YWHAE;ARL2;PSMD1;HGF;SOS1;MAP3K3;PSMC5;PSMD11;IL17RD;ERBB2;PSMC4;PSMD14;GFRA3;RPS27A;UBC;FGF5;NF1;SPTBN1;WDR83;MEN1;ARAF;GDNF;PEBP1;RASGRF1;PSMA3;FGF18;FGFR3;MAP2K7;PSMB1;PSMD4;LRRK2;JAK1;NEFL;SYNGAP1;PSMA5;ZDHHC9;PSMA7;NRAS;KRAS;TAOK3
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.34131853143956614,0.7809879579761263,0.7618421052631579,0.9188523773567435,1.0,8/19,33.57%,ZNF76;TENM1;CHD8;ICE1;RPTOR;PRDX5;POLR3F;ZC3H8
prerank,regulation of T cell activation (GO:0050863),0.3034105710584088,0.780464090727746,0.7889273356401384,0.9191754995657159,1.0,7/42,12.92%,TNFRSF1B;TBX21;CRTAM;ABL1;KAT2A;VTCN1;HSPD1
prerank,regulation of hormone secretion (GO:0046883),0.35321017933497045,0.7801215412366844,0.7463087248322148,0.9193152421062047,1.0,5/15,27.32%,EDN3;ANXA1;NMB;VAMP2;LIF
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3784442975140316,0.7800035982562565,0.7438136826783115,0.9191215879041295,1.0,6/11,27.68%,CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5
prerank,gonad development (GO:0008406),0.30475092524567715,0.7797332256910736,0.7929411764705883,0.9191311449361421,1.0,7/41,13.14%,FSHR;CYP19A1;SIX4;TGFB2;SOX9;INHBA;LRP2
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3541667520749328,0.77919346241265,0.762619372442019,0.919479512554399,1.0,10/16,22.08%,IRAK3;CLEC16A;GSPT1;TBC1D25;ETF1;HDAC6;CLN3;GLE1;UPF1;SHFL
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.27376780388049143,0.7789926203590883,0.8431983385254413,0.9193986583465805,1.0,13/101,13.19%,EGFR;PKD1;VEGFA;FGF2;CALM2;FGFR1;RHOA;EDN3;SYAP1;IRAK1;TELO2;TENM1;MAPRE3
prerank,long-term synaptic potentiation (GO:0060291),0.33248973263496195,0.7789707816104516,0.7700258397932817,0.9190687703797333,1.0,2/21,3.05%,MPP2;ARC
prerank,myoblast fusion (GO:0007520),0.3655781029412267,0.7785277375273109,0.7458100558659218,0.919331187466349,1.0,2/12,6.02%,PTGFRN;CD9
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.28404808121064706,0.7780737412370079,0.8271739130434783,0.9196068866880585,1.0,22/70,26.25%,ACVR1B;CRADD;TGFB2;BAG3;TNFRSF1B;BLOC1S2;ITGAV;BCL2L2;PDPK1;TNFRSF10B;CD27;INHBA;DEDD;BID;APPL1;FGFR3;IL4;DIABLO;BAD;TRADD;DAXX;RIPK1
prerank,basement membrane organization (GO:0071711),0.3627156147745869,0.7774529345353787,0.7592067988668555,0.9201069149298209,1.0,3/14,10.91%,NTN4;RAMP2;FLRT2
prerank,dendrite self-avoidance (GO:0070593),0.3468841333366668,0.777389573995174,0.7493472584856397,0.9198338587863014,1.0,3/16,14.32%,EMB;PALLD;IGSF9
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.346182516284057,0.777328534107512,0.7526178010471204,0.9195610139865461,1.0,3/17,9.77%,KLRK1;RAET1E;CRTAM
prerank,respiratory chain complex IV assembly (GO:0008535),0.33442663063128014,0.7757050610256401,0.7556142668428005,0.9214157891542736,1.0,10/21,32.51%,COA8;SURF1;BCS1L;COA6;FASTKD3;COX18;COX15;COA5;COX16;TIMM21
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.2836382521025252,-0.7756783911544118,0.8056537102473498,0.9293839239750692,1.0,1/14,0.35%,AUTS2
prerank,chemical synaptic transmission (GO:0007268),0.2610471455765363,0.7748111873726644,0.9476334340382678,0.9222300636766892,1.0,24/284,8.78%,PCDHB16;LRP6;GRIK4;SLC12A7;DLG2;EXOC4;UNC13B;CAMKK1;PMP22;CEL;KCNN1;ERC1;RIC3;GABRA3;DVL1;CHRNB2;KCNIP2;SLC6A2;GIPC1;SLC12A4;TBC1D24;DLG4;CHRNA5;DLG1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.31008618331710536,0.7745634680089222,0.7738693467336684,0.9222060884076715,1.0,2/33,4.91%,ID2;PRKCA
prerank,Golgi to lysosome transport (GO:0090160),-0.31128568809813917,-0.7742603782342145,0.7122302158273381,0.9301171892166324,1.0,2/11,6.73%,ANKFY1;SORT1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2958200487109812,0.7741451592237758,0.8004640371229699,0.9224080749501,1.0,16/48,26.52%,TOPORS;TNFRSF1B;PRKDC;ABL1;BCL2L2;ATM;CHEK2;AEN;E2F1;HIPK2;IKBKE;SFN;TP53;RPS27L;HTRA2;CDIP1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.329512559719902,0.7733454634748643,0.7711442786069652,0.9231211543581441,1.0,9/24,26.53%,PKD1;DNAAF4;PSMD14;EFNA1;UCHL5;PRKACA;USP14;PINK1;TMF1
prerank,histone ubiquitination (GO:0016574),0.33372618462406956,0.7728817788211659,0.7750325097529259,0.9234293726550363,1.0,12/21,37.66%,UBE2B;HUWE1;UBR2;PAF1;RNF20;USP22;UBE2A;UBE2N;WAC;DTX3L;ATXN7L3;RNF8
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3129679374918703,0.772701364159594,0.8002450980392157,0.9233189975531573,1.0,8/30,22.00%,ABCD3;ELOVL5;SLC27A6;ACSL6;ACSBG1;SLC27A2;PEX2;ABCD1
prerank,sphingosine biosynthetic process (GO:0046512),0.3831246215782405,0.772700069900707,0.7545582047685835,0.9226091359071915,1.0,1/11,1.73%,ACER3
prerank,sphingoid biosynthetic process (GO:0046520),0.3831246215782405,0.772700069900707,0.7545582047685835,0.9226091359071915,1.0,1/11,1.73%,ACER3
prerank,C-terminal protein amino acid modification (GO:0018410),-0.30168307775722913,-0.7725772725278742,0.7533333333333333,0.9312955201001503,1.0,3/11,17.07%,AGBL4;TTL;FOLH1
prerank,ketone body metabolic process (GO:1902224),0.3780251822761473,0.7719393369448669,0.7361111111111112,0.9232463898405042,1.0,4/10,14.03%,AACS;HMGCL;ACAT1;BDH2
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3320561829874806,0.7711188237975005,0.7779171894604768,0.924039506701024,1.0,8/21,24.47%,SFRP4;BMP4;RUNX1;MAFG;CBFB;SFN;CTSK;ROCK1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.29466812642334783,0.7703642087076172,0.8133640552995391,0.9246941062037807,1.0,10/45,16.21%,ZC3H7A;PUM1;MATR3;CYFIP1;METTL16;NOLC1;YTHDC1;PER1;FOXO3;ZC3H10
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.3020725276034702,-0.7700570266460138,0.795774647887324,0.9337699908566708,1.0,7/12,20.59%,BCL2;RPL26;CD74;SIRT1;CD44;KDM1A;TAF9
prerank,protein auto-ADP-ribosylation (GO:0070213),0.37013261386776286,0.7696275790510307,0.7552742616033755,0.9253328845617088,1.0,4/12,20.31%,PARP3;TNKS2;PARP1;PARP12
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.33469598006882284,0.7691587199209229,0.7620967741935484,0.9256201635324957,1.0,4/19,12.98%,ADA;TERT;AMPD3;DGUOK
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.31815087656103525,-0.7690602817469959,0.782608695652174,0.9337822704568528,1.0,2/10,5.46%,DPYD;UPB1
prerank,transport along microtubule (GO:0010970),0.36296965903191,0.7690112656435827,0.7605633802816901,0.9254564821690707,1.0,3/13,8.00%,BAG3;COPG1;ARHGAP21
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.3475672119409634,0.768933549622594,0.7635402906208718,0.9252038079914187,1.0,9/16,35.55%,ZC3H12D;UPF1;RBM24;ZFP36L1;KHSRP;PLEKHN1;MOV10;TARDBP;RC3H1
prerank,regulation of DNA recombination (GO:0000018),0.3094291074993798,0.7688507482358499,0.7917647058823529,0.9249566808181092,1.0,12/32,31.69%,SPIDR;KPNA2;RAD50;SMARCAD1;RAD51;IL4;SETD2;ZRANB3;RTEL1;IL7R;MSH2;BLM
prerank,positive regulation of telomerase activity (GO:0051973),0.30952326778938877,0.7686697886114753,0.7818396226415094,0.9248549757195251,1.0,10/33,30.44%,MAPK15;NEK7;NVL;CCT4;MAP2K7;TCP1;DKC1;PNKP;CTNNB1;HSP90AA1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3781296219017981,0.7685177014313017,0.7542613636363636,0.924702155007385,1.0,2/10,8.71%,LAPTM4B;TSKU
prerank,modulation by symbiont of host process (GO:0044003),-0.3096755986964397,-0.7681743177535357,0.7363344051446945,0.9336087150191804,1.0,3/10,14.75%,B2M;MRC1;UBA52
prerank,regulation of exocytosis (GO:0017157),0.2977516330443487,0.7679951663705397,0.8102272727272727,0.9250592831719723,1.0,11/46,17.30%,RAB2B;RAB21;RAB8A;NSF;ANXA1;RAB3D;STXBP5;CHMP3;STX4;RAB3B;SYTL4
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.27265791896246944,-0.7675805839945159,0.7898832684824902,0.9329879281222498,1.0,2/16,3.54%,BCL2L1;CXCL12
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.267732287321989,0.7670808433935891,0.8661174047373842,0.9259085942056063,1.0,15/110,13.81%,GNAS;DRD1;FSHR;ADGRL2;RAMP2;ADCY2;ADCY8;ADCY9;IAPP;RAMP1;VIP;GLP1R;MC4R;ABCA1;GPR12
prerank,fatty acid elongation (GO:0030497),-0.27838637632211516,-0.7663511421202864,0.7852112676056338,0.9333590305301921,1.0,2/13,4.86%,ELOVL7;HACD1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3454165895641418,0.7662840000042138,0.7742363877822045,0.9266450620961824,1.0,2/15,7.94%,ARPC1B;TRIM27
prerank,cholesterol efflux (GO:0033344),0.33045228450791436,0.7661969806927005,0.7636363636363637,0.9264074872647435,1.0,4/20,13.71%,SOAT1;TSKU;NPC1;ABCA1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3361788186416657,0.7661419533448093,0.7687253613666228,0.9261243373594241,1.0,5/18,19.50%,COA8;SURF1;BCS1L;FASTKD3;COX18
prerank,postreplication repair (GO:0006301),0.29317342539658486,0.7653983696679311,0.8070776255707762,0.9267085534621836,1.0,20/45,35.31%,UBE2B;VCP;FAAP20;UBE2L6;UBE2V2;RPS27A;UBC;REV1;USP10;PRIMPOL;POLD1;UBE2V1;UBE2A;MSH2;UBE2N;POLK;RPA3;PARP10;RFC4;NSMCE1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.31017479271229925,0.7647801829562096,0.793398533007335,0.9271589654727179,1.0,11/29,30.44%,PPP6R3;TERT;TELO2;RAD50;CDK2;TNKS1BP1;ANKRD28;DKC1;RTEL1;NOP10;HSP90AA1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.32301742684520096,0.7643970124421565,0.789873417721519,0.9273252825294394,1.0,7/23,28.45%,PDE6A;GUCY2D;SAG;GRK4;METAP2;NMT1;PDE6G
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3225964603631706,0.7639246788755504,0.8027638190954773,0.9275664753759388,1.0,1/25,0.51%,CMKLR1
prerank,regulation of endopeptidase activity (GO:0052548),0.28474947892895985,0.7637626552002473,0.8183807439824945,0.9274223357567698,1.0,11/59,20.20%,SERPINH1;TIMP2;TIMP3;SERPINF1;SERPINB9;HDAC1;SERPINE2;CRB2;AKT1;SERPING1;PSMA3
prerank,negative regulation of cell communication (GO:0010648),0.3322525727928621,0.7636100047402804,0.7817715019255456,0.927272219455731,1.0,3/21,13.52%,UBASH3B;ACVR1;SRMS
prerank,cellular response to interferon-gamma (GO:0071346),0.27273631838930573,0.7634415092104608,0.8667377398720683,0.9271545426002354,1.0,15/88,19.55%,PRKCD;SLC26A6;CCL13;CAMK2D;CCL15;MID1;GBP6;CASP1;TRIM26;EPRS1;DAPK3;ACOD1;SYNCRIP;PTAFR;IRF3
prerank,homologous chromosome segregation (GO:0045143),-0.2579664357540211,-0.7631632691074327,0.8347826086956521,0.9366224685632139,1.0,14/20,40.84%,FMN2;MEI4;FANCD2;PRDM9;SGO1;MAJIN;MEIOB;TERB1;PTTG1;RNF212B;MEIKIN;ANKRD31;TERB2;ZCWPW1
prerank,regulation of transposition (GO:0010528),0.351392545623042,0.7631143497390344,0.7510548523206751,0.927216003742603,1.0,2/13,18.73%,TEX15;UBR2
prerank,regulation of tissue remodeling (GO:0034103),0.3324332079102327,0.7630707772174203,0.768,0.9269202186855143,1.0,3/18,13.69%,DDR2;CST3;RUNX1
prerank,skeletal muscle contraction (GO:0003009),0.32941477752377624,0.7627609823547218,0.7673202614379085,0.9269353801883025,1.0,2/19,14.73%,TNNT3;STAC3
prerank,positive regulation of nervous system process (GO:0031646),0.3360895912253386,0.7618426377877321,0.7753246753246753,0.927779434844889,1.0,3/18,12.75%,UNC13B;TNFRSF1B;NCMAP
prerank,actin crosslink formation (GO:0051764),0.3586914004483228,0.7617899108322558,0.7552447552447552,0.9274966786011846,1.0,2/12,8.83%,DPYSL3;GAS2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3081108684635911,0.7616242600077311,0.7921760391198044,0.9273655264001277,1.0,7/33,18.70%,IRS1;PIK3C2B;PIK3CB;SIRT2;ERBB2;NF1;AKT1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.34696905865724204,0.7615960919728695,0.791268758526603,0.9270482504380664,1.0,6/15,22.51%,NOL3;FXN;HGF;AKT1;CLU;TRIAP1
prerank,actin nucleation (GO:0045010),0.32619414038717637,0.7614648548153691,0.7790549169859514,0.9268646701359868,1.0,4/21,15.31%,ARPC1B;TRIM27;SCIN;SPIRE2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.3388595802351731,0.7606814221234751,0.7648612945838837,0.9275290202369039,1.0,3/17,12.92%,UBASH3A;EZR;PTPN2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3530615610597835,0.7581151442318572,0.7568988173455979,0.9301384699395739,1.0,2/15,12.70%,PABPC1;AGO2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3530615610597835,0.7581151442318572,0.7568988173455979,0.9301384699395739,1.0,2/15,12.70%,PABPC1;AGO2
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3054352450642126,0.7577050408692787,0.7934386391251519,0.9303166462894744,1.0,2/29,6.48%,GAS6;HMGB1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.3740525723740507,0.7569782618990243,0.7575757575757576,0.9308980706296544,1.0,3/10,16.89%,GNPDA1;NANP;RENBP
prerank,cGMP biosynthetic process (GO:0006182),-0.313250238735006,-0.7567256115169544,0.7532467532467533,0.9442593830397032,1.0,2/10,9.38%,GUCY1B1;NPR1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.3013624948607083,0.7560182592520521,0.7892215568862275,0.9317729643129287,1.0,3/34,5.57%,MPP2;GABRA3;RAB3GAP1
prerank,exit from mitosis (GO:0010458),0.36741851406196346,0.7540506801753317,0.7916666666666666,0.9339169225142844,1.0,8/12,33.14%,SPAST;UBE2C;PPP2R2D;CHMP4B;CHMP2A;CTDP1;UBE2S;SIRT7
prerank,positive regulation of secretion (GO:0051047),0.36037150079378144,0.7535562527443213,0.7821637426900585,0.9341784367048996,1.0,2/11,14.92%,ACSL3;SCIN
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.2663979811445877,-0.7534029103970805,0.8025210084033614,0.947500527936818,1.0,4/16,11.88%,NR1H3;ABHD5;MFSD2A;SCARB1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.30252864556023573,0.7532740459661108,0.7962085308056872,0.9341843367097556,1.0,6/34,11.99%,LRP5;ANAPC5;CDC16;EDN3;PHIP;ANAPC4
prerank,postsynaptic membrane organization (GO:0001941),0.3396651132659603,0.7523243297739479,0.7838577291381669,0.9350219056823286,1.0,5/17,13.02%,CEL;DLG4;NRXN2;MUSK;NLGN1
prerank,positive regulation of type 2 immune response (GO:0002830),0.347688881133858,0.7522288779016225,0.7648648648648648,0.9347866062266248,1.0,4/14,20.97%,RARA;IL6;DENND1B;IL4
prerank,hexose transmembrane transport (GO:0008645),0.3263795439074815,0.7521092697365945,0.8002544529262087,0.9345865838787871,1.0,5/21,17.11%,SLC5A2;SLC2A9;SLC50A1;SLC2A2;SLC2A10
prerank,regulation of cellular component size (GO:0032535),0.30568255411956335,0.7519298611960178,0.8060453400503779,0.9344580154683121,1.0,3/30,4.64%,RDX;VAV2;PEX11A
prerank,regulation of embryonic development (GO:0045995),0.29912765907717453,0.7517839697438004,0.8142857142857143,0.9342831591628495,1.0,9/34,16.94%,PHLDB1;TLE6;POGLUT1;EHMT1;B4GALT5;TDG;CRB2;NPHP3;NIPBL
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.25733732444231583,-0.7512911591021224,0.8262548262548263,0.9489718667008984,1.0,1/17,1.38%,APOE
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3481301252103239,0.7510716524157838,0.7884615384615384,0.9348529594047786,1.0,5/13,27.14%,TBC1D10A;PERP;CYFIP2;BAD;RIPK2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3102627413270168,0.7510364570703082,0.7822878228782287,0.9345499633110254,1.0,2/26,6.48%,LBP;HMGB1
prerank,mitochondrial fusion (GO:0008053),0.33108277099041117,0.7507222051680572,0.770012706480305,0.9346039208456244,1.0,8/18,30.36%,MIEF2;SPG7;MFN1;AFG3L2;STOML2;FIS1;USP30;MIEF1
prerank,mitochondrial protein processing (GO:0034982),0.3648859223220837,0.7504524206743228,0.7688953488372093,0.9345957074370989,1.0,6/11,27.81%,SPG7;PMPCA;AFG3L2;STOML2;PMPCB;ATP23
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.27485441175191694,-0.7497738240807594,0.7890625,0.9496338060064066,1.0,4/14,14.48%,DPYD;UPB1;ERH;UMPS
prerank,protein destabilization (GO:0031648),0.3024161139280269,0.7496319681526222,0.8019441069258809,0.9352740600961144,1.0,12/32,32.05%,GSN;CREBBP;SERF1A;MUL1;PEX2;DERL1;GGA3;NR1D1;BTRC;PRKN;IRGM;PRNP
prerank,excitatory postsynaptic potential (GO:0060079),0.32222914462004226,0.7487452432907243,0.7669654289372599,0.9360422020776303,1.0,5/19,21.66%,MPP2;RAB3GAP1;AKT1;DRD2;LRRK2
prerank,development of primary male sexual characteristics (GO:0046546),0.3007510070791146,0.7485113459980031,0.7911164465786314,0.9359698899481743,1.0,6/34,13.14%,FSHR;SIX4;TGFB2;SOX9;INHBA;LRP2
prerank,epithelial cell-cell adhesion (GO:0090136),0.3634604098135489,0.748343460590261,0.7614285714285715,0.9358449957865285,1.0,2/11,7.67%,CCN3;JUP
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.29292579213291825,0.7480989271171844,0.823803967327888,0.9358092687826499,1.0,3/36,4.11%,GHR;CYP1B1;HES5
prerank,stress-activated MAPK cascade (GO:0051403),0.27688220148322856,0.747994786303572,0.856988082340195,0.9355939877932549,1.0,23/61,29.78%,MAP3K5;GPS1;MAPK8;CHUK;IRAK1;TAB2;MAP3K12;CUL1;MAP3K10;RPS27A;UBC;MAP2K3;MAPK9;GPS2;MAP2K7;TAOK2;RIPK2;MAP3K11;UBE2V1;BTRC;MAP2K4;CCM2;ZFP36L1
prerank,modulation by host of symbiont process (GO:0051851),-0.21971274201451224,-0.7477150556953505,0.9184782608695652,0.9510577521413887,1.0,13/31,31.67%,LEF1;NAPEPLD;CX3CR1;EP300;NUCKS1;HMGA2;POU2F3;AQP1;HPN;CCL5;JUN;SAP30;CCL4
prerank,copper ion homeostasis (GO:0055070),0.3374578499624074,0.7471847383524809,0.7898936170212766,0.9362531510800868,1.0,8/17,33.19%,ARF1;ABCB6;ANKRD9;XIAP;SLC31A2;ATP7A;PRNP;MT2A
prerank,regulation of neuron migration (GO:2001222),0.3128208696236797,0.7471782996805528,0.8037267080745342,0.9359060965811885,1.0,2/26,1.17%,COL3A1;SRGAP2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3450523345875475,0.7463994546775087,0.8031704095112285,0.9365575145342219,1.0,1/15,2.02%,NTRK1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.26994175486772565,-0.7460892651969921,0.8449612403100775,0.9517412801000449,1.0,11/15,40.32%,SYK;CD55;CCR2;SHH;IL12A;IL23A;PNP;EBI3;IHH;IL23R;IL12B
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.28877462596593884,0.7456669255005444,0.8278688524590164,0.937102280503752,1.0,11/38,22.78%,PKHD1;PHLPP2;XDH;PIK3CB;PPP2R5C;FLCN;AKT1;MUL1;BANK1;DRD2;TSC2
prerank,adipose tissue development (GO:0060612),0.3566166426967202,0.7455093447521156,0.7734265734265734,0.9369427904695994,1.0,2/11,9.26%,LRP5;SH3PXD2B
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.29320929638106674,-0.7445017508854502,0.7811447811447811,0.9523470049142633,1.0,9/12,40.32%,PAEP;IL17D;RASGRP1;IL18;ISL1;CARD9;IL23A;IL23R;IL12B
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.3125898345049603,0.7442178956723758,0.7982779827798278,0.9382276898388231,1.0,11/27,29.14%,MAP3K5;MAPK8;CHUK;CUL1;RPS27A;UBC;KAT7;MAP2K7;TAOK2;BTRC;CCM2
prerank,positive regulation of protein processing (GO:0010954),0.32552473660462394,0.7441751862691651,0.7926208651399491,0.9379345022067478,1.0,2/19,10.45%,GSN;LPCAT3
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.31292996351162916,0.7435566998724817,0.8058007566204287,0.9383550729870913,1.0,5/23,17.93%,INTS3;CDK5RAP3;ZW10;ZFYVE19;WEE2
prerank,intestinal absorption (GO:0050892),0.34301738823843814,0.7422991412961049,0.7879616963064295,0.9395282844302929,1.0,1/13,2.98%,SLC26A6
prerank,ceramide catabolic process (GO:0046514),0.34778571876257386,0.7419278213326425,0.7929634641407307,0.9396230650939369,1.0,3/14,19.42%,ACER3;HEXA;ASAH1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.3093417110011594,0.7417593239468733,0.8049382716049382,0.9394854349645196,1.0,11/26,32.38%,ITCH;ALPK1;IRAK1;TAB2;RPS27A;UBC;CYLD;RIPK2;UBE2V1;UBE2N;IFIH1
prerank,positive regulation of hormone secretion (GO:0046887),0.337007640097108,0.7415059266632488,0.7975708502024291,0.9394234557363952,1.0,2/17,9.29%,CYP19A1;EDN3
prerank,amino sugar metabolic process (GO:0006040),0.36840092468408747,0.7408761170388758,0.795774647887324,0.9398494056272352,1.0,2/10,7.90%,GFPT1;GFPT2
prerank,negative regulation of interferon-beta production (GO:0032688),0.3687971945129843,0.7406150452293595,0.7931526390870185,0.9398205969127142,1.0,1/10,3.93%,PTPRS
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.28910979708093004,0.7405374854755226,0.8321678321678322,0.9395714003260064,1.0,8/36,12.61%,CSNK2A2;CSNK2A1;CRADD;ING5;MADD;MAZ;DEPTOR;TGFBR1
prerank,regulation of complement activation (GO:0030449),0.2871880577802826,0.7404869813347165,0.8469626168224299,0.9392820598959127,1.0,7/40,20.48%,CFH;C9;C8B;SERPING1;C8G;CPB2;CLU
prerank,protein K48-linked ubiquitination (GO:0070936),0.2753995620936416,0.7402794027498174,0.8425821064552661,0.9391960091628233,1.0,20/54,30.01%,TOPORS;UBE2B;UBE2R2;RNF115;SYVN1;ITCH;UBR5;UBE2C;UBE2G2;RNF4;TTC3;RNF216;RNF146;AMFR;RNF126;FBXO38;RBX1;UBE2Q2;PRKN;UBE2H
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.28181214348390676,0.7391121411535679,0.847972972972973,0.9402641911653351,1.0,8/47,15.24%,EGFR;TGFB2;MID1;NBR1;FOXM1;ULK4;STK25;PER1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.34234523730122973,0.7388854375190856,0.8169014084507042,0.9401700032811903,1.0,2/14,18.72%,IL6;OSMR
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.26906532575842707,0.738616587575794,0.861878453038674,0.9401377832933125,1.0,21/62,27.23%,YBX3;NOL3;CCAR2;NFE2L2;SYVN1;HYOU1;URI1;BCL2L2;AKT1;DNAJA1;NOC2L;CLU;ACKR3;LRRK2;VNN1;HERPUD1;CREB3L1;PINK1;SELENOS;HTRA2;PLAUR
prerank,protein palmitoylation (GO:0018345),-0.21923958803397137,-0.7376929577900316,0.8743169398907104,0.9599058267086329,1.0,13/30,28.06%,ZDHHC14;GLUL;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,cellular copper ion homeostasis (GO:0006878),0.34324163733314317,0.7373352357949002,0.7909215955983494,0.9413069134177884,1.0,7/14,33.19%,ARF1;ABCB6;ANKRD9;SLC31A2;ATP7A;PRNP;MT2A
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.2992698133862398,-0.7373201798446549,0.7721088435374149,0.9588699525689627,1.0,3/10,12.75%,RIF1;DCLRE1C;TERF2IP
prerank,negative regulation of innate immune response (GO:0045824),-0.2105443483257389,-0.7369308881936831,0.89937106918239,0.957937720547968,1.0,8/34,13.38%,SAMHD1;USP18;NLRC5;TRIM21;A2M;DHX58;CACTIN;TNFAIP3
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2933491345401883,0.7366797420645561,0.8323632130384168,0.941743016962598,1.0,12/35,29.12%,MPG;OGG1;TDG;SMUG1;PARP1;POLB;PARG;POLD1;POLG;PNKP;ADPRS;MBD4
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2725818912715302,0.7364776161684362,0.851528384279476,0.9416357528083192,1.0,17/59,27.14%,ERC1;SHARPIN;CHUK;TAB2;TANK;RPS27A;UBC;NKIRAS1;AKT1;NFKBIA;BIRC3;MAP3K14;TBK1;ROCK1;TRADD;RIPK1;RIPK2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3012937318052986,0.7349521730082741,0.8424317617866005,0.9431634115144815,1.0,9/28,25.58%,CRADD;BAG3;BLOC1S2;TNFRSF10B;DEDD;BID;DIABLO;TRADD;DAXX
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.2797646820690653,0.7345178421879606,0.8627906976744186,0.9433385508414653,1.0,3/45,4.57%,PRKCD;CAMK2D;MID1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.2940142768420179,-0.7333771127519366,0.7815699658703071,0.9608718745932872,1.0,2/10,9.04%,RAPGEF3;PIH1D1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.35759324475929144,0.7320307577679831,0.8008474576271186,0.9460032381193352,1.0,6/10,36.22%,YOD1;ERLEC1;UBE2G2;INSIG1;OS9;UBAC2
prerank,protein autoprocessing (GO:0016540),0.32623235241577786,0.7319212321958063,0.8059701492537313,0.94577702114305,1.0,7/17,37.14%,FXN;CASP1;AFG3L2;HTRA2;PIDD1;MYRF;CTSL
prerank,regulation of interleukin-2 production (GO:0032663),0.2829370438877926,0.7316845481267306,0.8409610983981693,0.9456892680004912,1.0,9/43,19.84%,GLMN;TBX21;TRIM27;ANXA1;EZR;CD80;RUNX1;SPTBN1;HOMER2
prerank,positive regulation of interleukin-2 production (GO:0032743),0.3054490354148456,0.7315365542846327,0.7901234567901234,0.9455279994810333,1.0,5/25,17.10%,GLMN;ANXA1;CD80;RUNX1;SPTBN1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.32872952307164427,0.7315136024083344,0.7952127659574468,0.9451989414911024,1.0,2/16,8.03%,TNFRSF1B;IKZF3
prerank,regulation of cytokine production (GO:0001817),0.2562251252147737,0.7307382800651802,0.9109730848861284,0.945761724957747,1.0,19/126,16.81%,FOXP1;IL33;HDAC9;GLMN;TNFRSF1B;RPS6KA4;BTNL9;ANXA1;CRTAM;RIPK3;SOD1;CIDEA;KAT2A;TRAF3;VTCN1;PER1;IL6;N4BP1;CCN4
prerank,programmed necrotic cell death (GO:0097300),0.3264825417062225,0.7299198040067224,0.8028909329829172,0.9463886779277378,1.0,3/18,10.46%,PGAM5;TRPM7;RIPK3
prerank,regulation of immune effector process (GO:0002697),0.2835686640614107,0.7287167458856486,0.8514619883040936,0.9474637822552563,1.0,7/41,20.48%,CFH;C9;C8B;SERPING1;C8G;CPB2;CLU
prerank,cellular response to interleukin-1 (GO:0071347),0.2542640577871291,0.7283178448936904,0.9213483146067416,0.9475695916695016,1.0,32/143,21.97%,PTGIS;CCL13;PSMD7;CCL15;PSMA8;IRAK3;RPS6KA4;SOX9;PSMA4;CHUK;IRAK1;TAB2;PSMD12;CUL1;PSMA6;TANK;SQSTM1;PSMD1;MAP3K3;PSMC5;PSMD11;PSMC4;PSMD14;RPS27A;UBC;ACOD1;USP10;NFKBIA;PSMA3;PSMB1;PSMD4;UPF1
prerank,negative regulation of catalytic activity (GO:0043086),-0.2303829936087057,-0.7282592748592354,0.8721461187214612,0.9657751635401048,1.0,8/24,18.41%,NOTCH1;NES;IFIT1;NOS1;SIRT1;CAMK2A;MT3;PPP1R12A
prerank,negative regulation of signaling (GO:0023057),0.30681547727253566,0.7278131392021919,0.8252184769038702,0.947811401983513,1.0,5/25,20.95%,UBASH3B;ACVR1;SRMS;TRAT1;OPTN
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.27816175169962776,0.7277566458265496,0.8618346545866364,0.9475215178578538,1.0,13/46,28.51%,TOMM40;TIMM9;BCAP31;AIFM1;HSPD1;TOMM70;GRPEL1;AKT1;PINK1;TIMM17B;TIMM22;RALA;FIS1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3006527676699921,0.7277356914452331,0.8438256658595642,0.9471933163519984,1.0,5/31,13.12%,SPN;GLMN;ATM;VTCN1;CD80
prerank,negative regulation of histone modification (GO:0031057),0.33524371296129757,0.7276814473556947,0.8010973936899863,0.9469090636095134,1.0,3/14,19.97%,TWIST1;THAP7;NOC2L
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2618670773959847,0.7275374258502572,0.8661670235546038,0.9467227652149963,1.0,18/75,21.39%,MAP1B;FARP1;DOCK7;DVL1;RAB8A;LLGL1;S100B;FGFR2;TMEM106B;MEF2A;TBCD;APBB1;SLITRK2;CDK5;UNK;DRD2;SHTN1;ATL1
prerank,axon development (GO:0061564),0.25914721299932725,0.7273300640763046,0.8871139510117146,0.9466272799097017,1.0,21/78,25.05%,MAP1B;EPHB2;DOCK7;EPHB3;GAP43;RAB8A;LLGL1;S100B;FGFR2;PLP1;APBB1;SLITRK2;CDK5;MAPK8IP3;DRD2;SHTN1;ATL1;AFG3L2;LMTK2;TAOK2;ARHGAP35
prerank,pyroptosis (GO:0070269),-0.2556444254843205,-0.7256041679592292,0.8627450980392157,0.9675617801710059,1.0,6/15,26.37%,CASP4;AIM2;ZBP1;TREM2;NLRC4;APIP
prerank,macrophage migration (GO:1905517),-0.2699020592667002,-0.7244149798608032,0.8333333333333334,0.967470724768622,1.0,13/13,73.04%,EDNRB;TAFA4;CCR2;CCL5;CCL3;EDN2;SAA1;CXCL17;LGALS3;P2RX4;P2RY12;CKLF;CCL2
prerank,diol metabolic process (GO:0034311),0.319348210670069,0.724081200351228,0.8189987163029525,0.9500964495087836,1.0,2/19,6.19%,PLPP3;PLPP1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.24591658397005398,-0.7236045146802287,0.8809523809523809,0.9670013980384429,1.0,3/18,12.06%,PIK3R1;BOK;BCL2L11
prerank,negative regulation of protein depolymerization (GO:1901880),0.3025929122940366,0.7229387973398326,0.826302729528536,0.9510082917791972,1.0,2/24,3.11%,FGF13;LIMA1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.2671842419881475,0.7227379838685183,0.8880351262349067,0.9508821145627409,1.0,4/57,4.20%,VEGFA;GHR;HES5;STAT3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.3055631603373357,0.7226978649808987,0.8298906439854192,0.9505808646343467,1.0,8/25,25.33%,ACVR1B;STAT3;PRKDC;INHBA;FOXO3;PRMT1;ABCB10;BRD1
prerank,negative regulation of inflammatory response (GO:0050728),0.24759397254726143,0.7225757719785774,0.9493927125506073,0.9503651727534521,1.0,34/182,20.98%,PRKCD;PTGIS;GPR27;CCN3;DRD1;FSHR;RAMP2;ADCY2;ADCY8;TNFRSF1B;ADCY9;GPR20;IAPP;SHARPIN;RORA;RAMP1;VIP;LPCAT3;GIT1;GLP1R;PTPN2;MC4R;PTGDR;IL6;CREB1;OTULIN;CALCA;ACOD1;ADCY7;PRKACA;GNB1;GPS2;IL4;PRKAR2A
prerank,neuron apoptotic process (GO:0051402),0.3123563550818911,0.7218887839824718,0.8196078431372549,0.950792918289361,1.0,6/19,21.69%,CIT;ATN1;LIG4;BID;CDK5;DIABLO
prerank,glucose import (GO:0046323),0.34427949285904275,0.721264114870294,0.8158253751705321,0.9511443038368654,1.0,3/13,17.11%,SLC5A2;RAB4B;SLC2A10
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.3288158538944127,0.7206101535802568,0.7948717948717948,0.9515577897947741,1.0,6/15,32.32%,GNPDA1;RENBP;CHST5;OGA;NAGK;CHST7
prerank,regulation of sodium ion transport (GO:0002028),0.2914477407099254,0.7205207742003876,0.8427518427518428,0.9512966852753262,1.0,7/34,15.24%,NEDD4;SLMAP;SNTA1;DLG1;PRSS8;WNK1;PER1
prerank,regulation of ERAD pathway (GO:1904292),0.345602985514141,0.7200107854694596,0.796242774566474,0.9515247069412465,1.0,7/11,37.21%,USP13;USP19;HERPUD1;RNFT1;TMEM259;USP25;RNF185
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.23153954364321858,-0.719768339997479,0.8925233644859814,0.9699648101977483,1.0,6/22,21.03%,ROCK2;PPP4R4;STYXL1;PTPA;PPP1R11;PPP1R15A
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.31458848973037745,0.7195088423926665,0.8110539845758354,0.9517374473561292,1.0,2/19,11.17%,CARD16;GIT1
prerank,regulation of cellular catabolic process (GO:0031329),0.2638846845786499,0.7190673601421573,0.8871681415929203,0.9519275544216771,1.0,29/62,30.62%,MAPK15;OSBPL7;RAB8A;PIP4K2B;ABL1;ATM;USP33;WDR41;USP13;HDAC6;DAPK3;USP10;DCAF12;LRRK2;ABCD1;KAT8;RPTOR;SMCR8;ROCK1;SCARB2;LONP2;PIP4K2C;ABL2;CISD2;DRAM1;GPR137B;DRAM2;PRKN;KEAP1
prerank,nuclear body organization (GO:0030575),-0.27773175008817613,-0.7190070210583756,0.8235294117647058,0.969430999776136,1.0,1/12,0.62%,ETS1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.25386526999089387,-0.7189724282192322,0.8671875,0.9680086868833151,1.0,6/15,20.66%,CPEB2;DDX3X;ZC3H12A;ZFAND1;ATF3;PPIF
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3285932467882051,0.7188083618401749,0.8281036834924966,0.9518641180735576,1.0,5/16,16.22%,CAMK2D;PRKCA;SLC9A1;MEF2A;PARP1
prerank,positive regulation of peptidase activity (GO:0010952),0.3125215919815952,0.7179682269448247,0.8383311603650587,0.9525017460070194,1.0,5/20,24.52%,VCP;MAPK12;TANK;RCN3;PINK1
prerank,neuromuscular process controlling balance (GO:0050885),-0.27762931835533206,-0.7178592700860804,0.8807017543859649,0.9677720958783411,1.0,1/12,1.57%,NRXN1
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.23863827579496838,-0.7171699595030455,0.8590909090909091,0.9656786105426178,1.0,6/19,17.18%,POLR2G;POLR2E;POLR2C;TERF2IP;POLR2D;POLR2A
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.23863827579496838,-0.7171699595030455,0.8590909090909091,0.9656786105426178,1.0,6/19,17.18%,POLR2G;POLR2E;POLR2C;TERF2IP;POLR2D;POLR2A
prerank,cellular response to metal ion (GO:0071248),0.2501436888900959,0.7168206227644297,0.9219712525667351,0.9534502681254022,1.0,14/123,13.48%,EGFR;SLC12A2;DLG2;SYT8;CAMK2D;CLIC4;ADCY8;DLG4;MAPK8;CHUK;NEUROD2;NLGN1;ADD1;MEF2A
prerank,regulation of lamellipodium organization (GO:1902743),-0.25899416085891885,-0.7168130366625668,0.8326693227091634,0.9646281194883246,1.0,14/14,74.13%,CDC42;CAPZB;CD44;CARMIL2;VIL1;PDPN;EPHA2;DMTN;FER;TWF2;CARMIL1;RAC1;WAS;TWF1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3235722264870017,0.7167074455052327,0.8194993412384717,0.9532262984548057,1.0,6/16,34.35%,VTA1;CHMP4A;CHMP4B;TMEM50B;CHMP4C;TMEM50A
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.32080930472837427,0.7164676748982137,0.8057742782152231,0.9531610045511935,1.0,8/18,29.91%,NOL3;NFE2L2;AKT1;VNN1;PINK1;HTRA2;NME5;PRKN
prerank,positive regulation of exocytosis (GO:0045921),0.28373045335416963,0.7158883054637065,0.8469626168224299,0.9534582489214194,1.0,9/35,28.49%,SDC1;RAB2B;RAB3D;STXBP5;SYTL4;PDCD6IP;CHMP2A;RAB5A;RAB3A
prerank,positive regulation of exosomal secretion (GO:1903543),0.3245760495036457,0.7154267724921577,0.8344549125168237,0.9536380407625232,1.0,1/15,3.14%,SDC1
prerank,regulation of intracellular protein transport (GO:0033157),0.2916127261920032,0.7153277325957268,0.8447432762836186,0.9533963317758035,1.0,12/32,28.35%,BCAS3;BMP4;TENM1;UHMK1;NDEL1;PCM1;KIF20B;ICE1;VAMP2;TPR;GCC2;B3GAT3
prerank,positive regulation of cell development (GO:0010720),0.2908184488917284,0.7152837999323082,0.8417945690672963,0.9530938411843564,1.0,5/31,13.14%,SERPINF1;PDE3A;BMP4;LIG4;LRP2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3142765552929507,0.7149878163975436,0.8372093023255814,0.9530599196854257,1.0,7/19,27.14%,MAVS;CHUK;HSPD1;IRF3;SETD2;TBK1;RIPK2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.32985133807471256,0.7149582522330509,0.7997256515775034,0.9527449329199646,1.0,4/13,18.53%,MDFIC;CHP1;RAB23;SUFU
prerank,positive regulation of microtubule polymerization (GO:0031116),0.2921215682995213,0.714906648871464,0.8414634146341463,0.9524433841686073,1.0,13/28,30.27%,CKAP5;GIT1;AKAP9;ARL2;SLAIN2;DCTN1;CDK5RAP2;MET;DRG1;FES;TOGARAM1;MECP2;RAC1
prerank,rRNA catabolic process (GO:0016075),0.3214045284645582,0.7147300947254895,0.829105473965287,0.9522879996218746,1.0,4/16,17.07%,ERN2;XRN1;EXOSC4;DIS3
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3102566153186668,0.7146786843282484,0.812,0.9520033364710255,1.0,10/18,40.59%,ANXA1;NR3C1;KLF9;HNRNPU;ZFP36L1;SSTR2;FAM107A;PCK2;UBE2L3;REST
prerank,dephosphorylation (GO:0016311),0.2456286071301245,0.7137720348093849,0.9478527607361963,0.9526994170713071,1.0,15/147,9.49%,ALPL;PLPP3;PTPN3;PPP1CC;PLPP5;PTPRS;PTPRF;DUSP11;PTPRU;PLPP1;PPM1H;PPM1M;DAPP1;PTPN18;PPP3CC
prerank,dendritic cell migration (GO:0036336),0.31786638351351476,0.7134601395894072,0.8248663101604278,0.9526865939335993,1.0,3/16,15.84%,HMGB1;TRPM4;CXCR4
prerank,positive regulation of cell killing (GO:0031343),0.33998113697680843,0.7130585639201117,0.8043478260869565,0.9527667818197879,1.0,7/13,31.82%,FZD7;MAPK8;DVL2;NOX1;RAC1;CYBA;NOXO1
prerank,positive regulation of T cell differentiation (GO:0045582),0.2823487765539769,0.7120424416721883,0.8617401668653158,0.9535324533948407,1.0,2/36,2.48%,ZMIZ1;GLI2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.267796456759582,0.7117293157621823,0.8695652173913043,0.9535449494193071,1.0,29/54,39.27%,RRS1;LAS1L;NLE1;NVL;MRTO4;EIF6;PPAN;BOP1;RPL7A;NOC2L;WDR12;GTF3A;PAK1IP1;RRP15;MAK16;NOP53;RPF2;RSL1D1;HEATR3;RPLP0;MALSU1;RPL3;RPL10A;MDN1;LTO1;RSL24D1;RPL5;PES1;MRPL20
prerank,regulation of stem cell proliferation (GO:0072091),-0.24602985278739273,-0.711456628052565,0.8672199170124482,0.9690768146540781,1.0,4/17,18.51%,FBLN1;ACE;SOX11;KDM1A
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3080349832972804,0.7113069488982776,0.8266494178525227,0.9536675251869379,1.0,5/20,17.61%,IPO5;HEXIM1;LATS2;CDKN1C;MEN1
prerank,magnesium ion transport (GO:0015693),0.34187256728665694,0.7110968911737517,0.813953488372093,0.9535567519613102,1.0,7/12,28.20%,NIPA2;MRS2;CNNM4;MAGT1;MMGT1;NIPAL2;NIPAL1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.1979770197520634,-0.7108712422096385,0.9716312056737588,0.9682395223991802,1.0,16/40,22.04%,BCL2L1;DNM1L;PDCD5;GHITM;FAM162A;BCL2L11;MFF;GPX1;IGF1;OPA1;GPER1;PYCARD;BIK;PRELID1;PPIF;BNIP3
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.34045808688925844,0.7075246276172353,0.8231197771587744,0.9571804851256217,1.0,4/12,18.70%,FUT4;WNK1;MIA3;AKT1
prerank,ncRNA processing (GO:0034470),0.24250315938274303,0.7071820802414968,0.9696663296258847,0.9571905265617755,1.0,56/200,27.93%,C1D;RRP7A;SSB;INTS3;PRKRA;HNRNPA2B1;LAS1L;EMG1;INTS4;WDR3;AGO1;NVL;DGCR8;WDR55;ESF1;RRP12;AGO2;NOLC1;UTP14A;DCAF13;EXOSC4;NOC4L;MRTO4;BYSL;TUT7;ADAT1;DIS3;BOP1;SARS1;NOB1;RPL7A;MTREX;WDR12;ZCCHC8;NOP56;DDX49;FBL;SBDS;WDR36;WDR46;WDR75;RPP21;RPS9;TBL3;SENP3;UTP11;NOP58;PUS10;DKC1;INTS9;POP5;FCF1;NOP53;SRRT;RPL41;RPL30
prerank,protein targeting (GO:0006605),0.24974548053165385,0.7066367409111631,0.9386694386694386,0.9574383101864504,1.0,36/118,30.33%,LTBP2;SEC61A1;RABGEF1;TOMM40;GIPC1;TIMM9;PEX16;PEX1;BCAP31;ATG3;NLGN1;SPCS2;HPS4;TOMM70;HACL1;ZDHHC4;PEX6;ZFAND2B;ZDHHC20;LAMP2;PRKCI;ZDHHC9;TAOK2;TIMM17B;TIMM22;LONP2;KATNB1;PARD3;VPS37B;KIF13B;FIS1;SPCS1;SRPRA;ZFAND2A;PIKFYVE;SRP14
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.26055538321528143,0.7057692568751263,0.904550499445061,0.9580513495906657,1.0,16/59,28.84%,ABCD3;ACSF3;OSBPL7;CBR4;OSBP;ACACA;SRR;HSD17B8;SLC27A2;HSD3B7;MCAT;ACOT8;HOGA1;PER2;ACLY;SCP2
prerank,apical junction assembly (GO:0043297),0.2665420420182996,0.7054752591387681,0.8830734966592427,0.958030405541163,1.0,17/53,26.52%,MPP7;RAMP2;DLG1;RHOA;PKN2;PAK2;CLDN11;ARL2;MICALL2;TBCD;WDR1;CLDN15;PDCD6IP;PRKCI;AFDN;FBF1;PARD3
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.23075560090088104,-0.7051789070774582,0.9024390243902439,0.9730653537346203,1.0,7/21,19.49%,BCL2L1;BOK;BCL2L11;OPA1;HSPA1A;XBP1;CREB3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.3468245905511268,0.7048347050710693,0.8135838150289018,0.9583560414066715,1.0,2/10,12.37%,XDH;PIK3CB
prerank,protein localization to condensed chromosome (GO:1903083),0.33413297994148905,0.7045034060192524,0.826950354609929,0.9583565165759448,1.0,3/12,16.57%,MIS12;ZW10;IK
prerank,lipid droplet formation (GO:0140042),-0.28466955512894854,-0.7043681957708956,0.8161290322580645,0.9724743395893386,1.0,1/10,2.46%,CDS2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2963236065567841,0.7043194466243461,0.8367844092570037,0.9582104473877435,1.0,7/25,20.88%,ARAP1;AGR2;CBL;HIP1;CNOT9;AKT1;NUP62
prerank,response to axon injury (GO:0048678),0.3112643671341285,0.7041565311686001,0.8412903225806452,0.9580353329485884,1.0,3/18,11.86%,DPYSL3;GAP43;SOD1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.3485773497689332,0.7040677634875095,0.8124118476727785,0.9577772931755232,1.0,1/10,6.08%,CCAR2
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.18470761292975477,-0.7038000431628133,0.9487179487179487,0.9715729988264086,1.0,9/57,12.44%,KDR;DNM1L;HIP1R;PDCD5;PPARGC1A;BOK;FAM162A;BCL2L11;MFF
prerank,positive regulation of ATPase activity (GO:0032781),0.2781159547596073,0.703567198569961,0.8742724097788126,0.9579432977159993,1.0,4/41,11.00%,ATP1B1;TNNT3;PFN2;CHTOP
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.3511994690178156,0.7032735296000628,0.8117816091954023,0.9578834984944483,1.0,2/10,15.82%,AOC3;HDAC6
prerank,"wound healing, spreading of cells (GO:0044319)",0.2916334430727512,0.7024865177164803,0.8324742268041238,0.9583542661034573,1.0,4/24,17.44%,TMEFF2;RHOA;DDR1;CD151
prerank,replicative senescence (GO:0090399),0.3308433324098319,0.7015315553752859,0.8258345428156749,0.9590280184983236,1.0,3/12,11.36%,TERT;ATM;CHEK2
prerank,spliceosomal snRNP assembly (GO:0000387),0.27121602219044944,0.7010228588212118,0.8538922155688623,0.9592053218927885,1.0,14/38,32.70%,SNUPN;LSM2;GEMIN7;SMN1;SRSF10;SNRPB;GEMIN2;WDR77;USP4;DDX20;SNRPF;PRMT5;SART3;TGS1
prerank,peptide hormone secretion (GO:0030072),0.29682265292613813,0.7008358737620836,0.8523153942428036,0.9590426498854926,1.0,6/26,23.62%,EDN3;ANXA1;VIP;IL6;RAB1A;FAM3B
prerank,glycolytic process (GO:0006096),-0.21605276532612183,-0.7008159860376543,0.9317073170731708,0.9731887561645912,1.0,5/28,11.12%,HK2;PGAM4;PGAM1;GPI;ALDOC
prerank,glycoprotein catabolic process (GO:0006516),0.3136015800972607,0.7008009295580028,0.8518024032042724,0.9587264045030607,1.0,7/17,28.41%,EDEM2;NGLY1;FBXO17;OGA;ADAMTS9;MANBA;STT3B
prerank,sarcomere organization (GO:0045214),0.29127972802839985,0.7004401461370297,0.8480697384806973,0.9587496244695479,1.0,5/27,20.47%,SIX4;TNNT3;CSRP3;WDR1;CSRP2
prerank,protein-containing complex subunit organization (GO:0043933),0.24499140964832802,0.6989463689520468,0.9282744282744283,0.9600410426252007,1.0,35/109,26.89%,HES5;CD3E;GPAA1;SEH1L;SPG7;LLGL1;MDM4;DLG4;SOX9;ST13;WIPF1;SNX9;SHANK1;ZW10;CREBBP;KPNA3;EPRS1;TEAD2;DARS1;CAPZA1;REPS2;NDC1;KMT2A;PEX14;NUP35;AFG3L2;NIFK;DET1;TP53;VAMP2;PPID;TPR;PARD3;PPP2R1A;WAS
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.2797294844093314,0.6982112343224062,0.8630952380952381,0.9604669931013513,1.0,9/35,14.03%,SCD5;AACS;HMGCL;CBR4;FAR1;PPT2;ACAT1;ACACA;BDH2
prerank,glutamate metabolic process (GO:0006536),0.3122341358507704,0.6979573399748684,0.8235294117647058,0.9603720027092738,1.0,1/19,1.56%,GCLC
prerank,innate immune response (GO:0045087),0.2364414044135624,0.6975611458147332,0.9717171717171718,0.960431581619204,1.0,40/217,23.23%,LBP;COLEC11;TNK1;TRIM28;RNASE7;MAVS;HMGB1;IFNLR1;CXCL16;RNASE3;TRIM27;S100B;FCER1G;RNASE6;CHUK;ALPK1;IRAK1;MID2;DEFB1;SRMS;TRIM26;FRK;SRPK1;COLEC12;CYP27B1;OTULIN;SHMT2;TRIM13;TRIM6;DMBT1;CAPZA1;IL4;TRIM43;CD300LB;SHFL;TRIM8;SETD2;SLC11A1;VNN1;CYLD
prerank,regulation of humoral immune response (GO:0002920),0.2673758647095675,0.6974755719242353,0.8885057471264368,0.960182592249656,1.0,7/44,20.48%,CFH;C9;C8B;SERPING1;C8G;CPB2;CLU
prerank,positive regulation of vasoconstriction (GO:0045907),0.32890848901993736,0.6970498890952633,0.8507042253521127,0.9602708272904227,1.0,2/13,13.07%,TRPM4;F2R
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.32729521023386504,0.6961834796585068,0.8455056179775281,0.9608009793113038,1.0,5/13,22.45%,LPCAT3;MANF;USP19;CLU;EIF2AK3
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.24761480419292398,-0.695762257224347,0.8910505836575876,0.9768436129488204,1.0,3/16,9.14%,KLK2;ACE;BMPR2
prerank,mitochondrial membrane organization (GO:0007006),-0.20587895514845894,-0.6957454731042514,0.9289940828402367,0.9754067300622724,1.0,10/32,22.04%,BCL2;BCL2L1;CHCHD3;GHITM;MTX2;OPA1;MFN2;PPIF;SAMM50;BNIP3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.24163413842751522,0.6956587779861301,0.9359504132231405,0.9609899641276736,1.0,21/117,20.98%,GPR27;DRD1;FSHR;RAMP2;ADCY2;ADCY8;ADCY9;GPR20;IAPP;RAMP1;VIP;GLP1R;MC4R;PTGDR;IL6;CREB1;CALCA;ADCY7;PRKACA;GNB1;PRKAR2A
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.2989744323876292,0.695572137292893,0.8470437017994858,0.9607281014753689,1.0,5/20,23.25%,LONP1;HSPD1;PTGES3L;CLU;PSMG2
prerank,regulation of secretion (GO:0051046),-0.2592693162950409,-0.6951656292564043,0.8692579505300353,0.9745733034528834,1.0,7/13,30.34%,MYO6;OAS2;ERBB3;KCNQ1;NRG1;OPRK1;GPLD1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.2786498274933964,0.6947264422558173,0.8824969400244798,0.9612524419459633,1.0,7/32,16.86%,PRKCD;CALM2;SYMPK;CNEP1R1;PTBP1;NSMF;CALM3
prerank,protein ADP-ribosylation (GO:0006471),0.28486840023995724,0.6946330374273374,0.8827160493827161,0.9609989946367293,1.0,6/28,16.22%,PARP3;SIRT5;ARF4;TNKS2;SIRT2;PARP1
prerank,positive regulation of cytokine production (GO:0001819),0.23447883458306717,0.6928484893051626,0.986,0.9624833207375444,1.0,54/292,22.65%,FOXP1;LBP;F3;IL33;TWIST1;RAB7B;CYP1B1;GLMN;STAT3;ATF4;MAVS;PRKDC;IL12RB2;HMGB1;SULF1;POLR3H;TRIM27;RARA;FZD5;FCER1G;RORA;ANXA1;CRTAM;IRAK1;C1QTNF4;SOD1;KAT2A;CRCP;HSPD1;F2R;CD80;RUNX1;POLR3GL;SETD4;POLR2F;IL6;CREBBP;SPTBN1;NFKB2;HMOX1;TRIM6;SULF2;XRCC6;IRF3;POLR3K;APPL1;IL17RA;IL4;DRD2;RAB1A;TLR1;POLR1C;EIF2AK3;SLC11A1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.240417339623672,0.6917287669440136,0.944963655244029,0.9632645549436065,1.0,21/116,20.98%,GPR27;DRD1;FSHR;RAMP2;ADCY2;ADCY8;ADCY9;GPR20;IAPP;RAMP1;VIP;GLP1R;MC4R;PTGDR;IL6;CREB1;CALCA;ADCY7;PRKACA;GNB1;PRKAR2A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.23768909537834748,0.6908576643479653,0.9563008130081301,0.9638023886607379,1.0,32/168,21.07%,RPSA;DDX5;PABPC1;SAMD4A;CASC3;TENT4B;THRAP3;PNRC2;SMG6;GSPT1;SMG1;AGO1;DIS3L2;ATM;PATL1;EIF4G1;ETF1;XRN1;EXOSC4;MRTO4;CNOT8;RPS27A;TUT7;CNOT10;RC3H2;NCBP1;NCBP2;CNOT9;RPL7A;TNKS1BP1;PYM1;TENT2
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.2266261946632407,-0.6900109490421904,0.9324894514767933,0.9782584307696162,1.0,7/22,19.57%,BMP7;DYNLL1;PLEK;ANKLE2;SIRT1;CDKN2C;CDKN2D
prerank,regulation of keratinocyte differentiation (GO:0045616),0.28389013298585614,0.6899848944223769,0.8564356435643564,0.9643279111622577,1.0,7/24,24.47%,SRSF6;RUNX1;VDR;CYP27B1;CBFB;CTSK;ROCK1
prerank,negative regulation of cell cycle (GO:0045786),0.2502098005000711,0.689768142788904,0.9136069114470843,0.9641889968313802,1.0,15/73,19.69%,PDCD4;PTPN3;GAS1;IPO5;BMP4;TAF6;INHBA;HEXIM1;RHOB;CAMK2N1;LATS2;CDKN1C;MEN1;HECA;GMNC
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.28621596930776116,0.6894968529296376,0.8778337531486146,0.9641223762933285,1.0,4/25,13.07%,DRD1;ANK2;PDPK1;F2R
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.26042189854344555,-0.6894773705693182,0.8450184501845018,0.9772534264633254,1.0,13/13,73.99%,NECTIN2;FADD;IL12A;IL12RB1;IL23A;IL23R;IL12B;XCL1;PVR;SLC22A13;MR1;STX7;CYRIB
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.27853463253101907,-0.6890830159551233,0.8633333333333333,0.9762059746986,1.0,5/11,23.35%,AKAP6;NOS1AP;LRRC38;LRRC55;TREM2
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3294794073316605,0.6887502281608743,0.846262341325811,0.96453102216794,1.0,5/12,20.14%,SRR;PHGDH;MTHFD1;PSAT1;SEPHS2
prerank,indolalkylamine catabolic process (GO:0046218),0.3405132481923233,0.6886206416365311,0.8511904761904762,0.9643200447472597,1.0,2/10,20.64%,IDO2;KYAT1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.27014299844669143,-0.6885873955622563,0.8767123287671232,0.9751767352436249,1.0,4/12,12.94%,PIK3R1;BOK;BCL2L11;PTPN1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.23435552644684582,0.6881080687453407,0.9708835341365462,0.9645072919184594,1.0,59/208,28.51%,ESR1;CARD16;MAVS;BRD4;TRIM27;S100B;RHOA;SHARPIN;RORA;ROR1;LTBR;MAPKBP1;CHUK;ALPK1;IRAK1;TAB2;PDPK1;TNFRSF10B;MID2;TRAF3;TANK;F2R;CASP1;SQSTM1;AKAP13;PER1;ZDHHC13;MAP3K3;TRAF3IP2;UFL1;TRIM13;HMOX1;TRIM6;USP10;ZMYND11;IKBKE;CC2D1A;NUP62;OPTN;MUL1;MIER1;TRIM8;BIRC3;MAP3K14;TBK1;PINK1;TRADD;TFG;RIPK1;TMEM106A;NDFIP1;RIPK2;NEK6;CANT1;UBE2V1;PPM1B;GPR89A;SPHK2;NR1D1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.27685328891973093,0.6873602902413528,0.8736330498177399,0.9649196792359797,1.0,11/31,31.91%,EPHB2;KMT5C;CLCF1;STX4;IL6;MAD2L2;SHLD3;SHLD1;HMCES;PTPRC;SASH3
prerank,T cell activation involved in immune response (GO:0002286),0.32490309363486936,0.6872034516640971,0.8409090909090909,0.9647170774695784,1.0,4/12,22.65%,FCER1G;EIF2AK4;TNFSF18;SLC11A1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.3211613542079697,0.6869047687948772,0.8541666666666666,0.9646705805397667,1.0,3/13,13.71%,CD9;FCER1G;ABCA1
prerank,somite development (GO:0061053),0.33833037594426985,0.6863765645473892,0.8447293447293447,0.9648214246299512,1.0,3/11,16.73%,MEOX2;SMO;MTHFD1
prerank,rRNA processing (GO:0006364),0.2360604312231999,0.6858494472029875,0.967280163599182,0.9649879959938764,1.0,62/172,32.66%,C1D;PRKDC;RRP7A;LAS1L;EMG1;SRFBP1;WDR3;RIOK1;NVL;WDR55;ESF1;RRP12;NOLC1;UTP14A;DCAF13;EXOSC4;NOC4L;MRTO4;EIF6;BYSL;DIS3;BOP1;NOB1;RPL7A;TSR3;MTREX;WDR12;NOP56;DDX49;FBL;SBDS;WDR36;WDR46;WDR75;RPS9;TBL3;SENP3;RIOK2;UTP11;NOP58;RRP15;DKC1;MAK16;POP5;FCF1;NOP53;RPL41;RPL30;ERI1;PIH1D2;THUMPD1;EXOSC2;RIOK3;RPL27;RPL37A;RRP1B;NOP14;UTP3;RPL36A;EXOSC3;MPHOSPH6;UTP4
prerank,regulation of nuclear division (GO:0051783),0.29385647476219134,0.6850033801501709,0.855683269476373,0.965491929269256,1.0,8/20,29.56%,RCC1;DAPK3;KIF20B;CUL9;CDK13;CCDC8;CUL7;PRMT5
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.31911774251964475,0.6849176129361685,0.8619302949061662,0.9652344590425692,1.0,1/14,1.81%,YBX3
prerank,calcium-ion regulated exocytosis (GO:0017156),0.2830690916043207,0.6848844902750286,0.8772782503037667,0.9649167740729947,1.0,2/27,4.13%,SYT8;ARHGAP17
prerank,regulation of interferon-beta production (GO:0032648),0.264604946211228,0.6847128672813576,0.9018264840182648,0.9647491882340973,1.0,17/46,32.38%,PTPRS;MAVS;TRAF3;TOMM70;IRF3;RNF216;TBK1;PTPN11;YY1;RIPK2;PPM1B;RNF135;HSP90AA1;LILRB1;RIOK3;POLR3F;IFIH1
prerank,mismatch repair (GO:0006298),0.27988001006833285,0.6846409591346734,0.8674101610904585,0.9644610089461808,1.0,9/27,32.96%,ABL1;TDG;PMS2;MSH4;SETD2;POLD1;MSH2;ERCC1;RPA3
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3122747868803315,0.68433661751185,0.8655126498002663,0.9644107882921295,1.0,7/16,29.83%,HASPIN;NIPBL;POGZ;PDS5A;SMC1A;MAU2;PDS5B
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3379789801751097,0.6843315701782613,0.8429629629629629,0.964066933673336,1.0,4/10,24.30%,HOXB4;MLLT3;UFL1;TP53
prerank,negative regulation of cholesterol transport (GO:0032375),-0.284100182035026,-0.684044823903059,0.8517350157728707,0.9780301061617634,1.0,10/10,71.61%,APOC1;SHH;ABCG5;APOA2;PLA2G10;ABCG8;APOC3;ABCA2;NFKB1;SREBF2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.30305841332640493,0.6832729824825801,0.8558322411533421,0.9647324991886075,1.0,8/18,30.36%,MIEF2;MCU;MUL1;PINK1;RALA;FIS1;PRKN;MIEF1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.2882782411776951,0.6831163688285775,0.8841463414634146,0.964541604542275,1.0,5/25,20.81%,TWIST1;NSD1;HEY1;TRIM6;MAD2L2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.2437564281793088,0.6831063955493976,0.9172774869109948,0.964204888562793,1.0,20/94,16.53%,PSMD7;PSMA8;IRAK3;RPS6KA4;PSMA4;CHUK;IRAK1;TAB2;PSMD12;CUL1;PSMA6;SQSTM1;PSMD1;MAP3K3;PSMC5;PSMD11;PSMC4;PSMD14;RPS27A;UBC
prerank,positive regulation of establishment of protein localization (GO:1904951),0.2995840914963692,0.6827650979151292,0.8635135135135135,0.9642079076296781,1.0,8/19,27.68%,CHP1;CCT4;CCT6A;CCT8;TCP1;PTP4A3;DKC1;CCT5
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.2749387622722848,-0.6827229944144412,0.8541666666666666,0.9779221958244936,1.0,4/10,17.08%,PRKCQ;ZBTB7B;LGALS9;CD55
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.3257288992979799,0.6821169744723586,0.8433242506811989,0.9645072908789722,1.0,2/12,12.01%,PRKCA;CNEP1R1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.3273309381286596,0.6816637433285878,0.8565279770444764,0.9645947420830426,1.0,1/12,2.60%,DPYSL3
prerank,aromatic amino acid family catabolic process (GO:0009074),0.30877312643814986,0.6814777351582091,0.8509485094850948,0.9644411255746943,1.0,4/15,27.98%,IDO2;GSTZ1;KYAT1;HGD
prerank,sterol metabolic process (GO:0016125),0.25439347817477453,0.6811498082911823,0.9058050383351588,0.9643985922799547,1.0,20/60,30.61%,CYP19A1;CYP1B1;SOAT1;RXRA;TSKU;NSDHL;FDXR;ABCA1;EBP;SC5D;IL4;STARD3;APOF;HMGCR;ANGPTL3;SOAT2;OSBPL5;SQLE;INSIG1;OSBPL1A
prerank,lipid homeostasis (GO:0055088),0.25076674853530917,0.6807432859879182,0.9027624309392265,0.9644476985235105,1.0,17/57,26.43%,ACOXL;TLCD2;ACOX3;NR1D2;ABCA1;PNPLA3;THADA;ORMDL3;TLCD1;MLXIPL;RCN3;ORMDL1;ABCD1;TM6SF2;FITM2;POLD1;ANGPTL3
prerank,negative regulation of dephosphorylation (GO:0035305),0.299251167721772,0.6801894971508174,0.8982597054886211,0.9646369951504604,1.0,8/18,24.67%,PPP1R8;ZCCHC9;URI1;CHP1;ARPP19;PPP1R35;PPP1R36;YWHAB
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.30110670118403327,0.680024101059444,0.8593548387096774,0.9644471102177951,1.0,3/18,16.62%,MCMDC2;GINS4;MCM4
prerank,snRNA 3'-end processing (GO:0034472),0.2949149726853884,0.679987018265714,0.87001287001287,0.9641401144275183,1.0,7/19,32.29%,INTS14;EXOSC4;TOE1;INTS7;INTS6;EXOSC2;EXOSC3
prerank,positive regulation of interleukin-10 production (GO:0032733),0.27815408205164677,0.6798777798220164,0.8875598086124402,0.9639048058676236,1.0,4/30,15.26%,STAT3;HMGB1;HSPD1;IL6
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.28714240591509377,0.6789999337189483,0.8714107365792759,0.9644283691096707,1.0,8/24,27.75%,ITCH;IRAK1;TAB2;RPS27A;UBC;CYLD;RIPK2;UBE2V1
prerank,cellular response to UV-A (GO:0071492),0.3313018802969332,0.6774688362128908,0.8793103448275862,0.9655475169226142,1.0,4/11,30.12%,OPN3;MMP2;PPID;TIMP1
prerank,fatty acid transmembrane transport (GO:1902001),0.2998790545712246,0.677456720761621,0.8726790450928382,0.9652173652874059,1.0,1/19,0.93%,ABCD3
prerank,diol biosynthetic process (GO:0034312),0.31460523156955705,0.6774254956091151,0.8463576158940397,0.9648953006188401,1.0,1/15,1.73%,ACER3
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.2740750446127942,0.677077827788889,0.8722084367245657,0.9648887828911888,1.0,5/28,11.90%,MAP3K5;ATF4;ERN2;AIFM1;TNFRSF10B
prerank,regulation of defense response to virus by host (GO:0050691),0.27235792384699076,0.676371771814112,0.890625,0.9652231453151313,1.0,9/30,23.03%,MAVS;IFNLR1;TOMM70;TRAF3IP2;TRIM6;EIF2AK4;IL4;MUL1;RNF216
prerank,cellular response to dsRNA (GO:0071359),0.30913793542969065,0.676309332894584,0.853021978021978,0.964944553698241,1.0,7/15,34.60%,MAVS;COLEC12;MUL1;CGAS;RIOK3;IFIH1;DHX9
prerank,negative regulation of viral genome replication (GO:0045071),0.26168433519604967,0.6762902196096753,0.8914819136522754,0.9646159221766498,1.0,10/40,22.18%,MAVS;ILF3;RESF1;SETDB1;SRPK1;N4BP1;TRIM6;MPHOSPH8;SHFL;TASOR
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.2955314659295111,0.6761142566889469,0.8646112600536193,0.9644460266892881,1.0,4/18,15.26%,STAT3;SMAD4;CBL;IL6
prerank,determination of left/right symmetry (GO:0007368),0.2671025142995351,0.675148103890518,0.9105504587155964,0.965025033692277,1.0,11/37,28.54%,ODAD2;CCDC39;SMO;NPHP3;DNAAF4;CITED2;LEFTY1;PKD1L1;BBS7;ENKUR;STIL
prerank,vesicle transport along microtubule (GO:0047496),0.2872878167822095,0.6750731116496572,0.8891625615763546,0.964757945536922,1.0,2/23,4.81%,KIF13A;DYNC1H1
prerank,meiosis I (GO:0007127),0.2810802788313569,0.6748522861867404,0.8778337531486146,0.9646294542620948,1.0,3/23,18.61%,FOXJ3;HSF2BP;BRDT
prerank,positive regulation of T cell proliferation (GO:0042102),-0.17894769641646913,-0.6745297572148712,0.9724770642201835,0.9839555009734352,1.0,12/55,20.97%,IGFBP2;TFRC;VCAM1;SLC7A1;CD274;SYK;IGF1;PYCARD;RPS3;CD276;AGER;CCR2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.27971193592899046,0.6741691579758742,0.8768292682926829,0.9649143453218808,1.0,5/27,15.26%,NFAT5;RHOA;IRAK1;HSPD1;IL6
prerank,mitochondrial fission (GO:0000266),-0.24043197601223032,-0.673380636612828,0.9183673469387755,0.983534115413526,1.0,5/16,17.25%,DNM3;DNM1L;MFF;OPA1;MTFR2
prerank,intracellular lipid transport (GO:0032365),0.2911445295777669,0.673292119031215,0.8690012970168612,0.9653920933112292,1.0,1/21,0.93%,ABCD3
prerank,protein lipidation (GO:0006497),0.25088878117918867,0.6730498954749878,0.923162583518931,0.965266356499902,1.0,14/59,26.69%,PIGW;WIPI2;PIGF;ZDHHC16;HHAT;PIGL;PGAP2;ZDHHC13;ZDHHC20;DPM3;PIGV;ZDHHC9;PIGQ;PIGB
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.3321903784670528,0.6724381545853141,0.8433908045977011,0.9654874729711823,1.0,2/10,16.79%,KCNE5;SUMO1
prerank,response to exogenous dsRNA (GO:0043330),0.2959197371324007,0.6720543604053486,0.8804204993429697,0.9654846784852317,1.0,6/18,26.35%,MAVS;IRAK3;COLEC12;MUL1;SLC3A2;CGAS
prerank,ribosomal large subunit assembly (GO:0000027),0.2876853338437841,0.6713389223471365,0.865,0.9658323072373207,1.0,4/24,17.46%,RRS1;NLE1;PPAN;BOP1
prerank,positive regulation of histone methylation (GO:0031062),0.28026457244565606,0.6710453497766029,0.8865336658354115,0.9657740257169868,1.0,5/24,12.23%,PHF1;SMAD4;OGT;CHTOP;WDR5
prerank,regulation of response to oxidative stress (GO:1902882),-0.2675342645145979,-0.6709291628255695,0.8780487804878049,0.9842830173044604,1.0,1/11,1.66%,MCTP1
prerank,retinol metabolic process (GO:0042572),0.3034323352182196,0.6707643961946423,0.8493150684931506,0.9656849196264929,1.0,3/14,18.76%,CYP1B1;DHRS9;DHRS3
prerank,regulation of lipid catabolic process (GO:0050994),-0.2265638615164622,-0.6705393641663406,0.8918918918918919,0.9831835606582006,1.0,6/19,23.25%,ADRA2A;PRKAA1;BSCL2;TYSND1;ALK;APOC1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.2801421466793511,0.6705298245536063,0.8655778894472361,0.9655593474351917,1.0,2/25,5.57%,MPP2;RAB3GAP1
prerank,microtubule depolymerization (GO:0007019),0.2991723090277157,0.6701720485221114,0.8903394255874674,0.9655558232459467,1.0,4/17,20.56%,STMND1;CKAP5;KIF24;STMN2
prerank,regulation of innate immune response (GO:0045088),-0.17760873153777676,-0.6700358657745141,0.9891304347826086,0.9821606384872806,1.0,11/57,13.75%,IFNAR2;SAMHD1;USP18;GBP5;RNASEL;TRIM21;DHX58;CACTIN;PTPN1;TNFAIP3;LRP8
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.31557621980844464,0.6698041466346896,0.8664886515353805,0.9655469855073738,1.0,2/13,12.70%,PABPC1;AGO2
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.2234578186986768,-0.669427075032138,0.9259259259259259,0.9812512689990037,1.0,6/21,18.52%,KDR;LGALS9;IGF1;HTR2B;MT3;MAPK3
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.2803038863661149,0.6693019724643112,0.8591715976331361,0.9656586085259976,1.0,2/26,3.46%,ACER3;CYP1B1
prerank,regulation of gastrulation (GO:0010470),0.31723829734987474,0.669156491366836,0.8760330578512396,0.9654461032748889,1.0,2/14,6.19%,PHLDB1;POGLUT1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3307651632565091,0.6689593694443327,0.8764204545454546,0.9652907474452163,1.0,4/10,26.37%,WWP2;DNAJA1;SNX3;NDFIP1
prerank,negative regulation of reproductive process (GO:2000242),0.29719433368273196,0.6683605179373886,0.9031811894882434,0.9654809081906521,1.0,7/17,33.67%,SULF1;WEE2;CALR;WDR77;ARHGDIB;TIMP1;HYAL3
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.32500461264085767,0.6680210533992911,0.8577464788732394,0.965449825079976,1.0,3/11,24.89%,TIMM9;TOMM70;TIMM22
prerank,protein acylation (GO:0043543),0.26304143212434095,0.6679721260466079,0.9017543859649123,0.9651443333179477,1.0,10/38,23.44%,ING5;ZDHHC16;KAT2A;HHAT;ING4;ZDHHC13;CREBBP;ZDHHC20;ZDHHC9;KAT2B
prerank,UV-damage excision repair (GO:0070914),-0.2656789503421433,-0.6665538498632689,0.8754098360655738,0.9822109898801501,1.0,12/12,73.46%,ACTR5;SIRT1;INO80;MC1R;DDB2;POLA1;XPC;POLD3;CUL4B;ERCC1;DDB1;XPA
prerank,cellular response to ATP (GO:0071318),-0.24172788346832424,-0.6664259152151143,0.8955223880597015,0.980900462444184,1.0,14/14,75.85%,CIB2;P2RY1;P2RX7;P2RX3;P2RY2;PDXP;TRPV1;RYR3;P2RY4;HSP90B1;P2RX4;P2RY12;SSH1;TAF1
prerank,amide biosynthetic process (GO:0043604),0.25146864944396413,0.6655986820711052,0.9150622876557192,0.9669421621212296,1.0,4/47,8.39%,PCSK5;SMPD4;DMD;NANP
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3248587570621472,0.6650787156915436,0.8620199146514936,0.9670689145164116,1.0,11/11,67.54%,PKD2L1;RTP4;LPO;RTP2;PKD1L3;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3
prerank,cellular response to interferon-beta (GO:0035458),-0.24791965022628631,-0.6649737544212245,0.8925925925925926,0.9807094601793377,1.0,3/14,13.58%,STAT1;AIM2;NDUFA13
prerank,negative regulation of neuron differentiation (GO:0045665),0.2900709276061732,0.6648581779029932,0.8654822335025381,0.9669235581899251,1.0,6/22,20.37%,HES5;SOX9;HEY1;NEPRO;EIF2AK4;CALR
prerank,neuron maturation (GO:0042551),0.29064196755440347,0.6630470882409423,0.8924731182795699,0.9682156074649348,1.0,4/18,14.86%,LGI4;B4GALT5;PICK1;FARP2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3231828784001942,0.6627027680343657,0.8797736916548797,0.9681769123912433,1.0,1/11,2.13%,MUC1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.28347983257355513,0.6625885121867262,0.8814627994955864,0.9679385062619893,1.0,1/21,1.12%,FGF13
prerank,primary alcohol metabolic process (GO:0034308),0.27669671070892954,0.6622664440563869,0.9,0.9678770069069617,1.0,5/25,18.76%,CYP1B1;DHRS9;ALDH3A2;GDPD3;DHRS3
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.27525924886869135,0.6620848490868527,0.8921933085501859,0.9676928308377188,1.0,4/25,15.61%,LRPAP1;DLG4;ITGAV;WDR54
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.3046305194778927,0.6620428258037673,0.8713692946058091,0.9673921013487099,1.0,3/15,13.53%,SAT2;SMOX;SRM
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.26303524136382256,0.6613583668651833,0.9155446756425949,0.967663873990116,1.0,12/31,25.91%,PPP3CC;MAPK8;YWHAE;YWHAQ;TFDP1;E2F1;BID;SFN;TP53;BAD;YWHAB;NMT1
prerank,acetyl-CoA metabolic process (GO:0006084),0.3053417672667165,0.6611305227066709,0.8794037940379403,0.9675194233692066,1.0,5/15,28.48%,ACAT1;ACACA;HMGCS2;PPCS;ACLY
prerank,receptor recycling (GO:0001881),0.330057722561334,0.6609691093454871,0.8683473389355743,0.9673127453620666,1.0,4/10,24.66%,RAB11B;PHETA2;ARFGEF2;LMTK2
prerank,regulation of dopamine secretion (GO:0014059),0.2781489303015692,0.6608666131475853,0.9078282828282829,0.9670608030338628,1.0,2/25,6.91%,SYT8;CHRNB2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.253875536848345,0.6594705551578054,0.9110854503464203,0.9679636095025119,1.0,8/42,18.36%,VCP;FAAP20;WRN;UBE2L6;RPS27A;UBC;REV1;USP10
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.17354556450015565,-0.6591992944602479,0.9583333333333334,0.9840261870988274,1.0,7/53,11.67%,CALCRL;HTR2C;HTR4;OPRM1;CNR1;MC5R;CHRM3
prerank,synaptic vesicle cycle (GO:0099504),-0.19883020560954193,-0.6588303765424404,0.9597701149425287,0.9828744743032808,1.0,10/30,21.39%,RIMS1;PIP5K1C;SYNDIG1;SYT10;SNCA;SNAP25;SLC32A1;SYT7;SLC18A2;CPLX2
prerank,negative regulation of histone acetylation (GO:0035067),-0.26253139540197534,-0.6587677530577634,0.8786885245901639,0.9815039206582689,1.0,6/11,27.71%,SIRT1;SNCA;BRCA1;TAF7;SIN3A;SET
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.2959273124603662,0.6586106010611555,0.8928104575163399,0.9683743525705986,1.0,2/19,3.64%,CUX1;FBXW8
prerank,regulation of histone acetylation (GO:0035065),0.2627487432175032,0.6570583548863363,0.9089820359281438,0.9694121434899495,1.0,9/33,22.61%,TADA2A;RPS6KA4;SETD5;ARRB1;FLCN;THAP7;NOC2L;CAMK1;KMT2A
prerank,regulation of phosphate metabolic process (GO:0019220),-0.22484542098247629,-0.6568133583232065,0.8951965065502183,0.9816577624596651,1.0,4/16,13.09%,SMG7;SRPX2;PGAM1;BARD1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.25897402284763865,0.6555972446742891,0.9045346062052506,0.9703483137003535,1.0,7/36,14.35%,TCF7L2;PDE6A;FZD5;NFATC1;AGO1;AGO2;GNAO1
prerank,regulation of interleukin-10 production (GO:0032653),-0.18534446501456087,-0.6549882209573445,0.9769230769230769,0.981726977687353,1.0,13/44,20.76%,TNFRSF21;CD274;SYK;LGALS9;CD34;PRKCZ;TYROBP;NOD2;CD47;PYCARD;DLL1;ISG15;AGER
prerank,regulation of adaptive immune response (GO:0002819),0.2914381852623092,0.6549042643381879,0.8863346104725415,0.9706049203375574,1.0,4/18,19.92%,TRIM27;RIPK3;ADCY7;EIF2AK4
prerank,cellular response to exogenous dsRNA (GO:0071360),0.3137589707767356,0.6547499017167949,0.8764204545454546,0.9704039864104008,1.0,6/12,34.60%,MAVS;COLEC12;MUL1;CGAS;IFIH1;DHX9
prerank,cell junction maintenance (GO:0034331),-0.2368072451261671,-0.654481644891766,0.9182879377431906,0.9806545296791255,1.0,7/14,29.21%,CLDN1;CBLN2;CSF1R;CBLN1;MYADM;PARD6A;NLGN2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.22553710359859547,0.6543922970664472,0.9776649746192894,0.9703720977145587,1.0,17/152,15.23%,GNAS;DRD1;FSHR;ADGRL2;RAMP2;ADCY2;ADCY8;ADCY9;IAPP;RAMP1;VIP;GLP1R;MC4R;ABCA1;GPR12;GNAO1;GNA11
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.26376247567635425,-0.6537615391359958,0.8729641693811075,0.9797883918182106,1.0,10/10,73.65%,ZFP57;PCGF5;CTCFL;DNMT3L;PRMT7;KDM1B;PCGF3;MECP2;DNMT3A;IGF2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.26727874501762566,0.6532048709658691,0.8878048780487805,0.9710668562240896,1.0,11/28,31.49%,ITCH;IRAK1;TAB2;RPS27A;UBC;OTULIN;CYLD;RIPK2;UBE2V1;IRGM;UBE2N
prerank,B cell differentiation (GO:0030183),0.25095842503676385,0.6529238725105421,0.9269102990033222,0.9709708918678229,1.0,9/46,20.97%,HDAC9;HDAC4;SYVN1;PTPN2;CLCF1;TCF3;TPD52;GPS2;IL4
prerank,cholesterol metabolic process (GO:0008203),0.24143494516039155,0.6525513398585575,0.9488574537540805,0.9709469048620146,1.0,24/68,33.68%,SOAT1;CEL;RXRA;TSKU;NSDHL;ABCA1;LSS;EBP;IL4;STARD3;APOF;HMGCR;ANGPTL3;SOAT2;ACAT2;OSBPL5;ACLY;SQLE;INSIG1;OSBPL1A;GGPS1;GBA2;TM7SF2;PLPP6
prerank,mitochondrial transport (GO:0006839),0.2468124696162877,0.6524724120381948,0.9403824521934758,0.9706767748947468,1.0,14/53,24.89%,FLVCR1;SPG7;TOMM40;TIMM9;BCAP31;TOMM70;TMEM14C;BCS1L;COX18;STARD3;ABCB10;BAD;TIMM17B;TIMM22
prerank,sensory perception of pain (GO:0019233),0.2839573164952933,0.6522914929310406,0.9075520833333334,0.970491313451439,1.0,2/21,6.91%,PROK2;CHRNB2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.31974304386134567,0.6512487840715522,0.8856304985337243,0.9710439419168769,1.0,3/10,24.26%,CALM3;DRD2;CBARP
prerank,macrophage chemotaxis (GO:0048246),-0.26985123344422823,-0.6506338030961678,0.8766233766233766,0.9807364254412668,1.0,10/10,73.04%,EDNRB;TAFA4;CCL5;CCL3;EDN2;SAA1;CXCL17;LGALS3;CKLF;CCL2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.18035591009817617,-0.6485258181720266,0.9752066115702479,0.9808535544891214,1.0,4/44,6.27%,CYP7B1;PRKAG2;CYP27A1;INSIG2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.21644054793131082,-0.6481787722476989,0.9307359307359307,0.9797078566947739,1.0,7/20,20.41%,NT5C2;GMPS;IMPDH1;ADSS1;LHPP;PPAT;AMPD2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.2707440276885346,0.6463909416744879,0.9222082810539524,0.9747389341015728,1.0,6/26,22.34%,IRAK3;LRRC14;APPL2;APPL1;GPS2;BIRC3
prerank,regulation of mitochondrial fission (GO:0090140),0.272565214818982,0.6461227720006836,0.8871794871794871,0.9746131662820402,1.0,10/24,30.36%,MIEF2;MCU;MUL1;LRRK2;PINK1;CYRIB;RALA;FIS1;PRKN;MIEF1
prerank,rRNA metabolic process (GO:0016072),0.2226047767812678,0.6450124750778866,0.9735234215885947,0.975160960041019,1.0,55/160,32.66%,C1D;RRP7A;ERN2;LAS1L;EMG1;WDR3;NVL;WDR55;ESF1;RRP12;NOLC1;UTP14A;DCAF13;XRN1;EXOSC4;NOC4L;MRTO4;BYSL;DIS3;BOP1;NOB1;RPL7A;MTREX;WDR12;NOP56;DDX49;FBL;SBDS;WDR36;NIFK;WDR46;WDR75;RPS9;TBL3;SENP3;UTP11;NOP58;DKC1;POP5;FCF1;NOP53;RPL41;RPL30;DEDD2;PIH1D2;EXOSC2;RPL27;RPL37A;RRP1B;NOP14;UTP3;RPL36A;EXOSC3;MPHOSPH6;UTP4
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.289904324280586,0.6449992709844966,0.8876860622462788,0.9748304320757348,1.0,3/15,18.74%,CHEK2;HUS1;ATF2
prerank,carnitine metabolic process (GO:0009437),0.3125079373181706,0.6449711954563145,0.8765603328710125,0.9745109801742456,1.0,3/12,18.44%,CPT1C;CRAT;SHMT1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.23344820090300156,-0.6444326701988812,0.9305019305019305,0.9810033471967556,1.0,5/14,20.97%,SYK;LGALS9;PTPN22;CD55;CCR2
prerank,positive regulation of phagocytosis (GO:0050766),0.24260347612921793,0.6428282025957005,0.9192825112107623,0.975913521722584,1.0,8/47,22.65%,GAS6;FCER1G;PLA2G5;LMAN2;APPL2;CALR;TUB;SLC11A1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.26183761393493166,0.6419290662940089,0.906519065190652,0.9762926557831453,1.0,12/26,30.27%,AKAP9;ARL2;SLAIN2;DCTN1;STMN2;CDK5RAP2;MET;KATNB1;DRG1;FES;TOGARAM1;RAC1
prerank,histone H2A monoubiquitination (GO:0035518),0.29370641116564233,0.6414031406680943,0.8956639566395664,0.9763622840573722,1.0,4/17,18.27%,RNF2;RING1;PCGF2;RYBP
prerank,positive regulation of translational initiation (GO:0045948),0.2874089739523643,0.6409767345320017,0.9052924791086351,0.9763661949684499,1.0,6/18,28.61%,CDC123;KHDRBS1;UHMK1;RPS6KB1;YTHDF1;LARP1
prerank,bile acid metabolic process (GO:0008206),0.2644148682157725,0.6406822726494593,0.9103535353535354,0.9762485893224279,1.0,7/27,24.67%,OSBPL7;AKR1C1;NPC1;OSBP;SLC27A2;HSD3B7;ACOT8
prerank,heterochromatin organization (GO:0070828),-0.23435470482604104,-0.6405706117943618,0.9195402298850575,0.9823375377365847,1.0,1/14,0.70%,MECOM
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.3150544298065401,0.639287066196527,0.8988439306358381,0.9770124302505637,1.0,1/10,5.17%,GABRA3
prerank,divalent inorganic cation homeostasis (GO:0072507),0.26402229377354053,0.6392396264027621,0.9160206718346253,0.976710792915963,1.0,4/25,8.21%,CNNM2;TMC8;SELENON;TRPM7
prerank,cellular response to nitrogen compound (GO:1901699),0.27507313799273425,0.6391840582912139,0.8919949174078781,0.9764118088537715,1.0,12/20,36.15%,DDI2;SPIDR;AOC1;ATP2B4;DAXX;HSF1;DDX11;TIMELESS;RIOK3;BLM;EPG5;RTF2
prerank,response to gamma radiation (GO:0010332),0.26762933950758666,0.637986250173258,0.9055415617128464,0.9770147413328258,1.0,10/24,28.72%,WRN;ATM;LIG4;TLK2;TRIM13;MEN1;XRCC6;TP53;HSF1;ATR
prerank,organelle fission (GO:0048285),0.2695771026401797,0.6366058286958457,0.9139650872817955,0.9777535403227502,1.0,10/24,31.05%,PEX11A;DNM2;MTFR1;SEC16B;MUL1;ACOT8;FIS1;PRKN;MIEF1;MTFR1L
prerank,nuclear membrane disassembly (GO:0051081),0.2953761705303667,0.635698736716171,0.895364238410596,0.9780925052911738,1.0,3/14,20.24%,PRKCA;CNEP1R1;DCTN1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3048093840798503,0.6354415218711542,0.8950354609929078,0.9779369646122587,1.0,6/11,33.14%,SMARCA4;NOP53;PWP1;DDX11;NCL;SIRT7
prerank,zymogen activation (GO:0031638),0.24945873583344028,0.6340632721694233,0.9302600472813238,0.9786471568827764,1.0,8/39,27.14%,PRSS12;MMP14;TBC1D10A;PGK1;PERP;CYFIP2;BAD;RIPK2
prerank,myelin maintenance (GO:0043217),0.3097236080290424,0.6337758648667413,0.8757225433526011,0.978531559880041,1.0,4/10,22.00%,SOD1;CXCR4;CLU;ABCD1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.2670580204137794,0.6326787951436829,0.9174876847290641,0.9790197471910657,1.0,3/23,9.77%,KLRK1;RAET1E;CRTAM
prerank,positive regulation of viral genome replication (GO:0045070),0.25485268572488434,0.6324620491900329,0.9252450980392157,0.9788505342717008,1.0,4/29,14.25%,PABPC1;TMEM39A;PKN2;SRPK1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.26141473909763613,0.6314974881870868,0.9054916985951469,0.9792141352881498,1.0,6/26,18.74%,EYA2;FGFR1;TERT;INHBA;AKT1;GDNF
prerank,nucleoside catabolic process (GO:0009164),0.30088974053053946,0.63109285334862,0.8858773181169758,0.9791840091142892,1.0,3/11,20.79%,UPP2;DERA;NT5C
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.22974084535669967,-0.6300578392421508,0.9358490566037736,0.988135622215618,1.0,6/16,20.41%,GMPS;IMPDH1;ADSS1;LHPP;PPAT;AMPD2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.25374809716623514,0.6293434475104073,0.9395734597156398,0.9801778967575985,1.0,15/32,34.35%,PRKCD;CYFIP1;NOLC1;FOXO3;EIF2A;ATXN2;ROCK1;RBM3;EIF4E;PUM3;METAP1;TMED10;PCIF1;TCOF1;SAMD8
prerank,ceramide metabolic process (GO:0006672),0.23922321327302334,0.6284398436072037,0.9610244988864143,0.9805166861228484,1.0,4/49,6.19%,ACER3;PLPP3;SMPD4;PLPP1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.28137202104603065,0.6280661667145248,0.9082321187584346,0.9804434277952812,1.0,4/17,16.57%,MIS12;ZW10;HASPIN;IK
prerank,negative regulation of interleukin-2 production (GO:0032703),0.2780710650591923,0.6278595827398281,0.9108781127129751,0.9802466509759287,1.0,3/18,12.28%,TBX21;TRIM27;EZR
prerank,presynapse organization (GO:0099172),0.31179486028355474,0.6274005740562286,0.890625,0.9802495276175098,1.0,2/10,13.02%,DVL1;NLGN1
prerank,histone monoubiquitination (GO:0010390),-0.20648756258602613,-0.6273208533417487,0.9454545454545454,0.9884673595621103,1.0,6/24,16.69%,BCOR;SKP1;RNF40;UBE2E1;LEO1;CTR9
prerank,regulation of microtubule nucleation (GO:0010968),0.30952740051104377,0.6262864167485043,0.9136490250696379,0.9807220555250472,1.0,3/10,20.24%,CKAP5;GIT1;DCTN1
prerank,positive regulation of defense response (GO:0031349),0.22258850890061155,0.6256166796275401,0.9705573080967402,0.9808627679642602,1.0,4/89,5.42%,PDCD4;IL33;ABCC1;LRSAM1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.269037870641067,0.6255942634523244,0.92,0.9805385625207369,1.0,8/21,24.67%,PPP1R8;TIPRL;YWHAE;ARPP19;CRY2;BOD1L1;FKBP1B;YWHAB
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.21523128311882037,0.624097771567662,0.9908350305498982,0.9812956661057244,1.0,44/158,28.02%,CARD16;MAVS;BRD4;TRIM27;S100B;RHOA;SHARPIN;ROR1;LTBR;CHUK;ALPK1;IRAK1;TAB2;TNFRSF10B;MID2;F2R;CASP1;AKAP13;ZDHHC13;MAP3K3;TRAF3IP2;TRIM13;HMOX1;TRIM6;IKBKE;CC2D1A;NUP62;MUL1;MIER1;TRIM8;BIRC3;MAP3K14;TBK1;PINK1;TRADD;TFG;RIPK1;TMEM106A;NDFIP1;RIPK2;NEK6;CANT1;UBE2V1;GPR89A
prerank,bile acid biosynthetic process (GO:0006699),-0.19886214369821142,-0.6240345393264587,0.9818181818181818,0.9890616672520026,1.0,2/24,5.31%,CYP7B1;CYP27A1
prerank,thyroid hormone generation (GO:0006590),0.30637599379926955,0.6227530353619993,0.910581222056632,0.9819136901545515,1.0,1/10,5.71%,CPQ
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.2385992395479957,-0.622355817554748,0.9259259259259259,0.9886976788614109,1.0,4/12,24.06%,LAMA5;VANGL2;ACTB;ZDHHC7
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.2505262165961577,0.6212955294370685,0.9272300469483568,0.9826095385162793,1.0,3/30,7.26%,TWIST1;CCAR2;YJU2
prerank,mitotic spindle assembly (GO:0090307),0.2392787188183977,0.6212678183959437,0.9357060849598163,0.9822855225990613,1.0,15/42,32.66%,MISP;SMC3;RHOA;CHEK2;STAG1;CCDC61;ARHGEF10;WRAP73;SMC1A;SPICE1;GOLGA2;TOGARAM1;KIF2A;BCCIP;PIBF1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.28548651851278023,0.6200895319339412,0.9324324324324325,0.9827620735035241,1.0,1/15,2.13%,MUC1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.28845143161466974,0.6199874062043212,0.9055330634278003,0.9824946113695633,1.0,2/14,14.20%,TERT;TNKS2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.24612272126311027,0.61980453292142,0.9300699300699301,0.9822785103922408,1.0,5/36,15.82%,EPHB2;ARC;NRP1;HDAC1;HDAC6
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.2921013459964543,0.619742865935849,0.8962655601659751,0.9819796017393071,1.0,5/12,23.13%,IAPP;VBP1;CLU;LDLR;PFDN4
prerank,phasic smooth muscle contraction (GO:0014821),0.30913741273340656,0.6190157978979313,0.8989751098096632,0.982167418060015,1.0,3/10,21.33%,EDN3;GDNF;DRD2
prerank,aerobic respiration (GO:0009060),-0.20884566607199678,-0.6184328595606016,0.9469026548672567,0.9897675992860003,1.0,6/20,17.25%,ME3;UQCRC2;SLC25A14;UQCRB;UQCRC1;MTFR2
prerank,T cell receptor signaling pathway (GO:0050852),0.21423549883646034,0.6182665543495209,0.9794661190965093,0.9823361059282916,1.0,39/138,27.30%,PSMD7;CD3E;PSMA8;PRAM1;BTNL9;PAK2;PSMA4;CHUK;TAB2;PDPK1;PSMD12;PIK3CB;CUL1;KHDRBS1;PSMA6;VTCN1;WNK1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;RC3H2;DENND1B;TRAT1;PSMA3;PSMB1;PSMD4;PSMA5;STOML2;PSMA7;NFKBID;CSK;PSMC1;NCK1;MOG;WAS;RIPK2;PSMA1
prerank,protein targeting to mitochondrion (GO:0006626),0.23094607825291555,0.6165836203935763,0.9527027027027027,0.9831655767669317,1.0,8/52,16.96%,TOMM40;TIMM9;BCAP31;AIFM1;HSPD1;TOMM70;PMPCA;GRPEL1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.23602294508635033,0.6165777077950833,0.9501698754246886,0.9828291508152391,1.0,15/44,29.95%,PABPC1;FTO;PUM1;METTL16;AGO2;CNOT8;UPF1;RBM24;ROCK1;METTL14;RIDA;TNRC6A;YTHDF1;ZFP36L1;KHSRP
prerank,Rac protein signal transduction (GO:0016601),0.27443444973970416,0.6154474917730843,0.909323116219668,0.9832565722196509,1.0,3/18,14.86%,TIAM1;CYFIP1;FARP2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.23188918822737586,0.6151772904911033,0.9556313993174061,0.9831017857709266,1.0,8/50,17.59%,CDC6;CDK5RAP3;CCNT2;CCNG2;CCNE2;CAMK2N1;CDC25A;CDKN1C
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.22733070903795405,-0.6146697492586931,0.9691780821917808,0.9905358520868205,1.0,5/14,19.49%,BCL2L1;OPA1;HSPA1A;XBP1;CREB3
prerank,phosphate ion transmembrane transport (GO:0035435),0.2961362665994629,0.6144177214772797,0.9278779472954231,0.9832670986496487,1.0,5/12,30.86%,SLC25A3;SLC37A4;SLC37A3;SLC25A11;SLC20A2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.2052137729591569,-0.6140067719145748,0.9682539682539683,0.9894923788946676,1.0,12/23,36.53%,HPGD;GSTM1;ALOX12;ELOVL6;ASAH2;ALOX5;CYP2E1;GSTM4;CYP1A1;ACOT7;LTC4S;GSTP1
prerank,response to interferon-gamma (GO:0034341),0.22778966296346537,0.6130531347136958,0.9658213891951488,0.983830769466726,1.0,13/67,22.65%,SLC26A6;CCL13;CCL15;CXCL16;GBP6;CASP1;CYP27B1;EPRS1;DAPK3;ACOD1;SYNCRIP;SHFL;SLC11A1
prerank,positive regulation of lipid storage (GO:0010884),0.26678755491922873,0.6123088609394005,0.9204545454545454,0.9839846886307064,1.0,4/21,19.25%,EHD1;CIDEA;PLIN3;IKBKE
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2377727501364381,0.6110614914949041,0.9490950226244343,0.9844953623832701,1.0,8/45,18.83%,PTPN3;GAS1;TOM1L1;BMP4;ZW10;CDKN1C;WEE2;HECA
prerank,negative regulation of translational initiation (GO:0045947),0.286905015650689,0.6108242848930764,0.9148351648351648,0.9843197544909542,1.0,5/13,28.61%,AGO2;RBM4;EIF2AK4;TPR;LARP1
prerank,cellular amino acid catabolic process (GO:0009063),0.22055150628997508,0.6105149887553041,0.9787460148777896,0.9841955572721799,1.0,24/87,27.98%,HYKK;MTRR;DDAH1;IDO2;HMGCL;AUH;HNMT;ACAT1;CARNMT1;GCSH;GSTZ1;SHMT2;BCKDK;SHMT1;DAO;PHYKPL;KYAT1;BCAT1;GCDH;CRYM;BCKDHB;HIBCH;HOGA1;HGD
prerank,regulation of mitotic nuclear division (GO:0007088),0.22929267692951152,0.6105128709417369,0.9624309392265193,0.9838560374854278,1.0,16/55,26.37%,LRP5;TOM1L1;EDN3;BMP4;RCC1;LCMT1;PHIP;DAPK3;KIF20B;NUP62;CUL9;CDK5RAP2;CDK13;CCDC8;CUL7;IGF2
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.23662451678980556,-0.6102993011507553,0.9326599326599326,0.9902284926720835,1.0,2/11,12.24%,AHR;CEACAM1
prerank,B cell activation (GO:0042113),0.22410014783200688,0.6096139396506411,0.9656652360515021,0.9841115009803004,1.0,12/68,21.23%,EPHB2;HDAC9;HDAC4;CHRNB2;PTPN2;HSPD1;CLCF1;TCF3;TPD52;GPS2;IL4;BANK1
prerank,apoptotic nuclear changes (GO:0030262),0.25188294838158404,0.6087884218400762,0.9233668341708543,0.9843004218428795,1.0,5/24,18.12%,ERN2;HMGB1;CDK5RAP3;ACIN1;DFFB
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.27200422129349555,0.6086530684237789,0.9208731241473397,0.9840440607278627,1.0,6/15,34.03%,ANXA1;NR3C1;HNRNPU;ZFP36L1;SSTR2;FAM107A
prerank,transcription preinitiation complex assembly (GO:0070897),0.29203116611388025,0.6082413752730652,0.9049645390070922,0.9839713738407861,1.0,5/12,30.91%,BDP1;TBP;TAF1;GTF2A2;TAF1B
prerank,regulation of phagocytosis (GO:0050764),0.22997593277597178,0.6076383840243824,0.9626696832579186,0.9840179347080168,1.0,6/53,14.04%,GAS6;FCER1G;ITGAV;PLA2G5;PIP4P2;LMAN2
prerank,carbohydrate derivative catabolic process (GO:1901136),0.2707892250257956,0.6073897155792211,0.9203187250996016,0.9838440069484262,1.0,7/18,28.41%,DERA;NGLY1;FBXO17;OGA;ADAMTS9;MANBA;STT3B
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.2797699943920694,0.6073295558008763,0.9213483146067416,0.9835414724096486,1.0,7/13,38.99%,LSM2;SRSF10;USP4;DDX20;SART3;CD2BP2;PRPF31
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.2800038697314246,0.6073267214954094,0.9202702702702703,0.9832024292714301,1.0,5/15,23.76%,NLGN1;CLN3;USP46;DRD2;SYN3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.26180820518565356,0.606451786979942,0.9288389513108615,0.9834176212207086,1.0,3/23,11.17%,HDAC4;ACTN3;GIT1
prerank,detection of visible light (GO:0009584),-0.2166585711787391,-0.6059448477451338,0.9444444444444444,0.9912931048745646,1.0,2/16,12.15%,ABCA4;RP1
prerank,steroid biosynthetic process (GO:0006694),0.22755153900154537,0.6059112408771508,0.9691629955947136,0.9834145698671181,1.0,16/56,30.61%,CYP19A1;OSBPL7;FDXR;OSBP;LSS;PRLR;EBP;SC5D;SLC27A2;HSD3B7;ACOT8;HMGCR;SCP2;SQLE;INSIG1;OSBPL1A
prerank,positive regulation of histone modification (GO:0031058),0.2431814423350212,0.6048743368755579,0.9392133492252682,0.9837172966960376,1.0,8/33,24.33%,TADA2A;RPS6KA4;CHTOP;ARRB1;NIPBL;AKAP8;PAF1;SAP30BP
prerank,tryptophan metabolic process (GO:0006568),0.2919949279760313,0.6039760487423623,0.9171511627906976,0.9839684128662435,1.0,2/11,20.64%,IDO2;KYAT1
prerank,entry into host (GO:0044409),0.27908685724941124,0.6030689448894061,0.9278779472954231,0.9841768783281836,1.0,6/13,30.24%,CBL;ITGAV;CXCR4;MET;GRB2;CTNNB1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.2598475386731343,0.6027128770909421,0.9305373525557011,0.9840633027045117,1.0,2/20,7.53%,DRD1;ADCY9
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.253058449824497,0.6011595904391653,0.9305912596401028,0.9846971035503927,1.0,2/22,5.71%,AHNAK;DMD
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.2105579715811401,-0.6008253052703433,0.97265625,0.9925925698565159,1.0,2/16,7.50%,PDK1;ADIPOR1
prerank,stem cell development (GO:0048864),0.26923447964032976,0.6007846199259856,0.943089430894309,0.9845926667044403,1.0,8/16,34.92%,NOLC1;KLHL12;SOX8;TAPT1;PTPRC;SNAI2;TCOF1;PEF1
prerank,regulation of AMPA receptor activity (GO:2000311),0.2534399421766582,0.5996004242924825,0.9369592088998764,0.9849860437730424,1.0,5/25,17.67%,ARC;CNIH2;SHANK1;NLGN1;SHISA8
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.17648243405934394,-0.599461007215551,1.0,0.9919090698897506,1.0,37/38,72.68%,NDUFC2;NDUFA13;NDUFB2;NDUFAF1;NDUFB7;NDUFS1;NDUFA8;NDUFB11;NDUFS6;NDUFA4;NDUFA2;NDUFA12;NDUFC1;NDUFB4;NDUFV1;NDUFS5;NDUFB8;NDUFA11;NDUFS4;NDUFA5;NDUFA3;NDUFS2;NDUFS8;NDUFB5;NDUFB3;NDUFS3;NDUFB10;NDUFA10;NDUFAB1;NDUFA9;NDUFV3;NDUFA6;NDUFV2;NDUFB9;NDUFA7;NDUFA1;NDUFB6
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.18518295894993925,-0.5986595239547424,0.9585492227979274,0.9909313697802913,1.0,6/26,15.93%,CDK6;TMEM178A;MAFB;CEACAM1;HOXA7;C1QC
prerank,positive regulation of interleukin-13 production (GO:0032736),0.2901009137595826,0.5962849406521153,0.9186206896551724,0.9866824098798603,1.0,3/10,28.37%,RARA;IL4;SPHK2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.25119593064937173,0.5961665548947395,0.9436964504283966,0.9864109146048474,1.0,5/27,17.16%,DRD1;GPR20;F2R;GPR157;CALCA
prerank,negative regulation of histone methylation (GO:0031061),0.2893498371620973,0.5953641141412475,0.9207920792079208,0.9865568681370159,1.0,2/10,12.23%,PHF1;WDR5
prerank,covalent chromatin modification (GO:0016569),0.2738781658809563,0.5953312658288156,0.9278499278499278,0.9862377756214987,1.0,3/14,17.35%,SETD5;HDAC1;UFL1
prerank,positive regulation of isotype switching (GO:0045830),0.27343260021332044,0.5947994891021932,0.9347536617842876,0.9862184007302923,1.0,7/15,29.09%,KMT5C;CLCF1;MAD2L2;IL4;SHLD3;SHLD1;HMCES
prerank,alpha-amino acid metabolic process (GO:1901605),0.22724597879523278,0.5915207566102029,0.9601820250284414,0.9877984332508452,1.0,13/45,25.29%,NOX4;MTRR;DDAH1;SRR;MTHFD1;GNMT;MTHFR;RIMKLB;KYAT1;PYCR1;DPEP1;RIMKLA;SLC25A12
prerank,microtubule-based transport (GO:0099111),0.2808903625428578,0.5914022782527891,0.9231843575418994,0.9875290684494498,1.0,4/13,21.82%,ROPN1L;DNAAF4;DYNC1I2;SPAG17
prerank,purine nucleotide catabolic process (GO:0006195),0.2748563113195251,0.5911169342755208,0.9161028416779432,0.98735268178376,1.0,1/13,4.54%,XDH
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.2853629731853775,0.5892726829228077,0.9181692094313454,0.9880849331473444,1.0,2/11,14.29%,SCARA3;COLEC12
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.22418395327971896,-0.5876560071285307,0.9493243243243243,0.9948900883666865,1.0,6/12,28.37%,WDR18;METTL4;WRNIP1;GMNN;TIPIN;TICRR
prerank,response to muramyl dipeptide (GO:0032495),-0.22764035206996036,-0.586658612854533,0.9452554744525548,0.9939697232508474,1.0,4/12,16.35%,ARHGEF2;VIM;NOD2;PTPN22
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2403028144021576,0.5860938479017722,0.9397590361445783,0.9895493152696122,1.0,9/30,28.41%,UGGT2;FUT8;UGGT1;STT3A;DPM3;LMAN1;MAGT1;MGAT5;STT3B
prerank,erythrocyte development (GO:0048821),-0.2329420626451572,-0.5853234419954912,0.95,0.9931850569473527,1.0,10/10,76.73%,SH2B3;NCKAP1L;ALAS2;ALAS1;GATA1;DMTN;LYAR;MED1;ZBTB7A;ABCB10
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.2735197841180135,0.5823864680479397,0.9351351351351351,0.9911875247100004,1.0,6/13,35.20%,HSPA5;UFL1;NCK1;ATF6B;WFS1;DNAJB9
prerank,plasma membrane repair (GO:0001778),0.2734144151276416,0.5821189705705337,0.9272727272727272,0.9910002465789693,1.0,1/13,2.82%,AHNAK2
prerank,negative regulation of hormone secretion (GO:0046888),0.28392705678955577,0.5818719744823976,0.9266187050359712,0.9907950466294659,1.0,3/10,31.74%,RAB11FIP5;LIF;RAB11FIP3
prerank,glutamine family amino acid metabolic process (GO:0009064),0.23591667414111847,0.5813855064507975,0.9556592765460911,0.9907251462922482,1.0,14/33,34.22%,GCLC;DDAH1;CAD;RIMKLB;GCLM;KYAT1;PYCR1;RIMKLA;FPGS;NIT2;DGLUCY;ART4;ALDH18A1;GLUD1
prerank,primary miRNA processing (GO:0031053),0.2867857216085981,0.5808522747001594,0.9291907514450867,0.990675373543666,1.0,2/10,11.69%,HNRNPA2B1;DGCR8
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.24929552821327783,0.580684421257524,0.9513444302176697,0.9904255865385024,1.0,7/21,24.52%,SIRT5;COA8;SIRT2;HDAC6;AATF;ABCD1;PINK1
prerank,protein import into mitochondrial matrix (GO:0030150),0.2561823176682025,0.5800232433498147,0.9369127516778524,0.9904446508595268,1.0,6/18,32.51%,TOMM40;TOMM70;GRPEL1;TIMM17B;GRPEL2;TIMM21
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.24303201753034853,0.5797504556783536,0.9343863912515188,0.9902508711653255,1.0,2/25,4.16%,CSNK2A2;CSNK2A1
prerank,plasma membrane tubulation (GO:0097320),0.2666994206180864,0.5794923765845453,0.9388297872340425,0.9900487271898755,1.0,3/13,20.58%,EHD2;SNX9;CHMP4A
prerank,cellular response to inorganic substance (GO:0071241),0.2497551430007703,0.5784283600683227,0.9457070707070707,0.9902612203406457,1.0,9/21,31.69%,DDI2;SPIDR;AOC1;CDK2;DPEP1;DDX11;TIMELESS;MTR;BLM
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.262803279215232,0.5780411388368037,0.9476510067114094,0.9901203456111969,1.0,5/17,27.41%,KCNE5;SUMO1;RNF207;VAMP2;KCNRG
prerank,regulation of steroid metabolic process (GO:0019218),0.24260538734153048,0.5778757875078114,0.9595448798988622,0.9898719388264734,1.0,5/23,19.42%,LAMTOR1;DGKQ;RORA;STUB1;ASAH1
prerank,endochondral bone morphogenesis (GO:0060350),0.2835874703905058,0.5758689767794181,0.947136563876652,0.9905706426980854,1.0,3/11,20.61%,BMP4;TMEM119;FGFR3
prerank,sphingolipid metabolic process (GO:0006665),0.20207524556477788,0.5758335469598106,0.9938080495356038,0.9902537152822477,1.0,8/108,6.71%,ACER3;PLPP3;PDXDC1;KDSR;SMPD4;ELOVL5;PLPP1;ARSA
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.23544984345925396,0.5752059457922591,0.945321992709599,0.9902198750779109,1.0,3/29,9.77%,KLRK1;RAET1E;CRTAM
prerank,peptidyl-asparagine modification (GO:0018196),0.23418378455500988,0.5745824844294523,0.9580335731414868,0.9901952125218647,1.0,9/31,28.41%,UGGT2;FUT8;UGGT1;STT3A;DPM3;LMAN1;MAGT1;MGAT5;STT3B
prerank,branched-chain amino acid catabolic process (GO:0009083),0.2503990343550039,0.5745443901124186,0.9461942257217848,0.9895377429905027,1.0,6/20,27.11%,AUH;ACAT1;BCKDK;BCAT1;BCKDHB;HIBCH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.2503990343550039,0.5745443901124186,0.9461942257217848,0.9895377429905027,1.0,6/20,27.11%,AUH;ACAT1;BCKDK;BCAT1;BCKDHB;HIBCH
prerank,phosphate ion transport (GO:0006817),0.25748894494489005,0.5721509430459868,0.9373368146214099,0.9903882305549284,1.0,5/16,30.86%,SLC25A3;SLC37A4;SLC37A3;SLC25A11;SLC20A2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.2640509435467614,0.5713746699846677,0.9347222222222222,0.990443114437483,1.0,8/13,38.89%,IL6;MGAT5;HES1;PTPRC;IL7R;JAK3;CRLF2;JAK2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.2658404175758025,0.5709077946222537,0.9445214979195562,0.9903249970502692,1.0,1/13,4.20%,STAT3
prerank,glycosphingolipid metabolic process (GO:0006687),0.2225474369204185,0.5696021776480495,0.966396292004635,0.9906194282705467,1.0,8/42,19.42%,ST6GALNAC5;SMPD4;ARSA;GALC;HEXA;GLB1;SUMF2;ASAH1
prerank,regulation of response to interferon-gamma (GO:0060330),0.25852810504864615,0.5691121743354186,0.9588477366255144,0.9905097875388647,1.0,5/14,26.04%,PTPN2;SUMO1;JAK1;SOCS1;IFNGR2
prerank,inorganic ion transmembrane transport (GO:0098660),0.26870528851094877,0.5681854989613335,0.9452247191011236,0.9905976927669026,1.0,2/12,15.52%,TRPM4;PKD2L1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.18071923020561956,-0.5681495301650994,0.9911111111111112,0.9976190160458646,1.0,4/24,11.12%,HK2;PGAM1;GPI;ALDOC
prerank,canonical glycolysis (GO:0061621),-0.18071923020561956,-0.5681495301650994,0.9911111111111112,0.9976190160458646,1.0,4/24,11.12%,HK2;PGAM1;GPI;ALDOC
prerank,positive regulation of cell aging (GO:0090343),0.27046668289075954,0.5675643294772434,0.9321789321789322,0.990558104310037,1.0,4/11,26.35%,LMNA;HMGA1;ARG2;CGAS
prerank,regulation of protein localization to centrosome (GO:1904779),-0.2304087560375469,-0.5669145163799041,0.9545454545454546,0.9966600645906163,1.0,3/10,16.20%,APC;CEP72;NSFL1C
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.22165481080376062,0.5661982832748437,0.9785202863961814,0.9908547593939508,1.0,9/35,24.18%,CALM2;PPP6R1;TIPRL;PPP6R3;CALM3;PPP6R2;CRY2;BOD1L1;FKBP1B
prerank,insulin secretion (GO:0030073),0.2507328823167345,0.5660437482225473,0.9574468085106383,0.9905884524897396,1.0,3/19,13.45%,ANXA1;RAB11FIP5;RAB11B
prerank,cellular response to gamma radiation (GO:0071480),0.2496518735602248,0.5653505293863392,0.9496688741721855,0.9905671420395642,1.0,8/17,31.81%,WRN;ATM;TLK2;XRCC6;TP53;HSF1;ATR;YAP1
prerank,linoleic acid metabolic process (GO:0043651),0.25471213473906545,0.5647115733338238,0.9375796178343949,0.9905309933257683,1.0,5/17,27.16%,ELOVL5;FADS1;ABCD1;ALOXE3;ELOVL1
prerank,negative regulation of T cell activation (GO:0050868),0.22475088320407957,0.5639137058808604,0.9740871613663133,0.9905694450473002,1.0,4/35,13.12%,SPN;GLMN;VTCN1;CD80
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.2590675581220839,0.5636754758160767,0.9451697127937336,0.9903376669033,1.0,3/15,20.81%,ABL1;SMAD7;MAD2L2
prerank,intracellular sterol transport (GO:0032366),0.26477752719586756,0.5633472651346952,0.9418918918918919,0.9901478610651812,1.0,3/13,13.71%,NPC1;OSBP;ABCA1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.23457085821593845,0.5629933766353445,0.9504447268106735,0.9899851522575386,1.0,7/25,29.33%,FOXK1;ADPGK;PGK1;ENO2;PFKP;PFKL;GAPDHS
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.2418496722814148,0.5617716636220411,0.9628154050464808,0.990183470145265,1.0,5/20,25.91%,ADA;RPGRIP1L;GPRASP1;YWHAB;MET
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.2543774285272671,0.5606000941872041,0.9595300261096605,0.9903698630124542,1.0,6/16,37.07%,SOX9;APPL2;NCOR1;WDTC1;ACADL;ERLIN1
prerank,establishment of melanosome localization (GO:0032401),0.24305320675133674,0.5598444021800876,0.9472990777338604,0.99037259441146,1.0,7/19,31.15%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.2763552489198795,0.559169106471577,0.9479768786127167,0.9903382926938059,1.0,4/10,31.07%,IRAK3;TLE5;MAP2K5;PTPRC
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.23763356098006594,0.5589746481527725,0.9670468948035488,0.9900963727386619,1.0,3/22,12.92%,UBASH3A;EZR;PTPN2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2593919404294719,0.5577803519064185,0.9451871657754011,0.9902828792674854,1.0,1/14,6.37%,PUM1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2403272923157582,0.5569631277433171,0.9530456852791879,0.9903152313459639,1.0,8/22,33.50%,KAT2A;LAG3;RUNX1;CBFB;SOCS1;BCL6;CD46;FANCA
prerank,positive regulation of chromatin organization (GO:1905269),-0.2151421934835834,-0.5552345853462285,0.9560439560439561,0.9995429095194416,1.0,12/12,78.51%,TAL1;TERF2IP;SIN3A;TERF1;ACD;TINF2;ATRX;TERF2;UBE2N;DAXX;H3-3A;MIER1
prerank,regulation of viral genome replication (GO:0045069),0.20468422283813026,0.5545205965343581,0.9810901001112347,0.9910223001947409,1.0,19/56,33.01%,PABPC1;TMEM39A;MAVS;PKN2;ILF3;SRPK1;N4BP1;TRIM6;SHFL;STAU1;BANF1;PPID;HACD3;DDB1;LARP1;PPIH;TNIP1;IFIH1;PARP10
prerank,cholesterol biosynthetic process (GO:0006695),0.22541726805470516,0.5540171988784333,0.9725864123957092,0.9908950790568145,1.0,12/31,33.68%,NSDHL;LSS;EBP;SC5D;HMGCR;ACAT2;ACLY;SQLE;INSIG1;GGPS1;TM7SF2;PLPP6
prerank,maturation of LSU-rRNA (GO:0000470),0.23037617892502996,0.5531531651435813,0.9598997493734336,0.9909211441429361,1.0,11/26,33.52%,LAS1L;EIF6;BOP1;RPL7A;WDR12;NIFK;RRP15;MAK16;RPF2;RSL1D1;DDX18
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2391895213950309,0.5518490606628553,0.9630606860158312,0.9911416499472736,1.0,10/19,37.42%,AEN;HIPK2;TP53;RPS27L;CDIP1;MSH2;SNW1;DYRK2;PHLDA3;BCL3
prerank,ganglion development (GO:0061548),-0.22042947674945107,-0.550853143508789,0.9630872483221476,0.9996472348784445,1.0,2/11,15.73%,NRP2;UNC5C
prerank,regulation of osteoclast differentiation (GO:0045670),0.21946662927790409,0.5508086855664512,0.978391356542617,0.9912267041897225,1.0,1/33,1.84%,UBASH3B
prerank,determination of bilateral symmetry (GO:0009855),0.22960840693731338,0.5506513118853201,0.9651860744297719,0.9909545956701284,1.0,7/25,28.54%,ODAD2;NPHP3;DNAAF4;CITED2;LEFTY1;BBS7;STIL
prerank,tyrosine metabolic process (GO:0006570),-0.21395304546849975,-0.5477490398717163,0.9795221843003413,0.9992700492894171,1.0,4/11,25.69%,FAH;THAP4;TYR;IL4I1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.27066530822388934,0.5472082504983222,0.9533834586466166,0.9920015688093239,1.0,2/10,18.70%,MIA3;AKT1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.20001791542802222,0.5465399990576225,0.989010989010989,0.9919282740702251,1.0,7/63,15.26%,EPHB2;CD3E;CHRNB2;ANXA1;CD80;CLCF1;IL6
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.22731302279734916,0.5453656793757558,0.9742647058823529,0.9920166365376535,1.0,5/28,20.48%,OSBPL7;CDK5RAP3;AXIN1;PSMC5;CLU
prerank,alpha-amino acid catabolic process (GO:1901606),0.22069719927485593,0.5447411167160439,0.9768292682926829,0.9919192536813806,1.0,6/29,20.64%,MTRR;IDO2;ACAT1;GSTZ1;DAO;KYAT1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.22642224049577456,0.5433897800433621,0.9685534591194969,0.9920836182472098,1.0,9/24,30.50%,MAVS;TOMM70;TRAF3IP2;TRIM6;EIF2AK4;IL4;CGAS;HSP90AA1;LILRB1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.24837174007351198,0.5430989185102946,0.9516129032258065,0.9918496200255054,1.0,7/15,30.39%,CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5;NOP10
prerank,modulation by host of viral genome replication (GO:0044827),-0.1993345052737318,-0.5419113855518519,0.9887218045112782,0.9997260200746857,1.0,13/13,80.09%,ZC3H12A;IFI27;NUCKS1;FMR1;FBXL2;CCL8;CCNK;YTHDC2;PPIB;VAPA;PRKN;TBC1D20;EIF2AK4
prerank,superoxide anion generation (GO:0042554),0.25535486755916054,0.5414870907137161,0.9501385041551247,0.992127071345137,1.0,1/13,5.99%,NOX4
prerank,melanosome localization (GO:0032400),0.2293785701607426,0.5413606158656316,0.9583333333333334,0.9918376522347654,1.0,7/21,31.15%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,positive regulation of B cell activation (GO:0050871),0.20483299759620838,0.5411560762553574,0.9909706546275395,0.9915772042595106,1.0,7/50,15.26%,EPHB2;MMP14;CHRNB2;KMT5C;CD27;CLCF1;IL6
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.19081597502332356,0.5406203612878072,0.9968017057569296,0.9914423676501403,1.0,39/87,38.77%,ECSIT;COA8;AIFM1;ACAD9;NDUFS7;SURF1;BCS1L;TTC19;FASTKD3;COX18;NDUFAF4;UQCC3;SDHAF1;NDUFB6;DMAC2;NDUFA1;SDHAF2;COA5;SDHAF4;NDUFA7;NDUFB9;NDUFV2;COX16;NDUFA6;TIMM21;NDUFAF5;NDUFV3;SDHAF3;NDUFA9;UQCC1;NDUFAB1;UQCRFS1;NUBPL;COX14;NDUFA10;COX20;NDUFB10;NDUFS3;NDUFB3
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.22859010406264232,0.5376265356756637,0.9550706033376123,0.9921900609489506,1.0,5/23,24.89%,TIMM9;TOMM70;COX18;BAD;TIMM22
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2040431943746861,-0.5362202305179707,0.9727626459143969,0.9999414921442311,1.0,13/13,79.62%,ADHFE1;D2HGDH;GOT1;AADAT;GPT2;GOT2;OGDH;TAT;DLST;IDH1;IDH2;L2HGDH;PHYH
prerank,glycerol metabolic process (GO:0006071),-0.220860340456032,-0.5319798718466083,0.9768211920529801,0.9998029563430235,1.0,5/10,29.43%,GK;GK5;TPI1;GOT1;COQ3
prerank,negative regulation of DNA binding (GO:0043392),0.22165558150214906,0.5308902167220738,0.9586374695863747,0.994128929662506,1.0,7/28,20.81%,HEY1;SMO;SUMO1;MDFI;E2F1;NFKBIA;MAD2L2
prerank,positive regulation of T cell activation (GO:0050870),0.1950975963298829,0.5293512085881837,0.9912472647702407,0.9942957856409274,1.0,6/62,15.26%,ZMIZ1;CD3E;ANXA1;HSPD1;CD80;IL6
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.21578249011850353,0.5292974701078481,0.9693627450980392,0.9939758230759892,1.0,4/27,16.49%,ETNK1;ETNPPL;CHKB;PLA2G15
prerank,negative regulation of cell division (GO:0051782),0.2586964276893772,0.529086224541451,0.9666203059805285,0.9937185212040047,1.0,4/11,31.69%,ZFYVE19;E2F8;CHMP4C;BLM
prerank,negative regulation of phagocytosis (GO:0050765),0.23550610627799318,0.5290537140596454,0.9651612903225807,0.9933969642927926,1.0,4/17,24.38%,HMGB1;PIP4P2;APPL1;SNX3
prerank,mitochondrial genome maintenance (GO:0000002),0.2554373942092556,0.528462166373768,0.962589928057554,0.9932461493536061,1.0,3/11,16.22%,LONP1;MEF2A;PARP1
prerank,inner mitochondrial membrane organization (GO:0007007),0.19942737749039344,0.5284361893467718,0.9942857142857143,0.9929226314496744,1.0,17/47,36.54%,SPG7;TIMM9;MICOS10;LETM1;ATP5MC3;TOMM70;UQCC3;AFG3L2;TIMM22;ATP5MC2;DNAJC11;MTX3;ATP5PD;ATP5MF;TIMM8B;ATP5F1E;ATP5F1C
prerank,sensory perception of taste (GO:0050909),0.26330129838490135,0.5283181471389966,0.9601139601139601,0.9926253425022588,1.0,1/10,15.52%,PKD2L1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.256522205393328,0.5280267467186801,0.9655172413793104,0.9923875936405641,1.0,3/11,21.93%,SREBF1;CNEP1R1;LDLR
prerank,positive regulation of JUN kinase activity (GO:0043507),0.2256370316997176,0.526440859427044,0.9770992366412213,0.992532257196751,1.0,6/23,27.37%,MAP3K5;MAP3K10;DUSP19;TAOK3;DVL2;MAP3K11
prerank,sensory perception of smell (GO:0007608),-0.21337099811676083,-0.5232568306644088,0.9764309764309764,1.0,1.0,11/11,78.68%,SYT10;SLC24A4;ADCY3;BEST2;OMP;BBS4;OBP2B;GFY;MKKS;UBR3;DRD2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.2589014404170803,0.5225587219564873,0.9716312056737588,0.9933891021808485,1.0,3/12,22.13%,HNMT;SRM;SLC22A3
prerank,peptide biosynthetic process (GO:0043043),0.17970325348696217,0.5187249427445304,0.9989785495403473,0.9941927529148722,1.0,12/153,12.89%,PCSK5;RRBP1;RPSA;DMD;ABCF1;HARS2;GSPT1;MRPS18B;MRPS14;AGO2;EIF4G1;MRPL35
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.23924693647429027,0.518676162295964,0.9797297297297297,0.9938715655268356,1.0,5/14,31.07%,TNFRSF1B;IL4;LDLR;NR1D1;PTPRC
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.20651559851861148,-0.517867477129048,0.966996699669967,1.0,1.0,10/10,79.37%,THAP4;IL4I1;QDPR;KYNU;PCBD1;IYD;PAH;ATP7A;ASRGL1;KYAT1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.19066944321859616,0.5177734115110436,0.9955406911928651,0.9934760378352222,1.0,25/56,40.57%,ECSIT;ACAD9;NDUFS7;BCS1L;NDUFAF4;NDUFB6;DMAC2;NDUFA1;NDUFA7;NDUFB9;NDUFV2;NDUFA6;TIMM21;NDUFAF5;NDUFV3;NDUFA9;NDUFAB1;NUBPL;NDUFA10;NDUFB10;NDUFS3;NDUFB3;NDUFB5;TMEM126A;NDUFS8
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.19066944321859616,0.5177734115110436,0.9955406911928651,0.9934760378352222,1.0,25/56,40.57%,ECSIT;ACAD9;NDUFS7;BCS1L;NDUFAF4;NDUFB6;DMAC2;NDUFA1;NDUFA7;NDUFB9;NDUFV2;NDUFA6;TIMM21;NDUFAF5;NDUFV3;NDUFA9;NDUFAB1;NUBPL;NDUFA10;NDUFB10;NDUFS3;NDUFB3;NDUFB5;TMEM126A;NDUFS8
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.24533779416415186,0.5176542730791356,0.9691275167785235,0.9931757006833959,1.0,4/13,28.29%,HEY1;MAD2L2;TAF1;PER2
prerank,positive regulation of behavior (GO:0048520),0.25560676499659546,0.5174035510102276,0.9699570815450643,0.9929121375329468,1.0,2/10,13.02%,AGRP;NLGN1
prerank,negative regulation by host of viral transcription (GO:0043922),0.24439701173959438,0.5172056672165115,0.9775596072931276,0.9926341261808851,1.0,12/12,75.58%,HDAC1;TARDBP;TFAP4;INPP5K;REST;PSMC3;CCL3;CCL4;JUN;CCL5;POU2F3;HMGA2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.22389491875948903,0.5164160690279437,0.9664179104477612,0.9925443604577661,1.0,8/21,32.07%,UBE2C;CDC20;MAD2L2;RAB1A;GOLGA2;BTRC;UBE2S;GORASP1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.20720365372563493,0.515600546156797,0.9868421052631579,0.9924526617968812,1.0,5/33,18.31%,UBASH3A;EZR;PTPN2;KCNN4;TRAT1
prerank,T cell homeostasis (GO:0043029),0.25980488249037736,0.5134571053696538,0.9629629629629629,0.9927169705535567,1.0,5/10,33.57%,RIPK3;AKT1;PPP2R3C;JAK3;ZC3H8
prerank,microtubule anchoring (GO:0034453),0.24325153105294567,0.5110503803814042,0.9694868238557559,0.993017283078072,1.0,5/12,31.51%,PCM1;CAMSAP3;PEX14;GCC2;BCCIP
prerank,cristae formation (GO:0042407),0.21139851514408017,0.5098451140484156,0.9809160305343512,0.9930048228556915,1.0,11/27,36.54%,SPG7;LETM1;ATP5MC3;UQCC3;AFG3L2;ATP5MC2;DNAJC11;ATP5PD;ATP5MF;ATP5F1E;ATP5F1C
prerank,regulation of activated T cell proliferation (GO:0046006),0.2065809245869864,0.5063336983312839,0.9892344497607656,0.9935871217562698,1.0,3/30,10.46%,HMGB1;CRTAM;RIPK3
prerank,negative regulation by host of viral process (GO:0044793),-0.19929696817525577,-0.4954963222300629,0.990506329113924,1.0,1.0,10/10,80.09%,ZC3H12A;CRP;CCL8;PTX3;CCNK;LTF;PSMC3;VAPA;PRKN;EIF2AK4
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.23676342007211698,0.49266665659579173,0.9689703808180536,0.9963817756599715,1.0,2/11,18.51%,ARRB1;SAG
prerank,aspartate family amino acid catabolic process (GO:0009068),0.2161296573978932,0.4880543275002638,0.984375,0.9970139410327464,1.0,4/19,24.48%,HYKK;PHYKPL;GCDH;CRYM
prerank,secondary alcohol biosynthetic process (GO:1902653),0.19824788481160946,0.484454647534243,0.9892344497607656,0.9973563942974581,1.0,11/30,33.68%,NSDHL;LSS;EBP;HMGCR;ACAT2;ACLY;SQLE;INSIG1;GGPS1;TM7SF2;PLPP6
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.23324011786914453,0.48425616241846325,0.9825834542815675,0.9970652405264581,1.0,3/11,26.26%,IL4;HDAC2;TMEM106A
prerank,mesenchymal cell development (GO:0014031),0.21110197982048506,0.48326981645636147,0.9824561403508771,0.9969103852852848,1.0,8/18,34.92%,HEYL;NOLC1;KLHL12;SOX8;TAPT1;SNAI2;TCOF1;PEF1
prerank,B cell activation involved in immune response (GO:0002312),0.22593341311620443,0.48209791975256483,0.9808743169398907,0.9967910549112015,1.0,6/13,38.42%,LIG4;MSH2;GPR183;EXOSC3;RNF8;RNF168
prerank,carbohydrate catabolic process (GO:0016052),0.1873228422322458,0.47819744165884703,0.995249406175772,0.9971665508768125,1.0,11/38,30.22%,MAN2C1;DERA;PGK1;ENO2;MAN2B1;ENO4;PFKFB1;MANBA;PFKL;GAPDHS;LDHA
prerank,regulation of microglial cell activation (GO:1903978),-0.17344925293483127,-0.4759909360580513,0.9923954372623575,1.0,1.0,5/15,25.05%,SPHK1;CX3CL1;SYT11;TREM2;GRN
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.2128389734346755,0.4704767035966911,0.985545335085414,0.9981078373927632,1.0,5/16,31.96%,RIPK3;CYRIB;LILRB1;PTPRC;STX7
prerank,DNA catabolic process (GO:0006308),-0.181293157564344,-0.47020294245956207,0.996551724137931,1.0,1.0,11/11,81.89%,XRN2;DNASE1L1;SETMAR;ISG20;DNASE1;DNASE1L3;MUS81;REXO4;DNASE1L2;FBH1;DFFB
prerank,spermatid development (GO:0007286),-0.13646262023684783,-0.4684569265000207,1.0,1.0,1.0,6/32,22.73%,JAM2;NECTIN2;CEP57;TDRD5;ACRBP;SYCP3
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.22900024660549037,0.4641634787381989,0.9804195804195804,0.9987277049894218,1.0,3/11,21.59%,NCBP1;NCBP2;PAF1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.20592782900165285,0.4638416633143658,0.9857142857142858,0.9984393209241256,1.0,7/18,30.39%,CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5;NOP10
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.16249806132888367,-0.46033326322157897,0.9956896551724138,1.0,1.0,3/17,13.52%,ATP5ME;ATP5MC1;ATP5F1B
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.1633494116427942,-0.4601540614753474,1.0,1.0,1.0,3/16,13.52%,ATP5ME;ATP5MC1;ATP5F1B
prerank,positive regulation of interferon-beta production (GO:0032728),0.18447865239292396,0.4571356867096315,0.9940405244338498,0.9990034737716471,1.0,11/33,32.38%,MAVS;TOMM70;IRF3;TBK1;PTPN11;RIPK2;RNF135;HSP90AA1;RIOK3;POLR3F;IFIH1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.15637756704138667,-0.4561432316095473,0.9953271028037384,0.9999568706834494,1.0,18/18,84.39%,HIP1R;BOK;HSPA1A;TMEM14A;BAX;ZNF205;CHCHD10;TMEM102;GSK3B;FZD9;ACAA2;GSK3A;BAK1;MPV17L;SLC25A5;MUL1;BID;SLC35F6
prerank,positive regulation of lymphocyte activation (GO:0051251),0.18711174576001127,0.45277966339514203,0.9951397326852977,0.9992216694032912,1.0,6/28,26.97%,PRKDC;HSPD1;IL6;XRCC6;CYRIB;CCL2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.22428318062460104,0.45177929219333435,0.9847009735744089,0.9990073902024332,1.0,1/10,9.77%,CRTAM
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.18957426063073257,0.4497381396240111,0.9926739926739927,0.9989210272523921,1.0,4/24,16.90%,LIG4;RPS27A;UBC;POLB
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.16575626294970805,-0.44551094763027826,1.0,0.9993656298630098,1.0,14/14,83.45%,NECTIN2;IKBKG;RPS3;CARD11;CD226;TESPA1;LCK;BCL10;RAB29;CD81;RELA;PRKD2;TRAT1;KCNN4
prerank,positive regulation of immune response (GO:0050778),-0.11064662233609271,-0.4408457413774122,1.0,0.9982677375873094,1.0,22/64,33.14%,GBP5;CD74;RSAD2;LGALS9;SIRT1;NOD2;PYCARD;XBP1;ITGAM;POLR3B;POLR3D;HRG;GRN;FADD;NMI;CCL5;TLR8;IL15;CD226;MYB;IL12RB1;POLR3C
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.21276716919590125,0.4396440699633908,0.9956011730205279,0.9996892358612515,1.0,7/12,38.80%,YTHDC1;CDYL;HNRNPU;RBM15;RLIM;SMCHD1;PCGF3
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.20138069016534577,0.43778249330247615,0.9921156373193167,0.999556181578426,1.0,4/15,24.82%,SREBF1;CNEP1R1;LDLR;FITM2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.21658031876849032,0.43714998717599796,0.9903047091412742,0.9992820454208206,1.0,4/10,36.54%,ATP5MC3;ATP5MC2;ATP5PD;ATP5F1C
prerank,regulation of neutrophil migration (GO:1902622),0.2202835730109955,0.43665670375643734,0.9941520467836257,0.9989995181385936,1.0,3/10,30.27%,MPP1;BST1;RAC1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.1962674673888754,0.4360497675738049,0.9906666666666667,0.9987254185994511,1.0,2/16,14.37%,ERCC4;MSH4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.2166844516979476,0.4345380403078246,0.9956458635703919,0.9981958812565559,1.0,10/10,78.35%,WNK1;MAP2K5;KLF4;ADIPOQ;IL1RN;IL10;APOA1;MYADM;MBP;MAPK7
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.2166844516979476,0.4345380403078246,0.9956458635703919,0.9981958812565559,1.0,10/10,78.35%,WNK1;MAP2K5;KLF4;ADIPOQ;IL1RN;IL10;APOA1;MYADM;MBP;MAPK7
prerank,regulation of B cell activation (GO:0050864),0.1848277505782155,0.43388460085775843,0.9975216852540273,0.9979173807464554,1.0,4/25,21.23%,IKZF3;IL6;IL4;BANK1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.19382602152984113,0.428620394079126,0.9947229551451188,0.9980663424323292,1.0,7/18,33.74%,TCTA;IL4;GPR137B;LILRB3;LILRB1;FSTL3;FBN1
prerank,sterol biosynthetic process (GO:0016126),0.16761346332363952,0.41672543374098703,0.9988221436984688,0.9986206231623321,1.0,12/33,33.68%,NSDHL;LSS;EBP;SC5D;HMGCR;ACAT2;ACLY;SQLE;INSIG1;GGPS1;TM7SF2;PLPP6
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.1755676343713719,0.4165690201148767,0.9961489088575096,0.9983021249352533,1.0,2/22,12.92%,FZD5;HSPD1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.19357700088910418,0.4135424486005925,0.9958391123439667,0.9981663519412414,1.0,7/14,39.14%,BOP1;WDR12;NIFK;RPF2;DDX18;RPL7L1;PES1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.16012436047204576,0.393695867102301,0.9975579975579976,0.9988916555299208,1.0,1/29,5.15%,HORMAD1
prerank,negative regulation of synaptic transmission (GO:0050805),0.1560703007803958,0.3717678477650931,1.0,0.9992884992559641,1.0,7/23,31.59%,ARF1;PICK1;DRD2;LRRK2;PRRT1;ATAD1;MTMR2
